
<html lang="en"     class="pb-page"  data-request-id="c037dddb-929c-4ce5-9b66-aa19695f0523"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01152;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-4;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development and Therapeutic Potential of Selenazo Compounds" /></meta><meta name="dc.Creator" content="Ana Carolina  Ruberte" /></meta><meta name="dc.Creator" content="Carmen  Sanmartin" /></meta><meta name="dc.Creator" content="Carlos  Aydillo" /></meta><meta name="dc.Creator" content="Arun K.  Sharma" /></meta><meta name="dc.Creator" content="Daniel  Plano" /></meta><meta name="dc.Description" content="Incorporation of selenium (Se) atom into small molecules can substantially enhance their antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral, antibacterial, ant..." /></meta><meta name="Description" content="Incorporation of selenium (Se) atom into small molecules can substantially enhance their antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral, antibacterial, ant..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 22, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01152" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01152" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01152" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01152" /></link>
        
    
    

<title>Development and Therapeutic Potential of Selenazo Compounds | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01152" /></meta><meta property="og:title" content="Development and Therapeutic Potential of Selenazo Compounds" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0013.jpeg" /></meta><meta property="og:description" content="Incorporation of selenium (Se) atom into small molecules can substantially enhance their antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral, antibacterial, antifungal, antiparasitic, and neuroprotective effects. Specifically, selenazo compounds have received great attention owing to their chemical properties, pharmaceutical applications, and low toxicity. In this Perspective, we compile extensive literature evidence with the description and discussion of the most recent advances in different selenazo and selenadiazo motifs as potential pharmacological candidates. We also provide some perspectives on the challenges and future directions in the advancement of these selenazo compounds, each of which could generate drug candidates for various diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01152"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01152">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01152&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01152&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01152&amp;href=/doi/10.1021/acs.jmedchem.9b01152" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1473-1489</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01060" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b01317" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development and Therapeutic Potential of Selenazo Compounds</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ana Carolina Ruberte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Carolina Ruberte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Tecnología y Química Farmacéuticas, Facultad de Farmacia y Nutrición, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana+Carolina++Ruberte">Ana Carolina Ruberte</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carmen Sanmartin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carmen Sanmartin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Tecnología y Química Farmacéuticas, Facultad de Farmacia y Nutrición, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++Sanmartin">Carmen Sanmartin</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3431-7826" title="Orcid link">http://orcid.org/0000-0003-3431-7826</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carlos Aydillo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carlos Aydillo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Tecnología y Química Farmacéuticas, Facultad de Farmacia y Nutrición, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carlos++Aydillo">Carlos Aydillo</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0542-967X" title="Orcid link">http://orcid.org/0000-0002-0542-967X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Arun K. Sharma</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arun K. Sharma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Penn State Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States</div></div><span class="conrtib-corresp"><strong>*</strong>A.K.S.: phone, 1-717-531-4563; e-mail, <a href="/cdn-cgi/l/email-protection#dbbab0a8eaef9baba8aef5bebfae"><span class="__cf_email__" data-cfemail="badbd1c98b8efacac9cf94dfdecf">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arun+K.++Sharma">Arun K. Sharma</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7679-7779" title="Orcid link">http://orcid.org/0000-0002-7679-7779</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Daniel Plano</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Plano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departamento de Tecnología y Química Farmacéuticas, Facultad de Farmacia y Nutrición, Universidad de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</div><div class="loa-info-affiliations-info">Department of Pharmacology, Penn State Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States</div></div><span class="conrtib-corresp"><strong>*</strong>D.P.: phone, +34 948425600, ext 806358; e-mail, <a href="/cdn-cgi/l/email-protection#8ce8fce0ede2e3ccf9e2edfaa2e9ff"><span class="__cf_email__" data-cfemail="15716579747b7a55607b74633b7066">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Plano">Daniel Plano</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01152&amp;href=/doi/10.1021%2Facs.jmedchem.9b01152" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1473–1489</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 22, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 July 2019</li><li><span class="item_label"><b>Published</b> online</span>22 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 February 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01152" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01152</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1473%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAna%2BCarolina%2BRuberte%252C%2BCarmen%2BSanmartin%252C%2BCarlos%2BAydillo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D4%26contentID%3Dacs.jmedchem.9b01152%26title%3DDevelopment%2Band%2BTherapeutic%2BPotential%2Bof%2BSelenazo%2BCompounds%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1489%26publicationDate%3DFebruary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01152"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2088</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01152" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development and Therapeutic Potential of Selenazo Compounds&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Carolina Ruberte&quot;},{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Sanmartin&quot;},{&quot;first_name&quot;:&quot;Carlos&quot;,&quot;last_name&quot;:&quot;Aydillo&quot;},{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;K. Sharma&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Plano&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;1473-1489&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01152&quot;},&quot;abstract&quot;:&quot;Incorporation of selenium (Se) atom into small molecules can substantially enhance their antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral, antibacterial, antifungal, antiparasitic, and neuroprotective effects. Specifically, selenazo compounds have received great attention owing to their chemical properties, pharmaceutical applications, and low toxicity. In this Perspective, we compile extensive literature evidence with the description and discussion of the most recent advances in different selenazo and selenadiazo motifs as potential pharmacological candidates. We also provide some perspectives on the challenges and future directions in the advancement of these selenazo compounds, each of which could generate drug candidates for various diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01152&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01152" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01152&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01152" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01152&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01152" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01152&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01152&amp;href=/doi/10.1021/acs.jmedchem.9b01152" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01152" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01152" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01152%26sid%3Dliteratum%253Aachs%26pmid%3D31638805%26genre%3Darticle%26aulast%3DRuberte%26date%3D2020%26atitle%3DDevelopment%2Band%2BTherapeutic%2BPotential%2Bof%2BSelenazo%2BCompounds%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D4%26spage%3D1473%26epage%3D1489%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/jmcmar.2020.63.issue-4/20200227/jmcmar.2020.63.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Incorporation of selenium (Se) atom into small molecules can substantially enhance their antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral, antibacterial, antifungal, antiparasitic, and neuroprotective effects. Specifically, selenazo compounds have received great attention owing to their chemical properties, pharmaceutical applications, and low toxicity. In this Perspective, we compile extensive literature evidence with the description and discussion of the most recent advances in different selenazo and selenadiazo motifs as potential pharmacological candidates. We also provide some perspectives on the challenges and future directions in the advancement of these selenazo compounds, each of which could generate drug candidates for various diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The importance of selenium (Se) and its derivatives was recognized soon after the isolation of the element by Berzelius, and this persists to date.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Over time, several experimental models have demonstrated that Se is implicated in many physiological processes mainly through selenoproteins, which include at least 25 eukaryotic proteins.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The most commonly known are gluthathione peroxidases (GPx), iodothyronine deiodinases, thioredoxin reductases (TrxR), and selenoprotein P. The different GPx are involved in the elimination of free radicals, while the iodothyronine deiodinases enable the activation and deactivation of thyroid hormones. TrxR regenerates thioredoxin (Trx), an important antioxidant protein, and selenoprotein P is involved in the transport of Se throughout the body. In addition, Se supplementation directly or indirectly exerts antioxidant functions, thereby increasing the cellular defense against oxidative stress. Moreover, several reports have demonstrated the role of Se in human health including antioxidant, anti-inflammatory, antimutagenic, antitumoral or chemopreventive, antiviral, antibacterial, antifungal, antiparasitic, and neuroprotective effects.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Considering the aforementioned, development of Se compounds is a promising toolkit, which has attracted great interest recently, to achieve potent and selective therapeutic agents.</div><div class="NLM_p">Although there are three main categories of Se-containing compounds (inorganic, organic, and selenoproteins) with potential pharmacological properties, the most developed and studied are the organic derivatives.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The main reasons are their lower toxicity and comparable or even better bioactivity than inorganic Se compounds.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Different organic Se compounds have been reported, and the heterocycles containing Se have received great attention as therapeutic drugs for a plethora of diseases including cancer, diabetes, stroke, Alzheimer, inflammatory processes, etc. Several research and review articles have summarized compounds from different sources and with different mechanisms of action for these pathologies. Specifically, selenazo derivatives have occupied an important position in the field of pharmaceuticals development. Over the past six years, several review papers have appeared comprising mainly of the antioxidant,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> antitumoral,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> or anti-inflammatory<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> effects, among others, of several derivatives of 1,2-selenazoles. However, this Perspective encompasses a much wider variety of selenazo compounds, including selenadiazo scaffolds, and their broad pharmacological activities, merging all of them in a single review paper. Additionally, a summary of the structure–activity relationships is also presented, which could encourage readership to design novel selenazo compounds as potential multifunctional drugs.</div><div class="NLM_p last">Albeit several selenazo derivatives have demonstrated potent pharmacological effects over the past decade,<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> herein we compile extensive literature evidence, covering the past six years, with the description and discussion of the most recent advances in different selenazo and selenadiazo motifs as potential pharmacological candidates. For didactic purposes, we have classified the compounds according to different structural properties such as the relative position of Se and nitrogen and the number of nitrogen atoms present in the heterocycle. Different biological applications have been considered in each section.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  1,2-Selenazoles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The most relevant compound related to Se–N containing heterocycles is 2-phenyl-1,2-benzoisoselenazol-3-[2<i>H</i>]one, named ebselen (EBS; <b>I-1</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). It was first synthesized in 1924,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and in the 1980s it was rediscovered as a potential antioxidant and therapeutic agent.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16−20)</a> It is a multifunctional selenoorganic derivative, with immunomodulatory effects, currently under phase III clinical trials for cerebral ischemia, bipolar disorder, and noise-induced hearing loss.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Its multifunctional effects may be due to the fact that EBS can bind with at least 462 targeted proteins in HeLa cells, as identified by biotinylated EBS probe.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> EBS shows potent antioxidant capacity through the catalysis of several essential reactions for the protection of cellular components from oxidative and free radical damage. It was developed as a GPx mimic reducing hydroperoxides including hydrogen peroxide, phospholipid hydroperoxide, and cholesterol ester hydroperoxide.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In addition, EBS affects the Trx system and might cause cell dysfunction via inhibition of this enzyme.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> All these properties, in addition to its documented safety profile, make EBS a potent and safe bioactive molecule effective in the treatment of various diseases.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. EBS-related anticancer compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  EBS and Cancer</h3><div class="NLM_p">Studies by Azad and co-workers<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> have suggested a potential role for EBS in cancer prevention by inhibiting tumor necrosis factor α (TNF-α)-mediated nuclear factor κB (NF-κB) activity, sensitizing tumor cells to undergo apoptosis, ameliorating the progression of microvasculopathy, and partially restoring angiogenesis. It is remarkable that, based on its radical-scavenging action and its potential use in oxidative stress conditions, this molecule exerts a potent cytotoxic effect on pancreatic cancer AR42J cells<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and oxidative stress-induced apoptosis in human multiple myeloma cell lines.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> On the other hand, EBS can act through other emergent targets such as quiescin sulfhydryl oxidase 1 (QSOX1), an excellent biomarker in cancer since it is overexpressed in diverse tumor types such as pancreatic, breast, lung, and prostate cancers and plays a role in cancer progression and metastasis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Likewise, combination of EBS with radiotherapy shows major antitumor efficiency provoking apoptosis and inhibiting cancer cell progression, including the regulation of gene and protein expression along with the modulation of pro- and anti-inflammatory cytokines in a breast cancer model.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In view of these facts, many researchers have modified and incorporated this privileged scaffold into new molecules in order to identify novel drug candidates for the treatment of cancer. These efforts led to the discovery of ethaselen (BBSKE; <b>I-2</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a potent cancer cell growth inhibitor targeting TrxR1, an enzyme implicated in carcinogenesis and cancer progression. These observations have been confirmed in different tumor cell lines including HeLa (human cervical cancer), BGC823 (human stomach adenocarcinoma), HL60 and K562 (human leukemia), A549 (human lung cancer), LoVo (human colon cancer), Bel-7402 (human epithelial hepatoma), Tca8113 (human tongue cancer), and KB (human nasopharyngeal epidermal carcinoma) cells, as well as in a human non-small-cell lung cancer xenograft mouse model.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Moreover, combination of BBSKE with sodium selenite in non-small-cell lung cancer cells<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> or with sunitinib<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> in colorectal cancer showed synergistic effects, resulting in a promising new strategy for cancer therapy. In addition, this derivative is able to reverse cisplatin resistance in drug-resistant K562 cells.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Recently, Zheng et al.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> have reported that BBSKE could inhibit migration and invasion in human breast cancer MCF-7 cells and colorectal cancer LoVo cells. In addition, BBSKE not only leads to primary tumor regression but also significantly reduces metastasis in lung and liver in a mouse breast cancer 4T1 model. The underlying mechanisms may include the markedly elevated reactive oxygen species (ROS) level caused by TrxR inhibition, which results in disruption of a sophisticated network comprising epidermal growth factor receptor (EGFR), epithelial–mesenchymal transition (EMT), CD44, matrix metalloproteinase-9 (MMP-9), and vascular endothelial growth factor receptor 2 (VEGFR2).</div><div class="NLM_p">Taking into account the above-mentioned and inspired by these structures, many research groups have developed new series of compounds related to EBS and BBSKE in order to discover more effective agents and to explore new mechanisms of action. Among the different approaches proposed, hybridization (combination in a single chemical entity of two structures with different pharmacophoric features) is one of the most used approaches. Thus, Yan et al.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> reported new compounds (<b>I-3</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) designed by combining chemical structures of resveratrol and EBS. All the hybrid compounds exhibited potential antiproliferative activities against four human cancer cell lines (Bel-7402, A549, HeLa, and MCF-7). It is noticeable that the inclusion of two methoxide groups in the resveratrol moiety resulted in an increase in the level of apoptosis and the G<sub>2</sub>/M cell cycle arrest and also exhibited the best TrxR inhibitory activity. On the other hand, the incorporation of other versatile bioactive nucleus such as 1,2,4-triazole (<b>I-4</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> or 1,3,4-thiadiazole (<b>I-5</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> reinforced the idea that the nature of the functional groups on the triazole or thiadiazole rings is determinant for the antiproliferative activity and selectivity. For example, among the triazole compounds, the aliphatic chains were the most active against SMMC-7721 cells while in the thiadiazoles, the substituent groups over the phenyl ring were of vital importance for modulating the antitumor activity. It is well-known that chirality can influence the pharmacological activity of the compounds. Thus, Pacula et al.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> described the synthesis of new analogs of EBS with a chiral terpene scaffold (<b>I-6</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) or with several chiral amino acidic methyl esters (<b>I-7</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The determination of the anticancer and antioxidant activities showed that the highest antiproliferative activity was observed for <i>N</i>-leucinemethyl ester, while the other chiral compounds showed poor activity.</div><div class="NLM_p">Other structural modifications include the introduction of small functional groups to evaluate the impact in the biological profile. So the generation of ebselenols with an OH group in the benzisoselenazolone ring (<b>I-8</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) improved the GPx activity and exerted a scavenging effect on ROS and reactive nitrogen species (RNS) species produced by phorbol 12-myristate 13-acetate (PMA)-induced human mononuclear cells (MNC).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Besides, the dimerization of EBS through azo core in order to obtain azo-bis-EBSs (<b>I-9</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) has been explored. In general, this modification accomplished poor synthetic GPx mimics with no toxic effects.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">Related to alternative mechanisms of action, the overexpression of different isoforms of histone deacetylases (HDACs) has been found in several types of cancer cells and in neurological and inflammatory pathologies. For these reasons, HDAC inhibitors have been aggressively pursued as antineoplastic drugs. Wang et al.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> have published a study with a collection of EBS and its analogs including the EBS oxide (<b>I-10</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and different ebsulfur derivatives (<b>I-11</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). EBS was identified as HDAC5, HDAC6, HDAC8, and HDAC9 inhibitor with IC<sub>50</sub> values of 3.4, 6.9, 1.2, and 3.7 μM, respectively. In 2018, Tang and co-workers<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> published a paper related to the importance of the glycosaminoglycans (GAGs) biosynthesis dysfunctions in many pathological conditions, including tumor progression. On the basis of these observations, they developed novel β-<span class="smallcaps smallerCapital">d</span>-xylosides by conjugating EBS and xylose (<b>I-12</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) in order to understand the role of the aglycone and primed GAGs in contributing to β-<span class="smallcaps smallerCapital">d</span>-xyloside-dependent cytotoxicity in cancer cells. They concluded that only EBS-β-<span class="smallcaps smallerCapital">d</span>-xyloside showed significant cytotoxicity with IC<sub>50</sub> ranging from 6.4 to 7.3 μM in four human cancer cell lines. Recently, Bartolini et al.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> have proposed the glutathione <i>S</i>-transferase P (GSTP) as a new target for EBS and related compounds. This enzymatic system is implicated in both the prevention and therapy of drug resistant cancers. EBS has shown interaction with one of the isoenzymes, GSTP1, which plays a prominent role in the anticancer and redox modulation. Finally, the potential of some EBS derivatives as radiation mitigators must be considered. [[2-[4-(3-Oxo-1,2-benzoselenazol-2-yl)phenyl]acetyl]amino]ethyltriphenylphosphonium chloride (MitoEBS-2; <b>I-13</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is effective in reducing lipid hydroperoxides, preventing apoptotic cell death and increasing the survival when administered 24 h postradiation.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Additionally, benzisoselenazolones obtained by introducing isothiourea, tetramethylthiourea, and heterocyclic groups into the C-ring of EBS (<b>I-14</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) exhibited more potent antitumor activity in EBC-1 cells than EBS. Additionally, these derivatives have shown inhibition of autophosphorylation of mesenchymal epithelial transition factor (c-MET).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p last">In the case of BBSKE, some of the structural modifications have addressed its poor solubility. In 2016, Ye et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> designed and synthesized a new series of analogs by combining BBSKE and carmustine, a DNA-cross-link agent, resulting in deactivators of TrxR with high toxicity and low selectivity. The resultant 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3<i>H</i>)-yl)ethyl) ureas (<b>I-15</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) showed good solubility, low toxicity, and excellent antitumor activity. In addition, other minor modulations have been introduced such as the inclusion of alkyl chain of three carbon atoms. It was observed that this derivative (<b>I-16</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) inhibited glutamate dehydrogenase (GDH), an enzyme implicated in cancer disease, and presented higher anticancer activity.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2.  EBS and Neurodegenerative Diseases</h3><div class="NLM_p">Brain disorders with a vascular and/or neurodegenerative component affect one billion people worldwide, according to the World Health Organization (WHO). Among them, Alzheimer’s disease (AD) ranks first affecting 45–60% of the population followed by Parkinson’s disease (PD) affecting 2% of population.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Considering the antioxidant properties of EBS (<b>I-1</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), several studies have shown that this derivative has neuroprotective effects in damaged tissues after the interruption of blood flow<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> as well as may improve or at least preserve cognitive function in AD and other forms of dementia.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> These facts have been corroborated by Xie and co-workers<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> using both AD model cells and mice. They demonstrated that EBS was able to improve cognitive impairment, reduce the level of amyloid β (Aβ), and inhibit tau hyperphosphorylation. In addition, EBS suppressed ROS-mediated activation of p38 kinase, which subsequently reduced tau phosphorylation and β-secretase 1 (BACE1) levels and Aβ generation.</div><div class="NLM_p">This accumulated evidence has promoted the development of new derivatives of EBS by fusion/combination with other structures with recognized efficacy in AD treatment. Luo et al.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> described a new multitarget compound named “selenpezil” (<b>II-17</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), formed by the union of EBS and donepezil, a well-known acetylcholinesterase inhibitor used for AD treatment. Selenpezil showed potent acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition with no acute toxicity. These authors<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> further carried out new modifications in the parent compound, “selenpezil” by replacing the benzylpiperidine group in donepezil by several nitrogen heterocyclic rings (<b>II-18</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The results indicated that the presence of piperidine ring is crucial for the activity.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. EBS-related structures tested in neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other series of compounds have been designed and synthesized by hybridization between EBS and other described AChE inhibitors. Among these hybrid molecules tacrine-EBS analogs were potent inhibitors of AChE and BuChE. One of the derivatives having two methoxy groups in the EBS moiety and five carbons in the alkyl chain (<b>II-19</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) exhibited superior activity and a better balance of AChE and BuChE activities than tacrine.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Moreover, using rational computer assisted design, Wang et al.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> fused the pharmacophores of quinolin and EBS into new molecules to obtain “selenoxy-chinolins”. One of them, with a hydroxyl group in the EBS moiety (<b>II-20</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), was able to penetrate the central nervous system (CNS) without exhibiting acute toxicity and presented an effective interaction with Aβ. Later, the authors modulated these compounds and developed a series of 8-hydroxyquinoline derivatives substituted with benzo[<i>d</i>][1,2]selenazol-3(2<i>H</i>)-one at the 2-position. The resulting novel compounds (<b>II-21</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) provided a significant inhibition ability of the Cu(II)-induced Aβ aggregation of clioquinol and the scavenging peroxide ability of EBS.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In addition, other targets such as HDACs have attracted much attention for their use as potential targets for the treatment of AD, mainly the isoforms HDAC2 and HDAC6 both being overexpressed in the cortex and hippocampus of AD patients. Considering this, Hu et al. hypothesized that the fusion of two key features from EBS and the hydroxamic moiety, specific for HDAC pharmacophore, through different structural arrangements, could result in a new class of compounds (<b>II-22</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) for AD treatment. The results confirmed their hypothesis showing some of the compounds to exhibit better free oxygen radical scavenging ability than EBS, significant protective effects against damage induced by H<sub>2</sub>O<sub>2</sub>, and significant preventive effects against ROS accumulation.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p">Compared to AD, there are limited reports of application of selenazoles in PD. Only Tio et al.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> have reported a study in a transgenic drosophila showing that EBS may be a useful neuroprotective drug for carriers of coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2), which is related with late-onset Parkinson disease.</div><div class="NLM_p last">Finally, EBS has been used in mental illness. EBS inhibits the inositol monophosphatase (IMPase) following a mechanism similar to lithium. In addition, EBS also inhibited the 5-HT<sub>2A</sub> receptor function reducing impulsivity in rat models of impulsive behavior<a onclick="showRef(event, 'ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63 ref64">(61−64)</a> such as neuroprotective agent in depression or schizophrenia and bipolar disorder<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> or as suicidality prevention.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In addition, EBS has been explored as neuroprotective agent in rat spinal cord injury with limited effect.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.3.  EBS and Cardiovascular Diseases</h3><div class="NLM_p">It is well established that oxidative stress, particularly lipid peroxidation, could be the principal mechanism in the pathogenesis of myocardial injuries which would lead to death, and for this cause EBS has been explored to have potential applications in heart ischemic injuries.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> It acts by attenuating ischemia–reperfusion induced cardiomyocyte apoptosis seemingly by increasing the expression of Bcl-2, decreasing the expression of caspase-3 and -8, Bax, and poly(ADP-ribose) polymerase (PARP), and enhancing the expression and function of antioxidant enzymes.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> It can be used as an adjuvant to diminish the oxidative stress during cardiopulmonary bypass and hypothermia.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p last">Additionally, EBS has a special relevance as a promising cardioprotective agent against cardiotoxicity induced by doxorubicin (DOX) and daunorubicin, the two anthracyclines used in cancer therapy.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Endothelial dysfunction in uremia may be induced by accumulation of ROS, and deficient levels of glutathione peroxidase-3 (GPx3) may cause the development of kidney disease-induced cardiac risk. Thus, the potentiation of the antioxidant pathways by using GPx mimetic EBS can be an effective strategy to reduce the cardiovascular risk.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a> Recently, Haas et al.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> have reported that EBS can reduce the levels of proinflamatory cytokines secretion such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and interleukin-8 (IL-8) in cells maintained in different high dextrose concentrations acting as human coronary artery endothelial protector.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.4.  EBS and Diabetes</h3><div class="NLM_p">There exists a great controversy between the associations of high levels of dietary or serum Se levels and prevalent type 2 diabetes.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Some authors concluded that high levels of Se are associated with the presence of this illness,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> while others considered that circulatory Se concentration is essential for insulin regulation and energy metabolism.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> A study, published in 2013, refers that EBS ameliorated the hyperglycemia and lowered the glycosylated hemoglobin, prevented the oxidative stress and the nucleocytoplasmic dislocation of pancreatic and duodenal homeobox 1 (Pdx-1) and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MafA) in β-cells, and also β-cell apoptosis associated with hyperglycemia.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> In addition, two new EBS-analogs named <i>m</i>-hydroxy- (<b>III-23</b> in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) and ethanol-EBS (<b>III-24</b> in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) were designed as antidiabetic agents. Although the <i>m</i>-hydroxy EBS decreased end-points of two often linked diabetic complications <i>in vitro</i>, it did not augment the attenuation of diabetes associated atherosclerosis and renal injury in an <i>in vivo</i> model.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> EBS did not improve the oxidative stress profile or conduit and arteriolar vascular function.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. EBS-related derivatives used in diabetes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.5.  EBS and Miscellaneous Diseases</h3><div class="NLM_p">In the addition to the above, EBS and its derivatives could potentially have application in several other diseases. For example, EBS has been implicated as antibacterial agent. Despite growing research, multidrug-resistant bacteria have increased in frequency resulting in significant patient morbidity and mortality. Further, new and recurrent bacterial infections continue to impose significant challenges on global health care. EBS showed activity against several Gram-positive bacteria, such as <i>Clostridium difficile</i> infection by inhibiting the release of the toxic glucosyltransferase domain.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Another disease with high associated mortality where EBS may find use is anthrax. It has been described that EBS and its analogs (<b>IV-25</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) could be classified as a novel class of antibiotics for treating <i>B. anthracis</i> acting through TrxR inhibition. Moreover, these molecules exhibited low minimal inhibitory concentration values against <i>B. subtilis</i>, <i>B. cereus</i>, <i>S. aureus</i>, and <i>M. tuberculosis</i> with a pronounced bactericidal mode of action.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Thanna et al.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> described a library of EBS derivatives with potential inhibition of <i>M. tuberculosis</i> growth and <i>M. tuberculosis</i> antigen 85C (Ag85C) activity. The derivative with an allyl chain substituent (<b>IV-26</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) was identified as the most promising as antitubercular agent. As a go in depth in Ag85 as target, a study with the 85 C enzyme cocrystallized with different <i>p</i>-amino- (<b>IV-27</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), azido- (<b>IV-28</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), and adamantyl-EBS (<b>IV-29</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) derivatives was carried out by Goins and co-workers.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> The obtained results confirmed the importance of the structural modifications and their effects on the covalent bond on Cys209 residue and represented a guiding principle for developing new more specific and potent Ag85 inhibitors.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. EBS-related structures active against various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">EBS, due to its antiurease activity as well as the ability to inhibit H<sup>+</sup>/K<sup>+</sup>-ATPase proton pumps,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> may also emerge as relevant drug for treating infections caused by Gram-negative bacteria, e.g., the one caused by ureolitic <i>Helicobacter pylori</i> (<i>H. pylori</i>) which is resistant to antibiotics. Xu et al.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> investigated the effect of EBS on the GPx-ROS pathways and IL-8 expression induced by <i>H. pylori</i> in gastric cancer cells. The results suggested that EBS may inhibit ROS production triggered by <i>H. pylori</i>. The formulation as salts for some EBS derivatives (<b>IV-30</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) displayed significant actions against Gram-negative pathogens due to an alteration of intracellular levels of glutathione and cysteine thiols of proteins in the bacterial cells.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> In addition, the synergistic antibacterial effect of EBS in combination with silver is described as novel efficient treatment against multidrug-resistant Gram-negative infections.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p">Moreover, some compounds containing EBS as molecular template, act synergistically with well-known antimicrobials such as some members of carbapenem family against <i>Enterobacteriaceae</i>. A new synthesized derivative, <i>tert</i>-butyl (2-(3-oxobenzo[<i>d</i>][1,2]selenazol-2(3<i>H</i>)-yl)ethyl)carbamate (<b>IV-31</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), displayed stronger synergistic activity with meropenem (Mem) than EBS along with better physicochemical properties.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> On the basis of the promising results described above, some authors have advocated the repurposing of EBS for reducing the bacterial infections, mainly in patients infected with enterococci and exhibiting resistance to vancomycin.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Similar proposal has been explored by May et al.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> based on the impact of EBS on Trx. EBS has shown efficacy against a variety or pathogen organisms (<i>H. pilory</i>, <i>M. tuberculosis</i>, <i>E. coli</i>, <i>S. aureous</i>, <i>C. albicans</i>, <i>K. pneumoniae</i>, <i>A. niger</i>, <i>P. aeruginosa</i>, <i>P. falciparum</i>, ...). As an extension of these studies, EBS and derivatives were tested as potential antifungal and antiparasitic agents. Different mechanisms of action have been proposed. One of them has been the inhibition of the fungal plasma membrane H<sup>+</sup>-ATPase. This study was carried out in a fluconazole resistant strain of <i>C. albicans</i>, and some of the EBS-analogs (<b>IV-32</b> and <b>IV-33</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) demonstrated inhibitory activity comparable to the reference fluconazole.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Another suggested mechanism is the reduction of intracellular glutathione levels, accompanied by increasing ROS and disturbing the redox homeostasis in fungal cells.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> These facts had been analyzed already with EBS in combination with amphotericin B and voriconazole.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> In addition, EBS is emerging as a repositionable agent for the treatment of candidiasis and other mycoses.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> More recently, EBS has been reported as a potent and selective antifungal drug targeting TrxR.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Moreover, EBS has shown high effectivity for treating diarrhea caused by <i>Cryptosporidium parvum</i>, one of the main diarrheal pathogens in children. This effect might be attributed to its effects as inhibitor of cryptosporidium parvumglucose-phosphate isomerase as well as other enzymes in the parasite,<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> e.g., some hexokinase in a similar form as <i>Plasmodium falciparum</i> or <i>Tripanosoma brucei</i>.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Recently, EBS, in combination with amphotericin B, exhibits synergistic effects inhibiting <i>Trichosporon asahii</i> growth.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Finally, EBS and propyl EBS (<b>IV-34</b> in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) have been evaluated as amebicidal agents,<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> especially against primary amebic meningoencephalitis caused by <i>Naegleria fowleri</i>. Given the vast variety of pathways altered by EBS, efficacy values for each enzyme or protein altered by EBS have been summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for the sake of clarity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Efficacy Values on Enzymes and Proteins Amended by EBS</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzymes/proteins</th><th class="colsep0 rowsep0" align="center">efficacy</th><th class="colsep0 rowsep0" align="center">refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Cancer</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">quiescin sulfhydryl oxidase 1 (QSOX1)</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 5.4 (μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Cancer and Neurodegenerative and Inflammatory Diseases</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">isoforms of histone deacetylases (HDAC)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC5</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 3.4 (μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC6</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 6.9 (μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC8</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 1.2 (μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HDAC9</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 3.7 (μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Ischemia/Reperfusion Injury</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SOD</td><td class="colsep0 rowsep0" align="left">SOD activity = 0.105 (U/mg prt)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Mental Disease</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inositol monophosphatase (IMPase)</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub>(IMPase) = 1.5 (μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Infectious Diseases</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cysteine protease domain of <i>C. difficile</i> toxin B</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 17.2 (nM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TrxR of <i>B</i>. <i>anthracis</i></td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 1 (μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fungal plasma membrane H<sup>+</sup>-ATPase of <i>C</i>. <i>albicans</i></td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (ATPase) = 3.9 (μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TrxR of <i>A</i>. <i>fumigatus</i></td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> = 0.22 (μM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glucose 6-phosphate isomerase of <i>C. parvum</i></td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>m</sub> = 0.309 (mM)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">3.  1,3-Selenazoles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">1,3-Selenazoles have received a great deal of attention due to the wide variety of pharmacological activities reported for these heterocyclic compounds, including antibacterial,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> antifungical,<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> and antitumoral<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> activities.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.1.  1,3-Selenazoles and Infectious Diseases</h3><div class="NLM_p">Recently, 2,4-disubtituted (<b>V-35</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) and tetrahydro-2<i>H</i>-thiopyran-4-yl based (<b>V-36</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) selenazoles demonstrated significant bacteriostatic/bactericidal effect against Gram positive bacteria, both pathogenic staphylococci <i>S. aureus</i> and opportunistic bacteria, such as <i>S. epidermis</i> and <i>M. luteus</i>, respectively.<a onclick="showRef(event, 'ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref101 ref102">(101,102)</a> Tetrahydro-2<i>H</i>-thiopyran-4-yl based selenazoles have also shown very strong fungicidal or fungistatic activity against <i>albicans</i> and non-<i>albicans</i><i>Candida</i> spp. strains, such as <i>C. parapsilosis</i>, <i>C. sake</i>, <i>C. dubliniensis</i>, <i>C. famata</i>, <i>C. lusitaniae</i>, <i>C. krusei</i>, or <i>C. inconspicua</i>,<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> which may be due to the combined activity of sulfur and Se in these compounds. In addition, these tetrahydro-2<i>H</i>-thiopyran-4-yl based selenazoles demonstrated anticonvulsant and antiepileptic activity.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Hydrazinoselenazoles (<b>V-37</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) have shown better antibacterial activity than reference compound chloramphenicol on <i>K. pneumonia</i> KP63,<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> and ferrocenyl selenazoles (<b>V-38</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) demonstrated excellent activity against <i>E. coli</i>.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Interestingly, a nickel(II) complex containing 2-phenyl-4-selenazole carboxylic acid and 1,10-phenanthroline (phen) (<b>V-39</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) exhibits stronger antimicrobial activities against <i>E. coli</i>, <i>S. epidermidis</i>, <i>S. viridans</i>, <i>A. baumanii</i> than benzylpenicillin sodium.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. 1,3-Selenazole structures active against various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Structurally, two main functionalities are being used to decorate 1,3-selenazole core: (i) hydrazine entity with different substituted aromatic and carbo- or heterocycles and (ii) a transition metal element complexing or decorating the selenazo scaffold. On the basis of the reported bioactivity, we consider that this metalloselenazo association presents a great potential for developing novel anti-infectious agents.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.2.  1,3-Selenazoles and Cancer</h3><div class="NLM_p">A number of recent studies have indicated that 1,3-selenazole derivatives possess cytotoxic and/or cytostatic activity against several tumor cell lines. Thus, 1,3-selenazole-containing 1,3,4-thiadiazole derivatives (<b>V-40</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) showed potent activity against MCF-7 cells<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> and selenazolopyridine (<b>V-41</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) could induce apoptosis in MCF-7 cells by scavenging intracellular ROS.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> 2,5-Disubstituted 1,3-selenazoles (<b>V-42</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) have showed potent inhibition against the tumor-associated transmembrane human carbonic anhydrase IX isoform with effective antitumor activity in human prostate (PC3) and breast (MDA-MB-231) cancer cell lines.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Besides, di-<i>n</i>-butyltin(IV) and triphenyltin(IV) derivatives (<b>V-43</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) show much greater antitumoral activity in three cancer cell lines (Caco-2, A549, and HCT-116) than cisplatin, the anticancer drug used clinically.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Furthermore, some selenazolyl-hydrazones (<b>V-44</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) showed comparable or even better antitumoral activity against six human solid tumor cell lines than 5-fluorouracil (5-FU) and exhibited excellent antioxidant properties. Surprisingly, <i>p</i>-nitrophenyl-substituted and unsubstituted selenazolyl-hydrazones exhibited monoamine oxidases (MAO) B/A inhibition and MAO B inhibition, respectively, in nanomolar concentration range, which indicates their possible multitargeting properties for the treatment of neurodegenerative disorders.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Aryl-hydrazinyl and aryl-hydrazonyl-1,3-selenazoles (<b>V-45</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) have shown antiproliferative effects against two leukemia cell lines (CCRF-CEM and HL60).<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><div class="NLM_p last">Again, the two same structural features described in the previous section, e.g., hydrazine and metalloselenazole, are also present in the 1,3-selenazole derivatives with anticancer activity. Additionally, the conjugation of sulfur and Se atoms seems to also play a role. Thus, these findings reinforce the idea that these hydrazine- and metallo-conjugated 1,3-selenazoles may form a privileged lead skeleton in designing more potent and selective bioactive agents.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">3.3.  1,3-Selenazoles and Miscellaneous Diseases</h3><div class="NLM_p last">Some 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids (<b>V-46</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) have shown potent xanthine oxidase inhibition, and these appear to be promising candidates for the treatment of hyperuricemia, gout, and other diseases in which xanthine oxidase may be involved.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Likewise, some 1,3-selenazole-substituted ritonavir analogs (<b>V-47</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) exhibited promising anti-HIV-1 activity.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> For these reasons, 1,3-selenazoles can be considered as interesting new leading structures in search of new antibacterial, antifungal, antitumoral, antiepileptic, xanthine oxidase inhibiting, and anti-HIV-1 drugs.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">4.  1,2,3-Selenadiazoles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">These compounds are promising candidates for developing cancer therapeutics. Particularly, benzopyrano-1,2,3-selenadiazole derivatives (<b>VI-48</b> in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) were able to improve the hematological parameters of tumor-bearing mice, showing significant antitumoral activity and increasing the life span to a higher extent as compared with 5-FU.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> The antiproliferative effect of 4,5–dihydrobenzoferroceno[1,2-<i>d</i>][1,2,3]selenadiazole (<b>VI-49</b> in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) on ovarian carcinoma cell line was comparable to that produced by cisplatin. Additionally, this ferrocene derivative showed antiproliferative effect against cervical and breast cancer cell lines.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Besides, 17-[1′,2′,3′]-selenadiazolylpregnenolone derivatives (<b>VI-50</b> in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) showed selective inhibitory activity against prostate and ovarian cancer cells and the cytotoxicity was greater than that of abiraterone (anti-androgen chemotherapeutic drug for prostate cancer).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Besides, some of these heterocycles show high antifungal, antibacterial, and antimicrobial activities. Some examples include substituted 1,2,3-selenadiazoles (<b>VI-51, VI-52</b>, and <b>VI-53</b> in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), such as carbaldehyde-substituted derivatives (<b>VI-51</b> in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) that showed activity against the yeast-like fungi <i>C. albicans</i>.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Some of carbocycle-fused mono- and bis-1,2,3-selenadiazoles have shown moderate to good activity and have zone inhibition comparable to that of the standard clotrimazole and ciprofloxacin against <i>C. albicans</i> and against <i>E. coli</i> and <i>S. aureus</i>, respectively. Furthermore, some of these compounds, present high antituberculosis activity.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 1,2,3-Selenadiazole structures active against various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">5.  1,2,4-Selenadiazoles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The syntheses of 1,2,4-selenadiazoles are scarce, and only a few reports have appeared in the literature recently.<a onclick="showRef(event, 'ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref119 ref120">(119,120)</a> Nevertheless, there is a report concerning biological activity of diferrocenyl-1,2,4-selenadiazoles,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> demonstrating their antibacterial activity against <i>S. aureus</i>, <i>E. coli</i>, and <i>P. aeruginosa</i>.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">6.  1,2,5-Selenadiazoles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">1,2,5-Selenadiazoles are typically synthesized from 1,2-diamines with Se dioxide (SeO<sub>2</sub>) as Se source, although other Se reagents have been used (Se chlorides). The interest of scientific community for this Se scaffold is awakening not only in medicinal chemistry but also in diverse technological areas, such as solar cells development and light emitters, due its physical and optical properties. Therefore, many synthetic efforts have been made in order to structurally diversify 1,2,5-selenadiazole moiety. In recent years, this selenated scaffold has found a very promising use as antiproliferative and death promoter of cancerous cells through different pathways. Reports of effective synergetic combination with other therapies such as radiotherapy are constantly appearing in the literature and represent a positive advance against diverse cancers.</div><div class="NLM_p">Most of recently reported 1,2,5-selenadiazoles with biological activities are constructed from aryldiamines such as <i>o</i>-phenylenediamine and 3,3′-diaminobenzidine (DAB) scaffolds. Examples of active benzo[<i>c</i>][1,2,5]selenadiazoles (<b>VII-54</b> in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) with different substitutions on 5-position were reported by He et al.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Specifically, 5-nitrobenzo[<i>c</i>][1,2,5]selenadiazole was found to have the best anticancer activity in HeLa cervical cancer cells, due to the increased lipophilicity, resulting in a higher cellular uptake, which can be monitored due its fluorogenic nature. This compound also enhanced the sensitivity of cancerous cells to X-ray induced apoptosis by inhibition of TrxR, with good results <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Related benzo[<i>c</i>][1,2,5]selenadiazole-5-carboxylic acid was conjugated into polyethylenimine (PEI) nanoparticles with RGD (Arg-Gly-Asp) peptide as integrin targeting molecule, achieving good selectivity in human glioma cells and provoking apoptosis by ROS-mediated p53 phosphorylation pathway.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Conjugation in mesoporous silica nanoparticles (MSNs) improved blood–brain barrier (BBB) permeability and cellular uptake in glioma cells, achieving cell death.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Furthermore, it inhibited U87 tumor (glioblastoma) spheroids growth <i>in vitro</i> and prolonged blood circulation time.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Several alkyl benzo[<i>c</i>][1,2,5]selenadiazole-5-carboxylates were prepared and found to have a moderate activity (the lowest IC<sub>50</sub> being 28 μM) in several cancer cell lines.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> More importantly, it was found that 1,2,5-selenadiazoles bind to bovine serum albumin (BSA) through lipophilic interactions, improving cellular uptake.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> A collection of <i>N</i>-alkyl- and <i>N</i>-arylbenzo[<i>c</i>][1,2,5]selenadiazole-5-carboxamides were synthesized and tested <i>in vitro</i> against five human cancer cell lines, leading to the identification of various derivatives with high antiproliferative activities and radical scavenging ability.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Amides of 4-methylchacogen-anilines (O, S, and Se) and 2-aminobenzothiazole showed antiproliferative activity toward several cancer cell lines. The compound containing Se presents impressive selectivity toward cancer cells compared to normal cells in mammary and lung, improving at least 15-fold selectivity of EBS and BBSKE in both the cancer cell lines.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Related carboxamides with hydrophobic chains exhibited good IC<sub>50</sub> values in MCF-7 cancerous cells, obtaining better results when formulated with poloxamine micelles, i.e., dodecyl derivate in T904 cells (IC<sub>50</sub> = 0.05 μM, 100-fold improvement with respect to EBS).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> 6-Alkyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-yl derivatives, obtained from the corresponding amides, proved effective as cytotoxic compounds against breast cancer cell lines, especially toward triple-negative cell line MDA-MB-231.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Mechanism of action involves AKT inhibition and mitogen-activated protein kinase (MAPK) activation by overproduction of ROS.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. General structure of active 5-substitued selenadiazoles derived from <i>o</i>-phenylenediamine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">1,2,5-Selenadiazole-DAB derivative 4-(benzo[<i>c</i>][1,2,5]selenadiazol-6-yl)-benzene-1,2-diamine (<b>VIII-55</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) was shown to induce apoptosis in SWO-38 glioma cells by AKT dephosphorylation.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Derivatization of the previous 1,2-diamine to diaryl quinoxalines (<b>VIII-56</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) yielded other 1,2,5-selenadiazolic compounds able to enhance X-ray sensitization on A375 human melanoma and HeLa cells by induction of cell cycle arrest.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Chemo- and radio-combined treatment pointed out to a TrxR activity inhibition. Liang et al. developed the synthesis of analogous benzimidazole derivatives through condensation reactions with substituted benzaldehydes, obtaining in most cases mixtures of 5-(2-arylbenzimidazol-6-yl) (<b>VIII-57</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) and 5-(2-aryl-<i>N</i>-methylarylbenzimidazol-6-yl)1,2,5-selenadiazoles (<b>VIII-58</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> 3,4,5-Trimethoxybenzaldehyde derived 1,2,5-selenadiazoles also disrupted ROS balance of A375 melanoma cells through interaction with TrxR target, in agreement with the finding of TrxR model peptide scission.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> 2-(<i>p</i>-Methoxyphenyl)benzimidazol-6-yl derivative was found to have better antiproliferative activity than reference drug mitomycin and caused cell death through cell internalization by endocytosis and subsequent ROS-mediated apoptosis.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> In another study, benzaldehyde derivative was found to improve cellular uptake of DOX in hepatic HepG2 cells under hyperglycemia conditions, representing an opportunity to contest against diabetes-related drug resistance.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> In line with these results, another related compound, a 2-(<i>p</i>-methoxyphenyl)-<i>N</i>-(<i>p</i>-methoxyphenylmethyl)benzimidazol-6-yl derivative, was found to also improve DOX uptake in breast cancer MCF-7 cell lines.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Several of the same library of compounds were tested in antiproliferative assays against bladder cancer cell lines.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a><i>p</i>-Methylbenzaldehyde derived selenadiazole also showed breast cancer tumor growth inhibition in murine model, due to antiangiogenic effect, as reflected by a greater growth inhibition of endothelial cells HUVEC in Matrigel plug assays.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> 2-Indol-3-ylbenzimidazol-6-yl derivative was conjugated to a cyclic peptide containing RGD sequence, able to target αVβ3 integrin.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Taking advantage of fluorescent properties of the compound, improved cellular uptake of integrin-overexpressing cancer cells (HepG2) could be confirmed, thus enhancing the effectiveness of radiotherapy <i>in vitro</i> and reproducibility <i>in vivo</i>.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> 1,2,5-Selenadiazole moiety incorporated in 1,10-phenanthrolines and subsequent iron(II) complexes has been demonstrated to increase antiangiogenic efficiency, compared with nonselenated analog, by potently inducing endothelial cell apoptosis.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Active selenadiazoles derived from DAB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Combretastatin A-4, a tubulin polymerization inhibitor, was subjected to derivatization with 1,2,5-selenadiazole motif with a cis disposition of the two rings (<b>VIII-59</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Antiproliferative assays in several cancerous cell lines showed IC<sub>50</sub> values at nanomolar range, and activity was found to be caused by microtubule destabilization. One of these derivatives (G-1103) was also demonstrated to cause cell cycle arrest in G<sub>2</sub>/M phase and apoptosis in human HeLa and fibrosarcoma cells.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> A 1,2,5-selenadiazole derived quinolone (<b>VIII-60</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) presented good antiproliferative activity in HeLa cells through apoptosis induction, which improved when irradiated with ultraviolet A (UVA) light.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> The same compound also exhibited high antiproliferative activity in leukemia cells and immunomodulatory effect on murine cell lines.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><div class="NLM_p">In addition to their application in cancer, 1,2,5-selenadiazoles have shown application in other emerging fields, e.g., in semiconducting polymer dots (Pdots) used for fluorescent probes in biology and medicine. Pdots have been derivatized with 1,2,5-selenadiazole motif (<b>IX-61</b> in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), achieving an improved sensitivity for ratiometric detection of hypochlorous acid <i>in vivo</i>,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> an endogenous ROS linked to the progression of many human diseases. 1,2,5-Selenadiazole substructure has also been included in conjugated polymer nanoparticles (NPs) (<b>IX-62</b> in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), where switching the chalcogenide atom permits the adjustment in NP photoacoustic properties, which enables <i>in vivo</i> brain vasculature imaging.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Active 1,2,5-selenadiazoles derived from semiconducting polymer dots (Pdots) and polymer nanoparticles (NPs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A summary of the efficacy against a wide variety of diseases and related mechanism of actions of various selenazo compounds is outlined in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Efficacy and Mode of Action of Selenazo Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center">illness</th><th class="colsep0 rowsep0" align="center">mode of action</th><th class="colsep0 rowsep0" align="center">refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">1,2-Selenazoles</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ebselen (EBS) <b>I-1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Inhibition of NF-κB through TNF-α</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Oxidative stress-induced apoptosis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Quiescin sulfhydryl oxidase 1 (QSOX1)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Interation with one of the isoenzyme (GSTP1)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Cancer, neurodegenerative and inflammatory</td><td class="colsep0 rowsep0" align="left">Inhibition of isoforms of histone deacetylases (HDAC5, HDAC6, HDAC8, and HDAC9)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Ischemia/reperfusion injury</td><td class="colsep0 rowsep0" align="left">Antioxidant (increase of SOD activity)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Neurodegenerative (Alzheimer’s)</td><td class="colsep0 rowsep0" align="left">Inhibition of tau phosphorylation and BACE1 levels and Aβ generation (suppression of ROS-mediated activation of p38 kinases)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Neurodegenerative</td><td class="colsep0 rowsep0" align="left">Carriers of coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mental</td><td class="colsep0 rowsep0" align="left">Inhibition of inositol monophosphatase (IMPase) and 5-HT<sub>2A</sub> receptor</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref61 ref62 ref63 ref64 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63 ref64 ref65 ref66 ref67">(61−67)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Heart ischemic injury</td><td class="colsep0 rowsep0" align="left">Antioxidant; Bcl-2/Bax ratio; inhibition of caspase-3 and -8 and poly(ADP-ribose) polymerase (PARP).</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Cardiovascular</td><td class="colsep0 rowsep0" align="left">Interleukins (IL-1β, IL-6, and IL-8)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Diabetes</td><td class="colsep0 rowsep0" align="left">Preventing oxidative stress</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>Clostridium difficile</i> infection</td><td class="colsep0 rowsep0" align="left">Inhibition of cysteine protease domain of <i>C. difficile</i> toxin B</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Anthrax</td><td class="colsep0 rowsep0" align="left">TrxR inhibition</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>Helicobacter pylori</i> infection</td><td class="colsep0 rowsep0" align="left">Inhibition of H<sup>+</sup>/K<sup>+</sup>-ATPase proton pump; GPx-ROS pathways and interleukin-8 (IL-8)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Antibacterial, antimicrobial and antifungal</td><td class="colsep0 rowsep0" align="left">Thioredoxin and glutathione systems and inhibition of the fungal plasma membrane H<sup>+</sup>-ATPase</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref90 ref91 ref92 ref93 ref96'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92 ref93 ref96">(90−93,96)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>Cryptosporidium parvum</i> infection</td><td class="colsep0 rowsep0" align="left">Inhibition of <i>C. parvum</i> glucose-6-phosphate isomerase</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ethaselen (BBSKE) <b>I-2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Thioredoxin reductase 1 (TrxR1)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref30 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref33 ref34">(30,33,34)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Cell cycle arrest and apoptosis; TrxR</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-6</b> and <b>I-7</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Redox homeostasis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-8</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Redox homeostasis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-9</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Redox homeostasis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-10</b> and <b>I-11</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer, neurological and inflammatory</td><td class="colsep0 rowsep0" align="left">Inhibition of isoforms of histone deacetylases (HDAC5, HDAC6, HDAC8, and HDAC9)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-12</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Cell cycle arrest and apoptosis; intracellular localization of the glycosaminoglycans (GAGs)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-14</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Inhibition of autophosphorylation of c-MET</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-16</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Inhibition of glutamate dehydrogenase (GDH)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II-17</b> to <b>II-18</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</td><td class="colsep0 rowsep0" align="left">Alzheimer’s</td><td class="colsep0 rowsep0" align="left">Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II-20</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</td><td class="colsep0 rowsep0" align="left">Neurodegenerative</td><td class="colsep0 rowsep0" align="left">Aβ generation</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II-21</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</td><td class="colsep0 rowsep0" align="left">Neurodegenerative</td><td class="colsep0 rowsep0" align="left">Inhibition of Aβ aggregation induced by Cu(II) and scavenging peroxide</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>II-22</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>)</td><td class="colsep0 rowsep0" align="left">Alzheimer’s</td><td class="colsep0 rowsep0" align="left">Inhibition of isoforms HDACs and antioxidant</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>IV-25</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>)</td><td class="colsep0 rowsep0" align="left">Anthrax</td><td class="colsep0 rowsep0" align="left">Inhibition of TrxR</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>IV-25</b> to <b>IV-29</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>)</td><td class="colsep0 rowsep0" align="left">Tuberculosis</td><td class="colsep0 rowsep0" align="left">Inhibition of antigen 85 (Ag85) activity</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84">(82−84)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>IV-30</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>)</td><td class="colsep0 rowsep0" align="left">Gram-negative infections</td><td class="colsep0 rowsep0" align="left">Intracellular thiolstat</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>IV-32</b> and <b>IV-33</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>)</td><td class="colsep0 rowsep0" align="left"><i>C. albicans</i> infection</td><td class="colsep0 rowsep0" align="left">Inhibition of the fungal plasma membrane H<sup>+</sup>-ATPase; antioxidant</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>IV-34</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>)</td><td class="colsep0 rowsep0" align="left">Primary amebic meningoencephalitis (<i>Naegleriafowleri</i>)</td><td class="colsep0 rowsep0" align="left">Alterations in the ameba membrane</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">1,3-Selenazoles</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>V-41</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Apoptosis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>V-42</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Human carbonic anhydrase IX inhibition</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>V-44</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Antioxidant; monoamine oxidase A/B inhibition</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>V-46</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>)</td><td class="colsep0 rowsep0" align="left">Hyperuricemia</td><td class="colsep0 rowsep0" align="left">Xantine oxidase inhibition</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>V-47</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>)</td><td class="colsep0 rowsep0" align="left">HIV</td><td class="colsep0 rowsep0" align="left">HIV-1 protease</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">1,2,5-Selenadiazoles</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>VII-54</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Redox homeostasis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">MAPK activation and AKT inhibition</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>VII-55</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Apoptosis (AKT dephosphorylation)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>VII-57</b> and <b>VII-58</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">TrxR inhibition; ROS-induced apoptosis; angiogenesis inhibition; αVβ3 integrin modulation</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref130 ref133 ref135'); return false;" href="javascript:void(0);" class="ref ref130 ref133 ref135">(130,133,135)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>VII-59</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Microtubules; cell cycle; apoptosis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>VII-60</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>)</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Apoptosis; immunomodulation</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Efficacy and Mode of Action of Selenazo Compounds in Combination with Other Therapies or Radiation</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">combination</th><th class="colsep0 rowsep0" align="center">illness</th><th class="colsep0 rowsep0" align="center">mode of action</th><th class="colsep0 rowsep0" align="center">refs</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">1,2-selenazoles</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EBS (<b>I-1</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) + γ-radiation</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Inflammatory cytokines and NF-κB; apoptosis and angiogenic factors</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EBS (<b>I-1</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) + silver</td><td class="colsep0 rowsep0" align="left">Gram-negative infections</td><td class="colsep0 rowsep0" align="left">Thiol-dependent antioxidant systems</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EBS (<b>I-1</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) + amphotericin B and voriconazole</td><td class="colsep0 rowsep0" align="left">Antifungal</td><td class="colsep0 rowsep0" align="left">Redox homeostasis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref94 ref99'); return false;" href="javascript:void(0);" class="ref ref94 ref99">(94,99)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BBSKE (<b>I-2</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) + Na<sub>2</sub>SeO<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Cell cycle arrest; TrxR1 and ref-1/AP-1 pathway</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BBSKE (<b>I-2</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) + sunitinib</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Bcl-2/Bax ratio and VEGFR2</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>I-13</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) + γ-radiation</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Radiation mitigator</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>IV-31</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) + meropenem</td><td class="colsep0 rowsep0" align="left">Enterobacteriaceae</td><td class="colsep0 rowsep0" align="left">New Delhi metallo-β-lactamase-1 (NDM-1)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">1,2,5-selenadiazoles</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>VII-54</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) + X-ray radiation</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">TrxR inhibition</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>VII-55</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) + polyethylenimine and RGD peptide</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">ROS-mediated apoptosis</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>VII-56</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) + X-ray radiation</td><td class="colsep0 rowsep0" align="left">Cancer</td><td class="colsep0 rowsep0" align="left">Cell cycle arrest; TrxR1 inhibition and AKT and MAPK inactivation</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></td></tr></tbody></table></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">7.  Summary and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Incorporation of Se atom into small molecules is a recent toolkit used by medicinal chemists to yield potent and selective compounds mainly for cancer treatment and for several other diseases as well. There exist two main approaches to incorporate the atom of Se: (i) as an open chain, where the Se atom can be present in many functionalities,<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> such as selenocyanate (SeCN), diselenide (Se–Se), isoselenocyanate (NCSe),<a onclick="showRef(event, 'ref143 ref144'); return false;" href="javascript:void(0);" class="ref ref143 ref144">(143,144)</a> selenourea (H<sub>2</sub>N-C(═Se)-NH<sub>2</sub>), or methylseleno (CH<sub>3</sub>Se) and (ii) being part of a cyclic scaffold, where mostly the redox status of Se is +2, the +4 status being also possible in certain cases. There are many examples of very potent compounds achieved by the open chain functionalities, i.e., <i>p</i>-XSC,<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> diphenyldiselenide,<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> ISC-4,<a onclick="showRef(event, 'ref147 ref148'); return false;" href="javascript:void(0);" class="ref ref147 ref148">(147,148)</a> NISC-6,<a onclick="showRef(event, 'ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref149 ref150">(149,150)</a> Se-aspirin,<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> PBISe,<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> and EI-201.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Among the examples of cyclic Se compounds, heterocycles with Se atom in endo position emerge as very promising candidates for several diseases given their low toxicity. Specifically, selenazo compounds have emerged as valuable agents presenting some assets compared with different Se heterocyclic compounds. From a chemistry point of view, most selenazo compounds can be synthesized with good yields and few reaction steps. Because of the relative ease of synthesis, several modifications have been performed over the selenazo scaffold through a great variety of reactions and positions, as discussed herein. Most importantly, by means of simple modifications different properties of the selenazo compounds can be modulated, including efficacy against different diseases. One of the most used modulation strategy is the fragment-based design, which has achieved potent analogs, e.g., selenazo derivatives of tacrine (<b>II-18</b> in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>),<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> ferrocene (<b>VI-48</b> in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> and combrestatin A4 (<b>VIII-58</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref136 ref137'); return false;" href="javascript:void(0);" class="ref ref136 ref137">(136,137)</a> This strategy has the potential to lead to the development of bioactive selenazo compounds in order to obtain more potent and selective agents and therefore requires further attention. Other structural features that might have an impact on their activity are (i) the presence or absence of fused aromatic rings to the selenazo cycle, (ii) the existence or not of Se–N bond, and (iii) the ratio of Se/N in the cyclic scaffold. After critically revisiting the most recent literature, we consider the presence in the structure of at least one Se–N bond is important for the activity of the compounds. EBS (<b>I-1</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and BBSKE (<b>I-2</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), the two most well studied selenazo compounds, both present this bond and a phenyl ring fused to the Se cycle. Although most of the modifications have been made over these two compounds, we hypothesize that the use of different polycycles fused to the selenazo cycle and, mainly, the increase of the ratio of N atoms related to Se are worth considering in search for more potent, selective, multifunctional, and immunomodulatory agents.</div><div class="NLM_p">From the bioactivity point of view, selenazo compounds mostly exert their efficacy by means of radical species quenching through different catalytic cycles. Nonetheless, several mechanisms of action have been unveiled as discussed above in this article. Among them, TrxR modulation can be considered as a novel and promising target, amply discussed by Bian et al.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> The lack of toxicity and TrxR modulation, among other mechanisms, might be crucial features that allow further development of these derivatives. Overproduction of radical species is associated with the development of inflammation, aging, and various human diseases (such as cancer, cardiovascular, neurodegenerative, and metabolic disorders), along with side effects provoked by radiation. Given the plethora of pathways altered by selenazo compounds, we surmise that the combination of selenazo compounds with different drugs with complementary mechanisms of action or radiation, mitigating the side effects or sensitizing the cells, could have an outstanding impact on the treatment of many of these diseases. Nonetheless, considering altogether the facts reported herein, we consider TrxR inhibition as the most prominent and promising pathway to further explore these selenazo scaffolds. Likewise, cancer might be deemed as the disease where these derivatives can cause the greatest impact on the treatment.</div><div class="NLM_p last">In summary, selenazo skeleton stands out as privileged feature within the selenoheterocycles, presenting preclinical efficacy in a plethora of illnesses as different as cancer, diabetes, or cardiovascular disorders. Furthermore, these effects were achieved through a great variety of mechanisms of action, encompassing, among others, apoptosis, QSOX1, HDACs, and TrxR. Overall, recent developments clearly indicate that appropriately designed selenazo compounds could lead to promising drug candidates for various diseases in the near future.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01152" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arun K. Sharma</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Penn State Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7679-7779" title="Orcid link">http://orcid.org/0000-0002-7679-7779</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#01606a723035417172742f646574"><span class="__cf_email__" data-cfemail="c3a2a8b0f2f783b3b0b6eda6a7b6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Plano</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Tecnología y Química Farmacéuticas, Facultad
de Farmacia y Nutrición, Universidad
de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Penn State Cancer Institute, CH72, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c8acb8a4a9a6a788bda6a9bee6adbb"><span class="__cf_email__" data-cfemail="482c3824292627083d26293e662d3b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Carolina Ruberte</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Tecnología y Química Farmacéuticas, Facultad
de Farmacia y Nutrición, Universidad
de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Sanmartin</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Tecnología y Química Farmacéuticas, Facultad
de Farmacia y Nutrición, Universidad
de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3431-7826" title="Orcid link">http://orcid.org/0000-0003-3431-7826</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlos Aydillo</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Tecnología y Química Farmacéuticas, Facultad
de Farmacia y Nutrición, Universidad
de Navarra, Irunlarrea 1, E-31008 Pamplona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0542-967X" title="Orcid link">http://orcid.org/0000-0002-0542-967X</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Ana Carolina Ruberte</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=BIO-d7e3012-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ana Carolina Ruberte</b> graduated in Pharmacy in 2015, from University of Navarra, Spain. She is currently a Ph.D. student at the University of Navarra, supervised by Dra. Carmen Sanmartin and Dr. Daniel Plano. She is synthesizing and developing novel selenoheteroaryl derivatives for cancer prevention and therapy. She completed an internship at the Penn State College of Medicine, Hershey, PA, in the laboratory of Dr. Arun K. Sharma, where she synthesized and evaluated novel organoselenium compounds as selective antitumoral agents.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Carmen Sanmartin</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=BIO-d7e3017-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Carmen Sanmartin</b> is Full Professor of Organic and Pharmaceutical Chemistry at the University of Navarra. She is an experienced bioorganic and medicinal chemist with expertise in the design, synthesis, and biological evaluation of small molecules for multiple diseases such as hypertension, herpes, and HIV. More recently, the broad focus of her research has been on development of novel molecules containing selenium as antitumoral and leishmanicidal agents for the elucidation of their mechanism of action. Dr. Sanmartin is the Head of Department of Pharmaceutical Technology and Chemistry at the University of Navarra. Dra. Sanmartin has published more than 100 publications including original research articles, reviews, book chapters, and patents.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Carlos Aydillo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=BIO-d7e3022-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Carlos Aydillo</b> received his Ph.D. in Chemistry from University of La Rioja, Spain, in 2011, followed by several postdoc positions, at Copenhagen University, Denmark, among them. He is currently Assistant Professor of Organic Chemistry at University of Navarra. His area of expertise is the stereoselective organic synthesis and biological chemistry of biomolecules as natural/unnatural amino acids, glycoamino acids and peptides and the development of building blocks for chemical conjugation of these biomolecules. He is also interested in chalcogenide organic chemistry and in particular the synthesis and biological screening of new selenium-based drug candidates against cancerous cells.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Arun K. Sharma</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=BIO-d7e3027-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Arun K. Sharma</b> received his Ph.D. degree in Heterocyclic Chemistry in 1997 from North-Eastern Hill University (India). At present, he is an Associate Professor of Pharmacology at the Penn State College of Medicine, and Co-Director of the “Organic Synthesis Core” of the Penn State Hershey Cancer Institute. The broad focus of Dr. Sharma’s research has been on development of novel small drug-like molecules and elucidation of their efficacy and mechanism of action, particularly in the <i>in vitro</i> and <i>in vivo</i> cancer models. He has expertise in the synthesis, metabolism, efficacy determination, pharmacokinetics, and development of small drug-like molecules.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Daniel Plano</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=BIO-d7e3038-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniel Plano</b> received his B.Sc. in Chemistry from the University of Navarra at Pamplona. He also received the European Ph.D. degree in Science (Chemistry), awarded with the Extraordinary Ph.D. issued in 2010 by the School of Science of the University of Navarra (Spain). In 2011, he received a postdoctoral fellowship from the Navarra’s Government and joined the laboratory of A. K. Sharma where he was mainly working on developing novel small drug-like molecules for cancer prevention and therapy. In 2014, he became Assistant Professor at the Department of Pharmaceutical Technology and Chemistry of the University of Navarra. Nowadays, he has been adjudged with a “José Castillejo” scholarship granted by the Spanish Government (Ministerio de Educación y Formación Profesional) to join again Dr. Sharma’s lab for 3 months.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the Department of Pharmacology and Penn State Cancer Institute of the Penn State College of Medicine and the Plan de Investigacion de la Universidad de Navarra, PIUNA (ref 2018-19) for financial support. A.C.R. expresses her gratitude to the Asociación de Amigos de la Universidad de Navarra and Caixabank for the predoctoral fellowship. D.P. acknowledges the support of his scholarship by “José Castillejo” program granted by Spanish Government (Ministerio de Educación y Formación Profesional).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">5-FU</td><td class="NLM_def"><p class="first last">5-fluorouracil</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Ag85C</td><td class="NLM_def"><p class="first last">antigen 85C</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-secretase 1</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BBSKE</td><td class="NLM_def"><p class="first last">ethaselen</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">BuChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">c-MET</td><td class="NLM_def"><p class="first last">mesenchymal epithelial transition factor</p></td></tr><tr><td class="NLM_term">CHCHD2</td><td class="NLM_def"><p class="first last">coiled-coil-helix-coiled-coil-helix domain containing 2</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DAB</td><td class="NLM_def"><p class="first last">3,3′-diaminobenzidine</p></td></tr><tr><td class="NLM_term">DOX</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">EBS</td><td class="NLM_def"><p class="first last">ebselen</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial-mesenchymal transition</p></td></tr><tr><td class="NLM_term">GAGs</td><td class="NLM_def"><p class="first last">glycosaminoglycans</p></td></tr><tr><td class="NLM_term">GDH</td><td class="NLM_def"><p class="first last">glutamate dehydrogenase</p></td></tr><tr><td class="NLM_term">GPx</td><td class="NLM_def"><p class="first last">glutathione peroxidases</p></td></tr><tr><td class="NLM_term">GSTP</td><td class="NLM_def"><p class="first last">glutathione <i>S</i>-transferase P</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1β</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term">IL-8</td><td class="NLM_def"><p class="first last">interleukin-8</p></td></tr><tr><td class="NLM_term">IMPase</td><td class="NLM_def"><p class="first last">inositol monophosphatase</p></td></tr><tr><td class="NLM_term">MafA</td><td class="NLM_def"><p class="first last">v-maf musculoaponeurotic fibrosarcoma oncogene homolog A</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">Mem</td><td class="NLM_def"><p class="first last">meropenem</p></td></tr><tr><td class="NLM_term">MMP-9</td><td class="NLM_def"><p class="first last">matrix metalloproteinase 9</p></td></tr><tr><td class="NLM_term">MNC</td><td class="NLM_def"><p class="first last">mononuclear cell</p></td></tr><tr><td class="NLM_term">MSN</td><td class="NLM_def"><p class="first last">mesoporous silica nanoparticle</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κB</p></td></tr><tr><td class="NLM_term">NP</td><td class="NLM_def"><p class="first last">polymer nanoparticle</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">Pdots</td><td class="NLM_def"><p class="first last">semiconducting polymer dots</p></td></tr><tr><td class="NLM_term">Pdx-1</td><td class="NLM_def"><p class="first last">pancreatic and duodenal homeobox 1</p></td></tr><tr><td class="NLM_term">PEI</td><td class="NLM_def"><p class="first last">polyethylenimine</p></td></tr><tr><td class="NLM_term">phen</td><td class="NLM_def"><p class="first last">1,10-phenanthroline</p></td></tr><tr><td class="NLM_term">PMA</td><td class="NLM_def"><p class="first last">phorbol 12-myristate 13-acetate</p></td></tr><tr><td class="NLM_term">QSOX1</td><td class="NLM_def"><p class="first last">quiescin sulfhydryl oxidase 1</p></td></tr><tr><td class="NLM_term">RNS</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">Se</td><td class="NLM_def"><p class="first last">selenium</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">Trx</td><td class="NLM_def"><p class="first last">thioredoxin</p></td></tr><tr><td class="NLM_term">TrxR</td><td class="NLM_def"><p class="first last">thioredoxin reductase</p></td></tr><tr><td class="NLM_term">UVA</td><td class="NLM_def"><p class="first last">ultraviolet A</p></td></tr><tr><td class="NLM_term">VEGFR2</td><td class="NLM_def"><p class="first last">endothelial growth factor receptor 2</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 154 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagnoli, L.</span></span> <span> </span><span class="NLM_article-title">Celebrating two centuries of research in selenium chemistry: state of the art and new prospective</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2124</span>, <span class="refDoi"> DOI: 10.3390/molecules22122124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fmolecules22122124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=2124&author=C.+Santiauthor=L.+Bagnoli&title=Celebrating+two+centuries+of+research+in+selenium+chemistry%3A+state+of+the+art+and+new+prospective&doi=10.3390%2Fmolecules22122124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Celebrating two centuries of research in selenium chemistry: state of the art and new prospective</span></div><div class="casAuthors">Santi, Claudio; Bagnoli, Luana</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2124/1-2124/4</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In 2017, the 200th anniversary of the discovery of selenium was celebrated.  In 1817, the Swedish chemists, Berzelius and Gahn, on roasting 200 kg of sulfur from a pyrite from the Falun mine, obtained about 3 g of a ppt. that they first wrongly identified as tellurium.  Berzelius doubted this result and repeated the anal. some months later realizing that a new element was in his hands and he named this element Selenium (Greek: Selene, moon) in consideration of its resemblance to Tellurium (Latin: Tellus, earth).  Several events were organized in the year for this special celebration and this Special Issue would like to be an addnl. contribution to the success of a research that, esp. during the last decades, rapidly grew in different fields: synthesis, medicinal chem., biol., material, and environment.  These studies are strongly characterized by multi- and interdisciplinary connections, and, for this reason, we collected here contributions coming from different areas and disciplines, not exclusively synthetic org. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmAdPeR_BtrVg90H21EOLACvtfcHk0libRRqlDfWpXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWjsr0%253D&md5=80f85396167508eaed2e6b156da81b3f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22122124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22122124%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DC.%26aulast%3DBagnoli%26aufirst%3DL.%26atitle%3DCelebrating%2520two%2520centuries%2520of%2520research%2520in%2520selenium%2520chemistry%253A%2520state%2520of%2520the%2520art%2520and%2520new%2520prospective%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D2124%26doi%3D10.3390%2Fmolecules22122124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wrobel, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toborek, M.</span></span> <span> </span><span class="NLM_article-title">Biological activity of selenium: revisited</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1002/iub.1466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fiub.1466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26714931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2rs7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=97-105&author=J.+K.+Wrobelauthor=R.+Powerauthor=M.+Toborek&title=Biological+activity+of+selenium%3A+revisited&doi=10.1002%2Fiub.1466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activity of selenium: Revisited</span></div><div class="casAuthors">Wrobel, Jagoda K.; Power, Ronan; Toborek, Michal</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-105</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Inc.</span>)
        </div><div class="casAbstract">Selenium (Se) is an essential micronutrient that exerts multiple and complex effects on human health.  Se is essential for human well-being largely due to its potent antioxidant, anti-inflammatory, and antiviral properties.  The physiol. functions of Se are carried out by selenoproteins, in which Se is specifically incorporated as the amino acid, selenocysteine.  Importantly, both beneficial and toxic effects of Se have been reported suggesting that the mode of action of Se is strictly chem. form and concn. dependent.  Addnl., there is a relatively narrow window between Se deficiency and toxicity and growing evidence suggests that Se health effects depend greatly on the baseline level of this micronutrient.  Thus, Se supplementation is not an easy task and requires an individualized approach.  It is essential that we continue to explore and better characterize Se contg. compds. and mechanisms of action, which could be crucial for disease prevention and treatment. © 2015 IUBMB Life, 2015.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXqhFtOp1NBLVg90H21EOLACvtfcHk0liz1g9tj6cXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2rs7nL&md5=6464c0cf45ed3fb134e4b967143bbf5d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fiub.1466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fiub.1466%26sid%3Dliteratum%253Aachs%26aulast%3DWrobel%26aufirst%3DJ.%2BK.%26aulast%3DPower%26aufirst%3DR.%26aulast%3DToborek%26aufirst%3DM.%26atitle%3DBiological%2520activity%2520of%2520selenium%253A%2520revisited%26jtitle%3DIUBMB%2520Life%26date%3D2016%26volume%3D68%26spage%3D97%26epage%3D105%26doi%3D10.1002%2Fiub.1466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosnedlova, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepinska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalickova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruttkay-Nedecky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malevu, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sochor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melcova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zidkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizek, R.</span></span> <span> </span><span class="NLM_article-title">A summary of new findings on the biological effects of selenium in selected animal species-a critical review</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2209</span>, <span class="refDoi"> DOI: 10.3390/ijms18102209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms18102209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOjsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2209&author=B.+Hosnedlovaauthor=M.+Kepinskaauthor=S.+Skalickovaauthor=C.+Fernandezauthor=B.+Ruttkay-Nedeckyauthor=T.+D.+Malevuauthor=J.+Sochorauthor=M.+Baronauthor=M.+Melcovaauthor=J.+Zidkovaauthor=R.+Kizek&title=A+summary+of+new+findings+on+the+biological+effects+of+selenium+in+selected+animal+species-a+critical+review&doi=10.3390%2Fijms18102209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A summary of new findings on the biologicaleffects of selenium in selected animalspecies-a critical review</span></div><div class="casAuthors">Hosnedlova, Bozena; Kepinska, Marta; Skalickova, Sylvie; Fernandez, Carlos; Ruttkay-Nedecky, Branislav; Malevu, Thembinkosi Donald; Sochor, Jiri; Baron, Mojmir; Melcova, Magdalena; Zidkova, Jarmila; Kizek, Rene</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2209/1-2209/47</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Selenium is an essential trace element important for many physiol. processes, esp. for the functions of immune and reproductive systems, metab. of thyroid hormones, as well as antioxidant defense.  Selenium deficiency is usually manifested by an increased incidence of retention of placenta, metritis, mastitis, aborts, lowering fertility and increased susceptibility to infections.  In calves, lambs and kids, the selenium deficiency demonstrates by WMD (white muscle disease), in foals and donkey foals, it is assocd. with incidence of WMD and yellow fat disease, and in pigs it causes VESD (vitamin E/selenium deficiency) syndrome.  The prevention of these health disorders can be achieved by an adequate selenium supplementation to the diet.  The review summarizes the survey of knowledge on selenium, its biol. significance in the organism, the impact of its deficiency in mammalian livestock (comparison of ruminants vs. non-ruminants, herbivore vs. omnivore) and possibilities of its peroral administration.  The databases employed were as follows: Web of Science, PubMed, MEDLINE and Google Scholar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJxzPfJlMhDbVg90H21EOLACvtfcHk0liz1g9tj6cXIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOjsbzM&md5=119910d01bc4383d22977ce7735ec865</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fijms18102209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18102209%26sid%3Dliteratum%253Aachs%26aulast%3DHosnedlova%26aufirst%3DB.%26aulast%3DKepinska%26aufirst%3DM.%26aulast%3DSkalickova%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DRuttkay-Nedecky%26aufirst%3DB.%26aulast%3DMalevu%26aufirst%3DT.%2BD.%26aulast%3DSochor%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DM.%26aulast%3DMelcova%26aufirst%3DM.%26aulast%3DZidkova%26aufirst%3DJ.%26aulast%3DKizek%26aufirst%3DR.%26atitle%3DA%2520summary%2520of%2520new%2520findings%2520on%2520the%2520biological%2520effects%2520of%2520selenium%2520in%2520selected%2520animal%2520species-a%2520critical%2520review%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D2209%26doi%3D10.3390%2Fijms18102209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hondal, R. J.</span></span> <span> </span><span class="NLM_article-title">Why nature chose selenium</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1Ors70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=821-841&author=H.+J.+Reichauthor=R.+J.+Hondal&title=Why+nature+chose+selenium&doi=10.1021%2Facschembio.6b00031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Why Nature Chose Selenium</span></div><div class="casAuthors">Reich, Hans J.; Hondal, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">821-841</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors were asked by the Editors of ACS Chem. Biol. to write an article titled "Why Nature Chose Selenium" for the occasion of the upcoming bicentennial of the discovery of selenium by the Swedish chemist Jons Jacob Berzelius in 1817 and styled after the famous work of Frank Westheimer on the biol. chem. of phosphate.  This work gives a history of the important discoveries of the biol. processes that selenium participates in, and a point-by-point comparison of the chem. of selenium with the atom it replaces in biol., sulfur.  This anal. shows that redox chem. is the largest chem. difference between the two chalcogens.  This difference is very large for both one-electron and two-electron redox reactions.  Much of this difference is due to the inability of selenium to form π bonds of all types.  The outer valence electrons of selenium are also more loosely held than those of sulfur.  As a result, selenium is a better nucleophile and will react with reactive oxygen species faster than sulfur, but the resulting lack of π-bond character in the Se-O bond means that the Se-oxide can be much more readily reduced in comparison to S-oxides.  The combination of these properties means that replacement of sulfur with selenium in nature results in a selenium-contg. biomol. that resists permanent oxidn.  Multiple examples of this gain of function behavior from the literature are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnHxvzkvNsAbVg90H21EOLACvtfcHk0liJHlxJrThkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1Ors70%253D&md5=e1f53c0a82a1eb27b7c66ec75f15c5af</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00031%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DH.%2BJ.%26aulast%3DHondal%26aufirst%3DR.%2BJ.%26atitle%3DWhy%2520nature%2520chose%2520selenium%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D821%26epage%3D841%26doi%3D10.1021%2Facschembio.6b00031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A. T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. M.</span></span> <span> </span><span class="NLM_article-title">Selenium species: current status and potentials in cancer prevention and therapy</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">75</span>, <span class="refDoi"> DOI: 10.3390/ijms20010075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms20010075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFahtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=75&author=H.+W.+Tanauthor=H.+Y.+Moauthor=A.+T.+Y.+Lauauthor=Y.+M.+Xu&title=Selenium+species%3A+current+status+and+potentials+in+cancer+prevention+and+therapy&doi=10.3390%2Fijms20010075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium species: current status and potentials in cancer prevention and therapy</span></div><div class="casAuthors">Tan, Heng Wee; Mo, Hai-Ying; Lau, Andy T. Y.; Xu, Yan-Ming</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75/1-75/26</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Selenium (Se) acts as an essential trace element in the human body due to its unique biol. functions, particularly in the oxidn.-redn. system.  Although several clin. trials indicated no significant benefit of Se in preventing cancer, researchers reported that some Se species exhibit superior anticancer properties.  Therefore, a reassessment of the status of Se and Se compds. is necessary in order to provide clearer insights into the potentiality of Se in cancer prevention and therapy.  In this review, we organize relevant forms of Se species based on the three main categories of Se-inorg., org., and Se-contg. nanoparticles (SeNPs)-and overview their potential functions and applications in oncol.  Here, we specifically focus on the SeNPs as they have tremendous potential in oncol. and other fields.  In general, to make better use of Se compds. in cancer prevention and therapy, extensive further study is still required to understand the underlying mechanisms of the Se compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE45SgXQ6zELVg90H21EOLACvtfcHk0liJHlxJrThkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFahtr7F&md5=cd9dcd0c5245b0a5d7082130c5ba621f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fijms20010075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20010075%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DH.%2BW.%26aulast%3DMo%26aufirst%3DH.%2BY.%26aulast%3DLau%26aufirst%3DA.%2BT.%2BY.%26aulast%3DXu%26aufirst%3DY.%2BM.%26atitle%3DSelenium%2520species%253A%2520current%2520status%2520and%2520potentials%2520in%2520cancer%2520prevention%2520and%2520therapy%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D75%26doi%3D10.3390%2Fijms20010075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, T.</span></span> <span> </span><span class="NLM_article-title">Small organoselenium compounds: more than just glutathione peroxidase mimics</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">10074</span>– <span class="NLM_lpage">10076</span>, <span class="refDoi"> DOI: 10.1002/anie.201505056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fanie.201505056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyqurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=10074-10076&author=T.+Wirth&title=Small+organoselenium+compounds%3A+more+than+just+glutathione+peroxidase+mimics&doi=10.1002%2Fanie.201505056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Small Organoselenium Compounds: More than just Glutathione Peroxidase Mimics</span></div><div class="casAuthors">Wirth, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10074-10076</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review of organoselenium compds. as glutathione peroxidase mimics.  Glutathione peroxidase is one of the mammalian antioxidant enzymes which is able to decomp. ROS, such as peroxides.  The human enzymes have a selenocysteine residue in their active site which is responsible for the catalytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE5Iodc99pDLVg90H21EOLACvtfcHk0liJHlxJrThkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyqurrF&md5=b7cf2151dd89b251c5a49e88dd4b6bd1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fanie.201505056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201505056%26sid%3Dliteratum%253Aachs%26aulast%3DWirth%26aufirst%3DT.%26atitle%3DSmall%2520organoselenium%2520compounds%253A%2520more%2520than%2520just%2520glutathione%2520peroxidase%2520mimics%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D10074%26epage%3D10076%26doi%3D10.1002%2Fanie.201505056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piroddi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, F.</span></span> <span> </span><span class="NLM_article-title">Selenium containing compounds from poison to drug candidates: a review on the GPx-like activity</span>. <i>Curr. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.2174/2212796811307010003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2174%2F2212796811307010003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotlykt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=25-36&author=C.+Santiauthor=C.+Tideiauthor=C.+Scaleraauthor=M.+Piroddiauthor=F.+Galli&title=Selenium+containing+compounds+from+poison+to+drug+candidates%3A+a+review+on+the+GPx-like+activity&doi=10.2174%2F2212796811307010003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium containing compounds from poison to drug candidates: a review on the GPx-like activity</span></div><div class="casAuthors">Santi, Claudio; Tidei, Caterina; Scalera, Claudia; Piroddi, Marta; Galli, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-36</span>CODEN:
                <span class="NLM_cas:coden">CCBUB2</span>;
        ISSN:<span class="NLM_cas:issn">2212-7968</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress results from the formation of reactive oxygen species (ROS) such as peroxides that cause damage to cell membranes and react with various biomols. in mammalian cells.  The selenoenzyme glutathione peroxidase (GPx) destroys peroxides by catalyzing their redn. to alcs. or water with the stoichiometric reductant glutathione.  The effects of oxidative stress have been implicated in a variety of degenerative processes and disease states and for these reasons, there is considerable interest in the discovery of small mol. compds. that could reproduce a GPx-like activity.  A review on the most recent acquisition in this area is here reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6JziBQt1QbVg90H21EOLACvtfcHk0liJHlxJrThkEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotlykt70%253D&md5=cd39e1b58fa824b8d44c0e7283ed4e8a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F2212796811307010003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F2212796811307010003%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DC.%26aulast%3DTidei%26aufirst%3DC.%26aulast%3DScalera%26aufirst%3DC.%26aulast%3DPiroddi%26aufirst%3DM.%26aulast%3DGalli%26aufirst%3DF.%26atitle%3DSelenium%2520containing%2520compounds%2520from%2520poison%2520to%2520drug%2520candidates%253A%2520a%2520review%2520on%2520the%2520GPx-like%2520activity%26jtitle%3DCurr.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D7%26spage%3D25%26epage%3D36%26doi%3D10.2174%2F2212796811307010003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, D.</span>; <span class="NLM_string-name">Sancineto, L.</span>; <span class="NLM_string-name">de Bem, A. F.</span>; <span class="NLM_string-name">Tew, K. D.</span>; <span class="NLM_string-name">Santi, C.</span>; <span class="NLM_string-name">Radi, R.</span>; <span class="NLM_string-name">Toquato, P.</span>; <span class="NLM_string-name">Galli, F.</span></span> <span> </span><span class="NLM_article-title">Selenocompounds in cancer therapy: an overview</span>. In  <i>Selenium and Selenoproteins in Cancer</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, K. D.</span>, <span class="NLM_string-name">Galli, F.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">136</span>, pp  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">302</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fbs.acr.2017.07.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=259-302&author=D.+Bartolini&author=L.+Sancineto&author=A.+F.+de+Bem&author=K.+D.+Tew&author=C.+Santi&author=R.+Radi&author=P.+Toquato&author=F.+Galliauthor=K.+D.+Tew&author=F.+Galli&title=Selenium+and+Selenoproteins+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2017.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fbs.acr.2017.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DD.%26atitle%3DSelenocompounds%2520in%2520cancer%2520therapy%253A%2520an%2520overview%26btitle%3DSelenium%2520and%2520Selenoproteins%2520in%2520Cancer%26aulast%3DTew%26aufirst%3DK.%2BD.%26pub%3DAcademic%2520Press%26date%3D2017%26volume%3D136%26spage%3D259%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span> <span> </span><span class="NLM_article-title">Selenium compounds as therapeutic agents in cancer</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1850</i></span>,  <span class="NLM_fpage">1642</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbagen.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25459512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSnu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1850&publication_year=2015&pages=1642-1660&author=A.+P.+Fernandesauthor=V.+Gandin&title=Selenium+compounds+as+therapeutic+agents+in+cancer&doi=10.1016%2Fj.bbagen.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium compounds as therapeutic agents in cancer</span></div><div class="casAuthors">Fernandes, Aristi P.; Gandin, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1850</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1642-1660</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  With cancer cells encompassing consistently higher prodn. of reactive oxygen species (ROS) and with an induced antioxidant defense to counteract the increased basal ROS prodn., tumors have a limited reserve capacity resulting in an increased vulnerability of some cancer cells to ROS.  Based on this, oxidative stress has been recognized as a tumor-specific target for the rational design of new anticancer agents.  Among redox modulating compds., selenium compds. have gained substantial attention due to their promising chemotherapeutic potential.  This review aims in summarizing and providing the recent developments of our understanding of the mol. mechanisms that underlie the potential anticancer effects of selenium compds.  It is well established that selenium at higher doses readily can turn into a prooxidant and thereby exert its potential anticancer properties.  However, the biol. activity of selenium compds. and the mechanism behind these effects are highly dependent on its speciation and the specific metabolic pathways of cells and tissues.  Conversely, the chem. properties and the main mol. mechanisms of the most relevant inorg. and org. selenium compds. as well as selenium-based nanoparticles must be taken into account and are discussed herein.  Elucidating and deepening our mechanistic knowledge of selenium compds. will help in designing and optimizing compds. with more specific antitumor properties for possible future application of selenium compds. in the treatment of cancer.  This article is part of a Special Issue entitled Redox regulation of differentiation and de-differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptRneM5vXqrVg90H21EOLACvtfcHk0ljRWVRjHMNWJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSnu77E&md5=49d79e46bf4ab507c3a97d00d688ef20</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DA.%2BP.%26aulast%3DGandin%26aufirst%3DV.%26atitle%3DSelenium%2520compounds%2520as%2520therapeutic%2520agents%2520in%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2015%26volume%3D1850%26spage%3D1642%26epage%3D1660%26doi%3D10.1016%2Fj.bbagen.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.</span></span> <span> </span><span class="NLM_article-title">Organoselenium small molecules and chromium(III) complexes for intervention in chronic low-grade inflammation and type 2 diabetes</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.2174/1568026615666150827094815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2174%2F1568026615666150827094815" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=823-834&author=J.+Zhouauthor=H.+Xuauthor=K.+Huang&title=Organoselenium+small+molecules+and+chromium%28III%29+complexes+for+intervention+in+chronic+low-grade+inflammation+and+type+2+diabetes&doi=10.2174%2F1568026615666150827094815"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150827094815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150827094815%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DK.%26atitle%3DOrganoselenium%2520small%2520molecules%2520and%2520chromium%2528III%2529%2520complexes%2520for%2520intervention%2520in%2520chronic%2520low-grade%2520inflammation%2520and%2520type%25202%2520diabetes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D16%26spage%3D823%26epage%3D834%26doi%3D10.2174%2F1568026615666150827094815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bijian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaoui-Jamali, M. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2011.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22204902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=143-152&author=K.+Bijianauthor=Z.+Zhangauthor=B.+Xuauthor=S.+Jieauthor=B.+Chenauthor=S.+Wanauthor=J.+Wuauthor=T.+Jiangauthor=M.+A.+Alaoui-Jamali&title=Synthesis+and+biological+activity+of+novel+organoselenium+derivatives+targeting+multiple+kinases+and+capable+of+inhibiting+cancer+progression+to+metastases&doi=10.1016%2Fj.ejmech.2011.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases</span></div><div class="casAuthors">Bijian, Krikor; Zhang, Zhongwei; Xu, Bin; Jie, Su; Chen, Bo; Wan, Shengbiao; Wu, JianHui; Jiang, Tao; Alaoui-Jamali, Moulay A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-152</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The present study reports synthesis and biol. activity of novel benzoisoselenazolone compds. derived from ebselen and conjugated to a sugar mol.  Cell proliferation assay using cancer cells combined with in vitro biochem. assays revealed that benzoisoselenazolone, e.g. I, exerted antiproliferative activity, which correlated with selective in vitro inhibition of focal adhesion kinase, AKT-1, and protein kinase C-α.  Active mols. were able to significantly inhibit cell migration and invasion in vitro compared to cells treated with the vehicle alone or ebselen.  Moreover, in vivo anticancer activity focusing on lead compd. 2d and using an invasive human breast cancer orthotopic mouse model revealed a potent anti-metastatic activity at well-tolerated doses.  In summary, these novel benzoisoselenazolones we report herein target multiple kinases with established roles in cancer progression and possess anti-invasive and anti-metastatic activity in pre-clin. models supporting a potential for therapeutic application for human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4LeFcbaxPLVg90H21EOLACvtfcHk0ljRWVRjHMNWJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKmtro%253D&md5=8d27330fb6b7585e3f3c09c514eca020</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DBijian%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DJie%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DWan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DAlaoui-Jamali%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520novel%2520organoselenium%2520derivatives%2520targeting%2520multiple%2520kinases%2520and%2520capable%2520of%2520inhibiting%2520cancer%2520progression%2520to%2520metastases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D48%26spage%3D143%26epage%3D152%26doi%3D10.1016%2Fj.ejmech.2011.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbatsch, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of selenazole-containing peptides for cocrystallization with P-glycoprotein</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">873</span>, <span class="refDoi"> DOI: 10.1002/cbic.201100048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fcbic.201100048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=21387512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12htbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=868-873&author=H.+Taoauthor=Y.+Wengauthor=R.+Zhuoauthor=G.+Changauthor=I.+L.+Urbatschauthor=Q.+Zhang&title=Design+and+synthesis+of+selenazole-containing+peptides+for+cocrystallization+with+P-glycoprotein&doi=10.1002%2Fcbic.201100048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Selenazole-Containing Peptides for Cocrystallization with P-Glycoprotein</span></div><div class="casAuthors">Tao, Hou-Chao; Weng, Yue; Zhuo, Ru-Peng; Chang, Geoffrey; Urbatsch, Ina L.; Zhang, Qing-Hai</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">868-873</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Over-expression of P-glycoprotein (Pgp) in some cancer cells is a primary cause of multidrug resistance (MDR) that results in chemotherapy failure.  In order to produce a diverse array of selenium-labeled peptides for structural studies directed at mapping the flexible binding sites of Pgp, the authors developed a procedure for the efficient prepn. of optically pure selanazole-contg. peptides.  Thus, all 20 natural amino acid-derived selenazoles I (R = amino acid side chain) were synthesized in a three-step procedure starting from chiral nitriles (S)-BocNHCH(R)CN.  Next, selenazole-contg. cyclic peptides were prepd., and their binding activity towards Pgp was evaluated using a commonly used calcein acetoxymethyl ester (calcein-AM) transport assay in Pgp-overexpressing CR1R12 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6CvJyDd-yjrVg90H21EOLACvtfcHk0ljRWVRjHMNWJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12htbY%253D&md5=193fe810052e8ffc6b276b5ee7788171</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201100048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201100048%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DH.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DZhuo%26aufirst%3DR.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520selenazole-containing%2520peptides%2520for%2520cocrystallization%2520with%2520P-glycoprotein%26jtitle%3DChemBioChem%26date%3D2011%26volume%3D12%26spage%3D868%26epage%3D873%26doi%3D10.1002%2Fcbic.201100048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">887</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1248/cpb.c12-00250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1248%2Fcpb.c12-00250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22790823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=887-891&author=Z.+H.+Luoauthor=S.+Y.+Heauthor=B.+Q.+Chenauthor=Y.+P.+Shiauthor=Y.+M.+Liuauthor=C.+W.+Liauthor=Q.+S.+Wang&title=Synthesis+and+in+vitro+antitumor+activity+of+1%2C3%2C4-oxadiazole+derivatives+based+on+benzisoselenazolone&doi=10.1248%2Fcpb.c12-00250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone</span></div><div class="casAuthors">Luo, Zhen-Hua; He, Shuang-Yan; Chen, Bao-Quan; Shi, Yan-Ping; Liu, Yu-Ming; Li, Cai-Wen; Wang, Qiu-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">887-891</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A series of novel 1,3,4-oxadiazole derivs. based on benzisoselenazolone was prepd. and was tested for antiproliferative activity in vitro against human cancer cell lines: SSMC-7721 (liver cancer), MCF-7 (breast cancer), and A549 (lung cancer).  All the compds. exhibited antiproliferative activity and showed selective cytotoxicity against different cancer cells.  Two of the compds. showed significant antiproliferative activities against MCF-7 cells, with IC50 of 1.07 and 1.76 μM.  One of latter compds. was also the most potent compd. against SSMC-7721 cells, with IC50 = 4.46 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrlzBgbrZqILVg90H21EOLACvtfcHk0lhyq63N7aK4jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrsLjM&md5=f27622be25be99d96c7ee01b9b6531ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c12-00250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c12-00250%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DZ.%2BH.%26aulast%3DHe%26aufirst%3DS.%2BY.%26aulast%3DChen%26aufirst%3DB.%2BQ.%26aulast%3DShi%26aufirst%3DY.%2BP.%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DLi%26aufirst%3DC.%2BW.%26aulast%3DWang%26aufirst%3DQ.%2BS.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antitumor%2520activity%2520of%25201%252C3%252C4-oxadiazole%2520derivatives%2520based%2520on%2520benzisoselenazolone%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2012%26volume%3D60%26spage%3D887%26epage%3D891%26doi%3D10.1248%2Fcpb.c12-00250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a series of novel 2,4,5-trisubstituted selenazole compounds as potential PLTP inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5123</span>– <span class="NLM_lpage">5125</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2010.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=20667734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5123-5125&author=C.+Lingauthor=Z.+Zhengauthor=X.+C.+Jiangauthor=W.+Zhongauthor=S.+Li&title=Synthesis+of+a+series+of+novel+2%2C4%2C5-trisubstituted+selenazole+compounds+as+potential+PLTP+inhibitors&doi=10.1016%2Fj.bmcl.2010.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a series of novel 2,4,5-trisubstituted selenazole compounds as potential PLTP inhibitors</span></div><div class="casAuthors">Ling, Cui; Zheng, Zhibing; Jiang, Xian Cheng; Zhong, Wu; Li, Song</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5123-5125</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on a homol.-modeled structure of PLTP (plasma phospholipid transfer protein) and characteristic structural features of reported cholesteryl ester transfer protein (CETP) inhibitors, we designed and synthesized a novel series of 2,4,5-trisubstituted selenazole compds.  Biol. evaluation reveals that compds. I (R1 = Ph, R2 = H, R3 = H; R1 = Bu, R2 = R3 = OH) exhibit favorable PLTP activity, and their IC50s are 8 μM and 10 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXbnPlCTadJ7Vg90H21EOLACvtfcHk0lhyq63N7aK4jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbfL&md5=a06fb93ceefd7cd068e2793a62dc7dd8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DX.%2BC.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520series%2520of%2520novel%25202%252C4%252C5-trisubstituted%2520selenazole%2520compounds%2520as%2520potential%2520PLTP%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5123%26epage%3D5125%26doi%3D10.1016%2Fj.bmcl.2010.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiß, R.</span></span> <span> </span><span class="NLM_article-title">Über selenhaltige aromatische verbindungen (VI)</span>. <i>Ber. Dtsch. Chem. Ges. B</i> <span class="NLM_year" style="font-weight: bold;">1924</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1082</span>, <span class="refDoi"> DOI: 10.1002/cber.19240570703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fcber.19240570703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADyaB2cXitlChsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1924&pages=1077-1082&author=R.+Lesserauthor=R.+Wei%C3%9F&title=%C3%9Cber+selenhaltige+aromatische+verbindungen+%28VI%29&doi=10.1002%2Fcber.19240570703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic compounds containing selenium. VI</span></div><div class="casAuthors">Lesser, R.; Weiss, R.</div><div class="citationInfo"><span class="NLM_cas:title">Berichte der Deutschen Chemischen Gesellschaft [Abteilung] B: Abhandlungen</span>
        (<span class="NLM_cas:date">1924</span>),
    <span class="NLM_cas:volume">57B</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1077-82</span>CODEN:
                <span class="NLM_cas:coden">BDCBAD</span>;
        ISSN:<span class="NLM_cas:issn">0365-9488</span>.
    </div><div class="casAbstract">cf. C. A. 9, 80.  A more convenient method for the prepn. of selenoxanthone (I) has been worked out.  The product (II) of the action of CrO3 on I is not an addn. product of I, as previously supposed, but of selenoxide-xanthone (III) and its cleavage product is III itself, which on heating at its m. p. or under the influence of other reagents loses O, not H2O, giving I.  The soly. of III (in part even in H2O) with yellowish color is due to the addn. of H2O with production of HO groups.  The o-HSeC6H4COCl (IV) is very reactive, giving with NH3 benzoylene selenimide, Se.C6H4.CO.NH (V), with primary bases the corresponding substituted imides, with Na2S benzoylene selenosulfide (VI) and with Na2Se benzoylene diselenide (VII).  I, m. 191-2° (all m. ps. are cor.), is obtained in 10.3 g. yield of crude or 7.5 g. yield of pure product from 10 g. IV in 100 cc. dry thiophene-free C6H6 slowly treated with 11 g. AlCl3 and, when the gas evolution ceases, heated 1 hr. at 50-60° and then 1 hr. at the b. p. II, C13H8O2Se.CrO3, gives with NH3 III, decomps. 236-7°; air-dry, III contains varying amts. of H2O which it loses in vacuo over P2O5 or at 120-30°.  With PhMe instead of C6H6, IV gives β1- or β2-methylselenoxanthone, faintly yellowish, m. 112-3°, sol. in concd. H2SO4 with orange-yellow color.  V (7.4 g. crude product from 10 g. IV in cold C6H6 with dry NH3), needles or tables mutually interconvertible by seeding, m. 234-5°, both forms giving a red color with alc. FeCl3, forms alkali salts easily sol. in H2O but difficultly sol. in excess of alkali, gives in AcOH with CrO3 an addn. product which has approx. the compn. C7H5ONSe.CrO3 (no solvent suitable for crystn. could be found) but which on decompn. yields no homogeneous product; on long boiling with excess of Ac2O V gives an Ac deriv., begins to turn yellow 130°, m. 172-4°, sol. in hot AcOH with a yellowish color which disappears on cooling.  Benzoyleneselenmethylimide, obtained with MeNH2 gas instead of NH3, prisms with faintly yellowish shimmer, m. 159-60°, also obtained from the Ag salt of V with excess of MeI on the H2O bath in a sealed tube.  Et homolog, m. 102-3°.  Ph analog, from IV and PhNH2 in cold Et2O, m. 182-3°. o-Tolyl homolog, m. 187-8°.  N,N-Methylene di[benzoyleneselenimide], from the K salt of V and CH2I2 refluxed in AmOH, m. 331-2°.  VI (4.4 g. of crude product from 5.1 g. IV in 80 cc. Me2CO treated with 5 g. Na2S (fused in its H2O of crystn.) and then refluxed), orange, m. 83-4°, insol. in Na2CO3 or NaOH even on heating, dissolves unchanged in concd. H2SO4 with yellow color.  VII (8 g. from K2Se (prepd. by passing into 5.6 g. K2CO3 in 10 cc. H2O under CO2 the H2Se from 12 g. FeSe and 31 g. HCl of d. 1.12) treated cold with 10 g. IV in 50 cc. Me2CO and then refluxed 1 hr.), red, m. 91-2°, sol. in concd. H2SO4 with yellow color, the soln. becoming turbid on standing and evolving the odor of SO2. (PhCH2)2Se2, m. 90-1°, is obtained in 184 g. yield from 159 g. PhCH2Cl shaken with 100 g. red pptd. Se and 310 g. crystd. Na2S in 500 cc. H2O; 50 g. slowly added to 220 g. cold HNO3 (d. 1.4) gives 21 g. PhCH2SeO2H, m. 122-3° (Jackson, Ann. 179, 13(1875), gives 85°); Ba salt (2H2O); Ca salt (6H2O); the acid with PCl5 in dry Et2O gives, not the chloride, but (PhCH2)2SeCl2, m. 134-5° (Strecker and Willing, C. A. 9, 1179, give 128°).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYHvIwLyTdy7Vg90H21EOLACvtfcHk0lhyq63N7aK4jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaB2cXitlChsQ%253D%253D&md5=682d8cb16b87ccfe02e534e5fbda8a74</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcber.19240570703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.19240570703%26sid%3Dliteratum%253Aachs%26aulast%3DLesser%26aufirst%3DR.%26aulast%3DWei%25C3%259F%26aufirst%3DR.%26atitle%3D%25C3%259Cber%2520selenhaltige%2520aromatische%2520verbindungen%2520%2528VI%2529%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%2520B%26date%3D1924%26volume%3D57%26spage%3D1077%26epage%3D1082%26doi%3D10.1002%2Fcber.19240570703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safayhi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiegs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendel, A.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2691</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(85)90569-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2885%2990569-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=2990494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADyaL2MXkvFyntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=2691-2694&author=H.+Safayhiauthor=G.+Tiegsauthor=A.+Wendel&title=A+novel+biologically+active+seleno-organic+compound%2D%2DV.+Inhibition+by+ebselen+%28PZ+51%29+of+rat+peritoneal+neutrophil+lipoxygenase&doi=10.1016%2F0006-2952%2885%2990569-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active seleno-organic compound - V.  Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase</span></div><div class="casAuthors">Safayhi, Hasan; Tiegs, Gisa; Wendel, Albrecht</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2691-4</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Suspensions of rat peritoneal polymorphonuclear leukocytes (PMNLs) elicited with glycogen were stimulated by Ca and an ionophore to produce leukotrienes from endogenous arachidonic acid.  The effect of the nontoxic, anti-inflammatory seleno-org. compd., ebselen (PZ 51)(I)  [60940-34-3] was investigated.  When ethanolic exts. of the medium of stimulated cells were analyzed by HPLC, a concn.-dependent inhibition by ebselen of leukotriene b4 (LTB4)  [71160-24-2] formation with a concomitant decrease of 5-hydroxyeicosatetraenoic acid (5-HETE)  [71030-39-2] prodn. was found.  Half-max. inhibition was obsd. at 20-μM ebselen.  Similar findings were obtained after anal. of CHCl3 exts. of both cells and medium using a different HPLC system.  Under these conditions, enhanced 5-HETE formation was assocd. with reduced prodn. of LTB4 and other dihydroxyeicosatetraenoate (di-HETE) isomers, when purified glutathione peroxidase  [9013-66-5] plus GSH were present.  Thus, the reported GSH peroxidase-like activity of ebselen, catalyzing the redn. of 5-hydroperoxyeicosatetraenoate (5-HPETE)  [70968-82-0] to 5-HETE, can not account for these findings.  Therefore, the lipoxygenase  [9029-60-1] reaction itself apparently represents the site of inhibition of LTB4 formation by ebselen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWGSiwX1XyKbVg90H21EOLACvtfcHk0liMr8HLSW-xiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXkvFyntrY%253D&md5=0c6b904a21350720941f6fe0123ce1a5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2885%2990569-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252885%252990569-6%26sid%3Dliteratum%253Aachs%26aulast%3DSafayhi%26aufirst%3DH.%26aulast%3DTiegs%26aufirst%3DG.%26aulast%3DWendel%26aufirst%3DA.%26atitle%3DA%2520novel%2520biologically%2520active%2520seleno-organic%2520compound--V.%2520Inhibition%2520by%2520ebselen%2520%2528PZ%252051%2529%2520of%2520rat%2520peritoneal%2520neutrophil%2520lipoxygenase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D2691%26epage%3D2694%26doi%3D10.1016%2F0006-2952%2885%2990569-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active selenoorganic compound--IV. Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1185</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(85)90493-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2885%2990493-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=3994741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADyaL2M7pvFWqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=1185-1189&author=A.+Mullerauthor=H.+Gabrielauthor=H.+Sies&title=A+novel+biologically+active+selenoorganic+compound%2D%2DIV.+Protective+glutathione-dependent+effect+of+PZ+51+%28ebselen%29+against+ADP-Fe+induced+lipid+peroxidation+in+isolated+hepatocytes&doi=10.1016%2F0006-2952%2885%2990493-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active selenoorganic compound--IV. Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes</span></div><div class="casAuthors">Muller A; Gabriel H; Sies H</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1185-9</span>
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">PZ 51 (Ebselen) is capable of inhibiting ADP-Fe-induced lipid peroxidation in isolated hepatocytes, assessed by generation of low-level chemiluminescence, and the formation of alkanes (ethane, n-pentane) and malondialdehyde.  The sulphur analog PZ 25 is much less active.  PZ 51 is ineffective in glutathione-depleted hepatocytes that were obtained after phorone pretreatment of the animals.  However, other antioxidants, like (+)-cyanidanol-3 or diethyldithiocarbamate are effective in inhibiting lipid peroxidation also in glutathione-depleted cells.  The results are attributed to a GSH peroxidase-like activity of PZ 51.  Addition of the chemically synthetized compound, PZ 51-SG, a glutathione adduct of PZ 51, does not provide extra protection in GSH-depleted cells in comparison to the parent compound, PZ 51.  Dithioerythritol exhibits a protective effect, and PZ 51 is more efficient than in the absence of this thiol reductant.  Dithioerythritol also exerts an effect in glutathione-depleted cells.  A peroxidase-like activity using DTE as reductant is demonstrated in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlAtgJ8F5ZJQwxfk_AGB-EfW6udTcc2eZfgfwUsTBBybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7pvFWqsA%253D%253D&md5=9c105e936b8f63bb05adea11a9e3ceb3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2885%2990493-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252885%252990493-9%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DGabriel%26aufirst%3DH.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DA%2520novel%2520biologically%2520active%2520selenoorganic%2520compound--IV.%2520Protective%2520glutathione-dependent%2520effect%2520of%2520PZ%252051%2520%2528ebselen%2529%2520against%2520ADP-Fe%2520induced%2520lipid%2520peroxidation%2520in%2520isolated%2520hepatocytes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D1185%26epage%3D1189%26doi%3D10.1016%2F0006-2952%2885%2990493-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wendel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fausel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safayhi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiegs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otter, R.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">3241</span>– <span class="NLM_lpage">3245</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(84)90084-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2884%2990084-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=6487371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADyaL2MXjvFKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1984&pages=3241-3245&author=A.+Wendelauthor=M.+Fauselauthor=H.+Safayhiauthor=G.+Tiegsauthor=R.+Otter&title=A+novel+biologically+active+seleno-organic+compound%2D%2DII.+Activity+of+PZ+51+in+relation+to+glutathione+peroxidase&doi=10.1016%2F0006-2952%2884%2990084-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active seleno-organic compound - II.  Activity of PZ 51 in relation to glutathione peroxidase</span></div><div class="casAuthors">Wendel, Albrecht; Fausel, Martina; Safayhi, Hasan; Tiegs, Gisa; Otter, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3241-5</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The antiinflammatory compd. PZ 51 (I)  [60940-34-3] catalyzed GSSG formation from GSH in the presence of hydroperoxides in an NADPH/GSSG reductase system with the following rates (Δ log GSH/min per M selenium): 1.1 × 106 with H2O2, 1.2 × 106 with butylhydroperoxide, 1.7 × 106 with cumenehydroperoxide.  The reaction catalyzed by the sulfur analog of PZ 51 was negligible.  Similar results were obtained in a direct assay of glutathione peroxidase (GSH-Px)  [9013-66-5] activity based on GSH estn. by dithionitrobenzoate.  The activation energy of the reaction was detd. as 55 kJ/mol·deg in the presence of 30 μmol/L PZ 51 compared to 36.5 kJ/mol·deg obtained in the presence of 1 nmol/L pure GSH-Px isolated from bovine red blood cells.  In mouse liver microsomes NADPH-dependent aminopyrine dealkylase  [9037-69-8] activity was totally inhibited in the presence of 50 μmol/L PZ 51.  In vivo expts. with Se-deficient mice showed that the Se-moiety of PZ 51 is not available for the synthesis of the selenoenzyme GSH-Px after dietary treatment or i.p. doses up to 25 mg Se as PZ 51 per kg body wt.  After oral administration of labeled PZ 51, unlike with selenite, no radioactivity was incorporated into GSH-Px within 48 h.  The data suggest that several similarities between PZ 51 and the active site of GSH-Px exist, resulting in the capability of the compd. to catalyze the GSH-Px reaction.  An extracellular pharmacodynamic action of the drug seems likely.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU1AxhueKd6bVg90H21EOLACvtfcHk0liMr8HLSW-xiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXjvFKitw%253D%253D&md5=a1475814e1a0c5ab4599dd82235b2993</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2884%2990084-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252884%252990084-4%26sid%3Dliteratum%253Aachs%26aulast%3DWendel%26aufirst%3DA.%26aulast%3DFausel%26aufirst%3DM.%26aulast%3DSafayhi%26aufirst%3DH.%26aulast%3DTiegs%26aufirst%3DG.%26aulast%3DOtter%26aufirst%3DR.%26atitle%3DA%2520novel%2520biologically%2520active%2520seleno-organic%2520compound--II.%2520Activity%2520of%2520PZ%252051%2520in%2520relation%2520to%2520glutathione%2520peroxidase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1984%26volume%3D33%26spage%3D3241%26epage%3D3245%26doi%3D10.1016%2F0006-2952%2884%2990084-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindt, S.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active seleno-organic compound--III. Effects of PZ 51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">3247</span>– <span class="NLM_lpage">3250</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(84)90085-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2884%2990085-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=6593071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADyaL2MXktVShu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1984&pages=3247-3250&author=M.+J.+Parnhamauthor=S.+Kindt&title=A+novel+biologically+active+seleno-organic+compound%2D%2DIII.+Effects+of+PZ+51+%28ebselen%29+on+glutathione+peroxidase+and+secretory+activities+of+mouse+macrophages&doi=10.1016%2F0006-2952%2884%2990085-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active seleno-organic compound - III.  Effects of PZ 51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages</span></div><div class="casAuthors">Parnham, Michael J.; Kindt, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3247-50</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">PZ 51 (I) a selenium-contg. compd. with glutathione peroxidase (GSH-Px)-like activity, was administered to selenium-deficient mice for 5 days.  A significant increase in peritoneal macrophage GSH-Px activity after treatment was only obsd. when basal GSH-Px activity was almost zero (i.e. in 19 wk selenium-deficient animals), possibly due to binding of PZ 51 to the macrophages.  This indicates that PZ 51 releases very little, if any, free selenium for incorporation into endogenous GSH-Px.  The compd. in vitro exerted a concn.-dependent inhibition of the generation of chemiluminescence by resident mouse peritoneal macrophages and a partial inhibition of the prodn. of prostaglandin E2 by resident peritoneal macrophages.  β-Glucuronidase prodn. by C. parvum-activated peritoneal macrophages was unaffected by PZ 51.  These in vitro data can be explained on the basis of a selective peroxide scavenging and/or GSH-Px-like activity of PZ 51, offering a novel approach to anti-inflammatory therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc-UiEcsGUarVg90H21EOLACvtfcHk0lgdpQUKGhBF8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktVShu7g%253D&md5=967be0e8b251a7c2e9c1e3c5660966a6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2884%2990085-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252884%252990085-6%26sid%3Dliteratum%253Aachs%26aulast%3DParnham%26aufirst%3DM.%2BJ.%26aulast%3DKindt%26aufirst%3DS.%26atitle%3DA%2520novel%2520biologically%2520active%2520seleno-organic%2520compound--III.%2520Effects%2520of%2520PZ%252051%2520%2528ebselen%2529%2520on%2520glutathione%2520peroxidase%2520and%2520secretory%2520activities%2520of%2520mouse%2520macrophages%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1984%26volume%3D33%26spage%3D3247%26epage%3D3250%26doi%3D10.1016%2F0006-2952%2884%2990085-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadenas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen)</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">3235</span>– <span class="NLM_lpage">3239</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(84)90083-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2884%2990083-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=6487370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADyaL2M%252Fit1Onug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1984&pages=3235-3239&author=A.+Mullerauthor=E.+Cadenasauthor=P.+Grafauthor=H.+Sies&title=A+novel+biologically+active+seleno-organic+compound%2D%2DI.+Glutathione+peroxidase-like+activity+in+vitro+and+antioxidant+capacity+of+PZ+51+%28ebselen%29&doi=10.1016%2F0006-2952%2884%2990083-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen)</span></div><div class="casAuthors">Muller A; Cadenas E; Graf P; Sies H</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3235-9</span>
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">a synthetic seleno-organic compound, 2-phenyl-1,2-benzoisoselenazol-3(2H)-one (PZ 51), exhibits GSH peroxidase-like activity in vitro, in contrast to its sulfur analog, PZ 25.  In addition, PZ 51 behaves as an antioxidant shown by a temporary protection of rat liver microsomes against ascorbate/ADP-Fe-induced lipid peroxidation, an effect also elicited by PZ 25 but to a smaller extent.  This protection against lipid peroxidation is independent of GSH and of P-450 monooxygenase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrRhFmcWNw6sULxIEhxUjPfW6udTcc2eZXCwAkZ41lfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M%252Fit1Onug%253D%253D&md5=007fe0c40dbe5479f70c6391eda933d8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2884%2990083-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252884%252990083-2%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DCadenas%26aufirst%3DE.%26aulast%3DGraf%26aufirst%3DP.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DA%2520novel%2520biologically%2520active%2520seleno-organic%2520compound--I.%2520Glutathione%2520peroxidase-like%2520activity%2520in%2520vitro%2520and%2520antioxidant%2520capacity%2520of%2520PZ%252051%2520%2528ebselen%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1984%26volume%3D33%26spage%3D3235%26epage%3D3239%26doi%3D10.1016%2F0006-2952%2884%2990083-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klann, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulco, B. C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmeier, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, C. W.</span></span> <span> </span><span class="NLM_article-title">A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer’s disease</span>. <i>J. Psychiatr. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.jpsychires.2018.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.jpsychires.2018.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30521994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BB3crpt1KjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2019&pages=107-117&author=F.+Martiniauthor=S.+G.+Rosaauthor=I.+P.+Klannauthor=B.+C.+W.+Fulcoauthor=F.+B.+Carvalhoauthor=F.+L.+Rahmeierauthor=M.+C.+Fernandesauthor=C.+W.+Nogueira&title=A+multifunctional+compound+ebselen+reverses+memory+impairment%2C+apoptosis+and+oxidative+stress+in+a+mouse+model+of+sporadic+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jpsychires.2018.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease</span></div><div class="casAuthors">Martini Franciele; Rosa Suzan Goncalves; Klann Isabella Pregardier; Fulco Bruna Cruz Weber; Carvalho Fabiano Barbosa; Rahmeier Francine Luciano; Fernandes Marilda Cruz; Nogueira Cristina Wayne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer 's disease (AD) is characterized by progressive cognitive decline including memory impairment, cortical dysfunction, and neuropsychiatric disturbances.  The drug discovery to treat AD consists to develop compounds able to act in multiple molecular targets involved in the pathogenesis of the disease and the repositioning of old drugs for new application.  This way, the intracerebroventricular (icv) injection of streptozotocin (STZ) has been used as a metabolic model of sporadic AD.  The aim of the present study was to investigate whether ebselen (1-10 mg/kg), a multifunctional selenoorganic compound, ameliorates memory impairment, hippocampal oxidative stress, apoptosis and cell proliferation in a mouse model of sporadic AD induced by icv STZ (3 mg/kg, 1 μl/min).  The administration of ebselen (10 mg/kg, i.p.) reversed memory impairment and hippocampal oxidative stress, by increasing the activities of antioxidant enzymes and the level of a non-enzymatic antioxidant defense, in Swiss mice administered with icv STZ.  The anti-apoptotic property of ebselen was demonstrated by its effectiveness against the increase in the ratios of Bax/Bcl-2, cleaved PARP/PARP and the cleaved caspase-3 levels in the hippocampus of icv STZ mice.  Although ebselen reversed memory impairment, it was ineffective against the reduction in the number of BrdU positive cells induced by icv STZ.  In conclusion, the multifunctional selenoorganic compound ebselen was effective to reverse memory impairment, hippocampal oxidative stress and apoptosis in a mouse model of sporadic AD induced by icv STZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2LWJWidS9THRxY89Cm6SyfW6udTcc2eZXCwAkZ41lfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crpt1KjsA%253D%253D&md5=3d86850110eb7986c65035f3c5e29f16</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.jpsychires.2018.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpsychires.2018.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DMartini%26aufirst%3DF.%26aulast%3DRosa%26aufirst%3DS.%2BG.%26aulast%3DKlann%26aufirst%3DI.%2BP.%26aulast%3DFulco%26aufirst%3DB.%2BC.%2BW.%26aulast%3DCarvalho%26aufirst%3DF.%2BB.%26aulast%3DRahmeier%26aufirst%3DF.%2BL.%26aulast%3DFernandes%26aufirst%3DM.%2BC.%26aulast%3DNogueira%26aufirst%3DC.%2BW.%26atitle%3DA%2520multifunctional%2520compound%2520ebselen%2520reverses%2520memory%2520impairment%252C%2520apoptosis%2520and%2520oxidative%2520stress%2520in%2520a%2520mouse%2520model%2520of%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D2019%26volume%3D109%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.jpsychires.2018.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span> <span> </span><span class="NLM_article-title">Target discovery of ebselen with a biotinylated probe</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">9506</span>– <span class="NLM_lpage">9509</span>, <span class="refDoi"> DOI: 10.1039/C8CC04258F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC8CC04258F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30091742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=9506-9509&author=Z.+Chenauthor=Z.+Jiangauthor=N.+Chenauthor=Q.+Shiauthor=L.+Tongauthor=F.+Kongauthor=X.+Chengauthor=H.+Chenauthor=C.+Wangauthor=B.+Tang&title=Target+discovery+of+ebselen+with+a+biotinylated+probe&doi=10.1039%2FC8CC04258F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Target discovery of ebselen with a biotinylated probe</span></div><div class="casAuthors">Chen, Zhenzhen; Jiang, Zhongyao; Chen, Nan; Shi, Qian; Tong, Lili; Kong, Fanpeng; Cheng, Xiufen; Chen, Hao; Wang, Chu; Tang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">68</span>),
    <span class="NLM_cas:pages">9506-9509</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Despite numerous studies on ebselen over the past decade, its cellular targets remain obscure.  Here we synthesized a biotinylated ebselen probe (biotin-ebselen) and characterized ebselen-binding proteins via an efficient activity-based protein profiling (ABPP) method, which allowed for the robust identification of 462 targeted proteins in HeLa cells.  This first work of global target profiling of ebselen will be helpful to re-design ebselen-based therapy appropriately in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdllLJcNTxYLVg90H21EOLACvtfcHk0lhPLv_iFMDpUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWht7fF&md5=ff523727589707dd1461379f61407160</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC8CC04258F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CC04258F%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DB.%26atitle%3DTarget%2520discovery%2520of%2520ebselen%2520with%2520a%2520biotinylated%2520probe%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2018%26volume%3D54%26spage%3D9506%26epage%3D9509%26doi%3D10.1039%2FC8CC04258F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span> <span> </span><span class="NLM_article-title">The early research and development of ebselen</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1248</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2013.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bcp.2013.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24012716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVylu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=1248-1253&author=M.+J.+Parnhamauthor=H.+Sies&title=The+early+research+and+development+of+ebselen&doi=10.1016%2Fj.bcp.2013.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The early research and development of ebselen</span></div><div class="casAuthors">Parnham, Michael J.; Sies, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1248-1253</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one; PZ-51, DR-3305), is an organoselenium compd. with glutathione peroxidase (GPx)-like, thiol-dependent, hydroperoxide reducing activity.  As an enzyme mimic for activity of the selenoenzyme GPx, this compd. has proved to be highly useful in research on mechanisms in redox biol.  Furthermore, the reactivity of ebselen with protein thiols has helped to identify novel, selective targets for inhibitory actions on several enzymes of importance in pharmacol. and toxicol.  Importantly, the selenium in ebselen is not released and thus is not bioavailable, ebselen metabolites being excreted in bile and urine.  As a consequence, initial concerns about selenium toxicity, fortunately, were unfounded.  Potential applications in medical settings have been explored, notably in brain ischemia and stroke.  More recently, there has been a surge in interest as new medical applications have been taken into consideration.  The first publication on the biochem. effects of ebselen appeared 30 years ago, which prompted the authors to retrace the early development from their perspective.  It is a fascinating example of fruitful interaction between research-oriented industry and academia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbNs5kAFJVD7Vg90H21EOLACvtfcHk0lhPLv_iFMDpUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVylu7fN&md5=76722e2600ba62e2f6be8334593c1c05</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DParnham%26aufirst%3DM.%2BJ.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DThe%2520early%2520research%2520and%2520development%2520of%2520ebselen%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26spage%3D1248%26epage%3D1253%26doi%3D10.1016%2Fj.bcp.2013.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, N.</span></span> <span> </span><span class="NLM_article-title">Ebselen, a useful tool for understanding cellular redox biology and a promising drug candidate for use in human diseases</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>595</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2015.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.abb.2015.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27095225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtleisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=595&publication_year=2016&pages=109-112&author=N.+Noguchi&title=Ebselen%2C+a+useful+tool+for+understanding+cellular+redox+biology+and+a+promising+drug+candidate+for+use+in+human+diseases&doi=10.1016%2Fj.abb.2015.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen, a useful tool for understanding cellular redox biology and a promising drug candidate for use in human diseases</span></div><div class="casAuthors">Noguchi, Noriko</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">595</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109-112</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ebselen is an organoselenium compd. with glutathione peroxidase (GPx)-like hydroperoxide reducing activity.  Moreover, ebselen has its own unique reactivity, with functions that GPx does not have, since it reacts with many kinds of thiols other than glutathione.  Ebselen may affect the thioredoxin systems, through which it may contribute to regulation of cell function.  With high reactivity toward thiols, hydroperoxides, and peroxynitrite, ebselen has been used as a useful tool in research on cellular redox mechanisms.  Unlike α-tocopherol, ebselen does not scavenge lipid peroxyl radicals, which is another advantage of ebselen for use as a research tool in comparison with radical scavenging antioxidants.  Selenium is not released from the ebselen mol., which explains the low toxicity of ebselen.  To further understand the mechanism of cellular redox biol., it should be interesting to compare the effects of ebselen with that of selenoprotein P, which supplies selenium to GPx.  New medical applications of ebselen as a drug candidate for human diseases such as cancer and diabetes mellitus as well as brain stroke and ischemia will be expected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUS82VR1d17Vg90H21EOLACvtfcHk0lh1QmnPn2WQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtleisL0%253D&md5=1296b21fdafafec78648801c59adc9dc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2015.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2015.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DN.%26atitle%3DEbselen%252C%2520a%2520useful%2520tool%2520for%2520understanding%2520cellular%2520redox%2520biology%2520and%2520a%2520promising%2520drug%2520candidate%2520for%2520use%2520in%2520human%2520diseases%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2016%26volume%3D595%26spage%3D109%26epage%3D112%26doi%3D10.1016%2Fj.abb.2015.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azad, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomar, R. S.</span></span> <span> </span><span class="NLM_article-title">Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways</span>. <i>Mol. Biol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">4865</span>– <span class="NLM_lpage">4879</span>, <span class="refDoi"> DOI: 10.1007/s11033-014-3417-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs11033-014-3417-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24867080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Gntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=4865-4879&author=G.+K.+Azadauthor=R.+S.+Tomar&title=Ebselen%2C+a+promising+antioxidant+drug%3A+mechanisms+of+action+and+targets+of+biological+pathways&doi=10.1007%2Fs11033-014-3417-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways</span></div><div class="casAuthors">Azad, Gajendra Kumar; Tomar, Raghuvir S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4865-4879</span>CODEN:
                <span class="NLM_cas:coden">MLBRBU</span>;
        ISSN:<span class="NLM_cas:issn">0301-4851</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ebselen, an organoselenium compd., mimics glutathione peroxidase activity.  It is a multifunctional compd., which catalyzes several essential reactions for the protection of cellular components from oxidative and free radical damage.  Based on a no. of in vitro and in vivo studies, various mechanisms are proposed to understand the biomedical actions of ebselen in health and diseases.  It modulates metallo-proteins, enzymic cofactors, gene expression, epigenetics, antioxidant defenses and immune systems.  Owing to these properties, ebselen is currently under clin. trials for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis, and cancer.  A few ebselen-based pharmaceutical agents are under extensive investigation.  As ebselen has been shown to have significant cellular toxicity, appropriate studies are needed to redesign the ebselen-based therapy for clin. trials.  This review summarizes current understanding of the biochem. and mol. properties, and pharmacol. applications of ebselen and future directions in this area of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsR7BfKLYxAbVg90H21EOLACvtfcHk0lh1QmnPn2WQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Gntbw%253D&md5=9592c6d44387e26927af07e3c7d39b9c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs11033-014-3417-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11033-014-3417-x%26sid%3Dliteratum%253Aachs%26aulast%3DAzad%26aufirst%3DG.%2BK.%26aulast%3DTomar%26aufirst%3DR.%2BS.%26atitle%3DEbselen%252C%2520a%2520promising%2520antioxidant%2520drug%253A%2520mechanisms%2520of%2520action%2520and%2520targets%2520of%2520biological%2520pathways%26jtitle%3DMol.%2520Biol.%2520Rep.%26date%3D2014%26volume%3D41%26spage%3D4865%26epage%3D4879%26doi%3D10.1007%2Fs11033-014-3417-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santofimia-Castaño, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izquierdo-Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaza-Davila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Bermejo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateos-Rodriguez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salido, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span> <span> </span><span class="NLM_article-title">Ebselen impairs cellular oxidative state and induces endoplasmic reticulum stress and activation of crucial mitogen-activated protein kinases in pancreatic tumour AR42J cells</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1122</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1002/jcb.26280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fjcb.26280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28703940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1SksbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2018&pages=1122-1133&author=P.+Santofimia-Casta%C3%B1oauthor=A.+Izquierdo-Alvarezauthor=M.+Plaza-Davilaauthor=A.+Martinez-Ruizauthor=M.+Fernandez-Bermejoauthor=J.+M.+Mateos-Rodriguezauthor=G.+M.+Salidoauthor=A.+Gonzalez&title=Ebselen+impairs+cellular+oxidative+state+and+induces+endoplasmic+reticulum+stress+and+activation+of+crucial+mitogen-activated+protein+kinases+in+pancreatic+tumour+AR42J+cells&doi=10.1002%2Fjcb.26280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen impairs cellular oxidative state and induces endoplasmic reticulum stress and activation of crucial mitogen-activated protein kinases in pancreatic tumour AR42J cells</span></div><div class="casAuthors">Santofimia-Castano, Patricia; Izquierdo-Alvarez, Alicia; Plaza-Davila, Maria; Martinez-Ruiz, Antonio; Fernandez-Bermejo, Miguel; Mateos-Rodriguez, Jose M.; Salido, Gines M.; Gonzalez, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1122-1133</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) is an organoselenium radical scavenger compd., which has strong antioxidant and anti-inflammatory effects.  However, evidence suggests that this compd. could exert deleterious actions on cell physiol.  In this study, we have analyzed the effect of ebselen on rat pancreatic AR42J cells.  Cytosolic free-Ca2+ concn. ([Ca2+]c), cellular oxidative status, setting of endoplasmic reticulum stress, and phosphorylation of major mitogen-activated protein kinases were analyzed.  Our results show that ebselen evoked a concn.-dependent increase in [Ca2+]c.  The compd. induced an increase in the generation of reactive oxygen species in the mitochondria.  We also obsd. an increase in global cysteine oxidn. in the presence of ebselen.  In the presence of ebselen an impairment of cholecystokinin-evoked amylase release was noted.  Moreover, involvement of the unfolded protein response markers, ER chaperone and signaling regulator GRP78/BiP, eukaryotic translation initiation factor 2α and X-box binding protein 1 was detected.  Finally, increases in the phosphorylation of SAPK/JNK, p38 MAPK, and p44/42 MAPK in the presence of ebselen were also obsd.  Our results provide evidences for an impairment of cellular oxidative state and enzyme secretion, the induction of endoplasmic reticulum stress and the activation of crucial mitogen-activated protein kinases in the presence of ebselen.  As a consequence ebselen exerts a potential toxic effect on AR42J cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjeZyQ1exDl7Vg90H21EOLACvtfcHk0lh1QmnPn2WQZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1SksbzN&md5=24ed1266651fcc6e434e41b6279e61bc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fjcb.26280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.26280%26sid%3Dliteratum%253Aachs%26aulast%3DSantofimia-Casta%25C3%25B1o%26aufirst%3DP.%26aulast%3DIzquierdo-Alvarez%26aufirst%3DA.%26aulast%3DPlaza-Davila%26aufirst%3DM.%26aulast%3DMartinez-Ruiz%26aufirst%3DA.%26aulast%3DFernandez-Bermejo%26aufirst%3DM.%26aulast%3DMateos-Rodriguez%26aufirst%3DJ.%2BM.%26aulast%3DSalido%26aufirst%3DG.%2BM.%26aulast%3DGonzalez%26aufirst%3DA.%26atitle%3DEbselen%2520impairs%2520cellular%2520oxidative%2520state%2520and%2520induces%2520endoplasmic%2520reticulum%2520stress%2520and%2520activation%2520of%2520crucial%2520mitogen-activated%2520protein%2520kinases%2520in%2520pancreatic%2520tumour%2520AR42J%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2018%26volume%3D119%26spage%3D1122%26epage%3D1133%26doi%3D10.1002%2Fjcb.26280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis in human multiple myeloma cell lines by ebselen via enhancing the endogenous reactive oxygen species production</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">696107</span>, <span class="refDoi"> DOI: 10.1155/2014/696107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1155%2F2014%2F696107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24587987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC2cvpvVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=696107&author=L.+Zhangauthor=L.+Zhouauthor=J.+Duauthor=M.+Liauthor=C.+Qianauthor=Y.+Chengauthor=Y.+Pengauthor=J.+Xieauthor=D.+Wang&title=Induction+of+apoptosis+in+human+multiple+myeloma+cell+lines+by+ebselen+via+enhancing+the+endogenous+reactive+oxygen+species+production&doi=10.1155%2F2014%2F696107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis in human multiple myeloma cell lines by ebselen via enhancing the endogenous reactive oxygen species production</span></div><div class="casAuthors">Zhang Liang; Zhou Liwei; Du Jia; Li Mengxia; Qian Chengyuan; Cheng Yi; Peng Yang; Xie Jiayin; Wang Dong</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">696107</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ebselen a selenoorganic compound showing glutathione peroxidase like activity is an anti-inflammatory and antioxidative agent.  Its cytoprotective activity has been investigated in recent years.  However, experimental evidence also shows that ebselen causes cell death in several cancer cell types whose mechanism has not yet been elucidated.  In this study, we examined the effect of ebselen on multiple myeloma (MM) cell lines in vitro.  The results showed that ebselen significantly enhanced the production of reactive oxygen species (ROS) accompanied by cell viability decrease and apoptosis rate increase.  Further studies revealed that ebselen can induce Bax redistribution from the cytosol to mitochondria leading to mitochondrial membrane potential ΔΨm changes and cytochrome C release from the mitochondria to cytosol.  Furtherly, we found that exogenous addition of N-acetyl cysteine (NAC) completely diminished the cell damage induced by ebselen.  This result suggests that relatively high concentration of ebselen can induce MM cells apoptosis in culture by enhancing the production of endogenous ROS and triggering mitochondria mediated apoptotic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRByoz9pGRQNa2q3xNe7a7QfW6udTcc2eZybRyMXsHlLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvpvVWjtA%253D%253D&md5=22d209ef9051e3a5eb15d39dd08775ed</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1155%2F2014%2F696107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F696107%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520human%2520multiple%2520myeloma%2520cell%2520lines%2520by%2520ebselen%2520via%2520enhancing%2520the%2520endogenous%2520reactive%2520oxygen%2520species%2520production%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D696107%26doi%3D10.1155%2F2014%2F696107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanavan, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katchman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faigel, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.-t.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergienko, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, D. F.</span></span> <span> </span><span class="NLM_article-title">Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">18418</span>– <span class="NLM_lpage">18428</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.4099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.18632%2Foncotarget.4099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26158899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fhs1ertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=18418-18428&author=P.+D.+Hanavanauthor=C.+R.+Borgesauthor=B.+A.+Katchmanauthor=D.+O.+Faigelauthor=T.+H.+Hoauthor=C.-t.+Maauthor=E.+A.+Sergienkoauthor=N.+Meuriceauthor=J.+L.+Petitauthor=D.+F.+Lake&title=Ebselen+inhibits+QSOX1+enzymatic+activity+and+suppresses+invasion+of+pancreatic+and+renal+cancer+cell+lines&doi=10.18632%2Foncotarget.4099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines</span></div><div class="casAuthors">Hanavan Paul D; Lake Douglas F; Borges Chad R; Katchman Benjamin A; Faigel Douglas O; Ho Thai H; Meurice Nathalie; Petit Joachim L; Ma Chen-Ting; Sergienko Eduard A</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">18418-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Quiescin sulfhydryl oxidase 1 (QSOX1) is a highly conserved disulfide bond-generating enzyme that is overexpressed in diverse tumor types.  Its enzymatic activity promotes the growth and invasion of tumor cells and alters extracellular matrix composition.  In a nude mouse-human tumor xenograft model, tumors containing shRNA for QSOX1 grew significantly more slowly than controls, suggesting that QSOX1 supports a proliferative phenotype in vivo.  High throughput screening experiments identified ebselen as an in vitro inhibitor of QSOX1 enzymatic activity.  Ebselen treatment of pancreatic and renal cancer cell lines stalled tumor growth and inhibited invasion through Matrigel in vitro.  Daily oral treatment with ebselen resulted in a 58% reduction in tumor growth in mice bearing human pancreatic tumor xenografts compared to controls.  Mass spectrometric analysis of ebselen-treated QSOX1 mechanistically revealed that C165 and C237 of QSOX1 covalently bound to ebselen.  This report details the anti-neoplastic properties of ebselen in pancreatic and renal cancer cell lines.  The results here offer a "proof-of-principle" that enzymatic inhibition of QSOX1 may have clinical relevancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIO6QDcRzGzPx2phytoz6_fW6udTcc2eZybRyMXsHlLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fhs1ertQ%253D%253D&md5=7b5f38602a2396a04779bdb1fe504417</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4099%26sid%3Dliteratum%253Aachs%26aulast%3DHanavan%26aufirst%3DP.%2BD.%26aulast%3DBorges%26aufirst%3DC.%2BR.%26aulast%3DKatchman%26aufirst%3DB.%2BA.%26aulast%3DFaigel%26aufirst%3DD.%2BO.%26aulast%3DHo%26aufirst%3DT.%2BH.%26aulast%3DMa%26aufirst%3DC.-t.%26aulast%3DSergienko%26aufirst%3DE.%2BA.%26aulast%3DMeurice%26aufirst%3DN.%26aulast%3DPetit%26aufirst%3DJ.%2BL.%26aulast%3DLake%26aufirst%3DD.%2BF.%26atitle%3DEbselen%2520inhibits%2520QSOX1%2520enzymatic%2520activity%2520and%2520suppresses%2520invasion%2520of%2520pancreatic%2520and%2520renal%2520cancer%2520cell%2520lines%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D18418%26epage%3D18428%26doi%3D10.18632%2Foncotarget.4099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thabet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustafa, E.</span></span> <span> </span><span class="NLM_article-title">Synergistic effect of ebselen and gamma radiation on breast cancer cells</span>. <i>Int. J. Radiat. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1080/09553002.2017.1325024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1080%2F09553002.2017.1325024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28463038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2017&pages=784-792&author=N.+Thabetauthor=E.+Moustafa&title=Synergistic+effect+of+ebselen+and+gamma+radiation+on+breast+cancer+cells&doi=10.1080%2F09553002.2017.1325024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effect of Ebselen and gamma radiation on breast cancer cells</span></div><div class="casAuthors">Thabet, Noura M.; Moustafa, Enas M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">784-792</span>CODEN:
                <span class="NLM_cas:coden">IJRBE7</span>;
        ISSN:<span class="NLM_cas:issn">0955-3002</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Purpose: To explore the synergistic effect of a seleno-org. compd. Ebselen (Ebs) and/or γ-radiation to exert antitumor effects on human breast cancer (MCF-7) cell line in vitro.  Materials and methods: Ebs cytotoxicity at various concns. (10, 25, 50 and 75 μg), cell proliferation and clonogenic assay of Ebs and/or γ-radiation (at 1, 3 and 6 Gy), expression of p-IκBα and NF-κB, inflammatory cytokines levels (TNF-α, IL-2, INF-γ, IL-10 and TGF-β), apoptotic factors (Caspase-3, Granzyme-B and TRAIL) and angiogenic factor (VEGF) were investigated.  Results: The results showed that the effective dosage of this combination was obsd. at 25 μg/mL of Ebs with γ-radiation at 6 Gy.  Data displayed a significant redn. in NF-κB mRNA along with an elevation in granzyme-B mRNA and TRAIL mRNA expression.  Furthermore, protein expression of caspase-3 was elevated, whereas p-IκBα and p-NF-κB(p65) protein expression was reduced significantly.  Also, a significant decline in TNF-α, IL-2, INF-γ, TGF-β with a significant increase in IL-10 levels were revealed.  Meanwhile, a significant decrease in VEGF level and proliferation capacity were obsd.  Conclusions: We conclude that a combination of Ebs with radiotherapy has a major antitumor efficiency in inducing apoptosis and inhibiting cancer cell progression, due to the synergistic effect in regulating gene and protein expression, and in a modulating response of pro-and anti-inflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_q15ta4ZCx7Vg90H21EOLACvtfcHk0liMpS-Z0iys7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKhurs%253D&md5=039ae05f57afe4eeab24f0e870919fa0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1080%2F09553002.2017.1325024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09553002.2017.1325024%26sid%3Dliteratum%253Aachs%26aulast%3DThabet%26aufirst%3DN.%26aulast%3DMoustafa%26aufirst%3DE.%26atitle%3DSynergistic%2520effect%2520of%2520ebselen%2520and%2520gamma%2520radiation%2520on%2520breast%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Radiat.%2520Biol.%26date%3D2017%26volume%3D93%26spage%3D784%26epage%3D792%26doi%3D10.1080%2F09553002.2017.1325024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span> <span> </span><span class="NLM_article-title">Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1038/aps.2016.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1038%2Faps.2016.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27917873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFemu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=223-232&author=S.+F.+Yeauthor=J.+Liauthor=S.+M.+Jiauthor=H.+H.+Zengauthor=W.+Lu&title=Dose-biomarker-response+modeling+of+the+anticancer+effect+of+ethaselen+in+a+human+non-small+cell+lung+cancer+xenograft+mouse+model&doi=10.1038%2Faps.2016.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model</span></div><div class="casAuthors">Ye, Suo-fu; Li, Jian; Ji, Shuang-min; Zeng, Hui-hui; Lu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thioredoxin reductase (TrxR) is a component of several redox-sensitive signaling cascades that mediate important biol. processes such as cell survival, maturation, growth, migration and inhibition of apoptosis.  The expression levels of TrxR1 in some human carcinoma cell lines are nearly 10 times higher than those in normal cells.  Ethaselen is a novel antitumor candidate that exerts potent inhibition on non-small cell lung cancer (NSCLC) by targeting TrxR.  In this study we explored the relationship between the ethaselen dose and TrxR activity level and the relationship between TrxR degrdn. and tumor apoptosis in a human lung carcinoma A549 xenograft model.  BALB/c nude mice implanted with human NSCLC cell line A54 were administered ethaselen (36, 72, 108 mg·kg-1·d-1, ig) or vehicle for 10 d.  The tumor size and TrxR activity levels in tumor tissues were daily recorded and detected.  Based on the exptl. data, NONMEM 7.2 was used to develop an integrated dose-biomarker-response model for describing the quant. relationship between ethaselen dose and tumor eradication effects.  The time course of TrxR activity levels was modeled using an indirect response model (IDR model), in which the influence of the tumor growth rates on Kin with the linear correction factor γ1 (0.021 d/mm).  The drug binding-inhibition effects on Kout was described using a sigmoidal Emax model with Smax (5.95), SC50 (136 mg/kg) and Hill's coeff. γ2 (2.29).  The influence of TrxR activity inhibition on tumor eradication was characterized by an Emax model with an Emax (130 mm3/d) and EC50 (0.0676).  This model was further validated using a visual predictive check (VPC) and was used to predict the efficacy of different doses.  In conclusion, the properties and characteristics of ethaselen acting on TrxR degrdn. and subsequently resulting in tumor apoptosis are characterized by the IDR model and integrated dose-biomarker-response model with high goodness-of-fit and great predicative ability.  This approach shed new light on the detailed processes and mechanism of ethaselen action and may offer a valuable ref. for an appropriate dosing regimen for use in further clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZTDsUmqoHfrVg90H21EOLACvtfcHk0lh25wMNhKS2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFemu70%253D&md5=44d18ca03808ccd049b7a3e3e9aea222</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Faps.2016.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2016.114%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DS.%2BM.%26aulast%3DZeng%26aufirst%3DH.%2BH.%26aulast%3DLu%26aufirst%3DW.%26atitle%3DDose-biomarker-response%2520modeling%2520of%2520the%2520anticancer%2520effect%2520of%2520ethaselen%2520in%2520a%2520human%2520non-small%2520cell%2520lung%2520cancer%2520xenograft%2520mouse%2520model%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2017%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1038%2Faps.2016.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span> <span> </span><span class="NLM_article-title">Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2017.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.cbi.2017.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28757135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OhsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2017&pages=74-85&author=X.+Zhengauthor=W.+Xuauthor=R.+Sunauthor=H.+Yinauthor=C.+Dongauthor=H.+Zeng&title=Synergism+between+thioredoxin+reductase+inhibitor+ethaselen+and+sodium+selenite+in+inhibiting+proliferation+and+inducing+death+of+human+non-small+cell+lung+cancer+cells&doi=10.1016%2Fj.cbi.2017.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells</span></div><div class="casAuthors">Zheng, Xiaoqing; Xu, Wei; Sun, Ruoxuan; Yin, Hanwei; Dong, Chaoran; Zeng, Huihui</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-85</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">New effective treatment for human non-small cell lung cancer (NSCLC) is needed.  The thioredoxin (Trx) system composes of thioredoxin reductase (TrxR), Trx and NADPH.  In this study, we combined an org. selenium compd.--TrxR inhibitor ethaselen (BBSKE) with low dosage sodium selenite to inhibit proliferation and induce death of NSCLC cells, and identified underlying mechanisms.  Synergistic anti-proliferation effect of BBSKE and selenite was found in human NSCLC cell lines, A549, NCI-H1299 and NCI-1266.  A significant increase of apoptosis, necrosis and autophagy were obsd. in the group of BBSKE plus selenite in A549 cells.  The autophagy induced by BBSKE and selenite inhibited apoptosis and necrosis.  In addn., BBSKE plus selenite induced G2/M arrest, which was verified by the alteration of gene and protein expression of cell cycle regulatory complexes.  The intracellular enzyme activity of TrxR was remarkably decreased by cotreatment of BBSKE and selenite.  Besides, the mRNA and protein level of TrxR1 and Trx1 were significantly inhibited by cotreatment of BBSKE and selenite.  HEK 293 cells overexpressing TrxR1 were more sensitive to BBSKE plus selenite.  The nuclear translocation of Trx1 and Ref-1, as well as expression of Ref-1 and AP-1 were inhibited by combination treatment.  In short, BBSKE synergizes selenite in inhibiting proliferation and inducing death of NSCLC cells; BBSKE combined with selenite may be a treatment strategy for NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Nf655harybVg90H21EOLACvtfcHk0lh25wMNhKS2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OhsrbO&md5=72836b3fd29501295b99d449f1af1f3f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2017.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2017.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DC.%26aulast%3DZeng%26aufirst%3DH.%26atitle%3DSynergism%2520between%2520thioredoxin%2520reductase%2520inhibitor%2520ethaselen%2520and%2520sodium%2520selenite%2520in%2520inhibiting%2520proliferation%2520and%2520inducing%2520death%2520of%2520human%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2017%26volume%3D275%26spage%3D74%26epage%3D85%26doi%3D10.1016%2Fj.cbi.2017.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span> <span> </span><span class="NLM_article-title">Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2016.06.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.biopha.2016.06.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27372405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFWht73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2016&pages=212-220&author=X.+Zhengauthor=Y.+Zhangauthor=L.+Zhangauthor=W.+Xuauthor=W.+Maauthor=R.+Sunauthor=H.+Zeng&title=Synergistic+inhibition+of+sunitinib+and+ethaselen+against+human+colorectal+cancer+cells+proliferation&doi=10.1016%2Fj.biopha.2016.06.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation</span></div><div class="casAuthors">Zheng, Xiaoqing; Zhang, Yunhan; Zhang, Lei; Xu, Wei; Ma, Weiwei; Sun, Ruoxuan; Zeng, Huihui</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">212-220</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Sunitinib, a multi-targeted tyrosine kinase inhibitor, has been widely used in the therapy of advanced renal cell cancer and imatinib-resistant gastrointestinal stromal tumors.  However, little benefits could be obtained from sunitinib for patients with other types of solid tumors including colorectal cancer (CRC).  Ethaselen (BBSKE), a specific thioredoxin reductase 1 inhibitor, has shown convincing anticancer effects both in vivo and in vitro.  In this study, we explored the combinatory effect of sunitinib and BBSKE in human CRC cell lines LoVo, HT-29 and RKO.  Cotreatment of BBSKE and sunitinib with the ratio of 2:1 for 24 h displayed synergistic effect against CRC cells proliferation.  Apoptosis anal. also revealed that combination treatment of BBSKE and sunitinib (2:1) for 24 h induced higher apoptosis rate than either single treatment.  The synergistic effect against LoVo cells proliferation may be explained by sharp redn. of Bcl-2/Bax protein expression ratio, decrease of pro-Caspase-3 protein expression along with significantly augmented Caspase-3 enzymic activity, and release of cytochrome C from mitochondria to cytoplasm in the combination treatment group.  The significant inhibition of vascular endothelial growth factor receptor 2 (VEGFR2) phosphorylation might also account for the synergism in cotreatment group.  In short, sunitinib plus BBSKE is perhaps a promising strategy for colorectal cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVu1ylBpRdVLVg90H21EOLACvtfcHk0lh25wMNhKS2KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFWht73I&md5=35e1dd73f9e370306ecc8f8dc17e6d99</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.06.040%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DH.%26atitle%3DSynergistic%2520inhibition%2520of%2520sunitinib%2520and%2520ethaselen%2520against%2520human%2520colorectal%2520cancer%2520cells%2520proliferation%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D83%26spage%3D212%26epage%3D220%26doi%3D10.1016%2Fj.biopha.2016.06.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H. H.</span></span> <span> </span><span class="NLM_article-title">Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis</span>. <i>J. Zhejiang Univ., Sci., B</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1631/jzus.B1600073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1631%2Fjzus.B1600073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28471109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsVarsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=373-382&author=S.+F.+Yeauthor=Y.+Yangauthor=L.+Wuauthor=W.+W.+Maauthor=H.+H.+Zeng&title=Ethaselen%3A+a+novel+organoselenium+anticancer+agent+targeting+thioredoxin+reductase+1+reverses+cisplatin+resistance+in+drug-resistant+K562+cells+by+inducing+apoptosis&doi=10.1631%2Fjzus.B1600073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis</span></div><div class="casAuthors">Ye, Suo-fu; Yang, Yong; Wu, Lin; Ma, Wei-wei; Zeng, Hui-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Zhejiang University, Science, B</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-382</span>CODEN:
                <span class="NLM_cas:coden">JZUSAM</span>;
        ISSN:<span class="NLM_cas:issn">1673-1581</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">It has been reported that Ethaselen shows inhibitory effects on thioredoxin reductase (TrxR) activity and human tumor cell growth.  In order to find an efficient way to reverse cisplatin resistance, we investigated the reversal effects of Ethaselen on cisplatin resistance in K562/cisplatin (CDDP) cells that were established by pulse-inducing human erythrocyte leukemic cell line K562, which are fivefold more resistant to cisplatin compared to K562 cells.  The morphol. and growth showed that the adhesion of K562/CDDP further decreased while the cell vol. increased.  The proliferation of K562/CDDP is strengthened.  The antitumor activities in vitro were assessed by MTT (3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and combination index (CI), showing the significant synergic effects of cisplatin and Ethaselen.  Focusing on apoptosis, a series of comparisons was made between K562 and K562/CDDP.  Cisplatin induced higher reactive oxygen species (ROS) generation in K562 and subsequently induced the formation of mitochondrial permeability transition pores (PTPs).  In addn., cisplatin increased the ratio of Bax to Bcl-2 in K562, which can influence the mitochondrial membrane permeability.  PTP formation and mitochondrial membrane permeabilization eventually resulted in the release of cytochrome c and activation of the Caspase pathway.  However, these effects were not clearly seen in K562/CDDP, which may be the reason for the acquired CDDP resistance.  However, Ethaselen can induce a high level of ROS in K562/CDDP by TrxR activity inhibition and increased ratio of Bax to Bcl-2 in K562/CDDP by nuclear factor κB (NF-κB) suppression, which subsequently induces the release of cytochrome c in K562/CDDP.  This response is partly responsible for the reversal of the cisplatin resistance in K562/CDDP cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_ngsBrviFqLVg90H21EOLACvtfcHk0lhX81MFQi8_rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsVarsL0%253D&md5=5a37af3e551326fe6ec06f4c25ef1da6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1631%2Fjzus.B1600073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1631%252Fjzus.B1600073%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%2BF.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DZeng%26aufirst%3DH.%2BH.%26atitle%3DEthaselen%253A%2520a%2520novel%2520organoselenium%2520anticancer%2520agent%2520targeting%2520thioredoxin%2520reductase%25201%2520reverses%2520cisplatin%2520resistance%2520in%2520drug-resistant%2520K562%2520cells%2520by%2520inducing%2520apoptosis%26jtitle%3DJ.%2520Zhejiang%2520Univ.%252C%2520Sci.%252C%2520B%26date%3D2017%26volume%3D18%26spage%3D373%26epage%3D382%26doi%3D10.1631%2Fjzus.B1600073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H. H.</span></span> <span> </span><span class="NLM_article-title">The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2018.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.freeradbiomed.2018.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30496814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2it7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2019&pages=7-17&author=X.+Q.+Zhengauthor=Y.+F.+Chenauthor=M.+Baiauthor=Y.+X.+Liuauthor=B.+Y.+Xuauthor=R.+X.+Sunauthor=H.+H.+Zeng&title=The+antimetastatic+effect+and+underlying+mechanisms+of+thioredoxin+reductase+inhibitor+ethaselen&doi=10.1016%2Fj.freeradbiomed.2018.11.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen</span></div><div class="casAuthors">Zheng, Xiaoqing; Chen, Yifan; Bai, Man; Liu, Yuxi; Xu, Binyuan; Sun, Ruoxuan; Zeng, Huihui</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Treating cancer metastasis is of vital importance to prolong patients' survival.  Thioredoxin reductase (TrxR) is overexpressed in many cancer types and has been recognized as an anticancer target.  The organoselenium compd. ethaselen (BBSKE) has been proved to be a TrxR inhibitor and inhibit various types of tumor growth.  However, whether BBSKE could inhibit tumor metastasis remains unclear.  In this study, the authors aim to explore the antimetastatic effect of BBSKE and underlying mechanisms.  BBSKE was found to dose-dependently suppress migration and invasion of MCF-7 and LoVo cells in vitro.  The underlying mechanisms may include inhibition of TrxR activity, elevation of reactive oxygen species (ROS), decrease of EGFR activation and HER2 expression.  Besides, the epithelial to mesenchymal transition process and expression of CD44, MMP-9, VEGFR2 and PD-L1 were also abrogated.  Decreased migration and invasion, lower expression levels of EGFR, HER2, N-cadherin, CD44, MMP-9, VEGFR2 and PD-L1 were also obsd. in TrxR1-knockdown MCF-7 and LoVo cells.  In the mouse breast cancer 4T1 model, BBSKE not only inhibited progression of primary tumor, but also suppressed formation of metastatic lung nodules and liver micro-metastases, indicating that BBSKE could effectively abolish tumor metastasis.  In conclusion, the findings show that BBSKE is able to inhibit migration and invasion of cancer cells in vitro and in vivo, and may be used to prevent and treat metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PioZWqnzT7Vg90H21EOLACvtfcHk0lhX81MFQi8_rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2it7zN&md5=f634374d0a08160fa0a9dda5ff816725</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%2BQ.%26aulast%3DChen%26aufirst%3DY.%2BF.%26aulast%3DBai%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%2BX.%26aulast%3DXu%26aufirst%3DB.%2BY.%26aulast%3DSun%26aufirst%3DR.%2BX.%26aulast%3DZeng%26aufirst%3DH.%2BH.%26atitle%3DThe%2520antimetastatic%2520effect%2520and%2520underlying%2520mechanisms%2520of%2520thioredoxin%2520reductase%2520inhibitor%2520ethaselen%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2019%26volume%3D131%26spage%3D7%26epage%3D17%26doi%3D10.1016%2Fj.freeradbiomed.2018.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of benzoselenazole-stilbene hybrids as multi-target-directed anti-cancer agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2015.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25817772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1yitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=220-229&author=J.+Yanauthor=Y.+Guoauthor=Y.+Wangauthor=F.+Maoauthor=L.+Huangauthor=X.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+benzoselenazole-stilbene+hybrids+as+multi-target-directed+anti-cancer+agents&doi=10.1016%2Fj.ejmech.2015.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of benzoselenazole-stilbene hybrids as multi-target-directed anti-cancer agents</span></div><div class="casAuthors">Yan, Jun; Guo, Yueyan; Wang, Yali; Mao, Fei; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">220-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To identify novel multi-target-directed drug candidates for the treatment of cancer, a series of benzoselenazole-stilbene hybrids I [ R1 = H, OMe; R2 = H, OMe; R3 = H, OMe; R4 = H, OMe, Cl; R5 = H, OMe, F, Cl.] were synthesized by combining the pharmacophores of resveratrol and ebselen.  The biol. assay indicated that all of the hybrids exhibited antiproliferative activities against four human cancer cell lines and demonstrated good TrxR inhibitory activities.  The mechanism of cell apoptosis was investigated in G2/M cell cycle arrest induced by compd. I [ R1 = R2 = OMe, R3 = R4 = R5 = H] and the apoptosis of the human liver carcinoma Bel-7402 cell line.  The significant increase in intracellular ROS confirmed that compd. I [ R1 = R2 = OMe, R3 = R4 = R5 = H] was capable of causing oxidative stress-induced apoptosis in cancer cells.  Our results support the potential of compd. I [ R1 = R2 = OMe, R3 = R4 = R5 = H] as a candidate for further studies examg. the development of novel drugs for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJN_FfsJpNrrVg90H21EOLACvtfcHk0lhX81MFQi8_rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1yitbc%253D&md5=316682d03ce59a3e971dfa46c3744969</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520benzoselenazole-stilbene%2520hybrids%2520as%2520multi-target-directed%2520anti-cancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D220%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2015.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1279</span>– <span class="NLM_lpage">1281</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2016.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26786698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1279-1281&author=B.+L.+Liauthor=B.+Liauthor=R.+L.+Zhangauthor=J.+J.+Zhaoauthor=X.+F.+Wangauthor=Y.+M.+Liuauthor=Y.+P.+Shiauthor=J.+B.+Liuauthor=B.+Q.+Chen&title=Synthesis+and+antiproliferative+evaluation+of+novel+1%2C2%2C4-triazole+derivatives+incorporating+benzisoselenazolone+scaffold&doi=10.1016%2Fj.bmcl.2016.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold</span></div><div class="casAuthors">Li, Bao-Lin; Li, Bo; Zhang, Rui-Lian; Zhao, Ji-Jun; Wang, Xue-Feng; Liu, Yu-Ming; Shi, Yan-Ping; Liu, Jin-Biao; Chen, Bao-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1279-1281</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 1,2,4-triazole derivs. incorporating benzisoselenazolone scaffold were designed, synthesized and evaluated for their in vitro antiproliferative activities against human cancer cell lines SMMC-7721, HeLa, A549, and normal cell lines L929 by CCK-8 assay.  The preliminary bioassay results demonstrated that most of the tested compds. exhibited antiproliferative activity with different degrees and some compds. showed better effects than pos. controls 2,2'-(1,2-ethanediyl)bis[1,2-benzisoselenazol-3(2H)-one] (i.e., ethaselen) and 5-fluorouracil (i.e., 5-FU) against various cancer cell lines.  Several compds. displayed highly effective biol. activity against SMMC-7721 cells with IC50 values of 6.02 and 6.01 μM, resp.  One compd. showed significant y antiproliferative activities against HeLa cells with IC50 value of 3.94 μM.  One compd. exhibited the best inhibitory effect against A549 cells with IC50 value 9.14 μM.  Furthermore, most of the tested compds. showed weak cytotoxic effect against the normal cell lines L929.  The pharmacol. results suggest that the substituent groups are vital for improving the potency and selectivity of this class of compds.  The synthesis of the target compds. was achieved by a reaction of 2-(chloroseleno)benzoyl chloride with 5-(alkylthio)-1H-1,2,4-triazol-3-amine derivs.  The title compds. thus formed included [[(alkyl)thio]triazolyl]-1,2-benzisoselenazolone derivs. (ebselen analogs, ethaselen analogs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8NeJXV-0oXLVg90H21EOLACvtfcHk0lj8bBAiYhHHvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOgsbg%253D&md5=8f7415d4551a6fb731190506a8b75f76</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%2BL.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DR.%2BL.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DShi%26aufirst%3DY.%2BP.%26aulast%3DLiu%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DB.%2BQ.%26atitle%3DSynthesis%2520and%2520antiproliferative%2520evaluation%2520of%2520novel%25201%252C2%252C4-triazole%2520derivatives%2520incorporating%2520benzisoselenazolone%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1279%26epage%3D1281%26doi%3D10.1016%2Fj.bmcl.2016.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives incorporating benzisoselenazolone scaffold as potential antitumor agents</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.2174/1573406412666160201120806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2174%2F1573406412666160201120806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26833076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Srtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=631-639&author=X.+Fuauthor=S.+Liauthor=F.+Jingauthor=X.+Wangauthor=B.+Liauthor=J.+Zhaoauthor=Y.+Liuauthor=B.+Chen&title=Synthesis+and+biological+evaluation+of+novel+1%2C3%2C4-thiadiazole+derivatives+incorporating+benzisoselenazolone+scaffold+as+potential+antitumor+agents&doi=10.2174%2F1573406412666160201120806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel 1,3,4-thiadiazole Derivatives Incorporating Benzisoselenazolone Scaffold as Potential Antitumor Agents</span></div><div class="casAuthors">Fu, Xiaoyun; Li, Sha; Jing, Fen; Wang, Xuefeng; Li, Baolin; Zhao, Jijun; Liu, Yuming; Chen, Baoquan</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">631-639</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Based on the biol. signicance of benzisoselenazolone and 1,3,4-thiadiazole, a series of novel 1,3,4-thiadiazole derivs. incorporating benzisoselenazolone scaffold were designed and synthesized with ebselen as a lead compd.  Methods: Meanwhile, their in vitro antitumor activities were evaluated against SMMC-7721, MCF-7 and A549 human cancer cell lines by CCK-8 assay.  Results: The preliminary bioassay results demonstrated that all tested compds. 4a-q showed potent antitumor activities, and some compds. exhibited better effects than pos. control ethaselen and 5-fluorouracil (5-FU) against various cancer cell lines.  Furthermore, compds. 4b and 4m showed significant antitumor activities against SMMC-7721 cells with IC50 values of 1.89 and 1.89 M, resp.  Compds. 4c and 4n displayed highly effective biol. activities against MCF-7 cells with IC50 values of 2.88 and 2.28 M, resp.  Compd. 4i showed the best inhibitory effect against A549 cells with IC50 value of 1.76 M.  Conclusion: The pharmacol. results suggest that the substituent groups of Ph ring on the 1,3,4-thiadiazole are vital for modulating antitumor activities against various cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4ZrXoieBjWrVg90H21EOLACvtfcHk0lj8bBAiYhHHvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Srtr3K&md5=b796dbe06b591a16b5ca771871e57868</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F1573406412666160201120806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573406412666160201120806%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJing%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25201%252C3%252C4-thiadiazole%2520derivatives%2520incorporating%2520benzisoselenazolone%2520scaffold%2520as%2520potential%2520antitumor%2520agents%26jtitle%3DMed.%2520Chem.%26date%3D2016%26volume%3D12%26spage%3D631%26epage%3D639%26doi%3D10.2174%2F1573406412666160201120806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jing, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antiproliferative evaluation of novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1248/cpb.c15-00014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1248%2Fcpb.c15-00014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26027467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCns7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=431-437&author=F.+Jingauthor=X.+Fuauthor=S.+Liauthor=B.+Liauthor=J.+Zhaoauthor=X.+Wangauthor=Y.+Liuauthor=B.+Chen&title=Synthesis+and+in+vitro+antiproliferative+evaluation+of+novel+hybrids+from+1%2C3%2C4-thiadiazole+and+benzisoselenazolone&doi=10.1248%2Fcpb.c15-00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antiproliferative evaluation of novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone</span></div><div class="casAuthors">Jing, Fen; Fu, Xiaoyun; Li, Sha; Li, Baolin; Zhao, Jijun; Wang, Xuefeng; Liu, Yuming; Chen, Baoquan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">431-437</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone were designed, synthesized and evaluated for their in vitro antiproliferative activity by CCK-8 assay against three types of human cancer cell lines, SMMC-7721, MCF-7 and A549 cells.  The preliminary bioassay results demonstrated that all tested compds. I (R = H, 2-CH3, 3-OCH3, 4-Br, 2-NO2, etc.) showed potent antiproliferative activity, and some compds. exhibited better effects than pos. control ethaselen and 5-fluorouracil (5-FU) against various cancer cell lines.  Furthermore, compd. I (R = 4-OCH3) showed significant antiproliferative activity against SMMC-7721 cells with an IC50 value of 2.08 μM.  Compds. I (R = 2-CH3, 4-Br) displayed highly effective biol. activity against MCF-7 cells with an IC50 values of 2.03 and 2.06 μM, resp.  Compd. I (R = F) exhibited the best inhibitory effect against A549 cells with an IC50 value of 1.03 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9d7TL_oXBN7Vg90H21EOLACvtfcHk0lj8bBAiYhHHvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCns7rE&md5=1fe09c7e83f958fb50951f573cf59320</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c15-00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c15-00014%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antiproliferative%2520evaluation%2520of%2520novel%2520hybrids%2520from%25201%252C3%252C4-thiadiazole%2520and%2520benzisoselenazolone%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2015%26volume%3D63%26spage%3D431%26epage%3D437%26doi%3D10.1248%2Fcpb.c15-00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacula, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczor, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antosiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janecka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugosz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janecki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtczak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scianowski, J.</span></span> <span> </span><span class="NLM_article-title">New chiral ebselen analogues with antioxidant and cytotoxic potential</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">492</span>, <span class="refDoi"> DOI: 10.3390/molecules22030492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fmolecules22030492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCns7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=492&author=A.+J.+Paculaauthor=K.+B.+Kaczorauthor=J.+Antosiewiczauthor=A.+Janeckaauthor=A.+Dlugoszauthor=T.+Janeckiauthor=A.+Wojtczakauthor=J.+Scianowski&title=New+chiral+ebselen+analogues+with+antioxidant+and+cytotoxic+potential&doi=10.3390%2Fmolecules22030492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">New chiral ebselen analogues with antioxidant and cytotoxic potential</span></div><div class="casAuthors">Pacula, Agata J.; Kaczor, Katarzyna B.; Antosiewicz, Jedrzej; Janecka, Anna; Dlugosz, Angelika; Janecki, Tomasz; Wojtczak, Andrzej; Scianowski, Jacek</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492/1-492/14</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">New chiral camphane-derived benzisoselenazol-3(2H)-ones and corresponding diselenides was synthesized using a convenient one-pot procedure.  Se-N bond was efficiently converted to an Se-Se bond, which could also be easily re-oxidized to the initial benzisoselenazolone moiety.  The antioxidant activity of camphor derivs. was evaluated and compared to the reactivity of a series of N-amino acid benzisoselenazol-3(2H)-ones obtained by a modified procedure involving the improved synthesis and isolation of the diseleno bis(dibenzoic) acid.  The most efficient peroxide scavengers, N-bornyl and N-leucine Me ester benzisoselenazol-3(2H)-ones, were further evaluated as cytotoxic agents on four cancer cell lines (MCF-7, HEP G2, HL 6, and DU 145) and normal cell line PNT1A.  The highest antiproliferative potential was evaluated for two compds. bearing a 3- methylbutyl carbon chain, N-leucine Me ester and N-3-methylbutyl benzisoselenazol- 3(2H)-ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSvjk2F8Hkl7Vg90H21EOLACvtfcHk0lj8bBAiYhHHvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCns7vK&md5=e72828d882ff63e2bfbf826fd7e2ecf5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22030492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22030492%26sid%3Dliteratum%253Aachs%26aulast%3DPacula%26aufirst%3DA.%2BJ.%26aulast%3DKaczor%26aufirst%3DK.%2BB.%26aulast%3DAntosiewicz%26aufirst%3DJ.%26aulast%3DJanecka%26aufirst%3DA.%26aulast%3DDlugosz%26aufirst%3DA.%26aulast%3DJanecki%26aufirst%3DT.%26aulast%3DWojtczak%26aufirst%3DA.%26aulast%3DScianowski%26aufirst%3DJ.%26atitle%3DNew%2520chiral%2520ebselen%2520analogues%2520with%2520antioxidant%2520and%2520cytotoxic%2520potential%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D492%26doi%3D10.3390%2Fmolecules22030492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Multifunctional antioxidants: Regenerable radical-trapping and hydroperoxide-decomposing ebselenols</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3729</span>– <span class="NLM_lpage">3733</span>, <span class="refDoi"> DOI: 10.1002/anie.201510947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fanie.201510947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XisV2hu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=3729-3733&author=S.+Kumarauthor=J.+J.+Yanauthor=J.+F.+Poonauthor=V.+P.+Singhauthor=X.+Luauthor=M.+K.+Ottauthor=L.+Engmanauthor=S.+Kumar&title=Multifunctional+antioxidants%3A+Regenerable+radical-trapping+and+hydroperoxide-decomposing+ebselenols&doi=10.1002%2Fanie.201510947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional Antioxidants: Regenerable Radical-Trapping and Hydroperoxide-Decomposing Ebselenols</span></div><div class="casAuthors">Kumar, Shailesh; Yan, Jiajie; Poon, Jia-fei; Singh, Vijay P.; Lu, Xi; Karlsson Ott, Marjam; Engman, Lars; Kumar, Sangit</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3729-3733</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Regenerable, multifunctional ebselenol antioxidants were prepd. that could quench peroxyl radicals more efficiently than α-tocopherol.  These compds. act as better mimics of the glutathione peroxidase enzymes than ebselen.  Prodn. of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in human mononuclear cells was considerably decreased upon exposure to the organoselenium compds.  At a concn. of 25 μM, the ebselenol derivs. showed minimal toxicity in pre-osteoblast MC3T3 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_nvNQN2047Vg90H21EOLACvtfcHk0liDwTKuOjWckA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisV2hu7c%253D&md5=347641ec5105055b322dc4820e45dd13</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fanie.201510947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201510947%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DJ.%2BJ.%26aulast%3DPoon%26aufirst%3DJ.%2BF.%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DOtt%26aufirst%3DM.%2BK.%26aulast%3DEngman%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DMultifunctional%2520antioxidants%253A%2520Regenerable%2520radical-trapping%2520and%2520hydroperoxide-decomposing%2520ebselenols%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D3729%26epage%3D3733%26doi%3D10.1002%2Fanie.201510947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gates, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engman, L.</span></span> <span> </span><span class="NLM_article-title">Nitro-, azo-, and amino derivatives of ebselen: synthesis, structure, and cytoprotective effects</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b02418</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b02418" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2gsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=313-321&author=V.+P.+Singhauthor=J.+F.+Poonauthor=J.+J.+Yanauthor=X.+Luauthor=M.+K.+Ottauthor=R.+J.+Butcherauthor=P.+J.+Gatesauthor=L.+Engman&title=Nitro-%2C+azo-%2C+and+amino+derivatives+of+ebselen%3A+synthesis%2C+structure%2C+and+cytoprotective+effects&doi=10.1021%2Facs.joc.6b02418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Nitro-, Azo-, and Amino Derivatives of Ebselen: Synthesis, Structure, and Cytoprotective Effects</span></div><div class="casAuthors">Singh, Vijay P.; Poon, Jia-fei; Yan, Jiajie; Lu, Xi; Ott, Marjam Karlsson; Butcher, Ray J.; Gates, Paul J.; Engman, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel azo-bis-ebselen compds. I [R = Ph, 4-MeC6H4, 4-MeOC6H4, 1-naphthyl] were prepd. by redn. of 7-nitro-2-aryl-1,2-benzisoselenazol-3(2H)-ones II with sodium benzenetellurolate, NaTeC6H5, and by reaction of 2-bromo-3-nitrobenzamides with Na2Se2.  The X-ray structure of I [R = 4-MeC6H4] showed that the mol., due to strong intramol. secondary Se•••N interactions, is completely planar.  Azo-compds. I upon further reaction with NaTeC6H5 were reductively cleaved to provide two equiv. of the corresponding arom. amine.  The weak Se-N bond was not stable enough to survive the reaction conditions and diselenides III [R = 4-MeC6H4, 1-naphthyl] were isolated after work-up.  Whereas azo-bis-ebselens I were poor mimics of the glutathione peroxidase (GPx)-enzymes, nitroebselens II and IV and diselenides III were 3-6 fold more active than ebselen.  Based on 77Se NMR spectroscopy, a catalytic cycle for diselenide III [R = 1-naphthyl], involving aminoebselen V, was proposed.  As assessed by chemiluminescence measurements, the good GPx-mimics could reduce prodn. of reactive oxygen species (ROS) in stimulated human mononuclear cells more efficiently than Trolox.  No toxic effects of the compds. were seen in MC3T3-cells at 25 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof38wQdmlrb7Vg90H21EOLACvtfcHk0liDwTKuOjWckA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2gsrrP&md5=b88b6e321a8c67f1e2da839d76bff873</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b02418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b02418%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DPoon%26aufirst%3DJ.%2BF.%26aulast%3DYan%26aufirst%3DJ.%2BJ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DOtt%26aufirst%3DM.%2BK.%26aulast%3DButcher%26aufirst%3DR.%2BJ.%26aulast%3DGates%26aufirst%3DP.%2BJ.%26aulast%3DEngman%26aufirst%3DL.%26atitle%3DNitro-%252C%2520azo-%252C%2520and%2520amino%2520derivatives%2520of%2520ebselen%253A%2520synthesis%252C%2520structure%252C%2520and%2520cytoprotective%2520effects%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D313%26epage%3D321%26doi%3D10.1021%2Facs.joc.6b02418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adejare, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span> <span> </span><span class="NLM_article-title">Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S124977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2147%2FDDDT.S124977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28496307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslKns7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=1369-1382&author=Y.+Wangauthor=J.+Wallachauthor=S.+Duaneauthor=Y.+Wangauthor=J.+Wuauthor=J.+Wangauthor=A.+Adejareauthor=H.+Ma&title=Developing+selective+histone+deacetylases+%28HDACs%29+inhibitors+through+ebselen+and+analogs&doi=10.2147%2FDDDT.S124977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs</span></div><div class="casAuthors">Wang, Yuren; Wallach, Jason; Duane, Stephanie; Wang, Yuan; Wu, Jianghong; Wang, Jeffrey; Adejare, Adeboye; Ma, Haiching</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1369-1382</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are key regulators of gene expression in cells and have been investigated as important therapeutic targets for cancer and other diseases.  Different subtypes of HDACs appear to play disparate roles in the cells and are assocd. with specific diseases.  Therefore, substantial effort has been made to develop subtype-selective HDAC inhibitors.  In an effort to discover existing scaffolds with HDAC inhibitory activity, we screened a drug library approved by the US Food and Drug Administration and a National Institutes of Health Clin. Collection compd. library in HDAC enzymic assays.  Ebselen, a clin. safe compd., was identified as a weak inhibitor of several HDACs, including HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9 with half maximal inhibitory concns. approx. single digit of μM.  Two ebselen analogs, ebselen oxide and ebsulfur (a diselenide analog of ebselen), also inhibited these HDACs, however with improved potencies on HDAC8.  Benzisothiazol, the core structure of ebsulfur, specifically inhibited HDAC6 at a single digit of μM but had no inhibition on other HDACs.  Further efforts on structure-activity relationship based on the core structure of ebsulfur led to the discovery of a novel class of potent and selective HDAC6 inhibitors with RBC-2008 as the lead compd. with single-digit nM potency.  This class of histone deacetylase inhibitor features a novel pharmacophore with an ebsulfur scaffold selectively targeting HDAC6.  Consistent with its inhibition on HDAC6, RBC-2008 significantly increased the acetylation levels of α-tubulin in PC-3 cells.  Furthermore, treatment with these compds. led to cell death of multiple tumor cell lines in a dose-dependent manner.  These results demonstrated that ebselen and ebsulfur analogs are inhibitors of HDACs, supporting further preclin. development of this class of compds. for potential therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTSO9qayhR7rVg90H21EOLACvtfcHk0liDwTKuOjWckA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslKns7rM&md5=7c71fca15cacf6026275682e886245b2</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S124977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S124977%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWallach%26aufirst%3DJ.%26aulast%3DDuane%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAdejare%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DH.%26atitle%3DDeveloping%2520selective%2520histone%2520deacetylases%2520%2528HDACs%2529%2520inhibitors%2520through%2520ebselen%2520and%2520analogs%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2017%26volume%3D11%26spage%3D1369%26epage%3D1382%26doi%3D10.2147%2FDDDT.S124977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span> <span> </span><span class="NLM_article-title">Aglycone ebselen and beta-<i>d</i>-xyloside primed glycosaminoglycans co-contribute to ebselen beta-<i>d</i>-xyloside-induced cytotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2937</span>– <span class="NLM_lpage">2948</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01835</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01835" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtFCnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2937-2948&author=Y.+Tangauthor=S.+Zhangauthor=Y.+Changauthor=D.+Fanauthor=A.+Agostiniauthor=L.+Zhangauthor=T.+Jiang&title=Aglycone+ebselen+and+beta-d-xyloside+primed+glycosaminoglycans+co-contribute+to+ebselen+beta-d-xyloside-induced+cytotoxicity&doi=10.1021%2Facs.jmedchem.7b01835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Aglycone Ebselen and β-D-Xyloside Primed Glycosaminoglycans Co-contribute to Ebselen β-D-Xyloside-Induced Cytotoxicity</span></div><div class="casAuthors">Tang, Yang; Zhang, Siqi; Chang, Yajing; Fan, Dacheng; De Agostini, Ariane; Zhang, Lijuan; Jiang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2937-2948</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Most β-D-xylosides with hydrophobic aglycons are nontoxic primers for glycosaminoglycan assembly in animal cells.  However, when Ebselen was conjugated to D-xylose, D-glucose, D-galactose, and D-lactose (8A-D), only Ebselen β-D-xyloside (8A) showed significant cytotoxicity in human cancer cells.  The following facts indicated that the aglycon Ebselen and β-D-xyloside primed glycosaminoglycans co-contributed to the obsd. cytotoxicity: 1.  Ebselen induced S phase cell cycle arrest, whereas 8A induced G2/M cell cycle arrest; 2. 8A augmented early and late phase cancer cell apoptosis significantly compared to that of Ebselen and 8B-D; 3.  Both 8A and phenyl-β-D-xyloside primed glycosaminoglycans with similar disaccharide compns. in CHO-pgsA745 cells; 4.  Glycosaminoglycans could be detected inside of cells only when treated with 8A, indicating Ebselen contributed to the unique property of intracellular localization of the primed glycosaminoglycans.  Thus, 8A represents a lead compd. for the development of novel antitumor strategy by targeting glycosaminoglycans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-cuJzVNAY-LVg90H21EOLACvtfcHk0ljg_rN8Kyqr3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtFCnt78%253D&md5=e5bd66029fefb81a8e0a5a9a5b868c01</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01835%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DD.%26aulast%3DAgostini%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DT.%26atitle%3DAglycone%2520ebselen%2520and%2520beta-d-xyloside%2520primed%2520glycosaminoglycans%2520co-contribute%2520to%2520ebselen%2520beta-d-xyloside-induced%2520cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2937%26epage%3D2948%26doi%3D10.1021%2Facs.jmedchem.7b01835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torquato, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piroddi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, F.</span></span> <span> </span><span class="NLM_article-title">Targeting glutathione <i>S</i>-transferase P and its interactome with selenium compounds in cancer therapy</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">130</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2018.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbagen.2018.09.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30290218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFSqsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2019&pages=130-143&author=D.+Bartoliniauthor=P.+Torquatoauthor=M.+Piroddiauthor=F.+Galli&title=Targeting+glutathione+S-transferase+P+and+its+interactome+with+selenium+compounds+in+cancer+therapy&doi=10.1016%2Fj.bbagen.2018.09.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glutathione S-transferase P and its interactome with selenium compounds in cancer therapy</span></div><div class="casAuthors">Bartolini, D.; Torquato, P.; Piroddi, M.; Galli, F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130-143</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The glutathione (GSH) S-transferase family of detoxification and signalling proteins represents a major hub for the metab. of Selenium-derived compds.  At the same time, these compds. can be used to modulate the expression and multiple activities of GSTs and other glutathione-dependent genes, that are important aspects in both the chemoprevention and therapy of drug-resistant cancers.  In this context, the isoform GSTP-1 (GSTP) appears to play a fundamental role.  Besides promoting GSH-dependent detoxification of cellular electrophiles, GSTP phys. interacts with a no. of small mols. and cellular proteins producing regulatory effects across the main signal transduction and transcription pathways (identified as the "regulatory interactome of GSTP").  An emerging mol. mechanism behind such regulatory function is the activity of GSTP as a redox chaperonine responsible for the selective glutathionylation of protein Cys residues in the different subcellular compartments.  The redox-sensitive transcription factor Nrf2 was recently identified as one of the regulatory nodes of this interactome at the interface between inflammation, adaptive stress response, and cell death pathways.  The influence of Nrf2 in the stress response to cellular electrophiles and its regulatory interaction with GSTP are discussed in this review suggesting the hypothesis that this interaction may represent the actual pharmacol. target of Se compds. with thiol peroxidase activity.  These points are critically evaluated with a view to further development of these compds. in cancer prevention and the chemotherapy of drug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqEDrwhWsFDbVg90H21EOLACvtfcHk0ljg_rN8Kyqr3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFSqsLjF&md5=c4265f4a7bd8258ffe6f4ea4dce00d5f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2018.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2018.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DD.%26aulast%3DTorquato%26aufirst%3DP.%26aulast%3DPiroddi%26aufirst%3DM.%26aulast%3DGalli%26aufirst%3DF.%26atitle%3DTargeting%2520glutathione%2520S-transferase%2520P%2520and%2520its%2520interactome%2520with%2520selenium%2520compounds%2520in%2520cancer%2520therapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2019%26volume%3D1863%26spage%3D130%26epage%3D143%26doi%3D10.1016%2Fj.bbagen.2018.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piroddi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovagnoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manevich, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustarini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, F.</span></span> <span> </span><span class="NLM_article-title">Reaction kinetics and targeting to cellular glutathione <i>S</i>-transferase of the glutathione peroxidase mimetic PhSeZnCl and its <i>DL</i>-polylactide microparticle formulation</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.freeradbiomed.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25452145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2gs7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=56-65&author=D.+Bartoliniauthor=M.+Piroddiauthor=C.+Tideiauthor=S.+Giovagnoliauthor=D.+Pietrellaauthor=Y.+Manevichauthor=K.+D.+Tewauthor=D.+Giustariniauthor=R.+Rossiauthor=D.+M.+Townsendauthor=C.+Santiauthor=F.+Galli&title=Reaction+kinetics+and+targeting+to+cellular+glutathione+S-transferase+of+the+glutathione+peroxidase+mimetic+PhSeZnCl+and+its+DL-polylactide+microparticle+formulation&doi=10.1016%2Fj.freeradbiomed.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction kinetics and targeting to cellular glutathione S-transferase of the glutathione peroxidase mimetic PhSeZnCl and its D,L-polylactide microparticle formulation</span></div><div class="casAuthors">Bartolini, D.; Piroddi, M.; Tidei, C.; Giovagnoli, S.; Pietrella, D.; Manevich, Y.; Tew, K. D.; Giustarini, D.; Rossi, R.; Townsend, D. M.; Santi, C.; Galli, F.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-65</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Catalytic properties and cellular effects of the glutathione peroxidase (GPx)-mimetic compd. PhSeZnCl or its D,L-lactide polymer microencapsulation form (M-PhSeZnCl) were investigated and compared with the prototypical Se-org. compds. ebselen and diselenide (PhSe)2.  PhSeZnCl was confirmed to catalyze the ping-pong reaction of GPx with higher Vmax than ebselen and (PhSe)2, but the catalytic efficiency calcd. for the cosubstrates glutathione (GSH) and H2O2, and particularly the high reactivity against thiols (lowest Km for GSH in the series of test mols.), suggested poor biol. applicability of PhSeZnCl as a GPx mimetic.  Cytotoxicity of PhSeZnCl was demonstrated in various cancer cell lines via increased reactive oxygen species (ROS) generation, depletion of intracellular thiols, and induction of apoptosis.  Expts. carried out in GSH S-transferase P (GSTP)-overexpressing K562 human erythroleukemia cells and in GSTP1-1-knockout murine embryonic fibroblasts (MEFs) demonstrated that this cytosolic enzyme represents a preferential target of the redox disturbances produced by this Se-compd. with a key role in controlling H2O2 generation and the perturbation of stress/survival kinase signaling.  Microencapsulation was adopted as a strategy to control the thiol reactivity and oxidative stress effects of PhSeZnCl, then assessing applications alternative to anticancer.  The uptake of this "depowered" GPx-mimetic formulation, which occurred through an endocytosis-like mechanism, resulted in a marked redn. of cytotoxicity.  In MCF-7 cells transfected with different allelic variants of GSTP, M-PhSeZnCl lowered the burst of cellular ROS induced by the exposure to extracellular H2O2, and the extent of this effect changed between the GSTP variants.  Microencapsulation is a straightforward strategy to mitigate the toxicity of thiol-reactive Se-org. drugs that enhanced the antioxidant and cellular protective effects of PhSeZnCl.  A mechanistic linkage of these effects with the expression pattern and signaling properties of GSTP.  This has overcome the GPx-mimetic paradigm proposed for Se-org. drugs with a more pragmatic concept of GSTP signaling modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX_enWdcSLmrVg90H21EOLACvtfcHk0ljg_rN8Kyqr3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2gs7%252FF&md5=c4c47db1f922cc12918e4bb272b077f8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DD.%26aulast%3DPiroddi%26aufirst%3DM.%26aulast%3DTidei%26aufirst%3DC.%26aulast%3DGiovagnoli%26aufirst%3DS.%26aulast%3DPietrella%26aufirst%3DD.%26aulast%3DManevich%26aufirst%3DY.%26aulast%3DTew%26aufirst%3DK.%2BD.%26aulast%3DGiustarini%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DR.%26aulast%3DTownsend%26aufirst%3DD.%2BM.%26aulast%3DSanti%26aufirst%3DC.%26aulast%3DGalli%26aufirst%3DF.%26atitle%3DReaction%2520kinetics%2520and%2520targeting%2520to%2520cellular%2520glutathione%2520S-transferase%2520of%2520the%2520glutathione%2520peroxidase%2520mimetic%2520PhSeZnCl%2520and%2520its%2520DL-polylactide%2520microparticle%2520formulation%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D78%26spage%3D56%26epage%3D65%26doi%3D10.1016%2Fj.freeradbiomed.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoyanovsky, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epperly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayir, H.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a mitochondria-targeted mimic of glutathione peroxidase, mitoebselen-2, as a radiation mitigator</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1304</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1021/ml5003635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5003635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCisbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1304-1307&author=D.+A.+Stoyanovskyauthor=J.+F.+Jiangauthor=M.+P.+Murphyauthor=M.+Epperlyauthor=X.+L.+Zhangauthor=S.+Liauthor=J.+Greenbergerauthor=V.+Kaganauthor=H.+Bayir&title=Design+and+synthesis+of+a+mitochondria-targeted+mimic+of+glutathione+peroxidase%2C+mitoebselen-2%2C+as+a+radiation+mitigator&doi=10.1021%2Fml5003635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Mitochondria-Targeted Mimic of Glutathione Peroxidase, MitoEbselen-2, as a Radiation Mitigator</span></div><div class="casAuthors">Stoyanovsky, Detcho A.; Jiang, Jianfei; Murphy, Michael P.; Epperly, Michael; Zhang, Xiaolan; Li, Song; Greenberger, Joel; Kagan, Valerian; Bayir, Hulya</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1304-1307</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ionizing radiation (IR) triggers mitochondrial overprodn. of H2O2 and accumulation of lipid hydroperoxides leading to the induction of apoptotic and necroptotic cell death pathways.  Given the high catalytic efficiency of the seleno-enzyme glutathione peroxidase (Gpx) toward redn. of lipid hydroperoxides and H2O2, we tested the potential of mitochondria-targeted derivs. of ebselen to mitigate the deleterious effects of IR.  We report that 2-[[2-[4-(3-oxo-1,2-benzoselenazol-2-yl)phenyl]acetyl]amino]ethyl-triphenyl-phosphonium chloride (MitoPeroxidase 2) was effective in reducing lipid hydroperoxides, preventing apoptotic cell death, and, when administered 24 h postirradn., increased the survival of mice exposed to whole body γ-irradn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZkPX2R7noM7Vg90H21EOLACvtfcHk0ljMQ0C_9EEbGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCisbvJ&md5=6ecf025e846a25911b862947ecd48d55</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fml5003635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5003635%26sid%3Dliteratum%253Aachs%26aulast%3DStoyanovsky%26aufirst%3DD.%2BA.%26aulast%3DJiang%26aufirst%3DJ.%2BF.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DEpperly%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DGreenberger%26aufirst%3DJ.%26aulast%3DKagan%26aufirst%3DV.%26aulast%3DBayir%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520mitochondria-targeted%2520mimic%2520of%2520glutathione%2520peroxidase%252C%2520mitoebselen-2%252C%2520as%2520a%2520radiation%2520mitigator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1304%26epage%3D1307%26doi%3D10.1021%2Fml5003635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span> <span> </span><span class="NLM_article-title">Virtual screening guided design, synthesis and bioactivity study of benzisoselenazolones (BISAs) on inhibition of c-Met and its downstream signalling pathways</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2489</span>, <span class="refDoi"> DOI: 10.3390/ijms20102489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms20102489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BB3cXosVKhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=2489&author=S.+Zhangauthor=Q.+Songauthor=X.+Wangauthor=Z.+Weiauthor=R.+Yuauthor=X.+Wangauthor=T.+Jiang&title=Virtual+screening+guided+design%2C+synthesis+and+bioactivity+study+of+benzisoselenazolones+%28BISAs%29+on+inhibition+of+c-Met+and+its+downstream+signalling+pathways&doi=10.3390%2Fijms20102489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening guided design, synthesis and bioactivity study of benzisoselenazolones (BISAs) on inhibition of c-met and its downstream signalling pathways</span></div><div class="casAuthors">Zhang, Siqi; Song, Qiaoling; Wang, Xueting; Wei, Zhiqiang; Yu, Rilei; Wang, Xin; Jiang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2489</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">C-Met is a transmembrane receptor tyrosine kinase and an important therapeutic target for anticancer drugs.  In this study, we designed a small library contg. 300 BISAs mols. that consisted of carbohydrates, amino acids, isothiourea, tetramethylthiourea, guanidine and heterocyclic groups and screened c-Met targeting compds. using docking and MM/GBSA.  Guided by virtual screening, we synthesized a series of novel compds. and their activity on inhibition of the autophosphorylation of c-Met and its downstream signalling pathway proteins were evaluated.  We found a panel of benzisoselenazolones (BISAs) obtained by introducing isothiourea, tetramethylthiourea and heterocyclic groups into the C-ring of Ebselen, including 7a, 7b, 8a, 8b and 12c (with IC50 values of less than 20 μM in MET gene amplified lung cancer cell line EBC-1), exhibited more potent antitumor activity than Ebselen by cell growth assay combined with in vitro biochem. assays.  In addn., we also tested the antitumor activity of three cancer cell lines without MET gene amplification/activation, including DLD1, MDA-MB-231 and A549.  The neuroblastoma SK-N-SH cells with HGF overexpression which activates MET signalling are sensitive to MET inhibitors.  The results reveal that our compds. may be nonspecific multitarget kinase inhibitors, just like type-II small mol. inhibitors.  Western blot anal. showed that these inhibitors inhibited autophosphorylation of c-MET, and its downstream signalling pathways, such as PI3K/AKT and MARK/ERK.  Results suggest that bensoisoselenones can be used as a scaffold for the design of c-Met inhibiting drug leads, and this study opens up new possibilities for future antitumor drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfdM5HZ16ZdrVg90H21EOLACvtfcHk0ljMQ0C_9EEbGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXosVKhtw%253D%253D&md5=d670376e658abfcfb79c497e1f03a7f9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fijms20102489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20102489%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DT.%26atitle%3DVirtual%2520screening%2520guided%2520design%252C%2520synthesis%2520and%2520bioactivity%2520study%2520of%2520benzisoselenazolones%2520%2528BISAs%2529%2520on%2520inhibition%2520of%2520c-Met%2520and%2520its%2520downstream%2520signalling%2520pathways%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D2489%26doi%3D10.3390%2Fijms20102489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, SAR and biological evaluation of a novel series of 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3<i>H</i>)-yl)ethyl) urea: organoselenium compounds for cancer therapy</span>. <i>Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.14715/cmb/2016.62.7.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.14715%2Fcmb%2F2016.62.7.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27453265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC2s3jslWrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=6-14&author=S.+Yeauthor=X.+Zhengauthor=T.+Huauthor=H.+Zeng&title=Synthesis%2C+SAR+and+biological+evaluation+of+a+novel+series+of+1-%282-chloroethyl%29-1-nitroso-3-%282-%283-oxobenzoelenazol-2%283H%29-yl%29ethyl%29+urea%3A+organoselenium+compounds+for+cancer+therapy&doi=10.14715%2Fcmb%2F2016.62.7.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, SAR and biological evaluation of a novel series of 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3H)-yl)ethyl) urea: Organoselenium compounds for cancer therapy</span></div><div class="casAuthors">Ye S; Zheng X; Hu T; Zeng H</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and molecular biology (Noisy-le-Grand, France)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">6-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Thioredoxin reductase 1 (TrxR1) is an important potential anticancer drug target and closely related to both carcinogenesis and cancer progression.  Ethaselen (BBSKE), a novel organoselenium compound inhibiting TrxR1 with selective antitumor effect, while its symmetrical structure results in poor solubility.  Carmustine (BCNU), a DNA cross-link agent and also a deactivator of TrxR, is with high toxicity and low selectivity which limit its clinical application to some extents.  Herein, a novel compound, 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3H)-yl)ethyl)urea(4a-1), which was designed through the combination of Ethaselen and Carmustine, showed good solubility, good tagetability, low toxicity and excellent antitumor activity by synergism.  Using the structure of 4a-1 as a key active scaffold, a series of novel 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3H)-yl)ethyl)urea was designed, synthesized and evaluated to explore the structure-activity relationships (SARs) of these inhibitors and to improve their antitumor activities.  Notably, 1-(2-chloroethyl)-3-(2-(6-fluoro-3-oxobenzoselenazol-2(3H)-yl)ethyl)-1-nitrosourea(4b-1) was found to exhibit more potent antitumor activities comparable to 4a-1 against all the four cancer cell lines, including Mia PaCa-2, PANC-1, RKO, LoVo.  These results have highlighted compound 4b-1 as a new potential lead candidate for future development of novel potent broad-spectrum antitumor agents.  In addition, a SAR model was established to conduct further structural modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREabgMxXN_cLYtC3U5jeOifW6udTcc2eZ1xQ7xQCkCoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3jslWrtA%253D%253D&md5=a293240f031f81d0a8eafb4437b85dd7</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.14715%2Fcmb%2F2016.62.7.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14715%252Fcmb%252F2016.62.7.2%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DZeng%26aufirst%3DH.%26atitle%3DSynthesis%252C%2520SAR%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%25201-%25282-chloroethyl%2529-1-nitroso-3-%25282-%25283-oxobenzoelenazol-2%25283H%2529-yl%2529ethyl%2529%2520urea%253A%2520organoselenium%2520compounds%2520for%2520cancer%2520therapy%26jtitle%3DCell%2520Mol.%2520Biol.%26date%3D2016%26volume%3D62%26spage%3D6%26epage%3D14%26doi%3D10.14715%2Fcmb%2F2016.62.7.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, B. H.</span></span> <span> </span><span class="NLM_article-title">Propylselen inhibits cancer cell growth by targeting glutamate dehydrogenase at the NADP(+) binding site</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>509</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.12.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbrc.2018.12.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30583861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2ksbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2019&pages=262-267&author=W.+Houauthor=S.+Luauthor=H.+Zhaoauthor=Y.+Yuauthor=H.+Xuauthor=B.+Yuauthor=L.+Suauthor=C.+Linauthor=B.+H.+Ruan&title=Propylselen+inhibits+cancer+cell+growth+by+targeting+glutamate+dehydrogenase+at+the+NADP%28%2B%29+binding+site&doi=10.1016%2Fj.bbrc.2018.12.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Propylselen inhibits cancer cell growth by targeting glutamate dehydrogenase at the NADP+ binding site</span></div><div class="casAuthors">Hou, Wei; Lu, Shiying; Zhao, Han; Yu, Yan; Xu, Haodong; Yu, Biao; Su, Lin; Lin, Chenshui; Ruan, Benfang Helen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">262-267</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High levels of glutamate dehydrogenase (GDH) activity are assocd. with hypoglycemia, cancer, and Parkinson's disease.  Propylselen was synthesized to investigate its mechanism of GDH inhibition in comparison with Ebselen and Epigallocatechin gallate (EGCG).  Because Ebselen was found to crosslink with the peptide (AA299-341) at the active site of E.coli GDH, the Cys, Pro, and Lys residues of the corresponding peptide were mutagenized to Ala residues.  Using enzyme kinetics and biomol. interaction assays, we found that the conserved GDH P320 residue is important for propylselen binding, C321 for Ebselen binding, and K341 for EGCG binding.  In addn., these 3 mutations abolished NADP+ binding to E. coli GDH in the absence of glutamate substrate, but in the presence of glutamate, the catalytic activity of the mutants was reduced only by 2-4 fold, indicating that a substrate-induced fit mechanism exists in E. coli GDH.  Furthermore, biochem. anal. showed that NADP+ had high affinity (Kd of 77 nM) for GDH; by targeting the NADP binding site, propylselen effectively inhibited both E. coli and human GDH activity and improved anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhsvFCWyYis7Vg90H21EOLACvtfcHk0lgbpg87gT9q4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2ksbfN&md5=b0246df397700c6c34cf61b08ca8eb48</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.12.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.12.117%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DRuan%26aufirst%3DB.%2BH.%26atitle%3DPropylselen%2520inhibits%2520cancer%2520cell%2520growth%2520by%2520targeting%2520glutamate%2520dehydrogenase%2520at%2520the%2520NADP%2528%252B%2529%2520binding%2520site%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2019%26volume%3D509%26spage%3D262%26epage%3D267%26doi%3D10.1016%2Fj.bbrc.2018.12.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teijido, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacabelos, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacoepigenomic interventions as novel potential treatments for Alzheimer’s and Parkinson’s diseases</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3199</span>, <span class="refDoi"> DOI: 10.3390/ijms19103199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms19103199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlynu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=3199&author=O.+Teijidoauthor=R.+Cacabelos&title=Pharmacoepigenomic+interventions+as+novel+potential+treatments+for+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+diseases&doi=10.3390%2Fijms19103199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacoepigenomic interventions as novel potential treatments for Alzheimer's and Parkinson's diseases</span></div><div class="casAuthors">Teijido, Oscar; Cacabelos, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3199/1-3199/36</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cerebrovascular and neurodegenerative disorders affect one billion people around the world and result from a combination of genomic, epigenomic, metabolic, and environmental factors.  Diagnosis at late stages of disease progression, limited knowledge of gene biomarkers and mol. mechanisms of the pathol., and conventional compds. based on symptomatic rather than mechanistic features, det. the lack of success of current treatments, including current FDA-approved conventional drugs.  The epigenetic approach opens new avenues for the detection of early presymptomatic pathol. events that would allow the implementation of novel strategies in order to stop or delay the pathol. process.  The reversibility and potential restoring of epigenetic aberrations along with their potential use as targets for pharmacol. and dietary interventions sited the use of epidrugs as potential novel candidates for successful treatments of multifactorial disorders involving neurodegeneration.  This manuscript includes a description of the most relevant epigenetic mechanisms involved in the most prevalent neurodegenerative disorders worldwide, as well as the main potential epigenetic-based compds. under investigation for treatment of those disorders and their limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsK6bTQ038lLVg90H21EOLACvtfcHk0lgbpg87gT9q4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlynu7o%253D&md5=ced7bbb42c4a77b4a36970ca270672ea</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.3390%2Fijms19103199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19103199%26sid%3Dliteratum%253Aachs%26aulast%3DTeijido%26aufirst%3DO.%26aulast%3DCacabelos%26aufirst%3DR.%26atitle%3DPharmacoepigenomic%2520interventions%2520as%2520novel%2520potential%2520treatments%2520for%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520diseases%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D3199%26doi%3D10.3390%2Fijms19103199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aras, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altaş, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meydan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcıoǧlu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulutaş, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serarslan, Y.</span></span> <span> </span><span class="NLM_article-title">Effects of ebselen on ischemia/reperfusion injury in rat brain</span>. <i>Int. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.3109/00207454.2013.879581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3109%2F00207454.2013.879581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24405262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=771-776&author=M.+Arasauthor=M.+Alta%C5%9Fauthor=S.+Meydanauthor=E.+Nacarauthor=M.+Karc%C4%B1o%C7%A7luauthor=K.+T.+Uluta%C5%9Fauthor=Y.+Serarslan&title=Effects+of+ebselen+on+ischemia%2Freperfusion+injury+in+rat+brain&doi=10.3109%2F00207454.2013.879581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of ebselen on ischemia/reperfusion injury in rat brain</span></div><div class="casAuthors">Aras, M.; Altas, M.; Meydan, S.; Nacar, E.; Karcioglu, M.; Ulutas, K. T.; Serarslan, Y.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">771-776</span>CODEN:
                <span class="NLM_cas:coden">IJNUB7</span>;
        ISSN:<span class="NLM_cas:issn">0020-7454</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Aim: Interruption of blood flow may result in considerable tissue damage via ischemia/reperfusion (I/R) injury-induced oxidative stress in brain tissues.  The aim of the present study was to investigate the effects of Ebselen treatment in short-term global brain I/R injury in rats.  Material and Methods: The study was carried out on 27 Wistar-albino rats, divided into three groups including Sham group (n = 11), I/R group (n = 8) and I/R+Ebselen group (n = 8).  Results: Malondialdehyde (MDA) levels were significantly increased in I/R group in comparison with the Sham group and I/R+Ebselen group (p < 0.001 and p < 0.01).  Superoxide dismutase (SOD) activity was significantly lower in I/R group in comparison to both Sham (p < 0.001) and I/R+Ebselen (p < 0.01) groups.  Similarly, SOD activity was decreased in I/R+Ebselen group when compared with Sham group (p < 0.001).  Sham and I/R groups were similar in terms of nitric oxide (NO) levels.  In contrast, the NO level was lower in I/R+Ebselen group when compared with Sham (p < 0.001) and I/R (p < 0.01) groups.  There was no significant difference among the groups in terms of glutathione peroxidase and catalase activities.  In histopathol. examn., the brain tissues of rats that received Ebselen showed morphol. improvement.  Conclusion: Ebselen has neuron-protective effects due to its antioxidant properties as shown by the decrease in MDA overprodn., increase in SOD activity and the histol. improvement after administration of Ebselen to I/R in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqpkHWjCMpSLVg90H21EOLACvtfcHk0lgbpg87gT9q4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7nI&md5=a7da42ccb1da6ce0b805b5bb2dd52948</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3109%2F00207454.2013.879581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00207454.2013.879581%26sid%3Dliteratum%253Aachs%26aulast%3DAras%26aufirst%3DM.%26aulast%3DAlta%25C5%259F%26aufirst%3DM.%26aulast%3DMeydan%26aufirst%3DS.%26aulast%3DNacar%26aufirst%3DE.%26aulast%3DKarc%25C4%25B1o%25C7%25A7lu%26aufirst%3DM.%26aulast%3DUluta%25C5%259F%26aufirst%3DK.%2BT.%26aulast%3DSerarslan%26aufirst%3DY.%26atitle%3DEffects%2520of%2520ebselen%2520on%2520ischemia%252Freperfusion%2520injury%2520in%2520rat%2520brain%26jtitle%3DInt.%2520J.%2520Neurosci.%26date%3D2014%26volume%3D124%26spage%3D771%26epage%3D776%26doi%3D10.3109%2F00207454.2013.879581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira Porciuncula, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Rocha, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Souza, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghisleni, G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almeida, H. L.</span></span> <span> </span><span class="NLM_article-title">Selenium compounds prevent amyloid β-peptide neurotoxicity in rat primary hippocampal neurons</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2359</span>– <span class="NLM_lpage">2363</span>, <span class="refDoi"> DOI: 10.1007/s11064-013-1147-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs11064-013-1147-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24013888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2qs7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=2359-2363&author=G.+L.+Godoiauthor=L.+de+Oliveira+Porciunculaauthor=J.+F.+Schulzauthor=F.+N.+Kaufmannauthor=J.+B.+da+Rochaauthor=D.+O.+de+Souzaauthor=G.+Ghisleniauthor=H.+L.+de+Almeida&title=Selenium+compounds+prevent+amyloid+%CE%B2-peptide+neurotoxicity+in+rat+primary+hippocampal+neurons&doi=10.1007%2Fs11064-013-1147-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium Compounds Prevent Amyloid β-Peptide Neurotoxicity in Rat Primary Hippocampal Neurons</span></div><div class="casAuthors">Godoi, Gabriela Lorea; de Oliveira Porciuncula, Lisiane; Schulz, Janaina Fagundes; Kaufmann, Fernanda Neutzling; Batista da Rocha, Joao; Gomes de Souza, Diogo Onofre; Ghisleni, Gabriele; Larangeira de Almeida, Hiram, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2359-2363</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuropathol. hallmarks of Alzheimer's disease (AD) include amyloid plaque formation, neurofibrillary tangles, neuronal and synaptic loss.  This study aims to identify the neuroprotective effects of the selenium compds. on the neurotoxicity of amyloid β(1-42) in primary cultures of murine hippocampal neurons.  Samples were subjected to immunocytochem. and western blotting techniques to det. the role of treatments on neuronal viability and synaptic protein SNAP-25.  We obsd. a reduced cell viability amyloid β-peptide (1-42)-induced.  When cells were co-treated with amyloid β-peptide (1-42) and selenium compds., we verified a strong increase in relative cell viability and in the level of synaptic marker synaptosomal-assocd. protein SNAP-25 induced by selenium compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZijvmU9RPwLVg90H21EOLACvtfcHk0lhlnoCVv_ul_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2qs7zN&md5=12638e414b11bf171d132e92dae79bbf</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs11064-013-1147-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-013-1147-4%26sid%3Dliteratum%253Aachs%26aulast%3DGodoi%26aufirst%3DG.%2BL.%26aulast%3Dde%2BOliveira%2BPorciuncula%26aufirst%3DL.%26aulast%3DSchulz%26aufirst%3DJ.%2BF.%26aulast%3DKaufmann%26aufirst%3DF.%2BN.%26aulast%3Dda%2BRocha%26aufirst%3DJ.%2BB.%26aulast%3Dde%2BSouza%26aufirst%3DD.%2BO.%26aulast%3DGhisleni%26aufirst%3DG.%26aulast%3Dde%2BAlmeida%26aufirst%3DH.%2BL.%26atitle%3DSelenium%2520compounds%2520prevent%2520amyloid%2520%25CE%25B2-peptide%2520neurotoxicity%2520in%2520rat%2520primary%2520hippocampal%2520neurons%26jtitle%3DNeurochem.%2520Res.%26date%3D2013%26volume%3D38%26spage%3D2359%26epage%3D2363%26doi%3D10.1007%2Fs11064-013-1147-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span> <span> </span><span class="NLM_article-title">Ebselen ameliorates beta-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer’s disease mice</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.1007/s00775-017-1463-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs00775-017-1463-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28502066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslKlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=851-865&author=Y.+Xieauthor=Y.+Tanauthor=Y.+Zhengauthor=X.+Duauthor=Q.+Liu&title=Ebselen+ameliorates+beta-amyloid+pathology%2C+tau+pathology%2C+and+cognitive+impairment+in+triple-transgenic+Alzheimer%E2%80%99s+disease+mice&doi=10.1007%2Fs00775-017-1463-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice</span></div><div class="casAuthors">Xie, Yongli; Tan, Yibin; Zheng, Youbiao; Du, Xiubo; Liu, Qiong</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">851-865</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disease which is clin. characterized by memory loss and cognitive decline caused by protein misfolding and aggregation.  Imbalance between free radicals and the antioxidant system is a prominent and early feature in the neuropathol. of AD.  Selenium (Se), a vital trace element with excellent antioxidant potential, is preferentially retained in the brain in Se-limited conditions and has been reported to provide neuroprotection through resisting oxidative damage.  In this paper, we studied for the first time the potential of Ebselen, a lipid-sol. selenium compd. with GPx-like activity, in the treatment of cognitive dysfunction and neuropathol. of triple-transgenic AD (3 × Tg-AD) mice, AD model cell, and primary culture.  We demonstrated that Ebselen inhibited oxidative stress in both AD model cells and mouse brains with increasing GPx and SOD activities and meanwhile reduced p38 mitogen-activated protein kinases activities.  By decreasing the expression of amyloid precursor protein and β-secretase, Ebselen reduced the levels of Aβ in AD neurons and mouse brains, esp. the most toxic oligomeric form.  Besides, mislocation of phosphorylated tau in neurons and phosphorylation levels of tau protein at Thr231, Ser396, and Ser404 residues were also inhibited by Ebselen, probably by its regulatory roles in glycogen synthase kinase 3β and protein phosphatase 2A activity.  In addn., Ebselen mitigated the decrease of synaptic proteins including synaptophysin and postsynaptic d. protein 95 in AD model cells and neurons.  Consequently, the spatial learning and memory of 3 × Tg-AD mice were significantly improved upon Ebselen treatment.  This study provides a potential novel therapeutic approach for the prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrouRLS6A8OTrVg90H21EOLACvtfcHk0lhlnoCVv_ul_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslKlsbc%253D&md5=cbbb12bbc4aa957eefb1fad780e14625</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00775-017-1463-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-017-1463-2%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DQ.%26atitle%3DEbselen%2520ameliorates%2520beta-amyloid%2520pathology%252C%2520tau%2520pathology%252C%2520and%2520cognitive%2520impairment%2520in%2520triple-transgenic%2520Alzheimer%25E2%2580%2599s%2520disease%2520mice%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D22%26spage%3D851%26epage%3D865%26doi%3D10.1007%2Fs00775-017-1463-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of multi-target-directed ligands against Alzheimer’s disease based on the fusion of donepezil and ebselen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9089</span>– <span class="NLM_lpage">9099</span>, <span class="refDoi"> DOI: 10.1021/jm401047q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401047q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9089-9099&author=Z.+Luoauthor=J.+Shengauthor=Y.+Sunauthor=C.+Luauthor=J.+Yanauthor=A.+Liuauthor=H.+B.+Luoauthor=L.+Huangauthor=X.+Li&title=Synthesis+and+evaluation+of+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease+based+on+the+fusion+of+donepezil+and+ebselen&doi=10.1021%2Fjm401047q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer's Disease Based on the Fusion of Donepezil and Ebselen</span></div><div class="casAuthors">Luo, Zonghua; Sheng, Jianfei; Sun, Yang; Lu, Chuanjun; Yan, Jun; Liu, Anqiu; Luo, Hai-bin; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9089-9099</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzylpiperidinylalkyl benzoisoselenazolones I [R = H, MeO; R1 = H, Cl, F, MeO; X = (CH2)n; n = 1-4] were prepd. as donepezil-ebselen hybrids for potential use as anti-Alzheimer's disease agents.  I (R = R1 = MeO; n = 2) was one of the most potent acetylcholinesterase inhibitors of the compds. tested (IC50 values of 0.042 μM for Electrophorus electricus acetylcholinesterase and 0.097 μM for human acetylcholinesterase) and was found to be a strong butyrylcholinesterase inhibitor with an IC50 value of 1.586 μM, to possess rapid H2O2 and peroxynitrite scavenging activity and glutathione peroxidase-like activity (ν0 = 123.5 μM min-1), and to be a substrate of mammalian thioredoxin reductase.  I (R = R1 = MeO; n = 2) showed no acute toxicity at doses of up to 2000 mg/kg; by comparing its permeation in an artificial blood-brain barrier permeation assay, I (R = R1 = MeO; n = 2) was expected to be able to penetrate the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozFGgeDdrcXrVg90H21EOLACvtfcHk0lhlnoCVv_ul_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7jL&md5=a9b4972150c544edab25b3c2611960f9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm401047q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401047q%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520based%2520on%2520the%2520fusion%2520of%2520donepezil%2520and%2520ebselen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9089%26epage%3D9099%26doi%3D10.1021%2Fjm401047q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmc.2013.12.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24461494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1355-1361&author=Z.+Luoauthor=L.+Liangauthor=J.+Shengauthor=Y.+Pangauthor=J.+Liauthor=L.+Huangauthor=X.+Li&title=Synthesis+and+biological+evaluation+of+a+new+series+of+ebselen+derivatives+as+glutathione+peroxidase+%28GPx%29+mimics+and+cholinesterase+inhibitors+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2013.12.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease</span></div><div class="casAuthors">Luo, Zonghua; Liang, Liang; Sheng, Jianfei; Pang, Yanqing; Li, Jianheng; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1355-1361</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of ebselen derivs. were designed, synthesized and evaluated as inhibitors of cholinesterases (ChEs) and glutathione peroxidase (GPx) mimics.  Most of the compds. were found to be potent against AChEs and BuChE, compds. 5e and 5i, proved to be the most potent against AChE with IC50 values of 0.76 and 0.46 μM, resp.  Among these hybrids, most of the compds. were found to be good GPx mimics compare with ebselen.  The selected compds. 5e and 5i were also used to det. the catalytic parameters and in vitro hydrogen peroxide scavenging activity.  The results indicate that compds. 5e and 5i may be excellent multifunctional agents for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_j339r0RurVg90H21EOLACvtfcHk0ljKYoQi75hYTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSisrw%253D&md5=258d22850034133095ca45dec5667b25</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.066%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DSheng%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520new%2520series%2520of%2520ebselen%2520derivatives%2520as%2520glutathione%2520peroxidase%2520%2528GPx%2529%2520mimics%2520and%2520cholinesterase%2520inhibitors%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1355%26epage%3D1361%26doi%3D10.1016%2Fj.bmc.2013.12.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6737</span>– <span class="NLM_lpage">6742</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2013.10.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24220172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslygsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6737-6742&author=F.+Maoauthor=J.+Chenauthor=Q.+Zhouauthor=Z.+Luoauthor=L.+Huangauthor=X.+Li&title=Novel+tacrine-ebselen+hybrids+with+improved+cholinesterase+inhibitory%2C+hydrogen+peroxide+and+peroxynitrite+scavenging+activity&doi=10.1016%2Fj.bmcl.2013.10.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity</span></div><div class="casAuthors">Mao, Fei; Chen, Jianwen; Zhou, Qi; Luo, Zonghua; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6737-6742</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of tacrine-ebselen hybrids were synthesized and evaluated as possible multifunctional anti-Alzheimer's disease (AD) agents.  Compd. 6i, which is tacrine linked with 5,6-dimethoxybenzo[d][1,2]selenazol-3(2H)-one by a six-carbon spacer, was the most potent acetylcholinesterase (AChE) and butylcholinesterase (BuChE) inhibitor, with IC50 values of 2.55 and 2.80 nM, resp.  Furthermore, this compd. demonstrated similar hydrogen peroxide and peroxynitrite scavenging activity as ebselen by horseradish peroxidase assay and peroxynitrite scavenging activity assay, indicating that this hybrid is a good multifunctional drug candidate for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN03ry0LUstrVg90H21EOLACvtfcHk0ljKYoQi75hYTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslygsbvJ&md5=170be61dfea512595270709e0936fb7b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.034%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DNovel%2520tacrine-ebselen%2520hybrids%2520with%2520improved%2520cholinesterase%2520inhibitory%252C%2520hydrogen%2520peroxide%2520and%2520peroxynitrite%2520scavenging%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6737%26epage%3D6742%26doi%3D10.1016%2Fj.bmcl.2013.10.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Computer-assisted designed “selenoxy-chinolin“: a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation</span>. <i>Dalton Trans</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">20913</span>– <span class="NLM_lpage">20925</span>, <span class="refDoi"> DOI: 10.1039/C5DT02130H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC5DT02130H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26575390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslenu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=20913-20925&author=Z.+Wangauthor=Y.+Wangauthor=W.+Liauthor=Z.+Liuauthor=Z.+Luoauthor=Y.+Sunauthor=R.+Wuauthor=L.+Huangauthor=X.+Li&title=Computer-assisted+designed+%E2%80%9Cselenoxy-chinolin%E2%80%9C%3A+a+new+catalytic+mechanism+of+the+GPx-like+cycle+and+inhibition+of+metal-free+and+metal-associated+A%CE%B2+aggregation&doi=10.1039%2FC5DT02130H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-assisted designed "selenoxy-chinolin": a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation</span></div><div class="casAuthors">Wang, Zhiren; Wang, Yali; Li, Wenrui; Liu, Zhihong; Luo, Zonghua; Sun, Yang; Wu, Ruibo; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">20913-20925</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Using support from rational computer-assisted design, a novel series of hybrids (selenoxy-chinolin) designed by fusing the metal-chelating agent CQ and the antioxidant ebselen were synthesized and evaluated as multitarget-directed ligands.  Most of the hybrids demonstrated significant ability to mimic GPx, which is highly consistent with the prediction results of DFT studies for the selenenyl sulfide intermediates in the computational design.  Using 77Se, 1H and 13C NMR spectroscopy and high-resoln. mass spectroscopy (HRMS), a novel catalytic mechanism, including a new selenium quinone active species, was first demonstrated.  2D NMR studies indicated that the typical hybrid has an effective interaction with Aβ.  In addn., the optimal compd. 2-(7-chloro-8-hydroxyquinolin-5-yl)-5-hydroxybenzo[d][1,2]selenazol-3(2H)-one hydrochloride (12k) was found to possess an excellent ability to scavenge peroxide and to inhibit self- and metal-induced Aβ aggregation, and an ability to disassemble preformed self- and metal-induced Aβ aggregates effectively.  Furthermore, (12k) was able to penetrate the central nervous system (CNS) and did not exhibit any acute toxicity in mice at doses up to 2000 mg kg-1.  Overall, the authors demonstrated that hybrid (12k), through rational structure-based computational design, shows a potential for development as a therapeutic agent in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOa4CKjjugULVg90H21EOLACvtfcHk0ljKYoQi75hYTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslenu7fI&md5=03ca1ded5d7a33339564412d27877cfd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1039%2FC5DT02130H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5DT02130H%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DComputer-assisted%2520designed%2520%25E2%2580%259Cselenoxy-chinolin%25E2%2580%259C%253A%2520a%2520new%2520catalytic%2520mechanism%2520of%2520the%2520GPx-like%2520cycle%2520and%2520inhibition%2520of%2520metal-free%2520and%2520metal-associated%2520A%25CE%25B2%2520aggregation%26jtitle%3DDalton%2520Trans%26date%3D2015%26volume%3D44%26spage%3D20913%26epage%3D20925%26doi%3D10.1039%2FC5DT02130H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[<i>d</i>][1,2]selenazol-3(2<i>H</i>)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4741</span>– <span class="NLM_lpage">4749</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmc.2016.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27567080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWmtb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=4741-4749&author=B.+Wangauthor=Z.+Wangauthor=H.+Chenauthor=C.-J.+Luauthor=X.+Li&title=Synthesis+and+evaluation+of+8-hydroxyquinolin+derivatives+substituted+with+%28benzo%5Bd%5D%5B1%2C2%5Dselenazol-3%282H%29-one%29+as+effective+inhibitor+of+metal-induced+A%CE%B2+aggregation+and+antioxidant&doi=10.1016%2Fj.bmc.2016.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant</span></div><div class="casAuthors">Wang, Bo; Wang, Zhiren; Chen, Hong; Lu, Chuan-Jun; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4741-4749</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 8-hydroxyquinolin derivs. substituted with (benzo[d][1,2]selenazol-3(2H)-one) at the 2-position were synthesized and evaluated for treatment of Alzheimer's disease.  In vitro assays demonstrated that most of the target compds. exhibit significant inhibition of Cu(II)-induced Aβ1-42 aggregation, rapid H2O2 scavenging and glutathione peroxidize (GPx)-like catalytic activity.  Among these mols., 5-hydroxy-2-(8-hydroxyquinolin-2-yl)benzo[d][1,2] selenazol-3(2H)-one (9a) is the most potent peroxide scavenger that possesses the ability to scavenge most H2O2 within 200-220 min and possesses GPx-like activity (v0 = 106.0 μM·min-1), enabling modulation of metal-induced Aβ aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu979rk9wBurVg90H21EOLACvtfcHk0ljKYoQi75hYTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWmtb3F&md5=f8edc6d699f8fb908f5e0b11e2186d8e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DC.-J.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25208-hydroxyquinolin%2520derivatives%2520substituted%2520with%2520%2528benzo%255Bd%255D%255B1%252C2%255Dselenazol-3%25282H%2529-one%2529%2520as%2520effective%2520inhibitor%2520of%2520metal-induced%2520A%25CE%25B2%2520aggregation%2520and%2520antioxidant%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D4741%26epage%3D4749%26doi%3D10.1016%2Fj.bmc.2016.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5718</span>– <span class="NLM_lpage">5729</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmc.2018.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30385227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVentL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=5718-5729&author=J.+Huauthor=B.+Anauthor=T.+Panauthor=Z.+Liauthor=L.+Huangauthor=X.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+histone+deacetylase+inhibitors+possessing+glutathione+peroxidase-like+and+antioxidant+activities+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2018.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease</span></div><div class="casAuthors">Hu, Jinhui; An, Baijiao; Pan, Tingting; Li, Zhengcunxiao; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5718-5729</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of hybrids contg. the pharmacophores of the histone deacetylase (HDAC) inhibitor, SAHA, and the antioxidant ebselen were designed and synthesized as multi-target-directed ligands against Alzheimer's disease.  An in vitro assay indicated that some of these mols. exhibit potent HDAC inhibitory activity and ebselen-related pharmacol. effects.  Specifically, the optimal compd. 7f was found to be a potent HDAC inhibitor (IC50 = 0.037 μM), possessing rapid hydrogen peroxide scavenging activity and glutathione peroxidase-like activity (ν0 = 150.0 μM min-1) and good free oxygen radical absorbance capacity (value of ORAC: 2.2).  Furthermore, compd. 7f showed significant protective effects against damage induced by H2O2 and the ability to prevent ROS accumulation in PC12 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv2EKWVVijlLVg90H21EOLACvtfcHk0ljIPM61CuFYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVentL%252FK&md5=b9a5f6059db2b4c611f9a050e2b54d6f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520histone%2520deacetylase%2520inhibitors%2520possessing%2520glutathione%2520peroxidase-like%2520and%2520antioxidant%2520activities%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D5718%26epage%3D5729%26doi%3D10.1016%2Fj.bmc.2018.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukifli, Z. H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. K.</span></span> <span> </span><span class="NLM_article-title">Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">978</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1002/humu.23234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fhumu.23234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28432706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFGnsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=978-987&author=M.+Tioauthor=R.+Wenauthor=Y.+L.+Limauthor=Z.+H.+B.+Zukifliauthor=S.+Xieauthor=P.+Hoauthor=Z.+Zhouauthor=T.+W.+Kohauthor=Y.+Zhaoauthor=E.+K.+Tan&title=Varied+pathological+and+therapeutic+response+effects+associated+with+CHCHD2+mutant+and+risk+variants&doi=10.1002%2Fhumu.23234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants</span></div><div class="casAuthors">Tio, Murni; Wen, Rujing; Lim, Yih Lin; Bin Zukifli, Zul Haikhel; Xie, Shaoping; Ho, Patrick; Zhou, Zhidong; Koh, Tong-Wey; Zhao, Yi; Tan, Eng-King</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">978-987</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Mutations and polymorphic risk variant of coiled-coil-helix-coiled-coil-helix domain contg. 2 (CHCHD2) have been assocd. with late-onset Parkinson disease.  In vivo pathol. evidence of CHCHD2 mutations is currently lacking.  Utilizing transgenic Drosophila model, we examd. the relative pathophysiol. effect of the pathogenic (c.182C>T, p.Thr61Ile and c.434G>A, p.Arg145Gln) and the risk (c.5C>T, p.Pro2Leu) CHCHD2 variants.  All the transgenic models exhibited locomotor dysfunction that could be exacerbated by rotenone exposure, dopaminergic neuron degeneration, redn. in lifespan, mitochondrial dysfunction, oxidative stress, and impairment in synaptic transmission.  However, both mutants showed more severe early motor dysfunction, dopaminergic neuronal loss, and higher hydrogen peroxide prodn. compared with the risk variant.  P.Thr61Ile (co-segregated in three independent PD families) displayed the most severe phenotype followed by p.Arg145Gln (present only in index patient).  We treated the transgenic flies with Ebselen, a mitochondrial hydrogen peroxide scavenger compd.; Ebselen appears to be more effective in ameliorating motor function in the mutant than the risk variant models.  We provide the first in vivo evidence of the pathol. effects assocd. with CHCHD2 mutations.  There was a difference in the pathol. and drug response effects between the pathogenic and the risk variants.  Ebselen may be a useful neuroprotective drug for carriers of CHCHD2 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZfbu7qYfLr7Vg90H21EOLACvtfcHk0ljIPM61CuFYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFGnsbrL&md5=e2c73b2f59a2cd95f8252d02017c7e14</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fhumu.23234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.23234%26sid%3Dliteratum%253Aachs%26aulast%3DTio%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DY.%2BL.%26aulast%3DZukifli%26aufirst%3DZ.%2BH.%2BB.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DKoh%26aufirst%3DT.%2BW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DE.%2BK.%26atitle%3DVaried%2520pathological%2520and%2520therapeutic%2520response%2520effects%2520associated%2520with%2520CHCHD2%2520mutant%2520and%2520risk%2520variants%26jtitle%3DHum.%2520Mutat.%26date%3D2017%26volume%3D38%26spage%3D978%26epage%3D987%26doi%3D10.1002%2Fhumu.23234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barkus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferland, J. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannerman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winstanley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, T.</span></span> <span> </span><span class="NLM_article-title">The putative lithium-mimetic ebselen reduces impulsivity in rodent models</span>. <i>J. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1018</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1177/0269881118784876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1177%2F0269881118784876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29986609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1KktbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=1018-1026&author=C.+Barkusauthor=J.+M.+N.+Ferlandauthor=W.+K.+Adamsauthor=G.+C.+Churchillauthor=P.+J.+Cowenauthor=D.+M.+Bannermanauthor=R.+D.+Rogersauthor=C.+A.+Winstanleyauthor=T.+Sharp&title=The+putative+lithium-mimetic+ebselen+reduces+impulsivity+in+rodent+models&doi=10.1177%2F0269881118784876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The putative lithium-mimetic ebselen reduces impulsivity in rodent models</span></div><div class="casAuthors">Barkus, Chris; Ferland, Jacqueline-Marie N.; Adams, Wendy K.; Churchill, Grant C.; Cowen, Philip J.; Bannerman, David M.; Rogers, Robert D.; Winstanley, Catharine A.; Sharp, Trevor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1018-1026</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Aims:: Recently we identified that the neuroprotective agent ebselen, which is reportedly safe in humans, inhibited inositol monophosphatase, a candidate lithium mechanism.  Ebselen also reduced 5-HT receptor function which predicts impulsivity lowering properties.  Here we investigated the effect of ebselen in rat models of impulsive behavior.  Methods:: Ebselen was tested in two models of impulsivity with human analogs: the five-choice serial reaction time task (5-CSRTT) and rodent gambling task (rGT).  The main outcome measures were premature responses and choice behavior (rGT), which model motor impulsivity and choice impulsivity, resp.  Results:: At doses that decreased 5-HT2A receptor function (DOI-induced wet dog shakes), ebselen decreased premature responding in the 5-CSRTT both in the absence and presence of cocaine.  The 5-HT2A receptor antagonist MDL 100,907 also reduced premature responding in the 5-CSRTT although not in the presence of cocaine.  In the rGT ebselen showed a tendency to reduce premature responding but had no effect on choice behavior.  Conclusions:: These findings suggest that ebselen preferentially reduces motor impulsivity over choice impulsivity, and that inhibition of 5-HT2A receptor function is a contributing mechanism.  Collectively, these data support the repurposing of ebselen as an anti-impulsive treatment and fast-tracking to clin. trials in patient groups characterised by poor impulse control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcPM1S_kTKd7Vg90H21EOLACvtfcHk0ljApLZOk9RDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1KktbvK&md5=71acfd210afa70d085c58c5f7c2c45df</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1177%2F0269881118784876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881118784876%26sid%3Dliteratum%253Aachs%26aulast%3DBarkus%26aufirst%3DC.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%2BN.%26aulast%3DAdams%26aufirst%3DW.%2BK.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26aulast%3DBannerman%26aufirst%3DD.%2BM.%26aulast%3DRogers%26aufirst%3DR.%2BD.%26aulast%3DWinstanley%26aufirst%3DC.%2BA.%26aulast%3DSharp%26aufirst%3DT.%26atitle%3DThe%2520putative%2520lithium-mimetic%2520ebselen%2520reduces%2520impulsivity%2520in%2520rodent%2520models%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2018%26volume%3D32%26spage%3D1018%26epage%3D1026%26doi%3D10.1177%2F0269881118784876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpley, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godlewska, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, P. J.</span></span> <span> </span><span class="NLM_article-title">Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing</span>. <i>Psychopharmacology (Berl)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">2655</span>– <span class="NLM_lpage">2661</span>, <span class="refDoi"> DOI: 10.1007/s00213-016-4319-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs00213-016-4319-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27256357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fmt1SnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=2655-2661&author=C.+Masakiauthor=A.+L.+Sharpleyauthor=C.+M.+Cooperauthor=B.+R.+Godlewskaauthor=N.+Singhauthor=S.+R.+Vasudevanauthor=C.+J.+Harmerauthor=G.+C.+Churchillauthor=T.+Sharpauthor=R.+D.+Rogersauthor=P.+J.+Cowen&title=Effects+of+the+potential+lithium-mimetic%2C+ebselen%2C+on+impulsivity+and+emotional+processing&doi=10.1007%2Fs00213-016-4319-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing</span></div><div class="casAuthors">Masaki Charles; Sharpley Ann L; Cooper Charlotte M; Godlewska Beata R; Harmer Catherine J; Cowen Philip J; Singh Nisha; Vasudevan Sridhar R; Churchill Grant C; Sharp Trevor; Singh Nisha; Rogers Robert D</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2655-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Lithium remains the most effective treatment for bipolar disorder and also has important effects to lower suicidal behaviour, a property that may be linked to its ability to diminish impulsive, aggressive behaviour.  The antioxidant drug, ebselen, has been proposed as a possible lithium-mimetic based on its ability in animals to inhibit inositol monophosphatase (IMPase), an action which it shares with lithium.  OBJECTIVES:  The aim of the study was to determine whether treatment with ebselen altered emotional processing and diminished measures of risk-taking behaviour.  METHODS:  We studied 20 healthy participants who were tested on two occasions receiving either ebselen (3600 mg over 24 h) or identical placebo in a double-blind, randomized, cross-over design.  Three hours after the final dose of ebselen/placebo, participants completed the Cambridge Gambling Task (CGT) and a task that required the detection of emotional facial expressions (facial emotion recognition task (FERT)).  RESULTS:  On the CGT, relative to placebo, ebselen reduced delay aversion while on the FERT, it increased the recognition of positive vs negative facial expressions.  CONCLUSIONS:  The study suggests that at the dosage used, ebselen can decrease impulsivity and produce a positive bias in emotional processing.  These findings have implications for the possible use of ebselen in the disorders characterized by impulsive behaviour and dysphoric mood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSErvRl4Zklf_6AExegM5LLfW6udTcc2eZRYbofYlUIrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fmt1SnsQ%253D%253D&md5=e49d0f95c85519ade8c542ca8ea0adcc</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4319-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4319-5%26sid%3Dliteratum%253Aachs%26aulast%3DMasaki%26aufirst%3DC.%26aulast%3DSharpley%26aufirst%3DA.%2BL.%26aulast%3DCooper%26aufirst%3DC.%2BM.%26aulast%3DGodlewska%26aufirst%3DB.%2BR.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DVasudevan%26aufirst%3DS.%2BR.%26aulast%3DHarmer%26aufirst%3DC.%2BJ.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DSharp%26aufirst%3DT.%26aulast%3DRogers%26aufirst%3DR.%2BD.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26atitle%3DEffects%2520of%2520the%2520potential%2520lithium-mimetic%252C%2520ebselen%252C%2520on%2520impulsivity%2520and%2520emotional%2520processing%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2016%26volume%3D233%26spage%3D2655%26epage%3D2661%26doi%3D10.1007%2Fs00213-016-4319-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpley, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emir, U. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzallah, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluck, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span> <span> </span><span class="NLM_article-title">Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1768</span>– <span class="NLM_lpage">1778</span>, <span class="refDoi"> DOI: 10.1038/npp.2015.343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1038%2Fnpp.2015.343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26593266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVymur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=1768-1778&author=N.+Singhauthor=A.+L.+Sharpleyauthor=U.+E.+Emirauthor=C.+Masakiauthor=M.+M.+Herzallahauthor=M.+A.+Gluckauthor=T.+Sharpauthor=C.+J.+Harmerauthor=S.+R.+Vasudevanauthor=P.+J.+Cowenauthor=G.+C.+Churchill&title=Effect+of+the+putative+lithium+mimetic+ebselen+on+brain+myo-inositol%2C+sleep%2C+and+emotional+processing+in+humans&doi=10.1038%2Fnpp.2015.343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans</span></div><div class="casAuthors">Singh, Nisha; Sharpley, Ann L.; Emir, Uzay E.; Masaki, Charles; Herzallah, Mohammad M.; Gluck, Mark A.; Sharp, Trevor; Harmer, Catherine J.; Vasudevan, Sridhar R.; Cowen, Philip J.; Churchill, Grant C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1768-1778</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lithium remains the gold std. in treating bipolar disorder but has unwanted toxicity and side effects.  We previously reported that ebselen inhibits inositol monophosphatase (IMPase) and exhibits lithium-like effects in animal models through lowering of inositol.  Ebselen has been tested in clin. trials for other disorders, enabling us to det. for the first time the effect of a blood-brain barrier-penetrant IMPase inhibitor on human central nervous system (CNS) function.  We now report that in a double-blind, placebo-controlled trial with healthy participants, acute oral ebselen reduced brain myo-inositol in the anterior cingulate cortex, consistent with CNS target engagement.  Ebselen decreased slow-wave sleep and affected emotional processing by increasing recognition of some emotions, decreasing latency time in the acoustic startle paradigm, and decreasing the reinforcement of rewarding stimuli.  In summary, ebselen affects the phosphoinositide cycle and has CNS effects on surrogate markers that may be relevant to the treatment of bipolar disorder that can be tested in future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcZJVJiw6h-bVg90H21EOLACvtfcHk0ljBfw2cyJjMng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVymur3N&md5=df04f4330f783e1e75390586bebcade5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.343%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DSharpley%26aufirst%3DA.%2BL.%26aulast%3DEmir%26aufirst%3DU.%2BE.%26aulast%3DMasaki%26aufirst%3DC.%26aulast%3DHerzallah%26aufirst%3DM.%2BM.%26aulast%3DGluck%26aufirst%3DM.%2BA.%26aulast%3DSharp%26aufirst%3DT.%26aulast%3DHarmer%26aufirst%3DC.%2BJ.%26aulast%3DVasudevan%26aufirst%3DS.%2BR.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26atitle%3DEffect%2520of%2520the%2520putative%2520lithium%2520mimetic%2520ebselen%2520on%2520brain%2520myo-inositol%252C%2520sleep%252C%2520and%2520emotional%2520processing%2520in%2520humans%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D1768%26epage%3D1778%26doi%3D10.1038%2Fnpp.2015.343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antoniadou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouskou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsiwala, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadirci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, T.</span></span> <span> </span><span class="NLM_article-title">Ebselen has lithium-like effects on central 5-HT2A receptor function</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">2599</span>– <span class="NLM_lpage">2610</span>, <span class="refDoi"> DOI: 10.1111/bph.14179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1111%2Fbph.14179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29488218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvFWmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=2599-2610&author=I.+Antoniadouauthor=M.+Kouskouauthor=T.+Arsiwalaauthor=N.+Singhauthor=S.+R.+Vasudevanauthor=T.+Fowlerauthor=E.+Cadirciauthor=G.+C.+Churchillauthor=T.+Sharp&title=Ebselen+has+lithium-like+effects+on+central+5-HT2A+receptor+function&doi=10.1111%2Fbph.14179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen has lithium-like effects on central 5-HT2A receptor function</span></div><div class="casAuthors">Antoniadou, I.; Kouskou, M.; Arsiwala, T.; Singh, N.; Vasudevan, S. R.; Fowler, T.; Cadirci, E.; Churchill, G. C.; Sharp, T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2599-2610</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Lithium's antidepressant action may be mediated by inhibition of inositol monophosphatase (IMPase), a key enzyme in Gq-protein coupled receptor signalling.  Recently, the antioxidant agent ebselen was identified as an IMPase inhibitor.  Here, we investigated both ebselen and lithium in models of the 5-HT2A receptor, a Gq-protein coupled receptor involved in lithium's actions.  Exptl. Approach : 5-HT2A receptor function was assessed in mice by measuring the behavioral (head-twitches, ear scratches) and mol. (cortical immediate early gene [IEG] mRNA; Arc, c-fos, Egr2) responses to 5-HT2A receptor agonists.  Ebselen and lithium were administered either acutely or repeatedly prior to assessment of 5-HT2A receptor function.  Because lithium and 5-HT2A receptor antagonists augment the action of selective serotonin reuptake inhibitors (SSRIs), ebselen was tested for this activity by co-administration with the SSRI citalopram in microdialysis (extracellular 5-HT) expts.  Key Results : Acute and repeated administration of ebselen inhibited behavioral and IEG responses to the 5-HT2A receptor agonist DOI.  Repeated lithium also inhibited DOI-evoked behavioral and IEG responses.  In comparison, a selective IMPase inhibitor (L-690330) attenuated the behavioral response to DOI whereas glycogen synthase kinase inhibitor (AR-A014418) did not.  Finally, ebselen enhanced the increase in extracellular 5-HT induced by citalopram, and also increased regional brain 5-HT synthesis.  Conclusions and Implications : Our data demonstrated lithium-mimetic effects of ebselen in different exptl. models of 5-HT2A receptor function, probably mediated by IMPase inhibition.  This evidence of lithium-like neuropharmacol. effects of ebselen adds further support for the clin. testing of ebselen in mood disorders, including as an antidepressant augmenting agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGognf5awocjRbVg90H21EOLACvtfcHk0ljBfw2cyJjMng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvFWmtbg%253D&md5=271e1858fd8d782b93a2d2897a09db36</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fbph.14179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14179%26sid%3Dliteratum%253Aachs%26aulast%3DAntoniadou%26aufirst%3DI.%26aulast%3DKouskou%26aufirst%3DM.%26aulast%3DArsiwala%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DVasudevan%26aufirst%3DS.%2BR.%26aulast%3DFowler%26aufirst%3DT.%26aulast%3DCadirci%26aufirst%3DE.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DSharp%26aufirst%3DT.%26atitle%3DEbselen%2520has%2520lithium-like%2520effects%2520on%2520central%25205-HT2A%2520receptor%2520function%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D2599%26epage%3D2610%26doi%3D10.1111%2Fbph.14179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coronado, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, S.</span></span> <span> </span><span class="NLM_article-title">Putative neuroprotective pharmacotherapies to target the staged progression of mental illness</span>. <i>Early Interv Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1111/eip.12775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1111%2Feip.12775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30690898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BB3cjmtFOktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=1032-1049&author=O.+D.+Robertsonauthor=N.+G.+Coronadoauthor=R.+Sethiauthor=M.+Berkauthor=S.+Dodd&title=Putative+neuroprotective+pharmacotherapies+to+target+the+staged+progression+of+mental+illness&doi=10.1111%2Feip.12775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Putative neuroprotective pharmacotherapies to target the staged progression of mental illness</span></div><div class="casAuthors">Robertson Oliver D; Berk Michael; Dodd Seetal; Robertson Oliver D; Berk Michael; Dodd Seetal; Coronado Nieves G; Sethi Rickinder; Berk Michael; Dodd Seetal; Berk Michael; Dodd Seetal; Berk Michael</div><div class="citationInfo"><span class="NLM_cas:title">Early intervention in psychiatry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1032-1049</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM:  Neuropsychiatric disorders including depression, bipolar and schizophrenia frequently exhibit a neuroprogressive course from prodrome to chronicity.  There are a range of agents exhibiting capacity to attenuate biological mechanisms associated with neuroprogression.  This review will update the evidence for putative neuroprotective agents including clinical efficacy, mechanisms of action and limitations in current assessment tools, and identify novel agents with neuroprotective potential.  METHOD:  Data for this review were sourced from online databases PUBMED, Embase and Web of Science.  Only data published since 2012 were included in this review, no data were excluded based on language or publication origin.  RESULTS:  Each of the agents reviewed inhibit one or multiple pathways of neuroprogression including: inflammatory gene expression and cytokine release, oxidative and nitrosative stress, mitochondrial dysfunction, neurotrophin dysregulation and apoptotic signalling.  Some demonstrate clinical efficacy in preventing neural damage or loss, relapse or cognitive/functional decline.  Agents include: the psychotropic medications lithium, second generation antipsychotics and antidepressants; other pharmacological agents such as minocycline, aspirin, cyclooxygenase-2 inhibitors, statins, ketamine and alpha-2-delta ligands; and others such as erythropoietin, oestrogen, leptin, N-acetylcysteine, curcumin, melatonin and ebselen.  CONCLUSIONS:  Signals of evidence of clinical neuroprotection are evident for a number of candidate agents.  Adjunctive use of multiple agents may present a viable avenue to clinical realization of neuroprotection.  Definitive prospective studies of neuroprotection with multimodal assessment tools are required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgDkSQnKayf0PI-fCgwosgfW6udTcc2eaRuQDuvBMhc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjmtFOktw%253D%253D&md5=fe7a8c266d4d1edf69353362d4dd2151</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Feip.12775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Feip.12775%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DO.%2BD.%26aulast%3DCoronado%26aufirst%3DN.%2BG.%26aulast%3DSethi%26aufirst%3DR.%26aulast%3DBerk%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DS.%26atitle%3DPutative%2520neuroprotective%2520pharmacotherapies%2520to%2520target%2520the%2520staged%2520progression%2520of%2520mental%2520illness%26jtitle%3DEarly%2520Interv%2520Psychiatry%26date%3D2019%26volume%3D13%26spage%3D1032%26epage%3D1049%26doi%3D10.1111%2Feip.12775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le-Niculescu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phalen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dainton, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roseberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niezer, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venugopal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelbart, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schork, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandusky, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon, D. R.</span></span> <span> </span><span class="NLM_article-title">Precision medicine for suicidality: from universality to subtypes and personalization</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1250</span>– <span class="NLM_lpage">1273</span>, <span class="refDoi"> DOI: 10.1038/mp.2017.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1038%2Fmp.2017.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28809398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC1cfnslSnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1250-1273&author=A.+B.+Niculescuauthor=H.+Le-Niculescuauthor=D.+F.+Leveyauthor=P.+L.+Phalenauthor=H.+L.+Daintonauthor=K.+Roseberryauthor=E.+M.+Niculescuauthor=J.+O.+Niezerauthor=A.+Williamsauthor=D.+L.+Grahamauthor=T.+J.+Jonesauthor=V.+Venugopalauthor=A.+Ballewauthor=M.+Yardauthor=T.+Gelbartauthor=S.+M.+Kurianauthor=A.+Shekharauthor=N.+J.+Schorkauthor=G.+E.+Sanduskyauthor=D.+R.+Salomon&title=Precision+medicine+for+suicidality%3A+from+universality+to+subtypes+and+personalization&doi=10.1038%2Fmp.2017.128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Precision medicine for suicidality: from universality to subtypes and personalization</span></div><div class="casAuthors">Niculescu A B; Le-Niculescu H; Levey D F; Dainton H L; Roseberry K; Niculescu E M; Niezer J O; Venugopal V; Shekhar A; Niculescu A B; Levey D F; Niculescu A B; Phalen P L; Williams A; Graham D L; Jones T J; Niculescu A B; Yard M; Sandusky G E; Ballew A; Gelbart T; Kurian S M; Salomon D R; Schork N J</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1250-1273</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Suicide remains a clear, present and increasing public health problem, despite being a potentially preventable tragedy.  Its incidence is particularly high in people with overt or un(der)diagnosed psychiatric disorders.  Objective and precise identification of individuals at risk, ways of monitoring response to treatments and novel preventive therapeutics need to be discovered, employed and widely deployed.  We sought to investigate whether blood gene expression biomarkers for suicide (that is, a 'liquid biopsy' approach) can be identified that are more universal in nature, working across psychiatric diagnoses and genders, using larger cohorts than in previous studies.  Such markers may reflect and/or be a proxy for the core biology of suicide.  We were successful in this endeavor, using a comprehensive stepwise approach, leading to a wealth of findings.  Steps 1, 2 and 3 were discovery, prioritization and validation for tracking suicidality, resulting in a Top Dozen list of candidate biomarkers comprising the top biomarkers from each step, as well as a larger list of 148 candidate biomarkers that survived Bonferroni correction in the validation step.  Step 4 was testing the Top Dozen list and Bonferroni biomarker list for predictive ability for suicidal ideation (SI) and for future hospitalizations for suicidality in independent cohorts, leading to the identification of completely novel predictive biomarkers (such as CLN5 and AK2), as well as reinforcement of ours and others previous findings in the field (such as SLC4A4 and SKA2).  Additionally, we examined whether subtypes of suicidality can be identified based on mental state at the time of high SI and identified four potential subtypes: high anxiety, low mood, combined and non-affective (psychotic).  Such subtypes may delineate groups of individuals that are more homogenous in terms of suicidality biology and behavior.  We also studied a more personalized approach, by psychiatric diagnosis and gender, with a focus on bipolar males, the highest risk group.  Such a personalized approach may be more sensitive to gender differences and to the impact of psychiatric co-morbidities and medications.  We compared testing the universal biomarkers in everybody versus testing by subtypes versus personalized by gender and diagnosis, and show that the subtype and personalized approaches permit enhanced precision of predictions for different universal biomarkers.  In particular, LHFP appears to be a strong predictor for suicidality in males with depression.  We also directly examined whether biomarkers discovered using male bipolars only are better predictors in a male bipolar independent cohort than universal biomarkers and show evidence for a possible advantage of personalization.  We identified completely novel biomarkers (such as SPTBN1 and C7orf73), and reinforced previously known biomarkers (such as PTEN and SAT1).  For diagnostic ability testing purposes, we also examined as predictors phenotypic measures as apps (for suicide risk (CFI-S, Convergent Functional Information for Suicidality) and for anxiety and mood (SASS, Simplified Affective State Scale)) by themselves, as well as in combination with the top biomarkers (the combination being our a priori primary endpoint), to provide context and enhance precision of predictions.  We obtained area under the curves of 90% for SI and 77% for future hospitalizations in independent cohorts.  Step 5 was to look for mechanistic understanding, starting with examining evidence for the Top Dozen and Bonferroni biomarkers for involvement in other psychiatric and non-psychiatric disorders, as a mechanism for biological predisposition and vulnerability.  The biomarkers we identified also provide a window towards understanding the biology of suicide, implicating biological pathways related to neurogenesis, programmed cell death and insulin signaling from the universal biomarkers, as well as mTOR signaling from the male bipolar biomarkers.  In particular, HTR2A increase coupled with ARRB1 and GSK3B decreases in expression in suicidality may provide a synergistic mechanistical corrective target, as do SLC4A4 increase coupled with AHCYL1 and AHCYL2 decrease.  Step 6 was to move beyond diagnostics and mechanistical risk assessment, towards providing a foundation for personalized therapeutics.  Items scored positive in the CFI-S and subtypes identified by SASS in different individuals provide targets for personalized (psycho)therapy.  Some individual biomarkers are targets of existing drugs used to treat mood disorders and suicidality (lithium, clozapine and omega-3 fatty acids), providing a means toward pharmacogenomics stratification of patients and monitoring of response to treatment.  Such biomarkers merit evaluation in clinical trials.  Bioinformatics drug repurposing analyses with the gene expression biosignatures of the Top Dozen and Bonferroni-validated universal biomarkers identified novel potential therapeutics for suicidality, such as ebselen (a lithium mimetic), piracetam (a nootropic), chlorogenic acid (a polyphenol) and metformin (an antidiabetic and possible longevity promoting drug).  Finally, based on the totality of our data and of the evidence in the field to date, a convergent functional evidence score prioritizing biomarkers that have all around evidence (track suicidality, predict it, are reflective of biological predisposition and are potential drug targets) brought to the fore APOE and IL6 from among the universal biomarkers, suggesting an inflammatory/accelerated aging component that may be a targetable common denominator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcKsMrmubxoUodMGTatQ7LfW6udTcc2eYQfXiG7Jdk47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfnslSnsg%253D%253D&md5=97e1e98e0a07b44b367175b8e5b7574b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fmp.2017.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2017.128%26sid%3Dliteratum%253Aachs%26aulast%3DNiculescu%26aufirst%3DA.%2BB.%26aulast%3DLe-Niculescu%26aufirst%3DH.%26aulast%3DLevey%26aufirst%3DD.%2BF.%26aulast%3DPhalen%26aufirst%3DP.%2BL.%26aulast%3DDainton%26aufirst%3DH.%2BL.%26aulast%3DRoseberry%26aufirst%3DK.%26aulast%3DNiculescu%26aufirst%3DE.%2BM.%26aulast%3DNiezer%26aufirst%3DJ.%2BO.%26aulast%3DWilliams%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BL.%26aulast%3DJones%26aufirst%3DT.%2BJ.%26aulast%3DVenugopal%26aufirst%3DV.%26aulast%3DBallew%26aufirst%3DA.%26aulast%3DYard%26aufirst%3DM.%26aulast%3DGelbart%26aufirst%3DT.%26aulast%3DKurian%26aufirst%3DS.%2BM.%26aulast%3DShekhar%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DSandusky%26aufirst%3DG.%2BE.%26aulast%3DSalomon%26aufirst%3DD.%2BR.%26atitle%3DPrecision%2520medicine%2520for%2520suicidality%253A%2520from%2520universality%2520to%2520subtypes%2520and%2520personalization%26jtitle%3DMol.%2520Psychiatry%26date%3D2017%26volume%3D22%26spage%3D1250%26epage%3D1273%26doi%3D10.1038%2Fmp.2017.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slusarczyk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olakowska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larysz-Brysz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woszczycka-Korczynska, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Carrillo, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weglarz, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin-Kowalik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcol, W.</span></span> <span> </span><span class="NLM_article-title">Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury</span>. <i>Neural Regener. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.4103/1673-5374.251334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.4103%2F1673-5374.251334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30804257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BB3cfnsVOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1255-1261&author=W.+Slusarczykauthor=E.+Olakowskaauthor=M.+Larysz-Bryszauthor=I.+Woszczycka-Korczynskaauthor=D.+G.+de+Carrilloauthor=W.+P.+Weglarzauthor=J.+Lewin-Kowalikauthor=W.+Marcol&title=Use+of+ebselen+as+a+neuroprotective+agent+in+rat+spinal+cord+subjected+to+traumatic+injury&doi=10.4103%2F1673-5374.251334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury</span></div><div class="casAuthors">Slusarczyk Wojciech; Olakowska Edyta; Larysz-Brysz Magdalena; Woszczycka-Korczynska Izabella; de Carrillo Daria Gendosz; Lewin-Kowalik Joanna; Marcol Wieslaw; Weglarz Wladyslaw P</div><div class="citationInfo"><span class="NLM_cas:title">Neural regeneration research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1255-1261</span>
        ISSN:<span class="NLM_cas:issn">1673-5374</span>.
    </div><div class="casAbstract">Spinal cord injury (SCI) causes disturbances of motor skills.  Free radicals have been shown to be essential for the development of spinal cord trauma.  Despite some progress, until now no effective pharmacological therapies against SCI have been verified.  The purpose of our experiment was to investigate the neuroprotective effects of ebselen on experimental SCI.  Twenty-two rats subjected to SCI were randomly subjected to SCI with no further treatment (n = 10) or intragastric administration of ebselen (10 mg/kg) immediately and 24 hours after SCI.  Behavioral changes were assessed using the Basso, Beattie, and Bresnahan locomotor scale and footprint test during 12 weeks after SCI.  Histopathological and immunohistochemical analyses of spinal cords and brains were performed at 12 weeks after SCI.  Magnetic resonance imaging analysis of spinal cords was also performed at 12 weeks after SCI.  Rats treated with ebselen presented only limited neurobehavioral progress as well as reduced spinal cord injuries compared with the control group, namely length of lesions (cysts/scars) visualized histopathologically in the spinal cord sections was less but cavity area was very similar.  The same pattern was found in T2-weighted magnetic resonance images (cavities) and diffusion-weighted images (scars).  The number of FluoroGold retrogradely labeled neurons in brain stem and motor cortex was several-fold higher in ebselen-treated rats than in the control group.  The findings suggest that ebselen has only limited neuroprotective effects on injured spinal cord.  All exprimental procedures were approved by the Local Animal Ethics Committee for Experiments on Animals in Katowice (Katowice, Poland) (approval No. 19/2009).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6tNYVHCpU2EH3Rlp_k91zfW6udTcc2eYQfXiG7Jdk47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfnsVOjtA%253D%253D&md5=8d71e758cf3fad31d7396b1906c478ef</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.4103%2F1673-5374.251334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F1673-5374.251334%26sid%3Dliteratum%253Aachs%26aulast%3DSlusarczyk%26aufirst%3DW.%26aulast%3DOlakowska%26aufirst%3DE.%26aulast%3DLarysz-Brysz%26aufirst%3DM.%26aulast%3DWoszczycka-Korczynska%26aufirst%3DI.%26aulast%3Dde%2BCarrillo%26aufirst%3DD.%2BG.%26aulast%3DWeglarz%26aufirst%3DW.%2BP.%26aulast%3DLewin-Kowalik%26aufirst%3DJ.%26aulast%3DMarcol%26aufirst%3DW.%26atitle%3DUse%2520of%2520ebselen%2520as%2520a%2520neuroprotective%2520agent%2520in%2520rat%2520spinal%2520cord%2520subjected%2520to%2520traumatic%2520injury%26jtitle%3DNeural%2520Regener.%2520Res.%26date%3D2019%26volume%3D14%26spage%3D1255%26epage%3D1261%26doi%3D10.4103%2F1673-5374.251334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, C.</span></span> <span> </span><span class="NLM_article-title">Histidine-tryptophan-ketoglutarate solution with added ebselen augments myocardial protection in neonatal porcine hearts undergoing ischemia/reperfusion</span>. <i>Artif. Organs</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1111/aor.12340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1111%2Faor.12340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25511318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVehtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=126-133&author=Y.+Chenauthor=J.+P.+Liuauthor=S.+J.+Liauthor=F.+X.+Yanauthor=Q.+H.+Xueauthor=H.+Y.+Wangauthor=P.+Sunauthor=C.+Long&title=Histidine-tryptophan-ketoglutarate+solution+with+added+ebselen+augments+myocardial+protection+in+neonatal+porcine+hearts+undergoing+ischemia%2Freperfusion&doi=10.1111%2Faor.12340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Histidine-Tryptophan-Ketoglutarate Solution With Added Ebselen Augments Myocardial Protection in Neonatal Porcine Hearts Undergoing Ischemia/Reperfusion</span></div><div class="casAuthors">Chen, Yan; Liu, Jinping; Li, Shoujun; Yan, Fuxia; Xue, Qinghua; Wang, Huiying; Sun, Peng; Long, Cun</div><div class="citationInfo"><span class="NLM_cas:title">Artificial Organs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-133</span>CODEN:
                <span class="NLM_cas:coden">ARORD7</span>;
        ISSN:<span class="NLM_cas:issn">0160-564X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Whether modified histidine-tryptophan-ketoglutarate (HTK) soln. offers myocardial protection to newborn heart has not been documented.  The purpose of this study was to compare myocardial protection using HTK added by ebselen with HTK in a piglet model of cardiopulmonary bypass (CPB).  Fifteen piglets were randomly assigned to three groups: the control group (C group, n = 5), HTK soln. group (HTK group, n = 5), and HTK added by 10 nM ebselen group (HTK+E group, n = 5).  Animals in the two exptl. groups were placed on hypothermic CPB, after which the ascending aorta had been clamped for 2 h.  The control animals underwent normothermic CPB without cardiac arrest.  Myocardial antioxidant activities, myocytes apoptosis and mitochondrial structures, as well as the release of cytochrome c and the expression of Bax, Bcl-2, and HSP72 protein in myocardium were measured.  Increased myocardial superoxide dismutase (SOD) and Mn-SOD activities, decreased TUNEL-pos. cells, and reduced release of cytochrome c were noted in the HTK+E group compared with those in the HTK group (P = 0.021, P = 0.020, P = 0.045, and P = 0.010, resp.).  The Bax/Bcl-2 ratio in the HTK group was significantly higher than that in the C group (P = 0.024).  The expression of HSP72 protein and mRNA in the HTK+E group was higher than that in the HTK group (P = 0.039 and P = 0.035, resp.).  Mitochondrial score under electron microscope in the HTK+E group was lower than that in the HTK group (P = 0.047).  Improved antioxidant defense, reduced myocytes apoptosis, and better preserved mitochondrial structure were obsd. in the HTK+E group.  Ebselen added to HTK provides better myocardioprotection to HTK soln. for the neonatal heart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGremXgURufSMrVg90H21EOLACvtfcHk0lhvvgb12PyqPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVehtLw%253D&md5=a382988ace81316d98ce2c8b81ceb066</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Faor.12340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Faor.12340%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%2BP.%26aulast%3DLi%26aufirst%3DS.%2BJ.%26aulast%3DYan%26aufirst%3DF.%2BX.%26aulast%3DXue%26aufirst%3DQ.%2BH.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DLong%26aufirst%3DC.%26atitle%3DHistidine-tryptophan-ketoglutarate%2520solution%2520with%2520added%2520ebselen%2520augments%2520myocardial%2520protection%2520in%2520neonatal%2520porcine%2520hearts%2520undergoing%2520ischemia%252Freperfusion%26jtitle%3DArtif.%2520Organs%26date%3D2015%26volume%3D39%26spage%3D126%26epage%3D133%26doi%3D10.1111%2Faor.12340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Q. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Ebselen protects rat hearts against myocardial ischemia-reperfusion injury</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1419</span>, <span class="refDoi"> DOI: 10.3892/etm.2018.7089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3892%2Fetm.2018.7089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30680022" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1412-1419&author=B.+Chengauthor=J.+P.+Zhongauthor=F.+X.+Wuauthor=G.+L.+Liauthor=Q.+X.+Ruanauthor=G.+Luoauthor=H.+Jiang&title=Ebselen+protects+rat+hearts+against+myocardial+ischemia-reperfusion+injury&doi=10.3892%2Fetm.2018.7089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.3892%2Fetm.2018.7089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2018.7089%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DF.%2BX.%26aulast%3DLi%26aufirst%3DG.%2BL.%26aulast%3DRuan%26aufirst%3DQ.%2BX.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DEbselen%2520protects%2520rat%2520hearts%2520against%2520myocardial%2520ischemia-reperfusion%2520injury%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2018%26volume%3D17%26spage%3D1412%26epage%3D1419%26doi%3D10.3892%2Fetm.2018.7089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinbrenner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilgic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollschlager, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohrn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeken, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhyari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenberg, A.</span></span> <span> </span><span class="NLM_article-title">Selenium pretreatment for mitigation of ischemia/reperfusion injury in cardiovascular surgery: influence on acute organ damage and inflammatory response</span>. <i>Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1007/s10753-016-0368-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs10753-016-0368-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27192987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XotleisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=1363-1376&author=H.+Steinbrennerauthor=E.+Bilgicauthor=A.+Pintoauthor=M.+Engelsauthor=L.+Wollschlagerauthor=L.+Dohrnauthor=K.+Kellermannauthor=U.+Boekenauthor=P.+Akhyariauthor=A.+Lichtenberg&title=Selenium+pretreatment+for+mitigation+of+ischemia%2Freperfusion+injury+in+cardiovascular+surgery%3A+influence+on+acute+organ+damage+and+inflammatory+response&doi=10.1007%2Fs10753-016-0368-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium Pretreatment for Mitigation of Ischemia/Reperfusion Injury in Cardiovascular Surgery: Influence on Acute Organ Damage and Inflammatory Response</span></div><div class="casAuthors">Steinbrenner, Holger; Bilgic, Esra; Pinto, Antonio; Engels, Melanie; Wollschlaeger, Lena; Doehrn, Laura; Kellermann, Kristine; Boeken, Udo; Akhyari, Payam; Lichtenberg, Artur</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1376</span>CODEN:
                <span class="NLM_cas:coden">INFLD4</span>;
        ISSN:<span class="NLM_cas:issn">0360-3997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Ischemia/reperfusion injury (IRI) contributes to morbidity and mortality after cardiovascular surgery requiring cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA).  Multi-organ damage is assocd. with substantial decreases of blood selenium (Se) levels in patients undergoing cardiac surgery with CPB.  We compared the influence of a dietary surplus of Se and pretreatment with ebselen, a mimic of the selenoenzyme glutathione peroxidase, on IRI-induced tissue damage and inflammation.  Male Wistar rats were fed either a Se-adequate diet contg. 0.3 ppm Se or supplemented with 1 ppm Se (as sodium selenite) for 5 wk.  Two other groups of Se-adequate rats received i.p. injection of ebselen (30 mg/kg) or DMSO (solvent control) before surgery.  The animals were connected to a heart-lung-machine and underwent 45 min of global ischemia during circulatory arrest at 16 °C, followed by re-warming and reperfusion.  Selenite and ebselen suppressed IRI-induced leukocytosis and the increase in plasma levels of tissue damage markers (AST, ALT, LDH, troponin) during surgery but did not prevent the induction of proinflammatory cytokines (IL-6, TNF-α).  Both Se compds. affected phosphorylation and expression of proteins related to stress response and inflammation: Ebselen increased phosphorylation of STAT3 transcription factor in the heart and decreased phosphorylation of ERK1/2 MAP kinases in the lungs.  Selenite decreased ERK1/2 phosphorylation and HSP-70 expression in the heart.  Pretreatment with selenite or ebselen protected against acute IRI-induced tissue damage during CPB and DHCA.  Potential implications of their different actions with regard to mol. stress markers on the recovery after surgery represent promising targets for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6KNf2AAhsjbVg90H21EOLACvtfcHk0lhvvgb12PyqPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotleisLc%253D&md5=f77d71bfecdd1ad24333e3528b50292e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1007%2Fs10753-016-0368-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10753-016-0368-5%26sid%3Dliteratum%253Aachs%26aulast%3DSteinbrenner%26aufirst%3DH.%26aulast%3DBilgic%26aufirst%3DE.%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DEngels%26aufirst%3DM.%26aulast%3DWollschlager%26aufirst%3DL.%26aulast%3DDohrn%26aufirst%3DL.%26aulast%3DKellermann%26aufirst%3DK.%26aulast%3DBoeken%26aufirst%3DU.%26aulast%3DAkhyari%26aufirst%3DP.%26aulast%3DLichtenberg%26aufirst%3DA.%26atitle%3DSelenium%2520pretreatment%2520for%2520mitigation%2520of%2520ischemia%252Freperfusion%2520injury%2520in%2520cardiovascular%2520surgery%253A%2520influence%2520on%2520acute%2520organ%2520damage%2520and%2520inflammatory%2520response%26jtitle%3DInflammation%26date%3D2016%26volume%3D39%26spage%3D1363%26epage%3D1376%26doi%3D10.1007%2Fs10753-016-0368-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mordente, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestrini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martorana, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meucci, E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of anthracycline alcohol metabolite formation in human heart cytosol: a potential role for several promising drugs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1701</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.065110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1124%2Fdmd.115.065110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26265744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XislGhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=1691-1701&author=A.+Mordenteauthor=A.+Silvestriniauthor=G.+E.+Martoranaauthor=D.+Tavianauthor=E.+Meucci&title=Inhibition+of+anthracycline+alcohol+metabolite+formation+in+human+heart+cytosol%3A+a+potential+role+for+several+promising+drugs&doi=10.1124%2Fdmd.115.065110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of anthracycline alcohol metabolite formation in human heart cytosol: a potential role for several promising drugs</span></div><div class="casAuthors">Mordente, Alvaro; Silvestrini, Andrea; Ettore, Martorana Giuseppe; Tavian, Daniela; Meucci, Elisabetta</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1701</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The clin. efficacy of anthracyclines (e.g., doxorubicin and daunorubicin) in cancer therapy is limited by their severe cardiotoxicity, the etiol. of which is still not fully understood.  The development of anthracycline-induced cardiomyopathy has been found to correlate with myocardial formation and accumulation of anthracycline secondary alc. metabolites (e.g., doxorubicinol and daunorubicinol) that are produced by distinct cytosolic NADPH-dependent reductases.  The aim of the current study is to identify chem. compds. capable of inhibiting myocardial reductases implied in anthracycline reductive metab. in an attempt to decrease the prodn. of cardiotoxic C-13 alc. metabolites.  Among the variety of tested compds. (metal chelators, radical scavengers, antioxidants, β-blockers, nitrone spin traps, and lipid-lowering drugs), ebselen, cyclopentenone prostaglandins, nitric oxide donors, and short-chain coenzyme Q analogs resulted in being effective inhibitors of both doxorubicinol and daunorubicinol formation.  In particular, ebselen (as well as ebselen diselenide, its storage form in the cells) was the most potent inhibitor of cardiotoxic anthracycline alc. metabolites with 50% inhibition of doxorubicinol formation at 0.2 mol Eq of ebselen with respect to doxorubicin concn.  The high efficacy, together with its favorable pharmacol. profile (low toxicity, lack of adverse effects, and metabolic stability) portends ebselen as a promising cardioprotective agent against anthracycline-induced cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp1G9RtBKh5LVg90H21EOLACvtfcHk0ljXJKdNbgE-0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislGhtrk%253D&md5=f3fa0a2e480cc4fba0d1eba37ac99882</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.065110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.065110%26sid%3Dliteratum%253Aachs%26aulast%3DMordente%26aufirst%3DA.%26aulast%3DSilvestrini%26aufirst%3DA.%26aulast%3DMartorana%26aufirst%3DG.%2BE.%26aulast%3DTavian%26aufirst%3DD.%26aulast%3DMeucci%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520anthracycline%2520alcohol%2520metabolite%2520formation%2520in%2520human%2520heart%2520cytosol%253A%2520a%2520potential%2520role%2520for%2520several%2520promising%2520drugs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26spage%3D1691%26epage%3D1701%26doi%3D10.1124%2Fdmd.115.065110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torramade-Moix, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Rodriguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cases, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzado, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escolar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Ricart, M.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and anti-inflammatory strategies based on the potentiation of glutathione peroxidase activity prevent endothelial dysfunction in chronic kidney disease</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1300</span>, <span class="refDoi"> DOI: 10.1159/000495540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1159%2F000495540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30481789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFWrtrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=1287-1300&author=M.+Veraauthor=S.+Torramade-Moixauthor=S.+Martin-Rodriguezauthor=A.+Casesauthor=J.+M.+Cruzadoauthor=J.+Riveraauthor=G.+Escolarauthor=M.+Palomoauthor=M.+Diaz-Ricart&title=Antioxidant+and+anti-inflammatory+strategies+based+on+the+potentiation+of+glutathione+peroxidase+activity+prevent+endothelial+dysfunction+in+chronic+kidney+disease&doi=10.1159%2F000495540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant and Anti-Inflammatory Strategies Based on the Potentiation of Glutathione Peroxidase Activity Prevent Endothelial Dysfunction in Chronic Kidney Disease</span></div><div class="casAuthors">Vera, Manel; Torramade-Moix, Sergi; Martin-Rodriguez, Susana; Cases, Aleix; Cruzado, Josep M.; Rivera, Jose; Escolar, Gines; Palomo, Marta; Diaz-Ricart, Maribel</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1287-1300</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Accelerated atherosclerosis in chronic kidney disease (CKD) is preceded by endothelial dysfunction (ED), which exhibits a proinflammatory and prothrombotic phenotype and enhanced oxidative stress.  In this study, the effect of several compds. with anti-inflammatory and/or antioxidant properties on uremia-induced endothelial dysfunction has been evaluated in an in vitro model.  Methods: Endothelial cells (ECs) were exposed to sera from uremic patients in the absence and presence of the flavonoids apigenin, genistein and quercetin, the antioxidant enzyme mimetics (AEM) ebselen (glutathione peroxidase mimetic), EUK-134 and EUK-118 (both superoxide dismutase mimetics), and the pharmacol. drug N-acetylcysteine (NAC).  We explored changes in the expression of adhesion receptors on the cell surface, by immunofluorescence, the prodn. of radical oxygen species (ROS), by fluorescence detection, and the activation of signaling proteins related to inflammation, by both a phosphospecific antibody cell-based ELISA and immunoblotting techniques.  Results: Uremic media induced a significantly increased expression of ICAM-1, overprodn. of radical oxygen species (ROS) and activation of p38 mitogen activated protein kinase (p38MAPK) and Nuclear Factor kB (NFkB) in ECs.  Quercetin, the AEM and NAC showed a significant inhibitory effect on both ICAM-1 expression and ROS generation (p<0.05).  All the compds. reduced p38MAPK activation, but only the AEM, esp. ebselen, and NAC, both potentiating the glutathione peroxidase pathway, also inhibited NFkB activation.  These two compds. were capable of increasing endothelial glutathione levels, esp. in response to uremia.  Conclusion: Our results indicate that the potentiation of the antioxidant pathways can be an effective strategy to improve endothelial dysfunction in uremia and a potential target to reduce the cardiovascular risk in this population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv1ZckQLRxFbVg90H21EOLACvtfcHk0ljXJKdNbgE-0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFWrtrvE&md5=144632f213e8c25cb4c51b5924593624</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1159%2F000495540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000495540%26sid%3Dliteratum%253Aachs%26aulast%3DVera%26aufirst%3DM.%26aulast%3DTorramade-Moix%26aufirst%3DS.%26aulast%3DMartin-Rodriguez%26aufirst%3DS.%26aulast%3DCases%26aufirst%3DA.%26aulast%3DCruzado%26aufirst%3DJ.%2BM.%26aulast%3DRivera%26aufirst%3DJ.%26aulast%3DEscolar%26aufirst%3DG.%26aulast%3DPalomo%26aufirst%3DM.%26aulast%3DDiaz-Ricart%26aufirst%3DM.%26atitle%3DAntioxidant%2520and%2520anti-inflammatory%2520strategies%2520based%2520on%2520the%2520potentiation%2520of%2520glutathione%2520peroxidase%2520activity%2520prevent%2520endothelial%2520dysfunction%2520in%2520chronic%2520kidney%2520disease%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2018%26volume%3D51%26spage%3D1287%26epage%3D1300%26doi%3D10.1159%2F000495540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucci, Q. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handy, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loscalzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siedlecki, A. M.</span></span> <span> </span><span class="NLM_article-title">Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function</span>. <i>Nephrol., Dial., Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1093/ndt/gfx304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1093%2Fndt%2Fgfx304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29244159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1Ohur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=923-934&author=P.+Pangauthor=M.+Abbottauthor=M.+Abdiauthor=Q.+A.+Fucciauthor=N.+Chauhanauthor=M.+Mistriauthor=B.+Proctorauthor=M.+Chinauthor=B.+Wangauthor=W.+Yinauthor=T.+S.+Luauthor=A.+Halimauthor=K.+Limauthor=D.+E.+Handyauthor=J.+Loscalzoauthor=A.+M.+Siedlecki&title=Pre-clinical+model+of+severe+glutathione+peroxidase-3+deficiency+and+chronic+kidney+disease+results+in+coronary+artery+thrombosis+and+depressed+left+ventricular+function&doi=10.1093%2Fndt%2Fgfx304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function</span></div><div class="casAuthors">Pang, Paul; Abbott, Molly; Abdi, Malyun; Fucci, Quynh-Anh; Chauhan, Nikita; Mistri, Murti; Proctor, Brandon; Chin, Matthew; Wang, Bin; Yin, Wenqing; Lu, Tzong-Shi; Halim, Arvin; Lim, Kenneth; Handy, Diane E.; Loscalzo, Joseph; Siedlecki, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-934</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">1460-2385</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Chronic kidney disease (CKD) patients have deficient levels of glutathione peroxidase-3 (GPx3).  We hypothesized that GPx3 deficiency may lead to cardiovascular disease in the presence of chronic kidney disease due to an accumulation of reactive oxygen species and decreased microvascular perfusion of the myocardium.  Methods.  To isolate the exclusive effect of GPx3 deficiency in kidney disease-induced cardiac disease, we studied the GPx3 knockout mouse strain (GPx3-/-) in the setting of surgery-induced CKD.  Results.  RNA (RNA) microarray screening of non-stimulated GPx3 -/- heart tissue show increased expression of genes assocd. with cardiomyopathy including myh7, plac9, serpine1 and cd74 compared with wild-type (WT) controls.  GPx3-/- mice underwent surgically induced renal mass redn. to generate a model of CKD.  GPx3-/- +CKD mice underwent echocardiog. 4 wk after injury.  Fractional shortening (FS) was decreased to 32.9 ± 5.8% in GPx3-/- + CKD compared to 62.0% ± 10.3 in WT + CKD (P < 0.001).  Platelet aggregates were increased in the myocardium of GPx3-/- + CKD.  Asym. dimethylarginine (ADMA) levels were increased in both GPx3-/- + CKD and WT + CKD.  ADMA stimulated spontaneous platelet aggregation more quickly in washed platelets from GPx3-/-.  In vitro platelet aggregation was enhanced in samples from GPx3-/- + CKD.  Platelet aggregation in GPx3-/- + CKD samples was mitigated after in vivo administration of ebselen, a glutathione peroxidase mimetic.  FS improved in GPx3-/- CKD mice after ebselen treatment.  Conclusion.  These results suggest GPx3 deficiency is a substan-contributing factor to the development of kidney disease-induced cardiac disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruAIkxIOYeNrVg90H21EOLACvtfcHk0ljXJKdNbgE-0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1Ohur4%253D&md5=8402252b189c8d505cbc717a73866558</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfx304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfx304%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DP.%26aulast%3DAbbott%26aufirst%3DM.%26aulast%3DAbdi%26aufirst%3DM.%26aulast%3DFucci%26aufirst%3DQ.%2BA.%26aulast%3DChauhan%26aufirst%3DN.%26aulast%3DMistri%26aufirst%3DM.%26aulast%3DProctor%26aufirst%3DB.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DT.%2BS.%26aulast%3DHalim%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DK.%26aulast%3DHandy%26aufirst%3DD.%2BE.%26aulast%3DLoscalzo%26aufirst%3DJ.%26aulast%3DSiedlecki%26aufirst%3DA.%2BM.%26atitle%3DPre-clinical%2520model%2520of%2520severe%2520glutathione%2520peroxidase-3%2520deficiency%2520and%2520chronic%2520kidney%2520disease%2520results%2520in%2520coronary%2520artery%2520thrombosis%2520and%2520depressed%2520left%2520ventricular%2520function%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2018%26volume%3D33%26spage%3D923%26epage%3D934%26doi%3D10.1093%2Fndt%2Fgfx304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haas, M. J.</span>; <span class="NLM_string-name">Jurado-Flores, M.</span>; <span class="NLM_string-name">Hammoud, R.</span>; <span class="NLM_string-name">Feng, V.</span>; <span class="NLM_string-name">Gonzales, K.</span>; <span class="NLM_string-name">Onstead-Haas, L.</span>; <span class="NLM_string-name">A, D. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of pro-inflammatory cytokine secretion by select antioxidants in human coronary artery endothelial cells</span>.  <i>Int. J. Vitam. Nutr. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1024/0300-9831/a000520</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1024%2F0300-9831%2Fa000520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+J.+Haas&author=M.+Jurado-Flores&author=R.+Hammoud&author=V.+Feng&author=K.+Gonzales&author=L.+Onstead-Haas&author=D.+M.+A&title=Inhibition+of+pro-inflammatory+cytokine+secretion+by+select+antioxidants+in+human+coronary+artery+endothelial+cells&doi=10.1024%2F0300-9831%2Fa000520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1024%2F0300-9831%2Fa000520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1024%252F0300-9831%252Fa000520%26sid%3Dliteratum%253Aachs%26aulast%3DHaas%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520pro-inflammatory%2520cytokine%2520secretion%2520by%2520select%2520antioxidants%2520in%2520human%2520coronary%2520artery%2520endothelial%2520cells%26jtitle%3DInt.%2520J.%2520Vitam.%2520Nutr.%2520Res.%26date%3D2019%26doi%3D10.1024%2F0300-9831%2Fa000520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foote, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saboda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lance, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, E. T.</span></span> <span> </span><span class="NLM_article-title">Selenium and type 2 diabetes: systematic review</span>. <i>Nutrients</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1924</span>, <span class="refDoi"> DOI: 10.3390/nu10121924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fnu10121924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotlSqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1924&author=L.+N.+Kohlerauthor=J.+Footeauthor=C.+P.+Kelleyauthor=A.+Floreaauthor=C.+Shellyauthor=H.+S.+Chowauthor=P.+Hsuauthor=K.+Bataiauthor=N.+Ellisauthor=K.+Sabodaauthor=P.+Lanceauthor=E.+T.+Jacobs&title=Selenium+and+type+2+diabetes%3A+systematic+review&doi=10.3390%2Fnu10121924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium and type 2 diabetes: systematic review</span></div><div class="casAuthors">Kohler, Lindsay N.; Foote, Janet; Kelley, Connor P.; Florea, Ana; Shelly, Colleen; Chow, H-H. Sherry; Hsu, Paul; Batai, Ken; Ellis, Nathan; Saboda, Kathylynn; Lance, Peter; Jacobs, Elizabeth T.</div><div class="citationInfo"><span class="NLM_cas:title">Nutrients</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1924/1-1924/13</span>CODEN:
                <span class="NLM_cas:coden">NUTRHU</span>;
        ISSN:<span class="NLM_cas:issn">2072-6643</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Several studies have investigated the potential role of selenium (Se) in the development of type 2 diabetes (T2D) with disparate findings.  We conducted a systematic review and meta-anal. to synthesize the evidence of any assocn. between Se and T2D.  PubMed, Embase, and Scopus were searched following the Preferred Reporting Items for Systematic Reviews and Meta-anal. Approach (PRISMA).  Sixteen studies from 15 papers met inclusion criteria defined for this review.  Of the 13 observational studies included, 8 demonstrated a statistically significant pos. assocn. between concns. of Se and odds for T2D, with odds ratios (95% confidence intervals) ranging from 1.52 (1.01-2.28) to 7.64 (3.34-17.46), and a summary odds ratio (OR) (95% confidence interval (CI)) of 2.03 (1.51-2.72).  In contrast, among randomized clin. trials (RCTs) of Se, a higher risk of T2D was not obsd. for those who received Se compared to a placebo (OR = 1.18, 95% CI 0.95-1.47).  Taken together, the results for the relationship between Se and T2D differ between observational studies and randomized clin. trials (RCTs).  It remains unclear whether these differences are the result of uncontrolled confounding in the observational studies, or whether there is a modest effect of Se on the risk for T2D that may vary by duration of exposure.  Further investigations on the effects of Se on glucose metab. are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdvJIFon6ZqrVg90H21EOLACvtfcHk0lgDwpmuVUPlLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotlSqtbw%253D&md5=978d5fb526c788dfbf388e4e78723c3e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3390%2Fnu10121924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fnu10121924%26sid%3Dliteratum%253Aachs%26aulast%3DKohler%26aufirst%3DL.%2BN.%26aulast%3DFoote%26aufirst%3DJ.%26aulast%3DKelley%26aufirst%3DC.%2BP.%26aulast%3DFlorea%26aufirst%3DA.%26aulast%3DShelly%26aufirst%3DC.%26aulast%3DChow%26aufirst%3DH.%2BS.%26aulast%3DHsu%26aufirst%3DP.%26aulast%3DBatai%26aufirst%3DK.%26aulast%3DEllis%26aufirst%3DN.%26aulast%3DSaboda%26aufirst%3DK.%26aulast%3DLance%26aufirst%3DP.%26aulast%3DJacobs%26aufirst%3DE.%2BT.%26atitle%3DSelenium%2520and%2520type%25202%2520diabetes%253A%2520systematic%2520review%26jtitle%3DNutrients%26date%3D2018%26volume%3D10%26spage%3D1924%26doi%3D10.3390%2Fnu10121924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S.</span></span> <span> </span><span class="NLM_article-title">Association between serum selenium level and the presence of diabetes mellitus: a meta-analysis of observational studies</span>. <i>Diabetes Metab J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.4093/dmj.2018.0123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.4093%2Fdmj.2018.0123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30688047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BB3cjlvV2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2019&pages=447-460&author=J.+Kimauthor=H.+S.+Chungauthor=M.+K.+Choiauthor=Y.+K.+Rohauthor=H.+J.+Yooauthor=J.+H.+Parkauthor=D.+S.+Kimauthor=J.+M.+Yuauthor=S.+Moon&title=Association+between+serum+selenium+level+and+the+presence+of+diabetes+mellitus%3A+a+meta-analysis+of+observational+studies&doi=10.4093%2Fdmj.2018.0123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Association between Serum Selenium Level and the Presence of Diabetes Mellitus: A Meta-Analysis of Observational Studies</span></div><div class="casAuthors">Kim Juno; Choi Min Kyu; Roh Yong Kyun; Chung Hye Soo; Yu Jae Myung; Moon Shinje; Yoo Hyung Joon; Park Jung Hwan; Kim Dong Sun; Moon Shinje</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes & metabolism journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-460</span>
        ISSN:<span class="NLM_cas:issn">2233-6079</span>.
    </div><div class="casAbstract">BACKGROUND:  Epidemiological studies have suggested an association between selenium (Se) and diabetes mellitus (DM).  However, different studies have reported conflicting results.  Therefore, we performed a comprehensive meta-analysis to clarify the impact of Se on DM.  METHODS:  We searched the PubMed database for studies on the association between Se and DM from inception to June 2018.  RESULTS:  Twenty articles evaluating 47,930 participants were included in the analysis.  The meta-analysis found that high levels of Se were significantly associated with the presence of DM (pooled odds ratios [ORs], 1.88; 95% confidence interval [CI], 1.44 to 2.45).  However, significant heterogeneity was found (I2=82%).  Subgroup analyses were performed based on the Se measurement methods used in each study.  A significant association was found between high Se levels and the presence of DM in the studies that used blood (OR, 2.17; 95% CI, 1.60 to 2.93; I2=77%), diet (OR, 1.61; 95% CI, 1.10 to 2.36; I2=0%), and urine (OR, 1.49; 95% CI, 1.02 to 2.17; I2=0%) as samples to estimate Se levels, but not in studies on nails (OR, 1.24; 95% CI, 0.52 to 2.98; I2=91%).  Because of significant heterogeneity in the studies with blood, we conducted a sensitivity analysis and tested the publication bias.  The results were consistent after adjustment based on the sensitivity analysis as well as the trim and fill analysis for publication bias.  CONCLUSION:  This meta-analysis demonstrates that high levels of Se are associated with the presence of DM.  Further prospective and randomized controlled trials are warranted to elucidate the link better.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUC3f_iRJrahFwe7cAcrfPfW6udTcc2ebhGYx7FlGWnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjlvV2gsQ%253D%253D&md5=58ad7bdfbe7e0dea6e2b56948466dee7</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.4093%2Fdmj.2018.0123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4093%252Fdmj.2018.0123%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DH.%2BS.%26aulast%3DChoi%26aufirst%3DM.%2BK.%26aulast%3DRoh%26aufirst%3DY.%2BK.%26aulast%3DYoo%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BS.%26aulast%3DYu%26aufirst%3DJ.%2BM.%26aulast%3DMoon%26aufirst%3DS.%26atitle%3DAssociation%2520between%2520serum%2520selenium%2520level%2520and%2520the%2520presence%2520of%2520diabetes%2520mellitus%253A%2520a%2520meta-analysis%2520of%2520observational%2520studies%26jtitle%3DDiabetes%2520Metab%2520J.%26date%3D2019%26volume%3D43%26spage%3D447%26epage%3D460%26doi%3D10.4093%2Fdmj.2018.0123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sobczak, A. I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanowicz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajjan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. J.</span></span> <span> </span><span class="NLM_article-title">Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes</span>. <i>BioMetals</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1007/s10534-018-00167-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs10534-018-00167-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30671675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFGqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2019&pages=123-138&author=A.+I.+S.+Sobczakauthor=F.+Stefanowiczauthor=S.+J.+Pittauthor=R.+A.+Ajjanauthor=A.+J.+Stewart&title=Total+plasma+magnesium%2C+zinc%2C+copper+and+selenium+concentrations+in+type-I+and+type-II+diabetes&doi=10.1007%2Fs10534-018-00167-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes</span></div><div class="casAuthors">Sobczak, Amelie I. S.; Stefanowicz, Fiona; Pitt, Samantha J.; Ajjan, Ramzi A.; Stewart, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">BioMetals</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-138</span>CODEN:
                <span class="NLM_cas:coden">BOMEEH</span>;
        ISSN:<span class="NLM_cas:issn">0966-0844</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glycemia and insulin resistance are important regulators of multiple physiol. processes and their dysregulation has wide-ranging consequences, including alterations in plasma concns. of metal micronutrients.  Here, magnesium, zinc, copper, selenium and glycated albumin (HbA1c) concns. and quartile differences were examd. in 45 subjects with type-I diabetes (T1DM), 54 subjects with type-II diabetes (T2DM) and 62 control subjects in order to assess potential differences between sexes and between T1DM and T2DM.  Plasma magnesium concn. was decreased in T1DM subjects, with the second, third and fourth quartiles of magnesium concns. assocd. with the absence of T1DM.  This effect was obsd. in females but not males.  In T2DM, the highest quartile of selenium concns. and the third quartile of copper concns. assocd. with the absence of diabetes in males.  The highest quartile of magnesium concns. was assocd. with the absence of T2DM in males but not females.  HbA1c correlated with plasma concns. of magnesium (neg., in both sexes together in T1DM and T1DM males), copper (pos., in T1DM males and in both sexes together in T2DM), selenium (pos., in both sexes together in T1DM and T2DM, and T2DM females) and with zinc/copper ratio (neg., in both sexes together in T1DM and T2DM).  This study shows that plasma magnesium concn. is altered to the highest degree in T1DM, while in T2DM, plasma selenium and copper concns. are significantly affected.  This work increases our understanding of how T1DM and T2DM affects plasma metal concns. and may have future implications for diabetes management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFe-agJlueaLVg90H21EOLACvtfcHk0lgDwpmuVUPlLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFGqs7Y%253D&md5=9a5d80a05ac57da6b57577a4a9623b49</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2Fs10534-018-00167-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10534-018-00167-z%26sid%3Dliteratum%253Aachs%26aulast%3DSobczak%26aufirst%3DA.%2BI.%2BS.%26aulast%3DStefanowicz%26aufirst%3DF.%26aulast%3DPitt%26aufirst%3DS.%2BJ.%26aulast%3DAjjan%26aufirst%3DR.%2BA.%26aulast%3DStewart%26aufirst%3DA.%2BJ.%26atitle%3DTotal%2520plasma%2520magnesium%252C%2520zinc%252C%2520copper%2520and%2520selenium%2520concentrations%2520in%2520type-I%2520and%2520type-II%2520diabetes%26jtitle%3DBioMetals%26date%3D2019%26volume%3D32%26spage%3D123%26epage%3D138%26doi%3D10.1007%2Fs10534-018-00167-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parazzoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseid, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzel, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallerie, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmon, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, R. P.</span></span> <span> </span><span class="NLM_article-title">Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves beta-cell mass and function in ZDF rats</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3582</span>– <span class="NLM_lpage">3588</span>, <span class="refDoi"> DOI: 10.2337/db13-0357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2337%2Fdb13-0357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=23801580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOhtLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=3582-3588&author=J.+Mahadevanauthor=S.+Parazzoliauthor=E.+Oseidauthor=A.+V.+Hertzelauthor=D.+A.+Bernlohrauthor=S.+N.+Vallerieauthor=C.+Q.+Liuauthor=M.+Lopezauthor=J.+S.+Harmonauthor=R.+P.+Robertson&title=Ebselen+treatment+prevents+islet+apoptosis%2C+maintains+intranuclear+Pdx-1+and+MafA+levels%2C+and+preserves+beta-cell+mass+and+function+in+ZDF+rats&doi=10.2337%2Fdb13-0357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves β-cell mass and function in ZDF rats</span></div><div class="casAuthors">Mahadevan, Jana; Parazzoli, Susan; Oseid, Elizabeth; Hertzel, Ann V.; Bernlohr, David A.; Vallerie, Sara N.; Liu, Chang-qin; Lopez, Melissa; Harmon, Jamie S.; Robertson, R. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3582-3588</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">We reported earlier that β-cell-specific overexpression of glutathione peroxidase (GPx)-1 significantly ameliorated hyperglycemia in diabetic db/db mice and prevented glucotoxicity-induced deterioration of β-cell mass and function.  We have now ascertained whether early treatment of Zucker diabetic fatty (ZDF) rats with ebselen, an oral GPx mimetic, will prevent β-cell deterioration.  No other antihyperglycemia treatment was given.  Ebselen ameliorated fasting hyperglycemia, sustained nonfasting insulin levels, lowered nonfasting glucose levels, and lowered HbA1c levels with no effects on body wt.  Ebselen doubled β-cell mass, prevented apoptosis, prevented expression of oxidative stress markers, and enhanced intranuclear localization of pancreatic and duodenal homeobox (Pdx)-1 and v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (MafA), two crit. insulin transcription factors.  Minimal β-cell replication was obsd. in both groups.  These findings indicate that prevention of oxidative stress is the mechanism whereby ebselen prevents apoptosis and preserves intranuclear Pdx-1 and MafA, which, in turn, is a likely explanation for the beneficial effects of ebselen on β-cell mass and function.  Since ebselen is an oral antioxidant currently used in clin. trials, it is a novel therapeutic candidate to ameliorate fasting hyperglycemia and further deterioration of β-cell mass and function in humans undergoing the onset of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRvSjpd_MSnrVg90H21EOLACvtfcHk0liCgOWDCYqK7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOhtLjK&md5=a1f63a6bd3b745edfb0ee92bdc5032ad</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.2337%2Fdb13-0357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb13-0357%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DJ.%26aulast%3DParazzoli%26aufirst%3DS.%26aulast%3DOseid%26aufirst%3DE.%26aulast%3DHertzel%26aufirst%3DA.%2BV.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26aulast%3DVallerie%26aufirst%3DS.%2BN.%26aulast%3DLiu%26aufirst%3DC.%2BQ.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DHarmon%26aufirst%3DJ.%2BS.%26aulast%3DRobertson%26aufirst%3DR.%2BP.%26atitle%3DEbselen%2520treatment%2520prevents%2520islet%2520apoptosis%252C%2520maintains%2520intranuclear%2520Pdx-1%2520and%2520MafA%2520levels%252C%2520and%2520preserves%2520beta-cell%2520mass%2520and%2520function%2520in%2520ZDF%2520rats%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D3582%26epage%3D3588%26doi%3D10.2337%2Fdb13-0357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krippner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugesh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haan, J. B.</span></span> <span> </span><span class="NLM_article-title">The modified selenenyl amide, <i>m</i>-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e69193</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0069193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1371%2Fjournal.pone.0069193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=23874911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wms7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e69193&author=S.+M.+Tanauthor=A.+Sharmaauthor=D.+Y.+Yuenauthor=N.+Stefanovicauthor=G.+Krippnerauthor=G.+Mugeshauthor=Z.+Chaiauthor=J.+B.+de+Haan&title=The+modified+selenenyl+amide%2C+m-hydroxy+ebselen%2C+attenuates+diabetic+nephropathy+and+diabetes-associated+atherosclerosis+in+ApoE%2FGPx1+double+knockout+mice&doi=10.1371%2Fjournal.pone.0069193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The modified selenenyl amide, m-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice</span></div><div class="casAuthors">Tan, Sih Min; Sharma, Arpeeta; Yuen, Derek Y. C.; Stefanovic, Nada; Krippner, Guy; Mugesh, Govindasamy; Chai, Zhonglin; de Haan, Judy B.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e69193</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Seleno-org. glutathione peroxidase (GPx) mimetics, including ebselen (Eb), have been tested in in vitro studies for their ability to scavenge reactive oxygen and nitrogen species, including hydrogen peroxide and peroxynitrite.  In this study, we investigated the efficacies of two Eb analogs, m-hydroxy ebselen (ME) and ethanol-ebselen (EtE) and compared these with Eb in cell based assays.  We found that ME is superior in attenuating the activation of hydrogen peroxide-induced pro-inflammatory mediators, ERK and P38 in human aortic endothelial cells.  Consequently, we investigated the effects of ME in an in vivo model of diabetes, the ApoE/GPx1 double knockout (dKO) mouse.  We found that ME attenuates plaque formation in the aorta and lesion deposition within the aortic sinus of diabetic dKO mice.  Oxidative stress as assessed by 8-OHdG in urine and nitrotyrosine immunostaining in the aortic sinus and kidney tubules, was reduced by ME in diabetic dKO mice.  ME also attenuated diabetes-assocd. renal injury which included tubulointerstitial fibrosis and glomerulosclerosis.  Furthermore, the bioactivity of the pro-fibrotic cytokine transforming growth factor-β (TGF-β) as assessed by phospho-Smad2/3 immunostaining was attenuated after treatment with ME.  TGF-β-stimulated increases in collagen I and IV gene expression and protein levels were attenuated by ME in rat kidney tubular cells.  However, in contrast to the superior activity of ME in in vitro and cell based assays, ME did not further augment the attenuation of diabetes-assocd. atherosclerosis and renal injury in our in vivo model when compared with Eb.  In conclusion, this study strengthens the notion that bolstering GPx-like activity using synthetic mimetics may be a useful therapeutic strategy in lessening the burden of diabetic complications.  However, these studies highlight the importance of in vivo analyses to test the efficacies of novel Eb analogs, as in vitro and cell based assays are only partly predictive of the in vivo situation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuphh912ohebVg90H21EOLACvtfcHk0liCgOWDCYqK7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wms7jI&md5=1aa2f45d843e623b8c88548739fa4fa7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0069193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0069193%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%2BM.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DYuen%26aufirst%3DD.%2BY.%26aulast%3DStefanovic%26aufirst%3DN.%26aulast%3DKrippner%26aufirst%3DG.%26aulast%3DMugesh%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DZ.%26aulast%3Dde%2BHaan%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520modified%2520selenenyl%2520amide%252C%2520m-hydroxy%2520ebselen%252C%2520attenuates%2520diabetic%2520nephropathy%2520and%2520diabetes-associated%2520atherosclerosis%2520in%2520ApoE%252FGPx1%2520double%2520knockout%2520mice%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De69193%26doi%3D10.1371%2Fjournal.pone.0069193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beckman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfine, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopold, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creager, M. A.</span></span> <span> </span><span class="NLM_article-title">Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trial</span>. <i>Am. J. Physiol Heart Circ Physiol</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">H1431</span>– <span class="NLM_lpage">H1436</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00504.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1152%2Fajpheart.00504.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27765750" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=H1431-H1436&author=J.+A.+Beckmanauthor=A.+B.+Goldfineauthor=J.+A.+Leopoldauthor=M.+A.+Creager&title=Ebselen+does+not+improve+oxidative+stress+and+vascular+function+in+patients+with+diabetes%3A+a+randomized%2C+crossover+trial&doi=10.1152%2Fajpheart.00504.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00504.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00504.2016%26sid%3Dliteratum%253Aachs%26aulast%3DBeckman%26aufirst%3DJ.%2BA.%26aulast%3DGoldfine%26aufirst%3DA.%2BB.%26aulast%3DLeopold%26aufirst%3DJ.%2BA.%26aulast%3DCreager%26aufirst%3DM.%2BA.%26atitle%3DEbselen%2520does%2520not%2520improve%2520oxidative%2520stress%2520and%2520vascular%2520function%2520in%2520patients%2520with%2520diabetes%253A%2520a%2520randomized%252C%2520crossover%2520trial%26jtitle%3DAm.%2520J.%2520Physiol%2520Heart%2520Circ%2520Physiol%26date%3D2016%26volume%3D311%26spage%3DH1431%26epage%3DH1436%26doi%3D10.1152%2Fajpheart.00504.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bender, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreyra, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hryckowian, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Child, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solow-Cordero, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higginbottom, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banaei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonnenburg, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antivirulence agent for treating <i>Clostridium difficile</i> infection</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">306ra148</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aac9103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1126%2Fscitranslmed.aac9103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26400909" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=306ra148&author=K.+O.+Benderauthor=M.+Garlandauthor=J.+A.+Ferreyraauthor=A.+J.+Hryckowianauthor=M.+A.+Childauthor=A.+W.+Puriauthor=D.+E.+Solow-Corderoauthor=S.+K.+Higginbottomauthor=E.+Segalauthor=N.+Banaeiauthor=A.+Shenauthor=J.+L.+Sonnenburgauthor=M.+Bogyo&title=A+small-molecule+antivirulence+agent+for+treating+Clostridium+difficile+infection&doi=10.1126%2Fscitranslmed.aac9103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aac9103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aac9103%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DK.%2BO.%26aulast%3DGarland%26aufirst%3DM.%26aulast%3DFerreyra%26aufirst%3DJ.%2BA.%26aulast%3DHryckowian%26aufirst%3DA.%2BJ.%26aulast%3DChild%26aufirst%3DM.%2BA.%26aulast%3DPuri%26aufirst%3DA.%2BW.%26aulast%3DSolow-Cordero%26aufirst%3DD.%2BE.%26aulast%3DHigginbottom%26aufirst%3DS.%2BK.%26aulast%3DSegal%26aufirst%3DE.%26aulast%3DBanaei%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DSonnenburg%26aufirst%3DJ.%2BL.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DA%2520small-molecule%2520antivirulence%2520agent%2520for%2520treating%2520Clostridium%2520difficile%2520infection%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D306ra148%26doi%3D10.1126%2Fscitranslmed.aac9103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werngren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">Ebselen and analogs as inhibitors of <i>Bacillus anthracis</i> thioredoxin reductase and bactericidal antibacterials targeting <i>Bacillus species Staphylococcus aureus</i> and Mycobacterium tuberculosis</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1860</i></span>,  <span class="NLM_fpage">1265</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2016.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbagen.2016.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Wgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1860&publication_year=2016&pages=1265-1271&author=T.+N.+Gustafssonauthor=H.+Osmanauthor=J.+Werngrenauthor=S.+Hoffnerauthor=L.+Engmanauthor=A.+Holmgren&title=Ebselen+and+analogs+as+inhibitors+of+Bacillus+anthracis+thioredoxin+reductase+and+bactericidal+antibacterials+targeting+Bacillus+species+Staphylococcus+aureus+and+Mycobacterium+tuberculosis&doi=10.1016%2Fj.bbagen.2016.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis</span></div><div class="casAuthors">Gustafsson, Tomas N.; Osman, Harer; Werngren, Jim; Hoffner, Sven; Engman, Lars; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1860</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1265-1271</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bacillus anthracis is the causative agent of anthrax, a disease assocd. with a very high mortality rate in its invasive forms.  We studied a no. of ebselen analogs as inhibitors of B. anthracis thioredoxin reductase and their antibacterial activity on Bacillus subtilis, Staphylococcus aureus, Bacillus cereus and Mycobacterium tuberculosis.  The most potent compds. in the series gave IC50 values down to 70 nM for the pure enzyme and minimal inhibitory concns. (MICs) down to 0.4 μM (0.12 μg/mL) for B. subtilis, 1.5 μM (0.64 μg/mL) for S. aureus, 2 μM (0.86 μg/mL) for B. cereus and 10 μg/mL for M. tuberculosis.  Minimal bactericidal concns. (MBCs) were found at 1-1.5 times the MIC, indicating a general, class-dependent, bactericidal mode of action.  The combined bacteriol. and enzymol. data were used to construct a preliminary structure-activity-relationship for the benzoisoselenazol class of compds.  When S. aureus and B. subtilis were exposed to ebselen, we were unable to isolate resistant mutants on both solid and in liq. medium suggesting a high resistance barrier.  These results suggest that ebselen and analogs thereof could be developed into a novel antibiotic class, useful for the treatment of infections caused by B. anthracis, S. aureus, M. tuberculosis and other clin. important bacteria.  Furthermore, the high barrier against resistance development is encouraging for further drug development.  We have characterized the thioredoxin system from B. anthracis as a novel drug target and ebselen and analogs thereof as a potential new class of antibiotics targeting several important human pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe4ZHGAS7GNbVg90H21EOLACvtfcHk0lhpoPJ4lQV5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Wgu7c%253D&md5=5413ac764cfc9322cfb164293d4e40fd</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2016.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2016.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DGustafsson%26aufirst%3DT.%2BN.%26aulast%3DOsman%26aufirst%3DH.%26aulast%3DWerngren%26aufirst%3DJ.%26aulast%3DHoffner%26aufirst%3DS.%26aulast%3DEngman%26aufirst%3DL.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DEbselen%2520and%2520analogs%2520as%2520inhibitors%2520of%2520Bacillus%2520anthracis%2520thioredoxin%2520reductase%2520and%2520bactericidal%2520antibacterials%2520targeting%2520Bacillus%2520species%2520Staphylococcus%2520aureus%2520and%2520Mycobacterium%2520tuberculosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2016%26volume%3D1860%26spage%3D1265%26epage%3D1271%26doi%3D10.1016%2Fj.bbagen.2016.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goins, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudson, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slayden, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronning, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucheck, S. J.</span></span> <span> </span><span class="NLM_article-title">Thermal and photoinduced copper-promoted C-Se bond formation: synthesis of 2-alkyl-1,2-benzisoselenazol-3(2<i>H</i>)-ones and evaluation against Mycobacterium tuberculosis</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">3844</span>– <span class="NLM_lpage">3854</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.7b00440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.7b00440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFOqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=3844-3854&author=S.+Thannaauthor=C.+M.+Goinsauthor=S.+E.+Knudsonauthor=R.+A.+Slaydenauthor=D.+R.+Ronningauthor=S.+J.+Sucheck&title=Thermal+and+photoinduced+copper-promoted+C-Se+bond+formation%3A+synthesis+of+2-alkyl-1%2C2-benzisoselenazol-3%282H%29-ones+and+evaluation+against+Mycobacterium+tuberculosis&doi=10.1021%2Facs.joc.7b00440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Thermal and Photoinduced Copper-Promoted C-Se Bond Formation: Synthesis of 2-Alkyl-1,2-benzisoselenazol-3(2H)-ones and Evaluation against Mycobacterium tuberculosis</span></div><div class="casAuthors">Thanna, Sandeep; Goins, Christopher M.; Knudson, Susan E.; Slayden, Richard A.; Ronning, Donald R.; Sucheck, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3844-3854</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-Alkyl-1,2-benzisoselenazol-3(2H)-ones, represented by ebselen (1a), are being studied intensively for a range of medicinal applications.  We describe both a new thermal and photoinduced copper-mediated cross-coupling between potassium selenocyanate (KSeCN) and N-substituted ortho-halobenzamides to form 2-alkyl-1,2-benzisoselenazol-3(2H)-ones contg. a C-Se-N bond.  The copper ligand (1,10-phenanthroline) facilitates C-Se bond formation during heating via a mechanism that likely involves atom transfer (AT), whereas, in the absence of ligand, photoinduced activation likely proceeds through a single electron transfer (SET) mechanism.  A library of 15 2-alkyl-1,2-benzisoselenazol-3(2H)-ones was prepd.  One member of the library was azide-contg. deriv. 1j that was competent to undergo a strain-promoted azide-alkyne cycloaddn.  The library was evaluated for inhibition of Mycobacterium tuberculosis (Mtb) growth and Mtb Antigen 85C (Mtb Ag85C) activity.  Compd. 1f was most potent with a minimal inhibitory concn. (MIC) of 12.5 μg/mL and an Mtb Ag85C apparent IC50 of 8.8 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIuweCi3tSFLVg90H21EOLACvtfcHk0lhpoPJ4lQV5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFOqsbY%253D&md5=6a6bc3a006b04b5f6e076765167b5c6b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.7b00440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.7b00440%26sid%3Dliteratum%253Aachs%26aulast%3DThanna%26aufirst%3DS.%26aulast%3DGoins%26aufirst%3DC.%2BM.%26aulast%3DKnudson%26aufirst%3DS.%2BE.%26aulast%3DSlayden%26aufirst%3DR.%2BA.%26aulast%3DRonning%26aufirst%3DD.%2BR.%26aulast%3DSucheck%26aufirst%3DS.%2BJ.%26atitle%3DThermal%2520and%2520photoinduced%2520copper-promoted%2520C-Se%2520bond%2520formation%253A%2520synthesis%2520of%25202-alkyl-1%252C2-benzisoselenazol-3%25282H%2529-ones%2520and%2520evaluation%2520against%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D3844%26epage%3D3854%26doi%3D10.1021%2Facs.joc.7b00440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goins, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dajnowicz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucheck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronning, D. R.</span></span> <span> </span><span class="NLM_article-title">Exploring covalent allosteric inhibition of antigen 85C from <i>Mycobacterium tuberculosis</i> by ebselen derivatives</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVGhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=378-387&author=C.+M.+Goinsauthor=S.+Dajnowiczauthor=S.+Thannaauthor=S.+J.+Sucheckauthor=J.+M.+Parksauthor=D.+R.+Ronning&title=Exploring+covalent+allosteric+inhibition+of+antigen+85C+from+Mycobacterium+tuberculosis+by+ebselen+derivatives&doi=10.1021%2Facsinfecdis.7b00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring covalent allosteric inhibition of antigen 85C from Mycobacterium tuberculosis by ebselen derivatives</span></div><div class="casAuthors">Goins, Christopher M.; Dajnowicz, Steven; Thanna, Sandeep; Sucheck, Steven J.; Parks, Jerry M.; Ronning, Donald R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">378-387</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previous studies identified ebselen as a potent in vitro and in vivo inhibitor of the Mycobacterium tuberculosis (Mtb) antigen 85 (Ag85) complex, comprising three homologous enzymes required for the biosynthesis of the mycobacterial cell wall.  In this study, the Mtb Ag85C enzyme was cocrystd. with azido and adamantyl ebselen derivs., resulting in two crystallog. structures of 2.01 and 1.30 Å resoln., resp.  Both structures displayed the anticipated covalent modification of the solvent accessible, noncatalytic Cys209 residue forming a selenenylsulfide bond.  Continuous difference d. for both thiol modifiers allowed for the assessment of interactions that influence ebselen binding and inhibitor orientation that were unobserved in previous Ag85C ebselen structures.  The kinact/KI values for ebselen, adamantyl ebselen, and azido ebselen support the importance of obsd. constructive chem. interactions with Arg239 for increased in vitro efficacy toward Ag85C.  To better understand the in vitro kinetic properties of these ebselen derivs., the energetics of specific protein-inhibitor interactions and relative reaction free energies were calcd. for ebselen and both derivs. using d. functional theory.  These studies further support the different in vitro properties of ebselen and two select ebselen derivs. from our previously published ebselen library with respect to kinetics and protein-inhibitor interactions.  In both structures, the α9 helix was displaced farther from the enzyme active site than the previous Ag85C ebselen structure, resulting in the restructuring of a connecting loop and imparting a conformational change to residues believed to play a role in substrate binding specific to Ag85C.  These notable structural changes directly affect protein stability, reducing the overall melting temp. by up to 14.5 °C, resulting in the unfolding of protein at physiol. temps.  Addnl., this structural rearrangement due to covalent allosteric modification creates a sizable solvent network that encompasses the active site and extends to the modified Cys209 residue.  In all, this study outlines factors that influence enzyme inhibition by ebselen and its derivs. while further highlighting the effects of the covalent modification of Cys209 by said inhibitors on the structure and stability of Ag85C.  Furthermore, the results suggest a strategy for developing new classes of Ag85 inhibitors with increased specificity and potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF1-BS5Bc0xbVg90H21EOLACvtfcHk0lhpoPJ4lQV5Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVGhsb0%253D&md5=eb90ffe305812a089494d78180db8c2e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00003%26sid%3Dliteratum%253Aachs%26aulast%3DGoins%26aufirst%3DC.%2BM.%26aulast%3DDajnowicz%26aufirst%3DS.%26aulast%3DThanna%26aufirst%3DS.%26aulast%3DSucheck%26aufirst%3DS.%2BJ.%26aulast%3DParks%26aufirst%3DJ.%2BM.%26aulast%3DRonning%26aufirst%3DD.%2BR.%26atitle%3DExploring%2520covalent%2520allosteric%2520inhibition%2520of%2520antigen%252085C%2520from%2520Mycobacterium%2520tuberculosis%2520by%2520ebselen%2520derivatives%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D378%26epage%3D387%26doi%3D10.1021%2Facsinfecdis.7b00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macegoniuk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grela, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudzinska-Szostak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabowiecka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berlicki, L.</span></span> <span> </span><span class="NLM_article-title">1,2-Benzisoselenazol-3(2<i>H</i>)-one derivatives as a new class of bacterial urease inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8125</span>– <span class="NLM_lpage">8133</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00986</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00986" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlehsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8125-8133&author=K.+Macegoniukauthor=E.+Grelaauthor=J.+Palusauthor=E.+Rudzinska-Szostakauthor=A.+Grabowieckaauthor=M.+Biernatauthor=L.+Berlicki&title=1%2C2-Benzisoselenazol-3%282H%29-one+derivatives+as+a+new+class+of+bacterial+urease+inhibitors&doi=10.1021%2Facs.jmedchem.6b00986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-Benzisoselenazol-3(2H)-one Derivatives As a New Class of Bacterial Urease Inhibitors</span></div><div class="casAuthors">Macegoniuk, Katarzyna; Grela, Ewa; Palus, Jerzy; Rudzinska-Szostak, Ewa; Grabowiecka, Agnieszka; Biernat, Monika; Berlicki, Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8125-8133</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzisoselenazolones and aminocarbonylphenyl and alkoxycarbonylphenyl diselenides were prepd. and tested as inhibitors of bacterial ureases for use in the treatment of Helicobacter pylori infection; the compds. were tested for their inhibition of E. coli expressing urease and H. pylori.  Known benzisoselenazolone I (ebselen) was the most active compd. tested, inhibiting S. pasteurii and H. pylori bacterial ureases with Ki values of 2.11 and 226 nM, resp.  Many of the tested compds. inhibited bacterial ureases in E. coli and H. pylori cell culture in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9GtSln1SxrVg90H21EOLACvtfcHk0lgWBS_Now-H5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlehsrjJ&md5=2533ac1bd3bc0170f50a72bcc64a245f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00986%26sid%3Dliteratum%253Aachs%26aulast%3DMacegoniuk%26aufirst%3DK.%26aulast%3DGrela%26aufirst%3DE.%26aulast%3DPalus%26aufirst%3DJ.%26aulast%3DRudzinska-Szostak%26aufirst%3DE.%26aulast%3DGrabowiecka%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DM.%26aulast%3DBerlicki%26aufirst%3DL.%26atitle%3D1%252C2-Benzisoselenazol-3%25282H%2529-one%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520bacterial%2520urease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8125%26epage%3D8133%26doi%3D10.1021%2Facs.jmedchem.6b00986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Ebselen suppresses inflammation induced by <i>Helicobacter pylori</i> lipopolysaccharide via the p38 mitogen-activated protein kinase signaling pathway</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6847</span>– <span class="NLM_lpage">6851</span>, <span class="refDoi"> DOI: 10.3892/mmr.2018.8641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3892%2Fmmr.2018.8641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29488609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWlsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=6847-6851&author=L.+Xuauthor=C.+Gongauthor=G.+Liauthor=J.+Weiauthor=T.+Wangauthor=W.+Mengauthor=M.+Shiauthor=Y.+Wang&title=Ebselen+suppresses+inflammation+induced+by+Helicobacter+pylori+lipopolysaccharide+via+the+p38+mitogen-activated+protein+kinase+signaling+pathway&doi=10.3892%2Fmmr.2018.8641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen suppresses inflammation induced by Helicobacter pylori lipopolysaccharide via the p38 mitogen-activated protein kinase signaling pathway</span></div><div class="casAuthors">Xu, Ling; Gong, Changguo; Li, Guangming; Wei, Jue; Wang, Ting; Meng, Wenying; Shi, Min; Wang, Yugang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">6847-6851</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Ebselen is a seleno-org. compd. that has been demonstrated to have antioxidant and anti-inflammatory properties.  A previous study detd. that ebselen inhibits airway inflammation induced by inhalational lipopolysaccharide (LPS), however, the underlying mol. mechanism remains to be elucidated.  The present study investigated the effect of ebselen on the glutathione peroxidase (GPX)-reactive oxygen species (ROS) pathway and interleukin-8 (IL-8) expression induced by Helicobacter pylori LPS in gastric cancer (GC) cells.  Cells were treated with 200 ng/mL H. pylori-LPS in the presence or absence of ebselen for various durations and concns. (μmol/l).  The expression of toll-like receptor 4 (TLR4), GPX2, GPX4, p38 mitogen-activated protein kinase (p38 MAPK), phosphorylated-p38 MAPK, ROS prodn. and IL-8 expression were detected with western blotting or ELISA.  The present study revealed that TLR4 expression was upregulated; however, GPX2 and GPX4 expression was reduced following treatment with H. pylori LPS, which led to increased ROS prodn., subsequently altering the IL-8 expression level in GC cells.  Addnl., it was detd. that ebselen prevented the redn. in GPX2/4 levels induced by H. pylori LPS, however, TLR4 expression was not affected.  Ebselen may also block the expression of IL-8 by inhibiting phosphorylation of p38 MAPK.  These data suggest ebselen may inhibit ROS prodn. triggered by H. pylori LPS treatment via GPX2/4 instead of TLR4 signaling and reduce phosphorylation of p38 MAPK, resulting in altered prodn. of IL-8.  Ebselen may, therefore, be a potential therapeutic agent to mediate H. pylori LPS-induced cell damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uKoeiiMqNrVg90H21EOLACvtfcHk0lgWBS_Now-H5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWlsb3F&md5=2f701627d7a4b639c524f1d2a6f948a2</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2018.8641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2018.8641%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DEbselen%2520suppresses%2520inflammation%2520induced%2520by%2520Helicobacter%2520pylori%2520lipopolysaccharide%2520via%2520the%2520p38%2520mitogen-activated%2520protein%2520kinase%2520signaling%2520pathway%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2018%26volume%3D17%26spage%3D6847%26epage%3D6851%26doi%3D10.3892%2Fmmr.2018.8641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaupp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenyan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiljeva, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marc, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejarz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latacz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handzlik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, C.</span></span> <span> </span><span class="NLM_article-title">Selenazolinium salts as “small molecule satalysts” with high potency against ESKAPE bacterial pathogens</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2174</span>, <span class="refDoi"> DOI: 10.3390/molecules22122174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fmolecules22122174" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=2174&author=K.+Witekauthor=M.+J.+Nasimauthor=M.+Bischoffauthor=R.+Gauppauthor=P.+Arsenyanauthor=J.+Vasiljevaauthor=M.+A.+Marcauthor=A.+Olejarzauthor=G.+Lataczauthor=K.+Kiec-Kononowiczauthor=J.+Handzlikauthor=C.+Jacob&title=Selenazolinium+salts+as+%E2%80%9Csmall+molecule+satalysts%E2%80%9D+with+high+potency+against+ESKAPE+bacterial+pathogens&doi=10.3390%2Fmolecules22122174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22122174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22122174%26sid%3Dliteratum%253Aachs%26aulast%3DWitek%26aufirst%3DK.%26aulast%3DNasim%26aufirst%3DM.%2BJ.%26aulast%3DBischoff%26aufirst%3DM.%26aulast%3DGaupp%26aufirst%3DR.%26aulast%3DArsenyan%26aufirst%3DP.%26aulast%3DVasiljeva%26aufirst%3DJ.%26aulast%3DMarc%26aufirst%3DM.%2BA.%26aulast%3DOlejarz%26aufirst%3DA.%26aulast%3DLatacz%26aufirst%3DG.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26aulast%3DHandzlik%26aufirst%3DJ.%26aulast%3DJacob%26aufirst%3DC.%26atitle%3DSelenazolinium%2520salts%2520as%2520%25E2%2580%259Csmall%2520molecule%2520satalysts%25E2%2580%259D%2520with%2520high%2520potency%2520against%2520ESKAPE%2520bacterial%2520pathogens%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D2174%26doi%3D10.3390%2Fmolecules22122174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottenberg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">Synergistic antibacterial effect of silver and ebselen against multidrug-resistant Gram-negative bacterial infections</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.15252/emmm.201707661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.15252%2Femmm.201707661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28606995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsFSqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1165-1178&author=L.+Zouauthor=J.+Luauthor=J.+Wangauthor=X.+Renauthor=L.+Zhangauthor=Y.+Gaoauthor=M.+E.+Rottenbergauthor=A.+Holmgren&title=Synergistic+antibacterial+effect+of+silver+and+ebselen+against+multidrug-resistant+Gram-negative+bacterial+infections&doi=10.15252%2Femmm.201707661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic antibacterial effect of silver and ebselen against multidrug-resistant Gram-negative bacterial infections</span></div><div class="casAuthors">Zou, Lili; Lu, Jun; Wang, Jun; Ren, Xiaoyuan; Zhang, Lanlan; Gao, Yu; Rottenberg, Martin E.; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1165-1178</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Multidrug-resistant (MDR) Gram-neg. bacteria account for a majority of fatal infections, and development of new antibiotic principles and drugs is therefore of outstanding importance.  Here, we report that five most clin. difficult-to-treat MDR Gram-neg. bacteria are highly sensitive to a synergistic combination of silver and ebselen.  In contrast, silver has no synergistic toxicity with ebselen on mammalian cells.  The silver and ebselen combination causes a rapid depletion of glutathione and inhibition of the thioredoxin system in bacteria.  Silver ions were identified as strong inhibitors of Escherichia coli thioredoxin and thioredoxin reductase, which are required for ribonucleotide reductase and DNA synthesis and defense against oxidative stress.  The bactericidal efficacy of silver and ebselen was further verified in the treatment of mild and acute MDR E. coli peritonitis in mice.  These results demonstrate that thiol-dependent redox systems in bacteria can be targeted in the design of new antibacterial drugs.  The silver and ebselen combination offers a proof of concept in targeting essential bacterial systems and might be developed for novel efficient treatments against MDR Gram-neg. bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQjrfir48vY7Vg90H21EOLACvtfcHk0lgWBS_Now-H5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsFSqur0%253D&md5=308903f6cbcf5644372e3d64920c5b4d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.15252%2Femmm.201707661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201707661%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRottenberg%26aufirst%3DM.%2BE.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DSynergistic%2520antibacterial%2520effect%2520of%2520silver%2520and%2520ebselen%2520against%2520multidrug-resistant%2520Gram-negative%2520bacterial%2520infections%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2017%26volume%3D9%26spage%3D1165%26epage%3D1178%26doi%3D10.15252%2Femmm.201707661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span> <span> </span><span class="NLM_article-title">Investigation of synergistic antimicrobial effects of the drug combinations of meropenem and 1,2-benzisoselenazol-3(2<i>H</i>)-one derivatives on carbapenem-resistant Enterobacteriaceae producing NDM-1</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2018.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29894943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFaltbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2018&pages=285-302&author=W.+B.+Jinauthor=C.+Xuauthor=Q.+Chengauthor=X.+L.+Qiauthor=W.+Gaoauthor=Z.+Zhengauthor=E.+W.+C.+Chanauthor=Y.+C.+Leungauthor=T.+H.+Chanauthor=K.+Y.+Wongauthor=S.+Chenauthor=K.+F.+Chan&title=Investigation+of+synergistic+antimicrobial+effects+of+the+drug+combinations+of+meropenem+and+1%2C2-benzisoselenazol-3%282H%29-one+derivatives+on+carbapenem-resistant+Enterobacteriaceae+producing+NDM-1&doi=10.1016%2Fj.ejmech.2018.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of synergistic antimicrobial effects of the drug combinations of meropenem and 1,2-benzisoselenazol-3(2H)-one derivatives on carbapenem-resistant Enterobacteriaceae producing NDM-1</span></div><div class="casAuthors">Jin, Wen Bin; Xu, Chen; Cheng, Qipeng; Qi, Xiao Lin; Gao, Wei; Zheng, Zhiwei; Chan, Edward W. C.; Leung, Yun-Chung; Chan, Tak Hang; Wong, Kwok-Yin; Chen, Sheng; Chan, Kin-Fai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">285-302</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The worldwide prevalence of NDM-1-producing bacteria has drastically undermined the clin. efficacy of the last line antibiotic of carbapenems, prompting a need to devise effective strategy to preserve their clin. value.  Our previous studies have shown that ebselen can restore the efficacy of meropenem against a lab. strain that produces NDM-1.  Here we report the construction of a focused compd. library of 1,2-benzisoselenazol-3(2H)-one derivs. which comprise a total of forty-six candidate compds.  The structure-activity relationship of these compds. and their potential to serve as an adjuvant to enhance the antimicrobial efficacy of meropenem against a collection of clin. NDM-1-producing carbapenem-resistant Enterobacteriaceae isolates was examd.  Drug combination assays indicated that these derivs. exhibited synergistic antimicrobial activity when used along with meropenem, effectively restoring the activity of carbapenems against the resistant strains tested in a Galleria mellonella larvae in vivo infection model.  The mode of inhibition of one compd., namely 11_a38, which was depicted when tested on the purified NDM-1 enzyme, indicated that it could covalently bind to the enzyme and displaced one zinc ion from the active site.  Overall, this study provides a novel 1,2-benzisoselenazol-3(2H)-one scaffold that exhibits strong synergistic antimicrobial activity with carbapenems, and low cytotoxicity.  The prospect of application of such compds. as carbapenem adjuvants warrants further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2MzB9DLEArVg90H21EOLACvtfcHk0lhBM9_GSUk_Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFaltbzI&md5=ee1da1f67ac597f0f32b5c681dc1429c</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DW.%2BB.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DX.%2BL.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DE.%2BW.%2BC.%26aulast%3DLeung%26aufirst%3DY.%2BC.%26aulast%3DChan%26aufirst%3DT.%2BH.%26aulast%3DWong%26aufirst%3DK.%2BY.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DK.%2BF.%26atitle%3DInvestigation%2520of%2520synergistic%2520antimicrobial%2520effects%2520of%2520the%2520drug%2520combinations%2520of%2520meropenem%2520and%25201%252C2-benzisoselenazol-3%25282H%2529-one%2520derivatives%2520on%2520carbapenem-resistant%2520Enterobacteriaceae%2520producing%2520NDM-1%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D155%26spage%3D285%26epage%3D302%26doi%3D10.1016%2Fj.ejmech.2018.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">AbdelKhalek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abutaleb, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seleem, M. N.</span></span> <span> </span><span class="NLM_article-title">Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e0199710</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0199710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1371%2Fjournal.pone.0199710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29953486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFait7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0199710&author=A.+AbdelKhalekauthor=N.+S.+Abutalebauthor=H.+Mohammadauthor=M.+N.+Seleem&title=Repurposing+ebselen+for+decolonization+of+vancomycin-resistant+enterococci+%28VRE%29&doi=10.1371%2Fjournal.pone.0199710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)</span></div><div class="casAuthors">AbdelKhalek, Ahmed; Abutaleb, Nader S.; Mohammad, Haroon; Seleem, Mohamed N.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0199710/1-e0199710/14</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Enterococci represent one of the microbial world's most challenging enigmas.  Colonization of the gastrointestinal tract (GIT) of high-risk/immunocompromised patients by enterococci exhibiting resistance to vancomycin (VRE) can lead to life-threating infections, including bloodstream infections and endocarditis.  Decolonization of VRE from the GIT of high-risk patients represents an alternative method to suppress the risk of the infection.  It could be considered as a preventative measure to protect against VRE infections in high-risk individuals.  Though multiple agents (ramoplanin and bacitracin) have been evaluated clin., no drugs are currently approved for use in VRE decolonization of the GIT.  The present study evaluates ebselen, a clin. mol., for use as a decolonizing agent against VRE.  When evaluated against a broad array of enterococcal isolates in vitro, ebselen was found to be as potent as linezolid (min. inhibitory concn. against 90% of clin. isolates tested was 2 μg/mL).  Though VRE has a remarkable ability to develop resistance to antibacterial agents, no resistance to ebselen emerged after a clin. isolate of vancomycin-resistant E. faecium was serially-passaged with ebselen for 14 days.  Against VRE biofilm, a virulence factor that enables the bacteria to colonize the gut, ebselen demonstrated the ability to both inhibit biofilm formation and disrupt mature biofilm.  Furthermore, in a murine VRE colonization redn. model, ebselen proved as effective as ramoplanin in reducing the bacterial shedding and burden of VRE present in the fecal content (by > 99.99%), cecum, and ileum of mice.  Based on the promising results obtained, ebselen warrants further investigation as a novel decolonizing agent to quell VRE infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhBBPkXAGPGrVg90H21EOLACvtfcHk0lhBM9_GSUk_Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFait7jO&md5=8c992314d7bc28fe7d41d3d18626f6c5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0199710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0199710%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelKhalek%26aufirst%3DA.%26aulast%3DAbutaleb%26aufirst%3DN.%2BS.%26aulast%3DMohammad%26aufirst%3DH.%26aulast%3DSeleem%26aufirst%3DM.%2BN.%26atitle%3DRepurposing%2520ebselen%2520for%2520decolonization%2520of%2520vancomycin-resistant%2520enterococci%2520%2528VRE%2529%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26spage%3De0199710%26doi%3D10.1371%2Fjournal.pone.0199710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guentzel, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cap, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arulanandam, B. P.</span></span> <span> </span><span class="NLM_article-title">Repurposing auranofin, ebselen, and PX-12 as antimicrobial agents targeting the thioredoxin system</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">336</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.00336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3389%2Ffmicb.2018.00336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29556223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC1MnivVWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=336&author=H.+C.+Mayauthor=J.+J.+Yuauthor=M.+N.+Guentzelauthor=J.+P.+Chambersauthor=A.+P.+Capauthor=B.+P.+Arulanandam&title=Repurposing+auranofin%2C+ebselen%2C+and+PX-12+as+antimicrobial+agents+targeting+the+thioredoxin+system&doi=10.3389%2Ffmicb.2018.00336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System</span></div><div class="casAuthors">May Holly C; Yu Jieh-Juen; Guentzel M N; Chambers James P; Arulanandam Bernard P; May Holly C; Yu Jieh-Juen; Guentzel M N; Chambers James P; Arulanandam Bernard P; Cap Andrew P</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">336</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">As microbial resistance to drugs continues to rise at an alarming rate, finding new ways to combat pathogens is an issue of utmost importance.  Development of novel and specific antimicrobial drugs is a time-consuming and expensive process.  However, the re-purposing of previously tested and/or approved drugs could be a feasible way to circumvent this long and costly process.  In this review, we evaluate the U.S.  Food and Drug Administration tested drugs auranofin, ebselen, and PX-12 as antimicrobial agents targeting the thioredoxin system.  These drugs have been shown to act on bacterial, fungal, protozoan, and helminth pathogens without significant toxicity to the host.  We propose that the thioredoxin system could serve as a useful therapeutic target with broad spectrum antimicrobial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxOgzbAkjBfDC850By6mxpfW6udTcc2eaVBwR1Vnhtqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnivVWqtQ%253D%253D&md5=5143dcfa510396a56a1700799ec9c20a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.00336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.00336%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DH.%2BC.%26aulast%3DYu%26aufirst%3DJ.%2BJ.%26aulast%3DGuentzel%26aufirst%3DM.%2BN.%26aulast%3DChambers%26aufirst%3DJ.%2BP.%26aulast%3DCap%26aufirst%3DA.%2BP.%26aulast%3DArulanandam%26aufirst%3DB.%2BP.%26atitle%3DRepurposing%2520auranofin%252C%2520ebselen%252C%2520and%2520PX-12%2520as%2520antimicrobial%2520agents%2520targeting%2520the%2520thioredoxin%2520system%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D336%26doi%3D10.3389%2Ffmicb.2018.00336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orie, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basaric, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau-Cam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietka-Ottlik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlochowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billack, B.</span></span> <span> </span><span class="NLM_article-title">In vitro assessment of the growth and plasma membrane H(+) -ATPase inhibitory activity of ebselen and structurally related selenium- and sulfur-containing compounds in Candida albicans</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">e21892</span>, <span class="refDoi"> DOI: 10.1002/jbt.21892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fjbt.21892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=e21892&author=N.+N.+Orieauthor=A.+R.+Warrenauthor=J.+Basaricauthor=C.+Lau-Camauthor=M.+Pietka-Ottlikauthor=J.+Mlochowskiauthor=B.+Billack&title=In+vitro+assessment+of+the+growth+and+plasma+membrane+H%28%2B%29+-ATPase+inhibitory+activity+of+ebselen+and+structurally+related+selenium-+and+sulfur-containing+compounds+in+Candida+albicans&doi=10.1002%2Fjbt.21892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fjbt.21892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbt.21892%26sid%3Dliteratum%253Aachs%26aulast%3DOrie%26aufirst%3DN.%2BN.%26aulast%3DWarren%26aufirst%3DA.%2BR.%26aulast%3DBasaric%26aufirst%3DJ.%26aulast%3DLau-Cam%26aufirst%3DC.%26aulast%3DPietka-Ottlik%26aufirst%3DM.%26aulast%3DMlochowski%26aufirst%3DJ.%26aulast%3DBillack%26aufirst%3DB.%26atitle%3DIn%2520vitro%2520assessment%2520of%2520the%2520growth%2520and%2520plasma%2520membrane%2520H%2528%252B%2529%2520-ATPase%2520inhibitory%2520activity%2520of%2520ebselen%2520and%2520structurally%2520related%2520selenium-%2520and%2520sulfur-containing%2520compounds%2520in%2520Candida%2520albicans%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D2017%26volume%3D31%26spage%3De21892%26doi%3D10.1002%2Fjbt.21892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thangamani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldesouky, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascuzzi, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avramova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazbun, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seleem, M. N.</span></span> <span> </span><span class="NLM_article-title">Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1861</i></span>,  <span class="NLM_fpage">3002</span>– <span class="NLM_lpage">3010</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2016.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbagen.2016.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27712973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1861&publication_year=2017&pages=3002-3010&author=S.+Thangamaniauthor=H.+E.+Eldesoukyauthor=H.+Mohammadauthor=P.+E.+Pascuzziauthor=L.+Avramovaauthor=T.+R.+Hazbunauthor=M.+N.+Seleem&title=Ebselen+exerts+antifungal+activity+by+regulating+glutathione+%28GSH%29+and+reactive+oxygen+species+%28ROS%29+production+in+fungal+cells&doi=10.1016%2Fj.bbagen.2016.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells</span></div><div class="casAuthors">Thangamani, Shankar; Eldesouky, Hassan E.; Mohammad, Haroon; Pascuzzi, Pete E.; Avramova, Larisa; Hazbun, Tony R.; Seleem, Mohamed N.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1861</span>
        (<span class="NLM_cas:issue">1_Part_A</span>),
    <span class="NLM_cas:pages">3002-3010</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ebselen, an organoselenium compd. and a clin. safe mol. has been reported to possess potent antifungal activity, but its antifungal mechanism of action and in vivo antifungal activity remain unclear.  The antifungal effect of ebselen was tested against Candida albicans, C. glabrata, C. tropicalis, C. parapsilosis, Cryptococcus neoformans, and C. gattii clin. isolates.  Chemogenomic profiling and biochem. assays were employed to identify the antifungal target of ebselen.  Ebselen's antifungal activity in vivo was investigated in a Caenorhabditis elegans animal model.  Ebselen exhibits potent antifungal activity against both Candida spp. and Cryptococcus spp., at concns. ranging from 0.5 to 2 μg/mL.  Ebselen rapidly eradicates a high fungal inoculum within 2 h of treatment.  Investigation of the drug's antifungal mechanism of action indicates that ebselen depletes intracellular glutathione (GSH) levels, leading to increased prodn. of reactive oxygen species (ROS), and thereby disturbs the redox homeostasis in fungal cells.  Examn. of ebselen's in vivo antifungal activity in two Caenorhabditis elegans models of infection demonstrate that ebselen is superior to conventional antifungal drugs (fluconazole, flucytosine and amphotericin) in reducing Candida and Cryptococcus fungal load.  Ebselen possesses potent antifungal activity against clin. relevant isolates of both Candida and Cryptococcus by regulating GSH and ROS prodn.  The potent in vivo antifungal activity of ebselen supports further investigation for repurposing it for use as an antifungal agent..  The present study shows that ebselen targets glutathione and also support that glutathione as a potential target for antifungal drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3r43etsLebVg90H21EOLACvtfcHk0liKcrBv6AQuIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsLrP&md5=c2503ad29a4ab169d4f58e5857c1307a</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2016.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2016.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DThangamani%26aufirst%3DS.%26aulast%3DEldesouky%26aufirst%3DH.%2BE.%26aulast%3DMohammad%26aufirst%3DH.%26aulast%3DPascuzzi%26aufirst%3DP.%2BE.%26aulast%3DAvramova%26aufirst%3DL.%26aulast%3DHazbun%26aufirst%3DT.%2BR.%26aulast%3DSeleem%26aufirst%3DM.%2BN.%26atitle%3DEbselen%2520exerts%2520antifungal%2520activity%2520by%2520regulating%2520glutathione%2520%2528GSH%2529%2520and%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520production%2520in%2520fungal%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2017%26volume%3D1861%26spage%3D3002%26epage%3D3010%26doi%3D10.1016%2Fj.bbagen.2016.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venturini, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chassot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreto, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santurio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, S. H.</span></span> <span> </span><span class="NLM_article-title">Antifungal activities of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Fusarium spp</span>. <i>Med. Mycol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1093/mmy/myv120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1093%2Fmmy%2Fmyv120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26773133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1WntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=550-555&author=T.+P.+Venturiniauthor=F.+Chassotauthor=E.+S.+Loretoauthor=J.+T.+Kellerauthor=M.+I.+Azevedoauthor=G.+Zeniauthor=J.+M.+Santurioauthor=S.+H.+Alves&title=Antifungal+activities+of+diphenyl+diselenide+and+ebselen+alone+and+in+combination+with+antifungal+agents+against+Fusarium+spp&doi=10.1093%2Fmmy%2Fmyv120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal activities of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Fusarium spp</span></div><div class="casAuthors">Venturini, Tarcieli Pozzebon; Chassot, Francieli; Loreto, Erico Silva; Keller, Jessica Tairine; Azevedo, Maria Izabel; Zeni, Gilson; Santurio, Janio Morais; Alves, Sydney Hartz</div><div class="citationInfo"><span class="NLM_cas:title">Medical Mycology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">550-555</span>CODEN:
                <span class="NLM_cas:coden">MEMYFR</span>;
        ISSN:<span class="NLM_cas:issn">1369-3786</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Herein, we describe the in vitro activity of a combination of the organoselenium compds. di-Ph diselenide and ebselen alone and in combination with amphotericin B, caspofungin, itraconazole, and voriconazole against 25 clin. isolates of Fusarium spp.  For this anal., we used the broth microdilution method based on the M38-A2 technique and checkerboard microdilution method.  Di-Ph diselenide (MIC range = 4-32 μg/mL) and ebselen (MIC range = 2-8 μg/mL) showed in vitro activity against the isolates tested.  The most effective combinations were (synergism rates): ebselen + amphotericin B (88%), ebselen + voriconazole (80%), di-Ph diselenide + amphotericin B (72%), and di-Ph diselenide + voriconazole (64%).  Combination with caspofungin resulted in low rates of synergism: ebselen + caspofungin, 36%, and di-Ph diselenide + caspofungin, 28%; combination with itraconazole demonstrated indifferent interactions.  Antagonistic effects were not obsd. for any of the combinations tested.  Our findings suggest that the antifungal potential of di-Ph diselenide and ebselen deserves further investigation in in vivo exptl. models, esp. in combination with amphotericin B and voriconazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zXbM7_htubVg90H21EOLACvtfcHk0liKcrBv6AQuIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1WntLY%253D&md5=c29c593970aa627cc2b7b39993664302</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1093%2Fmmy%2Fmyv120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmmy%252Fmyv120%26sid%3Dliteratum%253Aachs%26aulast%3DVenturini%26aufirst%3DT.%2BP.%26aulast%3DChassot%26aufirst%3DF.%26aulast%3DLoreto%26aufirst%3DE.%2BS.%26aulast%3DKeller%26aufirst%3DJ.%2BT.%26aulast%3DAzevedo%26aufirst%3DM.%2BI.%26aulast%3DZeni%26aufirst%3DG.%26aulast%3DSanturio%26aufirst%3DJ.%2BM.%26aulast%3DAlves%26aufirst%3DS.%2BH.%26atitle%3DAntifungal%2520activities%2520of%2520diphenyl%2520diselenide%2520and%2520ebselen%2520alone%2520and%2520in%2520combination%2520with%2520antifungal%2520agents%2520against%2520Fusarium%2520spp%26jtitle%3DMed.%2520Mycol.%26date%3D2016%26volume%3D54%26spage%3D550%26epage%3D555%26doi%3D10.1093%2Fmmy%2Fmyv120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wormley, F. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederhold, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span> <span> </span><span class="NLM_article-title">Screening a repurposing library for inhibitors of multidrug-resistant <i>Candida auris</i> identifies ebselen as a repositionable candidate for antifungal drug development</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">e01084-18</span>, <span class="refDoi"> DOI: 10.1128/AAC.01084-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1128%2FAAC.01084-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30104269" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=e01084-18&author=G.+Wallauthor=A.+K.+Chaturvediauthor=F.+L.+Wormleyauthor=N.+P.+Wiederholdauthor=H.+P.+Pattersonauthor=T.+F.+Pattersonauthor=J.+L.+Lopez-Ribot&title=Screening+a+repurposing+library+for+inhibitors+of+multidrug-resistant+Candida+auris+identifies+ebselen+as+a+repositionable+candidate+for+antifungal+drug+development&doi=10.1128%2FAAC.01084-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1128%2FAAC.01084-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01084-18%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DA.%2BK.%26aulast%3DWormley%26aufirst%3DF.%2BL.%26aulast%3DWiederhold%26aufirst%3DN.%2BP.%26aulast%3DPatterson%26aufirst%3DH.%2BP.%26aulast%3DPatterson%26aufirst%3DT.%2BF.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26atitle%3DScreening%2520a%2520repurposing%2520library%2520for%2520inhibitors%2520of%2520multidrug-resistant%2520Candida%2520auris%2520identifies%2520ebselen%2520as%2520a%2520repositionable%2520candidate%2520for%2520antifungal%2520drug%2520development%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26spage%3De01084-18%26doi%3D10.1128%2FAAC.01084-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kidd, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont-Friedrich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arentz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coad, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, J. B.</span></span> <span> </span><span class="NLM_article-title">Structure, mechanism, and inhibition of <i>Aspergillus fumigatus</i> thioredoxin reductase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">e02281-18</span>, <span class="refDoi"> DOI: 10.1128/AAC.02281-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1128%2FAAC.02281-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30642940" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2019&pages=e02281-18&author=A.+C.+Marshallauthor=S.+E.+Kiddauthor=S.+J.+Lamont-Friedrichauthor=G.+Arentzauthor=P.+Hoffmannauthor=B.+R.+Coadauthor=J.+B.+Bruning&title=Structure%2C+mechanism%2C+and+inhibition+of+Aspergillus+fumigatus+thioredoxin+reductase&doi=10.1128%2FAAC.02281-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FAAC.02281-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02281-18%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DA.%2BC.%26aulast%3DKidd%26aufirst%3DS.%2BE.%26aulast%3DLamont-Friedrich%26aufirst%3DS.%2BJ.%26aulast%3DArentz%26aufirst%3DG.%26aulast%3DHoffmann%26aufirst%3DP.%26aulast%3DCoad%26aufirst%3DB.%2BR.%26aulast%3DBruning%26aufirst%3DJ.%2BB.%26atitle%3DStructure%252C%2520mechanism%252C%2520and%2520inhibition%2520of%2520Aspergillus%2520fumigatus%2520thioredoxin%2520reductase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2019%26volume%3D63%26spage%3De02281-18%26doi%3D10.1128%2FAAC.02281-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eltahan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of ebselen as an inhibitor of <i>Cryptosporidium parvum</i> glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs</span>. <i>Int. J. Parasitol.: Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2018.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ijpddr.2018.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29414105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvos12msQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=43-49&author=R.+Eltahanauthor=F.+Guoauthor=H.+Zhangauthor=L.+Xiangauthor=G.+Zhu&title=Discovery+of+ebselen+as+an+inhibitor+of+Cryptosporidium+parvum+glucose-6-phosphate+isomerase+%28CpGPI%29+by+high-throughput+screening+of+existing+drugs&doi=10.1016%2Fj.ijpddr.2018.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs</span></div><div class="casAuthors">Eltahan Rana; Guo Fengguang; Zhang Haili; Xiang Lixin; Zhu Guan</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology. Drugs and drug resistance</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-49</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cryptosporidium parvum is a water-borne and food-borne apicomplexan pathogen.  It is one of the top four diarrheal-causing pathogens in children under the age of five in developing countries, and an opportunistic pathogen in immunocompromised individuals.  Unlike other apicomplexans, C. parvum lacks Kreb's cycle and cytochrome-based respiration, thus relying mainly on glycolysis to produce ATP.  In this study, we characterized the primary biochemical features of the C. parvum glucose-6-phosphate isomerase (CpGPI) and determined its Michaelis constant towards fructose-6-phosphate (Km = 0.309 mM, Vmax = 31.72 nmol/μg/min).  We also discovered that ebselen, an organoselenium drug, was a selective inhibitor of CpGPI by high-throughput screening of 1200 known drugs.  Ebselen acted on CpGPI as an allosteric noncompetitive inhibitor (IC50 = 8.33 μM; Ki = 36.33 μM), while complete inhibition of CpGPI activity was not achieved.  Ebselen could also inhibit the growth of C. parvum in vitro (EC50 = 165 μM) at concentrations nontoxic to host cells, albeit with a relatively small in vitro safety window of 4.2 (cytotoxicity TC50 on HCT-8 cells = 700 μM).  Additionally, ebselen might also target other enzymes in the parasite, leading to the parasite growth reduction.  Therefore, although ebselen is useful in studying the inhibition of CpGPI enzyme activity, further proof is needed to chemically and/or genetically validate CpGPI as a drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsCIZ9a_pCghgd2Wuil24tfW6udTcc2eaiBHAaeYw8O7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvos12msQ%253D%253D&md5=cc0135747a87c15169c6f94aba7101b6</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2018.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2018.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DEltahan%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520ebselen%2520as%2520an%2520inhibitor%2520of%2520Cryptosporidium%2520parvum%2520glucose-6-phosphate%2520isomerase%2520%2528CpGPI%2529%2520by%2520high-throughput%2520screening%2520of%2520existing%2520drugs%26jtitle%3DInt.%2520J.%2520Parasitol.%253A%2520Drugs%2520Drug%2520Resist.%26date%3D2018%26volume%3D8%26spage%3D43%26epage%3D49%26doi%3D10.1016%2Fj.ijpddr.2018.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordhan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swasy, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackler, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anayee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, D. C.</span></span> <span> </span><span class="NLM_article-title">Evaluation of substituted ebselen derivatives as potential trypanocidal agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2016.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28043795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=537-541&author=H.+M.+Gordhanauthor=S.+L.+Patrickauthor=M.+I.+Swasyauthor=A.+L.+Hacklerauthor=M.+Anayeeauthor=J.+E.+Goldenauthor=J.+C.+Morrisauthor=D.+C.+Whitehead&title=Evaluation+of+substituted+ebselen+derivatives+as+potential+trypanocidal+agents&doi=10.1016%2Fj.bmcl.2016.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of substituted ebselen derivatives as potential trypanocidal agents</span></div><div class="casAuthors">Gordhan, Heeren M.; Patrick, Stephen L.; Swasy, Maria I.; Hackler, Amber L.; Anayee, Mark; Golden, Jennifer E.; Morris, James C.; Whitehead, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-541</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human African trypanosomiasis is a disease of sub-Saharan Africa, where millions are at risk for the illness.  The disease, commonly referred to as African sleeping sickness, is caused by an infection by the eukaryotic pathogen, Trypanosoma brucei.  Previously, a target-based high throughput screen revealed ebselen (EbSe), and its sulfur analog, EbS, to be potent in vitro inhibitors of the T. brucei hexokinase 1 (TbHK1).  These mols. also exhibited potent trypanocidal activity in vivo.  In this manuscript, we synthesized a series of sixteen EbSe and EbS derivs. bearing electron-withdrawing carboxylic acid and Me ester functional groups, and evaluated the influence of these substituents on the biol. efficacy of the parent scaffold.  With the exception of one Me ester deriv., these modifications ablated or blunted the potent TbHK1 inhibition of the parent scaffold.  Nonetheless, a few of the Me ester derivs. still exhibited trypanocidal effects with single-digit micromolar or high nanomolar EC50 values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomrTHPitYEv7Vg90H21EOLACvtfcHk0lgQtBF9mxq5Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyltQ%253D%253D&md5=98d0198882e5c9aeabdad4cf16660994</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DGordhan%26aufirst%3DH.%2BM.%26aulast%3DPatrick%26aufirst%3DS.%2BL.%26aulast%3DSwasy%26aufirst%3DM.%2BI.%26aulast%3DHackler%26aufirst%3DA.%2BL.%26aulast%3DAnayee%26aufirst%3DM.%26aulast%3DGolden%26aufirst%3DJ.%2BE.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DWhitehead%26aufirst%3DD.%2BC.%26atitle%3DEvaluation%2520of%2520substituted%2520ebselen%2520derivatives%2520as%2520potential%2520trypanocidal%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D537%26epage%3D541%26doi%3D10.1016%2Fj.bmcl.2016.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felli
Kubica, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedin Denardi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva de Loreto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiblen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morais Santurio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartz Alves, S.</span></span> <span> </span><span class="NLM_article-title">In vitro activity of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Trichosporon asahii</span>. <i>Mycoses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1111/myc.12906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1111%2Fmyc.12906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30784136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsV2ktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=428-433&author=T.+Felli%0AKubicaauthor=L.+Bedin+Denardiauthor=E.+Silva+de+Loretoauthor=G.+Zeniauthor=C.+Weiblenauthor=V.+Oliveiraauthor=J.+Morais+Santurioauthor=S.+Hartz+Alves&title=In+vitro+activity+of+diphenyl+diselenide+and+ebselen+alone+and+in+combination+with+antifungal+agents+against+Trichosporon+asahii&doi=10.1111%2Fmyc.12906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Trichosporon asahii</span></div><div class="casAuthors">Felli Kubica, Thais; Bedin Denardi, Laura; Silva de Loreto, Erico; Zeni, Gilson; Weiblen, Carla; Oliveira, Vanessa; Morais Santurio, Janio; Hartz Alves, Sydney</div><div class="citationInfo"><span class="NLM_cas:title">Mycoses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-433</span>CODEN:
                <span class="NLM_cas:coden">MYCSEU</span>;
        ISSN:<span class="NLM_cas:issn">1439-0507</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : This study evaluated the in vitro susceptibility of Trichosporon asahii strains to di-Ph diselenide (DPDS) and ebselen (EBS) alone and in combination with amphotericin B (AMB), fluconazole (FCZ), itraconazole (ITZ) and caspofungin (CAS) using the microdilution method.  EBS showed in vitro activity against T asahii strains with minimal inhibitory concn. (MIC) ranged from 0.25 to 8.0 μg/mL.  For DPDS, the MIC ranged from 8.0 to 64 μg/mL.  The combinations demonstrating the greatest synergism rate against fluconazole-resistant T asahii strains were the following: CAS + DPDS (96.67%), AMB + DPDS (93.33%), FCZ + DPDS (86.67%) and ITZ + DPDS (83.33%).  The combinations AMB + DPDS and AMB + EBS exhibited the highest synergism rate against the fluconazole-susceptible (FS) T asahii strains (90%).  Antagonism was obsd. in the following combinations: FCZ + EBS (80%) and FCZ + DPDS (13.33%) against the FS strains, and ITZ + EBS (20%) against the FR strains.  Our findings suggest that the antimicrobial activity of DPDS and EBS against T. asahii and its use as an adjuvant therapy with antifungal agents warrant in vivo exptl. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxpHhPijDiybVg90H21EOLACvtfcHk0lgQtBF9mxq5Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsV2ktL8%253D&md5=75c857326f4754f1d9121b2249709437</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fmyc.12906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmyc.12906%26sid%3Dliteratum%253Aachs%26aulast%3DFelli%2BKubica%26aufirst%3DT.%26aulast%3DBedin%2BDenardi%26aufirst%3DL.%26aulast%3DSilva%2Bde%2BLoreto%26aufirst%3DE.%26aulast%3DZeni%26aufirst%3DG.%26aulast%3DWeiblen%26aufirst%3DC.%26aulast%3DOliveira%26aufirst%3DV.%26aulast%3DMorais%2BSanturio%26aufirst%3DJ.%26aulast%3DHartz%2BAlves%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520activity%2520of%2520diphenyl%2520diselenide%2520and%2520ebselen%2520alone%2520and%2520in%2520combination%2520with%2520antifungal%2520agents%2520against%2520Trichosporon%2520asahii%26jtitle%3DMycoses%26date%3D2019%26volume%3D62%26spage%3D428%26epage%3D433%26doi%3D10.1111%2Fmyc.12906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-Olivares, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">In vitro efficacy of ebselen and BAY 11-7082 against Naegleria fowleri</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">414</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.00414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3389%2Ffmicb.2018.00414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29559968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC1MnjtF2hug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=414&author=A.+Debnathauthor=A.+T.+Nelsonauthor=A.+Silva-Olivaresauthor=M.+Shibayamaauthor=D.+Siegelauthor=J.+H.+McKerrow&title=In+vitro+efficacy+of+ebselen+and+BAY+11-7082+against+Naegleria+fowleri&doi=10.3389%2Ffmicb.2018.00414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri</span></div><div class="casAuthors">Debnath Anjan; McKerrow James H; Nelson Andrew T; Siegel Dionicio; Silva-Olivares Angelica; Shibayama Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">414</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Primary amebic meningoencephalitis (PAM) is a fatal infection caused by the free-living ameba Naegleria fowleri, popularly known as the "brain-eating ameba." The drugs of choice in treating PAM are the antifungal amphotericin B and an antileishmanial miltefosine, but these are not FDA-approved for this indication and use of amphotericin B is associated with severe adverse effects.  Moreover, very few patients treated with the combination therapy have survived PAM.  Therefore, development of efficient drugs is a critical unmet need to avert future deaths of children.  Since N. fowleri causes extensive inflammation in the brain it is important to select compounds that can enter brain to kill ameba.  In this study, we identified two central nervous system (CNS) active compounds, ebselen and BAY 11-7082 as amebicidal with EC50 of 6.2 and 1.6 μM, respectively.  The closely related BAY 11-7085 was also found active against N. fowleri with EC50 similar to BAY 11-7082.  We synthesized a soluble ebselen analog, which had amebicidal activity similar to ebselen.  Transmission electron microscopy of N. fowleri trophozoites incubated for 48 h with EC50 concentration of ebselen showed alteration in the cytoplasmic membrane, loss of the nuclear membrane, and appearance of electron-dense granules.  Incubation of N. fowleri trophozoites with EC50 concentrations of BAY 11-7082 and BAY 11-7085 for 48 h showed the presence of large lipid droplets in the cytoplasm, disruption of cytoplasmic and nuclear membranes and appearance of several vesicles and chromatin residues.  Blood-brain barrier permeable amebicidal compounds have potential as new drug leads for Naegleria infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtHTTMeEPedkHdcurJClFcfW6udTcc2ebupt_qV8LNQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnjtF2hug%253D%253D&md5=7f086c05ecaaaec5c123ae6a865f04cb</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.00414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.00414%26sid%3Dliteratum%253Aachs%26aulast%3DDebnath%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DA.%2BT.%26aulast%3DSilva-Olivares%26aufirst%3DA.%26aulast%3DShibayama%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DIn%2520vitro%2520efficacy%2520of%2520ebselen%2520and%2520BAY%252011-7082%2520against%2520Naegleria%2520fowleri%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D414%26doi%3D10.3389%2Ffmicb.2018.00414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ła̧czkowski, K. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motylewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranowska-Ła̧czkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernasiuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antimicrobial evaluation and theoretical prediction of NMR chemical shifts of thiazole and selenazole derivatives with high antifungal activity against Candida spp</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1108</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2015.12.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.molstruc.2015.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyqtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1108&publication_year=2016&pages=427-437&author=K.+Z.+%C5%81a%CC%A7czkowskiauthor=K.+Motylewskaauthor=A.+Baranowska-%C5%81a%CC%A7czkowskaauthor=A.+Biernasiukauthor=K.+Misiuraauthor=A.+Malmauthor=B.+Fern%C3%A1ndez&title=Synthesis%2C+antimicrobial+evaluation+and+theoretical+prediction+of+NMR+chemical+shifts+of+thiazole+and+selenazole+derivatives+with+high+antifungal+activity+against+Candida+spp&doi=10.1016%2Fj.molstruc.2015.12.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antimicrobial evaluation and theoretical prediction of NMR chemical shifts of thiazole and selenazole derivatives with high antifungal activity against Candida spp.</span></div><div class="casAuthors">Laczkowski, Krzysztof Z.; Motylewska, Katarzyna; Baranowska-Laczkowska, Angelika; Biernasiuk, Anna; Misiura, Konrad; Malm, Anna; Fernandez, Berta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">427-437</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis and investigation of antimicrobial activities of novel (E)-thiazoles and (E)-selenazoles I (R = CH3, 4-O2NC6H4, CH2CO2CH2CH3, etc.; R1 = CO2CH2CH3, H; X = S, Se) is presented.  To support the expt., theor. calcns. of the 1H NMR shifts were carried out for representative systems within the DFT B3LYP/6-311++G** approxn. which addnl. confirmed the structure of investigated compds. I.  Among the derivs., compds. I (R = 4-FC6H4, 4-CH3C6H4, CH2CO2CH2CH3, 2,4-F2C6H3, CH3; R1 = H; X = S) Candida albicans ATCC and Candida parapsilosis ATCC 22019 with MIC = 0.49-7.81μg/mL.  In the case of compds. I (R = 4-FC6H4, 4-OCH3C6H4, 4-CH3C6H4, CH2CO2CH2CH3, CH3; R1 = H; X = S), the activity was very strong against of Candida spp. isolated from clin. materials, i.e. C. albicans, Candida krusei, Candida inconspicua, Candida famata, Candida lusitaniae, Candida sake, C. parapsilosis and Candida dubliniensis with MIC = 0.24-15.62 μg/mL.  The activity of several of these was similar to the activity of commonly used antifungal agent fluconazole.  Addnl., compds. I (R = 4-O2NC6H4, 4-FC6H4, 4-NCC6H4, 4-BrC6H4, 4-ClC6H4, 4-CH3C6H4; R1 = H; X = Se) were found to be active against Gram-pos. bacteria, both pathogenic staphylococci Staphylococcus aureus ATCC with MIC = 31.25-125 μg/mL and opportunistic bacteria, such as Staphylococcus epidermidis ATCC 12228 and Micrococcus luteus ATCC 10240 with MIC = 7.81-31.25 μg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8Dgg9VMbt0rVg90H21EOLACvtfcHk0lg30BPkj5KMcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyqtbbJ&md5=2db5e1ca99225232159ed9fc092c5d30</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2015.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2015.12.033%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%2581a%25CC%25A7czkowski%26aufirst%3DK.%2BZ.%26aulast%3DMotylewska%26aufirst%3DK.%26aulast%3DBaranowska-%25C5%2581a%25CC%25A7czkowska%26aufirst%3DA.%26aulast%3DBiernasiuk%26aufirst%3DA.%26aulast%3DMisiura%26aufirst%3DK.%26aulast%3DMalm%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520antimicrobial%2520evaluation%2520and%2520theoretical%2520prediction%2520of%2520NMR%2520chemical%2520shifts%2520of%2520thiazole%2520and%2520selenazole%2520derivatives%2520with%2520high%2520antifungal%2520activity%2520against%2520Candida%2520spp%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2016%26volume%3D1108%26spage%3D427%26epage%3D437%26doi%3D10.1016%2Fj.molstruc.2015.12.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laczkowski, K. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernasiuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranowska-Laczkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furgala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malm, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antimicrobial and anticonvulsant screening of small library of tetrahydro-2<i>H</i>-thiopyran-4-yl based thiazoles and selenazoles</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1080/14756366.2016.1186020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1080%2F14756366.2016.1186020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27193505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1yqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=24-39&author=K.+Z.+Laczkowskiauthor=A.+Biernasiukauthor=A.+Baranowska-Laczkowskaauthor=S.+Zielinskaauthor=K.+Salatauthor=A.+Furgalaauthor=K.+Misiuraauthor=A.+Malm&title=Synthesis%2C+antimicrobial+and+anticonvulsant+screening+of+small+library+of+tetrahydro-2H-thiopyran-4-yl+based+thiazoles+and+selenazoles&doi=10.1080%2F14756366.2016.1186020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antimicrobial and anticonvulsant screening of small library of tetrahydro-2H-thiopyran-4-yl based thiazoles and selenazoles</span></div><div class="casAuthors">Laczkowski, Krzysztof Z.; Biernasiuk, Anna; Baranowska-Laczkowska, Angelika; Zielinska, Sylwia; Salat, Kinga; Furgala, Anna; Misiura, Konrad; Malm, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup2</span>),
    <span class="NLM_cas:pages">24-39</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Synthesis and investigation of antimicrobial activity of 22 novel thiazoles and selenazoles derived from dihydro-2H-thiopyran-4(3H)-one are presented.  Addnl., anticonvulsant activity of six derivs. is examinated.  Among the derivs., some compds. have very strong activity against Candida spp. with MIC = 1.95-15.62 μg/mL.  In the case of compds. the activity is very strong against some strains of Candida spp. isolated from clin. materials, with MIC = 0.98 to 15.62 μg/mL.  Addnl., compds. are found to be active against Gram-pos. bacteria with MIC = 7.81-62.5 μg/mL.  The results of anticonvulsant screening reveal that compds. I (X = S, Se; R = F, Cl) demonstrate a statistically significant anticonvulsant activity in the pentylenetetrazole model, whereas compds. and showed protection in 6-Hz psychomotor seizure model.  Noteworthy, none of these compds. I (X = S, Se; R = F) impaired animals' motor skills in the rotarod test.  We also performed quantum chem. calcn. of interaction and binding energies in complex of I (X = S; R = F) with cyclodextrin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL5wUp_jYCmLVg90H21EOLACvtfcHk0lgyt1IfStrlTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1yqur8%253D&md5=93fd104e2f6e0f467466cfe921d57faf</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1186020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1186020%26sid%3Dliteratum%253Aachs%26aulast%3DLaczkowski%26aufirst%3DK.%2BZ.%26aulast%3DBiernasiuk%26aufirst%3DA.%26aulast%3DBaranowska-Laczkowska%26aufirst%3DA.%26aulast%3DZielinska%26aufirst%3DS.%26aulast%3DSalat%26aufirst%3DK.%26aulast%3DFurgala%26aufirst%3DA.%26aulast%3DMisiura%26aufirst%3DK.%26aulast%3DMalm%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520antimicrobial%2520and%2520anticonvulsant%2520screening%2520of%2520small%2520library%2520of%2520tetrahydro-2H-thiopyran-4-yl%2520based%2520thiazoles%2520and%2520selenazoles%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D24%26epage%3D39%26doi%3D10.1080%2F14756366.2016.1186020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trallori, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">1214</span>– <span class="NLM_lpage">1222</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.08.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2018.08.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30193219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1GksLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=1214-1222&author=A.+Angeliauthor=E.+Tralloriauthor=M.+Ferraroniauthor=L.+Di+Cesare+Mannelliauthor=C.+Ghelardiniauthor=C.+T.+Supuran&title=Discovery+of+new+2%2C+5-disubstituted+1%2C3-selenazoles+as+selective+human+carbonic+anhydrase+IX+inhibitors+with+potent+anti-tumor+activity&doi=10.1016%2Fj.ejmech.2018.08.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new 2,5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity</span></div><div class="casAuthors">Angeli, Andrea; Trallori, Elena; Ferraroni, Marta; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1214-1222</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of disubstituted selenazole derivs. was synthesized and evaluated as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors against the human (h) isoforms hCA I, II, IV, VA, VB and IX, involved in a variety of diseases including glaucoma, retinitis pigmentosa, epilepsy, arthritis and tumors.  The investigated compds. showed potent inhibition against the tumor-assocd. transmembrane hCA IX, with KIs in the subnanomolar low nanomolar range, and were evaluated for their effects on cell viability against the human prostate (PC3) and breast (MDA-MB-231) cancer cell lines, showing effective anti-tumor activity.  These selenazoles are interesting leads for the development of new, isoform-selective CA IX inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj6ye62zw6FLVg90H21EOLACvtfcHk0lgyt1IfStrlTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1GksLbL&md5=1eff1a110f429c3792c6e01fb5aa196d</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.08.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.08.096%26sid%3Dliteratum%253Aachs%26aulast%3DAngeli%26aufirst%3DA.%26aulast%3DTrallori%26aufirst%3DE.%26aulast%3DFerraroni%26aufirst%3DM.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DDiscovery%2520of%2520new%25202%252C%25205-disubstituted%25201%252C3-selenazoles%2520as%2520selective%2520human%2520carbonic%2520anhydrase%2520IX%2520inhibitors%2520with%2520potent%2520anti-tumor%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D1214%26epage%3D1222%26doi%3D10.1016%2Fj.ejmech.2018.08.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mbaveng, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignat, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngameni, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaharia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngadjui, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuete, V.</span></span> <span> </span><span class="NLM_article-title">In vitro antibacterial activities of <i>p</i>-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypes</span>. <i>BMC Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/s40360-016-0046-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1186%2Fs40360-016-0046-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26782344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1ejtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=3&author=A.+T.+Mbavengauthor=A.+G.+Ignatauthor=B.+Ngameniauthor=V.+Zahariaauthor=B.+T.+Ngadjuiauthor=V.+Kuete&title=In+vitro+antibacterial+activities+of+p-toluenesulfonyl-hydrazinothiazoles+and+hydrazinoselenazoles+against+multi-drug+resistant+Gram-negative+phenotypes&doi=10.1186%2Fs40360-016-0046-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antibacterial activities of p-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypes</span></div><div class="casAuthors">Mbaveng, Armelle T.; Ignat, Adriana Grozav; Ngameni, Bathelemy; Zaharia, Valentin; Ngadjui, Bonaventure T.; Kuete, Victor</div><div class="citationInfo"><span class="NLM_cas:title">BMC Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3/1-3/7</span>CODEN:
                <span class="NLM_cas:coden">BPTMAB</span>;
        ISSN:<span class="NLM_cas:issn">2050-6511</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Bacterial multidrug resistance (MDR) constitutes a major hurdle in the treatment of infectious diseases worldwide.  The present study was designed to evaluate the antibacterial activities of synthetic p-toluenesulfonyl-hydrazinothiazoles against multidrug resistant Gram-neg. bacteria.  Methods: The broth microdilution method was used to det. the minimal inhibitory concns. (MIC).  Results: The results demonstrated that the best activities were obtained with hydrazinoselenazoles. p-Chlorobenzyliden- selenosemicarbazide, 4-methyl-2-[(4-chloro-benzyliden)-hydrazinyl]-1,3-selenazole, p-chloro-benzoylselenosemicarbazide and 4-chloromethyl-2-[(4-chlorobenziliden)-N-acetyl-hydrazinyl]-1,3-selenazole were more active than the choramphenicol on Klebsiella pneumoniae KP63.  Tested alone, the lowest MIC value of 16 mg/L was obtained with p-methoxy-benzyliden-selenosemicarbazide against Enterobacter aerogenes ATCC13048, K. pneumoniae ATCC112296 and KP55.  Tested in the presence of an efflux pump inhibitor, phenylalanine arginine β-naphthylamide (PÂI2N), the activity of p-chloro-benzyliden-selenosemicarbazide, 4-methyl-2-[(4-chloro-benzyliden)-hydrazinyl]-1,3-selenazole, p-chlorobenzoyl-selenosemicarbazide and p-methoxy-benzyliden-selenosemicarbazide significantly increased with MIC values below 10 mg/L obtained resp. on 43.8 %, 31.3 %, 62.5 % and 100 % of the 16 tested bacterial strains.  The lowest MIC value of 0.5 mg/L in the presence of PAβN was recorded with p-chloro-benzoyl-selenosemicarbazide against Escherichia coli ATCC8739 and KP55 as well as p-methoxybenzyliden- selenosemicarbazide against E. aerogenes KP55. p-Chloro-benzyliden-selenosemicarbazide and p-chloro-benzoyl-selenosemicarbazide contained the same pharmacophore as p-methoxy-benzylidenselenosemicarbazide.  Conclusion: This study indicates that p-chloro-benzyliden-selenosemicarbazide, p-chloro-benzoyl-selenosemicarbazide and p-methoxy-benzyliden-selenosemicarbazide could be explored more to develop novel antimicrobial drugs to fight MDR bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsv2rBBGd6GLVg90H21EOLACvtfcHk0limPJ5jw72jmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1ejtL8%253D&md5=5d2c32df7b38f113ba3fcbbdc25494b3</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1186%2Fs40360-016-0046-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40360-016-0046-0%26sid%3Dliteratum%253Aachs%26aulast%3DMbaveng%26aufirst%3DA.%2BT.%26aulast%3DIgnat%26aufirst%3DA.%2BG.%26aulast%3DNgameni%26aufirst%3DB.%26aulast%3DZaharia%26aufirst%3DV.%26aulast%3DNgadjui%26aufirst%3DB.%2BT.%26aulast%3DKuete%26aufirst%3DV.%26atitle%3DIn%2520vitro%2520antibacterial%2520activities%2520of%2520p-toluenesulfonyl-hydrazinothiazoles%2520and%2520hydrazinoselenazoles%2520against%2520multi-drug%2520resistant%2520Gram-negative%2520phenotypes%26jtitle%3DBMC%2520Pharmacol.%2520Toxicol.%26date%3D2016%26volume%3D17%26spage%3D3%26doi%3D10.1186%2Fs40360-016-0046-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Rubaie, A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Jadaan, S. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muslim, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Hasani, A. K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Salman, H. N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Fadal, S. A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and antibacterial activity of some new ferrocenyl selenazoles and 3,5-diferrocenyl-1,2,4-selenadiazole</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>774</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2014.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.jorganchem.2014.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOru7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=774&publication_year=2014&pages=43-47&author=A.+Z.+Al-Rubaieauthor=S.+A.+S.+Al-Jadaanauthor=S.+K.+Muslimauthor=E.+A.+Saeedauthor=E.+T.+Aliauthor=A.+K.+J.+Al-Hasaniauthor=H.+N.+K.+Al-Salmanauthor=S.+A.+M.+Al-Fadal&title=Synthesis%2C+characterization+and+antibacterial+activity+of+some+new+ferrocenyl+selenazoles+and+3%2C5-diferrocenyl-1%2C2%2C4-selenadiazole&doi=10.1016%2Fj.jorganchem.2014.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and antibacterial activity of some new ferrocenyl selenazoles and 3,5-diferrocenyl-1,2,4-selenadiazole</span></div><div class="casAuthors">Al-Rubaie, Ali Z.; Al-Jadaan, Shaker A. S.; Muslim, Salah K.; Saeed, Eman A.; Ali, Eman T.; Al-Hasani, Amer K. J.; Al-Salman, Hussien N. K.; Al-Fadal, Sabaa A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">774</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-47</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New ferrocenyl contg. selenazole derivs. were synthesized from reactions of aryl selenocarboxamide (i.e. Ar-C:Se(NH2); Ar = C6H5 (1), 4-Br-C6H4 (2), 4-PhC6H4 (3), 4-CH3OC6H4 (4), 4-CH3SC6H4 (5), 6-MeO-naphthyl (6), 4-MeO-naphthyl (7), 4-C2H5OC6H4 (8), 3,4-(CH3O)2C6H3 (9), and 3,5-(CH3O)2C6H3 (10)) with (2-bromoacetyl)ferrocene.  The structures of the new compds. were detd. by elemental analyses, IR, 1H and 13C NMR and mass spectroscopic data.  Reaction of 1-cyanoferrocene with sodium hydrogen selenide (NaHSe) in methanol gave the new ferrocenyl selenocarboxamide (11) in 27% yield.  Treatment of compd. 11 with a catalytic amt. of Na2[PdCl4] gave 3,5-diferrocenyl-1,2,4-selenadiazole (12) in 35% yield.  Both compds. were characterized elemental analyses and spectroscopic techniques.  Compds. 1-10 and 12 were screened as antibacterial agents against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa and showed promising properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxUNr9z5IwurVg90H21EOLACvtfcHk0limPJ5jw72jmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOru7%252FF&md5=3c8e3ea3aeb8926cc928720b0c30a267</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2014.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Rubaie%26aufirst%3DA.%2BZ.%26aulast%3DAl-Jadaan%26aufirst%3DS.%2BA.%2BS.%26aulast%3DMuslim%26aufirst%3DS.%2BK.%26aulast%3DSaeed%26aufirst%3DE.%2BA.%26aulast%3DAli%26aufirst%3DE.%2BT.%26aulast%3DAl-Hasani%26aufirst%3DA.%2BK.%2BJ.%26aulast%3DAl-Salman%26aufirst%3DH.%2BN.%2BK.%26aulast%3DAl-Fadal%26aufirst%3DS.%2BA.%2BM.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520antibacterial%2520activity%2520of%2520some%2520new%2520ferrocenyl%2520selenazoles%2520and%25203%252C5-diferrocenyl-1%252C2%252C4-selenadiazole%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2014%26volume%3D774%26spage%3D43%26epage%3D47%26doi%3D10.1016%2Fj.jorganchem.2014.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Q.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.-L.</span></span> <span> </span><span class="NLM_article-title">Synthesis, crystal structure, and biological activity of a nickel(II) complex constructed by 2-phenyl-4-selenazole carboxylic acid and 1,10-phenanthroline</span>. <i>J. Coord. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">2605</span>– <span class="NLM_lpage">2614</span>, <span class="refDoi"> DOI: 10.1080/00958972.2013.811497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1080%2F00958972.2013.811497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlGmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=2605-2614&author=B.-B.+Xuauthor=P.+Shiauthor=Q.-Y.+Guanauthor=X.+Shiauthor=G.-L.+Zhao&title=Synthesis%2C+crystal+structure%2C+and+biological+activity+of+a+nickel%28II%29+complex+constructed+by+2-phenyl-4-selenazole+carboxylic+acid+and+1%2C10-phenanthroline&doi=10.1080%2F00958972.2013.811497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, crystal structure, and biological activity of a nickel(II) complex constructed by 2-phenyl-4-selenazole carboxylic acid and 1,10-phenanthroline</span></div><div class="casAuthors">Xu, Bao-Bao; Shi, Pei; Guan, Quan-Yin; Shi, Xia; Zhao, Guo-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Coordination Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2605-2614</span>CODEN:
                <span class="NLM_cas:coden">JCCMBQ</span>;
        ISSN:<span class="NLM_cas:issn">0095-8972</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A nickel(II) complex, [NiL(phen)2]L·5H2O (HL = 2-phenyl-4-selenazolecarboxylic acid, C10H7O2NSe, phen = 1,10-phenanthroline), was synthesized and characterized by elemental anal. and IR.  The single crystal structure was detd. by single-crystal x-ray diffraction.  C88H78N12Ni2O19Se4 crystd. in the triclinic system, space group Pi.  The interaction between the complex and the calf thymus DNA was studied by an ethidium bromide fluorescent probe.  The antibacterial activities of the complex and ligand against five species of bacteria, Escherichia coli, Staphylococcus epidermidis, Streptococcus viridans, Staphylococcus aureus and Acinetobacter baumanii, were tested.  The anticancer activities of the complex against human pancreatic cancer line PANC-28 and human hepatocarcinoma line HuH7 were also studied by employing an MTT assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6LTyswCrbl7Vg90H21EOLACvtfcHk0limPJ5jw72jmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlGmsrg%253D&md5=be311c28bcfa1d329f11095186249dc0</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1080%2F00958972.2013.811497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00958972.2013.811497%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DB.-B.%26aulast%3DShi%26aufirst%3DP.%26aulast%3DGuan%26aufirst%3DQ.-Y.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.-L.%26atitle%3DSynthesis%252C%2520crystal%2520structure%252C%2520and%2520biological%2520activity%2520of%2520a%2520nickel%2528II%2529%2520complex%2520constructed%2520by%25202-phenyl-4-selenazole%2520carboxylic%2520acid%2520and%25201%252C10-phenanthroline%26jtitle%3DJ.%2520Coord.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D2605%26epage%3D2614%26doi%3D10.1080%2F00958972.2013.811497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6577</span>– <span class="NLM_lpage">6579</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2013.10.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24239016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWgtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6577-6579&author=H.+C.+Zhaoauthor=Y.+P.+Shiauthor=Y.+M.+Liuauthor=C.+W.+Liauthor=L.+N.+Xuanauthor=P.+Wangauthor=K.+Zhangauthor=B.+Q.+Chen&title=Synthesis+and+antitumor-evaluation+of+1%2C3-selenazole-containing+1%2C3%2C4-thiadiazole+derivatives&doi=10.1016%2Fj.bmcl.2013.10.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives</span></div><div class="casAuthors">Zhao, Hai-Chuan; Shi, Yan-Ping; Liu, Yu-Ming; Li, Cai-Wen; Xuan, Li-Na; Wang, Peng; Zhang, Kai; Chen, Bao-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6577-6579</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 1,3-selenazole-contg. 1,3,4-thiadiazole derivs. bearing Schiff base moieties were synthesized and evaluated for their in vitro antiproliferative activities against human breast cancer cells MCF-7 and mouse lymphocytic leukemia cells L1210 by CCK-8 assay.  The majority of the compds. showed better activity against MCF-7 cells, compared with lead compd. PCS.  In particular, compd. I was the most potent compd. with IC50 value of 4.02 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZu2K02knNdbVg90H21EOLACvtfcHk0limPJ5jw72jmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWgtLnE&md5=a770b10aca61186139aa14195e72ff03</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.062%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%2BC.%26aulast%3DShi%26aufirst%3DY.%2BP.%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DLi%26aufirst%3DC.%2BW.%26aulast%3DXuan%26aufirst%3DL.%2BN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DB.%2BQ.%26atitle%3DSynthesis%2520and%2520antitumor-evaluation%2520of%25201%252C3-selenazole-containing%25201%252C3%252C4-thiadiazole%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6577%26epage%3D6579%26doi%3D10.1016%2Fj.bmcl.2013.10.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2015.03.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25874334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslyqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=92-97&author=M.+Zhouauthor=S.+Jiauthor=Z.+Wuauthor=Y.+Liauthor=W.+Zhengauthor=H.+Zhouauthor=T.+Chen&title=Synthesis+of+selenazolopyridine+derivatives+with+capability+to+induce+apoptosis+in+human+breast+carcinoma+MCF-7+cells+through+scavenge+of+intracellular+ROS&doi=10.1016%2Fj.ejmech.2015.03.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS</span></div><div class="casAuthors">Zhou, Meiyun; Ji, Shengbin; Wu, Zhaojun; Li, Yiqun; Zheng, Wenjie; Zhou, Hua; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-97</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of selenazolopyridine derivs. have been synthesized and characterized by X-ray diffraction, high resoln. NMR and mass spectroscopy.  The in vitro anticancer activities of the synthetic compds. were screened against a panel of human cancer cell lines, human breast carcinoma MCF-7 cells, human liver carcinoma HepG2 cells and L02 normal cell line by MTT assay.  By analyzing the structure-activity relationship among the synthetic compds., it was found that 2-(phenylamino)selenazolo[5,4-b]pyridine, (PSeD, 7) had higher growth inhibitory effect on MCF-7 cells.  The intracellular mechanism of cell death was evaluated by flow cytometric anal. and ROS assay, which revealed that PSeD could induce MCF-7 cells apoptosis by scavenging intracellular ROS (reactive oxygen species).  Taken together, the authors regard PSeD as an antioxidant which could inhibit cancer cell growth through induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwHGwIiYygCrVg90H21EOLACvtfcHk0lgpSLOw6woyXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslyqurg%253D&md5=0adf84483128fa441d0c2707c52da1a2</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.069%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520selenazolopyridine%2520derivatives%2520with%2520capability%2520to%2520induce%2520apoptosis%2520in%2520human%2520breast%2520carcinoma%2520MCF-7%2520cells%2520through%2520scavenge%2520of%2520intracellular%2520ROS%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D96%26spage%3D92%26epage%3D97%26doi%3D10.1016%2Fj.ejmech.2015.03.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-z.</span></span> <span> </span><span class="NLM_article-title">Study of the effect of molecular structure and alkyl groups bound with tin(IV) on their cytotoxicity of organotin(IV) 2-phenyl-4-selenazole carboxylates</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">102885</span>– <span class="NLM_lpage">102894</span>, <span class="refDoi"> DOI: 10.1039/C5RA18445B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC5RA18445B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWlu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=102885-102894&author=M.+Hongauthor=Y.+Yangauthor=C.+Liauthor=L.+Xuauthor=D.+Liauthor=C.-z.+Li&title=Study+of+the+effect+of+molecular+structure+and+alkyl+groups+bound+with+tin%28IV%29+on+their+cytotoxicity+of+organotin%28IV%29+2-phenyl-4-selenazole+carboxylates&doi=10.1039%2FC5RA18445B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Study of the effect of molecular structure and alkyl groups bound with tin(IV) on their cytotoxicity of organotin(IV) 2-phenyl-4-selenazole carboxylates</span></div><div class="casAuthors">Hong, Min; Yang, Yuanguang; Li, Chuan; Xu, Lidan; Li, Dacheng; Li, Chen-zhong</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">124</span>),
    <span class="NLM_cas:pages">102885-102894</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Five organotin(IV) compds. Ph3SnL (1), (R2Sn)4O2L4 [R = n-Bu (2), n-Oct (3)], (R2Sn)4O2L2Cl2 [R = n-Bu (4), Me (5)], have been synthesized from the reactions of 2-phenyl-4-selenazole carboxylic acid (HL) with the corresponding organotin(IV) oxide or chlorides.  These compds. have been characterized by elemental anal., IR, 1H, 13C and 119Sn NMR spectroscopy, and single crystal x-ray diffraction anal.  Structural studies reveal that compd. 1 exhibits a mononuclear four-coordinated tetrahedral geometry.  Differently, the crystal structures of compds. 2-5 reveal the formation of the tetranuclear species contg. a planar Sn4O4 core.  All compds. were screened for their in vitro cytotoxic activities toward three cancer cell lines (Caco-2, A549, and HCT-116) and one normal rat hepatocyte cell line (BRL).  The results indicate that both di-n-butyltin(IV) and triphenyltin(IV) derivs. not only show excellent cytotoxic activities on cisplatin-sensitive lung cancer cell line A549 and but also exhibit good cytotoxicity against cisplatin-insensitive colon cancer cell lines HCT-116 and Caco-2.  Whereas, dimethyltin(IV) and di-n-octyltin(IV) complexes exhibit lower or no cytotoxic activity.  The structure-activity relationship of the cytotoxicity of the title complexes has also been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbBEsnQjf2g7Vg90H21EOLACvtfcHk0lgpSLOw6woyXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWlu7zI&md5=8aaa8f77727d6daaaf1f27f6b694f1e5</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1039%2FC5RA18445B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA18445B%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.-z.%26atitle%3DStudy%2520of%2520the%2520effect%2520of%2520molecular%2520structure%2520and%2520alkyl%2520groups%2520bound%2520with%2520tin%2528IV%2529%2520on%2520their%2520cytotoxicity%2520of%2520organotin%2528IV%2529%25202-phenyl-4-selenazole%2520carboxylates%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D102885%26epage%3D102894%26doi%3D10.1039%2FC5RA18445B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elshaflu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todorovic, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visnjevac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padron, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Sosa, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djordjevic, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubisic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipovic, N. R.</span></span> <span> </span><span class="NLM_article-title">Selenazolyl-hydrazones as novel selective MAO inhibitors with antiproliferative and antioxidant activities: experimental and in-silico studies</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">247</span>, <span class="refDoi"> DOI: 10.3389/fchem.2018.00247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3389%2Ffchem.2018.00247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30018949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFaisbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=247&author=H.+Elshafluauthor=T.+R.+Todorovicauthor=M.+Nikolicauthor=A.+Lolicauthor=A.+Visnjevacauthor=S.+Hagenowauthor=J.+M.+Padronauthor=A.+T.+Garcia-Sosaauthor=I.+S.+Djordjevicauthor=S.+Grubisicauthor=H.+Starkauthor=N.+R.+Filipovic&title=Selenazolyl-hydrazones+as+novel+selective+MAO+inhibitors+with+antiproliferative+and+antioxidant+activities%3A+experimental+and+in-silico+studies&doi=10.3389%2Ffchem.2018.00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Selenazolyl-hydrazones as novel selective MAO inhibitors with antiproliferative and antioxidant activities: experimental and in-silico studies</span></div><div class="casAuthors">Elshaflu, Hana; Todorovic, Tamara R.; Nikolic, Milan; Lolic, Aleksandar; Visnjevac, Aleksandar; Hagenow, Stefanie; Padron, Jose M.; Garcia-Sosa, Alfonso T.; Djordjevic, Ivana S.; Grubisic, Sonja; Stark, Holger; Filipovic, Nenad R.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247/1-247/18</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The novel approach in the treatment of complex multifactorial diseases, such as neurodegenerative disorders and cancer, requires a development of efficient multitargeting oriented drugs.  Since oxidative stress significantly contributes to the pathogenesis of cancer and neurodegenerative disorders, potential drug candidates should possess good antioxidant properties.  Due to promising biol. activities shown for structurally related (1,3-thiazol-2-yl)hydrazones, a focused library of 12 structurally related benzylidene-based (1,3-selenazol-2-yl)hydrazones was designed as potential multi-targeting compds.  Monoamine oxidases (MAO) A/B inhibition properties of this class of compds. have been investigated.  Surprisingly, the p-nitrophenyl-substituted (1,3-selenazol-2-yl)hydrazone 4 showed MAO B inhibition in a nanomolar concn. range (IC50 = 73 nM).  Excellent antioxidant properties were confirmed in a no. of different in vitro assays.  Antiproliferative activity screening on a panel of six human solid tumor cell lines showed that potencies of some of the investigated compds. was comparable or even better than that of the pos. control 5-fluorouracil.  In-silico calcns. of ADME properties pointed to promising good pharmacokinetic profiles of investigated compds.  Docking studies suggest that some compds., compared to pos. controls, have the ability to strongly interact with targets relevant to cancer such as 5'-nucleotidase, and to neurodegenerative diseases such as the small conductance calcium-activated potassium channel protein 1, in addn. to confirmation of inhibitory binding at MAO B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJcZ3XYHMw8rVg90H21EOLACvtfcHk0lgpSLOw6woyXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFaisbzF&md5=f9512cd703f6b1c05239935efdb3849f</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2018.00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2018.00247%26sid%3Dliteratum%253Aachs%26aulast%3DElshaflu%26aufirst%3DH.%26aulast%3DTodorovic%26aufirst%3DT.%2BR.%26aulast%3DNikolic%26aufirst%3DM.%26aulast%3DLolic%26aufirst%3DA.%26aulast%3DVisnjevac%26aufirst%3DA.%26aulast%3DHagenow%26aufirst%3DS.%26aulast%3DPadron%26aufirst%3DJ.%2BM.%26aulast%3DGarcia-Sosa%26aufirst%3DA.%2BT.%26aulast%3DDjordjevic%26aufirst%3DI.%2BS.%26aulast%3DGrubisic%26aufirst%3DS.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DFilipovic%26aufirst%3DN.%2BR.%26atitle%3DSelenazolyl-hydrazones%2520as%2520novel%2520selective%2520MAO%2520inhibitors%2520with%2520antiproliferative%2520and%2520antioxidant%2520activities%253A%2520experimental%2520and%2520in-silico%2520studies%26jtitle%3DFront.%2520Chem.%26date%3D2018%26volume%3D6%26spage%3D247%26doi%3D10.3389%2Ffchem.2018.00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grozav Ignat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silaghi-Dumitrescu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaharia, V.</span></span> <span> </span><span class="NLM_article-title">Microwave-assisted synthesis of new selenazole derivatives with antiproliferative activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4679</span>– <span class="NLM_lpage">4688</span>, <span class="refDoi"> DOI: 10.3390/molecules18044679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fmolecules18044679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=23603950" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=4679-4688&author=A.+Grozav+Ignatauthor=L.+Gainaauthor=V.+Kueteauthor=L.+Silaghi-Dumitrescuauthor=T.+Efferthauthor=V.+Zaharia&title=Microwave-assisted+synthesis+of+new+selenazole+derivatives+with+antiproliferative+activity&doi=10.3390%2Fmolecules18044679"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18044679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18044679%26sid%3Dliteratum%253Aachs%26aulast%3DGrozav%2BIgnat%26aufirst%3DA.%26aulast%3DGaina%26aufirst%3DL.%26aulast%3DKuete%26aufirst%3DV.%26aulast%3DSilaghi-Dumitrescu%26aufirst%3DL.%26aulast%3DEfferth%26aufirst%3DT.%26aulast%3DZaharia%26aufirst%3DV.%26atitle%3DMicrowave-assisted%2520synthesis%2520of%2520new%2520selenazole%2520derivatives%2520with%2520antiproliferative%2520activity%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D4679%26epage%3D4688%26doi%3D10.3390%2Fmolecules18044679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and bioevaluation of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids as potent xanthine oxidase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2014.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25113879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWisrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=508-516&author=Q.+Guanauthor=Z.+Chengauthor=X.+Maauthor=L.+Wangauthor=D.+Fengauthor=Y.+Cuiauthor=K.+Baoauthor=L.+Wuauthor=W.+Zhang&title=Synthesis+and+bioevaluation+of+2-phenyl-4-methyl-1%2C3-selenazole-5-carboxylic+acids+as+potent+xanthine+oxidase+inhibitors&doi=10.1016%2Fj.ejmech.2014.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and bioevaluation of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids as potent xanthine oxidase inhibitors</span></div><div class="casAuthors">Guan, Qi; Cheng, Zengjin; Ma, Xiaoxue; Wang, Lijie; Feng, Dongjie; Cui, Yuanhang; Bao, Kai; Wu, Lan; Zhang, Weige</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">508-516</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acid derivs. were synthesized and evaluated for inhibitory activity against xanthine oxidase in vitro.  Structure-activity relationship analyses have also been presented.  Most of the target compds. exhibited potency levels in the nanomolar range.  Compd. I emerged as the most potent xanthine oxidase inhibitor (IC50 = 5.5 nM) in comparison to febuxostat (IC50 = 18.6 nM).  Steady-state kinetics measurements with the bovine milk enzyme indicated a mixed type inhibition with Ki and Ki' values of 0.9 and 2.3 nM, resp.  A mol. modeling study on compd. I was performed to gain an insight into its binding mode with xanthine oxidase, and to provide the basis for further structure-guided design of new non-purine xanthine oxidase inhibitors related with the 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acid scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrG7CUw3s7mLVg90H21EOLACvtfcHk0lhw745CoBtUuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWisrbM&md5=92e866e1002a9d9c95e364ccd3d97e77</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520bioevaluation%2520of%25202-phenyl-4-methyl-1%252C3-selenazole-5-carboxylic%2520acids%2520as%2520potent%2520xanthine%2520oxidase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D508%26epage%3D516%26doi%3D10.1016%2Fj.ejmech.2014.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of selenazole-substituted ritonavir analogs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2379</span>– <span class="NLM_lpage">2381</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2018.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29934245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2jsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2379-2381&author=J.+Qiaoauthor=C.+Zhaoauthor=J.+Liuauthor=Y.+Du&title=Design+and+synthesis+of+selenazole-substituted+ritonavir+analogs&doi=10.1016%2Fj.bmcl.2018.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of selenazole-substituted ritonavir analogs</span></div><div class="casAuthors">Qiao, Junfei; Zhao, Chuanfang; Liu, Jun; Du, Yuguo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2379-2381</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the help of Surflex-Dock calcn., two ritonavir analogs, e.g., I, in which one thiazole unit was replaced by selenazole have been designed and synthesized.  The key selenazole structure was constructed from β-azido diselenide through a cascade diselenide cleavage/selenocarbonylation/Staudinger redn./aza-Wittig reaction and a following MnO2 oxidn.  The accordingly prepd. compds. exhibited good anti-HIV-1 (IIIB) activities comparable to that of the original ritonavir, as well as the pos. SI values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsmxZHbCK-7Vg90H21EOLACvtfcHk0lhw745CoBtUuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2jsrvJ&md5=b8c3fae632acadbd15e74d6f50291a1a</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520selenazole-substituted%2520ritonavir%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2379%26epage%3D2381%26doi%3D10.1016%2Fj.bmcl.2018.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Desoky, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badria, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abozeid, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandeel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, A. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antitumor studies of novel benzopyrano-1,2,3-selenadiazole and spiro[benzopyrano]-1,3,4-thiadiazoline derivatives</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2105</span>– <span class="NLM_lpage">2114</span>, <span class="refDoi"> DOI: 10.1007/s00044-012-0201-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs00044-012-0201-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Omu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=2105-2114&author=S.+I.+El-Desokyauthor=F.+A.+Badriaauthor=M.+A.+Abozeidauthor=E.+A.+Kandeelauthor=A.+H.+Abdel-Rahman&title=Synthesis+and+antitumor+studies+of+novel+benzopyrano-1%2C2%2C3-selenadiazole+and+spiro%5Bbenzopyrano%5D-1%2C3%2C4-thiadiazoline+derivatives&doi=10.1007%2Fs00044-012-0201-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antitumor studies of novel benzopyrano-1,2,3-selenadiazole and spiro[benzopyrano]-1,3,4-thiadiazoline derivatives</span></div><div class="casAuthors">El-Desoky, S. I.; Badria, F. A.; Abozeid, M. A.; Kandeel, E. A.; Abdel-Rahman, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2105-2114</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">A convenient and efficient synthetic protocol toward new selenadiazole and thiadiazoline derivs. incorporating a benzopyranone moiety from readily available starting materials was described.  The reaction of different 2,2-dialkyl and 2,2-spirocycloalkyl dihydrobenzopyranones I [R1 = R2 = Me; R1 = Me, R2 = Et; R1, R2 = (CH2)4, (CH2)5, (CH2)6] with semicarbazide hydrochloride and thiosemicarbazide afforded the corresponding semicarbazones and thiosemicarbazones, resp.  Furthermore, cyclization of the semicarbazones via oxidn. using selenium dioxide gave a novel series of chromenoselenadiazoles II.  A series of spirobenzopyrano-1,3,4-thiadiazolines III was synthesized by refluxing the thiosemicarbazones in acetic anhydride.  The synthesized compds. were tested in vitro against four cancer cell lines namely: MCF-7, VERO, WI-38, and HEPG-2.  In vivo studies were also performed using Ehrlich ascites carcinoma for antitumor activity.  Interestingly, compds. II (R1 = Me, R2 = Et) and III (R1 = R2 = Me) showed significant antitumor activities and were capable of improving the hematol. parameters as well as increasing the mean survival time of the mice bearing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8rTy3CTTnrbVg90H21EOLACvtfcHk0lgOah50uzOxQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Omu73F&md5=7332f8e3b483eedc73c7c3c6d9cb9b54</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1007%2Fs00044-012-0201-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-012-0201-0%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Desoky%26aufirst%3DS.%2BI.%26aulast%3DBadria%26aufirst%3DF.%2BA.%26aulast%3DAbozeid%26aufirst%3DM.%2BA.%26aulast%3DKandeel%26aufirst%3DE.%2BA.%26aulast%3DAbdel-Rahman%26aufirst%3DA.%2BH.%26atitle%3DSynthesis%2520and%2520antitumor%2520studies%2520of%2520novel%2520benzopyrano-1%252C2%252C3-selenadiazole%2520and%2520spiro%255Bbenzopyrano%255D-1%252C3%252C4-thiadiazoline%2520derivatives%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D2105%26epage%3D2114%26doi%3D10.1007%2Fs00044-012-0201-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasinszki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzsotján, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajgut, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupkó, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csámpai, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, spectral- and theoretical study, x-ray analysis, and antiproliferative activity of 4,5-dihydrobenzoferroceno[1,2-<i>d</i>][1,2,3]selenadiazole and its benzo-fused analogue</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>863</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2018.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.jorganchem.2018.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslKlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=863&publication_year=2018&pages=70-76&author=T.+Pasinszkiauthor=D.+Dzsotj%C3%A1nauthor=G.+G.+Lajgutauthor=V.+Harmatauthor=A.+Borauthor=I.+Zupk%C3%B3author=A.+Cs%C3%A1mpai&title=Synthesis%2C+spectral-+and+theoretical+study%2C+x-ray+analysis%2C+and+antiproliferative+activity+of+4%2C5-dihydrobenzoferroceno%5B1%2C2-d%5D%5B1%2C2%2C3%5Dselenadiazole+and+its+benzo-fused+analogue&doi=10.1016%2Fj.jorganchem.2018.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, spectral- and theoretical study, x-ray analysis, and antiproliferative activity of 4,5-dihydrobenzoferroceno[1,2-d][1,2,3]selenadiazole and its benzo-fused analogue</span></div><div class="casAuthors">Pasinszki, Tibor; Dzsotjan, Daniel; Lajgut, Gyozo Gyorgy; Harmat, Veronika; Bor, Andrea; Zupko, Istvan; Csampai, Antal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">863</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-76</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis, structure detn., and in vitro antiproliferative effect of 4,5-dihydronaphto[1,2-d][1,2,3]selenadiazole (1) and 4,5-dihydrobenzoferroceno[1,2-d][1,2,3]selenadiazole (2) are presented.  The synthesized mols. were characterized by NMR, IR, Raman, mass, and UV spectroscopies.  The equil. structures of 1 and 2 were calcd. using the B3LYP/6-31+G* quantum-chem. method, and the solid phase structure of 2 was detd. by single crystal X-ray diffraction.  The antiproliferative effect of 1 and 2 was investigated against three tumorous human cell lines.  Both compds. were active against cervical HeLa and ovarian A2780 cell lines, and 2 was also active against breast MDA-MB-231 cell growth.  The ferrocene deriv. 2 was found to be more effective than its org. analog 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvw9kSRyp6L7Vg90H21EOLACvtfcHk0lgOah50uzOxQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslKlsLo%253D&md5=18d17dd70ce428ee27a0b98b9e6095ff</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2018.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2018.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DPasinszki%26aufirst%3DT.%26aulast%3DDzsotj%25C3%25A1n%26aufirst%3DD.%26aulast%3DLajgut%26aufirst%3DG.%2BG.%26aulast%3DHarmat%26aufirst%3DV.%26aulast%3DBor%26aufirst%3DA.%26aulast%3DZupk%25C3%25B3%26aufirst%3DI.%26aulast%3DCs%25C3%25A1mpai%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520spectral-%2520and%2520theoretical%2520study%252C%2520x-ray%2520analysis%252C%2520and%2520antiproliferative%2520activity%2520of%25204%252C5-dihydrobenzoferroceno%255B1%252C2-d%255D%255B1%252C2%252C3%255Dselenadiazole%2520and%2520its%2520benzo-fused%2520analogue%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2018%26volume%3D863%26spage%3D70%26epage%3D76%26doi%3D10.1016%2Fj.jorganchem.2018.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiproliferative activity of 17-[1′,2′,3′]-selenadiazolylpregnenolone compounds</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.steroids.2018.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.steroids.2018.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30296550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFyrsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=151-158&author=J.+Cuiauthor=L.+Pangauthor=M.+Weiauthor=C.+Ganauthor=D.+Liuauthor=H.+Yuanauthor=Y.+Huang&title=Synthesis+and+antiproliferative+activity+of+17-%5B1%E2%80%B2%2C2%E2%80%B2%2C3%E2%80%B2%5D-selenadiazolylpregnenolone+compounds&doi=10.1016%2Fj.steroids.2018.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiproliferative activity of 17-[1',2',3']-selenadiazolylpregnenolone compounds</span></div><div class="casAuthors">Cui, Jianguo; Pang, Liping; Wei, Meizhen; Gan, Chunfang; Liu, Dandan; Yuan, Haiyan; Huang, Yanmin</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-158</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Using pregnenolone as a starting material, some 3-substituted 17-[1',2',3']-selenadiazolylpregnenolone derivs. I (R = COEt, 2-MeC6H4CO, 2-furylcarbonyl, etc.) were synthesized, and their structures were characterized by IR, NMR and HRMS.  The in vitro antitumor activity of the compds. was assayed against PC-3,SKOV3,T47D,MCF-7 and HEK293T cell lines.  The results show that some compds. display selective antiproliferative activity against PC-3 and SKOV3 cells lines and are almost inactive to normal kidney epithelial cells (HEK293T).  The IC50 value are much better than that of abiraterone (pos. control).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3opwhNL9Cm7Vg90H21EOLACvtfcHk0lgOah50uzOxQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFyrsLzM&md5=779af7d3db9f4b83d1fcc82e52e68d55</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2018.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2018.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DGan%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520antiproliferative%2520activity%2520of%252017-%255B1%25E2%2580%25B2%252C2%25E2%2580%25B2%252C3%25E2%2580%25B2%255D-selenadiazolylpregnenolone%2520compounds%26jtitle%3DSteroids%26date%3D2018%26volume%3D140%26spage%3D151%26epage%3D158%26doi%3D10.1016%2Fj.steroids.2018.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mhaidat, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Smadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Momani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzoubi, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Balas, Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antimicrobial and in vitro antitumor activities of a series of 1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3645</span>– <span class="NLM_lpage">3652</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S86054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2147%2FDDDT.S86054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26316694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=3645-3652&author=N.+M.+Mhaidatauthor=M.+Al-Smadiauthor=F.+Al-Momaniauthor=K.+H.+Alzoubiauthor=I.+Mansiauthor=Q.+Al-Balas&title=Synthesis%2C+antimicrobial+and+in+vitro+antitumor+activities+of+a+series+of+1%2C2%2C3-thiadiazole+and+1%2C2%2C3-selenadiazole+derivatives&doi=10.2147%2FDDDT.S86054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antimicrobial and in vitro antitumor activities of a series of 1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives</span></div><div class="casAuthors">Mhaidat, Nizar M.; Al-Smadi, Mousa; Al-Momani, Fouad; Alzoubi, Karem H.; Mansi, Iman; Al-Balas, Qosay</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3645-3652</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Three derivs. of substituted 1,2,3-thia- or 1,2,3-selenadiazole (4a-c) were prepd. and characterized by different chem. techniques.  These compds. were evaluated for their antimicrobial and antitumor activities.  Compds. 4a (propenoxide deriv.), 4b (carbaldehyde deriv.), and 4c (benzene deriv.) were active against the yeast-like fungi Candida albicans.  Compd. 4a was active against gram-neg. Escherichia coli, and compd. 4c was active against the gram-pos. Staphylococcus aureus.  For the antitumor activity, both compds. 4b and 4c were active against all tested tumor cell lines, namely, SW480, HCT116, C32, MV3, HMT3522, and MCF-7.  The activity of compd. 4c was greater than that of compd. 4b and more than that of the ref. antitumor 5-flourouracil against the SW480, HCT116, and MCF-7 tumor cell lines.  In conclusion, a no. of the prepd. 1,2,3-thia- or 1,2,3-selenadiazole compds. showed promising antifungal, antibacterial, and in vitro antitumor activities.  Further investigations are required to explore the mechanism by which active compd. are inducing their cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJIbr8k_CXJ7Vg90H21EOLACvtfcHk0lgOah50uzOxQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVOhtL8%253D&md5=0a49f60bfdd91e42dd7c02c95e38881c</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S86054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S86054%26sid%3Dliteratum%253Aachs%26aulast%3DMhaidat%26aufirst%3DN.%2BM.%26aulast%3DAl-Smadi%26aufirst%3DM.%26aulast%3DAl-Momani%26aufirst%3DF.%26aulast%3DAlzoubi%26aufirst%3DK.%2BH.%26aulast%3DMansi%26aufirst%3DI.%26aulast%3DAl-Balas%26aufirst%3DQ.%26atitle%3DSynthesis%252C%2520antimicrobial%2520and%2520in%2520vitro%2520antitumor%2520activities%2520of%2520a%2520series%2520of%25201%252C2%252C3-thiadiazole%2520and%25201%252C2%252C3-selenadiazole%2520derivatives%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2015%26volume%3D9%26spage%3D3645%26epage%3D3652%26doi%3D10.2147%2FDDDT.S86054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthusubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manisankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yogeeswari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, D.</span></span> <span> </span><span class="NLM_article-title">A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5465</span>– <span class="NLM_lpage">5472</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2011.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=21937152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=5465-5472&author=S.+Chitraauthor=N.+Paulauthor=S.+Muthusubramanianauthor=P.+Manisankarauthor=P.+Yogeeswariauthor=D.+Sriram&title=A+facile+synthesis+of+carbocycle-fused+mono+and+bis-1%2C2%2C3-selenadiazoles+and+their+antimicrobial+and+antimycobacterial+studies&doi=10.1016%2Fj.ejmech.2011.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies</span></div><div class="casAuthors">Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Yogeeswari, Perumal; Sriram, Dharmarajan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5465-5472</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of mono and bis-1,2,3-selenadiazole derivs. have been synthesized by the oxidative cyclization of mono and bis semicarbazones of 2-(3-oxo-1,3-diarylpropyl)-1-cyclohexanones using selenium(IV) oxide.  The newly synthesized compds. were evaluated for their in vitro antimicrobial activity against Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 11632) and Candida albicans (ATCC 90028) and in vitro antituberculosis activity against Mycobacterium tuberculosis H37Rv (MTB).  Among these compds., 1,3-di(4-chlorophenyl)-3-(4,5,6,7-tetrahydro-1,2,3-benzoselenadiazol-4-yl)-1-propanone (I) and 3-(4-chlorophenyl)-1-(4-methylphenyl)-3-(4,5,6,7-tetrahydro-1,2,3-benzoselenadiazol-4-yl)-1-propanone (II) were found to be the most active compds. with MIC of 3.3 and 3.5 μM resp. against MTB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiW3wG8fhBBbVg90H21EOLACvtfcHk0liLBPR5ABAOXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbfL&md5=e8be5da7844cf7e6605a07326bdbe1d8</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DChitra%26aufirst%3DS.%26aulast%3DPaul%26aufirst%3DN.%26aulast%3DMuthusubramanian%26aufirst%3DS.%26aulast%3DManisankar%26aufirst%3DP.%26aulast%3DYogeeswari%26aufirst%3DP.%26aulast%3DSriram%26aufirst%3DD.%26atitle%3DA%2520facile%2520synthesis%2520of%2520carbocycle-fused%2520mono%2520and%2520bis-1%252C2%252C3-selenadiazoles%2520and%2520their%2520antimicrobial%2520and%2520antimycobacterial%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D5465%26epage%3D5472%26doi%3D10.1016%2Fj.ejmech.2011.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S. J.</span></span> <span> </span><span class="NLM_article-title">Aerobic radical-cascade cycloaddition of isocyanides, selenium and imidamides: facile access to 1,2,4-selenadiazoles under metal-free conditions</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1618</span>, <span class="refDoi"> DOI: 10.1039/C6GC03521C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC6GC03521C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFSh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=1613-1618&author=Y.+Fangauthor=Z.+L.+Zhuauthor=P.+Xuauthor=S.+Y.+Wangauthor=S.+J.+Ji&title=Aerobic+radical-cascade+cycloaddition+of+isocyanides%2C+selenium+and+imidamides%3A+facile+access+to+1%2C2%2C4-selenadiazoles+under+metal-free+conditions&doi=10.1039%2FC6GC03521C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Aerobic radical-cascade cycloaddition of isocyanides, selenium and imidamides: facile access to 1,2,4-selenadiazoles under metal-free conditions</span></div><div class="casAuthors">Fang, Yi; Zhu, Zheng-Lin; Xu, Pei; Wang, Shun-Yi; Ji, Shun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1613-1618</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel and facile metal-free method for the green synthesis of 1,2,4-selenadiazol-5-amine derivs. through the aerobic radical-cascade multi-component reactions of isocyanides, Se powder and imidamides is reported herein.  O2 in the air was employed as the green oxidant to achieve the cycloaddn. with the generation of H2O as the sole byproduct.  It also features good functional group compatibility and broad substrate scope.  This method was successfully applied to the functionalization of biol. active mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpixL1HwwEg5rVg90H21EOLACvtfcHk0liLBPR5ABAOXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFSh&md5=ce31f224bc99c8058a8459590758cf1b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1039%2FC6GC03521C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6GC03521C%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%2BL.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%2BY.%26aulast%3DJi%26aufirst%3DS.%2BJ.%26atitle%3DAerobic%2520radical-cascade%2520cycloaddition%2520of%2520isocyanides%252C%2520selenium%2520and%2520imidamides%253A%2520facile%2520access%2520to%25201%252C2%252C4-selenadiazoles%2520under%2520metal-free%2520conditions%26jtitle%3DGreen%2520Chem.%26date%3D2017%26volume%3D19%26spage%3D1613%26epage%3D1618%26doi%3D10.1039%2FC6GC03521C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Putta, V. P. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujjarappa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vodnala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malakar, C. C.</span></span> <span> </span><span class="NLM_article-title">The facile and efficient organocatalytic platform for accessing 1,2,4-selenadiazoles and thiadiazoles under aerobic conditions</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">908</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2018.01.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.tetlet.2018.01.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFaqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=904-908&author=V.+P.+R.+K.+Puttaauthor=R.+Gujjarappaauthor=N.+Vodnalaauthor=R.+Guptaauthor=P.+P.+Pujarauthor=C.+C.+Malakar&title=The+facile+and+efficient+organocatalytic+platform+for+accessing+1%2C2%2C4-selenadiazoles+and+thiadiazoles+under+aerobic+conditions&doi=10.1016%2Fj.tetlet.2018.01.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The facile and efficient organocatalytic platform for accessing 1,2,4-selenadiazoles and thiadiazoles under aerobic conditions</span></div><div class="casAuthors">Putta, V. P. Rama Kishore; Gujjarappa, Raghuram; Vodnala, Nagaraju; Gupta, Richa; Pujar, Prasad P.; Malakar, Chandi C.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">904-908</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The organocatalytic approach towards synthesis of rarely explored 1,2,4-selenadiazole and thiadiazole scaffolds have been devised using corresponding carboxamides as substrates.  The transformations were realized using two distinct conditions in the presence of catalytic vitamin B3 or thiourea under aerobic conditions.  Developed methods overcome the assocd. limitations of previous reported approaches and the desired products were obtained in high yields and selectivity without the formation of toxic side-products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIUtmH00zBYrVg90H21EOLACvtfcHk0liLBPR5ABAOXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFaqsrs%253D&md5=4cac323979eab5a6bcb3adc11cc7d3c4</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2018.01.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2018.01.063%26sid%3Dliteratum%253Aachs%26aulast%3DPutta%26aufirst%3DV.%2BP.%2BR.%2BK.%26aulast%3DGujjarappa%26aufirst%3DR.%26aulast%3DVodnala%26aufirst%3DN.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DPujar%26aufirst%3DP.%2BP.%26aulast%3DMalakar%26aufirst%3DC.%2BC.%26atitle%3DThe%2520facile%2520and%2520efficient%2520organocatalytic%2520platform%2520for%2520accessing%25201%252C2%252C4-selenadiazoles%2520and%2520thiadiazoles%2520under%2520aerobic%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2018%26volume%3D59%26spage%3D904%26epage%3D908%26doi%3D10.1016%2Fj.tetlet.2018.01.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. F.</span></span> <span> </span><span class="NLM_article-title">Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">8383</span>– <span class="NLM_lpage">8393</span>, <span class="refDoi"> DOI: 10.1039/C5TB01501D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC5TB01501D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2jt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=8383-8393&author=L.+Z.+Heauthor=S.+B.+Jiauthor=H.+Q.+Laiauthor=T.+F.+Chen&title=Selenadiazole+derivatives+as+theranostic+agents+for+simultaneous+cancer+chemo-%2Fradiotherapy+by+targeting+thioredoxin+reductase&doi=10.1039%2FC5TB01501D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase</span></div><div class="casAuthors">He, Lizhen; Ji, Shengbin; Lai, Haoqiang; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">8383-8393</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The lack of early and timely diagnosis of tumors and the monitoring of their response to therapeutics have limited the successful cancer treatments.  Theranostic agents are expected to realize the dual-purpose of simultaneous diagnosis and therapy for treatments of cancers.  In the present study, the authors have examd. the effects of the chem. structure of selenadiazole derivs. (SeDs) on their anticancer efficacy and radio-sensitization against clin. used X-rays.  The results showed that the introduction of a nitro group (-NO2) into SeD-3 significantly enhanced the anticancer activity of SeDs.  The higher lipophilicity endowed SeD-3 with higher cellular internalization ability, resulting in higher cellular uptake and anticancer efficacy.  Specifically, the capacity of autofluorescence allowed the use of SeD-3 as a promising theranostic agent to directly monitor the cellular uptake, localization and biodistribution in vitro and in vivo.  Interestingly, SeD-3 also significantly enhanced the sensitivity of HeLa cervical cells to x-ray-induced apoptosis by targeting the inhibition of TrxR and promoting intracellular ROS overprodn., which activated the downstream ROS-mediated signaling pathways to regulate cell apoptosis.  Furthermore, SeD-3 exhibited satisfactory in vivo antitumor efficacy through the inhibition of tumor proliferation and induction of tumor cell apoptosis, and showed no toxicity to the main organs.  Moreover, from the results of hematol. anal., the authors found that not only inhibiting the tumor growth, treatment of SeD-3 also alleviated the damage of liver, kidney and heart function of nude mice induced by HeLa xenografts.  Taken together, this study demonstrates that SeDs could be further developed as an effective and safe theranostic agent for simultaneous cancer chemo-/radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR7PLmYlgGo7Vg90H21EOLACvtfcHk0liRcMqNEFgB7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2jt7fN&md5=b95cb48e9e6f658410f2d847e5d22df6</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1039%2FC5TB01501D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5TB01501D%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%2BZ.%26aulast%3DJi%26aufirst%3DS.%2BB.%26aulast%3DLai%26aufirst%3DH.%2BQ.%26aulast%3DChen%26aufirst%3DT.%2BF.%26atitle%3DSelenadiazole%2520derivatives%2520as%2520theranostic%2520agents%2520for%2520simultaneous%2520cancer%2520chemo-%252Fradiotherapy%2520by%2520targeting%2520thioredoxin%2520reductase%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2015%26volume%3D3%26spage%3D8383%26epage%3D8393%26doi%3D10.1039%2FC5TB01501D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of cancer-targeted benzoselenadiazole by RGD peptide functionalization for cancer theranostics</span>. <i>Macromol. Rapid Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1565</span>, <span class="refDoi"> DOI: 10.1002/marc.201500243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fmarc.201500243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26205253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=1559-1565&author=L.+Yangauthor=W.+Liauthor=Y.+Huangauthor=Y.+Zhouauthor=T.+Chen&title=Rational+design+of+cancer-targeted+benzoselenadiazole+by+RGD+peptide+functionalization+for+cancer+theranostics&doi=10.1002%2Fmarc.201500243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Cancer-Targeted Benzoselenadiazole by RGD Peptide Functionalization for Cancer Theranostics</span></div><div class="casAuthors">Yang, Liye; Li, Wenying; Huang, Yanyu; Zhou, Yangliang; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Macromolecular Rapid Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1559-1565</span>CODEN:
                <span class="NLM_cas:coden">MRCOE3</span>;
        ISSN:<span class="NLM_cas:issn">1022-1336</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A cancer-targeted conjugate of the selenadiazole deriv. BSeC (benzo[1,2,5] selenadiazole-5-carboxylic acid) with RGD peptide as targeting mol. and PEI (polyethylenimine) as a linker is rationally designed and synthesized in the present study.  The results show that RGD-PEI-BSeC forms nanoparticles in aq. soln. with a core-shell nanostructure and high stability under physiol. conditions.  This rational design effectively enhances the selective cellular uptake and cellular retention of BSeC in human glioma cells, and increases its selectivity between cancer and normal cells.  The nanoparticles enter the cells through receptor-mediated endocytosis via clathrin-mediated and nystatin-dependent lipid raft-mediated pathways.  Internalized nanoparticles trigger glioma cell apoptosis by activation of ROS-mediated p53 phosphorylation.  Therefore, this study provides a strategy for the rational design of selenium-contg. cancer-targeted theranostics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-AIge-_cZcrVg90H21EOLACvtfcHk0liRcMqNEFgB7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7fI&md5=a78aeec5a1dce6406ef0063567ef2218</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fmarc.201500243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmarc.201500243%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520cancer-targeted%2520benzoselenadiazole%2520by%2520RGD%2520peptide%2520functionalization%2520for%2520cancer%2520theranostics%26jtitle%3DMacromol.%2520Rapid%2520Commun.%26date%3D2015%26volume%3D36%26spage%3D1559%26epage%3D1565%26doi%3D10.1002%2Fmarc.201500243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">You, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. F.</span></span> <span> </span><span class="NLM_article-title">Tailored mesoporous silica nanosystem with enhanced permeability of the blood-brain barrier to antagonize glioblastoma</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">5980</span>– <span class="NLM_lpage">5990</span>, <span class="refDoi"> DOI: 10.1039/C6TB01329E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC6TB01329E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlagt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=5980-5990&author=Y.+Y.+Youauthor=L.+Y.+Yangauthor=L.+Z.+Heauthor=T.+F.+Chen&title=Tailored+mesoporous+silica+nanosystem+with+enhanced+permeability+of+the+blood-brain+barrier+to+antagonize+glioblastoma&doi=10.1039%2FC6TB01329E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Tailored mesoporous silica nanosystem with enhanced permeability of the blood-brain barrier to antagonize glioblastoma</span></div><div class="casAuthors">You, Yuanyuan; Yang, Liye; He, Lizhen; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">5980-5990</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cancer-targeted drug delivery systems with permeability of the blood-brain barrier (BBB) have become of great interest for the rational design of high-efficiency anticancer agents.  Herein, a tailored mesoporous silica nanoparticles (MSNs) nanosystem modified by RGD (arginine-glycine-aspartate) peptide was designed and tested for use as a carrier of anticancer agents, by using a novel org. selenium compd. BSeC as a model mol.  As expected, the nanosystem (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="86c4d5e3c5c6cbd5c8f5abd4c1c2">[email protected]</a>) could effectively enhance the BBB permeability and the cellular uptake of BSeC in tumor cells.  The internalized <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1351407650535e405d603e415457">[email protected]</a> triggered mitochondrial dysfunction and intracellular ROS overprodn., which subsequently activated the p53 and MAPKs pathways.  Moreover, the nanosystem could inhibit the U87 tumor spheroids growth, significantly prolong the blood circulation time of the loaded drug in vivo and effectively reduce its in vivo toxicity.  Taken together, this study provides a strategy for the rational design of a tailored nanomedicine with enhanced BBB permeability to treat human brain glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYh8vbM-J0rVg90H21EOLACvtfcHk0liRcMqNEFgB7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlagt7zJ&md5=99981b0ea66fe23be780a80675ca9cb6</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1039%2FC6TB01329E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6TB01329E%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DY.%2BY.%26aulast%3DYang%26aufirst%3DL.%2BY.%26aulast%3DHe%26aufirst%3DL.%2BZ.%26aulast%3DChen%26aufirst%3DT.%2BF.%26atitle%3DTailored%2520mesoporous%2520silica%2520nanosystem%2520with%2520enhanced%2520permeability%2520of%2520the%2520blood-brain%2520barrier%2520to%2520antagonize%2520glioblastoma%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2016%26volume%3D4%26spage%3D5980%26epage%3D5990%26doi%3D10.1039%2FC6TB01329E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. F.</span></span> <span> </span><span class="NLM_article-title">Enhancement of cell uptake and antitumor activity of selenadiazole derivatives through interaction and delivery by serum albumin</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">16721</span>– <span class="NLM_lpage">16729</span>, <span class="refDoi"> DOI: 10.1039/C6RA28801D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC6RA28801D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlKmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=16721-16729&author=S.+L.+Dengauthor=D.+L.+Zengauthor=Y.+Luoauthor=J.+F.+Zhaoauthor=X.+L.+Liauthor=Z.+N.+Zhaoauthor=T.+F.+Chen&title=Enhancement+of+cell+uptake+and+antitumor+activity+of+selenadiazole+derivatives+through+interaction+and+delivery+by+serum+albumin&doi=10.1039%2FC6RA28801D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of cell uptake and antitumor activity of selenadiazole derivatives through interaction and delivery by serum albumin</span></div><div class="casAuthors">Deng, Shulin; Zeng, Delong; Luo, Yi; Zhao, Jianfu; Li, Xiaoling; Zhao, Zhennan; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">16721-16729</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Serum albumin is an important carrier in the transport of endogenous and exogenous substances across cell membranes.  Small mol. drugs could bind to serum albumin to various extents after i.v. injection, which may affect the bioavailability, metab., pharmacol. and toxicol. potency.  Org. selenium (Se) compds. exhibit favorable biocompatibility and low toxicity that attracts increased attention from researchers.  Herein, a series of selenadiazole derivs. (4a-e) have been synthesized and their cytotoxicity towards various kinds of cells were evaluated.  The results suggested that iso-Pr benzo[c][1,2,5]selenadiazole-5-carboxylate (4d) exhibited a broad inhibition spectrum on the proliferation of tested cancer cells, with a relatively higher anticancer activity than other derivs.  We found that the differences in their anticancer activities were attributed to the various binding abilities of the Se compds. toward BSA.  The bimol. quenching const. (Kq), apparent quenching const. (KSV), effective binding const. (KA) and binding site no. (n) were obtained through fluorescence quenching calcns., which indicated that all compds. could efficiently bind to BSA mols. and the fluorescence quenching mechanism was mainly a static quenching procedure.  Moreover, serum albumin was found to interact with selenadiazole derivs. (4a-e), thus promoting the cellular uptake and anticancer activity of the Se compds.  Taken together, this study demonstrated that the synthetic selenadiazole derivs. exhibited high anticancer activity and cellular uptake through delivery by human serum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhLL-UzNjjbbVg90H21EOLACvtfcHk0lhG3GJ2VeaCmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlKmsbo%253D&md5=1fa5f893acc43c375fcfacec0be292e4</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1039%2FC6RA28801D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA28801D%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DS.%2BL.%26aulast%3DZeng%26aufirst%3DD.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%2BF.%26aulast%3DLi%26aufirst%3DX.%2BL.%26aulast%3DZhao%26aufirst%3DZ.%2BN.%26aulast%3DChen%26aufirst%3DT.%2BF.%26atitle%3DEnhancement%2520of%2520cell%2520uptake%2520and%2520antitumor%2520activity%2520of%2520selenadiazole%2520derivatives%2520through%2520interaction%2520and%2520delivery%2520by%2520serum%2520albumin%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D16721%26epage%3D16729%26doi%3D10.1039%2FC6RA28801D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruberte, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aydillo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartin, C.</span></span> <span> </span><span class="NLM_article-title">Novel selenadiazole derivatives as selective antitumor and radical scavenging agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2018.07.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30071406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWqsLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=14-27&author=A.+C.+Ruberteauthor=D.+Planoauthor=I.+Encioauthor=C.+Aydilloauthor=A.+K.+Sharmaauthor=C.+Sanmartin&title=Novel+selenadiazole+derivatives+as+selective+antitumor+and+radical+scavenging+agents&doi=10.1016%2Fj.ejmech.2018.07.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selenadiazole derivatives as selective antitumor and radical scavenging agents</span></div><div class="casAuthors">Ruberte, Ana Carolina; Plano, Daniel; Encio, Ignacio; Aydillo, Carlos; Sharma, Arun K.; Sanmartin, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14-27</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Twenty-seven novel benzo[c][1,2,5]selenadiazole-5-carboxylic acid (BSCA) derivs. I [R = Ph, 2-thiazolyl, 4-MeC6H4, etc.; n = 0, 1, 2, 3, 4] were designed and synthesized.  Anti-proliferative activity of these structures was tested in vitro against a panel of five human cancer cell lines, including prostate (PC-3), colon (HT-29), leukemia (CCRF-CEM), lung (HTB-54) and breast (MCF-7).  Four compds. I [R = 4-MeOC6H4, 4-MeSC6H4, 4-MeSeC6H4, 2-benzothiazolyl; n = 0] showed potent inhibitory activity with GI50 values below 10μM in at least one of the cancer cell lines.  The selectivity of these compds. was further examd. in two non-malignant cell lines derived from breast (184B5) and lung (BEAS-2B).  Compd. I [R = 4-MeSeC6H4; n = 0] exhibited promising anti-proliferative activity (GI50=3.7μM) in MCF-7cells, together with high selectivity index (SI>27.1).  The induction of cell death by compd. I [R = 4-MeSeC6H4; n = 0] was independent of the apoptotic process and it did not affect cell cycle progression either.  Likewise, radical scavenging properties of the new selenadiazole derivs. I were confirmed by testing their ability to scavenge DPPH radicals.  Four compds. I [R = Ph, 4-MeC6H4, 4-HSC6H4, 4-HSeC6H4; n = 0] showed potent radical scavenging activity, compd. I [R = 4-HSC6H4; n = 0] being the most effective.  Overall, while compd. I [R = 4-MeSeC6H4; n = 0] was identified as the most cell growth inhibitory agent and selectively toxic to cancer cells, compd. I [R = 4-HSC6H4; n = 0] proved to be the most potent antioxidant among the selenadiazole derivs. synthesized.  This series of compds. I could served as an excellent scaffold to achieve new and potent antioxidant compds. useful for several diseases, i.e. cancer, neurodegenerative, heart diseases and leishmaniasis, considering the high radical scavenging activity and low toxicity showed by most of the compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwC2K7grhW67Vg90H21EOLACvtfcHk0lhG3GJ2VeaCmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWqsLzK&md5=11772165f38a8dc0be2a499a7842ab72</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.063%26sid%3Dliteratum%253Aachs%26aulast%3DRuberte%26aufirst%3DA.%2BC.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DEncio%26aufirst%3DI.%26aulast%3DAydillo%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSanmartin%26aufirst%3DC.%26atitle%3DNovel%2520selenadiazole%2520derivatives%2520as%2520selective%2520antitumor%2520and%2520radical%2520scavenging%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D14%26epage%3D27%26doi%3D10.1016%2Fj.ejmech.2018.07.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uriz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo
Barbosa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreiss, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gaitano, G.</span></span> <span> </span><span class="NLM_article-title">Activity enhancement of selective antitumoral selenodiazoles formulated with poloxamine micelles</span>. <i>Colloids Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/j.colsurfb.2018.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.colsurfb.2018.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29960214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1agt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2018&pages=463-469&author=A.+Urizauthor=C.+Sanmartinauthor=D.+Planoauthor=R.+de+Melo%0ABarbosaauthor=C.+A.+Dreissauthor=G.+Gonzalez-Gaitano&title=Activity+enhancement+of+selective+antitumoral+selenodiazoles+formulated+with+poloxamine+micelles&doi=10.1016%2Fj.colsurfb.2018.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Activity enhancement of selective antitumoral selenodiazoles formulated with poloxamine micelles</span></div><div class="casAuthors">Uriz, Amaia; Sanmartin, Carmen; Plano, Daniel; de Melo Barbosa, Raquel; Dreiss, Cecile A.; Gonzalez-Gaitano, Gustavo</div><div class="citationInfo"><span class="NLM_cas:title">Colloids and Surfaces, B: Biointerfaces</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">CSBBEQ</span>;
        ISSN:<span class="NLM_cas:issn">0927-7765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selenium (Se) incorporated into org. frameworks has demonstrated anticancer activity against several cancer types.  One of the drawbacks of most of these constructs is their poor soly. and bioavailability, which can be overcome with the use of suitable nanocarriers.  We have synthesized a series of 5-substituted amide selenodiazoles, based on the parent structure of ebselen, an organoselenium drug with proven cytoprotective activity, and solubilized them in polymeric micelles of poloxamines, poly(ethylene oxide)-poly(propylene oxide) X-shaped tetrablock-copolymers.  Scattering methods (SANS and DLS) were employed to characterize the micellar nanocarriers.  MTT biol. evaluation highlights the selectivity of the Se-compds. towards cancer cells, with MCF-7 standing as the most responsive line.  The alkylation of the heterocycle with a 12-carbon hydrophobic tail displays the highest activity, showing a 100-fold increase with respect to ebselen.  This compd. also exhibits the greatest increase in soly. in poloxamine micelles, overall resulting in a one-fold increase in activity with respect to the non-formulated form, making it a hit compd. for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplFX2N2-1we7Vg90H21EOLACvtfcHk0lhG3GJ2VeaCmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1agt7vM&md5=6683d2c6e92475f7cd49edbde62c3c7e</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2018.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2018.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DUriz%26aufirst%3DA.%26aulast%3DSanmartin%26aufirst%3DC.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3Dde%2BMelo%2BBarbosa%26aufirst%3DR.%26aulast%3DDreiss%26aufirst%3DC.%2BA.%26aulast%3DGonzalez-Gaitano%26aufirst%3DG.%26atitle%3DActivity%2520enhancement%2520of%2520selective%2520antitumoral%2520selenodiazoles%2520formulated%2520with%2520poloxamine%2520micelles%26jtitle%3DColloids%2520Surf.%252C%2520B%26date%3D2018%26volume%3D170%26spage%3D463%26epage%3D469%26doi%3D10.1016%2Fj.colsurfb.2018.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Microwave-assisted syntheses of benzimidazole-containing selenadiazole derivatives that induce cell-cycle arrest and apoptosis in human breast cancer cells by activation of the ROS/AKT pathway</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2339</span>– <span class="NLM_lpage">2346</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fcmdc.201600261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27677422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKru7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2339-2346&author=Y.+Liangauthor=Y.+Zhouauthor=S.+Dengauthor=T.+Chen&title=Microwave-assisted+syntheses+of+benzimidazole-containing+selenadiazole+derivatives+that+induce+cell-cycle+arrest+and+apoptosis+in+human+breast+cancer+cells+by+activation+of+the+ROS%2FAKT+pathway&doi=10.1002%2Fcmdc.201600261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway</span></div><div class="casAuthors">Liang, Yuanwei; Zhou, Yangliang; Deng, Shulin; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2339-2346</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The use of selenium-contg. heterocyclic compds. as potent cancer chemopreventive and chemotherapeutic agents has been well documented by a large no. of clin. studies.  In this study we developed a new approach to synthesize four benzimidazole-contg. selenadiazole derivs. (BSeDs).  The method uses a combination of peptide coupling reagents and microwave irradn.  This strategy features milder reaction conditions, higher yields, and shorter reaction times.  The synthetic BSeDs were identified as potent antiproliferative agents against the human MCF-7 and MDA-MB-231 breast cancer cell lines.  Compds. 1 b (5-(6-methyl-1H-benzo[d]imidazol-2-yl)benzo[c][1,2,5]selenadiazole), 1 c (5-(6-chloro-1H-benzo[d]imidazol-2-yl)benzo[c][1,2,5]selenadiazole), and 1 d (5-(6-bromo-1H-benzo[d]imidazol-2-yl)benzo[c][1,2,5]selenadiazole) were found to show greater cytotoxicity against the triple-neg. breast cancer cell line MDA-MB-231 than MCF-7, and to exhibit dose-dependent inhibition of cell migration, in which a significant decrease in the zone of cell monolayer wound closure was obsd. relative to untreated controls.  Our results demonstrate that BSeDs can cause cell-cycle arrest and apoptosis in MDA-MB-231 cells by inducing DNA damage, inhibiting protein kinase B (AKT), and activating mitogen-activated protein kinase (MAPK) family members through the overprodn. of reactive oxygen species (ROS).  Taken together, the results of this study provide a facile microwave-assisted strategy for the synthesis of selenium-contg. org. compds. that exhibit a high level of anticancer efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEZt24WnURMbVg90H21EOLACvtfcHk0lhG3GJ2VeaCmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKru7nF&md5=719c3f5094bdf61791b83f3c399b8942</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600261%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DMicrowave-assisted%2520syntheses%2520of%2520benzimidazole-containing%2520selenadiazole%2520derivatives%2520that%2520induce%2520cell-cycle%2520arrest%2520and%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520activation%2520of%2520the%2520ROS%252FAKT%2520pathway%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2339%26epage%3D2346%26doi%3D10.1002%2Fcmdc.201600261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngai, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, X.</span></span> <span> </span><span class="NLM_article-title">A novel selenadiazole derivative induces apoptosis in human glioma cells by dephosphorylation of AKT</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">994</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1248/cpb.c14-00354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1248%2Fcpb.c14-00354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25273058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=994-999&author=Y.+Zhangauthor=S.+Zhengauthor=S.+M.+Ngaiauthor=W.+Zhengauthor=J.+Liauthor=T.+Chenauthor=X.+Zhong&title=A+novel+selenadiazole+derivative+induces+apoptosis+in+human+glioma+cells+by+dephosphorylation+of+AKT&doi=10.1248%2Fcpb.c14-00354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selenadiazole derivative induces apoptosis in human glioma cells by dephosphorylation of AKT</span></div><div class="casAuthors">Zhang, Yikai; Zheng, Shanyuan; Ngai, Sai-Ming; Zheng, Wenjie; Li, Jinying; Chen, Tianfeng; Zhong, Xueyun</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">994-999</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Selenadiazole derivs. are synthetic organoselenium compds. with improved anticancer activity and greater selectivity than inorg. selenium.  In this study, 4-(benzo[c][1,2,5]selenadiazol-6-yl)-benzene-1,2-diamine (BSBD) was shown to induce time- and dose-dependent apoptosis in SWO-38 human glioma cells by accumulation of a sub-G1 cell population, DNA fragmentation, nuclear condensation, caspase activation and poly(ADP-ribose) polymerase (PARP) cleavage.  Further mechanistic investigation showed that BSBD treatment induced dephosphorylation of AKT and DNA damage-mediated activation of p53, leading to extensive apoptosis through the mitochondrial pathway.  Our findings suggest that BSBD represents a potential human glioma therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqsIgbtZKLmrVg90H21EOLACvtfcHk0liNY46fDezgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFaqtQ%253D%253D&md5=559ba4373a7ce6e14f6cd3d8497b2874</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c14-00354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c14-00354%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DNgai%26aufirst%3DS.%2BM.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DX.%26atitle%3DA%2520novel%2520selenadiazole%2520derivative%2520induces%2520apoptosis%2520in%2520human%2520glioma%2520cells%2520by%2520dephosphorylation%2520of%2520AKT%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2014%26volume%3D62%26spage%3D994%26epage%3D999%26doi%3D10.1248%2Fcpb.c14-00354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.04.151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbrc.2014.04.151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24813998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlOqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2014&pages=88-93&author=Q.+Xieauthor=Y.+Zhouauthor=G.+Lanauthor=L.+Yangauthor=W.+Zhengauthor=Y.+Liangauthor=T.+Chen&title=Sensitization+of+cancer+cells+to+radiation+by+selenadiazole+derivatives+by+regulation+of+ROS-mediated+DNA+damage+and+ERK+and+AKT+pathways&doi=10.1016%2Fj.bbrc.2014.04.151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways</span></div><div class="casAuthors">Xie, Qiang; Zhou, Yangliang; Lan, Guoqiang; Yang, Liye; Zheng, Wenjie; Liang, Yuanwei; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-93</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">X-ray-based radiotherapy represents one of the most effective ways in treating human cancers.  However, radioresistance and side effect remain as the most challenging issue.  This study describes the design and application of novel selenadiazole derivs. as radiotherapy sensitizers to enhance X-ray-induced inhibitory effects on A375 human melanoma and Hela human cervical carcinoma cells.  The results showed that, pretreatment of the cells with selenadiazole derivs. dramatically enhance X-ray-induced growth inhibition and colony formation.  Flow cytometry anal. indicates that the sensitization by selenadiazole derivs. was mainly caused by induction of G2/M cell cycle arrest.  Results of Western blotting demonstrated that the combined treatment-induced A375 cells growth inhibition was achieved by triggering reactive oxygen species-mediated DNA damage involving inactivation of AKT and MAPKs.  Further investigation revealed that selenadiazole deriv. in combination with X-ray could synergistically inhibit the activity of thioredoxin reductase-1 in A375 cells.  Taken together, these results suggest that selenadiazole derivs. can act as novel radiosensitizer with potential application in combating human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkBbOmNXurm7Vg90H21EOLACvtfcHk0liNY46fDezgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlOqsbs%253D&md5=7c23c2becc1d6d13a053d67193324b38</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.04.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.04.151%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSensitization%2520of%2520cancer%2520cells%2520to%2520radiation%2520by%2520selenadiazole%2520derivatives%2520by%2520regulation%2520of%2520ROS-mediated%2520DNA%2520damage%2520and%2520ERK%2520and%2520AKT%2520pathways%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D449%26spage%3D88%26epage%3D93%26doi%3D10.1016%2Fj.bbrc.2014.04.151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2014.07.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25036792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GrsL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=335-342&author=Y.+W.+Liangauthor=J.+Zhengauthor=X.+Liauthor=W.+Zhengauthor=T.+Chen&title=Selenadiazole+derivatives+as+potent+thioredoxin+reductase+inhibitors+that+enhance+the+radiosensitivity+of+cancer+cells&doi=10.1016%2Fj.ejmech.2014.07.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells</span></div><div class="casAuthors">Liang, Yuan-Wei; Zheng, Junsheng; Li, Xiaoling; Zheng, Wenjie; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-342</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Thioredoxin system is an attractive target to overcome radioresistance in cancer therapy.  The redox enzyme thioredoxin reductase (TrxR) plays a vital role in restoring cellular thiol redox balance disrupted by radiation-induced reactive oxygens species (ROS) generation and oxidative damage.  In this study, a series of 1,2,5-selenadiazoles have been synthesized and identified as highly effective inhibitors of TrxR to disrupt the intracellular redox balance, and thus significantly enhanced the sensitivity of cancer cells to X-ray.  Upon irradn., 1,2,5-selenadiazoles displayed a marked synergistic inhibitory effect on radioresistant A375 melanoma cell through enhancement of ROS overprodn., and subsequent induction of ROS-promoted apoptotic pathways, which triggered then mitochondrial dysfunction and caspase activation, finally resulting in augment of radiotherapeutic efficacy.  Interestingly, we also found the interaction sites between 1,2,5-selenadiazole and the model peptide of TrxR, which can be confirmed by MALDI-ToF-MS.  These results clearly demonstrate TrxR as a potential target for therapy of radioresistant cancers, and selenadiazole derivs. may be attractive radiosensitizing agent by targeting TrxR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvmxu7zPB8mLVg90H21EOLACvtfcHk0liNY46fDezgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GrsL7K&md5=b91c308e0ad2cf3b3330e4cc47896bc5</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%2BW.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSelenadiazole%2520derivatives%2520as%2520potent%2520thioredoxin%2520reductase%2520inhibitors%2520that%2520enhance%2520the%2520radiosensitivity%2520of%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D335%26epage%3D342%26doi%3D10.1016%2Fj.ejmech.2014.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">642</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1002/asia.201403409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fasia.201403409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25641920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFamsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=642-652&author=Y.+Liuauthor=Y.+Luoauthor=X.+Liauthor=W.+Zhengauthor=T.+Chen&title=Rational+design+of+selenadiazole+derivatives+to+antagonize+hyperglycemia-induced+drug+resistance+in+cancer+cells&doi=10.1002%2Fasia.201403409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells</span></div><div class="casAuthors">Liu, Yuedan; Luo, Yi; Li, Xiaoling; Zheng, Wenjie; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">642-652</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Hyperglycemia is an important factor for chemoresistance of hepatocellular carcinoma patients with diabetes to therapeutics.  In the present study, a series of selenadiazole derivs. have been rationally designed, synthesized, and found be able to antagonize drug resistance in HepG2 cells to doxorubicin (DOX) under simulated diabetes conditions.  Hyperglycemia could promote the cell proliferation through upregulation of ERK and AKT phosphorylation.  However, the synthetic selenadiazole derivs. effectively potentiated the cellular uptake of DOX and enhanced the antiproliferative activity of DOX on HepG2 cells by induction of apoptosis, via regulation of ROS-mediated AMPK activation, inhibition of mTORC1, and an increase in DNA damage.  The selenadiazole derivs. that possess an increased lipophilicity could enhance the cellular uptake and anticancer efficacy of DOX.  Taken together, this study provides a rational design strategy of selenadiazole derivs. to overcome hyperglycemia-induced drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNWSI9eXyrl7Vg90H21EOLACvtfcHk0liQTtKebLRCHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFamsL0%253D&md5=9d449d10947fb85f30ee56dc456d8ff9</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1002%2Fasia.201403409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201403409%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520selenadiazole%2520derivatives%2520to%2520antagonize%2520hyperglycemia-induced%2520drug%2520resistance%2520in%2520cancer%2520cells%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2015%26volume%3D10%26spage%3D642%26epage%3D652%26doi%3D10.1002%2Fasia.201403409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1039/C7MT00001D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC7MT00001D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28374040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslSis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=535-545&author=J.+Zhaoauthor=D.+Zengauthor=Y.+Liuauthor=Y.+Luoauthor=S.+Jiauthor=X.+Liauthor=T.+Chen&title=Selenadiazole+derivatives+antagonize+hyperglycemia-induced+drug+resistance+in+breast+cancer+cells+by+activation+of+AMPK+pathways&doi=10.1039%2FC7MT00001D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways</span></div><div class="casAuthors">Zhao, Jianfu; Zeng, Delong; Liu, Yuedan; Luo, Yi; Ji, Shengbin; Li, Xiaoling; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">535-545</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Hyperglycemia is an important factor for chemoresistance of breast cancer patients with diabetes.  In the present study, a novel selenadiazole deriv. has been evaluated and found to be able to antagonize the doxorubicin (DOX) resistance of MCF-7 cells under simulated diabetes conditions.  Hyperglycemia promotes the proliferation, invasion and migration of MCF-7 cells through activation of ERK and AKT pathways, which could be inhibited by the synthetic selenadiazole deriv.  The antitumor effects of the selenadiazole deriv. were attributed to its ability to activate AMPK pathways.  Furthermore, the high lipophilicity (log P = 1.9) of the synthetic selenadiazole deriv. facilitated its uptake by cancer cells and subsequently potentiated the cellular uptake of DOX, leading to a strong enhancment of the antiproliferative activity of DOX on MCF-7 cells by induction of apoptosis.  The apoptosis was initiated by the ROS overprodn. induced by the cooperation of the selenadiazole deriv. and DOX.  The excessive ROS then caused damage to DNA, which upregulated the expression of proapoptosis Bcl-2 family proteins and led to fragmentation of mitochondria, which finally caused apoptosis of the cancer cells.  Taken together, this study provides a rational strategy for using selenadiazole derivs. to overcome hyperglycemia-induced drug resistance in breast cancer by activation of AMPK-mediated pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNO5YB1OVX-bVg90H21EOLACvtfcHk0liQTtKebLRCHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslSis7g%253D&md5=9ea8279067984f0b0787d4af28b1c35b</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1039%2FC7MT00001D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MT00001D%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSelenadiazole%2520derivatives%2520antagonize%2520hyperglycemia-induced%2520drug%2520resistance%2520in%2520breast%2520cancer%2520cells%2520by%2520activation%2520of%2520AMPK%2520pathways%26jtitle%3DMetallomics%26date%3D2017%26volume%3D9%26spage%3D535%26epage%3D545%26doi%3D10.1039%2FC7MT00001D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Selenadiazole derivatives inhibit angiogenesis-mediated human breast tumor growth by suppressing the VEGFR2-mediated ERK and AKT signaling pathways</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1447</span>– <span class="NLM_lpage">1457</span>, <span class="refDoi"> DOI: 10.1002/asia.201800110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fasia.201800110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29575811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1agsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1447-1457&author=H.+Laiauthor=X.+Fuauthor=C.+Sangauthor=L.+Houauthor=P.+Fengauthor=X.+Liauthor=T.+Chen&title=Selenadiazole+derivatives+inhibit+angiogenesis-mediated+human+breast+tumor+growth+by+suppressing+the+VEGFR2-mediated+ERK+and+AKT+signaling+pathways&doi=10.1002%2Fasia.201800110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways</span></div><div class="casAuthors">Lai, Haoqiang; Fu, Xiaoyan; Sang, Chengcheng; Hou, Liyuan; Feng, Pengju; Li, Xiaoling; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1447-1457</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selenadiazole derivs. (SeDs) have been found to show promise in chemo-/radiotherapy applications by activating various downstream signaling pathways.  However, the functional role of SeDs on angiogenesis, which is pivotal for tumor progression and metastasis, has not yet been elucidated.  In the present study, the authors have examd. the antiangiogenic activities of SeDs and elucidated their underlying mechanisms.  The results showed that the as-synthesized SeDs not only enhanced their anticancer activities against several human cancer cells but also showed more potent inhibition on human umbilical vein endothelial cells (HUVECs).  The in vitro results suggested that SeDs, esp. 1a (I), dose-dependently inhibited the vascular endothelial growth factor (VEGF)-induced cell migration, invasion, and capillary-like structure formation of HUVECs.  Compd. 1a also significantly suppressed VEGF-induced angiogenesis in a Matrigel plug assay as part of a C57/BL6 mice assay by down regulation of VEGF.  Furthermore, the authors found that 1a significantly inhibited MCF-7 human breast tumor growth in nude mice without severe systematic cytotoxicity.  Compd. 1a was more effective in inhibiting cell proliferation and induced a much more pronounced apoptosis effect in endothelial cells than MCF-7 cells, which implies that endothelial cells might be the primary target of 1a.  Further mechanistic studies on tumor growth inhibition effects and neovessel formation suppression demonstrated that 1a inhibited cell viability of MCF-7 and HUVECs by induction of cell apoptosis, accompanied by poly(ADP ribose)polymerase (PARP) cleavage and caspase activation.  Addnl., the 1a-induced antiangiogenesis effect was achieved by abolishing the VEGF-VEGFR2-ERK/AKT (ERK=extracellular signal-regulated kinases; AKT= protein kinase B) signal axis and enhanced the apoptosis effect by triggering reactive oxygen species (ROS)-mediated DNA damage.  Taken together, these results clearly demonstrate the antiangiogenic potency of SeDs and the underlying mol. mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0YPYFmB0IW7Vg90H21EOLACvtfcHk0liQTtKebLRCHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1agsr0%253D&md5=3537308039998ce78a0c84b275dfeb4f</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1002%2Fasia.201800110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201800110%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DH.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DSang%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSelenadiazole%2520derivatives%2520inhibit%2520angiogenesis-mediated%2520human%2520breast%2520tumor%2520growth%2520by%2520suppressing%2520the%2520VEGFR2-mediated%2520ERK%2520and%2520AKT%2520signaling%2520pathways%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2018%26volume%3D13%26spage%3D1447%26epage%3D1457%26doi%3D10.1002%2Fasia.201800110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of cancer-targeted selenadiazole derivative as efficient radiosensitizer for precise cancer therapy</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2039</span>– <span class="NLM_lpage">2049</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1KntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=2039-2049&author=D.+Zengauthor=S.+Dengauthor=C.+Sangauthor=J.+Zhaoauthor=T.+Chen&title=Rational+design+of+cancer-targeted+selenadiazole+derivative+as+efficient+radiosensitizer+for+precise+cancer+therapy&doi=10.1021%2Facs.bioconjchem.8b00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Cancer-Targeted Selenadiazole Derivative as Efficient Radiosensitizer for Precise Cancer Therapy</span></div><div class="casAuthors">Zeng, Delong; Deng, Shulin; Sang, Chengcheng; Zhao, Jianfu; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2039-2049</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. drug design based on the biochem. characteristics of cancer cells has become an important strategy for discovery of targeted therapies for personalized cancer medicine.  Herein, cancer targeting RGD peptide has been covalently conjugated to selenadiazole deriv. (RGD-SeD) to improve its cancer selectivity.  The RGD decoration significantly enhances the anticancer efficacy of RGD-SeD in αVβ3 integrin-overexpressing HepG2 liver cancer cells but not in normal liver cells.  Cellular uptake assay and fluorescent imaging confirmed the selectivity of RGD-SeD to integrin-overexpressing cancer cells.  RGD-SeD strongly sensitizes HepG2 cells to clin. used X-ray radiotherapy through ROS overprodn., which triggers DNA damage-mediated apoptosis and G2/M cell cycle arrest.  This X-ray-responsive DNA damage activates p53 signaling pathways by phosphorylation of ATM/ATR and γ-H2A.X.  Furthermore, in a HepG2 nude mice xenograft model, the combined treatment of RGD-SeD and X-ray demonstrates potent in vivo antitumor efficacy via induction of apoptotic cell death but shows no toxicity on the functions of major organs.  In summary, this study provides a strategy to design a selenium-based cancer targeting radiosensitizer for precise cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEuh6dC_Rr1LVg90H21EOLACvtfcHk0lgVz4KvDyKfkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1KntbY%253D&md5=095da8d983d7543c9519088f833fb9c5</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00247%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DSang%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520cancer-targeted%2520selenadiazole%2520derivative%2520as%2520efficient%2520radiosensitizer%2520for%2520precise%2520cancer%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D2039%26epage%3D2049%26doi%3D10.1021%2Facs.bioconjchem.8b00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Enhancement of antiangiogenic efficacy of iron(II) complex by selenium substitution</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1002/asia.201700272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fasia.201700272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28233940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVCqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=982-987&author=H.+Laiauthor=X.+Zhangauthor=P.+Fengauthor=L.+Xieauthor=J.+Chenauthor=T.+Chen&title=Enhancement+of+antiangiogenic+efficacy+of+iron%28II%29+complex+by+selenium+substitution&doi=10.1002%2Fasia.201700272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of Antiangiogenic Efficacy of Iron(II) complex by Selenium Substitution</span></div><div class="casAuthors">Lai, Haoqiang; Zhang, Xiang; Feng, Pengju; Xie, Lina; Chen, Jinjin; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">982-987</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Antiangiogenesis therapy is a proven strategy for the treatment of cancers.  Herein, we demonstrate that iron(II) complexes contg. 1,10-phenanthroline(phen) derivs. were capable of suppressing angiogenesis in vitro in a dose-dependent manner.  Interestingly, the introduction of selenium into an iron(II) complex (Fe(phenSe)3(ClO4)2 (phenSe=2-selenoimidazole[4,5-f]1,10-phenanthroline)) could enhance its antiangiogenic efficacy.  Mechanistic studies demonstrated that the complex potently induced endothelial cell apoptosis as evidenced by activation of caspases and PARP cleavage.  The iron(II) complex activated p53-mediated mitochondrial dysfunction as can be seen by the upregulation in the expression of p53 and proapoptotic Bcl-2 family proteins, and downregulation in the expression of Bcl-2 family proteins.  Addnl., the complex inhibited VEGF expression and gave rise to dephosphorylated AKT, which suppressed the transmission of the mitogenic signaling pathway.  Taken together, this study could provide a strategy for the rational design of high-efficacy antivascular agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoppaWtXIixrVg90H21EOLACvtfcHk0lgVz4KvDyKfkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVCqt70%253D&md5=da81522311ad974a6ce37e25fade46af</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2Fasia.201700272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201700272%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DEnhancement%2520of%2520antiangiogenic%2520efficacy%2520of%2520iron%2528II%2529%2520complex%2520by%2520selenium%2520substitution%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2017%26volume%3D12%26spage%3D982%26epage%3D987%26doi%3D10.1002%2Fasia.201700272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2014.09.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25233100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOls73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=1-9&author=Q.+Guanauthor=F.+Yangauthor=D.+Guoauthor=J.+Xuauthor=M.+Jiangauthor=C.+Liuauthor=K.+Baoauthor=Y.+Wuauthor=W.+Zhang&title=Synthesis+and+biological+evaluation+of+novel+3%2C4-diaryl-1%2C2%2C5-selenadiazol+analogues+of+combretastatin+A-4&doi=10.1016%2Fj.ejmech.2014.09.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazole analogs of combretastatin A-4</span></div><div class="casAuthors">Guan, Qi; Yang, Fushan; Guo, Dandan; Xu, Jingwen; Jiang, Mingyang; Liu, Chunjiang; Bao, Kai; Wu, Yingliang; Zhang, Weige</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A set of novel selenium-contg. heterocyclic analogs of 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]penol (combretastatin A-4,CA-4) have been designed and synthesized using a rigid 1,2,5-selenadiazole as a linker to fix the cis-orientation of ring-A and ring-B.  All of the target compds. were evaluated for their in vitro antiproliferative activity.  Several compds. exhibited superior potency against different tumor cell lines with IC50 values at the nanomolar level.  Moreover, one compd. significantly induced cell cycle arrest in the G2/M phase, [interphase (cell cycle) G2-phase, mitosis] inhibited tubulin polymn. into microtubules (microtubule-disrupting agents) and caused microtubule destabilization.  A mol. modeling study of one compd. was performed to elucidate its binding mode at the colchicine site in the tubulin dimer and to provide a basis for the further structure-guided design of novel CA-4 analogs.  The synthesis of target compds. was achieved by a reaction of selenium oxide (SeO2) with 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-1,2-ethanedione 1,2-dioxime, 1-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-1,2-ethanedione 1,2-dioxime and similar compds.  The tilte compds. thus formed included 3-(4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole, 3-[4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazol-3-yl]phenol, 2-methoxy-5-[4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazol-3-yl]benzenamine and related substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojVNKvNS-L3LVg90H21EOLACvtfcHk0lg5ERGV6giRCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOls73O&md5=06b3bfbea020ce4c1e1c1796e9a0cb6d</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.046%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25203%252C4-diaryl-1%252C2%252C5-selenadiazol%2520analogues%2520of%2520combretastatin%2520A-4%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.ejmech.2014.09.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span> <span> </span><span class="NLM_article-title">3-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a novel combretastatin A-4 analog, induces G2/M arrest and apoptosis by disrupting tubulin polymerization in human cervical HeLa cells and fibrosarcoma HT-1080 cells</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2014.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.cbi.2014.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25529822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkslWrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2015&pages=7-17&author=D.+Zuoauthor=D.+Guoauthor=X.+Jiangauthor=Q.+Guanauthor=H.+Qiauthor=J.+Xuauthor=Z.+Liauthor=F.+Yangauthor=W.+Zhangauthor=Y.+Wu&title=3-%283-Hydroxy-4-methoxyphenyl%29-4-%283%2C4%2C5-trimethoxyphenyl%29-1%2C2%2C5-selenadiazole+%28G-1103%29%2C+a+novel+combretastatin+A-4+analog%2C+induces+G2%2FM+arrest+and+apoptosis+by+disrupting+tubulin+polymerization+in+human+cervical+HeLa+cells+and+fibrosarcoma+HT-1080+cells&doi=10.1016%2Fj.cbi.2014.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">3-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a novel combretastatin A-4 analog, induces G2/M arrest and apoptosis by disrupting tubulin polymerization in human cervical HeLa cells and fibrosarcoma HT-1080 cells</span></div><div class="casAuthors">Zuo, Daiying; Guo, Dandan; Jiang, Xuewei; Guan, Qi; Qi, Huan; Xu, Jingwen; Li, Zengqiang; Yang, Fushan; Zhang, Weige; Wu, Yingliang</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Microtubule is a popular target for anticancer drugs.  In this study, we describe the effect 3-(3-hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a newly synthesized analog of combretastatin A-4 (CA-4), showing a strong time- and dose-dependent anti-proliferative effect on human cervical cancer HeLa cells and human fibrosarcoma HT-1080 cells.  We demonstrated that the growth inhibitory effects of G-1103 in HeLa and HT-1080 cells were assocd. with microtubule depolymn. and proved that G-1103 acted as microtubule destabilizing agent.  Furthermore, cell cycle anal. revealed that G-1103 treatment resulted in cell cycle arrest at the G2/M phase in a time-dependent manner with subsequent apoptosis induction.  Western blot anal. revealed that down-regulation of cdc25c and up-regulation of cyclin B1 was related with G2/M arrest in HeLa and HT-1080 cells treatment with G-1103.  In addn., G-1103 induced HeLa cell apoptosis by up-regulating cleaved caspase-3, Fas, cleaved caspase-8 expression, which indicated that G-1103 induced HeLa cell apoptosis was mainly assocd. with death receptor pathway.  However, G-1103 induced HT-1080 cell apoptosis by up-regulating cleaved caspase-3, Fas, cleaved caspase-8, Bax and cleaved caspase-9 expression and down-regulating anti-apoptotic protein Bcl-2 expression, which indicated that G-1103 induced HT-1080 cell apoptosis was assocd. with both mitochondrial and death receptor pathway.  Taken together, all the data demonstrated that G-1103 exhibited its antitumor activity through disrupting the microtubule assembly, causing cell cycle arrest and consequently inducing apoptosis in HeLa and HT-1080 cells.  Therefore, the novel compd. G-1103 is a promising microtubule inhibitor that has great potentials for therapeutic treatment of various malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMHS9FN5oZ27Vg90H21EOLACvtfcHk0lg5ERGV6giRCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkslWrtQ%253D%253D&md5=c21eb939d24b4fed952cd52fa1e12d83</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2014.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2014.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26atitle%3D3-%25283-Hydroxy-4-methoxyphenyl%2529-4-%25283%252C4%252C5-trimethoxyphenyl%2529-1%252C2%252C5-selenadiazole%2520%2528G-1103%2529%252C%2520a%2520novel%2520combretastatin%2520A-4%2520analog%252C%2520induces%2520G2%252FM%2520arrest%2520and%2520apoptosis%2520by%2520disrupting%2520tubulin%2520polymerization%2520in%2520human%2520cervical%2520HeLa%2520cells%2520and%2520fibrosarcoma%2520HT-1080%2520cells%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2015%26volume%3D227%26spage%3D7%26epage%3D17%26doi%3D10.1016%2Fj.cbi.2014.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jantova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrvova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milata, V.</span></span> <span> </span><span class="NLM_article-title">Pro-apoptotic effect of new quinolone 7- ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo [3,4-<i>h</i>]quinoline-7-carboxylate on cervical cancer cell line HeLa alone/with UVA irradiation</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2016.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.tiv.2016.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26916084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslSitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=35-44&author=S.+Jantovaauthor=N.+Mrvovaauthor=R.+Hudecauthor=J.+Sedlakauthor=M.+Panikauthor=V.+Milata&title=Pro-apoptotic+effect+of+new+quinolone+7-+ethyl+9-ethyl-6-oxo-6%2C9-dihydro%5B1%2C2%2C5%5Dselenadiazolo+%5B3%2C4-h%5Dquinoline-7-carboxylate+on+cervical+cancer+cell+line+HeLa+alone%2Fwith+UVA+irradiation&doi=10.1016%2Fj.tiv.2016.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Pro-apoptotic effect of new quinolone 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo [3,4-h]quinoline-7-carboxylate on cervical cancer cell line HeLa alone/with UVA irradiation</span></div><div class="casAuthors">Jantova, Sona; Mrvova, Natasa; Hudec, Roman; Sedlak, Jan; Panik, Miroslav; Milata, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-44</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">7-Et 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo [3,4-h]quinoline-7-carboxylate (E2h) is a new synthetically prepd. quinolone deriv., which in our primary study showed cytotoxic effects towards tumor cells.  The aim of the present study was to examine the antiproliferative and apoptosis inducing activities of E2h towards human cervical cancer cell line HeLa with/without the presence of UVA irradn.  Further, the mol. mechanism involved in E2h-induced apoptosis in HeLa cells was investigated.  Our results showed that both non-photoactivated and photoactivated E2h caused morphol. changes and inhibited the cell growth of HeLa cells in a time- and dose-dependent manner.  Irradn. increased the sensitivity of HeLa cells to E2h.  Quinolone induced S and G2/M arrest and apoptosis in HeLa cells, as characterized by DNA fragmentation and flow cytometry.  In addn., E2h elevated the level of reactive oxygen species and activated caspases 3.  In conclusions, E2h alone/in combination with UVA irradn. induced apoptosis in HeLa cells through the ROS-mitochondrial/caspase 3-dependent pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOHF8LqYqcx7Vg90H21EOLACvtfcHk0liccENQcClkAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslSitL8%253D&md5=8d6d2eb50bddc2e4b26662f8d16350c5</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2016.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2016.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DJantova%26aufirst%3DS.%26aulast%3DMrvova%26aufirst%3DN.%26aulast%3DHudec%26aufirst%3DR.%26aulast%3DSedlak%26aufirst%3DJ.%26aulast%3DPanik%26aufirst%3DM.%26aulast%3DMilata%26aufirst%3DV.%26atitle%3DPro-apoptotic%2520effect%2520of%2520new%2520quinolone%25207-%2520ethyl%25209-ethyl-6-oxo-6%252C9-dihydro%255B1%252C2%252C5%255Dselenadiazolo%2520%255B3%252C4-h%255Dquinoline-7-carboxylate%2520on%2520cervical%2520cancer%2520cell%2520line%2520HeLa%2520alone%252Fwith%2520UVA%2520irradiation%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2016%26volume%3D33%26spage%3D35%26epage%3D44%26doi%3D10.1016%2Fj.tiv.2016.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jantova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulovicova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulovicova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topolska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milata, V.</span></span> <span> </span><span class="NLM_article-title">Assessment of immunomodulatory activities and in vitro toxicity of new quinolone 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo[3,4-<i>h</i>]quinoline-7-carboxylate</span>. <i>Immunol. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1080/08820139.2017.1280050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1080%2F08820139.2017.1280050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28287857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1WntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=341-360&author=S.+Jantovaauthor=E.+Paulovicovaauthor=L.+Paulovicovaauthor=D.+Topolskaauthor=M.+Panikauthor=V.+Milata&title=Assessment+of+immunomodulatory+activities+and+in+vitro+toxicity+of+new+quinolone+7-ethyl+9-ethyl-6-oxo-6%2C9-dihydro%5B1%2C2%2C5%5Dselenadiazolo%5B3%2C4-h%5Dquinoline-7-carboxylate&doi=10.1080%2F08820139.2017.1280050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of Immunomodulatory Activities and in vitro Toxicity of New Quinolone 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo[3,4-h]quinoline-7-carboxylate</span></div><div class="casAuthors">Jantova, Sona; Paulovicova, Ema; Paulovicova, Lucia; Topolska, Dominika; Panik, Miroslav; Milata, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Investigations</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-360</span>CODEN:
                <span class="NLM_cas:coden">IMINEJ</span>;
        ISSN:<span class="NLM_cas:issn">0882-0139</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Our previous studies on leukemia cells L1210 and cervical cancer HeLa cells revealed cytotoxic effects of the 7-Et 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo[3,4-h]quinoline-7-carboxylate (E2h), a new synthetically prepd. quinolone deriv., toward selected cancer cell lines.  The aim of the present study was to examine the cytotoxicity of E2h toward next cell lines and tissues; i.e., human cancer HL-60 and A549 cells, human non-cancer fibroblast BHNF-1 cells, and reconstructed human epidermis tissues.  Further we investigated the immunomodulatory activity of E2h on murine macrophage RAW 264.7 cells.  Selenadiazoloquinolone E2h induced specific antiproliferative/cytotoxic activity against leukemia HL-60 cells and is the potent inducer of apoptotic cell death.  Quinolone deriv. demonstrated the immunomodulatory activities on RAW 264.7 cell line murine macrophages.  The immunobiol. studies revealed time- and concn.-dependent effective immunomodulation of pro- and anti-inflammatory cytokines' release and antiproliferative/cytotoxic effect following exposure of RAW 264.7 cells to E2h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ1GPV09y7ibVg90H21EOLACvtfcHk0liccENQcClkAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1WntLg%253D&md5=a35a251203c8810a2635d284a4def87d</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1080%2F08820139.2017.1280050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08820139.2017.1280050%26sid%3Dliteratum%253Aachs%26aulast%3DJantova%26aufirst%3DS.%26aulast%3DPaulovicova%26aufirst%3DE.%26aulast%3DPaulovicova%26aufirst%3DL.%26aulast%3DTopolska%26aufirst%3DD.%26aulast%3DPanik%26aufirst%3DM.%26aulast%3DMilata%26aufirst%3DV.%26atitle%3DAssessment%2520of%2520immunomodulatory%2520activities%2520and%2520in%2520vitro%2520toxicity%2520of%2520new%2520quinolone%25207-ethyl%25209-ethyl-6-oxo-6%252C9-dihydro%255B1%252C2%252C5%255Dselenadiazolo%255B3%252C4-h%255Dquinoline-7-carboxylate%26jtitle%3DImmunol.%2520Invest.%26date%3D2017%26volume%3D46%26spage%3D341%26epage%3D360%26doi%3D10.1080%2F08820139.2017.1280050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuFort, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hingorani, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, D. T.</span></span> <span> </span><span class="NLM_article-title">Photostable ratiometric Pdot probe for in vitro and in vivo imaging of hypochlorous acid</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">6911</span>– <span class="NLM_lpage">6918</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b01545</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b01545" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=6911-6918&author=L.+Wuauthor=I.+C.+Wuauthor=C.+C.+DuFortauthor=M.+A.+Carlsonauthor=X.+Wuauthor=L.+Chenauthor=C.+T.+Kuoauthor=Y.+Qinauthor=J.+Yuauthor=S.+R.+Hingoraniauthor=D.+T.+Chiu&title=Photostable+ratiometric+Pdot+probe+for+in+vitro+and+in+vivo+imaging+of+hypochlorous+acid&doi=10.1021%2Fjacs.7b01545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Photostable Ratiometric Pdot Probe for in Vitro and in Vivo Imaging of Hypochlorous Acid</span></div><div class="casAuthors">Wu, Li; Wu, I-Che; DuFort, Christopher C.; Carlson, Markus A.; Wu, Xu; Chen, Lei; Kuo, Chun-Ting; Qin, Yuling; Yu, Jiangbo; Hingorani, Sunil R.; Chiu, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6911-6918</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Developing probes for the detection of reactive oxygen species (ROS), a hallmark of many pathophysiol. process, is imperative to both understanding the precise roles of ROS in many life-threatening diseases and optimizing therapeutic interventions.  The authors herein report an all-in-one fluorescent semiconducting polymer based far-red to near-IR (NIR) Pdot nanoprobe for the ratiometric detection of hypochlorous acid (HOCl).  The fabrication takes the advantage of flexible polymer design by incorporating target-sensitive and target-inert fluorophores into a single conjugated polymer to avoid leakage or differential photobleaching problems existed in other nanoprobes.  The obtained nanoprobe has improved performance in HOCl sensing, such as high brightness, ideal far-red to NIR optical window, excellent photostability, self-referenced ratiometric response, fast response, and high selectivity.  The dual-emission property allows the sensitive imaging of HOCl fluctuations produced in living macrophage cells and peritonitis of living mice with high contrast.  This study not only provides a powerful and promising nanoprobe to be potentially used in the investigations of in situ HOCl status of diseases in living systems but also puts forward the design strategy of a new category of ratiometric fluorescent probes facilitating precise and reliable measurement in biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMlJ1RN6fYsbVg90H21EOLACvtfcHk0lj_Kc8_XckkyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSjtr8%253D&md5=ac4e8d0f0f7d462f182879703521c498</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b01545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b01545%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DI.%2BC.%26aulast%3DDuFort%26aufirst%3DC.%2BC.%26aulast%3DCarlson%26aufirst%3DM.%2BA.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DC.%2BT.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DHingorani%26aufirst%3DS.%2BR.%26aulast%3DChiu%26aufirst%3DD.%2BT.%26atitle%3DPhotostable%2520ratiometric%2520Pdot%2520probe%2520for%2520in%2520vitro%2520and%2520in%2520vivo%2520imaging%2520of%2520hypochlorous%2520acid%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D6911%26epage%3D6918%26doi%3D10.1021%2Fjacs.7b01545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuan, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Molecular engineering of photoacoustic performance by chalcogenide variation in conjugated polymer nanoparticles for brain vascular imaging</span>. <i>Small</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1703732</span>, <span class="refDoi"> DOI: 10.1002/smll.201703732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fsmll.201703732" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1703732&author=J.+Liuauthor=X.+Caiauthor=H.+C.+Panauthor=A.+Bandlaauthor=C.+K.+Chuanauthor=S.+Wangauthor=N.+Thakorauthor=L.+D.+Liaoauthor=B.+Liu&title=Molecular+engineering+of+photoacoustic+performance+by+chalcogenide+variation+in+conjugated+polymer+nanoparticles+for+brain+vascular+imaging&doi=10.1002%2Fsmll.201703732"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1002%2Fsmll.201703732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsmll.201703732%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%2BC.%26aulast%3DBandla%26aufirst%3DA.%26aulast%3DChuan%26aufirst%3DC.%2BK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DThakor%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DL.%2BD.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520engineering%2520of%2520photoacoustic%2520performance%2520by%2520chalcogenide%2520variation%2520in%2520conjugated%2520polymer%2520nanoparticles%2520for%2520brain%2520vascular%2520imaging%26jtitle%3DSmall%26date%3D2018%26volume%3D14%26spage%3D1703732%26doi%3D10.1002%2Fsmll.201703732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palop, J. A.</span></span> <span> </span><span class="NLM_article-title">Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">9649</span>– <span class="NLM_lpage">9672</span>, <span class="refDoi"> DOI: 10.3390/ijms13089649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms13089649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22949823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKlu7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=9649-9672&author=C.+Sanmartinauthor=D.+Planoauthor=A.+K.+Sharmaauthor=J.+A.+Palop&title=Selenium+compounds%2C+apoptosis+and+other+types+of+cell+death%3A+an+overview+for+cancer+therapy&doi=10.3390%2Fijms13089649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy</span></div><div class="casAuthors">Sanmartin, Carmen; Plano, Daniel; Sharma, Arun K.; Palop, Juan Antonio</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9649-9672</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Selenium (Se) is an essential trace element involved in different physiol. functions of the human body and plays a role in cancer prevention and treatment.  Induction of apoptosis is considered an important cellular event that can account for the cancer preventive effects of Se.  The mechanisms of Se-induced apoptosis are assocd. with the chem. forms of Se and their metab. as well as the type of cancer studied.  So, some selenocompounds, such as SeO2 involve the activation of caspase-3 while sodium selenite induces apoptosis in the absence of the activation of caspases.  Modulation of mitochondrial functions has been reported to play a key role in the regulation of apoptosis and also to be one of the targets of Se compds.  Other mechanisms for apoptosis induction are the modulation of glutathione and reactive oxygen species levels, which may function as intracellular messengers to regulate signaling pathways, or the regulation of kinase, among others.  Emerging evidence indicates the overlaps between the apoptosis and other types of cell death such as autophagy.  In this review we report different processes of cell death induced by Se compds. in cancer treatment and prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZGfUVLSWqdbVg90H21EOLACvtfcHk0lj_Kc8_XckkyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKlu7zF&md5=277e788dc4a0b22c590c767c80f26150</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.3390%2Fijms13089649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms13089649%26sid%3Dliteratum%253Aachs%26aulast%3DSanmartin%26aufirst%3DC.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DPalop%26aufirst%3DJ.%2BA.%26atitle%3DSelenium%2520compounds%252C%2520apoptosis%2520and%2520other%2520types%2520of%2520cell%2520death%253A%2520an%2520overview%2520for%2520cancer%2520therapy%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2012%26volume%3D13%26spage%3D9649%26epage%3D9672%26doi%3D10.3390%2Fijms13089649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frieben, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span> <span> </span><span class="NLM_article-title">Development of isoselenocyanate compounds’ syntheses and biological applications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5261</span>– <span class="NLM_lpage">5275</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01698</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01698" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFCgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5261-5275&author=E.+E.+Friebenauthor=S.+Aminauthor=A.+K.+Sharma&title=Development+of+isoselenocyanate+compounds%E2%80%99+syntheses+and+biological+applications&doi=10.1021%2Facs.jmedchem.8b01698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Isoselenocyanate Compounds' Syntheses and Biological Applications</span></div><div class="casAuthors">Frieben, Emily E.; Amin, Shantu; Sharma, Arun K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5261-5275</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the no. of cases and cancer-related deaths are projected to rise in upcoming years, it is urgent to find ways to prevent or treat cancer.  As such, food-derived products have gained attention as potential chemopreventive agents due to their availability, safety, and low cost.  Isothiocyanates, the breakdown products of sulfur-contg. glucosinolates in cruciferous vegetables, have shown substantial anticarcinogenic and chemopreventive activities for different human cancers.  Furthermore, organoselenium compds. are known to exhibit chemopreventive and chemotherapeutic activity; moreover, these compds. are more effective anticancer agents than their sulfur isosteres.  Hence, isothiocyanates have been modified to yield isoselenocyanates, which are more cytotoxic toward cancer cells when compared to their corresponding sulfur analogs.  Herein, the synthesis and development of isoselenocyanates as novel treatments for cancer and other diseases are reviewed, highlighting the diverse chem. and computational studies of this class of compds. as well as their pertinent biol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE6UAaxt1BvbVg90H21EOLACvtfcHk0lj_Kc8_XckkyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFCgsA%253D%253D&md5=be36d9edbbf4980c4eb01eba5a5ffbfe</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01698%26sid%3Dliteratum%253Aachs%26aulast%3DFrieben%26aufirst%3DE.%2BE.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DDevelopment%2520of%2520isoselenocyanate%2520compounds%25E2%2580%2599%2520syntheses%2520and%2520biological%2520applications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5261%26epage%3D5275%26doi%3D10.1021%2Facs.jmedchem.8b01698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cierpial, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luczak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kielbasinski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielczarek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiktorska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilmonczyk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milczarek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karwowska, K.</span></span> <span> </span><span class="NLM_article-title">Organofluorine isoselenocyanate analogues of sulforaphane: synthesis and anticancer activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2398</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fcmdc.201600442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27714934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1akt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2398-2409&author=T.+Cierpialauthor=J.+Luczakauthor=M.+Kwiatkowskaauthor=P.+Kielbasinskiauthor=L.+Mielczarekauthor=K.+Wiktorskaauthor=Z.+Chilmonczykauthor=M.+Milczarekauthor=K.+Karwowska&title=Organofluorine+isoselenocyanate+analogues+of+sulforaphane%3A+synthesis+and+anticancer+activity&doi=10.1002%2Fcmdc.201600442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Organofluorine Isoselenocyanate Analogues of Sulforaphane: Synthesis and Anticancer Activity</span></div><div class="casAuthors">Cierpial, Tomasz; Luczak, Jerzy; Kwiatkowska, Malgorzata; Kielbasinski, Piotr; Mielczarek, Lidia; Wiktorska, Katarzyna; Chilmonczyk, Zdzislaw; Milczarek, Malgorzata; Karwowska, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2398-2409</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of previously unknown sulforaphane analogs with organofluorine substituents bonded to the sulfinyl sulfur atom, an isoselenocyanate moiety in place of the isothiocyanate group, the central sulfur atom in various oxidn. states, and different nos. of methylene groups in the central alkyl chain were synthesized and fully characterized.  All new compds. were tested for their biol. properties in vitro and demonstrated much higher anticancer activity against two breast cancer cell lines than that shown by native sulforaphane; at the same time, the compds. were less toxic for normal cells.  The influence of the particular structural changes in the mols. on the cytotoxicity is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdPkG-lRLOgrVg90H21EOLACvtfcHk0lj5xy4-HMXB3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1akt7vJ&md5=9fd1f917d7e370d1679115aac1defb0a</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600442%26sid%3Dliteratum%253Aachs%26aulast%3DCierpial%26aufirst%3DT.%26aulast%3DLuczak%26aufirst%3DJ.%26aulast%3DKwiatkowska%26aufirst%3DM.%26aulast%3DKielbasinski%26aufirst%3DP.%26aulast%3DMielczarek%26aufirst%3DL.%26aulast%3DWiktorska%26aufirst%3DK.%26aulast%3DChilmonczyk%26aufirst%3DZ.%26aulast%3DMilczarek%26aufirst%3DM.%26aulast%3DKarwowska%26aufirst%3DK.%26atitle%3DOrganofluorine%2520isoselenocyanate%2520analogues%2520of%2520sulforaphane%253A%2520synthesis%2520and%2520anticancer%2520activity%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2398%26epage%3D2409%26doi%3D10.1002%2Fcmdc.201600442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmert, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bayoumy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aliaga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richie, J. P.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Induction of lung glutathione and glutamylcysteine ligase by 1,4-phenylenebis(methylene)selenocyanate and its glutathione conjugate: role of nuclear factor-erythroid 2-related factor 2</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2064</span>– <span class="NLM_lpage">2071</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2012.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.freeradbiomed.2012.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22542796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVaqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2064-2071&author=S.+W.+Emmertauthor=K.+El-Bayoumyauthor=A.+Dasauthor=Y.+W.+Sunauthor=S.+Aminauthor=D.+Desaiauthor=C.+Aliagaauthor=J.+P.+Richie&title=Induction+of+lung+glutathione+and+glutamylcysteine+ligase+by+1%2C4-phenylenebis%28methylene%29selenocyanate+and+its+glutathione+conjugate%3A+role+of+nuclear+factor-erythroid+2-related+factor+2&doi=10.1016%2Fj.freeradbiomed.2012.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of lung glutathione and glutamylcysteine ligase by 1,4-phenylenebis(methylene)selenocyanate and its glutathione conjugate: Role of nuclear factor-erythroid 2-related factor 2</span></div><div class="casAuthors">Emmert, Sans W.; El-Bayoumy, Karam; Das, Arunangshu; Sun, Yuan-Wan; Amin, Shantu; Desai, Dhimant; Aliaga, Cesar; Richie, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2064-2071</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthetic organoselenium agent 1,4-phenylenebis(methylene)selenocyanate (p-XSC) and its glutathione (GSH) conjugate (p-XSeSG) are potent chemopreventive agents in several preclin. models.  P-XSC is also an effective inducer of GSH in mouse lung.  Our objectives were to test the hypothesis that GSH induction by p-XSC occurs through upregulation of the rate-limiting GSH biosynthetic enzyme glutamylcysteine ligase (GCL), through activation of antioxidant response elements (AREs) in GCL genes via activation of nuclear factor-erythroid 2-related factor 2 (Nrf2).  P-XSC feeding (10 ppm Se) increased GSH (230%) and upregulated the catalytic subunit of GCL (GCLc) (55%), extracellular-related kinase (220%), and nuclear Nrf2 (610%) in lung but not liver after 14 days in the rat (P<0.05).  Similarly, p-XSeSG feeding (10 ppm) induced lung GCLc (88%) and GSH (200%) (P<0.05), whereas the naturally occurring selenomethionine had no effect.  Both p-XSC and p-XSeSG activated a luciferase reporter in HepG2 ARE-reporter cells up to threefold for p-XSC and greater than or equal to fivefold for p-XSeSG.  Luciferase activation by p-XSeSG was assocd. with enhanced levels of GSH, GCLc, and nuclear Nrf2, which were significantly reduced by co-incubation with short interfering RNA targeting Nrf2.  The dependence of GCL induction on Nrf2 was confirmed in Nrf2-deficient mouse embryonic fibroblasts, in which p-XSeSG induced GCL subunits in wild-type but not in Nrf2-deficient cells (P<0.05).  These results indicate that p-XSC may act through the Nrf2 pathway in vivo and that p-XSeSG is the putative metabolite responsible for such activation, thus offering p-XSeSG as a less toxic, yet highly efficacious, inducer of GSH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnWrg31BJnLrVg90H21EOLACvtfcHk0lj5xy4-HMXB3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVaqsL4%253D&md5=aadeafa393240603c16384e876b3afb4</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2012.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2012.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DEmmert%26aufirst%3DS.%2BW.%26aulast%3DEl-Bayoumy%26aufirst%3DK.%26aulast%3DDas%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DY.%2BW.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DAliaga%26aufirst%3DC.%26aulast%3DRichie%26aufirst%3DJ.%2BP.%26atitle%3DInduction%2520of%2520lung%2520glutathione%2520and%2520glutamylcysteine%2520ligase%2520by%25201%252C4-phenylenebis%2528methylene%2529selenocyanate%2520and%2520its%2520glutathione%2520conjugate%253A%2520role%2520of%2520nuclear%2520factor-erythroid%25202-related%2520factor%25202%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D2064%26epage%3D2071%26doi%3D10.1016%2Fj.freeradbiomed.2012.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prigol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchese, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jesse, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, C. W.</span></span> <span> </span><span class="NLM_article-title">Protective effect of diphenyl diselenide on ischemia and reperfusion-induced cerebral injury: involvement of oxidative stress and pro-inflammatory cytokines</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2249</span>– <span class="NLM_lpage">2258</span>, <span class="refDoi"> DOI: 10.1007/s11064-012-0853-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs11064-012-0853-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22846969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC38fkt1Sltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=2249-2258&author=C.+A.+Bruningauthor=M.+Prigolauthor=C.+Lucheseauthor=C.+R.+Jesseauthor=M.+M.+Duarteauthor=S.+S.+Romanauthor=C.+W.+Nogueira&title=Protective+effect+of+diphenyl+diselenide+on+ischemia+and+reperfusion-induced+cerebral+injury%3A+involvement+of+oxidative+stress+and+pro-inflammatory+cytokines&doi=10.1007%2Fs11064-012-0853-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effect of diphenyl diselenide on ischemia and reperfusion-induced cerebral injury: involvement of oxidative stress and pro-inflammatory cytokines</span></div><div class="casAuthors">Bruning Cesar A; Prigol Marina; Luchese Cristiane; Jesse Cristiano R; Duarte Marta M M F; Roman Silvane S; Nogueira Cristina W</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2249-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cerebrovascular diseases, including ischemic stroke, are associated with high mortality worldwide.  Oxidative stress and inflammation are important pathophysiological mechanisms involved in post-ischemic cerebral injury.  The present study was designed to investigate the potential protective effect of diphenyl diselenide (PhSe)(2), an organoselenium compound with antioxidant and anti-inflammatory properties, against ischemia/reperfusion (I/R) insult in rat brain.  The experimental model adopted was that of surgically-induced brain ischemia, performed by means of bilateral common carotid artery occlusion in rats.  The effect of a single oral dose of (PhSe)(2) (50 mg/kg), administered 30 min before the onset of ischemia, was investigated by assessing cerebral oxidative stress-related biochemical parameters and pro-inflammatory cytokines in plasma of rats.  The results demonstrated an increase in the levels of malondialdehyde (MDA), reactive oxygen species (ROS) and nitrate/nitrite as well as the alteration in the non-enzymatic and enzymatic (catalase and superoxide dismutase) antioxidant defense system induced by I/R insult in rat brain.  I/R insult increased the levels of IL-1β, IL-6, TNF-α and INF-γ in plasma of rats.  The administration of (PhSe)(2) restored cerebral levels of MDA, ROS, nitrate/nitrite and antioxidant defenses of rats exposed to I/R insult. (PhSe)(2) markedly reduced pro-inflammatory cytokines in plasma of I/R rats.  I/R insult increased the plasma levels of tissue damage markers, such as creatine kinase and α-1-acid glycoprotein.  Pretreatment with (PhSe)(2) was effective in reducing the levels of these proteins.  In addition, (PhSe)(2) attenuated cerebral histological alterations induced by I/R.  This study showed for the first time the in vivo protective effect of (PhSe)(2) against oxidative stress and pro-inflammatory cytokines-induced by I/R insult in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRo6b5OB-IAVuvW160gIxP_fW6udTcc2eZmqtKs0-sojbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fkt1Sltw%253D%253D&md5=f72dc300a9ccd14b7ec70804f0a78509</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs11064-012-0853-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-012-0853-7%26sid%3Dliteratum%253Aachs%26aulast%3DBruning%26aufirst%3DC.%2BA.%26aulast%3DPrigol%26aufirst%3DM.%26aulast%3DLuchese%26aufirst%3DC.%26aulast%3DJesse%26aufirst%3DC.%2BR.%26aulast%3DDuarte%26aufirst%3DM.%2BM.%26aulast%3DRoman%26aufirst%3DS.%2BS.%26aulast%3DNogueira%26aufirst%3DC.%2BW.%26atitle%3DProtective%2520effect%2520of%2520diphenyl%2520diselenide%2520on%2520ischemia%2520and%2520reperfusion-induced%2520cerebral%2520injury%253A%2520involvement%2520of%2520oxidative%2520stress%2520and%2520pro-inflammatory%2520cytokines%26jtitle%3DNeurochem.%2520Res.%26date%3D2012%26volume%3D37%26spage%3D2249%26epage%3D2258%26doi%3D10.1007%2Fs11064-012-0853-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karelia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pramanik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span> <span> </span><span class="NLM_article-title">Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1002/mc.22825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fmc.22825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29668110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosl2gu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1055-1066&author=W.+Wuauthor=D.+Kareliaauthor=K.+Pramanikauthor=S.+G.+Aminauthor=A.+K.+Sharmaauthor=C.+Jiangauthor=J.+Lu&title=Phenylbutyl+isoselenocyanate+induces+reactive+oxygen+species+to+inhibit+androgen+receptor+and+to+initiate+p53-mediated+apoptosis+in+LNCaP+prostate+cancer+cells&doi=10.1002%2Fmc.22825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells</span></div><div class="casAuthors">Wu, Wei; Karelia, Deepkamal; Pramanik, Kartick; Amin, Shantu G.; Sharma, Arun K.; Jiang, Cheng; Lu, Junxuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1055-1066</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Previous studies have established the in vivo bioavailability and efficacious dosages of phenylbutyl isoselenocyanate (ISC-4), a selenium-substituted isothiocyanate, against mouse xenograft models of human melanoma and colorectal cancer.  To explore its potential attributes against prostate cancer, we treated human LNCaP prostate cancer cells with ISC-4 and examd. their apoptosis responses, and interrogated the signaling mechanisms through pharmacol. and siRNA knockdown approaches.  Our results show that ISC-4 was more potent at inducing apoptosis than its sulfur analog phenylbutyl isothiocyanate (PBITC) without suppressing protein kinase AKT Ser473 phosphorylation.  ISC-4 induced apoptosis in concn.- and time-dependent manners, and the apoptosis execution was attenuated by pre-incubation with a pan caspase inhibitor.  ISC-4 decreased the abundance of androgen receptor (AR) and its best known target prostate specific antigen (PSA) without decreasing their steady state mRNA.  ISC-4 upregulated the abundance of p53 protein and its Ser15-phosphorylative activation, and that of DNA double strand break marker Ser139-p-H2A.  X coincident with apoptotic exposure.  Similar to the rapid induction of reactive oxygen species (ROS) by isothiocyanates, ISC-4 increased dihydroethidium-detectable signals in LNCaP cells.  Pre-incubation with ROS scavenger N-acetyl-L-cysteine preserved AR and PSA abundance, markedly reduced ISC-4-induced apoptosis and attenuated p53 Ser phosphorylation, p21Cip1, and p-H2A.  X. Furthermore, siRNA knockdown of p53 did not suppress ROS prodn., but decreased ISC-4-induced apoptosis.  Knocking down p53-targets PUMA and Bax exerted greater protective effect on ISC-4-induced apoptosis than depleting p21Cip1.  In summary, ISC-4 inhibited LNCaP cell growth and survival with ROS-mediated suppression of AR axis signaling and induction of p53-PUMA-Bax mitochondrial apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVaedDX25U4LVg90H21EOLACvtfcHk0ljqwSJDNThMtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosl2gu70%253D&md5=7b3546cc90969d2daad1164e70f983ac</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1002%2Fmc.22825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22825%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DKarelia%26aufirst%3DD.%26aulast%3DPramanik%26aufirst%3DK.%26aulast%3DAmin%26aufirst%3DS.%2BG.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DJ.%26atitle%3DPhenylbutyl%2520isoselenocyanate%2520induces%2520reactive%2520oxygen%2520species%2520to%2520inhibit%2520androgen%2520receptor%2520and%2520to%2520initiate%2520p53-mediated%2520apoptosis%2520in%2520LNCaP%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Carcinog.%26date%3D2018%26volume%3D57%26spage%3D1055%26epage%3D1066%26doi%3D10.1002%2Fmc.22825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhunapantula, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosca, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. P.</span></span> <span> </span><span class="NLM_article-title">Targeting Akt3 signaling in malignant melanoma using isoselenocyanates</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1674</span>– <span class="NLM_lpage">1685</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-2214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1158%2F1078-0432.CCR-08-2214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=19208796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVWrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1674-1685&author=A.+Sharmaauthor=A.+K.+Sharmaauthor=S.+V.+Madhunapantulaauthor=D.+Desaiauthor=S.+J.+Huhauthor=P.+Moscaauthor=S.+Aminauthor=G.+P.+Robertson&title=Targeting+Akt3+signaling+in+malignant+melanoma+using+isoselenocyanates&doi=10.1158%2F1078-0432.CCR-08-2214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates</span></div><div class="casAuthors">Sharma, Arati; Sharma, Arun K.; Madhunapantula, SubbaRao V.; Desai, Dhimant; Huh, Sung Jin; Mosca, Paul; Amin, Shantu; Robertson, Gavin P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1674-1685</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Melanoma is the most invasive and deadly form of skin cancer.  Few agents are available for treating advanced disease to enable long-term patient survival, which is driving the search for new compds. inhibiting deregulated pathways causing melanoma.  Akt3 is an important target in melanomas because its activity is increased in ∼70% of tumors, decreasing apoptosis in order to promote tumorigenesis.  Exptl. Design: Because naturally occurring products can be effective anticancer agents, a library was screened to identify Akt3 pathway inhibitors.  Isothiocyanates were identified as candidates, but low potency requiring high concns. for therapeutic efficacy made them unsuitable.  Therefore, more potent analogs called isoselenocyanates were created using the isothiocyanate backbone but increasing the alkyl chain length and replacing sulfur with selenium.  Efficacy was measured on cultured cells and tumors by quantifying proliferation, apoptosis, toxicity, and Akt3 pathway inhibition.  RESULTS: Isoselenocyanates significantly decreased Akt3 signaling in cultured melanoma cells and tumors.  Compds. having 4 to 6 carbon alkyl side chains with selenium substituted for sulfur, called ISC-4 and ISC-6, resp., decreased tumor development by ∼60% compared with the corresponding isothiocyanates, which had no effect.  No changes in animal body wt. or in blood parameters indicative of liver-, kidney-, or cardiac-related toxicity were obsd. with isoselenocyanates.  Mechanistically, isoselenocyanates ISC-4 and ISC-6 decreased melanoma tumorigenesis by causing an ∼3-fold increase in apoptosis.  CONCLUSIONS: Synthetic isoselenocyanates are therapeutically effective for inhibiting melanoma tumor development by targeting Akt3 signaling to increase apoptosis in melanoma cells with negligible assocd. systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwC9CIxZd0srVg90H21EOLACvtfcHk0ljqwSJDNThMtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVWrsrc%253D&md5=51dc90931aaab784c9fdb93fcd3df05d</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2214%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DMadhunapantula%26aufirst%3DS.%2BV.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DHuh%26aufirst%3DS.%2BJ.%26aulast%3DMosca%26aufirst%3DP.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DRobertson%26aufirst%3DG.%2BP.%26atitle%3DTargeting%2520Akt3%2520signaling%2520in%2520malignant%2520melanoma%2520using%2520isoselenocyanates%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D1674%26epage%3D1685%26doi%3D10.1158%2F1078-0432.CCR-08-2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Rubio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrea, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena Guerrero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sesma Herrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamboa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguewa, P. A.</span></span> <span> </span><span class="NLM_article-title">Leishmanicidal activity of isoselenocyanate derivatives</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">e00904-18</span>, <span class="refDoi"> DOI: 10.1128/AAC.00904-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1128%2FAAC.00904-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30478164" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2019&pages=e00904-18&author=C.+Fernandez-Rubioauthor=E.+Larreaauthor=J.+Pena+Guerreroauthor=E.+Sesma+Herreroauthor=I.+Gamboaauthor=C.+Berrioauthor=D.+Planoauthor=S.+Aminauthor=A.+K.+Sharmaauthor=P.+A.+Nguewa&title=Leishmanicidal+activity+of+isoselenocyanate+derivatives&doi=10.1128%2FAAC.00904-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1128%2FAAC.00904-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00904-18%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Rubio%26aufirst%3DC.%26aulast%3DLarrea%26aufirst%3DE.%26aulast%3DPena%2BGuerrero%26aufirst%3DJ.%26aulast%3DSesma%2BHerrero%26aufirst%3DE.%26aulast%3DGamboa%26aufirst%3DI.%26aulast%3DBerrio%26aufirst%3DC.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DNguewa%26aufirst%3DP.%2BA.%26atitle%3DLeishmanicidal%2520activity%2520of%2520isoselenocyanate%2520derivatives%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2019%26volume%3D63%26spage%3De00904-18%26doi%3D10.1128%2FAAC.00904-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karelia, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sk, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowda, A. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramisetti, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and identification of a novel napthalamide-isoselenocyanate compound NISC-6 as a dual topoisomerase-IIalpha and AKT pathway inhibitor, and evaluation of its anti-melanoma activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2017.04.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28458134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFWks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=282-295&author=D.+N.+Kareliaauthor=U.+H.+Skauthor=P.+Singhauthor=A.+S.+P.+Gowdaauthor=M.+K.+Pandeyauthor=S.+R.+Ramisettiauthor=S.+Aminauthor=A.+K.+Sharma&title=Design%2C+synthesis%2C+and+identification+of+a+novel+napthalamide-isoselenocyanate+compound+NISC-6+as+a+dual+topoisomerase-IIalpha+and+AKT+pathway+inhibitor%2C+and+evaluation+of+its+anti-melanoma+activity&doi=10.1016%2Fj.ejmech.2017.04.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and identification of a novel naphthalamide-isoselenocyanate compound NISC-6 as a dual Topoisomerase-IIα and Akt pathway inhibitor, and evaluation of its anti-melanoma activity</span></div><div class="casAuthors">Karelia, Deepkamal N.; Sk, Ugir Hossain; Singh, Parvesh; Gowda, A. S. Prakasha; Pandey, Manoj K.; Ramisetti, Srinivasa R.; Amin, Shantu; Sharma, Arun K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">282-295</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Naphthalimidylalkyl isoselenocyanates such as I and naphthalimidylethyl isoselenoureas were prepd. as dual Akt and topoisomerase IIα inhibitors for use as antitumor agents in the treatment of melanoma with either wild-type or mutant BRAF.  The naphthalimidylalkyl isoselenocyanates were more effective in inhibiting cancer cell viability than the naphthalimidylethyl isoselenoureas.  I was identified as the most cytotoxic compd. in both BRAFV600E mutated and BRAFWT cells, and its selectivity for cancer cells over noncancerous human cells was detd.  I docked strongly into the binding sites of Akt1 and human topoisomerase IIα (Topo-IIα); I inhibited both Akt and topoisomerase IIα activities dose-dependently in vitro.  I induced apoptosis in human melanoma cells and inhibited tumor growth by ∼69% in a melanoma mouse xenograft model; its mol. wt., nos. of hydrogen bond acceptors and donors, total polar surface area, and lipophilicity were calcd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoytXX5btAY0bVg90H21EOLACvtfcHk0lhxfiEIDPGFwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFWks7o%253D&md5=d0e56970248ba501e6caac8e003c829c</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.052%26sid%3Dliteratum%253Aachs%26aulast%3DKarelia%26aufirst%3DD.%2BN.%26aulast%3DSk%26aufirst%3DU.%2BH.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DGowda%26aufirst%3DA.%2BS.%2BP.%26aulast%3DPandey%26aufirst%3DM.%2BK.%26aulast%3DRamisetti%26aufirst%3DS.%2BR.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520identification%2520of%2520a%2520novel%2520napthalamide-isoselenocyanate%2520compound%2520NISC-6%2520as%2520a%2520dual%2520topoisomerase-IIalpha%2520and%2520AKT%2520pathway%2520inhibitor%252C%2520and%2520evaluation%2520of%2520its%2520anti-melanoma%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D282%26epage%3D295%26doi%3D10.1016%2Fj.ejmech.2017.04.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karelia, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spallholz, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel selenium (Se-NSAID) molecules as anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1946</span>– <span class="NLM_lpage">1959</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01503</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01503" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFCiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1946-1959&author=D.+Planoauthor=D.+N.+Kareliaauthor=M.+K.+Pandeyauthor=J.+E.+Spallholzauthor=S.+Aminauthor=A.+K.+Sharma&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+selenium+%28Se-NSAID%29+molecules+as+anticancer+agents&doi=10.1021%2Facs.jmedchem.5b01503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents</span></div><div class="casAuthors">Plano, Daniel; Karelia, Deepkamal N.; Pandey, Manoj K.; Spallholz, Julian E.; Amin, Shantu; Sharma, Arun K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1946-1959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and anticancer evaluation of novel selenium-nonsteroidal anti-inflammatory drug (Se-NSAID) hybrid mols. are reported.  The Se-aspirin analog I was identified as the most effective agent in reducing the viability of different cancer cell lines, particularly colorectal cancer (CRC) cells, was more selective toward cancer cells than normal cells, and was >10 times more potent than 5-FU, the current therapy for CRC.  Compd. I inhibits CRC growth via the inhibition of the cell cycle in G1 and G2/M phases and reduces the cell cycle markers like cyclin E1 and B1 in a dose dependent manner; the inhibition of the cell cycle may be dependent on the ability of I to induce p21 expression.  Furthermore, I induces apoptosis by activating caspase 3/7 and PARP cleavage, and its longer exposure causes increase in intracellular ROS levels in CRC cells.  Taken together, I has the potential to be developed further as a chemotherapeutic agent for CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR85CRRLLIlrVg90H21EOLACvtfcHk0lhxfiEIDPGFwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFCiuw%253D%253D&md5=220f9f5ca563e6e84b0e34fc64306744</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01503%26sid%3Dliteratum%253Aachs%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DKarelia%26aufirst%3DD.%2BN.%26aulast%3DPandey%26aufirst%3DM.%2BK.%26aulast%3DSpallholz%26aufirst%3DJ.%2BE.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520selenium%2520%2528Se-NSAID%2529%2520molecules%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1946%26epage%3D1959%26doi%3D10.1021%2Facs.jmedchem.5b01503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tagaram, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rountree, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staveley-O’Carroll, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimchi, E. T.</span></span> <span> </span><span class="NLM_article-title">A selenium containing inhibitor for the treatment of hepatocellular cancer</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.3390/ph9020018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fph9020018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvFyrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=18&author=H.+R.+Tagaramauthor=D.+Desaiauthor=G.+Liauthor=D.+Liuauthor=C.+B.+Rountreeauthor=K.+Gowdaauthor=A.+Bergauthor=S.+Aminauthor=K.+F.+Staveley-O%E2%80%99Carrollauthor=E.+T.+Kimchi&title=A+selenium+containing+inhibitor+for+the+treatment+of+hepatocellular+cancer&doi=10.3390%2Fph9020018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">A selenium containing inhibitor for the treatment of hepatocellular cancer</span></div><div class="casAuthors">Tagaram, Hephzibah Rani S.; Desai, Dhimant; Li, Guangfu; Liu, Dai; Bart, Rountree C.; Gowda, Kavitha; Berg, Arthur; Amin, Shantu; Staveley-O'Carroll, Kevin F.; Kimchi, Eric T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">18/1-18/14</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world.  New treatment strategies are desperately needed due to limited std. therapies.  Activation of the Erk, Akt, and STAT3pathways is implicated in the prognosis of HCC.  The Se,Se'-1,4-phenylenebis(1,2- ethanediyl) bisisoselenourea (PBISe), is a selenium-contg. MAPK and PI3 kinase inhibitor, effectively inhibit tumorigenesis in a variety of exptl. models.  The aim of our study is to demonstrate the potential role of PBISe in the treatment of HCC.  The anti-proliferative and pro-apoptotic ability of PBISe is studied in vitro in four human HCC cell lines and in vivo in a spontaneous murine HCC model.  Inhibition of cancer growth was performed by cell viability assay and apoptosis by caspase 3/7, PARP cleavage, annexin-V, and TUNEL assays.  Role of PBISe on PI3 kinase, MAPK and STAT3 signaling is detd. by Western blotting.  In vivo effects of PBISe on tumor sizes were monitored using MRI in a spontaneous murine HCC.  Liver tissues from the PBISe-treated mice are analyzed for angiogenesis, proliferation, and signaling pathway markers.  Overall, PBISe activated caspase-3/7 and increased DNA fragmentation, which is pos. correlated with the increased PARP cleavage.  PBISe promoted apoptosis by inhibiting PI3K, MAPK, and STAT3 signaling with significant redn. in the tumor sizes (p < 0.007).  PBISe-treated tumors reduced survival marker PCNA, and angiogenesis markers Vegf-A, Vegf-R3 and CD34.  These results demonstrate the chemotherapeutic effects of PBISe, by inhibiting tumor growth and facilitating tumor apoptosis for HCC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTIQdOtgKAHbVg90H21EOLACvtfcHk0lhxfiEIDPGFwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvFyrtg%253D%253D&md5=53271f9971d467dfe8e5e1ca023c1d40</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.3390%2Fph9020018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph9020018%26sid%3Dliteratum%253Aachs%26aulast%3DTagaram%26aufirst%3DH.%2BR.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DRountree%26aufirst%3DC.%2BB.%26aulast%3DGowda%26aufirst%3DK.%26aulast%3DBerg%26aufirst%3DA.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DStaveley-O%25E2%2580%2599Carroll%26aufirst%3DK.%2BF.%26aulast%3DKimchi%26aufirst%3DE.%2BT.%26atitle%3DA%2520selenium%2520containing%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatocellular%2520cancer%26jtitle%3DPharmaceuticals%26date%3D2016%26volume%3D9%26spage%3D18%26doi%3D10.3390%2Fph9020018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agliano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguewa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redrado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Zubeldia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palop, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo, A.</span></span> <span> </span><span class="NLM_article-title">The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3031</span>– <span class="NLM_lpage">3043</span>, <span class="refDoi"> DOI: 10.2174/092986712800672076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2174%2F092986712800672076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22455594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFertr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3031-3043&author=E.+Ibanezauthor=A.+Aglianoauthor=C.+Priorauthor=P.+Nguewaauthor=M.+Redradoauthor=I.+Gonzalez-Zubeldiaauthor=D.+Planoauthor=J.+A.+Palopauthor=C.+Sanmartinauthor=A.+Calvo&title=The+quinoline+imidoselenocarbamate+EI201+blocks+the+AKT%2FmTOR+pathway+and+targets+cancer+stem+cells+leading+to+a+strong+antitumor+activity&doi=10.2174%2F092986712800672076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity</span></div><div class="casAuthors">Ibanez, E.; Agliano, A.; Prior, C.; Nguewa, P.; Redrado, M.; Gonzalez-Zubeldia, I.; Plano, D.; Palop, J. A.; Sanmartin, C.; Calvo, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3031-3043</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Methylimidoselenocarbamates have previously proven to display potent antitumor activities.  In the present study we show that these compds. act as multikinase inhibitors.  We found that the most effective compd., quinoline imidoselenocarbamate EI201, inhibits the PI3K/AKT/mTOR pathway, which is persistently activated and contributes to malignant progression in various cancers.  EI201 blocked the phosphorylation of AKT, mTOR and several of its downstream regulators (p70S6K and 4E-BP1) and ERK1/2 in PC-3, HT-29 and MCF-7 cells in vitro, inducing both autophagy and apoptosis.  EI201 also contributes to the loss of maintenance of the selfrenewal and tumorigenic capacity of cancer stem cells (CSCs).  0.1 μMol/L EI201 triggered a redn. in size and no. of tumorspheres in PC-3, HT-29 and MCF-7 cells and 4 μmol/L induced the elimination of almost all the tumorspheres in the three studied cell lines.  In addn., EI201 suppressed almost 80% prostate tumor growth in vivo (p < 0.01) compared to controls at a relatively low dose (10 mg/kg) in a mouse xenograft model.  There was a significant decrease in the s.c. primary tumor [18F]-FDG uptake (76.5% redn., p < 0.05) and in the total tumor burden (76.8% redn., p < 0.05) after EI201 treatment compared to vehicle control, without causing toxicity in mice.  Taken together, our results support further development of EI201 as a novel multi-kinase inhibitor that may be useful against cancers with aberrant upregulation of PI3K/AKT and MAPK signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5jsfLcw3MmbVg90H21EOLACvtfcHk0lhxfiEIDPGFwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFertr8%253D&md5=b3c6a3983ea9e8508d4a6459dba3ba35</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.2174%2F092986712800672076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712800672076%26sid%3Dliteratum%253Aachs%26aulast%3DIbanez%26aufirst%3DE.%26aulast%3DAgliano%26aufirst%3DA.%26aulast%3DPrior%26aufirst%3DC.%26aulast%3DNguewa%26aufirst%3DP.%26aulast%3DRedrado%26aufirst%3DM.%26aulast%3DGonzalez-Zubeldia%26aufirst%3DI.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DPalop%26aufirst%3DJ.%2BA.%26aulast%3DSanmartin%26aufirst%3DC.%26aulast%3DCalvo%26aufirst%3DA.%26atitle%3DThe%2520quinoline%2520imidoselenocarbamate%2520EI201%2520blocks%2520the%2520AKT%252FmTOR%2520pathway%2520and%2520targets%2520cancer%2520stem%2520cells%2520leading%2520to%2520a%2520strong%2520antitumor%2520activity%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3031%26epage%3D3043%26doi%3D10.2174%2F092986712800672076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Targeting the thioredoxin system as a strategy for cancer therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7309</span>– <span class="NLM_lpage">7321</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvFSjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7309-7321&author=M.+Bianauthor=R.+Fanauthor=S.+Zhaoauthor=W.+Liu&title=Targeting+the+thioredoxin+system+as+a+strategy+for+cancer+therapy&doi=10.1021%2Facs.jmedchem.8b01595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the thioredoxin system as a strategy for cancer therapy</span></div><div class="casAuthors">Bian, Mianli; Fan, Rong; Zhao, Sai; Liu, Wukun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7309-7321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Thioredoxin reductase (TrxR) participates in the regulation of redox reactions in organisms.  It works mainly via its substrate mol., thioredoxin, to maintain the redox balance and regulate signal transduction, which controls cell proliferation, differentiation, death, and other important physiol. processes.  In recent years, increasing evidence has shown that the overactivation of TrxR is related to the development of tumors.  The exploration of TrxR-targeted antitumor drugs has attracted wide attention and is expected to provide new therapies for cancer treatment.  In this perspective, we highlight the specific relationship between TrxR and apoptotic signaling pathways.  The cytoplasm and mitochondria both contain TrxR, resulting in the activation of apoptosis.  TrxR activity influences reactive oxygen species (ROS) and further regulates the inflammatory signaling pathway.  In addn., we discuss representative TrxR inhibitors with anticancer activity and analyze the challenges in developing TrxR inhibitors as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsl-4Fp0n4rVg90H21EOLACvtfcHk0lh660vetyCvkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvFSjt7s%253D&md5=95309462c2e2d52137f8f637fe5a1948</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01595%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DTargeting%2520the%2520thioredoxin%2520system%2520as%2520a%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7309%26epage%3D7321%26doi%3D10.1021%2Facs.jmedchem.8b01595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Helen A. Goulart, José S. S. Neto, Angelita M. Barcellos, Krigor B. Silva, Maiara C. de Moraes, Raquel G. Jacob, Eder J. Lenardão, Thiago Barcellos, <span class="NLM_string-name hlFld-ContribAuthor">Gelson Perin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-Selanyl- and 4-Tellanyl-1H-isochromen-1-ones Promoted by Diorganyl Dichalcogenides and Oxone. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00271%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B4-Selanyl-%252Band%252B4-Tellanyl-1H-isochromen-1-ones%252BPromoted%252Bby%252BDiorganyl%252BDichalcogenides%252Band%252BOxone%26aulast%3DGoulart%26aufirst%3DHelen%2BA.%26date%3D2021%26date%3D2021%26date%3D03022021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hairong  Tang</span>, <span class="hlFld-ContribAuthor ">Yuru  Liang</span>, <span class="hlFld-ContribAuthor ">Jiayi  Cheng</span>, <span class="hlFld-ContribAuthor ">Kuiling  Ding</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113531. <a href="https://doi.org/10.1016/j.ejmech.2021.113531" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113531%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252Bchiral%252Bselenium-containing%252B1%25252C4-diarylazetidin-2-ones%252Bwith%252Bpotent%252Bantitumor%252Bactivities%252Bby%252Bdisrupting%252Btubulin%252Bpolymerization%252Band%252Binducing%252Breactive%252Boxygen%252Bspecies%252Bproduction%26aulast%3DTang%26aufirst%3DHairong%26date%3D2021%26volume%3D221%26spage%3D113531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lailiang  Qu</span>, <span class="hlFld-ContribAuthor ">Limei  Ji</span>, <span class="hlFld-ContribAuthor ">Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Heng  Luo</span>, <span class="hlFld-ContribAuthor ">Shang  Li</span>, <span class="hlFld-ContribAuthor ">Wan  Peng</span>, <span class="hlFld-ContribAuthor ">Fucheng  Yin</span>, <span class="hlFld-ContribAuthor ">Dehua  Lu</span>, <span class="hlFld-ContribAuthor ">Xingchen  Liu</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113441. <a href="https://doi.org/10.1016/j.ejmech.2021.113441" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113441%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bmulti-target-directed%252Bligands%252Bwith%252BBACE-1%252Binhibitory%252Band%252BNrf2%252Bagonist%252Bactivities%252Bas%252Bpotential%252Bagents%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DQu%26aufirst%3DLailiang%26date%3D2021%26volume%3D219%26spage%3D113441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  Santi</span>, <span class="hlFld-ContribAuthor ">Cecilia  Scimmi</span>, <span class="hlFld-ContribAuthor ">Luca  Sancineto</span>. </span><span class="cited-content_cbyCitation_article-title">Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (14)
                                     , 4230. <a href="https://doi.org/10.3390/molecules26144230" title="DOI URL">https://doi.org/10.3390/molecules26144230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26144230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26144230%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEbselen%252Band%252BAnalogues%25253A%252BPharmacological%252BProperties%252Band%252BSynthetic%252BStrategies%252Bfor%252BTheir%252BPreparation%26aulast%3DSanti%26aufirst%3DClaudio%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D14%26spage%3D4230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Kumar</span>, <span class="hlFld-ContribAuthor ">Manisha  Yadav</span>, <span class="hlFld-ContribAuthor ">Babli  Chhillar</span>, <span class="hlFld-ContribAuthor ">Vijay P.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Regenerable Radical‐Trapping and Preventive Selenazolonamine Antioxidants. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 1492-1499. <a href="https://doi.org/10.1002/ajoc.202100169" title="DOI URL">https://doi.org/10.1002/ajoc.202100169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100169%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegenerable%252BRadical%2525E2%252580%252590Trapping%252Band%252BPreventive%252BSelenazolonamine%252BAntioxidants%26aulast%3DKumar%26aufirst%3DManish%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D1492%26epage%3D1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim V.  Musalov</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Potapov</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Yakimov</span>, <span class="hlFld-ContribAuthor ">Maria V.  Musalova</span>, <span class="hlFld-ContribAuthor ">Arkady A.  Maylyan</span>, <span class="hlFld-ContribAuthor ">Sergey V.  Zinchenko</span>, <span class="hlFld-ContribAuthor ">Svetlana V.  Amosova</span>. </span><span class="cited-content_cbyCitation_article-title">A Regioselective Synthesis of Novel Functionalized Organochalcogen Compounds by Chalcogenocyclofunctionalization Reactions Based on Chalcogen Halides and Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (12)
                                     , 3729. <a href="https://doi.org/10.3390/molecules26123729" title="DOI URL">https://doi.org/10.3390/molecules26123729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26123729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26123729%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BRegioselective%252BSynthesis%252Bof%252BNovel%252BFunctionalized%252BOrganochalcogen%252BCompounds%252Bby%252BChalcogenocyclofunctionalization%252BReactions%252BBased%252Bon%252BChalcogen%252BHalides%252Band%252BNatural%252BProducts%26aulast%3DMusalov%26aufirst%3DMaxim%2BV.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D12%26spage%3D3729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim V.  Musalov</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Potapov</span>, <span class="hlFld-ContribAuthor ">Svetlana V.  Amosova</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of a New Family of 2,6-Disulfanyl-9-selenabicyclo[3.3.1]nonanes. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (10)
                                     , 2849. <a href="https://doi.org/10.3390/molecules26102849" title="DOI URL">https://doi.org/10.3390/molecules26102849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26102849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26102849%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEfficient%252BSynthesis%252Bof%252Ba%252BNew%252BFamily%252Bof%252B2%25252C6-Disulfanyl-9-selenabicyclo%25255B3.3.1%25255Dnonanes%26aulast%3DMusalov%26aufirst%3DMaxim%2BV.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D10%26spage%3D2849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Sharifiaghdam</span>, <span class="hlFld-ContribAuthor ">Elnaz  Shaabani</span>, <span class="hlFld-ContribAuthor ">Zeynab  Sharifiaghdam</span>, <span class="hlFld-ContribAuthor ">Herlinde  De Keersmaecker</span>, <span class="hlFld-ContribAuthor ">Riet  De Rycke</span>, <span class="hlFld-ContribAuthor ">Stefaan  De Smedt</span>, <span class="hlFld-ContribAuthor ">Reza  Faridi-Majidi</span>, <span class="hlFld-ContribAuthor ">Kevin  Braeckmans</span>, <span class="hlFld-ContribAuthor ">Juan C.  Fraire</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced siRNA Delivery and Selective Apoptosis Induction in H1299 Cancer Cells by Layer-by-Layer-Assembled Se Nanocomplexes: Toward More Efficient Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmolb.2021.639184" title="DOI URL">https://doi.org/10.3389/fmolb.2021.639184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2021.639184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2021.639184%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DEnhanced%252BsiRNA%252BDelivery%252Band%252BSelective%252BApoptosis%252BInduction%252Bin%252BH1299%252BCancer%252BCells%252Bby%252BLayer-by-Layer-Assembled%252BSe%252BNanocomplexes%25253A%252BToward%252BMore%252BEfficient%252BCancer%252BTherapy%26aulast%3DSharifiaghdam%26aufirst%3DMaryam%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina W.  Nogueira</span>, <span class="hlFld-ContribAuthor ">Nilda V.  Barbosa</span>, <span class="hlFld-ContribAuthor ">João B. T.  Rocha</span>. </span><span class="cited-content_cbyCitation_article-title">Toxicology and pharmacology of synthetic organoselenium compounds: an update. </span><span class="cited-content_cbyCitation_journal-name">Archives of Toxicology</span><span> <strong>2021,</strong> <em>95 </em>
                                    (4)
                                     , 1179-1226. <a href="https://doi.org/10.1007/s00204-021-03003-5" title="DOI URL">https://doi.org/10.1007/s00204-021-03003-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00204-021-03003-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00204-021-03003-5%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Toxicology%26atitle%3DToxicology%252Band%252Bpharmacology%252Bof%252Bsynthetic%252Borganoselenium%252Bcompounds%25253A%252Ban%252Bupdate%26aulast%3DNogueira%26aufirst%3DCristina%2BW.%26date%3D2021%26date%3D2021%26volume%3D95%26issue%3D4%26spage%3D1179%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Kumar</span>, <span class="hlFld-ContribAuthor ">Babli  Chhillar</span>, <span class="hlFld-ContribAuthor ">Manisha  Yadav</span>, <span class="hlFld-ContribAuthor ">Poonam  Sagar</span>, <span class="hlFld-ContribAuthor ">Nitin K.  Singhal</span>, <span class="hlFld-ContribAuthor ">Paul J.  Gates</span>, <span class="hlFld-ContribAuthor ">Ray J.  Butcher</span>, <span class="hlFld-ContribAuthor ">Vijay P.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic and highly regenerable aminic organoselenium antioxidants with cytoprotective effects. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (9)
                                     , 2015-2022. <a href="https://doi.org/10.1039/D0OB02368J" title="DOI URL">https://doi.org/10.1039/D0OB02368J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02368J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02368J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCatalytic%252Band%252Bhighly%252Bregenerable%252Baminic%252Borganoselenium%252Bantioxidants%252Bwith%252Bcytoprotective%252Beffects%26aulast%3DKumar%26aufirst%3DManish%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D9%26spage%3D2015%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamal  Rafique</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Rampon</span>, <span class="hlFld-ContribAuthor ">Juliano B.  Azeredo</span>, <span class="hlFld-ContribAuthor ">Felipe L.  Coelho</span>, <span class="hlFld-ContribAuthor ">Paulo H.  Schneider</span>, <span class="hlFld-ContribAuthor ">Antonio L.  Braga</span>. </span><span class="cited-content_cbyCitation_article-title">Light‐mediated Seleno‐Functionalization of Organic Molecules: Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1002/tcr.202100006" title="DOI URL">https://doi.org/10.1002/tcr.202100006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.202100006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.202100006%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DLight%2525E2%252580%252590mediated%252BSeleno%2525E2%252580%252590Functionalization%252Bof%252BOrganic%252BMolecules%25253A%252BRecent%252BAdvances%26aulast%3DRafique%26aufirst%3DJamal%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyanka N.  Makhal</span>, <span class="hlFld-ContribAuthor ">Arijit  Nandi</span>, <span class="hlFld-ContribAuthor ">Venkata Rao  Kaki</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the Recent Synthetic Advances of Organoselenium Compounds. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (4)
                                     , 663-679. <a href="https://doi.org/10.1002/slct.202004029" title="DOI URL">https://doi.org/10.1002/slct.202004029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202004029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202004029%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DInsights%252Binto%252Bthe%252BRecent%252BSynthetic%252BAdvances%252Bof%252BOrganoselenium%252BCompounds%26aulast%3DMakhal%26aufirst%3DPriyanka%2BN.%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D4%26spage%3D663%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin‐Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan‐Fang  Zhong</span>, <span class="hlFld-ContribAuthor ">Zu‐Yu  Mo</span>, <span class="hlFld-ContribAuthor ">Shi‐Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Yan‐Li  Xu</span>, <span class="hlFld-ContribAuthor ">Hai‐Tao  Tang</span>, <span class="hlFld-ContribAuthor ">Ying‐Ming  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Seleno Oxindoles
              via
              Electrochemical Cyclization of
              N
              ‐arylacrylamides with Diorganyl Diselenides. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (1)
                                     , 208-214. <a href="https://doi.org/10.1002/adsc.202001192" title="DOI URL">https://doi.org/10.1002/adsc.202001192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001192%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSynthesis%252Bof%252BSeleno%252BOxindoles%252Bvia%252BElectrochemical%252BCyclization%252Bof%252BN%252B%2525E2%252580%252590arylacrylamides%252Bwith%252BDiorganyl%252BDiselenides%26aulast%3DWang%26aufirst%3DXin%25E2%2580%2590Yu%26date%3D2021%26date%3D2020%26volume%3D363%26issue%3D1%26spage%3D208%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Qiao</span>, <span class="hlFld-ContribAuthor ">Ningning  Wei</span>, <span class="hlFld-ContribAuthor ">Lin  Jin</span>, <span class="hlFld-ContribAuthor ">Hongyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiajie  Luo</span>, <span class="hlFld-ContribAuthor ">Yanru  Zhang</span>, <span class="hlFld-ContribAuthor ">KeWei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The Mpro Structure-Based Modifications of Ebselen Derivatives for Improved Antiviral Activity Against SARS-CoV-2 Virus. </span><span class="cited-content_cbyCitation_journal-name">SSRN Electronic Journal</span><span> <strong>2021,</strong> <em>300 </em><a href="https://doi.org/10.2139/ssrn.3800390" title="DOI URL">https://doi.org/10.2139/ssrn.3800390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2139/ssrn.3800390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2139%2Fssrn.3800390%26sid%3Dliteratum%253Aachs%26jtitle%3DSSRN%2520Electronic%2520Journal%26atitle%3DThe%252BMpro%252BStructure-Based%252BModifications%252Bof%252BEbselen%252BDerivatives%252Bfor%252BImproved%252BAntiviral%252BActivity%252BAgainst%252BSARS-CoV-2%252BVirus%26aulast%3DQiao%26aufirst%3DZhen%26date%3D2021%26volume%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola S.  Hellwig</span>, <span class="hlFld-ContribAuthor ">Thiago J.  Peglow</span>, <span class="hlFld-ContribAuthor ">Filipe  Penteado</span>, <span class="hlFld-ContribAuthor ">Luana  Bagnoli</span>, <span class="hlFld-ContribAuthor ">Gelson  Perin</span>, <span class="hlFld-ContribAuthor ">Eder J.  Lenardão</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis of Selenophenes and Their Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (24)
                                     , 5907. <a href="https://doi.org/10.3390/molecules25245907" title="DOI URL">https://doi.org/10.3390/molecules25245907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25245907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25245907%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BSelenophenes%252Band%252BTheir%252BDerivatives%26aulast%3DHellwig%26aufirst%3DPaola%2BS.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D24%26spage%3D5907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikhail  V. Andreev</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Potapov</span>, <span class="hlFld-ContribAuthor ">Maxim V.  Musalov</span>, <span class="hlFld-ContribAuthor ">Svetlana V.  Amosova</span>. </span><span class="cited-content_cbyCitation_article-title">(Z,Z)-Selanediylbis(2-propenamides): Novel Class of Organoselenium Compounds with High Glutathione Peroxidase-Like Activity. Regio- and Stereoselective Reaction of Sodium Selenide with 3-Trimethylsilyl-2-propynamides. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (24)
                                     , 5940. <a href="https://doi.org/10.3390/molecules25245940" title="DOI URL">https://doi.org/10.3390/molecules25245940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25245940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25245940%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D%252528Z%25252CZ%252529-Selanediylbis%2525282-propenamides%252529%25253A%252BNovel%252BClass%252Bof%252BOrganoselenium%252BCompounds%252Bwith%252BHigh%252BGlutathione%252BPeroxidase-Like%252BActivity.%252BRegio-%252Band%252BStereoselective%252BReaction%252Bof%252BSodium%252BSelenide%252Bwith%252B3-Trimethylsilyl-2-propynamides%26aulast%3DV.%2BAndreev%26aufirst%3DMikhail%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D24%26spage%3D5940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriel P.  Costa</span>, <span class="hlFld-ContribAuthor ">Mariana F.  Bach</span>, <span class="hlFld-ContribAuthor ">Maiara C.  Moraes</span>, <span class="hlFld-ContribAuthor ">Thiago  Barcellos</span>, <span class="hlFld-ContribAuthor ">Eder J.  Lenardão</span>, <span class="hlFld-ContribAuthor ">Márcio S.  Silva</span>, <span class="hlFld-ContribAuthor ">Diego  Alves</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential Organocatalytic Synthesis of [1,2,3]Triazolo[1,5‐
              a
              ]quinolines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (22)
                                     , 5044-5055. <a href="https://doi.org/10.1002/adsc.202000887" title="DOI URL">https://doi.org/10.1002/adsc.202000887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000887%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSequential%252BOrganocatalytic%252BSynthesis%252Bof%252B%25255B1%25252C2%25252C3%25255DTriazolo%25255B1%25252C5%2525E2%252580%252590%252Ba%252B%25255Dquinolines%26aulast%3DCosta%26aufirst%3DGabriel%2BP.%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D22%26spage%3D5044%26epage%3D5055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aneta  Ostróżka-Cieślik</span>, <span class="hlFld-ContribAuthor ">Barbara  Dolińska</span>, <span class="hlFld-ContribAuthor ">Florian  Ryszka</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Selenium as a Component of Preservation Solutions for Kidney Transplantation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3592. <a href="https://doi.org/10.3390/molecules25163592" title="DOI URL">https://doi.org/10.3390/molecules25163592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163592%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTherapeutic%252BPotential%252Bof%252BSelenium%252Bas%252Ba%252BComponent%252Bof%252BPreservation%252BSolutions%252Bfor%252BKidney%252BTransplantation%26aulast%3DOstr%25C3%25B3%25C5%25BCka-Cie%25C5%259Blik%26aufirst%3DAneta%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Temitope O.  Olomola</span>, <span class="hlFld-ContribAuthor ">Malose J.  Mphahlele</span>, <span class="hlFld-ContribAuthor ">Samantha  Gildenhuys</span>. </span><span class="cited-content_cbyCitation_article-title">Benzofuran-selenadiazole hybrids as novel α-glucosidase and cyclooxygenase-2 inhibitors with antioxidant and cytotoxic properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>100 </em>, 103945. <a href="https://doi.org/10.1016/j.bioorg.2020.103945" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103945</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103945%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DBenzofuran-selenadiazole%252Bhybrids%252Bas%252Bnovel%252B%2525CE%2525B1-glucosidase%252Band%252Bcyclooxygenase-2%252Binhibitors%252Bwith%252Bantioxidant%252Band%252Bcytotoxic%252Bproperties%26aulast%3DOlomola%26aufirst%3DTemitope%2BO.%26date%3D2020%26volume%3D100%26spage%3D103945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haifeng  Gan</span>, <span class="hlFld-ContribAuthor ">Mengru  Cao</span>, <span class="hlFld-ContribAuthor ">Hongli  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2‐Arylbenzoselenazoles from Se‐mediated Redox Condensation of 2‐Chloronitrobenzene and Arylmethyl Chloride. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (15)
                                     , 4548-4551. <a href="https://doi.org/10.1002/slct.202000642" title="DOI URL">https://doi.org/10.1002/slct.202000642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202000642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202000642%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252B2%2525E2%252580%252590Arylbenzoselenazoles%252Bfrom%252BSe%2525E2%252580%252590mediated%252BRedox%252BCondensation%252Bof%252B2%2525E2%252580%252590Chloronitrobenzene%252Band%252BArylmethyl%252BChloride%26aulast%3DGan%26aufirst%3DHaifeng%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D15%26spage%3D4548%26epage%3D4551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mysore S.  Shashidhar</span>, <span class="hlFld-ContribAuthor ">Nivedita T.  Patil</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in the synthesis of biologically relevant inositol derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 283-329. <a href="https://doi.org/10.1016/B978-0-12-816675-8.00007-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-816675-8.00007-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816675-8.00007-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816675-8.00007-5%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252Bdevelopments%252Bin%252Bthe%252Bsynthesis%252Bof%252Bbiologically%252Brelevant%252Binositol%252Bderivatives%26aulast%3DShashidhar%26aufirst%3DMysore%2BS.%26date%3D2020%26spage%3D283%26epage%3D329%26pub%3DElsevier%26atitle%3DCarbohydrates%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2020%26volume%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana Carolina  Ruberte</span>, <span class="hlFld-ContribAuthor ">Sandra  Ramos-Inza</span>, <span class="hlFld-ContribAuthor ">Carlos  Aydillo</span>, <span class="hlFld-ContribAuthor ">Irene  Talavera</span>, <span class="hlFld-ContribAuthor ">Ignacio  Encío</span>, <span class="hlFld-ContribAuthor ">Daniel  Plano</span>, <span class="hlFld-ContribAuthor ">Carmen  Sanmartín</span>. </span><span class="cited-content_cbyCitation_article-title">Novel N,N′-Disubstituted Acylselenoureas as Potential Antioxidant and Cytotoxic Agents. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2020,</strong> <em>9 </em>
                                    (1)
                                     , 55. <a href="https://doi.org/10.3390/antiox9010055" title="DOI URL">https://doi.org/10.3390/antiox9010055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox9010055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox9010055%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DNovel%252BN%25252CN%2525E2%252580%2525B2-Disubstituted%252BAcylselenoureas%252Bas%252BPotential%252BAntioxidant%252Band%252BCytotoxic%252BAgents%26aulast%3DRuberte%26aufirst%3DAna%2BCarolina%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D1%26spage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. EBS-related anticancer compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. EBS-related structures tested in neurodegenerative diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. EBS-related derivatives used in diabetes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. EBS-related structures active against various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. 1,3-Selenazole structures active against various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 1,2,3-Selenadiazole structures active against various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. General structure of active 5-substitued selenadiazoles derived from <i>o</i>-phenylenediamine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Active selenadiazoles derived from DAB.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/medium/jm9b01152_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Active 1,2,5-selenadiazoles derived from semiconducting polymer dots (Pdots) and polymer nanoparticles (NPs).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-4/acs.jmedchem.9b01152/20200221/images/large/jm9b01152_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01152&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 154 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagnoli, L.</span></span> <span> </span><span class="NLM_article-title">Celebrating two centuries of research in selenium chemistry: state of the art and new prospective</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2124</span>, <span class="refDoi"> DOI: 10.3390/molecules22122124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fmolecules22122124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=2124&author=C.+Santiauthor=L.+Bagnoli&title=Celebrating+two+centuries+of+research+in+selenium+chemistry%3A+state+of+the+art+and+new+prospective&doi=10.3390%2Fmolecules22122124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Celebrating two centuries of research in selenium chemistry: state of the art and new prospective</span></div><div class="casAuthors">Santi, Claudio; Bagnoli, Luana</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2124/1-2124/4</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In 2017, the 200th anniversary of the discovery of selenium was celebrated.  In 1817, the Swedish chemists, Berzelius and Gahn, on roasting 200 kg of sulfur from a pyrite from the Falun mine, obtained about 3 g of a ppt. that they first wrongly identified as tellurium.  Berzelius doubted this result and repeated the anal. some months later realizing that a new element was in his hands and he named this element Selenium (Greek: Selene, moon) in consideration of its resemblance to Tellurium (Latin: Tellus, earth).  Several events were organized in the year for this special celebration and this Special Issue would like to be an addnl. contribution to the success of a research that, esp. during the last decades, rapidly grew in different fields: synthesis, medicinal chem., biol., material, and environment.  These studies are strongly characterized by multi- and interdisciplinary connections, and, for this reason, we collected here contributions coming from different areas and disciplines, not exclusively synthetic org. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEmAdPeR_BtrVg90H21EOLACvtfcHk0li2yUsngF_6-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWjsr0%253D&md5=80f85396167508eaed2e6b156da81b3f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22122124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22122124%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DC.%26aulast%3DBagnoli%26aufirst%3DL.%26atitle%3DCelebrating%2520two%2520centuries%2520of%2520research%2520in%2520selenium%2520chemistry%253A%2520state%2520of%2520the%2520art%2520and%2520new%2520prospective%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D2124%26doi%3D10.3390%2Fmolecules22122124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wrobel, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Power, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toborek, M.</span></span> <span> </span><span class="NLM_article-title">Biological activity of selenium: revisited</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1002/iub.1466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fiub.1466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26714931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2rs7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=97-105&author=J.+K.+Wrobelauthor=R.+Powerauthor=M.+Toborek&title=Biological+activity+of+selenium%3A+revisited&doi=10.1002%2Fiub.1466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological activity of selenium: Revisited</span></div><div class="casAuthors">Wrobel, Jagoda K.; Power, Ronan; Toborek, Michal</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-105</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Inc.</span>)
        </div><div class="casAbstract">Selenium (Se) is an essential micronutrient that exerts multiple and complex effects on human health.  Se is essential for human well-being largely due to its potent antioxidant, anti-inflammatory, and antiviral properties.  The physiol. functions of Se are carried out by selenoproteins, in which Se is specifically incorporated as the amino acid, selenocysteine.  Importantly, both beneficial and toxic effects of Se have been reported suggesting that the mode of action of Se is strictly chem. form and concn. dependent.  Addnl., there is a relatively narrow window between Se deficiency and toxicity and growing evidence suggests that Se health effects depend greatly on the baseline level of this micronutrient.  Thus, Se supplementation is not an easy task and requires an individualized approach.  It is essential that we continue to explore and better characterize Se contg. compds. and mechanisms of action, which could be crucial for disease prevention and treatment. © 2015 IUBMB Life, 2015.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXqhFtOp1NBLVg90H21EOLACvtfcHk0li2yUsngF_6-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2rs7nL&md5=6464c0cf45ed3fb134e4b967143bbf5d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fiub.1466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fiub.1466%26sid%3Dliteratum%253Aachs%26aulast%3DWrobel%26aufirst%3DJ.%2BK.%26aulast%3DPower%26aufirst%3DR.%26aulast%3DToborek%26aufirst%3DM.%26atitle%3DBiological%2520activity%2520of%2520selenium%253A%2520revisited%26jtitle%3DIUBMB%2520Life%26date%3D2016%26volume%3D68%26spage%3D97%26epage%3D105%26doi%3D10.1002%2Fiub.1466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosnedlova, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepinska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalickova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruttkay-Nedecky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malevu, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sochor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melcova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zidkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizek, R.</span></span> <span> </span><span class="NLM_article-title">A summary of new findings on the biological effects of selenium in selected animal species-a critical review</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2209</span>, <span class="refDoi"> DOI: 10.3390/ijms18102209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms18102209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOjsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2209&author=B.+Hosnedlovaauthor=M.+Kepinskaauthor=S.+Skalickovaauthor=C.+Fernandezauthor=B.+Ruttkay-Nedeckyauthor=T.+D.+Malevuauthor=J.+Sochorauthor=M.+Baronauthor=M.+Melcovaauthor=J.+Zidkovaauthor=R.+Kizek&title=A+summary+of+new+findings+on+the+biological+effects+of+selenium+in+selected+animal+species-a+critical+review&doi=10.3390%2Fijms18102209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A summary of new findings on the biologicaleffects of selenium in selected animalspecies-a critical review</span></div><div class="casAuthors">Hosnedlova, Bozena; Kepinska, Marta; Skalickova, Sylvie; Fernandez, Carlos; Ruttkay-Nedecky, Branislav; Malevu, Thembinkosi Donald; Sochor, Jiri; Baron, Mojmir; Melcova, Magdalena; Zidkova, Jarmila; Kizek, Rene</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2209/1-2209/47</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Selenium is an essential trace element important for many physiol. processes, esp. for the functions of immune and reproductive systems, metab. of thyroid hormones, as well as antioxidant defense.  Selenium deficiency is usually manifested by an increased incidence of retention of placenta, metritis, mastitis, aborts, lowering fertility and increased susceptibility to infections.  In calves, lambs and kids, the selenium deficiency demonstrates by WMD (white muscle disease), in foals and donkey foals, it is assocd. with incidence of WMD and yellow fat disease, and in pigs it causes VESD (vitamin E/selenium deficiency) syndrome.  The prevention of these health disorders can be achieved by an adequate selenium supplementation to the diet.  The review summarizes the survey of knowledge on selenium, its biol. significance in the organism, the impact of its deficiency in mammalian livestock (comparison of ruminants vs. non-ruminants, herbivore vs. omnivore) and possibilities of its peroral administration.  The databases employed were as follows: Web of Science, PubMed, MEDLINE and Google Scholar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJxzPfJlMhDbVg90H21EOLACvtfcHk0li2yUsngF_6-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOjsbzM&md5=119910d01bc4383d22977ce7735ec865</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fijms18102209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18102209%26sid%3Dliteratum%253Aachs%26aulast%3DHosnedlova%26aufirst%3DB.%26aulast%3DKepinska%26aufirst%3DM.%26aulast%3DSkalickova%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DRuttkay-Nedecky%26aufirst%3DB.%26aulast%3DMalevu%26aufirst%3DT.%2BD.%26aulast%3DSochor%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DM.%26aulast%3DMelcova%26aufirst%3DM.%26aulast%3DZidkova%26aufirst%3DJ.%26aulast%3DKizek%26aufirst%3DR.%26atitle%3DA%2520summary%2520of%2520new%2520findings%2520on%2520the%2520biological%2520effects%2520of%2520selenium%2520in%2520selected%2520animal%2520species-a%2520critical%2520review%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D2209%26doi%3D10.3390%2Fijms18102209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reich, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hondal, R. J.</span></span> <span> </span><span class="NLM_article-title">Why nature chose selenium</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1Ors70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=821-841&author=H.+J.+Reichauthor=R.+J.+Hondal&title=Why+nature+chose+selenium&doi=10.1021%2Facschembio.6b00031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Why Nature Chose Selenium</span></div><div class="casAuthors">Reich, Hans J.; Hondal, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">821-841</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors were asked by the Editors of ACS Chem. Biol. to write an article titled "Why Nature Chose Selenium" for the occasion of the upcoming bicentennial of the discovery of selenium by the Swedish chemist Jons Jacob Berzelius in 1817 and styled after the famous work of Frank Westheimer on the biol. chem. of phosphate.  This work gives a history of the important discoveries of the biol. processes that selenium participates in, and a point-by-point comparison of the chem. of selenium with the atom it replaces in biol., sulfur.  This anal. shows that redox chem. is the largest chem. difference between the two chalcogens.  This difference is very large for both one-electron and two-electron redox reactions.  Much of this difference is due to the inability of selenium to form π bonds of all types.  The outer valence electrons of selenium are also more loosely held than those of sulfur.  As a result, selenium is a better nucleophile and will react with reactive oxygen species faster than sulfur, but the resulting lack of π-bond character in the Se-O bond means that the Se-oxide can be much more readily reduced in comparison to S-oxides.  The combination of these properties means that replacement of sulfur with selenium in nature results in a selenium-contg. biomol. that resists permanent oxidn.  Multiple examples of this gain of function behavior from the literature are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnHxvzkvNsAbVg90H21EOLACvtfcHk0lhtxyitHp9jtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1Ors70%253D&md5=e1f53c0a82a1eb27b7c66ec75f15c5af</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00031%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DH.%2BJ.%26aulast%3DHondal%26aufirst%3DR.%2BJ.%26atitle%3DWhy%2520nature%2520chose%2520selenium%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D821%26epage%3D841%26doi%3D10.1021%2Facschembio.6b00031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, A. T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. M.</span></span> <span> </span><span class="NLM_article-title">Selenium species: current status and potentials in cancer prevention and therapy</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">75</span>, <span class="refDoi"> DOI: 10.3390/ijms20010075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms20010075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFahtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=75&author=H.+W.+Tanauthor=H.+Y.+Moauthor=A.+T.+Y.+Lauauthor=Y.+M.+Xu&title=Selenium+species%3A+current+status+and+potentials+in+cancer+prevention+and+therapy&doi=10.3390%2Fijms20010075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium species: current status and potentials in cancer prevention and therapy</span></div><div class="casAuthors">Tan, Heng Wee; Mo, Hai-Ying; Lau, Andy T. Y.; Xu, Yan-Ming</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75/1-75/26</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Selenium (Se) acts as an essential trace element in the human body due to its unique biol. functions, particularly in the oxidn.-redn. system.  Although several clin. trials indicated no significant benefit of Se in preventing cancer, researchers reported that some Se species exhibit superior anticancer properties.  Therefore, a reassessment of the status of Se and Se compds. is necessary in order to provide clearer insights into the potentiality of Se in cancer prevention and therapy.  In this review, we organize relevant forms of Se species based on the three main categories of Se-inorg., org., and Se-contg. nanoparticles (SeNPs)-and overview their potential functions and applications in oncol.  Here, we specifically focus on the SeNPs as they have tremendous potential in oncol. and other fields.  In general, to make better use of Se compds. in cancer prevention and therapy, extensive further study is still required to understand the underlying mechanisms of the Se compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE45SgXQ6zELVg90H21EOLACvtfcHk0lhtxyitHp9jtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFahtr7F&md5=cd9dcd0c5245b0a5d7082130c5ba621f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fijms20010075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20010075%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DH.%2BW.%26aulast%3DMo%26aufirst%3DH.%2BY.%26aulast%3DLau%26aufirst%3DA.%2BT.%2BY.%26aulast%3DXu%26aufirst%3DY.%2BM.%26atitle%3DSelenium%2520species%253A%2520current%2520status%2520and%2520potentials%2520in%2520cancer%2520prevention%2520and%2520therapy%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D75%26doi%3D10.3390%2Fijms20010075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, T.</span></span> <span> </span><span class="NLM_article-title">Small organoselenium compounds: more than just glutathione peroxidase mimics</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">10074</span>– <span class="NLM_lpage">10076</span>, <span class="refDoi"> DOI: 10.1002/anie.201505056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fanie.201505056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyqurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=10074-10076&author=T.+Wirth&title=Small+organoselenium+compounds%3A+more+than+just+glutathione+peroxidase+mimics&doi=10.1002%2Fanie.201505056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Small Organoselenium Compounds: More than just Glutathione Peroxidase Mimics</span></div><div class="casAuthors">Wirth, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10074-10076</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review of organoselenium compds. as glutathione peroxidase mimics.  Glutathione peroxidase is one of the mammalian antioxidant enzymes which is able to decomp. ROS, such as peroxides.  The human enzymes have a selenocysteine residue in their active site which is responsible for the catalytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE5Iodc99pDLVg90H21EOLACvtfcHk0lhtxyitHp9jtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyqurrF&md5=b7cf2151dd89b251c5a49e88dd4b6bd1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fanie.201505056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201505056%26sid%3Dliteratum%253Aachs%26aulast%3DWirth%26aufirst%3DT.%26atitle%3DSmall%2520organoselenium%2520compounds%253A%2520more%2520than%2520just%2520glutathione%2520peroxidase%2520mimics%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D10074%26epage%3D10076%26doi%3D10.1002%2Fanie.201505056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalera, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piroddi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, F.</span></span> <span> </span><span class="NLM_article-title">Selenium containing compounds from poison to drug candidates: a review on the GPx-like activity</span>. <i>Curr. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.2174/2212796811307010003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2174%2F2212796811307010003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotlykt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=25-36&author=C.+Santiauthor=C.+Tideiauthor=C.+Scaleraauthor=M.+Piroddiauthor=F.+Galli&title=Selenium+containing+compounds+from+poison+to+drug+candidates%3A+a+review+on+the+GPx-like+activity&doi=10.2174%2F2212796811307010003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium containing compounds from poison to drug candidates: a review on the GPx-like activity</span></div><div class="casAuthors">Santi, Claudio; Tidei, Caterina; Scalera, Claudia; Piroddi, Marta; Galli, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-36</span>CODEN:
                <span class="NLM_cas:coden">CCBUB2</span>;
        ISSN:<span class="NLM_cas:issn">2212-7968</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress results from the formation of reactive oxygen species (ROS) such as peroxides that cause damage to cell membranes and react with various biomols. in mammalian cells.  The selenoenzyme glutathione peroxidase (GPx) destroys peroxides by catalyzing their redn. to alcs. or water with the stoichiometric reductant glutathione.  The effects of oxidative stress have been implicated in a variety of degenerative processes and disease states and for these reasons, there is considerable interest in the discovery of small mol. compds. that could reproduce a GPx-like activity.  A review on the most recent acquisition in this area is here reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6JziBQt1QbVg90H21EOLACvtfcHk0lhtxyitHp9jtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotlykt70%253D&md5=cd39e1b58fa824b8d44c0e7283ed4e8a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F2212796811307010003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F2212796811307010003%26sid%3Dliteratum%253Aachs%26aulast%3DSanti%26aufirst%3DC.%26aulast%3DTidei%26aufirst%3DC.%26aulast%3DScalera%26aufirst%3DC.%26aulast%3DPiroddi%26aufirst%3DM.%26aulast%3DGalli%26aufirst%3DF.%26atitle%3DSelenium%2520containing%2520compounds%2520from%2520poison%2520to%2520drug%2520candidates%253A%2520a%2520review%2520on%2520the%2520GPx-like%2520activity%26jtitle%3DCurr.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D7%26spage%3D25%26epage%3D36%26doi%3D10.2174%2F2212796811307010003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, D.</span>; <span class="NLM_string-name">Sancineto, L.</span>; <span class="NLM_string-name">de Bem, A. F.</span>; <span class="NLM_string-name">Tew, K. D.</span>; <span class="NLM_string-name">Santi, C.</span>; <span class="NLM_string-name">Radi, R.</span>; <span class="NLM_string-name">Toquato, P.</span>; <span class="NLM_string-name">Galli, F.</span></span> <span> </span><span class="NLM_article-title">Selenocompounds in cancer therapy: an overview</span>. In  <i>Selenium and Selenoproteins in Cancer</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, K. D.</span>, <span class="NLM_string-name">Galli, F.</span></span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">136</span>, pp  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">302</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fbs.acr.2017.07.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=259-302&author=D.+Bartolini&author=L.+Sancineto&author=A.+F.+de+Bem&author=K.+D.+Tew&author=C.+Santi&author=R.+Radi&author=P.+Toquato&author=F.+Galliauthor=K.+D.+Tew&author=F.+Galli&title=Selenium+and+Selenoproteins+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fbs.acr.2017.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fbs.acr.2017.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DD.%26atitle%3DSelenocompounds%2520in%2520cancer%2520therapy%253A%2520an%2520overview%26btitle%3DSelenium%2520and%2520Selenoproteins%2520in%2520Cancer%26aulast%3DTew%26aufirst%3DK.%2BD.%26pub%3DAcademic%2520Press%26date%3D2017%26volume%3D136%26spage%3D259%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span> <span> </span><span class="NLM_article-title">Selenium compounds as therapeutic agents in cancer</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1850</i></span>,  <span class="NLM_fpage">1642</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbagen.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25459512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSnu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1850&publication_year=2015&pages=1642-1660&author=A.+P.+Fernandesauthor=V.+Gandin&title=Selenium+compounds+as+therapeutic+agents+in+cancer&doi=10.1016%2Fj.bbagen.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium compounds as therapeutic agents in cancer</span></div><div class="casAuthors">Fernandes, Aristi P.; Gandin, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1850</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1642-1660</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  With cancer cells encompassing consistently higher prodn. of reactive oxygen species (ROS) and with an induced antioxidant defense to counteract the increased basal ROS prodn., tumors have a limited reserve capacity resulting in an increased vulnerability of some cancer cells to ROS.  Based on this, oxidative stress has been recognized as a tumor-specific target for the rational design of new anticancer agents.  Among redox modulating compds., selenium compds. have gained substantial attention due to their promising chemotherapeutic potential.  This review aims in summarizing and providing the recent developments of our understanding of the mol. mechanisms that underlie the potential anticancer effects of selenium compds.  It is well established that selenium at higher doses readily can turn into a prooxidant and thereby exert its potential anticancer properties.  However, the biol. activity of selenium compds. and the mechanism behind these effects are highly dependent on its speciation and the specific metabolic pathways of cells and tissues.  Conversely, the chem. properties and the main mol. mechanisms of the most relevant inorg. and org. selenium compds. as well as selenium-based nanoparticles must be taken into account and are discussed herein.  Elucidating and deepening our mechanistic knowledge of selenium compds. will help in designing and optimizing compds. with more specific antitumor properties for possible future application of selenium compds. in the treatment of cancer.  This article is part of a Special Issue entitled Redox regulation of differentiation and de-differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqptRneM5vXqrVg90H21EOLACvtfcHk0lg_WQiaAxWp3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSnu77E&md5=49d79e46bf4ab507c3a97d00d688ef20</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DA.%2BP.%26aulast%3DGandin%26aufirst%3DV.%26atitle%3DSelenium%2520compounds%2520as%2520therapeutic%2520agents%2520in%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2015%26volume%3D1850%26spage%3D1642%26epage%3D1660%26doi%3D10.1016%2Fj.bbagen.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.</span></span> <span> </span><span class="NLM_article-title">Organoselenium small molecules and chromium(III) complexes for intervention in chronic low-grade inflammation and type 2 diabetes</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.2174/1568026615666150827094815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2174%2F1568026615666150827094815" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=823-834&author=J.+Zhouauthor=H.+Xuauthor=K.+Huang&title=Organoselenium+small+molecules+and+chromium%28III%29+complexes+for+intervention+in+chronic+low-grade+inflammation+and+type+2+diabetes&doi=10.2174%2F1568026615666150827094815"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150827094815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150827094815%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DK.%26atitle%3DOrganoselenium%2520small%2520molecules%2520and%2520chromium%2528III%2529%2520complexes%2520for%2520intervention%2520in%2520chronic%2520low-grade%2520inflammation%2520and%2520type%25202%2520diabetes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D16%26spage%3D823%26epage%3D834%26doi%3D10.2174%2F1568026615666150827094815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bijian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaoui-Jamali, M. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2011.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22204902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=143-152&author=K.+Bijianauthor=Z.+Zhangauthor=B.+Xuauthor=S.+Jieauthor=B.+Chenauthor=S.+Wanauthor=J.+Wuauthor=T.+Jiangauthor=M.+A.+Alaoui-Jamali&title=Synthesis+and+biological+activity+of+novel+organoselenium+derivatives+targeting+multiple+kinases+and+capable+of+inhibiting+cancer+progression+to+metastases&doi=10.1016%2Fj.ejmech.2011.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastases</span></div><div class="casAuthors">Bijian, Krikor; Zhang, Zhongwei; Xu, Bin; Jie, Su; Chen, Bo; Wan, Shengbiao; Wu, JianHui; Jiang, Tao; Alaoui-Jamali, Moulay A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-152</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The present study reports synthesis and biol. activity of novel benzoisoselenazolone compds. derived from ebselen and conjugated to a sugar mol.  Cell proliferation assay using cancer cells combined with in vitro biochem. assays revealed that benzoisoselenazolone, e.g. I, exerted antiproliferative activity, which correlated with selective in vitro inhibition of focal adhesion kinase, AKT-1, and protein kinase C-α.  Active mols. were able to significantly inhibit cell migration and invasion in vitro compared to cells treated with the vehicle alone or ebselen.  Moreover, in vivo anticancer activity focusing on lead compd. 2d and using an invasive human breast cancer orthotopic mouse model revealed a potent anti-metastatic activity at well-tolerated doses.  In summary, these novel benzoisoselenazolones we report herein target multiple kinases with established roles in cancer progression and possess anti-invasive and anti-metastatic activity in pre-clin. models supporting a potential for therapeutic application for human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4LeFcbaxPLVg90H21EOLACvtfcHk0lg_WQiaAxWp3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKmtro%253D&md5=8d27330fb6b7585e3f3c09c514eca020</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DBijian%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DJie%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DWan%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DAlaoui-Jamali%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520novel%2520organoselenium%2520derivatives%2520targeting%2520multiple%2520kinases%2520and%2520capable%2520of%2520inhibiting%2520cancer%2520progression%2520to%2520metastases%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D48%26spage%3D143%26epage%3D152%26doi%3D10.1016%2Fj.ejmech.2011.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbatsch, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of selenazole-containing peptides for cocrystallization with P-glycoprotein</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">873</span>, <span class="refDoi"> DOI: 10.1002/cbic.201100048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fcbic.201100048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=21387512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt12htbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=868-873&author=H.+Taoauthor=Y.+Wengauthor=R.+Zhuoauthor=G.+Changauthor=I.+L.+Urbatschauthor=Q.+Zhang&title=Design+and+synthesis+of+selenazole-containing+peptides+for+cocrystallization+with+P-glycoprotein&doi=10.1002%2Fcbic.201100048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Selenazole-Containing Peptides for Cocrystallization with P-Glycoprotein</span></div><div class="casAuthors">Tao, Hou-Chao; Weng, Yue; Zhuo, Ru-Peng; Chang, Geoffrey; Urbatsch, Ina L.; Zhang, Qing-Hai</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">868-873</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Over-expression of P-glycoprotein (Pgp) in some cancer cells is a primary cause of multidrug resistance (MDR) that results in chemotherapy failure.  In order to produce a diverse array of selenium-labeled peptides for structural studies directed at mapping the flexible binding sites of Pgp, the authors developed a procedure for the efficient prepn. of optically pure selanazole-contg. peptides.  Thus, all 20 natural amino acid-derived selenazoles I (R = amino acid side chain) were synthesized in a three-step procedure starting from chiral nitriles (S)-BocNHCH(R)CN.  Next, selenazole-contg. cyclic peptides were prepd., and their binding activity towards Pgp was evaluated using a commonly used calcein acetoxymethyl ester (calcein-AM) transport assay in Pgp-overexpressing CR1R12 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6CvJyDd-yjrVg90H21EOLACvtfcHk0liP10ziB0I1cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt12htbY%253D&md5=193fe810052e8ffc6b276b5ee7788171</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201100048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201100048%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DH.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DZhuo%26aufirst%3DR.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520selenazole-containing%2520peptides%2520for%2520cocrystallization%2520with%2520P-glycoprotein%26jtitle%3DChemBioChem%26date%3D2011%26volume%3D12%26spage%3D868%26epage%3D873%26doi%3D10.1002%2Fcbic.201100048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">887</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1248/cpb.c12-00250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1248%2Fcpb.c12-00250" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22790823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=887-891&author=Z.+H.+Luoauthor=S.+Y.+Heauthor=B.+Q.+Chenauthor=Y.+P.+Shiauthor=Y.+M.+Liuauthor=C.+W.+Liauthor=Q.+S.+Wang&title=Synthesis+and+in+vitro+antitumor+activity+of+1%2C3%2C4-oxadiazole+derivatives+based+on+benzisoselenazolone&doi=10.1248%2Fcpb.c12-00250"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antitumor activity of 1,3,4-oxadiazole derivatives based on benzisoselenazolone</span></div><div class="casAuthors">Luo, Zhen-Hua; He, Shuang-Yan; Chen, Bao-Quan; Shi, Yan-Ping; Liu, Yu-Ming; Li, Cai-Wen; Wang, Qiu-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">887-891</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A series of novel 1,3,4-oxadiazole derivs. based on benzisoselenazolone was prepd. and was tested for antiproliferative activity in vitro against human cancer cell lines: SSMC-7721 (liver cancer), MCF-7 (breast cancer), and A549 (lung cancer).  All the compds. exhibited antiproliferative activity and showed selective cytotoxicity against different cancer cells.  Two of the compds. showed significant antiproliferative activities against MCF-7 cells, with IC50 of 1.07 and 1.76 μM.  One of latter compds. was also the most potent compd. against SSMC-7721 cells, with IC50 = 4.46 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrlzBgbrZqILVg90H21EOLACvtfcHk0liP10ziB0I1cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrsLjM&md5=f27622be25be99d96c7ee01b9b6531ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c12-00250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c12-00250%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DZ.%2BH.%26aulast%3DHe%26aufirst%3DS.%2BY.%26aulast%3DChen%26aufirst%3DB.%2BQ.%26aulast%3DShi%26aufirst%3DY.%2BP.%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DLi%26aufirst%3DC.%2BW.%26aulast%3DWang%26aufirst%3DQ.%2BS.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antitumor%2520activity%2520of%25201%252C3%252C4-oxadiazole%2520derivatives%2520based%2520on%2520benzisoselenazolone%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2012%26volume%3D60%26spage%3D887%26epage%3D891%26doi%3D10.1248%2Fcpb.c12-00250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a series of novel 2,4,5-trisubstituted selenazole compounds as potential PLTP inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5123</span>– <span class="NLM_lpage">5125</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2010.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=20667734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5123-5125&author=C.+Lingauthor=Z.+Zhengauthor=X.+C.+Jiangauthor=W.+Zhongauthor=S.+Li&title=Synthesis+of+a+series+of+novel+2%2C4%2C5-trisubstituted+selenazole+compounds+as+potential+PLTP+inhibitors&doi=10.1016%2Fj.bmcl.2010.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a series of novel 2,4,5-trisubstituted selenazole compounds as potential PLTP inhibitors</span></div><div class="casAuthors">Ling, Cui; Zheng, Zhibing; Jiang, Xian Cheng; Zhong, Wu; Li, Song</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5123-5125</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on a homol.-modeled structure of PLTP (plasma phospholipid transfer protein) and characteristic structural features of reported cholesteryl ester transfer protein (CETP) inhibitors, we designed and synthesized a novel series of 2,4,5-trisubstituted selenazole compds.  Biol. evaluation reveals that compds. I (R1 = Ph, R2 = H, R3 = H; R1 = Bu, R2 = R3 = OH) exhibit favorable PLTP activity, and their IC50s are 8 μM and 10 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXbnPlCTadJ7Vg90H21EOLACvtfcHk0liP10ziB0I1cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVehsbfL&md5=a06fb93ceefd7cd068e2793a62dc7dd8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DX.%2BC.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520a%2520series%2520of%2520novel%25202%252C4%252C5-trisubstituted%2520selenazole%2520compounds%2520as%2520potential%2520PLTP%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5123%26epage%3D5125%26doi%3D10.1016%2Fj.bmcl.2010.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiß, R.</span></span> <span> </span><span class="NLM_article-title">Über selenhaltige aromatische verbindungen (VI)</span>. <i>Ber. Dtsch. Chem. Ges. B</i> <span class="NLM_year" style="font-weight: bold;">1924</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1082</span>, <span class="refDoi"> DOI: 10.1002/cber.19240570703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fcber.19240570703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADyaB2cXitlChsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1924&pages=1077-1082&author=R.+Lesserauthor=R.+Wei%C3%9F&title=%C3%9Cber+selenhaltige+aromatische+verbindungen+%28VI%29&doi=10.1002%2Fcber.19240570703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic compounds containing selenium. VI</span></div><div class="casAuthors">Lesser, R.; Weiss, R.</div><div class="citationInfo"><span class="NLM_cas:title">Berichte der Deutschen Chemischen Gesellschaft [Abteilung] B: Abhandlungen</span>
        (<span class="NLM_cas:date">1924</span>),
    <span class="NLM_cas:volume">57B</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1077-82</span>CODEN:
                <span class="NLM_cas:coden">BDCBAD</span>;
        ISSN:<span class="NLM_cas:issn">0365-9488</span>.
    </div><div class="casAbstract">cf. C. A. 9, 80.  A more convenient method for the prepn. of selenoxanthone (I) has been worked out.  The product (II) of the action of CrO3 on I is not an addn. product of I, as previously supposed, but of selenoxide-xanthone (III) and its cleavage product is III itself, which on heating at its m. p. or under the influence of other reagents loses O, not H2O, giving I.  The soly. of III (in part even in H2O) with yellowish color is due to the addn. of H2O with production of HO groups.  The o-HSeC6H4COCl (IV) is very reactive, giving with NH3 benzoylene selenimide, Se.C6H4.CO.NH (V), with primary bases the corresponding substituted imides, with Na2S benzoylene selenosulfide (VI) and with Na2Se benzoylene diselenide (VII).  I, m. 191-2° (all m. ps. are cor.), is obtained in 10.3 g. yield of crude or 7.5 g. yield of pure product from 10 g. IV in 100 cc. dry thiophene-free C6H6 slowly treated with 11 g. AlCl3 and, when the gas evolution ceases, heated 1 hr. at 50-60° and then 1 hr. at the b. p. II, C13H8O2Se.CrO3, gives with NH3 III, decomps. 236-7°; air-dry, III contains varying amts. of H2O which it loses in vacuo over P2O5 or at 120-30°.  With PhMe instead of C6H6, IV gives β1- or β2-methylselenoxanthone, faintly yellowish, m. 112-3°, sol. in concd. H2SO4 with orange-yellow color.  V (7.4 g. crude product from 10 g. IV in cold C6H6 with dry NH3), needles or tables mutually interconvertible by seeding, m. 234-5°, both forms giving a red color with alc. FeCl3, forms alkali salts easily sol. in H2O but difficultly sol. in excess of alkali, gives in AcOH with CrO3 an addn. product which has approx. the compn. C7H5ONSe.CrO3 (no solvent suitable for crystn. could be found) but which on decompn. yields no homogeneous product; on long boiling with excess of Ac2O V gives an Ac deriv., begins to turn yellow 130°, m. 172-4°, sol. in hot AcOH with a yellowish color which disappears on cooling.  Benzoyleneselenmethylimide, obtained with MeNH2 gas instead of NH3, prisms with faintly yellowish shimmer, m. 159-60°, also obtained from the Ag salt of V with excess of MeI on the H2O bath in a sealed tube.  Et homolog, m. 102-3°.  Ph analog, from IV and PhNH2 in cold Et2O, m. 182-3°. o-Tolyl homolog, m. 187-8°.  N,N-Methylene di[benzoyleneselenimide], from the K salt of V and CH2I2 refluxed in AmOH, m. 331-2°.  VI (4.4 g. of crude product from 5.1 g. IV in 80 cc. Me2CO treated with 5 g. Na2S (fused in its H2O of crystn.) and then refluxed), orange, m. 83-4°, insol. in Na2CO3 or NaOH even on heating, dissolves unchanged in concd. H2SO4 with yellow color.  VII (8 g. from K2Se (prepd. by passing into 5.6 g. K2CO3 in 10 cc. H2O under CO2 the H2Se from 12 g. FeSe and 31 g. HCl of d. 1.12) treated cold with 10 g. IV in 50 cc. Me2CO and then refluxed 1 hr.), red, m. 91-2°, sol. in concd. H2SO4 with yellow color, the soln. becoming turbid on standing and evolving the odor of SO2. (PhCH2)2Se2, m. 90-1°, is obtained in 184 g. yield from 159 g. PhCH2Cl shaken with 100 g. red pptd. Se and 310 g. crystd. Na2S in 500 cc. H2O; 50 g. slowly added to 220 g. cold HNO3 (d. 1.4) gives 21 g. PhCH2SeO2H, m. 122-3° (Jackson, Ann. 179, 13(1875), gives 85°); Ba salt (2H2O); Ca salt (6H2O); the acid with PCl5 in dry Et2O gives, not the chloride, but (PhCH2)2SeCl2, m. 134-5° (Strecker and Willing, C. A. 9, 1179, give 128°).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYHvIwLyTdy7Vg90H21EOLACvtfcHk0liP10ziB0I1cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaB2cXitlChsQ%253D%253D&md5=682d8cb16b87ccfe02e534e5fbda8a74</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcber.19240570703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcber.19240570703%26sid%3Dliteratum%253Aachs%26aulast%3DLesser%26aufirst%3DR.%26aulast%3DWei%25C3%259F%26aufirst%3DR.%26atitle%3D%25C3%259Cber%2520selenhaltige%2520aromatische%2520verbindungen%2520%2528VI%2529%26jtitle%3DBer.%2520Dtsch.%2520Chem.%2520Ges.%2520B%26date%3D1924%26volume%3D57%26spage%3D1077%26epage%3D1082%26doi%3D10.1002%2Fcber.19240570703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Safayhi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiegs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendel, A.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2691</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(85)90569-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2885%2990569-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=2990494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADyaL2MXkvFyntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=2691-2694&author=H.+Safayhiauthor=G.+Tiegsauthor=A.+Wendel&title=A+novel+biologically+active+seleno-organic+compound%2D%2DV.+Inhibition+by+ebselen+%28PZ+51%29+of+rat+peritoneal+neutrophil+lipoxygenase&doi=10.1016%2F0006-2952%2885%2990569-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active seleno-organic compound - V.  Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase</span></div><div class="casAuthors">Safayhi, Hasan; Tiegs, Gisa; Wendel, Albrecht</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2691-4</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Suspensions of rat peritoneal polymorphonuclear leukocytes (PMNLs) elicited with glycogen were stimulated by Ca and an ionophore to produce leukotrienes from endogenous arachidonic acid.  The effect of the nontoxic, anti-inflammatory seleno-org. compd., ebselen (PZ 51)(I)  [60940-34-3] was investigated.  When ethanolic exts. of the medium of stimulated cells were analyzed by HPLC, a concn.-dependent inhibition by ebselen of leukotriene b4 (LTB4)  [71160-24-2] formation with a concomitant decrease of 5-hydroxyeicosatetraenoic acid (5-HETE)  [71030-39-2] prodn. was found.  Half-max. inhibition was obsd. at 20-μM ebselen.  Similar findings were obtained after anal. of CHCl3 exts. of both cells and medium using a different HPLC system.  Under these conditions, enhanced 5-HETE formation was assocd. with reduced prodn. of LTB4 and other dihydroxyeicosatetraenoate (di-HETE) isomers, when purified glutathione peroxidase  [9013-66-5] plus GSH were present.  Thus, the reported GSH peroxidase-like activity of ebselen, catalyzing the redn. of 5-hydroperoxyeicosatetraenoate (5-HPETE)  [70968-82-0] to 5-HETE, can not account for these findings.  Therefore, the lipoxygenase  [9029-60-1] reaction itself apparently represents the site of inhibition of LTB4 formation by ebselen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWGSiwX1XyKbVg90H21EOLACvtfcHk0lhbfex1jMqdHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXkvFyntrY%253D&md5=0c6b904a21350720941f6fe0123ce1a5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2885%2990569-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252885%252990569-6%26sid%3Dliteratum%253Aachs%26aulast%3DSafayhi%26aufirst%3DH.%26aulast%3DTiegs%26aufirst%3DG.%26aulast%3DWendel%26aufirst%3DA.%26atitle%3DA%2520novel%2520biologically%2520active%2520seleno-organic%2520compound--V.%2520Inhibition%2520by%2520ebselen%2520%2528PZ%252051%2529%2520of%2520rat%2520peritoneal%2520neutrophil%2520lipoxygenase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D2691%26epage%3D2694%26doi%3D10.1016%2F0006-2952%2885%2990569-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active selenoorganic compound--IV. Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1185</span>– <span class="NLM_lpage">1189</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(85)90493-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2885%2990493-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=3994741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADyaL2M7pvFWqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1985&pages=1185-1189&author=A.+Mullerauthor=H.+Gabrielauthor=H.+Sies&title=A+novel+biologically+active+selenoorganic+compound%2D%2DIV.+Protective+glutathione-dependent+effect+of+PZ+51+%28ebselen%29+against+ADP-Fe+induced+lipid+peroxidation+in+isolated+hepatocytes&doi=10.1016%2F0006-2952%2885%2990493-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active selenoorganic compound--IV. Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes</span></div><div class="casAuthors">Muller A; Gabriel H; Sies H</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1185-9</span>
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">PZ 51 (Ebselen) is capable of inhibiting ADP-Fe-induced lipid peroxidation in isolated hepatocytes, assessed by generation of low-level chemiluminescence, and the formation of alkanes (ethane, n-pentane) and malondialdehyde.  The sulphur analog PZ 25 is much less active.  PZ 51 is ineffective in glutathione-depleted hepatocytes that were obtained after phorone pretreatment of the animals.  However, other antioxidants, like (+)-cyanidanol-3 or diethyldithiocarbamate are effective in inhibiting lipid peroxidation also in glutathione-depleted cells.  The results are attributed to a GSH peroxidase-like activity of PZ 51.  Addition of the chemically synthetized compound, PZ 51-SG, a glutathione adduct of PZ 51, does not provide extra protection in GSH-depleted cells in comparison to the parent compound, PZ 51.  Dithioerythritol exhibits a protective effect, and PZ 51 is more efficient than in the absence of this thiol reductant.  Dithioerythritol also exerts an effect in glutathione-depleted cells.  A peroxidase-like activity using DTE as reductant is demonstrated in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlAtgJ8F5ZJQwxfk_AGB-EfW6udTcc2eZ8IMhG8G8T0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7pvFWqsA%253D%253D&md5=9c105e936b8f63bb05adea11a9e3ceb3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2885%2990493-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252885%252990493-9%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DGabriel%26aufirst%3DH.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DA%2520novel%2520biologically%2520active%2520selenoorganic%2520compound--IV.%2520Protective%2520glutathione-dependent%2520effect%2520of%2520PZ%252051%2520%2528ebselen%2529%2520against%2520ADP-Fe%2520induced%2520lipid%2520peroxidation%2520in%2520isolated%2520hepatocytes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1985%26volume%3D34%26spage%3D1185%26epage%3D1189%26doi%3D10.1016%2F0006-2952%2885%2990493-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wendel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fausel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safayhi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiegs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otter, R.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">3241</span>– <span class="NLM_lpage">3245</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(84)90084-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2884%2990084-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=6487371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADyaL2MXjvFKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1984&pages=3241-3245&author=A.+Wendelauthor=M.+Fauselauthor=H.+Safayhiauthor=G.+Tiegsauthor=R.+Otter&title=A+novel+biologically+active+seleno-organic+compound%2D%2DII.+Activity+of+PZ+51+in+relation+to+glutathione+peroxidase&doi=10.1016%2F0006-2952%2884%2990084-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active seleno-organic compound - II.  Activity of PZ 51 in relation to glutathione peroxidase</span></div><div class="casAuthors">Wendel, Albrecht; Fausel, Martina; Safayhi, Hasan; Tiegs, Gisa; Otter, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3241-5</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The antiinflammatory compd. PZ 51 (I)  [60940-34-3] catalyzed GSSG formation from GSH in the presence of hydroperoxides in an NADPH/GSSG reductase system with the following rates (Δ log GSH/min per M selenium): 1.1 × 106 with H2O2, 1.2 × 106 with butylhydroperoxide, 1.7 × 106 with cumenehydroperoxide.  The reaction catalyzed by the sulfur analog of PZ 51 was negligible.  Similar results were obtained in a direct assay of glutathione peroxidase (GSH-Px)  [9013-66-5] activity based on GSH estn. by dithionitrobenzoate.  The activation energy of the reaction was detd. as 55 kJ/mol·deg in the presence of 30 μmol/L PZ 51 compared to 36.5 kJ/mol·deg obtained in the presence of 1 nmol/L pure GSH-Px isolated from bovine red blood cells.  In mouse liver microsomes NADPH-dependent aminopyrine dealkylase  [9037-69-8] activity was totally inhibited in the presence of 50 μmol/L PZ 51.  In vivo expts. with Se-deficient mice showed that the Se-moiety of PZ 51 is not available for the synthesis of the selenoenzyme GSH-Px after dietary treatment or i.p. doses up to 25 mg Se as PZ 51 per kg body wt.  After oral administration of labeled PZ 51, unlike with selenite, no radioactivity was incorporated into GSH-Px within 48 h.  The data suggest that several similarities between PZ 51 and the active site of GSH-Px exist, resulting in the capability of the compd. to catalyze the GSH-Px reaction.  An extracellular pharmacodynamic action of the drug seems likely.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU1AxhueKd6bVg90H21EOLACvtfcHk0lhbfex1jMqdHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXjvFKitw%253D%253D&md5=a1475814e1a0c5ab4599dd82235b2993</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2884%2990084-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252884%252990084-4%26sid%3Dliteratum%253Aachs%26aulast%3DWendel%26aufirst%3DA.%26aulast%3DFausel%26aufirst%3DM.%26aulast%3DSafayhi%26aufirst%3DH.%26aulast%3DTiegs%26aufirst%3DG.%26aulast%3DOtter%26aufirst%3DR.%26atitle%3DA%2520novel%2520biologically%2520active%2520seleno-organic%2520compound--II.%2520Activity%2520of%2520PZ%252051%2520in%2520relation%2520to%2520glutathione%2520peroxidase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1984%26volume%3D33%26spage%3D3241%26epage%3D3245%26doi%3D10.1016%2F0006-2952%2884%2990084-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindt, S.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active seleno-organic compound--III. Effects of PZ 51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">3247</span>– <span class="NLM_lpage">3250</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(84)90085-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2884%2990085-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=6593071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADyaL2MXktVShu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1984&pages=3247-3250&author=M.+J.+Parnhamauthor=S.+Kindt&title=A+novel+biologically+active+seleno-organic+compound%2D%2DIII.+Effects+of+PZ+51+%28ebselen%29+on+glutathione+peroxidase+and+secretory+activities+of+mouse+macrophages&doi=10.1016%2F0006-2952%2884%2990085-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active seleno-organic compound - III.  Effects of PZ 51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages</span></div><div class="casAuthors">Parnham, Michael J.; Kindt, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3247-50</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">PZ 51 (I) a selenium-contg. compd. with glutathione peroxidase (GSH-Px)-like activity, was administered to selenium-deficient mice for 5 days.  A significant increase in peritoneal macrophage GSH-Px activity after treatment was only obsd. when basal GSH-Px activity was almost zero (i.e. in 19 wk selenium-deficient animals), possibly due to binding of PZ 51 to the macrophages.  This indicates that PZ 51 releases very little, if any, free selenium for incorporation into endogenous GSH-Px.  The compd. in vitro exerted a concn.-dependent inhibition of the generation of chemiluminescence by resident mouse peritoneal macrophages and a partial inhibition of the prodn. of prostaglandin E2 by resident peritoneal macrophages.  β-Glucuronidase prodn. by C. parvum-activated peritoneal macrophages was unaffected by PZ 51.  These in vitro data can be explained on the basis of a selective peroxide scavenging and/or GSH-Px-like activity of PZ 51, offering a novel approach to anti-inflammatory therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc-UiEcsGUarVg90H21EOLACvtfcHk0lhq5sNpLZFLnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktVShu7g%253D&md5=967be0e8b251a7c2e9c1e3c5660966a6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2884%2990085-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252884%252990085-6%26sid%3Dliteratum%253Aachs%26aulast%3DParnham%26aufirst%3DM.%2BJ.%26aulast%3DKindt%26aufirst%3DS.%26atitle%3DA%2520novel%2520biologically%2520active%2520seleno-organic%2520compound--III.%2520Effects%2520of%2520PZ%252051%2520%2528ebselen%2529%2520on%2520glutathione%2520peroxidase%2520and%2520secretory%2520activities%2520of%2520mouse%2520macrophages%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1984%26volume%3D33%26spage%3D3247%26epage%3D3250%26doi%3D10.1016%2F0006-2952%2884%2990085-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadenas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span> <span> </span><span class="NLM_article-title">A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen)</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">3235</span>– <span class="NLM_lpage">3239</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(84)90083-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2F0006-2952%2884%2990083-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=6487370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADyaL2M%252Fit1Onug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1984&pages=3235-3239&author=A.+Mullerauthor=E.+Cadenasauthor=P.+Grafauthor=H.+Sies&title=A+novel+biologically+active+seleno-organic+compound%2D%2DI.+Glutathione+peroxidase-like+activity+in+vitro+and+antioxidant+capacity+of+PZ+51+%28ebselen%29&doi=10.1016%2F0006-2952%2884%2990083-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen)</span></div><div class="casAuthors">Muller A; Cadenas E; Graf P; Sies H</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical pharmacology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3235-9</span>
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">a synthetic seleno-organic compound, 2-phenyl-1,2-benzoisoselenazol-3(2H)-one (PZ 51), exhibits GSH peroxidase-like activity in vitro, in contrast to its sulfur analog, PZ 25.  In addition, PZ 51 behaves as an antioxidant shown by a temporary protection of rat liver microsomes against ascorbate/ADP-Fe-induced lipid peroxidation, an effect also elicited by PZ 25 but to a smaller extent.  This protection against lipid peroxidation is independent of GSH and of P-450 monooxygenase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRrRhFmcWNw6sULxIEhxUjPfW6udTcc2eb-nYM2lt7UQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M%252Fit1Onug%253D%253D&md5=007fe0c40dbe5479f70c6391eda933d8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2884%2990083-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252884%252990083-2%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DCadenas%26aufirst%3DE.%26aulast%3DGraf%26aufirst%3DP.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DA%2520novel%2520biologically%2520active%2520seleno-organic%2520compound--I.%2520Glutathione%2520peroxidase-like%2520activity%2520in%2520vitro%2520and%2520antioxidant%2520capacity%2520of%2520PZ%252051%2520%2528ebselen%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1984%26volume%3D33%26spage%3D3235%26epage%3D3239%26doi%3D10.1016%2F0006-2952%2884%2990083-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klann, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulco, B. C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmeier, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, C. W.</span></span> <span> </span><span class="NLM_article-title">A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer’s disease</span>. <i>J. Psychiatr. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.jpsychires.2018.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.jpsychires.2018.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30521994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BB3crpt1KjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2019&pages=107-117&author=F.+Martiniauthor=S.+G.+Rosaauthor=I.+P.+Klannauthor=B.+C.+W.+Fulcoauthor=F.+B.+Carvalhoauthor=F.+L.+Rahmeierauthor=M.+C.+Fernandesauthor=C.+W.+Nogueira&title=A+multifunctional+compound+ebselen+reverses+memory+impairment%2C+apoptosis+and+oxidative+stress+in+a+mouse+model+of+sporadic+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jpsychires.2018.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease</span></div><div class="casAuthors">Martini Franciele; Rosa Suzan Goncalves; Klann Isabella Pregardier; Fulco Bruna Cruz Weber; Carvalho Fabiano Barbosa; Rahmeier Francine Luciano; Fernandes Marilda Cruz; Nogueira Cristina Wayne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer 's disease (AD) is characterized by progressive cognitive decline including memory impairment, cortical dysfunction, and neuropsychiatric disturbances.  The drug discovery to treat AD consists to develop compounds able to act in multiple molecular targets involved in the pathogenesis of the disease and the repositioning of old drugs for new application.  This way, the intracerebroventricular (icv) injection of streptozotocin (STZ) has been used as a metabolic model of sporadic AD.  The aim of the present study was to investigate whether ebselen (1-10 mg/kg), a multifunctional selenoorganic compound, ameliorates memory impairment, hippocampal oxidative stress, apoptosis and cell proliferation in a mouse model of sporadic AD induced by icv STZ (3 mg/kg, 1 μl/min).  The administration of ebselen (10 mg/kg, i.p.) reversed memory impairment and hippocampal oxidative stress, by increasing the activities of antioxidant enzymes and the level of a non-enzymatic antioxidant defense, in Swiss mice administered with icv STZ.  The anti-apoptotic property of ebselen was demonstrated by its effectiveness against the increase in the ratios of Bax/Bcl-2, cleaved PARP/PARP and the cleaved caspase-3 levels in the hippocampus of icv STZ mice.  Although ebselen reversed memory impairment, it was ineffective against the reduction in the number of BrdU positive cells induced by icv STZ.  In conclusion, the multifunctional selenoorganic compound ebselen was effective to reverse memory impairment, hippocampal oxidative stress and apoptosis in a mouse model of sporadic AD induced by icv STZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2LWJWidS9THRxY89Cm6SyfW6udTcc2eb-nYM2lt7UQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crpt1KjsA%253D%253D&md5=3d86850110eb7986c65035f3c5e29f16</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.jpsychires.2018.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpsychires.2018.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DMartini%26aufirst%3DF.%26aulast%3DRosa%26aufirst%3DS.%2BG.%26aulast%3DKlann%26aufirst%3DI.%2BP.%26aulast%3DFulco%26aufirst%3DB.%2BC.%2BW.%26aulast%3DCarvalho%26aufirst%3DF.%2BB.%26aulast%3DRahmeier%26aufirst%3DF.%2BL.%26aulast%3DFernandes%26aufirst%3DM.%2BC.%26aulast%3DNogueira%26aufirst%3DC.%2BW.%26atitle%3DA%2520multifunctional%2520compound%2520ebselen%2520reverses%2520memory%2520impairment%252C%2520apoptosis%2520and%2520oxidative%2520stress%2520in%2520a%2520mouse%2520model%2520of%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D2019%26volume%3D109%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.jpsychires.2018.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B.</span></span> <span> </span><span class="NLM_article-title">Target discovery of ebselen with a biotinylated probe</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">9506</span>– <span class="NLM_lpage">9509</span>, <span class="refDoi"> DOI: 10.1039/C8CC04258F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC8CC04258F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30091742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=9506-9509&author=Z.+Chenauthor=Z.+Jiangauthor=N.+Chenauthor=Q.+Shiauthor=L.+Tongauthor=F.+Kongauthor=X.+Chengauthor=H.+Chenauthor=C.+Wangauthor=B.+Tang&title=Target+discovery+of+ebselen+with+a+biotinylated+probe&doi=10.1039%2FC8CC04258F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Target discovery of ebselen with a biotinylated probe</span></div><div class="casAuthors">Chen, Zhenzhen; Jiang, Zhongyao; Chen, Nan; Shi, Qian; Tong, Lili; Kong, Fanpeng; Cheng, Xiufen; Chen, Hao; Wang, Chu; Tang, Bo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">68</span>),
    <span class="NLM_cas:pages">9506-9509</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Despite numerous studies on ebselen over the past decade, its cellular targets remain obscure.  Here we synthesized a biotinylated ebselen probe (biotin-ebselen) and characterized ebselen-binding proteins via an efficient activity-based protein profiling (ABPP) method, which allowed for the robust identification of 462 targeted proteins in HeLa cells.  This first work of global target profiling of ebselen will be helpful to re-design ebselen-based therapy appropriately in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdllLJcNTxYLVg90H21EOLACvtfcHk0lg6cJbJ_PD-DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWht7fF&md5=ff523727589707dd1461379f61407160</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC8CC04258F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CC04258F%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DF.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DB.%26atitle%3DTarget%2520discovery%2520of%2520ebselen%2520with%2520a%2520biotinylated%2520probe%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2018%26volume%3D54%26spage%3D9506%26epage%3D9509%26doi%3D10.1039%2FC8CC04258F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parnham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sies, H.</span></span> <span> </span><span class="NLM_article-title">The early research and development of ebselen</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1248</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2013.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bcp.2013.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24012716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVylu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=1248-1253&author=M.+J.+Parnhamauthor=H.+Sies&title=The+early+research+and+development+of+ebselen&doi=10.1016%2Fj.bcp.2013.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The early research and development of ebselen</span></div><div class="casAuthors">Parnham, Michael J.; Sies, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1248-1253</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one; PZ-51, DR-3305), is an organoselenium compd. with glutathione peroxidase (GPx)-like, thiol-dependent, hydroperoxide reducing activity.  As an enzyme mimic for activity of the selenoenzyme GPx, this compd. has proved to be highly useful in research on mechanisms in redox biol.  Furthermore, the reactivity of ebselen with protein thiols has helped to identify novel, selective targets for inhibitory actions on several enzymes of importance in pharmacol. and toxicol.  Importantly, the selenium in ebselen is not released and thus is not bioavailable, ebselen metabolites being excreted in bile and urine.  As a consequence, initial concerns about selenium toxicity, fortunately, were unfounded.  Potential applications in medical settings have been explored, notably in brain ischemia and stroke.  More recently, there has been a surge in interest as new medical applications have been taken into consideration.  The first publication on the biochem. effects of ebselen appeared 30 years ago, which prompted the authors to retrace the early development from their perspective.  It is a fascinating example of fruitful interaction between research-oriented industry and academia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbNs5kAFJVD7Vg90H21EOLACvtfcHk0lg6cJbJ_PD-DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVylu7fN&md5=76722e2600ba62e2f6be8334593c1c05</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DParnham%26aufirst%3DM.%2BJ.%26aulast%3DSies%26aufirst%3DH.%26atitle%3DThe%2520early%2520research%2520and%2520development%2520of%2520ebselen%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26spage%3D1248%26epage%3D1253%26doi%3D10.1016%2Fj.bcp.2013.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, N.</span></span> <span> </span><span class="NLM_article-title">Ebselen, a useful tool for understanding cellular redox biology and a promising drug candidate for use in human diseases</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>595</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2015.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.abb.2015.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27095225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtleisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=595&publication_year=2016&pages=109-112&author=N.+Noguchi&title=Ebselen%2C+a+useful+tool+for+understanding+cellular+redox+biology+and+a+promising+drug+candidate+for+use+in+human+diseases&doi=10.1016%2Fj.abb.2015.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen, a useful tool for understanding cellular redox biology and a promising drug candidate for use in human diseases</span></div><div class="casAuthors">Noguchi, Noriko</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">595</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109-112</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ebselen is an organoselenium compd. with glutathione peroxidase (GPx)-like hydroperoxide reducing activity.  Moreover, ebselen has its own unique reactivity, with functions that GPx does not have, since it reacts with many kinds of thiols other than glutathione.  Ebselen may affect the thioredoxin systems, through which it may contribute to regulation of cell function.  With high reactivity toward thiols, hydroperoxides, and peroxynitrite, ebselen has been used as a useful tool in research on cellular redox mechanisms.  Unlike α-tocopherol, ebselen does not scavenge lipid peroxyl radicals, which is another advantage of ebselen for use as a research tool in comparison with radical scavenging antioxidants.  Selenium is not released from the ebselen mol., which explains the low toxicity of ebselen.  To further understand the mechanism of cellular redox biol., it should be interesting to compare the effects of ebselen with that of selenoprotein P, which supplies selenium to GPx.  New medical applications of ebselen as a drug candidate for human diseases such as cancer and diabetes mellitus as well as brain stroke and ischemia will be expected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTUS82VR1d17Vg90H21EOLACvtfcHk0lg6cJbJ_PD-DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtleisL0%253D&md5=1296b21fdafafec78648801c59adc9dc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2015.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2015.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DN.%26atitle%3DEbselen%252C%2520a%2520useful%2520tool%2520for%2520understanding%2520cellular%2520redox%2520biology%2520and%2520a%2520promising%2520drug%2520candidate%2520for%2520use%2520in%2520human%2520diseases%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2016%26volume%3D595%26spage%3D109%26epage%3D112%26doi%3D10.1016%2Fj.abb.2015.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azad, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomar, R. S.</span></span> <span> </span><span class="NLM_article-title">Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways</span>. <i>Mol. Biol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">4865</span>– <span class="NLM_lpage">4879</span>, <span class="refDoi"> DOI: 10.1007/s11033-014-3417-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs11033-014-3417-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24867080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Gntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=4865-4879&author=G.+K.+Azadauthor=R.+S.+Tomar&title=Ebselen%2C+a+promising+antioxidant+drug%3A+mechanisms+of+action+and+targets+of+biological+pathways&doi=10.1007%2Fs11033-014-3417-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways</span></div><div class="casAuthors">Azad, Gajendra Kumar; Tomar, Raghuvir S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4865-4879</span>CODEN:
                <span class="NLM_cas:coden">MLBRBU</span>;
        ISSN:<span class="NLM_cas:issn">0301-4851</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Ebselen, an organoselenium compd., mimics glutathione peroxidase activity.  It is a multifunctional compd., which catalyzes several essential reactions for the protection of cellular components from oxidative and free radical damage.  Based on a no. of in vitro and in vivo studies, various mechanisms are proposed to understand the biomedical actions of ebselen in health and diseases.  It modulates metallo-proteins, enzymic cofactors, gene expression, epigenetics, antioxidant defenses and immune systems.  Owing to these properties, ebselen is currently under clin. trials for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis, and cancer.  A few ebselen-based pharmaceutical agents are under extensive investigation.  As ebselen has been shown to have significant cellular toxicity, appropriate studies are needed to redesign the ebselen-based therapy for clin. trials.  This review summarizes current understanding of the biochem. and mol. properties, and pharmacol. applications of ebselen and future directions in this area of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsR7BfKLYxAbVg90H21EOLACvtfcHk0lg6cJbJ_PD-DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Gntbw%253D&md5=9592c6d44387e26927af07e3c7d39b9c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs11033-014-3417-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11033-014-3417-x%26sid%3Dliteratum%253Aachs%26aulast%3DAzad%26aufirst%3DG.%2BK.%26aulast%3DTomar%26aufirst%3DR.%2BS.%26atitle%3DEbselen%252C%2520a%2520promising%2520antioxidant%2520drug%253A%2520mechanisms%2520of%2520action%2520and%2520targets%2520of%2520biological%2520pathways%26jtitle%3DMol.%2520Biol.%2520Rep.%26date%3D2014%26volume%3D41%26spage%3D4865%26epage%3D4879%26doi%3D10.1007%2Fs11033-014-3417-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santofimia-Castaño, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izquierdo-Alvarez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaza-Davila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Bermejo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateos-Rodriguez, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salido, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span> <span> </span><span class="NLM_article-title">Ebselen impairs cellular oxidative state and induces endoplasmic reticulum stress and activation of crucial mitogen-activated protein kinases in pancreatic tumour AR42J cells</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1122</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1002/jcb.26280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fjcb.26280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28703940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1SksbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2018&pages=1122-1133&author=P.+Santofimia-Casta%C3%B1oauthor=A.+Izquierdo-Alvarezauthor=M.+Plaza-Davilaauthor=A.+Martinez-Ruizauthor=M.+Fernandez-Bermejoauthor=J.+M.+Mateos-Rodriguezauthor=G.+M.+Salidoauthor=A.+Gonzalez&title=Ebselen+impairs+cellular+oxidative+state+and+induces+endoplasmic+reticulum+stress+and+activation+of+crucial+mitogen-activated+protein+kinases+in+pancreatic+tumour+AR42J+cells&doi=10.1002%2Fjcb.26280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen impairs cellular oxidative state and induces endoplasmic reticulum stress and activation of crucial mitogen-activated protein kinases in pancreatic tumour AR42J cells</span></div><div class="casAuthors">Santofimia-Castano, Patricia; Izquierdo-Alvarez, Alicia; Plaza-Davila, Maria; Martinez-Ruiz, Antonio; Fernandez-Bermejo, Miguel; Mateos-Rodriguez, Jose M.; Salido, Gines M.; Gonzalez, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1122-1133</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) is an organoselenium radical scavenger compd., which has strong antioxidant and anti-inflammatory effects.  However, evidence suggests that this compd. could exert deleterious actions on cell physiol.  In this study, we have analyzed the effect of ebselen on rat pancreatic AR42J cells.  Cytosolic free-Ca2+ concn. ([Ca2+]c), cellular oxidative status, setting of endoplasmic reticulum stress, and phosphorylation of major mitogen-activated protein kinases were analyzed.  Our results show that ebselen evoked a concn.-dependent increase in [Ca2+]c.  The compd. induced an increase in the generation of reactive oxygen species in the mitochondria.  We also obsd. an increase in global cysteine oxidn. in the presence of ebselen.  In the presence of ebselen an impairment of cholecystokinin-evoked amylase release was noted.  Moreover, involvement of the unfolded protein response markers, ER chaperone and signaling regulator GRP78/BiP, eukaryotic translation initiation factor 2α and X-box binding protein 1 was detected.  Finally, increases in the phosphorylation of SAPK/JNK, p38 MAPK, and p44/42 MAPK in the presence of ebselen were also obsd.  Our results provide evidences for an impairment of cellular oxidative state and enzyme secretion, the induction of endoplasmic reticulum stress and the activation of crucial mitogen-activated protein kinases in the presence of ebselen.  As a consequence ebselen exerts a potential toxic effect on AR42J cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjeZyQ1exDl7Vg90H21EOLACvtfcHk0likGaUEdy1VBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1SksbzN&md5=24ed1266651fcc6e434e41b6279e61bc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fjcb.26280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.26280%26sid%3Dliteratum%253Aachs%26aulast%3DSantofimia-Casta%25C3%25B1o%26aufirst%3DP.%26aulast%3DIzquierdo-Alvarez%26aufirst%3DA.%26aulast%3DPlaza-Davila%26aufirst%3DM.%26aulast%3DMartinez-Ruiz%26aufirst%3DA.%26aulast%3DFernandez-Bermejo%26aufirst%3DM.%26aulast%3DMateos-Rodriguez%26aufirst%3DJ.%2BM.%26aulast%3DSalido%26aufirst%3DG.%2BM.%26aulast%3DGonzalez%26aufirst%3DA.%26atitle%3DEbselen%2520impairs%2520cellular%2520oxidative%2520state%2520and%2520induces%2520endoplasmic%2520reticulum%2520stress%2520and%2520activation%2520of%2520crucial%2520mitogen-activated%2520protein%2520kinases%2520in%2520pancreatic%2520tumour%2520AR42J%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2018%26volume%3D119%26spage%3D1122%26epage%3D1133%26doi%3D10.1002%2Fjcb.26280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span> <span> </span><span class="NLM_article-title">Induction of apoptosis in human multiple myeloma cell lines by ebselen via enhancing the endogenous reactive oxygen species production</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">696107</span>, <span class="refDoi"> DOI: 10.1155/2014/696107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1155%2F2014%2F696107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24587987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC2cvpvVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=696107&author=L.+Zhangauthor=L.+Zhouauthor=J.+Duauthor=M.+Liauthor=C.+Qianauthor=Y.+Chengauthor=Y.+Pengauthor=J.+Xieauthor=D.+Wang&title=Induction+of+apoptosis+in+human+multiple+myeloma+cell+lines+by+ebselen+via+enhancing+the+endogenous+reactive+oxygen+species+production&doi=10.1155%2F2014%2F696107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of apoptosis in human multiple myeloma cell lines by ebselen via enhancing the endogenous reactive oxygen species production</span></div><div class="casAuthors">Zhang Liang; Zhou Liwei; Du Jia; Li Mengxia; Qian Chengyuan; Cheng Yi; Peng Yang; Xie Jiayin; Wang Dong</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">696107</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ebselen a selenoorganic compound showing glutathione peroxidase like activity is an anti-inflammatory and antioxidative agent.  Its cytoprotective activity has been investigated in recent years.  However, experimental evidence also shows that ebselen causes cell death in several cancer cell types whose mechanism has not yet been elucidated.  In this study, we examined the effect of ebselen on multiple myeloma (MM) cell lines in vitro.  The results showed that ebselen significantly enhanced the production of reactive oxygen species (ROS) accompanied by cell viability decrease and apoptosis rate increase.  Further studies revealed that ebselen can induce Bax redistribution from the cytosol to mitochondria leading to mitochondrial membrane potential ΔΨm changes and cytochrome C release from the mitochondria to cytosol.  Furtherly, we found that exogenous addition of N-acetyl cysteine (NAC) completely diminished the cell damage induced by ebselen.  This result suggests that relatively high concentration of ebselen can induce MM cells apoptosis in culture by enhancing the production of endogenous ROS and triggering mitochondria mediated apoptotic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRByoz9pGRQNa2q3xNe7a7QfW6udTcc2eZAoa1rsOV0ILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvpvVWjtA%253D%253D&md5=22d209ef9051e3a5eb15d39dd08775ed</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1155%2F2014%2F696107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F696107%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%26atitle%3DInduction%2520of%2520apoptosis%2520in%2520human%2520multiple%2520myeloma%2520cell%2520lines%2520by%2520ebselen%2520via%2520enhancing%2520the%2520endogenous%2520reactive%2520oxygen%2520species%2520production%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2014%26volume%3D2014%26spage%3D696107%26doi%3D10.1155%2F2014%2F696107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanavan, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katchman, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faigel, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.-t.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergienko, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurice, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, D. F.</span></span> <span> </span><span class="NLM_article-title">Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">18418</span>– <span class="NLM_lpage">18428</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.4099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.18632%2Foncotarget.4099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26158899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fhs1ertQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=18418-18428&author=P.+D.+Hanavanauthor=C.+R.+Borgesauthor=B.+A.+Katchmanauthor=D.+O.+Faigelauthor=T.+H.+Hoauthor=C.-t.+Maauthor=E.+A.+Sergienkoauthor=N.+Meuriceauthor=J.+L.+Petitauthor=D.+F.+Lake&title=Ebselen+inhibits+QSOX1+enzymatic+activity+and+suppresses+invasion+of+pancreatic+and+renal+cancer+cell+lines&doi=10.18632%2Foncotarget.4099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines</span></div><div class="casAuthors">Hanavan Paul D; Lake Douglas F; Borges Chad R; Katchman Benjamin A; Faigel Douglas O; Ho Thai H; Meurice Nathalie; Petit Joachim L; Ma Chen-Ting; Sergienko Eduard A</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">18418-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Quiescin sulfhydryl oxidase 1 (QSOX1) is a highly conserved disulfide bond-generating enzyme that is overexpressed in diverse tumor types.  Its enzymatic activity promotes the growth and invasion of tumor cells and alters extracellular matrix composition.  In a nude mouse-human tumor xenograft model, tumors containing shRNA for QSOX1 grew significantly more slowly than controls, suggesting that QSOX1 supports a proliferative phenotype in vivo.  High throughput screening experiments identified ebselen as an in vitro inhibitor of QSOX1 enzymatic activity.  Ebselen treatment of pancreatic and renal cancer cell lines stalled tumor growth and inhibited invasion through Matrigel in vitro.  Daily oral treatment with ebselen resulted in a 58% reduction in tumor growth in mice bearing human pancreatic tumor xenografts compared to controls.  Mass spectrometric analysis of ebselen-treated QSOX1 mechanistically revealed that C165 and C237 of QSOX1 covalently bound to ebselen.  This report details the anti-neoplastic properties of ebselen in pancreatic and renal cancer cell lines.  The results here offer a "proof-of-principle" that enzymatic inhibition of QSOX1 may have clinical relevancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIO6QDcRzGzPx2phytoz6_fW6udTcc2eZAoa1rsOV0ILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fhs1ertQ%253D%253D&md5=7b5f38602a2396a04779bdb1fe504417</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4099%26sid%3Dliteratum%253Aachs%26aulast%3DHanavan%26aufirst%3DP.%2BD.%26aulast%3DBorges%26aufirst%3DC.%2BR.%26aulast%3DKatchman%26aufirst%3DB.%2BA.%26aulast%3DFaigel%26aufirst%3DD.%2BO.%26aulast%3DHo%26aufirst%3DT.%2BH.%26aulast%3DMa%26aufirst%3DC.-t.%26aulast%3DSergienko%26aufirst%3DE.%2BA.%26aulast%3DMeurice%26aufirst%3DN.%26aulast%3DPetit%26aufirst%3DJ.%2BL.%26aulast%3DLake%26aufirst%3DD.%2BF.%26atitle%3DEbselen%2520inhibits%2520QSOX1%2520enzymatic%2520activity%2520and%2520suppresses%2520invasion%2520of%2520pancreatic%2520and%2520renal%2520cancer%2520cell%2520lines%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D18418%26epage%3D18428%26doi%3D10.18632%2Foncotarget.4099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thabet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustafa, E.</span></span> <span> </span><span class="NLM_article-title">Synergistic effect of ebselen and gamma radiation on breast cancer cells</span>. <i>Int. J. Radiat. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1080/09553002.2017.1325024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1080%2F09553002.2017.1325024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28463038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2017&pages=784-792&author=N.+Thabetauthor=E.+Moustafa&title=Synergistic+effect+of+ebselen+and+gamma+radiation+on+breast+cancer+cells&doi=10.1080%2F09553002.2017.1325024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effect of Ebselen and gamma radiation on breast cancer cells</span></div><div class="casAuthors">Thabet, Noura M.; Moustafa, Enas M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">784-792</span>CODEN:
                <span class="NLM_cas:coden">IJRBE7</span>;
        ISSN:<span class="NLM_cas:issn">0955-3002</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Purpose: To explore the synergistic effect of a seleno-org. compd. Ebselen (Ebs) and/or γ-radiation to exert antitumor effects on human breast cancer (MCF-7) cell line in vitro.  Materials and methods: Ebs cytotoxicity at various concns. (10, 25, 50 and 75 μg), cell proliferation and clonogenic assay of Ebs and/or γ-radiation (at 1, 3 and 6 Gy), expression of p-IκBα and NF-κB, inflammatory cytokines levels (TNF-α, IL-2, INF-γ, IL-10 and TGF-β), apoptotic factors (Caspase-3, Granzyme-B and TRAIL) and angiogenic factor (VEGF) were investigated.  Results: The results showed that the effective dosage of this combination was obsd. at 25 μg/mL of Ebs with γ-radiation at 6 Gy.  Data displayed a significant redn. in NF-κB mRNA along with an elevation in granzyme-B mRNA and TRAIL mRNA expression.  Furthermore, protein expression of caspase-3 was elevated, whereas p-IκBα and p-NF-κB(p65) protein expression was reduced significantly.  Also, a significant decline in TNF-α, IL-2, INF-γ, TGF-β with a significant increase in IL-10 levels were revealed.  Meanwhile, a significant decrease in VEGF level and proliferation capacity were obsd.  Conclusions: We conclude that a combination of Ebs with radiotherapy has a major antitumor efficiency in inducing apoptosis and inhibiting cancer cell progression, due to the synergistic effect in regulating gene and protein expression, and in a modulating response of pro-and anti-inflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_q15ta4ZCx7Vg90H21EOLACvtfcHk0liSFfYg2-uqDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKhurs%253D&md5=039ae05f57afe4eeab24f0e870919fa0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1080%2F09553002.2017.1325024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09553002.2017.1325024%26sid%3Dliteratum%253Aachs%26aulast%3DThabet%26aufirst%3DN.%26aulast%3DMoustafa%26aufirst%3DE.%26atitle%3DSynergistic%2520effect%2520of%2520ebselen%2520and%2520gamma%2520radiation%2520on%2520breast%2520cancer%2520cells%26jtitle%3DInt.%2520J.%2520Radiat.%2520Biol.%26date%3D2017%26volume%3D93%26spage%3D784%26epage%3D792%26doi%3D10.1080%2F09553002.2017.1325024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span> <span> </span><span class="NLM_article-title">Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1038/aps.2016.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1038%2Faps.2016.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27917873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFemu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=223-232&author=S.+F.+Yeauthor=J.+Liauthor=S.+M.+Jiauthor=H.+H.+Zengauthor=W.+Lu&title=Dose-biomarker-response+modeling+of+the+anticancer+effect+of+ethaselen+in+a+human+non-small+cell+lung+cancer+xenograft+mouse+model&doi=10.1038%2Faps.2016.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model</span></div><div class="casAuthors">Ye, Suo-fu; Li, Jian; Ji, Shuang-min; Zeng, Hui-hui; Lu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thioredoxin reductase (TrxR) is a component of several redox-sensitive signaling cascades that mediate important biol. processes such as cell survival, maturation, growth, migration and inhibition of apoptosis.  The expression levels of TrxR1 in some human carcinoma cell lines are nearly 10 times higher than those in normal cells.  Ethaselen is a novel antitumor candidate that exerts potent inhibition on non-small cell lung cancer (NSCLC) by targeting TrxR.  In this study we explored the relationship between the ethaselen dose and TrxR activity level and the relationship between TrxR degrdn. and tumor apoptosis in a human lung carcinoma A549 xenograft model.  BALB/c nude mice implanted with human NSCLC cell line A54 were administered ethaselen (36, 72, 108 mg·kg-1·d-1, ig) or vehicle for 10 d.  The tumor size and TrxR activity levels in tumor tissues were daily recorded and detected.  Based on the exptl. data, NONMEM 7.2 was used to develop an integrated dose-biomarker-response model for describing the quant. relationship between ethaselen dose and tumor eradication effects.  The time course of TrxR activity levels was modeled using an indirect response model (IDR model), in which the influence of the tumor growth rates on Kin with the linear correction factor γ1 (0.021 d/mm).  The drug binding-inhibition effects on Kout was described using a sigmoidal Emax model with Smax (5.95), SC50 (136 mg/kg) and Hill's coeff. γ2 (2.29).  The influence of TrxR activity inhibition on tumor eradication was characterized by an Emax model with an Emax (130 mm3/d) and EC50 (0.0676).  This model was further validated using a visual predictive check (VPC) and was used to predict the efficacy of different doses.  In conclusion, the properties and characteristics of ethaselen acting on TrxR degrdn. and subsequently resulting in tumor apoptosis are characterized by the IDR model and integrated dose-biomarker-response model with high goodness-of-fit and great predicative ability.  This approach shed new light on the detailed processes and mechanism of ethaselen action and may offer a valuable ref. for an appropriate dosing regimen for use in further clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZTDsUmqoHfrVg90H21EOLACvtfcHk0liSFfYg2-uqDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFemu70%253D&md5=44d18ca03808ccd049b7a3e3e9aea222</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Faps.2016.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2016.114%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DS.%2BM.%26aulast%3DZeng%26aufirst%3DH.%2BH.%26aulast%3DLu%26aufirst%3DW.%26atitle%3DDose-biomarker-response%2520modeling%2520of%2520the%2520anticancer%2520effect%2520of%2520ethaselen%2520in%2520a%2520human%2520non-small%2520cell%2520lung%2520cancer%2520xenograft%2520mouse%2520model%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2017%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1038%2Faps.2016.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span> <span> </span><span class="NLM_article-title">Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2017.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.cbi.2017.07.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28757135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OhsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2017&pages=74-85&author=X.+Zhengauthor=W.+Xuauthor=R.+Sunauthor=H.+Yinauthor=C.+Dongauthor=H.+Zeng&title=Synergism+between+thioredoxin+reductase+inhibitor+ethaselen+and+sodium+selenite+in+inhibiting+proliferation+and+inducing+death+of+human+non-small+cell+lung+cancer+cells&doi=10.1016%2Fj.cbi.2017.07.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells</span></div><div class="casAuthors">Zheng, Xiaoqing; Xu, Wei; Sun, Ruoxuan; Yin, Hanwei; Dong, Chaoran; Zeng, Huihui</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-85</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">New effective treatment for human non-small cell lung cancer (NSCLC) is needed.  The thioredoxin (Trx) system composes of thioredoxin reductase (TrxR), Trx and NADPH.  In this study, we combined an org. selenium compd.--TrxR inhibitor ethaselen (BBSKE) with low dosage sodium selenite to inhibit proliferation and induce death of NSCLC cells, and identified underlying mechanisms.  Synergistic anti-proliferation effect of BBSKE and selenite was found in human NSCLC cell lines, A549, NCI-H1299 and NCI-1266.  A significant increase of apoptosis, necrosis and autophagy were obsd. in the group of BBSKE plus selenite in A549 cells.  The autophagy induced by BBSKE and selenite inhibited apoptosis and necrosis.  In addn., BBSKE plus selenite induced G2/M arrest, which was verified by the alteration of gene and protein expression of cell cycle regulatory complexes.  The intracellular enzyme activity of TrxR was remarkably decreased by cotreatment of BBSKE and selenite.  Besides, the mRNA and protein level of TrxR1 and Trx1 were significantly inhibited by cotreatment of BBSKE and selenite.  HEK 293 cells overexpressing TrxR1 were more sensitive to BBSKE plus selenite.  The nuclear translocation of Trx1 and Ref-1, as well as expression of Ref-1 and AP-1 were inhibited by combination treatment.  In short, BBSKE synergizes selenite in inhibiting proliferation and inducing death of NSCLC cells; BBSKE combined with selenite may be a treatment strategy for NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Nf655harybVg90H21EOLACvtfcHk0liSFfYg2-uqDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OhsrbO&md5=72836b3fd29501295b99d449f1af1f3f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2017.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2017.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DC.%26aulast%3DZeng%26aufirst%3DH.%26atitle%3DSynergism%2520between%2520thioredoxin%2520reductase%2520inhibitor%2520ethaselen%2520and%2520sodium%2520selenite%2520in%2520inhibiting%2520proliferation%2520and%2520inducing%2520death%2520of%2520human%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2017%26volume%3D275%26spage%3D74%26epage%3D85%26doi%3D10.1016%2Fj.cbi.2017.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span> <span> </span><span class="NLM_article-title">Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2016.06.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.biopha.2016.06.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27372405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFWht73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2016&pages=212-220&author=X.+Zhengauthor=Y.+Zhangauthor=L.+Zhangauthor=W.+Xuauthor=W.+Maauthor=R.+Sunauthor=H.+Zeng&title=Synergistic+inhibition+of+sunitinib+and+ethaselen+against+human+colorectal+cancer+cells+proliferation&doi=10.1016%2Fj.biopha.2016.06.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation</span></div><div class="casAuthors">Zheng, Xiaoqing; Zhang, Yunhan; Zhang, Lei; Xu, Wei; Ma, Weiwei; Sun, Ruoxuan; Zeng, Huihui</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">212-220</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Sunitinib, a multi-targeted tyrosine kinase inhibitor, has been widely used in the therapy of advanced renal cell cancer and imatinib-resistant gastrointestinal stromal tumors.  However, little benefits could be obtained from sunitinib for patients with other types of solid tumors including colorectal cancer (CRC).  Ethaselen (BBSKE), a specific thioredoxin reductase 1 inhibitor, has shown convincing anticancer effects both in vivo and in vitro.  In this study, we explored the combinatory effect of sunitinib and BBSKE in human CRC cell lines LoVo, HT-29 and RKO.  Cotreatment of BBSKE and sunitinib with the ratio of 2:1 for 24 h displayed synergistic effect against CRC cells proliferation.  Apoptosis anal. also revealed that combination treatment of BBSKE and sunitinib (2:1) for 24 h induced higher apoptosis rate than either single treatment.  The synergistic effect against LoVo cells proliferation may be explained by sharp redn. of Bcl-2/Bax protein expression ratio, decrease of pro-Caspase-3 protein expression along with significantly augmented Caspase-3 enzymic activity, and release of cytochrome C from mitochondria to cytoplasm in the combination treatment group.  The significant inhibition of vascular endothelial growth factor receptor 2 (VEGFR2) phosphorylation might also account for the synergism in cotreatment group.  In short, sunitinib plus BBSKE is perhaps a promising strategy for colorectal cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVu1ylBpRdVLVg90H21EOLACvtfcHk0lj3XfD8tanFCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFWht73I&md5=35e1dd73f9e370306ecc8f8dc17e6d99</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.06.040%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DH.%26atitle%3DSynergistic%2520inhibition%2520of%2520sunitinib%2520and%2520ethaselen%2520against%2520human%2520colorectal%2520cancer%2520cells%2520proliferation%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D83%26spage%3D212%26epage%3D220%26doi%3D10.1016%2Fj.biopha.2016.06.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H. H.</span></span> <span> </span><span class="NLM_article-title">Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis</span>. <i>J. Zhejiang Univ., Sci., B</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1631/jzus.B1600073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1631%2Fjzus.B1600073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28471109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsVarsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=373-382&author=S.+F.+Yeauthor=Y.+Yangauthor=L.+Wuauthor=W.+W.+Maauthor=H.+H.+Zeng&title=Ethaselen%3A+a+novel+organoselenium+anticancer+agent+targeting+thioredoxin+reductase+1+reverses+cisplatin+resistance+in+drug-resistant+K562+cells+by+inducing+apoptosis&doi=10.1631%2Fjzus.B1600073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis</span></div><div class="casAuthors">Ye, Suo-fu; Yang, Yong; Wu, Lin; Ma, Wei-wei; Zeng, Hui-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Zhejiang University, Science, B</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-382</span>CODEN:
                <span class="NLM_cas:coden">JZUSAM</span>;
        ISSN:<span class="NLM_cas:issn">1673-1581</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">It has been reported that Ethaselen shows inhibitory effects on thioredoxin reductase (TrxR) activity and human tumor cell growth.  In order to find an efficient way to reverse cisplatin resistance, we investigated the reversal effects of Ethaselen on cisplatin resistance in K562/cisplatin (CDDP) cells that were established by pulse-inducing human erythrocyte leukemic cell line K562, which are fivefold more resistant to cisplatin compared to K562 cells.  The morphol. and growth showed that the adhesion of K562/CDDP further decreased while the cell vol. increased.  The proliferation of K562/CDDP is strengthened.  The antitumor activities in vitro were assessed by MTT (3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and combination index (CI), showing the significant synergic effects of cisplatin and Ethaselen.  Focusing on apoptosis, a series of comparisons was made between K562 and K562/CDDP.  Cisplatin induced higher reactive oxygen species (ROS) generation in K562 and subsequently induced the formation of mitochondrial permeability transition pores (PTPs).  In addn., cisplatin increased the ratio of Bax to Bcl-2 in K562, which can influence the mitochondrial membrane permeability.  PTP formation and mitochondrial membrane permeabilization eventually resulted in the release of cytochrome c and activation of the Caspase pathway.  However, these effects were not clearly seen in K562/CDDP, which may be the reason for the acquired CDDP resistance.  However, Ethaselen can induce a high level of ROS in K562/CDDP by TrxR activity inhibition and increased ratio of Bax to Bcl-2 in K562/CDDP by nuclear factor κB (NF-κB) suppression, which subsequently induces the release of cytochrome c in K562/CDDP.  This response is partly responsible for the reversal of the cisplatin resistance in K562/CDDP cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_ngsBrviFqLVg90H21EOLACvtfcHk0lj3XfD8tanFCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsVarsL0%253D&md5=5a37af3e551326fe6ec06f4c25ef1da6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1631%2Fjzus.B1600073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1631%252Fjzus.B1600073%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%2BF.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DZeng%26aufirst%3DH.%2BH.%26atitle%3DEthaselen%253A%2520a%2520novel%2520organoselenium%2520anticancer%2520agent%2520targeting%2520thioredoxin%2520reductase%25201%2520reverses%2520cisplatin%2520resistance%2520in%2520drug-resistant%2520K562%2520cells%2520by%2520inducing%2520apoptosis%26jtitle%3DJ.%2520Zhejiang%2520Univ.%252C%2520Sci.%252C%2520B%26date%3D2017%26volume%3D18%26spage%3D373%26epage%3D382%26doi%3D10.1631%2Fjzus.B1600073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H. H.</span></span> <span> </span><span class="NLM_article-title">The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2018.11.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.freeradbiomed.2018.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30496814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2it7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2019&pages=7-17&author=X.+Q.+Zhengauthor=Y.+F.+Chenauthor=M.+Baiauthor=Y.+X.+Liuauthor=B.+Y.+Xuauthor=R.+X.+Sunauthor=H.+H.+Zeng&title=The+antimetastatic+effect+and+underlying+mechanisms+of+thioredoxin+reductase+inhibitor+ethaselen&doi=10.1016%2Fj.freeradbiomed.2018.11.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen</span></div><div class="casAuthors">Zheng, Xiaoqing; Chen, Yifan; Bai, Man; Liu, Yuxi; Xu, Binyuan; Sun, Ruoxuan; Zeng, Huihui</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Treating cancer metastasis is of vital importance to prolong patients' survival.  Thioredoxin reductase (TrxR) is overexpressed in many cancer types and has been recognized as an anticancer target.  The organoselenium compd. ethaselen (BBSKE) has been proved to be a TrxR inhibitor and inhibit various types of tumor growth.  However, whether BBSKE could inhibit tumor metastasis remains unclear.  In this study, the authors aim to explore the antimetastatic effect of BBSKE and underlying mechanisms.  BBSKE was found to dose-dependently suppress migration and invasion of MCF-7 and LoVo cells in vitro.  The underlying mechanisms may include inhibition of TrxR activity, elevation of reactive oxygen species (ROS), decrease of EGFR activation and HER2 expression.  Besides, the epithelial to mesenchymal transition process and expression of CD44, MMP-9, VEGFR2 and PD-L1 were also abrogated.  Decreased migration and invasion, lower expression levels of EGFR, HER2, N-cadherin, CD44, MMP-9, VEGFR2 and PD-L1 were also obsd. in TrxR1-knockdown MCF-7 and LoVo cells.  In the mouse breast cancer 4T1 model, BBSKE not only inhibited progression of primary tumor, but also suppressed formation of metastatic lung nodules and liver micro-metastases, indicating that BBSKE could effectively abolish tumor metastasis.  In conclusion, the findings show that BBSKE is able to inhibit migration and invasion of cancer cells in vitro and in vivo, and may be used to prevent and treat metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PioZWqnzT7Vg90H21EOLACvtfcHk0lgw9ES2ChwRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2it7zN&md5=f634374d0a08160fa0a9dda5ff816725</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%2BQ.%26aulast%3DChen%26aufirst%3DY.%2BF.%26aulast%3DBai%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%2BX.%26aulast%3DXu%26aufirst%3DB.%2BY.%26aulast%3DSun%26aufirst%3DR.%2BX.%26aulast%3DZeng%26aufirst%3DH.%2BH.%26atitle%3DThe%2520antimetastatic%2520effect%2520and%2520underlying%2520mechanisms%2520of%2520thioredoxin%2520reductase%2520inhibitor%2520ethaselen%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2019%26volume%3D131%26spage%3D7%26epage%3D17%26doi%3D10.1016%2Fj.freeradbiomed.2018.11.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of benzoselenazole-stilbene hybrids as multi-target-directed anti-cancer agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2015.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25817772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1yitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=220-229&author=J.+Yanauthor=Y.+Guoauthor=Y.+Wangauthor=F.+Maoauthor=L.+Huangauthor=X.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+benzoselenazole-stilbene+hybrids+as+multi-target-directed+anti-cancer+agents&doi=10.1016%2Fj.ejmech.2015.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of benzoselenazole-stilbene hybrids as multi-target-directed anti-cancer agents</span></div><div class="casAuthors">Yan, Jun; Guo, Yueyan; Wang, Yali; Mao, Fei; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">220-229</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To identify novel multi-target-directed drug candidates for the treatment of cancer, a series of benzoselenazole-stilbene hybrids I [ R1 = H, OMe; R2 = H, OMe; R3 = H, OMe; R4 = H, OMe, Cl; R5 = H, OMe, F, Cl.] were synthesized by combining the pharmacophores of resveratrol and ebselen.  The biol. assay indicated that all of the hybrids exhibited antiproliferative activities against four human cancer cell lines and demonstrated good TrxR inhibitory activities.  The mechanism of cell apoptosis was investigated in G2/M cell cycle arrest induced by compd. I [ R1 = R2 = OMe, R3 = R4 = R5 = H] and the apoptosis of the human liver carcinoma Bel-7402 cell line.  The significant increase in intracellular ROS confirmed that compd. I [ R1 = R2 = OMe, R3 = R4 = R5 = H] was capable of causing oxidative stress-induced apoptosis in cancer cells.  Our results support the potential of compd. I [ R1 = R2 = OMe, R3 = R4 = R5 = H] as a candidate for further studies examg. the development of novel drugs for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJN_FfsJpNrrVg90H21EOLACvtfcHk0lgw9ES2ChwRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1yitbc%253D&md5=316682d03ce59a3e971dfa46c3744969</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520benzoselenazole-stilbene%2520hybrids%2520as%2520multi-target-directed%2520anti-cancer%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D220%26epage%3D229%26doi%3D10.1016%2Fj.ejmech.2015.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1279</span>– <span class="NLM_lpage">1281</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2016.01.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26786698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1279-1281&author=B.+L.+Liauthor=B.+Liauthor=R.+L.+Zhangauthor=J.+J.+Zhaoauthor=X.+F.+Wangauthor=Y.+M.+Liuauthor=Y.+P.+Shiauthor=J.+B.+Liuauthor=B.+Q.+Chen&title=Synthesis+and+antiproliferative+evaluation+of+novel+1%2C2%2C4-triazole+derivatives+incorporating+benzisoselenazolone+scaffold&doi=10.1016%2Fj.bmcl.2016.01.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold</span></div><div class="casAuthors">Li, Bao-Lin; Li, Bo; Zhang, Rui-Lian; Zhao, Ji-Jun; Wang, Xue-Feng; Liu, Yu-Ming; Shi, Yan-Ping; Liu, Jin-Biao; Chen, Bao-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1279-1281</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 1,2,4-triazole derivs. incorporating benzisoselenazolone scaffold were designed, synthesized and evaluated for their in vitro antiproliferative activities against human cancer cell lines SMMC-7721, HeLa, A549, and normal cell lines L929 by CCK-8 assay.  The preliminary bioassay results demonstrated that most of the tested compds. exhibited antiproliferative activity with different degrees and some compds. showed better effects than pos. controls 2,2'-(1,2-ethanediyl)bis[1,2-benzisoselenazol-3(2H)-one] (i.e., ethaselen) and 5-fluorouracil (i.e., 5-FU) against various cancer cell lines.  Several compds. displayed highly effective biol. activity against SMMC-7721 cells with IC50 values of 6.02 and 6.01 μM, resp.  One compd. showed significant y antiproliferative activities against HeLa cells with IC50 value of 3.94 μM.  One compd. exhibited the best inhibitory effect against A549 cells with IC50 value 9.14 μM.  Furthermore, most of the tested compds. showed weak cytotoxic effect against the normal cell lines L929.  The pharmacol. results suggest that the substituent groups are vital for improving the potency and selectivity of this class of compds.  The synthesis of the target compds. was achieved by a reaction of 2-(chloroseleno)benzoyl chloride with 5-(alkylthio)-1H-1,2,4-triazol-3-amine derivs.  The title compds. thus formed included [[(alkyl)thio]triazolyl]-1,2-benzisoselenazolone derivs. (ebselen analogs, ethaselen analogs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8NeJXV-0oXLVg90H21EOLACvtfcHk0lgw9ES2ChwRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOgsbg%253D&md5=8f7415d4551a6fb731190506a8b75f76</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%2BL.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DR.%2BL.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DShi%26aufirst%3DY.%2BP.%26aulast%3DLiu%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DB.%2BQ.%26atitle%3DSynthesis%2520and%2520antiproliferative%2520evaluation%2520of%2520novel%25201%252C2%252C4-triazole%2520derivatives%2520incorporating%2520benzisoselenazolone%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D1279%26epage%3D1281%26doi%3D10.1016%2Fj.bmcl.2016.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jing, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives incorporating benzisoselenazolone scaffold as potential antitumor agents</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">639</span>, <span class="refDoi"> DOI: 10.2174/1573406412666160201120806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2174%2F1573406412666160201120806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26833076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Srtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=631-639&author=X.+Fuauthor=S.+Liauthor=F.+Jingauthor=X.+Wangauthor=B.+Liauthor=J.+Zhaoauthor=Y.+Liuauthor=B.+Chen&title=Synthesis+and+biological+evaluation+of+novel+1%2C3%2C4-thiadiazole+derivatives+incorporating+benzisoselenazolone+scaffold+as+potential+antitumor+agents&doi=10.2174%2F1573406412666160201120806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Novel 1,3,4-thiadiazole Derivatives Incorporating Benzisoselenazolone Scaffold as Potential Antitumor Agents</span></div><div class="casAuthors">Fu, Xiaoyun; Li, Sha; Jing, Fen; Wang, Xuefeng; Li, Baolin; Zhao, Jijun; Liu, Yuming; Chen, Baoquan</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">631-639</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Based on the biol. signicance of benzisoselenazolone and 1,3,4-thiadiazole, a series of novel 1,3,4-thiadiazole derivs. incorporating benzisoselenazolone scaffold were designed and synthesized with ebselen as a lead compd.  Methods: Meanwhile, their in vitro antitumor activities were evaluated against SMMC-7721, MCF-7 and A549 human cancer cell lines by CCK-8 assay.  Results: The preliminary bioassay results demonstrated that all tested compds. 4a-q showed potent antitumor activities, and some compds. exhibited better effects than pos. control ethaselen and 5-fluorouracil (5-FU) against various cancer cell lines.  Furthermore, compds. 4b and 4m showed significant antitumor activities against SMMC-7721 cells with IC50 values of 1.89 and 1.89 M, resp.  Compds. 4c and 4n displayed highly effective biol. activities against MCF-7 cells with IC50 values of 2.88 and 2.28 M, resp.  Compd. 4i showed the best inhibitory effect against A549 cells with IC50 value of 1.76 M.  Conclusion: The pharmacol. results suggest that the substituent groups of Ph ring on the 1,3,4-thiadiazole are vital for modulating antitumor activities against various cancer cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4ZrXoieBjWrVg90H21EOLACvtfcHk0liAcZ_IsFZ3Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Srtr3K&md5=b796dbe06b591a16b5ca771871e57868</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F1573406412666160201120806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573406412666160201120806%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJing%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25201%252C3%252C4-thiadiazole%2520derivatives%2520incorporating%2520benzisoselenazolone%2520scaffold%2520as%2520potential%2520antitumor%2520agents%26jtitle%3DMed.%2520Chem.%26date%3D2016%26volume%3D12%26spage%3D631%26epage%3D639%26doi%3D10.2174%2F1573406412666160201120806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jing, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antiproliferative evaluation of novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1248/cpb.c15-00014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1248%2Fcpb.c15-00014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26027467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCns7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=431-437&author=F.+Jingauthor=X.+Fuauthor=S.+Liauthor=B.+Liauthor=J.+Zhaoauthor=X.+Wangauthor=Y.+Liuauthor=B.+Chen&title=Synthesis+and+in+vitro+antiproliferative+evaluation+of+novel+hybrids+from+1%2C3%2C4-thiadiazole+and+benzisoselenazolone&doi=10.1248%2Fcpb.c15-00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antiproliferative evaluation of novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone</span></div><div class="casAuthors">Jing, Fen; Fu, Xiaoyun; Li, Sha; Li, Baolin; Zhao, Jijun; Wang, Xuefeng; Liu, Yuming; Chen, Baoquan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">431-437</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Novel hybrids from 1,3,4-thiadiazole and benzisoselenazolone were designed, synthesized and evaluated for their in vitro antiproliferative activity by CCK-8 assay against three types of human cancer cell lines, SMMC-7721, MCF-7 and A549 cells.  The preliminary bioassay results demonstrated that all tested compds. I (R = H, 2-CH3, 3-OCH3, 4-Br, 2-NO2, etc.) showed potent antiproliferative activity, and some compds. exhibited better effects than pos. control ethaselen and 5-fluorouracil (5-FU) against various cancer cell lines.  Furthermore, compd. I (R = 4-OCH3) showed significant antiproliferative activity against SMMC-7721 cells with an IC50 value of 2.08 μM.  Compds. I (R = 2-CH3, 4-Br) displayed highly effective biol. activity against MCF-7 cells with an IC50 values of 2.03 and 2.06 μM, resp.  Compd. I (R = F) exhibited the best inhibitory effect against A549 cells with an IC50 value of 1.03 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9d7TL_oXBN7Vg90H21EOLACvtfcHk0liAcZ_IsFZ3Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCns7rE&md5=1fe09c7e83f958fb50951f573cf59320</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c15-00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c15-00014%26sid%3Dliteratum%253Aachs%26aulast%3DJing%26aufirst%3DF.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antiproliferative%2520evaluation%2520of%2520novel%2520hybrids%2520from%25201%252C3%252C4-thiadiazole%2520and%2520benzisoselenazolone%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2015%26volume%3D63%26spage%3D431%26epage%3D437%26doi%3D10.1248%2Fcpb.c15-00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacula, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczor, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antosiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janecka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dlugosz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janecki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtczak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scianowski, J.</span></span> <span> </span><span class="NLM_article-title">New chiral ebselen analogues with antioxidant and cytotoxic potential</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">492</span>, <span class="refDoi"> DOI: 10.3390/molecules22030492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fmolecules22030492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCns7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=492&author=A.+J.+Paculaauthor=K.+B.+Kaczorauthor=J.+Antosiewiczauthor=A.+Janeckaauthor=A.+Dlugoszauthor=T.+Janeckiauthor=A.+Wojtczakauthor=J.+Scianowski&title=New+chiral+ebselen+analogues+with+antioxidant+and+cytotoxic+potential&doi=10.3390%2Fmolecules22030492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">New chiral ebselen analogues with antioxidant and cytotoxic potential</span></div><div class="casAuthors">Pacula, Agata J.; Kaczor, Katarzyna B.; Antosiewicz, Jedrzej; Janecka, Anna; Dlugosz, Angelika; Janecki, Tomasz; Wojtczak, Andrzej; Scianowski, Jacek</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492/1-492/14</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">New chiral camphane-derived benzisoselenazol-3(2H)-ones and corresponding diselenides was synthesized using a convenient one-pot procedure.  Se-N bond was efficiently converted to an Se-Se bond, which could also be easily re-oxidized to the initial benzisoselenazolone moiety.  The antioxidant activity of camphor derivs. was evaluated and compared to the reactivity of a series of N-amino acid benzisoselenazol-3(2H)-ones obtained by a modified procedure involving the improved synthesis and isolation of the diseleno bis(dibenzoic) acid.  The most efficient peroxide scavengers, N-bornyl and N-leucine Me ester benzisoselenazol-3(2H)-ones, were further evaluated as cytotoxic agents on four cancer cell lines (MCF-7, HEP G2, HL 6, and DU 145) and normal cell line PNT1A.  The highest antiproliferative potential was evaluated for two compds. bearing a 3- methylbutyl carbon chain, N-leucine Me ester and N-3-methylbutyl benzisoselenazol- 3(2H)-ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSvjk2F8Hkl7Vg90H21EOLACvtfcHk0liAcZ_IsFZ3Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCns7vK&md5=e72828d882ff63e2bfbf826fd7e2ecf5</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22030492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22030492%26sid%3Dliteratum%253Aachs%26aulast%3DPacula%26aufirst%3DA.%2BJ.%26aulast%3DKaczor%26aufirst%3DK.%2BB.%26aulast%3DAntosiewicz%26aufirst%3DJ.%26aulast%3DJanecka%26aufirst%3DA.%26aulast%3DDlugosz%26aufirst%3DA.%26aulast%3DJanecki%26aufirst%3DT.%26aulast%3DWojtczak%26aufirst%3DA.%26aulast%3DScianowski%26aufirst%3DJ.%26atitle%3DNew%2520chiral%2520ebselen%2520analogues%2520with%2520antioxidant%2520and%2520cytotoxic%2520potential%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D492%26doi%3D10.3390%2Fmolecules22030492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Multifunctional antioxidants: Regenerable radical-trapping and hydroperoxide-decomposing ebselenols</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3729</span>– <span class="NLM_lpage">3733</span>, <span class="refDoi"> DOI: 10.1002/anie.201510947</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fanie.201510947" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XisV2hu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=3729-3733&author=S.+Kumarauthor=J.+J.+Yanauthor=J.+F.+Poonauthor=V.+P.+Singhauthor=X.+Luauthor=M.+K.+Ottauthor=L.+Engmanauthor=S.+Kumar&title=Multifunctional+antioxidants%3A+Regenerable+radical-trapping+and+hydroperoxide-decomposing+ebselenols&doi=10.1002%2Fanie.201510947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional Antioxidants: Regenerable Radical-Trapping and Hydroperoxide-Decomposing Ebselenols</span></div><div class="casAuthors">Kumar, Shailesh; Yan, Jiajie; Poon, Jia-fei; Singh, Vijay P.; Lu, Xi; Karlsson Ott, Marjam; Engman, Lars; Kumar, Sangit</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3729-3733</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Regenerable, multifunctional ebselenol antioxidants were prepd. that could quench peroxyl radicals more efficiently than α-tocopherol.  These compds. act as better mimics of the glutathione peroxidase enzymes than ebselen.  Prodn. of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in human mononuclear cells was considerably decreased upon exposure to the organoselenium compds.  At a concn. of 25 μM, the ebselenol derivs. showed minimal toxicity in pre-osteoblast MC3T3 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN_nvNQN2047Vg90H21EOLACvtfcHk0liAcZ_IsFZ3Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisV2hu7c%253D&md5=347641ec5105055b322dc4820e45dd13</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fanie.201510947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201510947%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DJ.%2BJ.%26aulast%3DPoon%26aufirst%3DJ.%2BF.%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DOtt%26aufirst%3DM.%2BK.%26aulast%3DEngman%26aufirst%3DL.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DMultifunctional%2520antioxidants%253A%2520Regenerable%2520radical-trapping%2520and%2520hydroperoxide-decomposing%2520ebselenols%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D3729%26epage%3D3733%26doi%3D10.1002%2Fanie.201510947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gates, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engman, L.</span></span> <span> </span><span class="NLM_article-title">Nitro-, azo-, and amino derivatives of ebselen: synthesis, structure, and cytoprotective effects</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.6b02418</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.6b02418" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2gsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=313-321&author=V.+P.+Singhauthor=J.+F.+Poonauthor=J.+J.+Yanauthor=X.+Luauthor=M.+K.+Ottauthor=R.+J.+Butcherauthor=P.+J.+Gatesauthor=L.+Engman&title=Nitro-%2C+azo-%2C+and+amino+derivatives+of+ebselen%3A+synthesis%2C+structure%2C+and+cytoprotective+effects&doi=10.1021%2Facs.joc.6b02418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Nitro-, Azo-, and Amino Derivatives of Ebselen: Synthesis, Structure, and Cytoprotective Effects</span></div><div class="casAuthors">Singh, Vijay P.; Poon, Jia-fei; Yan, Jiajie; Lu, Xi; Ott, Marjam Karlsson; Butcher, Ray J.; Gates, Paul J.; Engman, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel azo-bis-ebselen compds. I [R = Ph, 4-MeC6H4, 4-MeOC6H4, 1-naphthyl] were prepd. by redn. of 7-nitro-2-aryl-1,2-benzisoselenazol-3(2H)-ones II with sodium benzenetellurolate, NaTeC6H5, and by reaction of 2-bromo-3-nitrobenzamides with Na2Se2.  The X-ray structure of I [R = 4-MeC6H4] showed that the mol., due to strong intramol. secondary Se•••N interactions, is completely planar.  Azo-compds. I upon further reaction with NaTeC6H5 were reductively cleaved to provide two equiv. of the corresponding arom. amine.  The weak Se-N bond was not stable enough to survive the reaction conditions and diselenides III [R = 4-MeC6H4, 1-naphthyl] were isolated after work-up.  Whereas azo-bis-ebselens I were poor mimics of the glutathione peroxidase (GPx)-enzymes, nitroebselens II and IV and diselenides III were 3-6 fold more active than ebselen.  Based on 77Se NMR spectroscopy, a catalytic cycle for diselenide III [R = 1-naphthyl], involving aminoebselen V, was proposed.  As assessed by chemiluminescence measurements, the good GPx-mimics could reduce prodn. of reactive oxygen species (ROS) in stimulated human mononuclear cells more efficiently than Trolox.  No toxic effects of the compds. were seen in MC3T3-cells at 25 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof38wQdmlrb7Vg90H21EOLACvtfcHk0ljbewVjR2T05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2gsrrP&md5=b88b6e321a8c67f1e2da839d76bff873</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.6b02418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.6b02418%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DPoon%26aufirst%3DJ.%2BF.%26aulast%3DYan%26aufirst%3DJ.%2BJ.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DOtt%26aufirst%3DM.%2BK.%26aulast%3DButcher%26aufirst%3DR.%2BJ.%26aulast%3DGates%26aufirst%3DP.%2BJ.%26aulast%3DEngman%26aufirst%3DL.%26atitle%3DNitro-%252C%2520azo-%252C%2520and%2520amino%2520derivatives%2520of%2520ebselen%253A%2520synthesis%252C%2520structure%252C%2520and%2520cytoprotective%2520effects%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D313%26epage%3D321%26doi%3D10.1021%2Facs.joc.6b02418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adejare, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span> <span> </span><span class="NLM_article-title">Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1369</span>– <span class="NLM_lpage">1382</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S124977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2147%2FDDDT.S124977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28496307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslKns7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=1369-1382&author=Y.+Wangauthor=J.+Wallachauthor=S.+Duaneauthor=Y.+Wangauthor=J.+Wuauthor=J.+Wangauthor=A.+Adejareauthor=H.+Ma&title=Developing+selective+histone+deacetylases+%28HDACs%29+inhibitors+through+ebselen+and+analogs&doi=10.2147%2FDDDT.S124977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs</span></div><div class="casAuthors">Wang, Yuren; Wallach, Jason; Duane, Stephanie; Wang, Yuan; Wu, Jianghong; Wang, Jeffrey; Adejare, Adeboye; Ma, Haiching</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1369-1382</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are key regulators of gene expression in cells and have been investigated as important therapeutic targets for cancer and other diseases.  Different subtypes of HDACs appear to play disparate roles in the cells and are assocd. with specific diseases.  Therefore, substantial effort has been made to develop subtype-selective HDAC inhibitors.  In an effort to discover existing scaffolds with HDAC inhibitory activity, we screened a drug library approved by the US Food and Drug Administration and a National Institutes of Health Clin. Collection compd. library in HDAC enzymic assays.  Ebselen, a clin. safe compd., was identified as a weak inhibitor of several HDACs, including HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9 with half maximal inhibitory concns. approx. single digit of μM.  Two ebselen analogs, ebselen oxide and ebsulfur (a diselenide analog of ebselen), also inhibited these HDACs, however with improved potencies on HDAC8.  Benzisothiazol, the core structure of ebsulfur, specifically inhibited HDAC6 at a single digit of μM but had no inhibition on other HDACs.  Further efforts on structure-activity relationship based on the core structure of ebsulfur led to the discovery of a novel class of potent and selective HDAC6 inhibitors with RBC-2008 as the lead compd. with single-digit nM potency.  This class of histone deacetylase inhibitor features a novel pharmacophore with an ebsulfur scaffold selectively targeting HDAC6.  Consistent with its inhibition on HDAC6, RBC-2008 significantly increased the acetylation levels of α-tubulin in PC-3 cells.  Furthermore, treatment with these compds. led to cell death of multiple tumor cell lines in a dose-dependent manner.  These results demonstrated that ebselen and ebsulfur analogs are inhibitors of HDACs, supporting further preclin. development of this class of compds. for potential therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTSO9qayhR7rVg90H21EOLACvtfcHk0ljbewVjR2T05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslKns7rM&md5=7c71fca15cacf6026275682e886245b2</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S124977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S124977%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWallach%26aufirst%3DJ.%26aulast%3DDuane%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAdejare%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DH.%26atitle%3DDeveloping%2520selective%2520histone%2520deacetylases%2520%2528HDACs%2529%2520inhibitors%2520through%2520ebselen%2520and%2520analogs%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2017%26volume%3D11%26spage%3D1369%26epage%3D1382%26doi%3D10.2147%2FDDDT.S124977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span> <span> </span><span class="NLM_article-title">Aglycone ebselen and beta-<i>d</i>-xyloside primed glycosaminoglycans co-contribute to ebselen beta-<i>d</i>-xyloside-induced cytotoxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2937</span>– <span class="NLM_lpage">2948</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01835</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01835" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtFCnt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2937-2948&author=Y.+Tangauthor=S.+Zhangauthor=Y.+Changauthor=D.+Fanauthor=A.+Agostiniauthor=L.+Zhangauthor=T.+Jiang&title=Aglycone+ebselen+and+beta-d-xyloside+primed+glycosaminoglycans+co-contribute+to+ebselen+beta-d-xyloside-induced+cytotoxicity&doi=10.1021%2Facs.jmedchem.7b01835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Aglycone Ebselen and β-D-Xyloside Primed Glycosaminoglycans Co-contribute to Ebselen β-D-Xyloside-Induced Cytotoxicity</span></div><div class="casAuthors">Tang, Yang; Zhang, Siqi; Chang, Yajing; Fan, Dacheng; De Agostini, Ariane; Zhang, Lijuan; Jiang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2937-2948</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Most β-D-xylosides with hydrophobic aglycons are nontoxic primers for glycosaminoglycan assembly in animal cells.  However, when Ebselen was conjugated to D-xylose, D-glucose, D-galactose, and D-lactose (8A-D), only Ebselen β-D-xyloside (8A) showed significant cytotoxicity in human cancer cells.  The following facts indicated that the aglycon Ebselen and β-D-xyloside primed glycosaminoglycans co-contributed to the obsd. cytotoxicity: 1.  Ebselen induced S phase cell cycle arrest, whereas 8A induced G2/M cell cycle arrest; 2. 8A augmented early and late phase cancer cell apoptosis significantly compared to that of Ebselen and 8B-D; 3.  Both 8A and phenyl-β-D-xyloside primed glycosaminoglycans with similar disaccharide compns. in CHO-pgsA745 cells; 4.  Glycosaminoglycans could be detected inside of cells only when treated with 8A, indicating Ebselen contributed to the unique property of intracellular localization of the primed glycosaminoglycans.  Thus, 8A represents a lead compd. for the development of novel antitumor strategy by targeting glycosaminoglycans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-cuJzVNAY-LVg90H21EOLACvtfcHk0ljbewVjR2T05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtFCnt78%253D&md5=e5bd66029fefb81a8e0a5a9a5b868c01</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01835%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DD.%26aulast%3DAgostini%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DT.%26atitle%3DAglycone%2520ebselen%2520and%2520beta-d-xyloside%2520primed%2520glycosaminoglycans%2520co-contribute%2520to%2520ebselen%2520beta-d-xyloside-induced%2520cytotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2937%26epage%3D2948%26doi%3D10.1021%2Facs.jmedchem.7b01835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torquato, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piroddi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, F.</span></span> <span> </span><span class="NLM_article-title">Targeting glutathione <i>S</i>-transferase P and its interactome with selenium compounds in cancer therapy</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1863</i></span>,  <span class="NLM_fpage">130</span>– <span class="NLM_lpage">143</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2018.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbagen.2018.09.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30290218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFSqsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2019&pages=130-143&author=D.+Bartoliniauthor=P.+Torquatoauthor=M.+Piroddiauthor=F.+Galli&title=Targeting+glutathione+S-transferase+P+and+its+interactome+with+selenium+compounds+in+cancer+therapy&doi=10.1016%2Fj.bbagen.2018.09.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glutathione S-transferase P and its interactome with selenium compounds in cancer therapy</span></div><div class="casAuthors">Bartolini, D.; Torquato, P.; Piroddi, M.; Galli, F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130-143</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The glutathione (GSH) S-transferase family of detoxification and signalling proteins represents a major hub for the metab. of Selenium-derived compds.  At the same time, these compds. can be used to modulate the expression and multiple activities of GSTs and other glutathione-dependent genes, that are important aspects in both the chemoprevention and therapy of drug-resistant cancers.  In this context, the isoform GSTP-1 (GSTP) appears to play a fundamental role.  Besides promoting GSH-dependent detoxification of cellular electrophiles, GSTP phys. interacts with a no. of small mols. and cellular proteins producing regulatory effects across the main signal transduction and transcription pathways (identified as the "regulatory interactome of GSTP").  An emerging mol. mechanism behind such regulatory function is the activity of GSTP as a redox chaperonine responsible for the selective glutathionylation of protein Cys residues in the different subcellular compartments.  The redox-sensitive transcription factor Nrf2 was recently identified as one of the regulatory nodes of this interactome at the interface between inflammation, adaptive stress response, and cell death pathways.  The influence of Nrf2 in the stress response to cellular electrophiles and its regulatory interaction with GSTP are discussed in this review suggesting the hypothesis that this interaction may represent the actual pharmacol. target of Se compds. with thiol peroxidase activity.  These points are critically evaluated with a view to further development of these compds. in cancer prevention and the chemotherapy of drug-resistant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqEDrwhWsFDbVg90H21EOLACvtfcHk0lhC7hWkV_qBuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFSqsLjF&md5=c4265f4a7bd8258ffe6f4ea4dce00d5f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2018.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2018.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DD.%26aulast%3DTorquato%26aufirst%3DP.%26aulast%3DPiroddi%26aufirst%3DM.%26aulast%3DGalli%26aufirst%3DF.%26atitle%3DTargeting%2520glutathione%2520S-transferase%2520P%2520and%2520its%2520interactome%2520with%2520selenium%2520compounds%2520in%2520cancer%2520therapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2019%26volume%3D1863%26spage%3D130%26epage%3D143%26doi%3D10.1016%2Fj.bbagen.2018.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piroddi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovagnoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manevich, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giustarini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, F.</span></span> <span> </span><span class="NLM_article-title">Reaction kinetics and targeting to cellular glutathione <i>S</i>-transferase of the glutathione peroxidase mimetic PhSeZnCl and its <i>DL</i>-polylactide microparticle formulation</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.freeradbiomed.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25452145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2gs7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=56-65&author=D.+Bartoliniauthor=M.+Piroddiauthor=C.+Tideiauthor=S.+Giovagnoliauthor=D.+Pietrellaauthor=Y.+Manevichauthor=K.+D.+Tewauthor=D.+Giustariniauthor=R.+Rossiauthor=D.+M.+Townsendauthor=C.+Santiauthor=F.+Galli&title=Reaction+kinetics+and+targeting+to+cellular+glutathione+S-transferase+of+the+glutathione+peroxidase+mimetic+PhSeZnCl+and+its+DL-polylactide+microparticle+formulation&doi=10.1016%2Fj.freeradbiomed.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction kinetics and targeting to cellular glutathione S-transferase of the glutathione peroxidase mimetic PhSeZnCl and its D,L-polylactide microparticle formulation</span></div><div class="casAuthors">Bartolini, D.; Piroddi, M.; Tidei, C.; Giovagnoli, S.; Pietrella, D.; Manevich, Y.; Tew, K. D.; Giustarini, D.; Rossi, R.; Townsend, D. M.; Santi, C.; Galli, F.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56-65</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Catalytic properties and cellular effects of the glutathione peroxidase (GPx)-mimetic compd. PhSeZnCl or its D,L-lactide polymer microencapsulation form (M-PhSeZnCl) were investigated and compared with the prototypical Se-org. compds. ebselen and diselenide (PhSe)2.  PhSeZnCl was confirmed to catalyze the ping-pong reaction of GPx with higher Vmax than ebselen and (PhSe)2, but the catalytic efficiency calcd. for the cosubstrates glutathione (GSH) and H2O2, and particularly the high reactivity against thiols (lowest Km for GSH in the series of test mols.), suggested poor biol. applicability of PhSeZnCl as a GPx mimetic.  Cytotoxicity of PhSeZnCl was demonstrated in various cancer cell lines via increased reactive oxygen species (ROS) generation, depletion of intracellular thiols, and induction of apoptosis.  Expts. carried out in GSH S-transferase P (GSTP)-overexpressing K562 human erythroleukemia cells and in GSTP1-1-knockout murine embryonic fibroblasts (MEFs) demonstrated that this cytosolic enzyme represents a preferential target of the redox disturbances produced by this Se-compd. with a key role in controlling H2O2 generation and the perturbation of stress/survival kinase signaling.  Microencapsulation was adopted as a strategy to control the thiol reactivity and oxidative stress effects of PhSeZnCl, then assessing applications alternative to anticancer.  The uptake of this "depowered" GPx-mimetic formulation, which occurred through an endocytosis-like mechanism, resulted in a marked redn. of cytotoxicity.  In MCF-7 cells transfected with different allelic variants of GSTP, M-PhSeZnCl lowered the burst of cellular ROS induced by the exposure to extracellular H2O2, and the extent of this effect changed between the GSTP variants.  Microencapsulation is a straightforward strategy to mitigate the toxicity of thiol-reactive Se-org. drugs that enhanced the antioxidant and cellular protective effects of PhSeZnCl.  A mechanistic linkage of these effects with the expression pattern and signaling properties of GSTP.  This has overcome the GPx-mimetic paradigm proposed for Se-org. drugs with a more pragmatic concept of GSTP signaling modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX_enWdcSLmrVg90H21EOLACvtfcHk0lhC7hWkV_qBuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2gs7%252FF&md5=c4c47db1f922cc12918e4bb272b077f8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DD.%26aulast%3DPiroddi%26aufirst%3DM.%26aulast%3DTidei%26aufirst%3DC.%26aulast%3DGiovagnoli%26aufirst%3DS.%26aulast%3DPietrella%26aufirst%3DD.%26aulast%3DManevich%26aufirst%3DY.%26aulast%3DTew%26aufirst%3DK.%2BD.%26aulast%3DGiustarini%26aufirst%3DD.%26aulast%3DRossi%26aufirst%3DR.%26aulast%3DTownsend%26aufirst%3DD.%2BM.%26aulast%3DSanti%26aufirst%3DC.%26aulast%3DGalli%26aufirst%3DF.%26atitle%3DReaction%2520kinetics%2520and%2520targeting%2520to%2520cellular%2520glutathione%2520S-transferase%2520of%2520the%2520glutathione%2520peroxidase%2520mimetic%2520PhSeZnCl%2520and%2520its%2520DL-polylactide%2520microparticle%2520formulation%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D78%26spage%3D56%26epage%3D65%26doi%3D10.1016%2Fj.freeradbiomed.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoyanovsky, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epperly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayir, H.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a mitochondria-targeted mimic of glutathione peroxidase, mitoebselen-2, as a radiation mitigator</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1304</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1021/ml5003635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5003635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCisbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1304-1307&author=D.+A.+Stoyanovskyauthor=J.+F.+Jiangauthor=M.+P.+Murphyauthor=M.+Epperlyauthor=X.+L.+Zhangauthor=S.+Liauthor=J.+Greenbergerauthor=V.+Kaganauthor=H.+Bayir&title=Design+and+synthesis+of+a+mitochondria-targeted+mimic+of+glutathione+peroxidase%2C+mitoebselen-2%2C+as+a+radiation+mitigator&doi=10.1021%2Fml5003635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Mitochondria-Targeted Mimic of Glutathione Peroxidase, MitoEbselen-2, as a Radiation Mitigator</span></div><div class="casAuthors">Stoyanovsky, Detcho A.; Jiang, Jianfei; Murphy, Michael P.; Epperly, Michael; Zhang, Xiaolan; Li, Song; Greenberger, Joel; Kagan, Valerian; Bayir, Hulya</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1304-1307</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ionizing radiation (IR) triggers mitochondrial overprodn. of H2O2 and accumulation of lipid hydroperoxides leading to the induction of apoptotic and necroptotic cell death pathways.  Given the high catalytic efficiency of the seleno-enzyme glutathione peroxidase (Gpx) toward redn. of lipid hydroperoxides and H2O2, we tested the potential of mitochondria-targeted derivs. of ebselen to mitigate the deleterious effects of IR.  We report that 2-[[2-[4-(3-oxo-1,2-benzoselenazol-2-yl)phenyl]acetyl]amino]ethyl-triphenyl-phosphonium chloride (MitoPeroxidase 2) was effective in reducing lipid hydroperoxides, preventing apoptotic cell death, and, when administered 24 h postirradn., increased the survival of mice exposed to whole body γ-irradn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZkPX2R7noM7Vg90H21EOLACvtfcHk0lhC7hWkV_qBuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCisbvJ&md5=6ecf025e846a25911b862947ecd48d55</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fml5003635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5003635%26sid%3Dliteratum%253Aachs%26aulast%3DStoyanovsky%26aufirst%3DD.%2BA.%26aulast%3DJiang%26aufirst%3DJ.%2BF.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DEpperly%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DGreenberger%26aufirst%3DJ.%26aulast%3DKagan%26aufirst%3DV.%26aulast%3DBayir%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520mitochondria-targeted%2520mimic%2520of%2520glutathione%2520peroxidase%252C%2520mitoebselen-2%252C%2520as%2520a%2520radiation%2520mitigator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1304%26epage%3D1307%26doi%3D10.1021%2Fml5003635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span> <span> </span><span class="NLM_article-title">Virtual screening guided design, synthesis and bioactivity study of benzisoselenazolones (BISAs) on inhibition of c-Met and its downstream signalling pathways</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2489</span>, <span class="refDoi"> DOI: 10.3390/ijms20102489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms20102489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BB3cXosVKhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=2489&author=S.+Zhangauthor=Q.+Songauthor=X.+Wangauthor=Z.+Weiauthor=R.+Yuauthor=X.+Wangauthor=T.+Jiang&title=Virtual+screening+guided+design%2C+synthesis+and+bioactivity+study+of+benzisoselenazolones+%28BISAs%29+on+inhibition+of+c-Met+and+its+downstream+signalling+pathways&doi=10.3390%2Fijms20102489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual screening guided design, synthesis and bioactivity study of benzisoselenazolones (BISAs) on inhibition of c-met and its downstream signalling pathways</span></div><div class="casAuthors">Zhang, Siqi; Song, Qiaoling; Wang, Xueting; Wei, Zhiqiang; Yu, Rilei; Wang, Xin; Jiang, Tao</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2489</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">C-Met is a transmembrane receptor tyrosine kinase and an important therapeutic target for anticancer drugs.  In this study, we designed a small library contg. 300 BISAs mols. that consisted of carbohydrates, amino acids, isothiourea, tetramethylthiourea, guanidine and heterocyclic groups and screened c-Met targeting compds. using docking and MM/GBSA.  Guided by virtual screening, we synthesized a series of novel compds. and their activity on inhibition of the autophosphorylation of c-Met and its downstream signalling pathway proteins were evaluated.  We found a panel of benzisoselenazolones (BISAs) obtained by introducing isothiourea, tetramethylthiourea and heterocyclic groups into the C-ring of Ebselen, including 7a, 7b, 8a, 8b and 12c (with IC50 values of less than 20 μM in MET gene amplified lung cancer cell line EBC-1), exhibited more potent antitumor activity than Ebselen by cell growth assay combined with in vitro biochem. assays.  In addn., we also tested the antitumor activity of three cancer cell lines without MET gene amplification/activation, including DLD1, MDA-MB-231 and A549.  The neuroblastoma SK-N-SH cells with HGF overexpression which activates MET signalling are sensitive to MET inhibitors.  The results reveal that our compds. may be nonspecific multitarget kinase inhibitors, just like type-II small mol. inhibitors.  Western blot anal. showed that these inhibitors inhibited autophosphorylation of c-MET, and its downstream signalling pathways, such as PI3K/AKT and MARK/ERK.  Results suggest that bensoisoselenones can be used as a scaffold for the design of c-Met inhibiting drug leads, and this study opens up new possibilities for future antitumor drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfdM5HZ16ZdrVg90H21EOLACvtfcHk0ljrmKha1Yp3Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXosVKhtw%253D%253D&md5=d670376e658abfcfb79c497e1f03a7f9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fijms20102489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20102489%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DT.%26atitle%3DVirtual%2520screening%2520guided%2520design%252C%2520synthesis%2520and%2520bioactivity%2520study%2520of%2520benzisoselenazolones%2520%2528BISAs%2529%2520on%2520inhibition%2520of%2520c-Met%2520and%2520its%2520downstream%2520signalling%2520pathways%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D2489%26doi%3D10.3390%2Fijms20102489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, SAR and biological evaluation of a novel series of 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3<i>H</i>)-yl)ethyl) urea: organoselenium compounds for cancer therapy</span>. <i>Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.14715/cmb/2016.62.7.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.14715%2Fcmb%2F2016.62.7.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27453265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC2s3jslWrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2016&pages=6-14&author=S.+Yeauthor=X.+Zhengauthor=T.+Huauthor=H.+Zeng&title=Synthesis%2C+SAR+and+biological+evaluation+of+a+novel+series+of+1-%282-chloroethyl%29-1-nitroso-3-%282-%283-oxobenzoelenazol-2%283H%29-yl%29ethyl%29+urea%3A+organoselenium+compounds+for+cancer+therapy&doi=10.14715%2Fcmb%2F2016.62.7.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, SAR and biological evaluation of a novel series of 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3H)-yl)ethyl) urea: Organoselenium compounds for cancer therapy</span></div><div class="casAuthors">Ye S; Zheng X; Hu T; Zeng H</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and molecular biology (Noisy-le-Grand, France)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">6-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Thioredoxin reductase 1 (TrxR1) is an important potential anticancer drug target and closely related to both carcinogenesis and cancer progression.  Ethaselen (BBSKE), a novel organoselenium compound inhibiting TrxR1 with selective antitumor effect, while its symmetrical structure results in poor solubility.  Carmustine (BCNU), a DNA cross-link agent and also a deactivator of TrxR, is with high toxicity and low selectivity which limit its clinical application to some extents.  Herein, a novel compound, 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3H)-yl)ethyl)urea(4a-1), which was designed through the combination of Ethaselen and Carmustine, showed good solubility, good tagetability, low toxicity and excellent antitumor activity by synergism.  Using the structure of 4a-1 as a key active scaffold, a series of novel 1-(2-chloroethyl)-1-nitroso-3-(2-(3-oxobenzoelenazol-2(3H)-yl)ethyl)urea was designed, synthesized and evaluated to explore the structure-activity relationships (SARs) of these inhibitors and to improve their antitumor activities.  Notably, 1-(2-chloroethyl)-3-(2-(6-fluoro-3-oxobenzoselenazol-2(3H)-yl)ethyl)-1-nitrosourea(4b-1) was found to exhibit more potent antitumor activities comparable to 4a-1 against all the four cancer cell lines, including Mia PaCa-2, PANC-1, RKO, LoVo.  These results have highlighted compound 4b-1 as a new potential lead candidate for future development of novel potent broad-spectrum antitumor agents.  In addition, a SAR model was established to conduct further structural modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREabgMxXN_cLYtC3U5jeOifW6udTcc2eYG11U8NmzhJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3jslWrtA%253D%253D&md5=a293240f031f81d0a8eafb4437b85dd7</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.14715%2Fcmb%2F2016.62.7.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14715%252Fcmb%252F2016.62.7.2%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DZeng%26aufirst%3DH.%26atitle%3DSynthesis%252C%2520SAR%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%25201-%25282-chloroethyl%2529-1-nitroso-3-%25282-%25283-oxobenzoelenazol-2%25283H%2529-yl%2529ethyl%2529%2520urea%253A%2520organoselenium%2520compounds%2520for%2520cancer%2520therapy%26jtitle%3DCell%2520Mol.%2520Biol.%26date%3D2016%26volume%3D62%26spage%3D6%26epage%3D14%26doi%3D10.14715%2Fcmb%2F2016.62.7.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, B. H.</span></span> <span> </span><span class="NLM_article-title">Propylselen inhibits cancer cell growth by targeting glutamate dehydrogenase at the NADP(+) binding site</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>509</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.12.117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbrc.2018.12.117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30583861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2ksbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2019&pages=262-267&author=W.+Houauthor=S.+Luauthor=H.+Zhaoauthor=Y.+Yuauthor=H.+Xuauthor=B.+Yuauthor=L.+Suauthor=C.+Linauthor=B.+H.+Ruan&title=Propylselen+inhibits+cancer+cell+growth+by+targeting+glutamate+dehydrogenase+at+the+NADP%28%2B%29+binding+site&doi=10.1016%2Fj.bbrc.2018.12.117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Propylselen inhibits cancer cell growth by targeting glutamate dehydrogenase at the NADP+ binding site</span></div><div class="casAuthors">Hou, Wei; Lu, Shiying; Zhao, Han; Yu, Yan; Xu, Haodong; Yu, Biao; Su, Lin; Lin, Chenshui; Ruan, Benfang Helen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">262-267</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">High levels of glutamate dehydrogenase (GDH) activity are assocd. with hypoglycemia, cancer, and Parkinson's disease.  Propylselen was synthesized to investigate its mechanism of GDH inhibition in comparison with Ebselen and Epigallocatechin gallate (EGCG).  Because Ebselen was found to crosslink with the peptide (AA299-341) at the active site of E.coli GDH, the Cys, Pro, and Lys residues of the corresponding peptide were mutagenized to Ala residues.  Using enzyme kinetics and biomol. interaction assays, we found that the conserved GDH P320 residue is important for propylselen binding, C321 for Ebselen binding, and K341 for EGCG binding.  In addn., these 3 mutations abolished NADP+ binding to E. coli GDH in the absence of glutamate substrate, but in the presence of glutamate, the catalytic activity of the mutants was reduced only by 2-4 fold, indicating that a substrate-induced fit mechanism exists in E. coli GDH.  Furthermore, biochem. anal. showed that NADP+ had high affinity (Kd of 77 nM) for GDH; by targeting the NADP binding site, propylselen effectively inhibited both E. coli and human GDH activity and improved anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhsvFCWyYis7Vg90H21EOLACvtfcHk0ljrmKha1Yp3Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2ksbfN&md5=b0246df397700c6c34cf61b08ca8eb48</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.12.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.12.117%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DRuan%26aufirst%3DB.%2BH.%26atitle%3DPropylselen%2520inhibits%2520cancer%2520cell%2520growth%2520by%2520targeting%2520glutamate%2520dehydrogenase%2520at%2520the%2520NADP%2528%252B%2529%2520binding%2520site%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2019%26volume%3D509%26spage%3D262%26epage%3D267%26doi%3D10.1016%2Fj.bbrc.2018.12.117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teijido, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacabelos, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacoepigenomic interventions as novel potential treatments for Alzheimer’s and Parkinson’s diseases</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3199</span>, <span class="refDoi"> DOI: 10.3390/ijms19103199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms19103199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlynu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=3199&author=O.+Teijidoauthor=R.+Cacabelos&title=Pharmacoepigenomic+interventions+as+novel+potential+treatments+for+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+diseases&doi=10.3390%2Fijms19103199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacoepigenomic interventions as novel potential treatments for Alzheimer's and Parkinson's diseases</span></div><div class="casAuthors">Teijido, Oscar; Cacabelos, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3199/1-3199/36</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Cerebrovascular and neurodegenerative disorders affect one billion people around the world and result from a combination of genomic, epigenomic, metabolic, and environmental factors.  Diagnosis at late stages of disease progression, limited knowledge of gene biomarkers and mol. mechanisms of the pathol., and conventional compds. based on symptomatic rather than mechanistic features, det. the lack of success of current treatments, including current FDA-approved conventional drugs.  The epigenetic approach opens new avenues for the detection of early presymptomatic pathol. events that would allow the implementation of novel strategies in order to stop or delay the pathol. process.  The reversibility and potential restoring of epigenetic aberrations along with their potential use as targets for pharmacol. and dietary interventions sited the use of epidrugs as potential novel candidates for successful treatments of multifactorial disorders involving neurodegeneration.  This manuscript includes a description of the most relevant epigenetic mechanisms involved in the most prevalent neurodegenerative disorders worldwide, as well as the main potential epigenetic-based compds. under investigation for treatment of those disorders and their limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsK6bTQ038lLVg90H21EOLACvtfcHk0lggUR32_hub8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlynu7o%253D&md5=ced7bbb42c4a77b4a36970ca270672ea</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.3390%2Fijms19103199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19103199%26sid%3Dliteratum%253Aachs%26aulast%3DTeijido%26aufirst%3DO.%26aulast%3DCacabelos%26aufirst%3DR.%26atitle%3DPharmacoepigenomic%2520interventions%2520as%2520novel%2520potential%2520treatments%2520for%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520diseases%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D3199%26doi%3D10.3390%2Fijms19103199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aras, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altaş, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meydan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcıoǧlu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulutaş, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serarslan, Y.</span></span> <span> </span><span class="NLM_article-title">Effects of ebselen on ischemia/reperfusion injury in rat brain</span>. <i>Int. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.3109/00207454.2013.879581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3109%2F00207454.2013.879581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24405262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=771-776&author=M.+Arasauthor=M.+Alta%C5%9Fauthor=S.+Meydanauthor=E.+Nacarauthor=M.+Karc%C4%B1o%C7%A7luauthor=K.+T.+Uluta%C5%9Fauthor=Y.+Serarslan&title=Effects+of+ebselen+on+ischemia%2Freperfusion+injury+in+rat+brain&doi=10.3109%2F00207454.2013.879581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of ebselen on ischemia/reperfusion injury in rat brain</span></div><div class="casAuthors">Aras, M.; Altas, M.; Meydan, S.; Nacar, E.; Karcioglu, M.; Ulutas, K. T.; Serarslan, Y.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">771-776</span>CODEN:
                <span class="NLM_cas:coden">IJNUB7</span>;
        ISSN:<span class="NLM_cas:issn">0020-7454</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Aim: Interruption of blood flow may result in considerable tissue damage via ischemia/reperfusion (I/R) injury-induced oxidative stress in brain tissues.  The aim of the present study was to investigate the effects of Ebselen treatment in short-term global brain I/R injury in rats.  Material and Methods: The study was carried out on 27 Wistar-albino rats, divided into three groups including Sham group (n = 11), I/R group (n = 8) and I/R+Ebselen group (n = 8).  Results: Malondialdehyde (MDA) levels were significantly increased in I/R group in comparison with the Sham group and I/R+Ebselen group (p < 0.001 and p < 0.01).  Superoxide dismutase (SOD) activity was significantly lower in I/R group in comparison to both Sham (p < 0.001) and I/R+Ebselen (p < 0.01) groups.  Similarly, SOD activity was decreased in I/R+Ebselen group when compared with Sham group (p < 0.001).  Sham and I/R groups were similar in terms of nitric oxide (NO) levels.  In contrast, the NO level was lower in I/R+Ebselen group when compared with Sham (p < 0.001) and I/R (p < 0.01) groups.  There was no significant difference among the groups in terms of glutathione peroxidase and catalase activities.  In histopathol. examn., the brain tissues of rats that received Ebselen showed morphol. improvement.  Conclusion: Ebselen has neuron-protective effects due to its antioxidant properties as shown by the decrease in MDA overprodn., increase in SOD activity and the histol. improvement after administration of Ebselen to I/R in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqpkHWjCMpSLVg90H21EOLACvtfcHk0lggUR32_hub8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWhu7nI&md5=a7da42ccb1da6ce0b805b5bb2dd52948</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3109%2F00207454.2013.879581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00207454.2013.879581%26sid%3Dliteratum%253Aachs%26aulast%3DAras%26aufirst%3DM.%26aulast%3DAlta%25C5%259F%26aufirst%3DM.%26aulast%3DMeydan%26aufirst%3DS.%26aulast%3DNacar%26aufirst%3DE.%26aulast%3DKarc%25C4%25B1o%25C7%25A7lu%26aufirst%3DM.%26aulast%3DUluta%25C5%259F%26aufirst%3DK.%2BT.%26aulast%3DSerarslan%26aufirst%3DY.%26atitle%3DEffects%2520of%2520ebselen%2520on%2520ischemia%252Freperfusion%2520injury%2520in%2520rat%2520brain%26jtitle%3DInt.%2520J.%2520Neurosci.%26date%3D2014%26volume%3D124%26spage%3D771%26epage%3D776%26doi%3D10.3109%2F00207454.2013.879581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira Porciuncula, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, F. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Rocha, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Souza, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghisleni, G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almeida, H. L.</span></span> <span> </span><span class="NLM_article-title">Selenium compounds prevent amyloid β-peptide neurotoxicity in rat primary hippocampal neurons</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2359</span>– <span class="NLM_lpage">2363</span>, <span class="refDoi"> DOI: 10.1007/s11064-013-1147-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs11064-013-1147-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24013888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2qs7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=2359-2363&author=G.+L.+Godoiauthor=L.+de+Oliveira+Porciunculaauthor=J.+F.+Schulzauthor=F.+N.+Kaufmannauthor=J.+B.+da+Rochaauthor=D.+O.+de+Souzaauthor=G.+Ghisleniauthor=H.+L.+de+Almeida&title=Selenium+compounds+prevent+amyloid+%CE%B2-peptide+neurotoxicity+in+rat+primary+hippocampal+neurons&doi=10.1007%2Fs11064-013-1147-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium Compounds Prevent Amyloid β-Peptide Neurotoxicity in Rat Primary Hippocampal Neurons</span></div><div class="casAuthors">Godoi, Gabriela Lorea; de Oliveira Porciuncula, Lisiane; Schulz, Janaina Fagundes; Kaufmann, Fernanda Neutzling; Batista da Rocha, Joao; Gomes de Souza, Diogo Onofre; Ghisleni, Gabriele; Larangeira de Almeida, Hiram, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2359-2363</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuropathol. hallmarks of Alzheimer's disease (AD) include amyloid plaque formation, neurofibrillary tangles, neuronal and synaptic loss.  This study aims to identify the neuroprotective effects of the selenium compds. on the neurotoxicity of amyloid β(1-42) in primary cultures of murine hippocampal neurons.  Samples were subjected to immunocytochem. and western blotting techniques to det. the role of treatments on neuronal viability and synaptic protein SNAP-25.  We obsd. a reduced cell viability amyloid β-peptide (1-42)-induced.  When cells were co-treated with amyloid β-peptide (1-42) and selenium compds., we verified a strong increase in relative cell viability and in the level of synaptic marker synaptosomal-assocd. protein SNAP-25 induced by selenium compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZijvmU9RPwLVg90H21EOLACvtfcHk0lggUR32_hub8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2qs7zN&md5=12638e414b11bf171d132e92dae79bbf</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs11064-013-1147-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-013-1147-4%26sid%3Dliteratum%253Aachs%26aulast%3DGodoi%26aufirst%3DG.%2BL.%26aulast%3Dde%2BOliveira%2BPorciuncula%26aufirst%3DL.%26aulast%3DSchulz%26aufirst%3DJ.%2BF.%26aulast%3DKaufmann%26aufirst%3DF.%2BN.%26aulast%3Dda%2BRocha%26aufirst%3DJ.%2BB.%26aulast%3Dde%2BSouza%26aufirst%3DD.%2BO.%26aulast%3DGhisleni%26aufirst%3DG.%26aulast%3Dde%2BAlmeida%26aufirst%3DH.%2BL.%26atitle%3DSelenium%2520compounds%2520prevent%2520amyloid%2520%25CE%25B2-peptide%2520neurotoxicity%2520in%2520rat%2520primary%2520hippocampal%2520neurons%26jtitle%3DNeurochem.%2520Res.%26date%3D2013%26volume%3D38%26spage%3D2359%26epage%3D2363%26doi%3D10.1007%2Fs11064-013-1147-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span> <span> </span><span class="NLM_article-title">Ebselen ameliorates beta-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer’s disease mice</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.1007/s00775-017-1463-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs00775-017-1463-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28502066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslKlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=851-865&author=Y.+Xieauthor=Y.+Tanauthor=Y.+Zhengauthor=X.+Duauthor=Q.+Liu&title=Ebselen+ameliorates+beta-amyloid+pathology%2C+tau+pathology%2C+and+cognitive+impairment+in+triple-transgenic+Alzheimer%E2%80%99s+disease+mice&doi=10.1007%2Fs00775-017-1463-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice</span></div><div class="casAuthors">Xie, Yongli; Tan, Yibin; Zheng, Youbiao; Du, Xiubo; Liu, Qiong</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">851-865</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disease which is clin. characterized by memory loss and cognitive decline caused by protein misfolding and aggregation.  Imbalance between free radicals and the antioxidant system is a prominent and early feature in the neuropathol. of AD.  Selenium (Se), a vital trace element with excellent antioxidant potential, is preferentially retained in the brain in Se-limited conditions and has been reported to provide neuroprotection through resisting oxidative damage.  In this paper, we studied for the first time the potential of Ebselen, a lipid-sol. selenium compd. with GPx-like activity, in the treatment of cognitive dysfunction and neuropathol. of triple-transgenic AD (3 × Tg-AD) mice, AD model cell, and primary culture.  We demonstrated that Ebselen inhibited oxidative stress in both AD model cells and mouse brains with increasing GPx and SOD activities and meanwhile reduced p38 mitogen-activated protein kinases activities.  By decreasing the expression of amyloid precursor protein and β-secretase, Ebselen reduced the levels of Aβ in AD neurons and mouse brains, esp. the most toxic oligomeric form.  Besides, mislocation of phosphorylated tau in neurons and phosphorylation levels of tau protein at Thr231, Ser396, and Ser404 residues were also inhibited by Ebselen, probably by its regulatory roles in glycogen synthase kinase 3β and protein phosphatase 2A activity.  In addn., Ebselen mitigated the decrease of synaptic proteins including synaptophysin and postsynaptic d. protein 95 in AD model cells and neurons.  Consequently, the spatial learning and memory of 3 × Tg-AD mice were significantly improved upon Ebselen treatment.  This study provides a potential novel therapeutic approach for the prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrouRLS6A8OTrVg90H21EOLACvtfcHk0liX21dvxvXtNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslKlsbc%253D&md5=cbbb12bbc4aa957eefb1fad780e14625</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00775-017-1463-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-017-1463-2%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DQ.%26atitle%3DEbselen%2520ameliorates%2520beta-amyloid%2520pathology%252C%2520tau%2520pathology%252C%2520and%2520cognitive%2520impairment%2520in%2520triple-transgenic%2520Alzheimer%25E2%2580%2599s%2520disease%2520mice%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2017%26volume%3D22%26spage%3D851%26epage%3D865%26doi%3D10.1007%2Fs00775-017-1463-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of multi-target-directed ligands against Alzheimer’s disease based on the fusion of donepezil and ebselen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9089</span>– <span class="NLM_lpage">9099</span>, <span class="refDoi"> DOI: 10.1021/jm401047q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401047q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9089-9099&author=Z.+Luoauthor=J.+Shengauthor=Y.+Sunauthor=C.+Luauthor=J.+Yanauthor=A.+Liuauthor=H.+B.+Luoauthor=L.+Huangauthor=X.+Li&title=Synthesis+and+evaluation+of+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease+based+on+the+fusion+of+donepezil+and+ebselen&doi=10.1021%2Fjm401047q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer's Disease Based on the Fusion of Donepezil and Ebselen</span></div><div class="casAuthors">Luo, Zonghua; Sheng, Jianfei; Sun, Yang; Lu, Chuanjun; Yan, Jun; Liu, Anqiu; Luo, Hai-bin; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9089-9099</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzylpiperidinylalkyl benzoisoselenazolones I [R = H, MeO; R1 = H, Cl, F, MeO; X = (CH2)n; n = 1-4] were prepd. as donepezil-ebselen hybrids for potential use as anti-Alzheimer's disease agents.  I (R = R1 = MeO; n = 2) was one of the most potent acetylcholinesterase inhibitors of the compds. tested (IC50 values of 0.042 μM for Electrophorus electricus acetylcholinesterase and 0.097 μM for human acetylcholinesterase) and was found to be a strong butyrylcholinesterase inhibitor with an IC50 value of 1.586 μM, to possess rapid H2O2 and peroxynitrite scavenging activity and glutathione peroxidase-like activity (ν0 = 123.5 μM min-1), and to be a substrate of mammalian thioredoxin reductase.  I (R = R1 = MeO; n = 2) showed no acute toxicity at doses of up to 2000 mg/kg; by comparing its permeation in an artificial blood-brain barrier permeation assay, I (R = R1 = MeO; n = 2) was expected to be able to penetrate the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozFGgeDdrcXrVg90H21EOLACvtfcHk0liX21dvxvXtNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7jL&md5=a9b4972150c544edab25b3c2611960f9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm401047q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401047q%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520based%2520on%2520the%2520fusion%2520of%2520donepezil%2520and%2520ebselen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9089%26epage%3D9099%26doi%3D10.1021%2Fjm401047q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmc.2013.12.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24461494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1355-1361&author=Z.+Luoauthor=L.+Liangauthor=J.+Shengauthor=Y.+Pangauthor=J.+Liauthor=L.+Huangauthor=X.+Li&title=Synthesis+and+biological+evaluation+of+a+new+series+of+ebselen+derivatives+as+glutathione+peroxidase+%28GPx%29+mimics+and+cholinesterase+inhibitors+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2013.12.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease</span></div><div class="casAuthors">Luo, Zonghua; Liang, Liang; Sheng, Jianfei; Pang, Yanqing; Li, Jianheng; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1355-1361</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of ebselen derivs. were designed, synthesized and evaluated as inhibitors of cholinesterases (ChEs) and glutathione peroxidase (GPx) mimics.  Most of the compds. were found to be potent against AChEs and BuChE, compds. 5e and 5i, proved to be the most potent against AChE with IC50 values of 0.76 and 0.46 μM, resp.  Among these hybrids, most of the compds. were found to be good GPx mimics compare with ebselen.  The selected compds. 5e and 5i were also used to det. the catalytic parameters and in vitro hydrogen peroxide scavenging activity.  The results indicate that compds. 5e and 5i may be excellent multifunctional agents for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_j339r0RurVg90H21EOLACvtfcHk0liX21dvxvXtNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSisrw%253D&md5=258d22850034133095ca45dec5667b25</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.066%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DSheng%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520new%2520series%2520of%2520ebselen%2520derivatives%2520as%2520glutathione%2520peroxidase%2520%2528GPx%2529%2520mimics%2520and%2520cholinesterase%2520inhibitors%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1355%26epage%3D1361%26doi%3D10.1016%2Fj.bmc.2013.12.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6737</span>– <span class="NLM_lpage">6742</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2013.10.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24220172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslygsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6737-6742&author=F.+Maoauthor=J.+Chenauthor=Q.+Zhouauthor=Z.+Luoauthor=L.+Huangauthor=X.+Li&title=Novel+tacrine-ebselen+hybrids+with+improved+cholinesterase+inhibitory%2C+hydrogen+peroxide+and+peroxynitrite+scavenging+activity&doi=10.1016%2Fj.bmcl.2013.10.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity</span></div><div class="casAuthors">Mao, Fei; Chen, Jianwen; Zhou, Qi; Luo, Zonghua; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6737-6742</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of tacrine-ebselen hybrids were synthesized and evaluated as possible multifunctional anti-Alzheimer's disease (AD) agents.  Compd. 6i, which is tacrine linked with 5,6-dimethoxybenzo[d][1,2]selenazol-3(2H)-one by a six-carbon spacer, was the most potent acetylcholinesterase (AChE) and butylcholinesterase (BuChE) inhibitor, with IC50 values of 2.55 and 2.80 nM, resp.  Furthermore, this compd. demonstrated similar hydrogen peroxide and peroxynitrite scavenging activity as ebselen by horseradish peroxidase assay and peroxynitrite scavenging activity assay, indicating that this hybrid is a good multifunctional drug candidate for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN03ry0LUstrVg90H21EOLACvtfcHk0lgZVatkJvqNEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslygsbvJ&md5=170be61dfea512595270709e0936fb7b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.034%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DNovel%2520tacrine-ebselen%2520hybrids%2520with%2520improved%2520cholinesterase%2520inhibitory%252C%2520hydrogen%2520peroxide%2520and%2520peroxynitrite%2520scavenging%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6737%26epage%3D6742%26doi%3D10.1016%2Fj.bmcl.2013.10.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Computer-assisted designed “selenoxy-chinolin“: a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation</span>. <i>Dalton Trans</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">20913</span>– <span class="NLM_lpage">20925</span>, <span class="refDoi"> DOI: 10.1039/C5DT02130H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC5DT02130H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26575390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslenu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=20913-20925&author=Z.+Wangauthor=Y.+Wangauthor=W.+Liauthor=Z.+Liuauthor=Z.+Luoauthor=Y.+Sunauthor=R.+Wuauthor=L.+Huangauthor=X.+Li&title=Computer-assisted+designed+%E2%80%9Cselenoxy-chinolin%E2%80%9C%3A+a+new+catalytic+mechanism+of+the+GPx-like+cycle+and+inhibition+of+metal-free+and+metal-associated+A%CE%B2+aggregation&doi=10.1039%2FC5DT02130H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-assisted designed "selenoxy-chinolin": a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation</span></div><div class="casAuthors">Wang, Zhiren; Wang, Yali; Li, Wenrui; Liu, Zhihong; Luo, Zonghua; Sun, Yang; Wu, Ruibo; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">20913-20925</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Using support from rational computer-assisted design, a novel series of hybrids (selenoxy-chinolin) designed by fusing the metal-chelating agent CQ and the antioxidant ebselen were synthesized and evaluated as multitarget-directed ligands.  Most of the hybrids demonstrated significant ability to mimic GPx, which is highly consistent with the prediction results of DFT studies for the selenenyl sulfide intermediates in the computational design.  Using 77Se, 1H and 13C NMR spectroscopy and high-resoln. mass spectroscopy (HRMS), a novel catalytic mechanism, including a new selenium quinone active species, was first demonstrated.  2D NMR studies indicated that the typical hybrid has an effective interaction with Aβ.  In addn., the optimal compd. 2-(7-chloro-8-hydroxyquinolin-5-yl)-5-hydroxybenzo[d][1,2]selenazol-3(2H)-one hydrochloride (12k) was found to possess an excellent ability to scavenge peroxide and to inhibit self- and metal-induced Aβ aggregation, and an ability to disassemble preformed self- and metal-induced Aβ aggregates effectively.  Furthermore, (12k) was able to penetrate the central nervous system (CNS) and did not exhibit any acute toxicity in mice at doses up to 2000 mg kg-1.  Overall, the authors demonstrated that hybrid (12k), through rational structure-based computational design, shows a potential for development as a therapeutic agent in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOa4CKjjugULVg90H21EOLACvtfcHk0lgZVatkJvqNEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslenu7fI&md5=03ca1ded5d7a33339564412d27877cfd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1039%2FC5DT02130H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5DT02130H%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DComputer-assisted%2520designed%2520%25E2%2580%259Cselenoxy-chinolin%25E2%2580%259C%253A%2520a%2520new%2520catalytic%2520mechanism%2520of%2520the%2520GPx-like%2520cycle%2520and%2520inhibition%2520of%2520metal-free%2520and%2520metal-associated%2520A%25CE%25B2%2520aggregation%26jtitle%3DDalton%2520Trans%26date%3D2015%26volume%3D44%26spage%3D20913%26epage%3D20925%26doi%3D10.1039%2FC5DT02130H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[<i>d</i>][1,2]selenazol-3(2<i>H</i>)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4741</span>– <span class="NLM_lpage">4749</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmc.2016.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27567080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWmtb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=4741-4749&author=B.+Wangauthor=Z.+Wangauthor=H.+Chenauthor=C.-J.+Luauthor=X.+Li&title=Synthesis+and+evaluation+of+8-hydroxyquinolin+derivatives+substituted+with+%28benzo%5Bd%5D%5B1%2C2%5Dselenazol-3%282H%29-one%29+as+effective+inhibitor+of+metal-induced+A%CE%B2+aggregation+and+antioxidant&doi=10.1016%2Fj.bmc.2016.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant</span></div><div class="casAuthors">Wang, Bo; Wang, Zhiren; Chen, Hong; Lu, Chuan-Jun; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4741-4749</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 8-hydroxyquinolin derivs. substituted with (benzo[d][1,2]selenazol-3(2H)-one) at the 2-position were synthesized and evaluated for treatment of Alzheimer's disease.  In vitro assays demonstrated that most of the target compds. exhibit significant inhibition of Cu(II)-induced Aβ1-42 aggregation, rapid H2O2 scavenging and glutathione peroxidize (GPx)-like catalytic activity.  Among these mols., 5-hydroxy-2-(8-hydroxyquinolin-2-yl)benzo[d][1,2] selenazol-3(2H)-one (9a) is the most potent peroxide scavenger that possesses the ability to scavenge most H2O2 within 200-220 min and possesses GPx-like activity (v0 = 106.0 μM·min-1), enabling modulation of metal-induced Aβ aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu979rk9wBurVg90H21EOLACvtfcHk0lgZVatkJvqNEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWmtb3F&md5=f8edc6d699f8fb908f5e0b11e2186d8e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DC.-J.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25208-hydroxyquinolin%2520derivatives%2520substituted%2520with%2520%2528benzo%255Bd%255D%255B1%252C2%255Dselenazol-3%25282H%2529-one%2529%2520as%2520effective%2520inhibitor%2520of%2520metal-induced%2520A%25CE%25B2%2520aggregation%2520and%2520antioxidant%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D4741%26epage%3D4749%26doi%3D10.1016%2Fj.bmc.2016.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5718</span>– <span class="NLM_lpage">5729</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmc.2018.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30385227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVentL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=5718-5729&author=J.+Huauthor=B.+Anauthor=T.+Panauthor=Z.+Liauthor=L.+Huangauthor=X.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+histone+deacetylase+inhibitors+possessing+glutathione+peroxidase-like+and+antioxidant+activities+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2018.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease</span></div><div class="casAuthors">Hu, Jinhui; An, Baijiao; Pan, Tingting; Li, Zhengcunxiao; Huang, Ling; Li, Xingshu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5718-5729</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of hybrids contg. the pharmacophores of the histone deacetylase (HDAC) inhibitor, SAHA, and the antioxidant ebselen were designed and synthesized as multi-target-directed ligands against Alzheimer's disease.  An in vitro assay indicated that some of these mols. exhibit potent HDAC inhibitory activity and ebselen-related pharmacol. effects.  Specifically, the optimal compd. 7f was found to be a potent HDAC inhibitor (IC50 = 0.037 μM), possessing rapid hydrogen peroxide scavenging activity and glutathione peroxidase-like activity (ν0 = 150.0 μM min-1) and good free oxygen radical absorbance capacity (value of ORAC: 2.2).  Furthermore, compd. 7f showed significant protective effects against damage induced by H2O2 and the ability to prevent ROS accumulation in PC12 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv2EKWVVijlLVg90H21EOLACvtfcHk0lgZVatkJvqNEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVentL%252FK&md5=b9a5f6059db2b4c611f9a050e2b54d6f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DAn%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520histone%2520deacetylase%2520inhibitors%2520possessing%2520glutathione%2520peroxidase-like%2520and%2520antioxidant%2520activities%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D5718%26epage%3D5729%26doi%3D10.1016%2Fj.bmc.2018.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukifli, Z. H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E. K.</span></span> <span> </span><span class="NLM_article-title">Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants</span>. <i>Hum. Mutat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">978</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1002/humu.23234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fhumu.23234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28432706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFGnsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=978-987&author=M.+Tioauthor=R.+Wenauthor=Y.+L.+Limauthor=Z.+H.+B.+Zukifliauthor=S.+Xieauthor=P.+Hoauthor=Z.+Zhouauthor=T.+W.+Kohauthor=Y.+Zhaoauthor=E.+K.+Tan&title=Varied+pathological+and+therapeutic+response+effects+associated+with+CHCHD2+mutant+and+risk+variants&doi=10.1002%2Fhumu.23234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants</span></div><div class="casAuthors">Tio, Murni; Wen, Rujing; Lim, Yih Lin; Bin Zukifli, Zul Haikhel; Xie, Shaoping; Ho, Patrick; Zhou, Zhidong; Koh, Tong-Wey; Zhao, Yi; Tan, Eng-King</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">978-987</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Mutations and polymorphic risk variant of coiled-coil-helix-coiled-coil-helix domain contg. 2 (CHCHD2) have been assocd. with late-onset Parkinson disease.  In vivo pathol. evidence of CHCHD2 mutations is currently lacking.  Utilizing transgenic Drosophila model, we examd. the relative pathophysiol. effect of the pathogenic (c.182C>T, p.Thr61Ile and c.434G>A, p.Arg145Gln) and the risk (c.5C>T, p.Pro2Leu) CHCHD2 variants.  All the transgenic models exhibited locomotor dysfunction that could be exacerbated by rotenone exposure, dopaminergic neuron degeneration, redn. in lifespan, mitochondrial dysfunction, oxidative stress, and impairment in synaptic transmission.  However, both mutants showed more severe early motor dysfunction, dopaminergic neuronal loss, and higher hydrogen peroxide prodn. compared with the risk variant.  P.Thr61Ile (co-segregated in three independent PD families) displayed the most severe phenotype followed by p.Arg145Gln (present only in index patient).  We treated the transgenic flies with Ebselen, a mitochondrial hydrogen peroxide scavenger compd.; Ebselen appears to be more effective in ameliorating motor function in the mutant than the risk variant models.  We provide the first in vivo evidence of the pathol. effects assocd. with CHCHD2 mutations.  There was a difference in the pathol. and drug response effects between the pathogenic and the risk variants.  Ebselen may be a useful neuroprotective drug for carriers of CHCHD2 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZfbu7qYfLr7Vg90H21EOLACvtfcHk0ljSoJMYr4Crxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFGnsbrL&md5=e2c73b2f59a2cd95f8252d02017c7e14</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fhumu.23234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.23234%26sid%3Dliteratum%253Aachs%26aulast%3DTio%26aufirst%3DM.%26aulast%3DWen%26aufirst%3DR.%26aulast%3DLim%26aufirst%3DY.%2BL.%26aulast%3DZukifli%26aufirst%3DZ.%2BH.%2BB.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DKoh%26aufirst%3DT.%2BW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DE.%2BK.%26atitle%3DVaried%2520pathological%2520and%2520therapeutic%2520response%2520effects%2520associated%2520with%2520CHCHD2%2520mutant%2520and%2520risk%2520variants%26jtitle%3DHum.%2520Mutat.%26date%3D2017%26volume%3D38%26spage%3D978%26epage%3D987%26doi%3D10.1002%2Fhumu.23234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barkus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferland, J. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannerman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winstanley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, T.</span></span> <span> </span><span class="NLM_article-title">The putative lithium-mimetic ebselen reduces impulsivity in rodent models</span>. <i>J. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1018</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1177/0269881118784876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1177%2F0269881118784876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29986609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1KktbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=1018-1026&author=C.+Barkusauthor=J.+M.+N.+Ferlandauthor=W.+K.+Adamsauthor=G.+C.+Churchillauthor=P.+J.+Cowenauthor=D.+M.+Bannermanauthor=R.+D.+Rogersauthor=C.+A.+Winstanleyauthor=T.+Sharp&title=The+putative+lithium-mimetic+ebselen+reduces+impulsivity+in+rodent+models&doi=10.1177%2F0269881118784876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The putative lithium-mimetic ebselen reduces impulsivity in rodent models</span></div><div class="casAuthors">Barkus, Chris; Ferland, Jacqueline-Marie N.; Adams, Wendy K.; Churchill, Grant C.; Cowen, Philip J.; Bannerman, David M.; Rogers, Robert D.; Winstanley, Catharine A.; Sharp, Trevor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1018-1026</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Aims:: Recently we identified that the neuroprotective agent ebselen, which is reportedly safe in humans, inhibited inositol monophosphatase, a candidate lithium mechanism.  Ebselen also reduced 5-HT receptor function which predicts impulsivity lowering properties.  Here we investigated the effect of ebselen in rat models of impulsive behavior.  Methods:: Ebselen was tested in two models of impulsivity with human analogs: the five-choice serial reaction time task (5-CSRTT) and rodent gambling task (rGT).  The main outcome measures were premature responses and choice behavior (rGT), which model motor impulsivity and choice impulsivity, resp.  Results:: At doses that decreased 5-HT2A receptor function (DOI-induced wet dog shakes), ebselen decreased premature responding in the 5-CSRTT both in the absence and presence of cocaine.  The 5-HT2A receptor antagonist MDL 100,907 also reduced premature responding in the 5-CSRTT although not in the presence of cocaine.  In the rGT ebselen showed a tendency to reduce premature responding but had no effect on choice behavior.  Conclusions:: These findings suggest that ebselen preferentially reduces motor impulsivity over choice impulsivity, and that inhibition of 5-HT2A receptor function is a contributing mechanism.  Collectively, these data support the repurposing of ebselen as an anti-impulsive treatment and fast-tracking to clin. trials in patient groups characterised by poor impulse control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcPM1S_kTKd7Vg90H21EOLACvtfcHk0ljSoJMYr4Crxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1KktbvK&md5=71acfd210afa70d085c58c5f7c2c45df</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1177%2F0269881118784876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881118784876%26sid%3Dliteratum%253Aachs%26aulast%3DBarkus%26aufirst%3DC.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%2BN.%26aulast%3DAdams%26aufirst%3DW.%2BK.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26aulast%3DBannerman%26aufirst%3DD.%2BM.%26aulast%3DRogers%26aufirst%3DR.%2BD.%26aulast%3DWinstanley%26aufirst%3DC.%2BA.%26aulast%3DSharp%26aufirst%3DT.%26atitle%3DThe%2520putative%2520lithium-mimetic%2520ebselen%2520reduces%2520impulsivity%2520in%2520rodent%2520models%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2018%26volume%3D32%26spage%3D1018%26epage%3D1026%26doi%3D10.1177%2F0269881118784876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpley, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godlewska, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, P. J.</span></span> <span> </span><span class="NLM_article-title">Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing</span>. <i>Psychopharmacology (Berl)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">2655</span>– <span class="NLM_lpage">2661</span>, <span class="refDoi"> DOI: 10.1007/s00213-016-4319-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs00213-016-4319-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27256357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fmt1SnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=2655-2661&author=C.+Masakiauthor=A.+L.+Sharpleyauthor=C.+M.+Cooperauthor=B.+R.+Godlewskaauthor=N.+Singhauthor=S.+R.+Vasudevanauthor=C.+J.+Harmerauthor=G.+C.+Churchillauthor=T.+Sharpauthor=R.+D.+Rogersauthor=P.+J.+Cowen&title=Effects+of+the+potential+lithium-mimetic%2C+ebselen%2C+on+impulsivity+and+emotional+processing&doi=10.1007%2Fs00213-016-4319-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing</span></div><div class="casAuthors">Masaki Charles; Sharpley Ann L; Cooper Charlotte M; Godlewska Beata R; Harmer Catherine J; Cowen Philip J; Singh Nisha; Vasudevan Sridhar R; Churchill Grant C; Sharp Trevor; Singh Nisha; Rogers Robert D</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2655-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Lithium remains the most effective treatment for bipolar disorder and also has important effects to lower suicidal behaviour, a property that may be linked to its ability to diminish impulsive, aggressive behaviour.  The antioxidant drug, ebselen, has been proposed as a possible lithium-mimetic based on its ability in animals to inhibit inositol monophosphatase (IMPase), an action which it shares with lithium.  OBJECTIVES:  The aim of the study was to determine whether treatment with ebselen altered emotional processing and diminished measures of risk-taking behaviour.  METHODS:  We studied 20 healthy participants who were tested on two occasions receiving either ebselen (3600 mg over 24 h) or identical placebo in a double-blind, randomized, cross-over design.  Three hours after the final dose of ebselen/placebo, participants completed the Cambridge Gambling Task (CGT) and a task that required the detection of emotional facial expressions (facial emotion recognition task (FERT)).  RESULTS:  On the CGT, relative to placebo, ebselen reduced delay aversion while on the FERT, it increased the recognition of positive vs negative facial expressions.  CONCLUSIONS:  The study suggests that at the dosage used, ebselen can decrease impulsivity and produce a positive bias in emotional processing.  These findings have implications for the possible use of ebselen in the disorders characterized by impulsive behaviour and dysphoric mood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSErvRl4Zklf_6AExegM5LLfW6udTcc2eYSXPPTRfIXTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fmt1SnsQ%253D%253D&md5=e49d0f95c85519ade8c542ca8ea0adcc</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4319-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4319-5%26sid%3Dliteratum%253Aachs%26aulast%3DMasaki%26aufirst%3DC.%26aulast%3DSharpley%26aufirst%3DA.%2BL.%26aulast%3DCooper%26aufirst%3DC.%2BM.%26aulast%3DGodlewska%26aufirst%3DB.%2BR.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DVasudevan%26aufirst%3DS.%2BR.%26aulast%3DHarmer%26aufirst%3DC.%2BJ.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DSharp%26aufirst%3DT.%26aulast%3DRogers%26aufirst%3DR.%2BD.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26atitle%3DEffects%2520of%2520the%2520potential%2520lithium-mimetic%252C%2520ebselen%252C%2520on%2520impulsivity%2520and%2520emotional%2520processing%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2016%26volume%3D233%26spage%3D2655%26epage%3D2661%26doi%3D10.1007%2Fs00213-016-4319-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpley, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emir, U. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzallah, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluck, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span> <span> </span><span class="NLM_article-title">Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1768</span>– <span class="NLM_lpage">1778</span>, <span class="refDoi"> DOI: 10.1038/npp.2015.343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1038%2Fnpp.2015.343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26593266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVymur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=1768-1778&author=N.+Singhauthor=A.+L.+Sharpleyauthor=U.+E.+Emirauthor=C.+Masakiauthor=M.+M.+Herzallahauthor=M.+A.+Gluckauthor=T.+Sharpauthor=C.+J.+Harmerauthor=S.+R.+Vasudevanauthor=P.+J.+Cowenauthor=G.+C.+Churchill&title=Effect+of+the+putative+lithium+mimetic+ebselen+on+brain+myo-inositol%2C+sleep%2C+and+emotional+processing+in+humans&doi=10.1038%2Fnpp.2015.343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans</span></div><div class="casAuthors">Singh, Nisha; Sharpley, Ann L.; Emir, Uzay E.; Masaki, Charles; Herzallah, Mohammad M.; Gluck, Mark A.; Sharp, Trevor; Harmer, Catherine J.; Vasudevan, Sridhar R.; Cowen, Philip J.; Churchill, Grant C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1768-1778</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lithium remains the gold std. in treating bipolar disorder but has unwanted toxicity and side effects.  We previously reported that ebselen inhibits inositol monophosphatase (IMPase) and exhibits lithium-like effects in animal models through lowering of inositol.  Ebselen has been tested in clin. trials for other disorders, enabling us to det. for the first time the effect of a blood-brain barrier-penetrant IMPase inhibitor on human central nervous system (CNS) function.  We now report that in a double-blind, placebo-controlled trial with healthy participants, acute oral ebselen reduced brain myo-inositol in the anterior cingulate cortex, consistent with CNS target engagement.  Ebselen decreased slow-wave sleep and affected emotional processing by increasing recognition of some emotions, decreasing latency time in the acoustic startle paradigm, and decreasing the reinforcement of rewarding stimuli.  In summary, ebselen affects the phosphoinositide cycle and has CNS effects on surrogate markers that may be relevant to the treatment of bipolar disorder that can be tested in future clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcZJVJiw6h-bVg90H21EOLACvtfcHk0ljakOvqyhSz4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVymur3N&md5=df04f4330f783e1e75390586bebcade5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.343%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DSharpley%26aufirst%3DA.%2BL.%26aulast%3DEmir%26aufirst%3DU.%2BE.%26aulast%3DMasaki%26aufirst%3DC.%26aulast%3DHerzallah%26aufirst%3DM.%2BM.%26aulast%3DGluck%26aufirst%3DM.%2BA.%26aulast%3DSharp%26aufirst%3DT.%26aulast%3DHarmer%26aufirst%3DC.%2BJ.%26aulast%3DVasudevan%26aufirst%3DS.%2BR.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26atitle%3DEffect%2520of%2520the%2520putative%2520lithium%2520mimetic%2520ebselen%2520on%2520brain%2520myo-inositol%252C%2520sleep%252C%2520and%2520emotional%2520processing%2520in%2520humans%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D1768%26epage%3D1778%26doi%3D10.1038%2Fnpp.2015.343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antoniadou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouskou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsiwala, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadirci, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchill, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, T.</span></span> <span> </span><span class="NLM_article-title">Ebselen has lithium-like effects on central 5-HT2A receptor function</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">2599</span>– <span class="NLM_lpage">2610</span>, <span class="refDoi"> DOI: 10.1111/bph.14179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1111%2Fbph.14179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29488218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvFWmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=2599-2610&author=I.+Antoniadouauthor=M.+Kouskouauthor=T.+Arsiwalaauthor=N.+Singhauthor=S.+R.+Vasudevanauthor=T.+Fowlerauthor=E.+Cadirciauthor=G.+C.+Churchillauthor=T.+Sharp&title=Ebselen+has+lithium-like+effects+on+central+5-HT2A+receptor+function&doi=10.1111%2Fbph.14179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen has lithium-like effects on central 5-HT2A receptor function</span></div><div class="casAuthors">Antoniadou, I.; Kouskou, M.; Arsiwala, T.; Singh, N.; Vasudevan, S. R.; Fowler, T.; Cadirci, E.; Churchill, G. C.; Sharp, T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2599-2610</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Lithium's antidepressant action may be mediated by inhibition of inositol monophosphatase (IMPase), a key enzyme in Gq-protein coupled receptor signalling.  Recently, the antioxidant agent ebselen was identified as an IMPase inhibitor.  Here, we investigated both ebselen and lithium in models of the 5-HT2A receptor, a Gq-protein coupled receptor involved in lithium's actions.  Exptl. Approach : 5-HT2A receptor function was assessed in mice by measuring the behavioral (head-twitches, ear scratches) and mol. (cortical immediate early gene [IEG] mRNA; Arc, c-fos, Egr2) responses to 5-HT2A receptor agonists.  Ebselen and lithium were administered either acutely or repeatedly prior to assessment of 5-HT2A receptor function.  Because lithium and 5-HT2A receptor antagonists augment the action of selective serotonin reuptake inhibitors (SSRIs), ebselen was tested for this activity by co-administration with the SSRI citalopram in microdialysis (extracellular 5-HT) expts.  Key Results : Acute and repeated administration of ebselen inhibited behavioral and IEG responses to the 5-HT2A receptor agonist DOI.  Repeated lithium also inhibited DOI-evoked behavioral and IEG responses.  In comparison, a selective IMPase inhibitor (L-690330) attenuated the behavioral response to DOI whereas glycogen synthase kinase inhibitor (AR-A014418) did not.  Finally, ebselen enhanced the increase in extracellular 5-HT induced by citalopram, and also increased regional brain 5-HT synthesis.  Conclusions and Implications : Our data demonstrated lithium-mimetic effects of ebselen in different exptl. models of 5-HT2A receptor function, probably mediated by IMPase inhibition.  This evidence of lithium-like neuropharmacol. effects of ebselen adds further support for the clin. testing of ebselen in mood disorders, including as an antidepressant augmenting agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGognf5awocjRbVg90H21EOLACvtfcHk0ljakOvqyhSz4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvFWmtbg%253D&md5=271e1858fd8d782b93a2d2897a09db36</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fbph.14179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14179%26sid%3Dliteratum%253Aachs%26aulast%3DAntoniadou%26aufirst%3DI.%26aulast%3DKouskou%26aufirst%3DM.%26aulast%3DArsiwala%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DVasudevan%26aufirst%3DS.%2BR.%26aulast%3DFowler%26aufirst%3DT.%26aulast%3DCadirci%26aufirst%3DE.%26aulast%3DChurchill%26aufirst%3DG.%2BC.%26aulast%3DSharp%26aufirst%3DT.%26atitle%3DEbselen%2520has%2520lithium-like%2520effects%2520on%2520central%25205-HT2A%2520receptor%2520function%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D2599%26epage%3D2610%26doi%3D10.1111%2Fbph.14179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coronado, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, S.</span></span> <span> </span><span class="NLM_article-title">Putative neuroprotective pharmacotherapies to target the staged progression of mental illness</span>. <i>Early Interv Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1111/eip.12775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1111%2Feip.12775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30690898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BB3cjmtFOktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2019&pages=1032-1049&author=O.+D.+Robertsonauthor=N.+G.+Coronadoauthor=R.+Sethiauthor=M.+Berkauthor=S.+Dodd&title=Putative+neuroprotective+pharmacotherapies+to+target+the+staged+progression+of+mental+illness&doi=10.1111%2Feip.12775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Putative neuroprotective pharmacotherapies to target the staged progression of mental illness</span></div><div class="casAuthors">Robertson Oliver D; Berk Michael; Dodd Seetal; Robertson Oliver D; Berk Michael; Dodd Seetal; Coronado Nieves G; Sethi Rickinder; Berk Michael; Dodd Seetal; Berk Michael; Dodd Seetal; Berk Michael</div><div class="citationInfo"><span class="NLM_cas:title">Early intervention in psychiatry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1032-1049</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM:  Neuropsychiatric disorders including depression, bipolar and schizophrenia frequently exhibit a neuroprogressive course from prodrome to chronicity.  There are a range of agents exhibiting capacity to attenuate biological mechanisms associated with neuroprogression.  This review will update the evidence for putative neuroprotective agents including clinical efficacy, mechanisms of action and limitations in current assessment tools, and identify novel agents with neuroprotective potential.  METHOD:  Data for this review were sourced from online databases PUBMED, Embase and Web of Science.  Only data published since 2012 were included in this review, no data were excluded based on language or publication origin.  RESULTS:  Each of the agents reviewed inhibit one or multiple pathways of neuroprogression including: inflammatory gene expression and cytokine release, oxidative and nitrosative stress, mitochondrial dysfunction, neurotrophin dysregulation and apoptotic signalling.  Some demonstrate clinical efficacy in preventing neural damage or loss, relapse or cognitive/functional decline.  Agents include: the psychotropic medications lithium, second generation antipsychotics and antidepressants; other pharmacological agents such as minocycline, aspirin, cyclooxygenase-2 inhibitors, statins, ketamine and alpha-2-delta ligands; and others such as erythropoietin, oestrogen, leptin, N-acetylcysteine, curcumin, melatonin and ebselen.  CONCLUSIONS:  Signals of evidence of clinical neuroprotection are evident for a number of candidate agents.  Adjunctive use of multiple agents may present a viable avenue to clinical realization of neuroprotection.  Definitive prospective studies of neuroprotection with multimodal assessment tools are required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgDkSQnKayf0PI-fCgwosgfW6udTcc2eaaH0I-DAyqS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjmtFOktw%253D%253D&md5=fe7a8c266d4d1edf69353362d4dd2151</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Feip.12775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Feip.12775%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DO.%2BD.%26aulast%3DCoronado%26aufirst%3DN.%2BG.%26aulast%3DSethi%26aufirst%3DR.%26aulast%3DBerk%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DS.%26atitle%3DPutative%2520neuroprotective%2520pharmacotherapies%2520to%2520target%2520the%2520staged%2520progression%2520of%2520mental%2520illness%26jtitle%3DEarly%2520Interv%2520Psychiatry%26date%3D2019%26volume%3D13%26spage%3D1032%26epage%3D1049%26doi%3D10.1111%2Feip.12775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le-Niculescu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levey, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phalen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dainton, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roseberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niculescu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niezer, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venugopal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballew, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelbart, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schork, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandusky, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon, D. R.</span></span> <span> </span><span class="NLM_article-title">Precision medicine for suicidality: from universality to subtypes and personalization</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1250</span>– <span class="NLM_lpage">1273</span>, <span class="refDoi"> DOI: 10.1038/mp.2017.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1038%2Fmp.2017.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28809398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC1cfnslSnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1250-1273&author=A.+B.+Niculescuauthor=H.+Le-Niculescuauthor=D.+F.+Leveyauthor=P.+L.+Phalenauthor=H.+L.+Daintonauthor=K.+Roseberryauthor=E.+M.+Niculescuauthor=J.+O.+Niezerauthor=A.+Williamsauthor=D.+L.+Grahamauthor=T.+J.+Jonesauthor=V.+Venugopalauthor=A.+Ballewauthor=M.+Yardauthor=T.+Gelbartauthor=S.+M.+Kurianauthor=A.+Shekharauthor=N.+J.+Schorkauthor=G.+E.+Sanduskyauthor=D.+R.+Salomon&title=Precision+medicine+for+suicidality%3A+from+universality+to+subtypes+and+personalization&doi=10.1038%2Fmp.2017.128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Precision medicine for suicidality: from universality to subtypes and personalization</span></div><div class="casAuthors">Niculescu A B; Le-Niculescu H; Levey D F; Dainton H L; Roseberry K; Niculescu E M; Niezer J O; Venugopal V; Shekhar A; Niculescu A B; Levey D F; Niculescu A B; Phalen P L; Williams A; Graham D L; Jones T J; Niculescu A B; Yard M; Sandusky G E; Ballew A; Gelbart T; Kurian S M; Salomon D R; Schork N J</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1250-1273</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Suicide remains a clear, present and increasing public health problem, despite being a potentially preventable tragedy.  Its incidence is particularly high in people with overt or un(der)diagnosed psychiatric disorders.  Objective and precise identification of individuals at risk, ways of monitoring response to treatments and novel preventive therapeutics need to be discovered, employed and widely deployed.  We sought to investigate whether blood gene expression biomarkers for suicide (that is, a 'liquid biopsy' approach) can be identified that are more universal in nature, working across psychiatric diagnoses and genders, using larger cohorts than in previous studies.  Such markers may reflect and/or be a proxy for the core biology of suicide.  We were successful in this endeavor, using a comprehensive stepwise approach, leading to a wealth of findings.  Steps 1, 2 and 3 were discovery, prioritization and validation for tracking suicidality, resulting in a Top Dozen list of candidate biomarkers comprising the top biomarkers from each step, as well as a larger list of 148 candidate biomarkers that survived Bonferroni correction in the validation step.  Step 4 was testing the Top Dozen list and Bonferroni biomarker list for predictive ability for suicidal ideation (SI) and for future hospitalizations for suicidality in independent cohorts, leading to the identification of completely novel predictive biomarkers (such as CLN5 and AK2), as well as reinforcement of ours and others previous findings in the field (such as SLC4A4 and SKA2).  Additionally, we examined whether subtypes of suicidality can be identified based on mental state at the time of high SI and identified four potential subtypes: high anxiety, low mood, combined and non-affective (psychotic).  Such subtypes may delineate groups of individuals that are more homogenous in terms of suicidality biology and behavior.  We also studied a more personalized approach, by psychiatric diagnosis and gender, with a focus on bipolar males, the highest risk group.  Such a personalized approach may be more sensitive to gender differences and to the impact of psychiatric co-morbidities and medications.  We compared testing the universal biomarkers in everybody versus testing by subtypes versus personalized by gender and diagnosis, and show that the subtype and personalized approaches permit enhanced precision of predictions for different universal biomarkers.  In particular, LHFP appears to be a strong predictor for suicidality in males with depression.  We also directly examined whether biomarkers discovered using male bipolars only are better predictors in a male bipolar independent cohort than universal biomarkers and show evidence for a possible advantage of personalization.  We identified completely novel biomarkers (such as SPTBN1 and C7orf73), and reinforced previously known biomarkers (such as PTEN and SAT1).  For diagnostic ability testing purposes, we also examined as predictors phenotypic measures as apps (for suicide risk (CFI-S, Convergent Functional Information for Suicidality) and for anxiety and mood (SASS, Simplified Affective State Scale)) by themselves, as well as in combination with the top biomarkers (the combination being our a priori primary endpoint), to provide context and enhance precision of predictions.  We obtained area under the curves of 90% for SI and 77% for future hospitalizations in independent cohorts.  Step 5 was to look for mechanistic understanding, starting with examining evidence for the Top Dozen and Bonferroni biomarkers for involvement in other psychiatric and non-psychiatric disorders, as a mechanism for biological predisposition and vulnerability.  The biomarkers we identified also provide a window towards understanding the biology of suicide, implicating biological pathways related to neurogenesis, programmed cell death and insulin signaling from the universal biomarkers, as well as mTOR signaling from the male bipolar biomarkers.  In particular, HTR2A increase coupled with ARRB1 and GSK3B decreases in expression in suicidality may provide a synergistic mechanistical corrective target, as do SLC4A4 increase coupled with AHCYL1 and AHCYL2 decrease.  Step 6 was to move beyond diagnostics and mechanistical risk assessment, towards providing a foundation for personalized therapeutics.  Items scored positive in the CFI-S and subtypes identified by SASS in different individuals provide targets for personalized (psycho)therapy.  Some individual biomarkers are targets of existing drugs used to treat mood disorders and suicidality (lithium, clozapine and omega-3 fatty acids), providing a means toward pharmacogenomics stratification of patients and monitoring of response to treatment.  Such biomarkers merit evaluation in clinical trials.  Bioinformatics drug repurposing analyses with the gene expression biosignatures of the Top Dozen and Bonferroni-validated universal biomarkers identified novel potential therapeutics for suicidality, such as ebselen (a lithium mimetic), piracetam (a nootropic), chlorogenic acid (a polyphenol) and metformin (an antidiabetic and possible longevity promoting drug).  Finally, based on the totality of our data and of the evidence in the field to date, a convergent functional evidence score prioritizing biomarkers that have all around evidence (track suicidality, predict it, are reflective of biological predisposition and are potential drug targets) brought to the fore APOE and IL6 from among the universal biomarkers, suggesting an inflammatory/accelerated aging component that may be a targetable common denominator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcKsMrmubxoUodMGTatQ7LfW6udTcc2ebVrXNIKSDq_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfnslSnsg%253D%253D&md5=97e1e98e0a07b44b367175b8e5b7574b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fmp.2017.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2017.128%26sid%3Dliteratum%253Aachs%26aulast%3DNiculescu%26aufirst%3DA.%2BB.%26aulast%3DLe-Niculescu%26aufirst%3DH.%26aulast%3DLevey%26aufirst%3DD.%2BF.%26aulast%3DPhalen%26aufirst%3DP.%2BL.%26aulast%3DDainton%26aufirst%3DH.%2BL.%26aulast%3DRoseberry%26aufirst%3DK.%26aulast%3DNiculescu%26aufirst%3DE.%2BM.%26aulast%3DNiezer%26aufirst%3DJ.%2BO.%26aulast%3DWilliams%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BL.%26aulast%3DJones%26aufirst%3DT.%2BJ.%26aulast%3DVenugopal%26aufirst%3DV.%26aulast%3DBallew%26aufirst%3DA.%26aulast%3DYard%26aufirst%3DM.%26aulast%3DGelbart%26aufirst%3DT.%26aulast%3DKurian%26aufirst%3DS.%2BM.%26aulast%3DShekhar%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DSandusky%26aufirst%3DG.%2BE.%26aulast%3DSalomon%26aufirst%3DD.%2BR.%26atitle%3DPrecision%2520medicine%2520for%2520suicidality%253A%2520from%2520universality%2520to%2520subtypes%2520and%2520personalization%26jtitle%3DMol.%2520Psychiatry%26date%3D2017%26volume%3D22%26spage%3D1250%26epage%3D1273%26doi%3D10.1038%2Fmp.2017.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slusarczyk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olakowska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larysz-Brysz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woszczycka-Korczynska, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Carrillo, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weglarz, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin-Kowalik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcol, W.</span></span> <span> </span><span class="NLM_article-title">Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury</span>. <i>Neural Regener. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1255</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.4103/1673-5374.251334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.4103%2F1673-5374.251334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30804257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BB3cfnsVOjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1255-1261&author=W.+Slusarczykauthor=E.+Olakowskaauthor=M.+Larysz-Bryszauthor=I.+Woszczycka-Korczynskaauthor=D.+G.+de+Carrilloauthor=W.+P.+Weglarzauthor=J.+Lewin-Kowalikauthor=W.+Marcol&title=Use+of+ebselen+as+a+neuroprotective+agent+in+rat+spinal+cord+subjected+to+traumatic+injury&doi=10.4103%2F1673-5374.251334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury</span></div><div class="casAuthors">Slusarczyk Wojciech; Olakowska Edyta; Larysz-Brysz Magdalena; Woszczycka-Korczynska Izabella; de Carrillo Daria Gendosz; Lewin-Kowalik Joanna; Marcol Wieslaw; Weglarz Wladyslaw P</div><div class="citationInfo"><span class="NLM_cas:title">Neural regeneration research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1255-1261</span>
        ISSN:<span class="NLM_cas:issn">1673-5374</span>.
    </div><div class="casAbstract">Spinal cord injury (SCI) causes disturbances of motor skills.  Free radicals have been shown to be essential for the development of spinal cord trauma.  Despite some progress, until now no effective pharmacological therapies against SCI have been verified.  The purpose of our experiment was to investigate the neuroprotective effects of ebselen on experimental SCI.  Twenty-two rats subjected to SCI were randomly subjected to SCI with no further treatment (n = 10) or intragastric administration of ebselen (10 mg/kg) immediately and 24 hours after SCI.  Behavioral changes were assessed using the Basso, Beattie, and Bresnahan locomotor scale and footprint test during 12 weeks after SCI.  Histopathological and immunohistochemical analyses of spinal cords and brains were performed at 12 weeks after SCI.  Magnetic resonance imaging analysis of spinal cords was also performed at 12 weeks after SCI.  Rats treated with ebselen presented only limited neurobehavioral progress as well as reduced spinal cord injuries compared with the control group, namely length of lesions (cysts/scars) visualized histopathologically in the spinal cord sections was less but cavity area was very similar.  The same pattern was found in T2-weighted magnetic resonance images (cavities) and diffusion-weighted images (scars).  The number of FluoroGold retrogradely labeled neurons in brain stem and motor cortex was several-fold higher in ebselen-treated rats than in the control group.  The findings suggest that ebselen has only limited neuroprotective effects on injured spinal cord.  All exprimental procedures were approved by the Local Animal Ethics Committee for Experiments on Animals in Katowice (Katowice, Poland) (approval No. 19/2009).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6tNYVHCpU2EH3Rlp_k91zfW6udTcc2ebVrXNIKSDq_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfnsVOjtA%253D%253D&md5=8d71e758cf3fad31d7396b1906c478ef</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.4103%2F1673-5374.251334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F1673-5374.251334%26sid%3Dliteratum%253Aachs%26aulast%3DSlusarczyk%26aufirst%3DW.%26aulast%3DOlakowska%26aufirst%3DE.%26aulast%3DLarysz-Brysz%26aufirst%3DM.%26aulast%3DWoszczycka-Korczynska%26aufirst%3DI.%26aulast%3Dde%2BCarrillo%26aufirst%3DD.%2BG.%26aulast%3DWeglarz%26aufirst%3DW.%2BP.%26aulast%3DLewin-Kowalik%26aufirst%3DJ.%26aulast%3DMarcol%26aufirst%3DW.%26atitle%3DUse%2520of%2520ebselen%2520as%2520a%2520neuroprotective%2520agent%2520in%2520rat%2520spinal%2520cord%2520subjected%2520to%2520traumatic%2520injury%26jtitle%3DNeural%2520Regener.%2520Res.%26date%3D2019%26volume%3D14%26spage%3D1255%26epage%3D1261%26doi%3D10.4103%2F1673-5374.251334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, C.</span></span> <span> </span><span class="NLM_article-title">Histidine-tryptophan-ketoglutarate solution with added ebselen augments myocardial protection in neonatal porcine hearts undergoing ischemia/reperfusion</span>. <i>Artif. Organs</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1111/aor.12340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1111%2Faor.12340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25511318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVehtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=126-133&author=Y.+Chenauthor=J.+P.+Liuauthor=S.+J.+Liauthor=F.+X.+Yanauthor=Q.+H.+Xueauthor=H.+Y.+Wangauthor=P.+Sunauthor=C.+Long&title=Histidine-tryptophan-ketoglutarate+solution+with+added+ebselen+augments+myocardial+protection+in+neonatal+porcine+hearts+undergoing+ischemia%2Freperfusion&doi=10.1111%2Faor.12340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Histidine-Tryptophan-Ketoglutarate Solution With Added Ebselen Augments Myocardial Protection in Neonatal Porcine Hearts Undergoing Ischemia/Reperfusion</span></div><div class="casAuthors">Chen, Yan; Liu, Jinping; Li, Shoujun; Yan, Fuxia; Xue, Qinghua; Wang, Huiying; Sun, Peng; Long, Cun</div><div class="citationInfo"><span class="NLM_cas:title">Artificial Organs</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-133</span>CODEN:
                <span class="NLM_cas:coden">ARORD7</span>;
        ISSN:<span class="NLM_cas:issn">0160-564X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Whether modified histidine-tryptophan-ketoglutarate (HTK) soln. offers myocardial protection to newborn heart has not been documented.  The purpose of this study was to compare myocardial protection using HTK added by ebselen with HTK in a piglet model of cardiopulmonary bypass (CPB).  Fifteen piglets were randomly assigned to three groups: the control group (C group, n = 5), HTK soln. group (HTK group, n = 5), and HTK added by 10 nM ebselen group (HTK+E group, n = 5).  Animals in the two exptl. groups were placed on hypothermic CPB, after which the ascending aorta had been clamped for 2 h.  The control animals underwent normothermic CPB without cardiac arrest.  Myocardial antioxidant activities, myocytes apoptosis and mitochondrial structures, as well as the release of cytochrome c and the expression of Bax, Bcl-2, and HSP72 protein in myocardium were measured.  Increased myocardial superoxide dismutase (SOD) and Mn-SOD activities, decreased TUNEL-pos. cells, and reduced release of cytochrome c were noted in the HTK+E group compared with those in the HTK group (P = 0.021, P = 0.020, P = 0.045, and P = 0.010, resp.).  The Bax/Bcl-2 ratio in the HTK group was significantly higher than that in the C group (P = 0.024).  The expression of HSP72 protein and mRNA in the HTK+E group was higher than that in the HTK group (P = 0.039 and P = 0.035, resp.).  Mitochondrial score under electron microscope in the HTK+E group was lower than that in the HTK group (P = 0.047).  Improved antioxidant defense, reduced myocytes apoptosis, and better preserved mitochondrial structure were obsd. in the HTK+E group.  Ebselen added to HTK provides better myocardioprotection to HTK soln. for the neonatal heart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGremXgURufSMrVg90H21EOLACvtfcHk0lj_wLXbRDayFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVehtLw%253D&md5=a382988ace81316d98ce2c8b81ceb066</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Faor.12340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Faor.12340%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%2BP.%26aulast%3DLi%26aufirst%3DS.%2BJ.%26aulast%3DYan%26aufirst%3DF.%2BX.%26aulast%3DXue%26aufirst%3DQ.%2BH.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DLong%26aufirst%3DC.%26atitle%3DHistidine-tryptophan-ketoglutarate%2520solution%2520with%2520added%2520ebselen%2520augments%2520myocardial%2520protection%2520in%2520neonatal%2520porcine%2520hearts%2520undergoing%2520ischemia%252Freperfusion%26jtitle%3DArtif.%2520Organs%26date%3D2015%26volume%3D39%26spage%3D126%26epage%3D133%26doi%3D10.1111%2Faor.12340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, Q. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Ebselen protects rat hearts against myocardial ischemia-reperfusion injury</span>. <i>Exp. Ther. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1419</span>, <span class="refDoi"> DOI: 10.3892/etm.2018.7089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3892%2Fetm.2018.7089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30680022" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1412-1419&author=B.+Chengauthor=J.+P.+Zhongauthor=F.+X.+Wuauthor=G.+L.+Liauthor=Q.+X.+Ruanauthor=G.+Luoauthor=H.+Jiang&title=Ebselen+protects+rat+hearts+against+myocardial+ischemia-reperfusion+injury&doi=10.3892%2Fetm.2018.7089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.3892%2Fetm.2018.7089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fetm.2018.7089%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DF.%2BX.%26aulast%3DLi%26aufirst%3DG.%2BL.%26aulast%3DRuan%26aufirst%3DQ.%2BX.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DEbselen%2520protects%2520rat%2520hearts%2520against%2520myocardial%2520ischemia-reperfusion%2520injury%26jtitle%3DExp.%2520Ther.%2520Med.%26date%3D2018%26volume%3D17%26spage%3D1412%26epage%3D1419%26doi%3D10.3892%2Fetm.2018.7089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinbrenner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilgic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollschlager, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohrn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeken, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhyari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenberg, A.</span></span> <span> </span><span class="NLM_article-title">Selenium pretreatment for mitigation of ischemia/reperfusion injury in cardiovascular surgery: influence on acute organ damage and inflammatory response</span>. <i>Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1007/s10753-016-0368-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs10753-016-0368-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27192987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XotleisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=1363-1376&author=H.+Steinbrennerauthor=E.+Bilgicauthor=A.+Pintoauthor=M.+Engelsauthor=L.+Wollschlagerauthor=L.+Dohrnauthor=K.+Kellermannauthor=U.+Boekenauthor=P.+Akhyariauthor=A.+Lichtenberg&title=Selenium+pretreatment+for+mitigation+of+ischemia%2Freperfusion+injury+in+cardiovascular+surgery%3A+influence+on+acute+organ+damage+and+inflammatory+response&doi=10.1007%2Fs10753-016-0368-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium Pretreatment for Mitigation of Ischemia/Reperfusion Injury in Cardiovascular Surgery: Influence on Acute Organ Damage and Inflammatory Response</span></div><div class="casAuthors">Steinbrenner, Holger; Bilgic, Esra; Pinto, Antonio; Engels, Melanie; Wollschlaeger, Lena; Doehrn, Laura; Kellermann, Kristine; Boeken, Udo; Akhyari, Payam; Lichtenberg, Artur</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1376</span>CODEN:
                <span class="NLM_cas:coden">INFLD4</span>;
        ISSN:<span class="NLM_cas:issn">0360-3997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Ischemia/reperfusion injury (IRI) contributes to morbidity and mortality after cardiovascular surgery requiring cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA).  Multi-organ damage is assocd. with substantial decreases of blood selenium (Se) levels in patients undergoing cardiac surgery with CPB.  We compared the influence of a dietary surplus of Se and pretreatment with ebselen, a mimic of the selenoenzyme glutathione peroxidase, on IRI-induced tissue damage and inflammation.  Male Wistar rats were fed either a Se-adequate diet contg. 0.3 ppm Se or supplemented with 1 ppm Se (as sodium selenite) for 5 wk.  Two other groups of Se-adequate rats received i.p. injection of ebselen (30 mg/kg) or DMSO (solvent control) before surgery.  The animals were connected to a heart-lung-machine and underwent 45 min of global ischemia during circulatory arrest at 16 °C, followed by re-warming and reperfusion.  Selenite and ebselen suppressed IRI-induced leukocytosis and the increase in plasma levels of tissue damage markers (AST, ALT, LDH, troponin) during surgery but did not prevent the induction of proinflammatory cytokines (IL-6, TNF-α).  Both Se compds. affected phosphorylation and expression of proteins related to stress response and inflammation: Ebselen increased phosphorylation of STAT3 transcription factor in the heart and decreased phosphorylation of ERK1/2 MAP kinases in the lungs.  Selenite decreased ERK1/2 phosphorylation and HSP-70 expression in the heart.  Pretreatment with selenite or ebselen protected against acute IRI-induced tissue damage during CPB and DHCA.  Potential implications of their different actions with regard to mol. stress markers on the recovery after surgery represent promising targets for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6KNf2AAhsjbVg90H21EOLACvtfcHk0ljJMj-qcSEQlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotleisLc%253D&md5=f77d71bfecdd1ad24333e3528b50292e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1007%2Fs10753-016-0368-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10753-016-0368-5%26sid%3Dliteratum%253Aachs%26aulast%3DSteinbrenner%26aufirst%3DH.%26aulast%3DBilgic%26aufirst%3DE.%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DEngels%26aufirst%3DM.%26aulast%3DWollschlager%26aufirst%3DL.%26aulast%3DDohrn%26aufirst%3DL.%26aulast%3DKellermann%26aufirst%3DK.%26aulast%3DBoeken%26aufirst%3DU.%26aulast%3DAkhyari%26aufirst%3DP.%26aulast%3DLichtenberg%26aufirst%3DA.%26atitle%3DSelenium%2520pretreatment%2520for%2520mitigation%2520of%2520ischemia%252Freperfusion%2520injury%2520in%2520cardiovascular%2520surgery%253A%2520influence%2520on%2520acute%2520organ%2520damage%2520and%2520inflammatory%2520response%26jtitle%3DInflammation%26date%3D2016%26volume%3D39%26spage%3D1363%26epage%3D1376%26doi%3D10.1007%2Fs10753-016-0368-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mordente, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestrini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martorana, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meucci, E.</span></span> <span> </span><span class="NLM_article-title">Inhibition of anthracycline alcohol metabolite formation in human heart cytosol: a potential role for several promising drugs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1701</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.065110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1124%2Fdmd.115.065110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26265744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XislGhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=1691-1701&author=A.+Mordenteauthor=A.+Silvestriniauthor=G.+E.+Martoranaauthor=D.+Tavianauthor=E.+Meucci&title=Inhibition+of+anthracycline+alcohol+metabolite+formation+in+human+heart+cytosol%3A+a+potential+role+for+several+promising+drugs&doi=10.1124%2Fdmd.115.065110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of anthracycline alcohol metabolite formation in human heart cytosol: a potential role for several promising drugs</span></div><div class="casAuthors">Mordente, Alvaro; Silvestrini, Andrea; Ettore, Martorana Giuseppe; Tavian, Daniela; Meucci, Elisabetta</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1701</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The clin. efficacy of anthracyclines (e.g., doxorubicin and daunorubicin) in cancer therapy is limited by their severe cardiotoxicity, the etiol. of which is still not fully understood.  The development of anthracycline-induced cardiomyopathy has been found to correlate with myocardial formation and accumulation of anthracycline secondary alc. metabolites (e.g., doxorubicinol and daunorubicinol) that are produced by distinct cytosolic NADPH-dependent reductases.  The aim of the current study is to identify chem. compds. capable of inhibiting myocardial reductases implied in anthracycline reductive metab. in an attempt to decrease the prodn. of cardiotoxic C-13 alc. metabolites.  Among the variety of tested compds. (metal chelators, radical scavengers, antioxidants, β-blockers, nitrone spin traps, and lipid-lowering drugs), ebselen, cyclopentenone prostaglandins, nitric oxide donors, and short-chain coenzyme Q analogs resulted in being effective inhibitors of both doxorubicinol and daunorubicinol formation.  In particular, ebselen (as well as ebselen diselenide, its storage form in the cells) was the most potent inhibitor of cardiotoxic anthracycline alc. metabolites with 50% inhibition of doxorubicinol formation at 0.2 mol Eq of ebselen with respect to doxorubicin concn.  The high efficacy, together with its favorable pharmacol. profile (low toxicity, lack of adverse effects, and metabolic stability) portends ebselen as a promising cardioprotective agent against anthracycline-induced cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp1G9RtBKh5LVg90H21EOLACvtfcHk0ljJMj-qcSEQlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislGhtrk%253D&md5=f3fa0a2e480cc4fba0d1eba37ac99882</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.065110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.065110%26sid%3Dliteratum%253Aachs%26aulast%3DMordente%26aufirst%3DA.%26aulast%3DSilvestrini%26aufirst%3DA.%26aulast%3DMartorana%26aufirst%3DG.%2BE.%26aulast%3DTavian%26aufirst%3DD.%26aulast%3DMeucci%26aufirst%3DE.%26atitle%3DInhibition%2520of%2520anthracycline%2520alcohol%2520metabolite%2520formation%2520in%2520human%2520heart%2520cytosol%253A%2520a%2520potential%2520role%2520for%2520several%2520promising%2520drugs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26spage%3D1691%26epage%3D1701%26doi%3D10.1124%2Fdmd.115.065110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torramade-Moix, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Rodriguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cases, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzado, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escolar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Ricart, M.</span></span> <span> </span><span class="NLM_article-title">Antioxidant and anti-inflammatory strategies based on the potentiation of glutathione peroxidase activity prevent endothelial dysfunction in chronic kidney disease</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1300</span>, <span class="refDoi"> DOI: 10.1159/000495540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1159%2F000495540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30481789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFWrtrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=1287-1300&author=M.+Veraauthor=S.+Torramade-Moixauthor=S.+Martin-Rodriguezauthor=A.+Casesauthor=J.+M.+Cruzadoauthor=J.+Riveraauthor=G.+Escolarauthor=M.+Palomoauthor=M.+Diaz-Ricart&title=Antioxidant+and+anti-inflammatory+strategies+based+on+the+potentiation+of+glutathione+peroxidase+activity+prevent+endothelial+dysfunction+in+chronic+kidney+disease&doi=10.1159%2F000495540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant and Anti-Inflammatory Strategies Based on the Potentiation of Glutathione Peroxidase Activity Prevent Endothelial Dysfunction in Chronic Kidney Disease</span></div><div class="casAuthors">Vera, Manel; Torramade-Moix, Sergi; Martin-Rodriguez, Susana; Cases, Aleix; Cruzado, Josep M.; Rivera, Jose; Escolar, Gines; Palomo, Marta; Diaz-Ricart, Maribel</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1287-1300</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Accelerated atherosclerosis in chronic kidney disease (CKD) is preceded by endothelial dysfunction (ED), which exhibits a proinflammatory and prothrombotic phenotype and enhanced oxidative stress.  In this study, the effect of several compds. with anti-inflammatory and/or antioxidant properties on uremia-induced endothelial dysfunction has been evaluated in an in vitro model.  Methods: Endothelial cells (ECs) were exposed to sera from uremic patients in the absence and presence of the flavonoids apigenin, genistein and quercetin, the antioxidant enzyme mimetics (AEM) ebselen (glutathione peroxidase mimetic), EUK-134 and EUK-118 (both superoxide dismutase mimetics), and the pharmacol. drug N-acetylcysteine (NAC).  We explored changes in the expression of adhesion receptors on the cell surface, by immunofluorescence, the prodn. of radical oxygen species (ROS), by fluorescence detection, and the activation of signaling proteins related to inflammation, by both a phosphospecific antibody cell-based ELISA and immunoblotting techniques.  Results: Uremic media induced a significantly increased expression of ICAM-1, overprodn. of radical oxygen species (ROS) and activation of p38 mitogen activated protein kinase (p38MAPK) and Nuclear Factor kB (NFkB) in ECs.  Quercetin, the AEM and NAC showed a significant inhibitory effect on both ICAM-1 expression and ROS generation (p<0.05).  All the compds. reduced p38MAPK activation, but only the AEM, esp. ebselen, and NAC, both potentiating the glutathione peroxidase pathway, also inhibited NFkB activation.  These two compds. were capable of increasing endothelial glutathione levels, esp. in response to uremia.  Conclusion: Our results indicate that the potentiation of the antioxidant pathways can be an effective strategy to improve endothelial dysfunction in uremia and a potential target to reduce the cardiovascular risk in this population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv1ZckQLRxFbVg90H21EOLACvtfcHk0lgV7_9uiX9sCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFWrtrvE&md5=144632f213e8c25cb4c51b5924593624</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1159%2F000495540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000495540%26sid%3Dliteratum%253Aachs%26aulast%3DVera%26aufirst%3DM.%26aulast%3DTorramade-Moix%26aufirst%3DS.%26aulast%3DMartin-Rodriguez%26aufirst%3DS.%26aulast%3DCases%26aufirst%3DA.%26aulast%3DCruzado%26aufirst%3DJ.%2BM.%26aulast%3DRivera%26aufirst%3DJ.%26aulast%3DEscolar%26aufirst%3DG.%26aulast%3DPalomo%26aufirst%3DM.%26aulast%3DDiaz-Ricart%26aufirst%3DM.%26atitle%3DAntioxidant%2520and%2520anti-inflammatory%2520strategies%2520based%2520on%2520the%2520potentiation%2520of%2520glutathione%2520peroxidase%2520activity%2520prevent%2520endothelial%2520dysfunction%2520in%2520chronic%2520kidney%2520disease%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2018%26volume%3D51%26spage%3D1287%26epage%3D1300%26doi%3D10.1159%2F000495540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucci, Q. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handy, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loscalzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siedlecki, A. M.</span></span> <span> </span><span class="NLM_article-title">Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function</span>. <i>Nephrol., Dial., Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1093/ndt/gfx304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1093%2Fndt%2Fgfx304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29244159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1Ohur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=923-934&author=P.+Pangauthor=M.+Abbottauthor=M.+Abdiauthor=Q.+A.+Fucciauthor=N.+Chauhanauthor=M.+Mistriauthor=B.+Proctorauthor=M.+Chinauthor=B.+Wangauthor=W.+Yinauthor=T.+S.+Luauthor=A.+Halimauthor=K.+Limauthor=D.+E.+Handyauthor=J.+Loscalzoauthor=A.+M.+Siedlecki&title=Pre-clinical+model+of+severe+glutathione+peroxidase-3+deficiency+and+chronic+kidney+disease+results+in+coronary+artery+thrombosis+and+depressed+left+ventricular+function&doi=10.1093%2Fndt%2Fgfx304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function</span></div><div class="casAuthors">Pang, Paul; Abbott, Molly; Abdi, Malyun; Fucci, Quynh-Anh; Chauhan, Nikita; Mistri, Murti; Proctor, Brandon; Chin, Matthew; Wang, Bin; Yin, Wenqing; Lu, Tzong-Shi; Halim, Arvin; Lim, Kenneth; Handy, Diane E.; Loscalzo, Joseph; Siedlecki, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">923-934</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">1460-2385</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Chronic kidney disease (CKD) patients have deficient levels of glutathione peroxidase-3 (GPx3).  We hypothesized that GPx3 deficiency may lead to cardiovascular disease in the presence of chronic kidney disease due to an accumulation of reactive oxygen species and decreased microvascular perfusion of the myocardium.  Methods.  To isolate the exclusive effect of GPx3 deficiency in kidney disease-induced cardiac disease, we studied the GPx3 knockout mouse strain (GPx3-/-) in the setting of surgery-induced CKD.  Results.  RNA (RNA) microarray screening of non-stimulated GPx3 -/- heart tissue show increased expression of genes assocd. with cardiomyopathy including myh7, plac9, serpine1 and cd74 compared with wild-type (WT) controls.  GPx3-/- mice underwent surgically induced renal mass redn. to generate a model of CKD.  GPx3-/- +CKD mice underwent echocardiog. 4 wk after injury.  Fractional shortening (FS) was decreased to 32.9 ± 5.8% in GPx3-/- + CKD compared to 62.0% ± 10.3 in WT + CKD (P < 0.001).  Platelet aggregates were increased in the myocardium of GPx3-/- + CKD.  Asym. dimethylarginine (ADMA) levels were increased in both GPx3-/- + CKD and WT + CKD.  ADMA stimulated spontaneous platelet aggregation more quickly in washed platelets from GPx3-/-.  In vitro platelet aggregation was enhanced in samples from GPx3-/- + CKD.  Platelet aggregation in GPx3-/- + CKD samples was mitigated after in vivo administration of ebselen, a glutathione peroxidase mimetic.  FS improved in GPx3-/- CKD mice after ebselen treatment.  Conclusion.  These results suggest GPx3 deficiency is a substan-contributing factor to the development of kidney disease-induced cardiac disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruAIkxIOYeNrVg90H21EOLACvtfcHk0lgV7_9uiX9sCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1Ohur4%253D&md5=8402252b189c8d505cbc717a73866558</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfx304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfx304%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DP.%26aulast%3DAbbott%26aufirst%3DM.%26aulast%3DAbdi%26aufirst%3DM.%26aulast%3DFucci%26aufirst%3DQ.%2BA.%26aulast%3DChauhan%26aufirst%3DN.%26aulast%3DMistri%26aufirst%3DM.%26aulast%3DProctor%26aufirst%3DB.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DT.%2BS.%26aulast%3DHalim%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DK.%26aulast%3DHandy%26aufirst%3DD.%2BE.%26aulast%3DLoscalzo%26aufirst%3DJ.%26aulast%3DSiedlecki%26aufirst%3DA.%2BM.%26atitle%3DPre-clinical%2520model%2520of%2520severe%2520glutathione%2520peroxidase-3%2520deficiency%2520and%2520chronic%2520kidney%2520disease%2520results%2520in%2520coronary%2520artery%2520thrombosis%2520and%2520depressed%2520left%2520ventricular%2520function%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2018%26volume%3D33%26spage%3D923%26epage%3D934%26doi%3D10.1093%2Fndt%2Fgfx304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haas, M. J.</span>; <span class="NLM_string-name">Jurado-Flores, M.</span>; <span class="NLM_string-name">Hammoud, R.</span>; <span class="NLM_string-name">Feng, V.</span>; <span class="NLM_string-name">Gonzales, K.</span>; <span class="NLM_string-name">Onstead-Haas, L.</span>; <span class="NLM_string-name">A, D. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of pro-inflammatory cytokine secretion by select antioxidants in human coronary artery endothelial cells</span>.  <i>Int. J. Vitam. Nutr. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1024/0300-9831/a000520</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1024%2F0300-9831%2Fa000520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+J.+Haas&author=M.+Jurado-Flores&author=R.+Hammoud&author=V.+Feng&author=K.+Gonzales&author=L.+Onstead-Haas&author=D.+M.+A&title=Inhibition+of+pro-inflammatory+cytokine+secretion+by+select+antioxidants+in+human+coronary+artery+endothelial+cells&doi=10.1024%2F0300-9831%2Fa000520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1024%2F0300-9831%2Fa000520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1024%252F0300-9831%252Fa000520%26sid%3Dliteratum%253Aachs%26aulast%3DHaas%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520pro-inflammatory%2520cytokine%2520secretion%2520by%2520select%2520antioxidants%2520in%2520human%2520coronary%2520artery%2520endothelial%2520cells%26jtitle%3DInt.%2520J.%2520Vitam.%2520Nutr.%2520Res.%26date%3D2019%26doi%3D10.1024%2F0300-9831%2Fa000520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohler, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foote, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saboda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lance, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, E. T.</span></span> <span> </span><span class="NLM_article-title">Selenium and type 2 diabetes: systematic review</span>. <i>Nutrients</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1924</span>, <span class="refDoi"> DOI: 10.3390/nu10121924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fnu10121924" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotlSqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1924&author=L.+N.+Kohlerauthor=J.+Footeauthor=C.+P.+Kelleyauthor=A.+Floreaauthor=C.+Shellyauthor=H.+S.+Chowauthor=P.+Hsuauthor=K.+Bataiauthor=N.+Ellisauthor=K.+Sabodaauthor=P.+Lanceauthor=E.+T.+Jacobs&title=Selenium+and+type+2+diabetes%3A+systematic+review&doi=10.3390%2Fnu10121924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium and type 2 diabetes: systematic review</span></div><div class="casAuthors">Kohler, Lindsay N.; Foote, Janet; Kelley, Connor P.; Florea, Ana; Shelly, Colleen; Chow, H-H. Sherry; Hsu, Paul; Batai, Ken; Ellis, Nathan; Saboda, Kathylynn; Lance, Peter; Jacobs, Elizabeth T.</div><div class="citationInfo"><span class="NLM_cas:title">Nutrients</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1924/1-1924/13</span>CODEN:
                <span class="NLM_cas:coden">NUTRHU</span>;
        ISSN:<span class="NLM_cas:issn">2072-6643</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Several studies have investigated the potential role of selenium (Se) in the development of type 2 diabetes (T2D) with disparate findings.  We conducted a systematic review and meta-anal. to synthesize the evidence of any assocn. between Se and T2D.  PubMed, Embase, and Scopus were searched following the Preferred Reporting Items for Systematic Reviews and Meta-anal. Approach (PRISMA).  Sixteen studies from 15 papers met inclusion criteria defined for this review.  Of the 13 observational studies included, 8 demonstrated a statistically significant pos. assocn. between concns. of Se and odds for T2D, with odds ratios (95% confidence intervals) ranging from 1.52 (1.01-2.28) to 7.64 (3.34-17.46), and a summary odds ratio (OR) (95% confidence interval (CI)) of 2.03 (1.51-2.72).  In contrast, among randomized clin. trials (RCTs) of Se, a higher risk of T2D was not obsd. for those who received Se compared to a placebo (OR = 1.18, 95% CI 0.95-1.47).  Taken together, the results for the relationship between Se and T2D differ between observational studies and randomized clin. trials (RCTs).  It remains unclear whether these differences are the result of uncontrolled confounding in the observational studies, or whether there is a modest effect of Se on the risk for T2D that may vary by duration of exposure.  Further investigations on the effects of Se on glucose metab. are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdvJIFon6ZqrVg90H21EOLACvtfcHk0lgV7_9uiX9sCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotlSqtbw%253D&md5=978d5fb526c788dfbf388e4e78723c3e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3390%2Fnu10121924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fnu10121924%26sid%3Dliteratum%253Aachs%26aulast%3DKohler%26aufirst%3DL.%2BN.%26aulast%3DFoote%26aufirst%3DJ.%26aulast%3DKelley%26aufirst%3DC.%2BP.%26aulast%3DFlorea%26aufirst%3DA.%26aulast%3DShelly%26aufirst%3DC.%26aulast%3DChow%26aufirst%3DH.%2BS.%26aulast%3DHsu%26aufirst%3DP.%26aulast%3DBatai%26aufirst%3DK.%26aulast%3DEllis%26aufirst%3DN.%26aulast%3DSaboda%26aufirst%3DK.%26aulast%3DLance%26aufirst%3DP.%26aulast%3DJacobs%26aufirst%3DE.%2BT.%26atitle%3DSelenium%2520and%2520type%25202%2520diabetes%253A%2520systematic%2520review%26jtitle%3DNutrients%26date%3D2018%26volume%3D10%26spage%3D1924%26doi%3D10.3390%2Fnu10121924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roh, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S.</span></span> <span> </span><span class="NLM_article-title">Association between serum selenium level and the presence of diabetes mellitus: a meta-analysis of observational studies</span>. <i>Diabetes Metab J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">447</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.4093/dmj.2018.0123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.4093%2Fdmj.2018.0123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30688047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BB3cjlvV2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2019&pages=447-460&author=J.+Kimauthor=H.+S.+Chungauthor=M.+K.+Choiauthor=Y.+K.+Rohauthor=H.+J.+Yooauthor=J.+H.+Parkauthor=D.+S.+Kimauthor=J.+M.+Yuauthor=S.+Moon&title=Association+between+serum+selenium+level+and+the+presence+of+diabetes+mellitus%3A+a+meta-analysis+of+observational+studies&doi=10.4093%2Fdmj.2018.0123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Association between Serum Selenium Level and the Presence of Diabetes Mellitus: A Meta-Analysis of Observational Studies</span></div><div class="casAuthors">Kim Juno; Choi Min Kyu; Roh Yong Kyun; Chung Hye Soo; Yu Jae Myung; Moon Shinje; Yoo Hyung Joon; Park Jung Hwan; Kim Dong Sun; Moon Shinje</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes & metabolism journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">447-460</span>
        ISSN:<span class="NLM_cas:issn">2233-6079</span>.
    </div><div class="casAbstract">BACKGROUND:  Epidemiological studies have suggested an association between selenium (Se) and diabetes mellitus (DM).  However, different studies have reported conflicting results.  Therefore, we performed a comprehensive meta-analysis to clarify the impact of Se on DM.  METHODS:  We searched the PubMed database for studies on the association between Se and DM from inception to June 2018.  RESULTS:  Twenty articles evaluating 47,930 participants were included in the analysis.  The meta-analysis found that high levels of Se were significantly associated with the presence of DM (pooled odds ratios [ORs], 1.88; 95% confidence interval [CI], 1.44 to 2.45).  However, significant heterogeneity was found (I2=82%).  Subgroup analyses were performed based on the Se measurement methods used in each study.  A significant association was found between high Se levels and the presence of DM in the studies that used blood (OR, 2.17; 95% CI, 1.60 to 2.93; I2=77%), diet (OR, 1.61; 95% CI, 1.10 to 2.36; I2=0%), and urine (OR, 1.49; 95% CI, 1.02 to 2.17; I2=0%) as samples to estimate Se levels, but not in studies on nails (OR, 1.24; 95% CI, 0.52 to 2.98; I2=91%).  Because of significant heterogeneity in the studies with blood, we conducted a sensitivity analysis and tested the publication bias.  The results were consistent after adjustment based on the sensitivity analysis as well as the trim and fill analysis for publication bias.  CONCLUSION:  This meta-analysis demonstrates that high levels of Se are associated with the presence of DM.  Further prospective and randomized controlled trials are warranted to elucidate the link better.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUC3f_iRJrahFwe7cAcrfPfW6udTcc2easf9cU6YIOxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cjlvV2gsQ%253D%253D&md5=58ad7bdfbe7e0dea6e2b56948466dee7</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.4093%2Fdmj.2018.0123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4093%252Fdmj.2018.0123%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DH.%2BS.%26aulast%3DChoi%26aufirst%3DM.%2BK.%26aulast%3DRoh%26aufirst%3DY.%2BK.%26aulast%3DYoo%26aufirst%3DH.%2BJ.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DD.%2BS.%26aulast%3DYu%26aufirst%3DJ.%2BM.%26aulast%3DMoon%26aufirst%3DS.%26atitle%3DAssociation%2520between%2520serum%2520selenium%2520level%2520and%2520the%2520presence%2520of%2520diabetes%2520mellitus%253A%2520a%2520meta-analysis%2520of%2520observational%2520studies%26jtitle%3DDiabetes%2520Metab%2520J.%26date%3D2019%26volume%3D43%26spage%3D447%26epage%3D460%26doi%3D10.4093%2Fdmj.2018.0123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sobczak, A. I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanowicz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitt, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajjan, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. J.</span></span> <span> </span><span class="NLM_article-title">Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes</span>. <i>BioMetals</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1007/s10534-018-00167-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs10534-018-00167-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30671675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFGqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2019&pages=123-138&author=A.+I.+S.+Sobczakauthor=F.+Stefanowiczauthor=S.+J.+Pittauthor=R.+A.+Ajjanauthor=A.+J.+Stewart&title=Total+plasma+magnesium%2C+zinc%2C+copper+and+selenium+concentrations+in+type-I+and+type-II+diabetes&doi=10.1007%2Fs10534-018-00167-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes</span></div><div class="casAuthors">Sobczak, Amelie I. S.; Stefanowicz, Fiona; Pitt, Samantha J.; Ajjan, Ramzi A.; Stewart, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">BioMetals</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-138</span>CODEN:
                <span class="NLM_cas:coden">BOMEEH</span>;
        ISSN:<span class="NLM_cas:issn">0966-0844</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glycemia and insulin resistance are important regulators of multiple physiol. processes and their dysregulation has wide-ranging consequences, including alterations in plasma concns. of metal micronutrients.  Here, magnesium, zinc, copper, selenium and glycated albumin (HbA1c) concns. and quartile differences were examd. in 45 subjects with type-I diabetes (T1DM), 54 subjects with type-II diabetes (T2DM) and 62 control subjects in order to assess potential differences between sexes and between T1DM and T2DM.  Plasma magnesium concn. was decreased in T1DM subjects, with the second, third and fourth quartiles of magnesium concns. assocd. with the absence of T1DM.  This effect was obsd. in females but not males.  In T2DM, the highest quartile of selenium concns. and the third quartile of copper concns. assocd. with the absence of diabetes in males.  The highest quartile of magnesium concns. was assocd. with the absence of T2DM in males but not females.  HbA1c correlated with plasma concns. of magnesium (neg., in both sexes together in T1DM and T1DM males), copper (pos., in T1DM males and in both sexes together in T2DM), selenium (pos., in both sexes together in T1DM and T2DM, and T2DM females) and with zinc/copper ratio (neg., in both sexes together in T1DM and T2DM).  This study shows that plasma magnesium concn. is altered to the highest degree in T1DM, while in T2DM, plasma selenium and copper concns. are significantly affected.  This work increases our understanding of how T1DM and T2DM affects plasma metal concns. and may have future implications for diabetes management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFe-agJlueaLVg90H21EOLACvtfcHk0liTRmSCYplA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFGqs7Y%253D&md5=9a5d80a05ac57da6b57577a4a9623b49</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2Fs10534-018-00167-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10534-018-00167-z%26sid%3Dliteratum%253Aachs%26aulast%3DSobczak%26aufirst%3DA.%2BI.%2BS.%26aulast%3DStefanowicz%26aufirst%3DF.%26aulast%3DPitt%26aufirst%3DS.%2BJ.%26aulast%3DAjjan%26aufirst%3DR.%2BA.%26aulast%3DStewart%26aufirst%3DA.%2BJ.%26atitle%3DTotal%2520plasma%2520magnesium%252C%2520zinc%252C%2520copper%2520and%2520selenium%2520concentrations%2520in%2520type-I%2520and%2520type-II%2520diabetes%26jtitle%3DBioMetals%26date%3D2019%26volume%3D32%26spage%3D123%26epage%3D138%26doi%3D10.1007%2Fs10534-018-00167-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parazzoli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseid, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzel, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallerie, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmon, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, R. P.</span></span> <span> </span><span class="NLM_article-title">Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves beta-cell mass and function in ZDF rats</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3582</span>– <span class="NLM_lpage">3588</span>, <span class="refDoi"> DOI: 10.2337/db13-0357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2337%2Fdb13-0357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=23801580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOhtLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=3582-3588&author=J.+Mahadevanauthor=S.+Parazzoliauthor=E.+Oseidauthor=A.+V.+Hertzelauthor=D.+A.+Bernlohrauthor=S.+N.+Vallerieauthor=C.+Q.+Liuauthor=M.+Lopezauthor=J.+S.+Harmonauthor=R.+P.+Robertson&title=Ebselen+treatment+prevents+islet+apoptosis%2C+maintains+intranuclear+Pdx-1+and+MafA+levels%2C+and+preserves+beta-cell+mass+and+function+in+ZDF+rats&doi=10.2337%2Fdb13-0357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves β-cell mass and function in ZDF rats</span></div><div class="casAuthors">Mahadevan, Jana; Parazzoli, Susan; Oseid, Elizabeth; Hertzel, Ann V.; Bernlohr, David A.; Vallerie, Sara N.; Liu, Chang-qin; Lopez, Melissa; Harmon, Jamie S.; Robertson, R. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3582-3588</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">We reported earlier that β-cell-specific overexpression of glutathione peroxidase (GPx)-1 significantly ameliorated hyperglycemia in diabetic db/db mice and prevented glucotoxicity-induced deterioration of β-cell mass and function.  We have now ascertained whether early treatment of Zucker diabetic fatty (ZDF) rats with ebselen, an oral GPx mimetic, will prevent β-cell deterioration.  No other antihyperglycemia treatment was given.  Ebselen ameliorated fasting hyperglycemia, sustained nonfasting insulin levels, lowered nonfasting glucose levels, and lowered HbA1c levels with no effects on body wt.  Ebselen doubled β-cell mass, prevented apoptosis, prevented expression of oxidative stress markers, and enhanced intranuclear localization of pancreatic and duodenal homeobox (Pdx)-1 and v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (MafA), two crit. insulin transcription factors.  Minimal β-cell replication was obsd. in both groups.  These findings indicate that prevention of oxidative stress is the mechanism whereby ebselen prevents apoptosis and preserves intranuclear Pdx-1 and MafA, which, in turn, is a likely explanation for the beneficial effects of ebselen on β-cell mass and function.  Since ebselen is an oral antioxidant currently used in clin. trials, it is a novel therapeutic candidate to ameliorate fasting hyperglycemia and further deterioration of β-cell mass and function in humans undergoing the onset of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRvSjpd_MSnrVg90H21EOLACvtfcHk0liTRmSCYplA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOhtLjK&md5=a1f63a6bd3b745edfb0ee92bdc5032ad</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.2337%2Fdb13-0357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb13-0357%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DJ.%26aulast%3DParazzoli%26aufirst%3DS.%26aulast%3DOseid%26aufirst%3DE.%26aulast%3DHertzel%26aufirst%3DA.%2BV.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26aulast%3DVallerie%26aufirst%3DS.%2BN.%26aulast%3DLiu%26aufirst%3DC.%2BQ.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DHarmon%26aufirst%3DJ.%2BS.%26aulast%3DRobertson%26aufirst%3DR.%2BP.%26atitle%3DEbselen%2520treatment%2520prevents%2520islet%2520apoptosis%252C%2520maintains%2520intranuclear%2520Pdx-1%2520and%2520MafA%2520levels%252C%2520and%2520preserves%2520beta-cell%2520mass%2520and%2520function%2520in%2520ZDF%2520rats%26jtitle%3DDiabetes%26date%3D2013%26volume%3D62%26spage%3D3582%26epage%3D3588%26doi%3D10.2337%2Fdb13-0357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krippner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugesh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haan, J. B.</span></span> <span> </span><span class="NLM_article-title">The modified selenenyl amide, <i>m</i>-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e69193</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0069193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1371%2Fjournal.pone.0069193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=23874911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wms7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e69193&author=S.+M.+Tanauthor=A.+Sharmaauthor=D.+Y.+Yuenauthor=N.+Stefanovicauthor=G.+Krippnerauthor=G.+Mugeshauthor=Z.+Chaiauthor=J.+B.+de+Haan&title=The+modified+selenenyl+amide%2C+m-hydroxy+ebselen%2C+attenuates+diabetic+nephropathy+and+diabetes-associated+atherosclerosis+in+ApoE%2FGPx1+double+knockout+mice&doi=10.1371%2Fjournal.pone.0069193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The modified selenenyl amide, m-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice</span></div><div class="casAuthors">Tan, Sih Min; Sharma, Arpeeta; Yuen, Derek Y. C.; Stefanovic, Nada; Krippner, Guy; Mugesh, Govindasamy; Chai, Zhonglin; de Haan, Judy B.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e69193</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Seleno-org. glutathione peroxidase (GPx) mimetics, including ebselen (Eb), have been tested in in vitro studies for their ability to scavenge reactive oxygen and nitrogen species, including hydrogen peroxide and peroxynitrite.  In this study, we investigated the efficacies of two Eb analogs, m-hydroxy ebselen (ME) and ethanol-ebselen (EtE) and compared these with Eb in cell based assays.  We found that ME is superior in attenuating the activation of hydrogen peroxide-induced pro-inflammatory mediators, ERK and P38 in human aortic endothelial cells.  Consequently, we investigated the effects of ME in an in vivo model of diabetes, the ApoE/GPx1 double knockout (dKO) mouse.  We found that ME attenuates plaque formation in the aorta and lesion deposition within the aortic sinus of diabetic dKO mice.  Oxidative stress as assessed by 8-OHdG in urine and nitrotyrosine immunostaining in the aortic sinus and kidney tubules, was reduced by ME in diabetic dKO mice.  ME also attenuated diabetes-assocd. renal injury which included tubulointerstitial fibrosis and glomerulosclerosis.  Furthermore, the bioactivity of the pro-fibrotic cytokine transforming growth factor-β (TGF-β) as assessed by phospho-Smad2/3 immunostaining was attenuated after treatment with ME.  TGF-β-stimulated increases in collagen I and IV gene expression and protein levels were attenuated by ME in rat kidney tubular cells.  However, in contrast to the superior activity of ME in in vitro and cell based assays, ME did not further augment the attenuation of diabetes-assocd. atherosclerosis and renal injury in our in vivo model when compared with Eb.  In conclusion, this study strengthens the notion that bolstering GPx-like activity using synthetic mimetics may be a useful therapeutic strategy in lessening the burden of diabetic complications.  However, these studies highlight the importance of in vivo analyses to test the efficacies of novel Eb analogs, as in vitro and cell based assays are only partly predictive of the in vivo situation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuphh912ohebVg90H21EOLACvtfcHk0lgThjRhLSF32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wms7jI&md5=1aa2f45d843e623b8c88548739fa4fa7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0069193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0069193%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%2BM.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DYuen%26aufirst%3DD.%2BY.%26aulast%3DStefanovic%26aufirst%3DN.%26aulast%3DKrippner%26aufirst%3DG.%26aulast%3DMugesh%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DZ.%26aulast%3Dde%2BHaan%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520modified%2520selenenyl%2520amide%252C%2520m-hydroxy%2520ebselen%252C%2520attenuates%2520diabetic%2520nephropathy%2520and%2520diabetes-associated%2520atherosclerosis%2520in%2520ApoE%252FGPx1%2520double%2520knockout%2520mice%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De69193%26doi%3D10.1371%2Fjournal.pone.0069193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beckman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldfine, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopold, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creager, M. A.</span></span> <span> </span><span class="NLM_article-title">Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trial</span>. <i>Am. J. Physiol Heart Circ Physiol</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">H1431</span>– <span class="NLM_lpage">H1436</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00504.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1152%2Fajpheart.00504.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27765750" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=H1431-H1436&author=J.+A.+Beckmanauthor=A.+B.+Goldfineauthor=J.+A.+Leopoldauthor=M.+A.+Creager&title=Ebselen+does+not+improve+oxidative+stress+and+vascular+function+in+patients+with+diabetes%3A+a+randomized%2C+crossover+trial&doi=10.1152%2Fajpheart.00504.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00504.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00504.2016%26sid%3Dliteratum%253Aachs%26aulast%3DBeckman%26aufirst%3DJ.%2BA.%26aulast%3DGoldfine%26aufirst%3DA.%2BB.%26aulast%3DLeopold%26aufirst%3DJ.%2BA.%26aulast%3DCreager%26aufirst%3DM.%2BA.%26atitle%3DEbselen%2520does%2520not%2520improve%2520oxidative%2520stress%2520and%2520vascular%2520function%2520in%2520patients%2520with%2520diabetes%253A%2520a%2520randomized%252C%2520crossover%2520trial%26jtitle%3DAm.%2520J.%2520Physiol%2520Heart%2520Circ%2520Physiol%26date%3D2016%26volume%3D311%26spage%3DH1431%26epage%3DH1436%26doi%3D10.1152%2Fajpheart.00504.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bender, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreyra, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hryckowian, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Child, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solow-Cordero, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higginbottom, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banaei, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonnenburg, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antivirulence agent for treating <i>Clostridium difficile</i> infection</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">306ra148</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aac9103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1126%2Fscitranslmed.aac9103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26400909" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=306ra148&author=K.+O.+Benderauthor=M.+Garlandauthor=J.+A.+Ferreyraauthor=A.+J.+Hryckowianauthor=M.+A.+Childauthor=A.+W.+Puriauthor=D.+E.+Solow-Corderoauthor=S.+K.+Higginbottomauthor=E.+Segalauthor=N.+Banaeiauthor=A.+Shenauthor=J.+L.+Sonnenburgauthor=M.+Bogyo&title=A+small-molecule+antivirulence+agent+for+treating+Clostridium+difficile+infection&doi=10.1126%2Fscitranslmed.aac9103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aac9103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aac9103%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DK.%2BO.%26aulast%3DGarland%26aufirst%3DM.%26aulast%3DFerreyra%26aufirst%3DJ.%2BA.%26aulast%3DHryckowian%26aufirst%3DA.%2BJ.%26aulast%3DChild%26aufirst%3DM.%2BA.%26aulast%3DPuri%26aufirst%3DA.%2BW.%26aulast%3DSolow-Cordero%26aufirst%3DD.%2BE.%26aulast%3DHigginbottom%26aufirst%3DS.%2BK.%26aulast%3DSegal%26aufirst%3DE.%26aulast%3DBanaei%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DSonnenburg%26aufirst%3DJ.%2BL.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DA%2520small-molecule%2520antivirulence%2520agent%2520for%2520treating%2520Clostridium%2520difficile%2520infection%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D306ra148%26doi%3D10.1126%2Fscitranslmed.aac9103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werngren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">Ebselen and analogs as inhibitors of <i>Bacillus anthracis</i> thioredoxin reductase and bactericidal antibacterials targeting <i>Bacillus species Staphylococcus aureus</i> and Mycobacterium tuberculosis</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1860</i></span>,  <span class="NLM_fpage">1265</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2016.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbagen.2016.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Wgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1860&publication_year=2016&pages=1265-1271&author=T.+N.+Gustafssonauthor=H.+Osmanauthor=J.+Werngrenauthor=S.+Hoffnerauthor=L.+Engmanauthor=A.+Holmgren&title=Ebselen+and+analogs+as+inhibitors+of+Bacillus+anthracis+thioredoxin+reductase+and+bactericidal+antibacterials+targeting+Bacillus+species+Staphylococcus+aureus+and+Mycobacterium+tuberculosis&doi=10.1016%2Fj.bbagen.2016.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis</span></div><div class="casAuthors">Gustafsson, Tomas N.; Osman, Harer; Werngren, Jim; Hoffner, Sven; Engman, Lars; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1860</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1265-1271</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bacillus anthracis is the causative agent of anthrax, a disease assocd. with a very high mortality rate in its invasive forms.  We studied a no. of ebselen analogs as inhibitors of B. anthracis thioredoxin reductase and their antibacterial activity on Bacillus subtilis, Staphylococcus aureus, Bacillus cereus and Mycobacterium tuberculosis.  The most potent compds. in the series gave IC50 values down to 70 nM for the pure enzyme and minimal inhibitory concns. (MICs) down to 0.4 μM (0.12 μg/mL) for B. subtilis, 1.5 μM (0.64 μg/mL) for S. aureus, 2 μM (0.86 μg/mL) for B. cereus and 10 μg/mL for M. tuberculosis.  Minimal bactericidal concns. (MBCs) were found at 1-1.5 times the MIC, indicating a general, class-dependent, bactericidal mode of action.  The combined bacteriol. and enzymol. data were used to construct a preliminary structure-activity-relationship for the benzoisoselenazol class of compds.  When S. aureus and B. subtilis were exposed to ebselen, we were unable to isolate resistant mutants on both solid and in liq. medium suggesting a high resistance barrier.  These results suggest that ebselen and analogs thereof could be developed into a novel antibiotic class, useful for the treatment of infections caused by B. anthracis, S. aureus, M. tuberculosis and other clin. important bacteria.  Furthermore, the high barrier against resistance development is encouraging for further drug development.  We have characterized the thioredoxin system from B. anthracis as a novel drug target and ebselen and analogs thereof as a potential new class of antibiotics targeting several important human pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe4ZHGAS7GNbVg90H21EOLACvtfcHk0lgThjRhLSF32A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Wgu7c%253D&md5=5413ac764cfc9322cfb164293d4e40fd</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2016.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2016.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DGustafsson%26aufirst%3DT.%2BN.%26aulast%3DOsman%26aufirst%3DH.%26aulast%3DWerngren%26aufirst%3DJ.%26aulast%3DHoffner%26aufirst%3DS.%26aulast%3DEngman%26aufirst%3DL.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DEbselen%2520and%2520analogs%2520as%2520inhibitors%2520of%2520Bacillus%2520anthracis%2520thioredoxin%2520reductase%2520and%2520bactericidal%2520antibacterials%2520targeting%2520Bacillus%2520species%2520Staphylococcus%2520aureus%2520and%2520Mycobacterium%2520tuberculosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2016%26volume%3D1860%26spage%3D1265%26epage%3D1271%26doi%3D10.1016%2Fj.bbagen.2016.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goins, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudson, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slayden, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronning, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucheck, S. J.</span></span> <span> </span><span class="NLM_article-title">Thermal and photoinduced copper-promoted C-Se bond formation: synthesis of 2-alkyl-1,2-benzisoselenazol-3(2<i>H</i>)-ones and evaluation against Mycobacterium tuberculosis</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">3844</span>– <span class="NLM_lpage">3854</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.7b00440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.7b00440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFOqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=3844-3854&author=S.+Thannaauthor=C.+M.+Goinsauthor=S.+E.+Knudsonauthor=R.+A.+Slaydenauthor=D.+R.+Ronningauthor=S.+J.+Sucheck&title=Thermal+and+photoinduced+copper-promoted+C-Se+bond+formation%3A+synthesis+of+2-alkyl-1%2C2-benzisoselenazol-3%282H%29-ones+and+evaluation+against+Mycobacterium+tuberculosis&doi=10.1021%2Facs.joc.7b00440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Thermal and Photoinduced Copper-Promoted C-Se Bond Formation: Synthesis of 2-Alkyl-1,2-benzisoselenazol-3(2H)-ones and Evaluation against Mycobacterium tuberculosis</span></div><div class="casAuthors">Thanna, Sandeep; Goins, Christopher M.; Knudson, Susan E.; Slayden, Richard A.; Ronning, Donald R.; Sucheck, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3844-3854</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-Alkyl-1,2-benzisoselenazol-3(2H)-ones, represented by ebselen (1a), are being studied intensively for a range of medicinal applications.  We describe both a new thermal and photoinduced copper-mediated cross-coupling between potassium selenocyanate (KSeCN) and N-substituted ortho-halobenzamides to form 2-alkyl-1,2-benzisoselenazol-3(2H)-ones contg. a C-Se-N bond.  The copper ligand (1,10-phenanthroline) facilitates C-Se bond formation during heating via a mechanism that likely involves atom transfer (AT), whereas, in the absence of ligand, photoinduced activation likely proceeds through a single electron transfer (SET) mechanism.  A library of 15 2-alkyl-1,2-benzisoselenazol-3(2H)-ones was prepd.  One member of the library was azide-contg. deriv. 1j that was competent to undergo a strain-promoted azide-alkyne cycloaddn.  The library was evaluated for inhibition of Mycobacterium tuberculosis (Mtb) growth and Mtb Antigen 85C (Mtb Ag85C) activity.  Compd. 1f was most potent with a minimal inhibitory concn. (MIC) of 12.5 μg/mL and an Mtb Ag85C apparent IC50 of 8.8 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIuweCi3tSFLVg90H21EOLACvtfcHk0li47-XJFykjXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFOqsbY%253D&md5=6a6bc3a006b04b5f6e076765167b5c6b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.7b00440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.7b00440%26sid%3Dliteratum%253Aachs%26aulast%3DThanna%26aufirst%3DS.%26aulast%3DGoins%26aufirst%3DC.%2BM.%26aulast%3DKnudson%26aufirst%3DS.%2BE.%26aulast%3DSlayden%26aufirst%3DR.%2BA.%26aulast%3DRonning%26aufirst%3DD.%2BR.%26aulast%3DSucheck%26aufirst%3DS.%2BJ.%26atitle%3DThermal%2520and%2520photoinduced%2520copper-promoted%2520C-Se%2520bond%2520formation%253A%2520synthesis%2520of%25202-alkyl-1%252C2-benzisoselenazol-3%25282H%2529-ones%2520and%2520evaluation%2520against%2520Mycobacterium%2520tuberculosis%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D3844%26epage%3D3854%26doi%3D10.1021%2Facs.joc.7b00440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goins, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dajnowicz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucheck, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronning, D. R.</span></span> <span> </span><span class="NLM_article-title">Exploring covalent allosteric inhibition of antigen 85C from <i>Mycobacterium tuberculosis</i> by ebselen derivatives</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.7b00003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.7b00003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktVGhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=378-387&author=C.+M.+Goinsauthor=S.+Dajnowiczauthor=S.+Thannaauthor=S.+J.+Sucheckauthor=J.+M.+Parksauthor=D.+R.+Ronning&title=Exploring+covalent+allosteric+inhibition+of+antigen+85C+from+Mycobacterium+tuberculosis+by+ebselen+derivatives&doi=10.1021%2Facsinfecdis.7b00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring covalent allosteric inhibition of antigen 85C from Mycobacterium tuberculosis by ebselen derivatives</span></div><div class="casAuthors">Goins, Christopher M.; Dajnowicz, Steven; Thanna, Sandeep; Sucheck, Steven J.; Parks, Jerry M.; Ronning, Donald R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">378-387</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previous studies identified ebselen as a potent in vitro and in vivo inhibitor of the Mycobacterium tuberculosis (Mtb) antigen 85 (Ag85) complex, comprising three homologous enzymes required for the biosynthesis of the mycobacterial cell wall.  In this study, the Mtb Ag85C enzyme was cocrystd. with azido and adamantyl ebselen derivs., resulting in two crystallog. structures of 2.01 and 1.30 Å resoln., resp.  Both structures displayed the anticipated covalent modification of the solvent accessible, noncatalytic Cys209 residue forming a selenenylsulfide bond.  Continuous difference d. for both thiol modifiers allowed for the assessment of interactions that influence ebselen binding and inhibitor orientation that were unobserved in previous Ag85C ebselen structures.  The kinact/KI values for ebselen, adamantyl ebselen, and azido ebselen support the importance of obsd. constructive chem. interactions with Arg239 for increased in vitro efficacy toward Ag85C.  To better understand the in vitro kinetic properties of these ebselen derivs., the energetics of specific protein-inhibitor interactions and relative reaction free energies were calcd. for ebselen and both derivs. using d. functional theory.  These studies further support the different in vitro properties of ebselen and two select ebselen derivs. from our previously published ebselen library with respect to kinetics and protein-inhibitor interactions.  In both structures, the α9 helix was displaced farther from the enzyme active site than the previous Ag85C ebselen structure, resulting in the restructuring of a connecting loop and imparting a conformational change to residues believed to play a role in substrate binding specific to Ag85C.  These notable structural changes directly affect protein stability, reducing the overall melting temp. by up to 14.5 °C, resulting in the unfolding of protein at physiol. temps.  Addnl., this structural rearrangement due to covalent allosteric modification creates a sizable solvent network that encompasses the active site and extends to the modified Cys209 residue.  In all, this study outlines factors that influence enzyme inhibition by ebselen and its derivs. while further highlighting the effects of the covalent modification of Cys209 by said inhibitors on the structure and stability of Ag85C.  Furthermore, the results suggest a strategy for developing new classes of Ag85 inhibitors with increased specificity and potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF1-BS5Bc0xbVg90H21EOLACvtfcHk0li47-XJFykjXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktVGhsb0%253D&md5=eb90ffe305812a089494d78180db8c2e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.7b00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.7b00003%26sid%3Dliteratum%253Aachs%26aulast%3DGoins%26aufirst%3DC.%2BM.%26aulast%3DDajnowicz%26aufirst%3DS.%26aulast%3DThanna%26aufirst%3DS.%26aulast%3DSucheck%26aufirst%3DS.%2BJ.%26aulast%3DParks%26aufirst%3DJ.%2BM.%26aulast%3DRonning%26aufirst%3DD.%2BR.%26atitle%3DExploring%2520covalent%2520allosteric%2520inhibition%2520of%2520antigen%252085C%2520from%2520Mycobacterium%2520tuberculosis%2520by%2520ebselen%2520derivatives%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D378%26epage%3D387%26doi%3D10.1021%2Facsinfecdis.7b00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macegoniuk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grela, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudzinska-Szostak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabowiecka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berlicki, L.</span></span> <span> </span><span class="NLM_article-title">1,2-Benzisoselenazol-3(2<i>H</i>)-one derivatives as a new class of bacterial urease inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8125</span>– <span class="NLM_lpage">8133</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00986</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00986" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlehsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8125-8133&author=K.+Macegoniukauthor=E.+Grelaauthor=J.+Palusauthor=E.+Rudzinska-Szostakauthor=A.+Grabowieckaauthor=M.+Biernatauthor=L.+Berlicki&title=1%2C2-Benzisoselenazol-3%282H%29-one+derivatives+as+a+new+class+of+bacterial+urease+inhibitors&doi=10.1021%2Facs.jmedchem.6b00986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">1,2-Benzisoselenazol-3(2H)-one Derivatives As a New Class of Bacterial Urease Inhibitors</span></div><div class="casAuthors">Macegoniuk, Katarzyna; Grela, Ewa; Palus, Jerzy; Rudzinska-Szostak, Ewa; Grabowiecka, Agnieszka; Biernat, Monika; Berlicki, Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8125-8133</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzisoselenazolones and aminocarbonylphenyl and alkoxycarbonylphenyl diselenides were prepd. and tested as inhibitors of bacterial ureases for use in the treatment of Helicobacter pylori infection; the compds. were tested for their inhibition of E. coli expressing urease and H. pylori.  Known benzisoselenazolone I (ebselen) was the most active compd. tested, inhibiting S. pasteurii and H. pylori bacterial ureases with Ki values of 2.11 and 226 nM, resp.  Many of the tested compds. inhibited bacterial ureases in E. coli and H. pylori cell culture in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9GtSln1SxrVg90H21EOLACvtfcHk0li47-XJFykjXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlehsrjJ&md5=2533ac1bd3bc0170f50a72bcc64a245f</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00986%26sid%3Dliteratum%253Aachs%26aulast%3DMacegoniuk%26aufirst%3DK.%26aulast%3DGrela%26aufirst%3DE.%26aulast%3DPalus%26aufirst%3DJ.%26aulast%3DRudzinska-Szostak%26aufirst%3DE.%26aulast%3DGrabowiecka%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DM.%26aulast%3DBerlicki%26aufirst%3DL.%26atitle%3D1%252C2-Benzisoselenazol-3%25282H%2529-one%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520bacterial%2520urease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8125%26epage%3D8133%26doi%3D10.1021%2Facs.jmedchem.6b00986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Ebselen suppresses inflammation induced by <i>Helicobacter pylori</i> lipopolysaccharide via the p38 mitogen-activated protein kinase signaling pathway</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6847</span>– <span class="NLM_lpage">6851</span>, <span class="refDoi"> DOI: 10.3892/mmr.2018.8641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3892%2Fmmr.2018.8641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29488609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWlsb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=6847-6851&author=L.+Xuauthor=C.+Gongauthor=G.+Liauthor=J.+Weiauthor=T.+Wangauthor=W.+Mengauthor=M.+Shiauthor=Y.+Wang&title=Ebselen+suppresses+inflammation+induced+by+Helicobacter+pylori+lipopolysaccharide+via+the+p38+mitogen-activated+protein+kinase+signaling+pathway&doi=10.3892%2Fmmr.2018.8641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen suppresses inflammation induced by Helicobacter pylori lipopolysaccharide via the p38 mitogen-activated protein kinase signaling pathway</span></div><div class="casAuthors">Xu, Ling; Gong, Changguo; Li, Guangming; Wei, Jue; Wang, Ting; Meng, Wenying; Shi, Min; Wang, Yugang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">6847-6851</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Ebselen is a seleno-org. compd. that has been demonstrated to have antioxidant and anti-inflammatory properties.  A previous study detd. that ebselen inhibits airway inflammation induced by inhalational lipopolysaccharide (LPS), however, the underlying mol. mechanism remains to be elucidated.  The present study investigated the effect of ebselen on the glutathione peroxidase (GPX)-reactive oxygen species (ROS) pathway and interleukin-8 (IL-8) expression induced by Helicobacter pylori LPS in gastric cancer (GC) cells.  Cells were treated with 200 ng/mL H. pylori-LPS in the presence or absence of ebselen for various durations and concns. (μmol/l).  The expression of toll-like receptor 4 (TLR4), GPX2, GPX4, p38 mitogen-activated protein kinase (p38 MAPK), phosphorylated-p38 MAPK, ROS prodn. and IL-8 expression were detected with western blotting or ELISA.  The present study revealed that TLR4 expression was upregulated; however, GPX2 and GPX4 expression was reduced following treatment with H. pylori LPS, which led to increased ROS prodn., subsequently altering the IL-8 expression level in GC cells.  Addnl., it was detd. that ebselen prevented the redn. in GPX2/4 levels induced by H. pylori LPS, however, TLR4 expression was not affected.  Ebselen may also block the expression of IL-8 by inhibiting phosphorylation of p38 MAPK.  These data suggest ebselen may inhibit ROS prodn. triggered by H. pylori LPS treatment via GPX2/4 instead of TLR4 signaling and reduce phosphorylation of p38 MAPK, resulting in altered prodn. of IL-8.  Ebselen may, therefore, be a potential therapeutic agent to mediate H. pylori LPS-induced cell damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uKoeiiMqNrVg90H21EOLACvtfcHk0ljrmMXJrSXHxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWlsb3F&md5=2f701627d7a4b639c524f1d2a6f948a2</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2018.8641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2018.8641%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DMeng%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DEbselen%2520suppresses%2520inflammation%2520induced%2520by%2520Helicobacter%2520pylori%2520lipopolysaccharide%2520via%2520the%2520p38%2520mitogen-activated%2520protein%2520kinase%2520signaling%2520pathway%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2018%26volume%3D17%26spage%3D6847%26epage%3D6851%26doi%3D10.3892%2Fmmr.2018.8641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaupp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenyan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasiljeva, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marc, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejarz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latacz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handzlik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, C.</span></span> <span> </span><span class="NLM_article-title">Selenazolinium salts as “small molecule satalysts” with high potency against ESKAPE bacterial pathogens</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2174</span>, <span class="refDoi"> DOI: 10.3390/molecules22122174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fmolecules22122174" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=2174&author=K.+Witekauthor=M.+J.+Nasimauthor=M.+Bischoffauthor=R.+Gauppauthor=P.+Arsenyanauthor=J.+Vasiljevaauthor=M.+A.+Marcauthor=A.+Olejarzauthor=G.+Lataczauthor=K.+Kiec-Kononowiczauthor=J.+Handzlikauthor=C.+Jacob&title=Selenazolinium+salts+as+%E2%80%9Csmall+molecule+satalysts%E2%80%9D+with+high+potency+against+ESKAPE+bacterial+pathogens&doi=10.3390%2Fmolecules22122174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22122174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22122174%26sid%3Dliteratum%253Aachs%26aulast%3DWitek%26aufirst%3DK.%26aulast%3DNasim%26aufirst%3DM.%2BJ.%26aulast%3DBischoff%26aufirst%3DM.%26aulast%3DGaupp%26aufirst%3DR.%26aulast%3DArsenyan%26aufirst%3DP.%26aulast%3DVasiljeva%26aufirst%3DJ.%26aulast%3DMarc%26aufirst%3DM.%2BA.%26aulast%3DOlejarz%26aufirst%3DA.%26aulast%3DLatacz%26aufirst%3DG.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26aulast%3DHandzlik%26aufirst%3DJ.%26aulast%3DJacob%26aufirst%3DC.%26atitle%3DSelenazolinium%2520salts%2520as%2520%25E2%2580%259Csmall%2520molecule%2520satalysts%25E2%2580%259D%2520with%2520high%2520potency%2520against%2520ESKAPE%2520bacterial%2520pathogens%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D2174%26doi%3D10.3390%2Fmolecules22122174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottenberg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">Synergistic antibacterial effect of silver and ebselen against multidrug-resistant Gram-negative bacterial infections</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1165</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.15252/emmm.201707661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.15252%2Femmm.201707661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28606995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsFSqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1165-1178&author=L.+Zouauthor=J.+Luauthor=J.+Wangauthor=X.+Renauthor=L.+Zhangauthor=Y.+Gaoauthor=M.+E.+Rottenbergauthor=A.+Holmgren&title=Synergistic+antibacterial+effect+of+silver+and+ebselen+against+multidrug-resistant+Gram-negative+bacterial+infections&doi=10.15252%2Femmm.201707661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic antibacterial effect of silver and ebselen against multidrug-resistant Gram-negative bacterial infections</span></div><div class="casAuthors">Zou, Lili; Lu, Jun; Wang, Jun; Ren, Xiaoyuan; Zhang, Lanlan; Gao, Yu; Rottenberg, Martin E.; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1165-1178</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Multidrug-resistant (MDR) Gram-neg. bacteria account for a majority of fatal infections, and development of new antibiotic principles and drugs is therefore of outstanding importance.  Here, we report that five most clin. difficult-to-treat MDR Gram-neg. bacteria are highly sensitive to a synergistic combination of silver and ebselen.  In contrast, silver has no synergistic toxicity with ebselen on mammalian cells.  The silver and ebselen combination causes a rapid depletion of glutathione and inhibition of the thioredoxin system in bacteria.  Silver ions were identified as strong inhibitors of Escherichia coli thioredoxin and thioredoxin reductase, which are required for ribonucleotide reductase and DNA synthesis and defense against oxidative stress.  The bactericidal efficacy of silver and ebselen was further verified in the treatment of mild and acute MDR E. coli peritonitis in mice.  These results demonstrate that thiol-dependent redox systems in bacteria can be targeted in the design of new antibacterial drugs.  The silver and ebselen combination offers a proof of concept in targeting essential bacterial systems and might be developed for novel efficient treatments against MDR Gram-neg. bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQjrfir48vY7Vg90H21EOLACvtfcHk0ljrmMXJrSXHxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsFSqur0%253D&md5=308903f6cbcf5644372e3d64920c5b4d</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.15252%2Femmm.201707661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201707661%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRottenberg%26aufirst%3DM.%2BE.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DSynergistic%2520antibacterial%2520effect%2520of%2520silver%2520and%2520ebselen%2520against%2520multidrug-resistant%2520Gram-negative%2520bacterial%2520infections%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2017%26volume%3D9%26spage%3D1165%26epage%3D1178%26doi%3D10.15252%2Femmm.201707661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. F.</span></span> <span> </span><span class="NLM_article-title">Investigation of synergistic antimicrobial effects of the drug combinations of meropenem and 1,2-benzisoselenazol-3(2<i>H</i>)-one derivatives on carbapenem-resistant Enterobacteriaceae producing NDM-1</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2018.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29894943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFaltbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2018&pages=285-302&author=W.+B.+Jinauthor=C.+Xuauthor=Q.+Chengauthor=X.+L.+Qiauthor=W.+Gaoauthor=Z.+Zhengauthor=E.+W.+C.+Chanauthor=Y.+C.+Leungauthor=T.+H.+Chanauthor=K.+Y.+Wongauthor=S.+Chenauthor=K.+F.+Chan&title=Investigation+of+synergistic+antimicrobial+effects+of+the+drug+combinations+of+meropenem+and+1%2C2-benzisoselenazol-3%282H%29-one+derivatives+on+carbapenem-resistant+Enterobacteriaceae+producing+NDM-1&doi=10.1016%2Fj.ejmech.2018.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of synergistic antimicrobial effects of the drug combinations of meropenem and 1,2-benzisoselenazol-3(2H)-one derivatives on carbapenem-resistant Enterobacteriaceae producing NDM-1</span></div><div class="casAuthors">Jin, Wen Bin; Xu, Chen; Cheng, Qipeng; Qi, Xiao Lin; Gao, Wei; Zheng, Zhiwei; Chan, Edward W. C.; Leung, Yun-Chung; Chan, Tak Hang; Wong, Kwok-Yin; Chen, Sheng; Chan, Kin-Fai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">285-302</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The worldwide prevalence of NDM-1-producing bacteria has drastically undermined the clin. efficacy of the last line antibiotic of carbapenems, prompting a need to devise effective strategy to preserve their clin. value.  Our previous studies have shown that ebselen can restore the efficacy of meropenem against a lab. strain that produces NDM-1.  Here we report the construction of a focused compd. library of 1,2-benzisoselenazol-3(2H)-one derivs. which comprise a total of forty-six candidate compds.  The structure-activity relationship of these compds. and their potential to serve as an adjuvant to enhance the antimicrobial efficacy of meropenem against a collection of clin. NDM-1-producing carbapenem-resistant Enterobacteriaceae isolates was examd.  Drug combination assays indicated that these derivs. exhibited synergistic antimicrobial activity when used along with meropenem, effectively restoring the activity of carbapenems against the resistant strains tested in a Galleria mellonella larvae in vivo infection model.  The mode of inhibition of one compd., namely 11_a38, which was depicted when tested on the purified NDM-1 enzyme, indicated that it could covalently bind to the enzyme and displaced one zinc ion from the active site.  Overall, this study provides a novel 1,2-benzisoselenazol-3(2H)-one scaffold that exhibits strong synergistic antimicrobial activity with carbapenems, and low cytotoxicity.  The prospect of application of such compds. as carbapenem adjuvants warrants further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2MzB9DLEArVg90H21EOLACvtfcHk0ljrmMXJrSXHxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFaltbzI&md5=ee1da1f67ac597f0f32b5c681dc1429c</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DW.%2BB.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DX.%2BL.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DChan%26aufirst%3DE.%2BW.%2BC.%26aulast%3DLeung%26aufirst%3DY.%2BC.%26aulast%3DChan%26aufirst%3DT.%2BH.%26aulast%3DWong%26aufirst%3DK.%2BY.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DK.%2BF.%26atitle%3DInvestigation%2520of%2520synergistic%2520antimicrobial%2520effects%2520of%2520the%2520drug%2520combinations%2520of%2520meropenem%2520and%25201%252C2-benzisoselenazol-3%25282H%2529-one%2520derivatives%2520on%2520carbapenem-resistant%2520Enterobacteriaceae%2520producing%2520NDM-1%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D155%26spage%3D285%26epage%3D302%26doi%3D10.1016%2Fj.ejmech.2018.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">AbdelKhalek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abutaleb, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seleem, M. N.</span></span> <span> </span><span class="NLM_article-title">Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">e0199710</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0199710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1371%2Fjournal.pone.0199710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29953486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFait7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=e0199710&author=A.+AbdelKhalekauthor=N.+S.+Abutalebauthor=H.+Mohammadauthor=M.+N.+Seleem&title=Repurposing+ebselen+for+decolonization+of+vancomycin-resistant+enterococci+%28VRE%29&doi=10.1371%2Fjournal.pone.0199710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)</span></div><div class="casAuthors">AbdelKhalek, Ahmed; Abutaleb, Nader S.; Mohammad, Haroon; Seleem, Mohamed N.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0199710/1-e0199710/14</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Enterococci represent one of the microbial world's most challenging enigmas.  Colonization of the gastrointestinal tract (GIT) of high-risk/immunocompromised patients by enterococci exhibiting resistance to vancomycin (VRE) can lead to life-threating infections, including bloodstream infections and endocarditis.  Decolonization of VRE from the GIT of high-risk patients represents an alternative method to suppress the risk of the infection.  It could be considered as a preventative measure to protect against VRE infections in high-risk individuals.  Though multiple agents (ramoplanin and bacitracin) have been evaluated clin., no drugs are currently approved for use in VRE decolonization of the GIT.  The present study evaluates ebselen, a clin. mol., for use as a decolonizing agent against VRE.  When evaluated against a broad array of enterococcal isolates in vitro, ebselen was found to be as potent as linezolid (min. inhibitory concn. against 90% of clin. isolates tested was 2 μg/mL).  Though VRE has a remarkable ability to develop resistance to antibacterial agents, no resistance to ebselen emerged after a clin. isolate of vancomycin-resistant E. faecium was serially-passaged with ebselen for 14 days.  Against VRE biofilm, a virulence factor that enables the bacteria to colonize the gut, ebselen demonstrated the ability to both inhibit biofilm formation and disrupt mature biofilm.  Furthermore, in a murine VRE colonization redn. model, ebselen proved as effective as ramoplanin in reducing the bacterial shedding and burden of VRE present in the fecal content (by > 99.99%), cecum, and ileum of mice.  Based on the promising results obtained, ebselen warrants further investigation as a novel decolonizing agent to quell VRE infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhBBPkXAGPGrVg90H21EOLACvtfcHk0lix5v2wBBGlsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFait7jO&md5=8c992314d7bc28fe7d41d3d18626f6c5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0199710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0199710%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelKhalek%26aufirst%3DA.%26aulast%3DAbutaleb%26aufirst%3DN.%2BS.%26aulast%3DMohammad%26aufirst%3DH.%26aulast%3DSeleem%26aufirst%3DM.%2BN.%26atitle%3DRepurposing%2520ebselen%2520for%2520decolonization%2520of%2520vancomycin-resistant%2520enterococci%2520%2528VRE%2529%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26spage%3De0199710%26doi%3D10.1371%2Fjournal.pone.0199710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guentzel, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cap, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arulanandam, B. P.</span></span> <span> </span><span class="NLM_article-title">Repurposing auranofin, ebselen, and PX-12 as antimicrobial agents targeting the thioredoxin system</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">336</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.00336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3389%2Ffmicb.2018.00336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29556223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC1MnivVWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=336&author=H.+C.+Mayauthor=J.+J.+Yuauthor=M.+N.+Guentzelauthor=J.+P.+Chambersauthor=A.+P.+Capauthor=B.+P.+Arulanandam&title=Repurposing+auranofin%2C+ebselen%2C+and+PX-12+as+antimicrobial+agents+targeting+the+thioredoxin+system&doi=10.3389%2Ffmicb.2018.00336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System</span></div><div class="casAuthors">May Holly C; Yu Jieh-Juen; Guentzel M N; Chambers James P; Arulanandam Bernard P; May Holly C; Yu Jieh-Juen; Guentzel M N; Chambers James P; Arulanandam Bernard P; Cap Andrew P</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">336</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">As microbial resistance to drugs continues to rise at an alarming rate, finding new ways to combat pathogens is an issue of utmost importance.  Development of novel and specific antimicrobial drugs is a time-consuming and expensive process.  However, the re-purposing of previously tested and/or approved drugs could be a feasible way to circumvent this long and costly process.  In this review, we evaluate the U.S.  Food and Drug Administration tested drugs auranofin, ebselen, and PX-12 as antimicrobial agents targeting the thioredoxin system.  These drugs have been shown to act on bacterial, fungal, protozoan, and helminth pathogens without significant toxicity to the host.  We propose that the thioredoxin system could serve as a useful therapeutic target with broad spectrum antimicrobial activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxOgzbAkjBfDC850By6mxpfW6udTcc2eahwsKcuKsj87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnivVWqtQ%253D%253D&md5=5143dcfa510396a56a1700799ec9c20a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.00336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.00336%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DH.%2BC.%26aulast%3DYu%26aufirst%3DJ.%2BJ.%26aulast%3DGuentzel%26aufirst%3DM.%2BN.%26aulast%3DChambers%26aufirst%3DJ.%2BP.%26aulast%3DCap%26aufirst%3DA.%2BP.%26aulast%3DArulanandam%26aufirst%3DB.%2BP.%26atitle%3DRepurposing%2520auranofin%252C%2520ebselen%252C%2520and%2520PX-12%2520as%2520antimicrobial%2520agents%2520targeting%2520the%2520thioredoxin%2520system%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D336%26doi%3D10.3389%2Ffmicb.2018.00336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orie, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basaric, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau-Cam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietka-Ottlik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlochowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billack, B.</span></span> <span> </span><span class="NLM_article-title">In vitro assessment of the growth and plasma membrane H(+) -ATPase inhibitory activity of ebselen and structurally related selenium- and sulfur-containing compounds in Candida albicans</span>. <i>J. Biochem. Mol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">e21892</span>, <span class="refDoi"> DOI: 10.1002/jbt.21892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fjbt.21892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=e21892&author=N.+N.+Orieauthor=A.+R.+Warrenauthor=J.+Basaricauthor=C.+Lau-Camauthor=M.+Pietka-Ottlikauthor=J.+Mlochowskiauthor=B.+Billack&title=In+vitro+assessment+of+the+growth+and+plasma+membrane+H%28%2B%29+-ATPase+inhibitory+activity+of+ebselen+and+structurally+related+selenium-+and+sulfur-containing+compounds+in+Candida+albicans&doi=10.1002%2Fjbt.21892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fjbt.21892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbt.21892%26sid%3Dliteratum%253Aachs%26aulast%3DOrie%26aufirst%3DN.%2BN.%26aulast%3DWarren%26aufirst%3DA.%2BR.%26aulast%3DBasaric%26aufirst%3DJ.%26aulast%3DLau-Cam%26aufirst%3DC.%26aulast%3DPietka-Ottlik%26aufirst%3DM.%26aulast%3DMlochowski%26aufirst%3DJ.%26aulast%3DBillack%26aufirst%3DB.%26atitle%3DIn%2520vitro%2520assessment%2520of%2520the%2520growth%2520and%2520plasma%2520membrane%2520H%2528%252B%2529%2520-ATPase%2520inhibitory%2520activity%2520of%2520ebselen%2520and%2520structurally%2520related%2520selenium-%2520and%2520sulfur-containing%2520compounds%2520in%2520Candida%2520albicans%26jtitle%3DJ.%2520Biochem.%2520Mol.%2520Toxicol.%26date%3D2017%26volume%3D31%26spage%3De21892%26doi%3D10.1002%2Fjbt.21892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thangamani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldesouky, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascuzzi, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avramova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazbun, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seleem, M. N.</span></span> <span> </span><span class="NLM_article-title">Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1861</i></span>,  <span class="NLM_fpage">3002</span>– <span class="NLM_lpage">3010</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2016.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbagen.2016.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27712973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1861&publication_year=2017&pages=3002-3010&author=S.+Thangamaniauthor=H.+E.+Eldesoukyauthor=H.+Mohammadauthor=P.+E.+Pascuzziauthor=L.+Avramovaauthor=T.+R.+Hazbunauthor=M.+N.+Seleem&title=Ebselen+exerts+antifungal+activity+by+regulating+glutathione+%28GSH%29+and+reactive+oxygen+species+%28ROS%29+production+in+fungal+cells&doi=10.1016%2Fj.bbagen.2016.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Ebselen exerts antifungal activity by regulating glutathione (GSH) and reactive oxygen species (ROS) production in fungal cells</span></div><div class="casAuthors">Thangamani, Shankar; Eldesouky, Hassan E.; Mohammad, Haroon; Pascuzzi, Pete E.; Avramova, Larisa; Hazbun, Tony R.; Seleem, Mohamed N.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1861</span>
        (<span class="NLM_cas:issue">1_Part_A</span>),
    <span class="NLM_cas:pages">3002-3010</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ebselen, an organoselenium compd. and a clin. safe mol. has been reported to possess potent antifungal activity, but its antifungal mechanism of action and in vivo antifungal activity remain unclear.  The antifungal effect of ebselen was tested against Candida albicans, C. glabrata, C. tropicalis, C. parapsilosis, Cryptococcus neoformans, and C. gattii clin. isolates.  Chemogenomic profiling and biochem. assays were employed to identify the antifungal target of ebselen.  Ebselen's antifungal activity in vivo was investigated in a Caenorhabditis elegans animal model.  Ebselen exhibits potent antifungal activity against both Candida spp. and Cryptococcus spp., at concns. ranging from 0.5 to 2 μg/mL.  Ebselen rapidly eradicates a high fungal inoculum within 2 h of treatment.  Investigation of the drug's antifungal mechanism of action indicates that ebselen depletes intracellular glutathione (GSH) levels, leading to increased prodn. of reactive oxygen species (ROS), and thereby disturbs the redox homeostasis in fungal cells.  Examn. of ebselen's in vivo antifungal activity in two Caenorhabditis elegans models of infection demonstrate that ebselen is superior to conventional antifungal drugs (fluconazole, flucytosine and amphotericin) in reducing Candida and Cryptococcus fungal load.  Ebselen possesses potent antifungal activity against clin. relevant isolates of both Candida and Cryptococcus by regulating GSH and ROS prodn.  The potent in vivo antifungal activity of ebselen supports further investigation for repurposing it for use as an antifungal agent..  The present study shows that ebselen targets glutathione and also support that glutathione as a potential target for antifungal drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3r43etsLebVg90H21EOLACvtfcHk0lgB40bAF00n6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ajsLrP&md5=c2503ad29a4ab169d4f58e5857c1307a</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2016.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2016.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DThangamani%26aufirst%3DS.%26aulast%3DEldesouky%26aufirst%3DH.%2BE.%26aulast%3DMohammad%26aufirst%3DH.%26aulast%3DPascuzzi%26aufirst%3DP.%2BE.%26aulast%3DAvramova%26aufirst%3DL.%26aulast%3DHazbun%26aufirst%3DT.%2BR.%26aulast%3DSeleem%26aufirst%3DM.%2BN.%26atitle%3DEbselen%2520exerts%2520antifungal%2520activity%2520by%2520regulating%2520glutathione%2520%2528GSH%2529%2520and%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520production%2520in%2520fungal%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2017%26volume%3D1861%26spage%3D3002%26epage%3D3010%26doi%3D10.1016%2Fj.bbagen.2016.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venturini, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chassot, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreto, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santurio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, S. H.</span></span> <span> </span><span class="NLM_article-title">Antifungal activities of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Fusarium spp</span>. <i>Med. Mycol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1093/mmy/myv120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1093%2Fmmy%2Fmyv120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26773133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1WntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2016&pages=550-555&author=T.+P.+Venturiniauthor=F.+Chassotauthor=E.+S.+Loretoauthor=J.+T.+Kellerauthor=M.+I.+Azevedoauthor=G.+Zeniauthor=J.+M.+Santurioauthor=S.+H.+Alves&title=Antifungal+activities+of+diphenyl+diselenide+and+ebselen+alone+and+in+combination+with+antifungal+agents+against+Fusarium+spp&doi=10.1093%2Fmmy%2Fmyv120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal activities of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Fusarium spp</span></div><div class="casAuthors">Venturini, Tarcieli Pozzebon; Chassot, Francieli; Loreto, Erico Silva; Keller, Jessica Tairine; Azevedo, Maria Izabel; Zeni, Gilson; Santurio, Janio Morais; Alves, Sydney Hartz</div><div class="citationInfo"><span class="NLM_cas:title">Medical Mycology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">550-555</span>CODEN:
                <span class="NLM_cas:coden">MEMYFR</span>;
        ISSN:<span class="NLM_cas:issn">1369-3786</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Herein, we describe the in vitro activity of a combination of the organoselenium compds. di-Ph diselenide and ebselen alone and in combination with amphotericin B, caspofungin, itraconazole, and voriconazole against 25 clin. isolates of Fusarium spp.  For this anal., we used the broth microdilution method based on the M38-A2 technique and checkerboard microdilution method.  Di-Ph diselenide (MIC range = 4-32 μg/mL) and ebselen (MIC range = 2-8 μg/mL) showed in vitro activity against the isolates tested.  The most effective combinations were (synergism rates): ebselen + amphotericin B (88%), ebselen + voriconazole (80%), di-Ph diselenide + amphotericin B (72%), and di-Ph diselenide + voriconazole (64%).  Combination with caspofungin resulted in low rates of synergism: ebselen + caspofungin, 36%, and di-Ph diselenide + caspofungin, 28%; combination with itraconazole demonstrated indifferent interactions.  Antagonistic effects were not obsd. for any of the combinations tested.  Our findings suggest that the antifungal potential of di-Ph diselenide and ebselen deserves further investigation in in vivo exptl. models, esp. in combination with amphotericin B and voriconazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zXbM7_htubVg90H21EOLACvtfcHk0lgB40bAF00n6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1WntLY%253D&md5=c29c593970aa627cc2b7b39993664302</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1093%2Fmmy%2Fmyv120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmmy%252Fmyv120%26sid%3Dliteratum%253Aachs%26aulast%3DVenturini%26aufirst%3DT.%2BP.%26aulast%3DChassot%26aufirst%3DF.%26aulast%3DLoreto%26aufirst%3DE.%2BS.%26aulast%3DKeller%26aufirst%3DJ.%2BT.%26aulast%3DAzevedo%26aufirst%3DM.%2BI.%26aulast%3DZeni%26aufirst%3DG.%26aulast%3DSanturio%26aufirst%3DJ.%2BM.%26aulast%3DAlves%26aufirst%3DS.%2BH.%26atitle%3DAntifungal%2520activities%2520of%2520diphenyl%2520diselenide%2520and%2520ebselen%2520alone%2520and%2520in%2520combination%2520with%2520antifungal%2520agents%2520against%2520Fusarium%2520spp%26jtitle%3DMed.%2520Mycol.%26date%3D2016%26volume%3D54%26spage%3D550%26epage%3D555%26doi%3D10.1093%2Fmmy%2Fmyv120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wormley, F. L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederhold, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span> <span> </span><span class="NLM_article-title">Screening a repurposing library for inhibitors of multidrug-resistant <i>Candida auris</i> identifies ebselen as a repositionable candidate for antifungal drug development</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">e01084-18</span>, <span class="refDoi"> DOI: 10.1128/AAC.01084-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1128%2FAAC.01084-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30104269" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=e01084-18&author=G.+Wallauthor=A.+K.+Chaturvediauthor=F.+L.+Wormleyauthor=N.+P.+Wiederholdauthor=H.+P.+Pattersonauthor=T.+F.+Pattersonauthor=J.+L.+Lopez-Ribot&title=Screening+a+repurposing+library+for+inhibitors+of+multidrug-resistant+Candida+auris+identifies+ebselen+as+a+repositionable+candidate+for+antifungal+drug+development&doi=10.1128%2FAAC.01084-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1128%2FAAC.01084-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01084-18%26sid%3Dliteratum%253Aachs%26aulast%3DWall%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DA.%2BK.%26aulast%3DWormley%26aufirst%3DF.%2BL.%26aulast%3DWiederhold%26aufirst%3DN.%2BP.%26aulast%3DPatterson%26aufirst%3DH.%2BP.%26aulast%3DPatterson%26aufirst%3DT.%2BF.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26atitle%3DScreening%2520a%2520repurposing%2520library%2520for%2520inhibitors%2520of%2520multidrug-resistant%2520Candida%2520auris%2520identifies%2520ebselen%2520as%2520a%2520repositionable%2520candidate%2520for%2520antifungal%2520drug%2520development%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2018%26volume%3D62%26spage%3De01084-18%26doi%3D10.1128%2FAAC.01084-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kidd, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont-Friedrich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arentz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coad, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, J. B.</span></span> <span> </span><span class="NLM_article-title">Structure, mechanism, and inhibition of <i>Aspergillus fumigatus</i> thioredoxin reductase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">e02281-18</span>, <span class="refDoi"> DOI: 10.1128/AAC.02281-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1128%2FAAC.02281-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30642940" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2019&pages=e02281-18&author=A.+C.+Marshallauthor=S.+E.+Kiddauthor=S.+J.+Lamont-Friedrichauthor=G.+Arentzauthor=P.+Hoffmannauthor=B.+R.+Coadauthor=J.+B.+Bruning&title=Structure%2C+mechanism%2C+and+inhibition+of+Aspergillus+fumigatus+thioredoxin+reductase&doi=10.1128%2FAAC.02281-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FAAC.02281-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02281-18%26sid%3Dliteratum%253Aachs%26aulast%3DMarshall%26aufirst%3DA.%2BC.%26aulast%3DKidd%26aufirst%3DS.%2BE.%26aulast%3DLamont-Friedrich%26aufirst%3DS.%2BJ.%26aulast%3DArentz%26aufirst%3DG.%26aulast%3DHoffmann%26aufirst%3DP.%26aulast%3DCoad%26aufirst%3DB.%2BR.%26aulast%3DBruning%26aufirst%3DJ.%2BB.%26atitle%3DStructure%252C%2520mechanism%252C%2520and%2520inhibition%2520of%2520Aspergillus%2520fumigatus%2520thioredoxin%2520reductase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2019%26volume%3D63%26spage%3De02281-18%26doi%3D10.1128%2FAAC.02281-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eltahan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of ebselen as an inhibitor of <i>Cryptosporidium parvum</i> glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs</span>. <i>Int. J. Parasitol.: Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2018.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ijpddr.2018.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29414105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvos12msQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=43-49&author=R.+Eltahanauthor=F.+Guoauthor=H.+Zhangauthor=L.+Xiangauthor=G.+Zhu&title=Discovery+of+ebselen+as+an+inhibitor+of+Cryptosporidium+parvum+glucose-6-phosphate+isomerase+%28CpGPI%29+by+high-throughput+screening+of+existing+drugs&doi=10.1016%2Fj.ijpddr.2018.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs</span></div><div class="casAuthors">Eltahan Rana; Guo Fengguang; Zhang Haili; Xiang Lixin; Zhu Guan</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology. Drugs and drug resistance</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-49</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cryptosporidium parvum is a water-borne and food-borne apicomplexan pathogen.  It is one of the top four diarrheal-causing pathogens in children under the age of five in developing countries, and an opportunistic pathogen in immunocompromised individuals.  Unlike other apicomplexans, C. parvum lacks Kreb's cycle and cytochrome-based respiration, thus relying mainly on glycolysis to produce ATP.  In this study, we characterized the primary biochemical features of the C. parvum glucose-6-phosphate isomerase (CpGPI) and determined its Michaelis constant towards fructose-6-phosphate (Km = 0.309 mM, Vmax = 31.72 nmol/μg/min).  We also discovered that ebselen, an organoselenium drug, was a selective inhibitor of CpGPI by high-throughput screening of 1200 known drugs.  Ebselen acted on CpGPI as an allosteric noncompetitive inhibitor (IC50 = 8.33 μM; Ki = 36.33 μM), while complete inhibition of CpGPI activity was not achieved.  Ebselen could also inhibit the growth of C. parvum in vitro (EC50 = 165 μM) at concentrations nontoxic to host cells, albeit with a relatively small in vitro safety window of 4.2 (cytotoxicity TC50 on HCT-8 cells = 700 μM).  Additionally, ebselen might also target other enzymes in the parasite, leading to the parasite growth reduction.  Therefore, although ebselen is useful in studying the inhibition of CpGPI enzyme activity, further proof is needed to chemically and/or genetically validate CpGPI as a drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsCIZ9a_pCghgd2Wuil24tfW6udTcc2eYS4u04aG2ADrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvos12msQ%253D%253D&md5=cc0135747a87c15169c6f94aba7101b6</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2018.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2018.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DEltahan%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520ebselen%2520as%2520an%2520inhibitor%2520of%2520Cryptosporidium%2520parvum%2520glucose-6-phosphate%2520isomerase%2520%2528CpGPI%2529%2520by%2520high-throughput%2520screening%2520of%2520existing%2520drugs%26jtitle%3DInt.%2520J.%2520Parasitol.%253A%2520Drugs%2520Drug%2520Resist.%26date%3D2018%26volume%3D8%26spage%3D43%26epage%3D49%26doi%3D10.1016%2Fj.ijpddr.2018.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordhan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swasy, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackler, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anayee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, D. C.</span></span> <span> </span><span class="NLM_article-title">Evaluation of substituted ebselen derivatives as potential trypanocidal agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2016.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28043795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=537-541&author=H.+M.+Gordhanauthor=S.+L.+Patrickauthor=M.+I.+Swasyauthor=A.+L.+Hacklerauthor=M.+Anayeeauthor=J.+E.+Goldenauthor=J.+C.+Morrisauthor=D.+C.+Whitehead&title=Evaluation+of+substituted+ebselen+derivatives+as+potential+trypanocidal+agents&doi=10.1016%2Fj.bmcl.2016.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of substituted ebselen derivatives as potential trypanocidal agents</span></div><div class="casAuthors">Gordhan, Heeren M.; Patrick, Stephen L.; Swasy, Maria I.; Hackler, Amber L.; Anayee, Mark; Golden, Jennifer E.; Morris, James C.; Whitehead, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-541</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human African trypanosomiasis is a disease of sub-Saharan Africa, where millions are at risk for the illness.  The disease, commonly referred to as African sleeping sickness, is caused by an infection by the eukaryotic pathogen, Trypanosoma brucei.  Previously, a target-based high throughput screen revealed ebselen (EbSe), and its sulfur analog, EbS, to be potent in vitro inhibitors of the T. brucei hexokinase 1 (TbHK1).  These mols. also exhibited potent trypanocidal activity in vivo.  In this manuscript, we synthesized a series of sixteen EbSe and EbS derivs. bearing electron-withdrawing carboxylic acid and Me ester functional groups, and evaluated the influence of these substituents on the biol. efficacy of the parent scaffold.  With the exception of one Me ester deriv., these modifications ablated or blunted the potent TbHK1 inhibition of the parent scaffold.  Nonetheless, a few of the Me ester derivs. still exhibited trypanocidal effects with single-digit micromolar or high nanomolar EC50 values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomrTHPitYEv7Vg90H21EOLACvtfcHk0ljrnP6fS7gd2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyltQ%253D%253D&md5=98d0198882e5c9aeabdad4cf16660994</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DGordhan%26aufirst%3DH.%2BM.%26aulast%3DPatrick%26aufirst%3DS.%2BL.%26aulast%3DSwasy%26aufirst%3DM.%2BI.%26aulast%3DHackler%26aufirst%3DA.%2BL.%26aulast%3DAnayee%26aufirst%3DM.%26aulast%3DGolden%26aufirst%3DJ.%2BE.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DWhitehead%26aufirst%3DD.%2BC.%26atitle%3DEvaluation%2520of%2520substituted%2520ebselen%2520derivatives%2520as%2520potential%2520trypanocidal%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D537%26epage%3D541%26doi%3D10.1016%2Fj.bmcl.2016.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felli
Kubica, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedin Denardi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva de Loreto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiblen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morais Santurio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartz Alves, S.</span></span> <span> </span><span class="NLM_article-title">In vitro activity of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Trichosporon asahii</span>. <i>Mycoses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1111/myc.12906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1111%2Fmyc.12906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30784136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsV2ktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=428-433&author=T.+Felli%0AKubicaauthor=L.+Bedin+Denardiauthor=E.+Silva+de+Loretoauthor=G.+Zeniauthor=C.+Weiblenauthor=V.+Oliveiraauthor=J.+Morais+Santurioauthor=S.+Hartz+Alves&title=In+vitro+activity+of+diphenyl+diselenide+and+ebselen+alone+and+in+combination+with+antifungal+agents+against+Trichosporon+asahii&doi=10.1111%2Fmyc.12906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Trichosporon asahii</span></div><div class="casAuthors">Felli Kubica, Thais; Bedin Denardi, Laura; Silva de Loreto, Erico; Zeni, Gilson; Weiblen, Carla; Oliveira, Vanessa; Morais Santurio, Janio; Hartz Alves, Sydney</div><div class="citationInfo"><span class="NLM_cas:title">Mycoses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-433</span>CODEN:
                <span class="NLM_cas:coden">MYCSEU</span>;
        ISSN:<span class="NLM_cas:issn">1439-0507</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : This study evaluated the in vitro susceptibility of Trichosporon asahii strains to di-Ph diselenide (DPDS) and ebselen (EBS) alone and in combination with amphotericin B (AMB), fluconazole (FCZ), itraconazole (ITZ) and caspofungin (CAS) using the microdilution method.  EBS showed in vitro activity against T asahii strains with minimal inhibitory concn. (MIC) ranged from 0.25 to 8.0 μg/mL.  For DPDS, the MIC ranged from 8.0 to 64 μg/mL.  The combinations demonstrating the greatest synergism rate against fluconazole-resistant T asahii strains were the following: CAS + DPDS (96.67%), AMB + DPDS (93.33%), FCZ + DPDS (86.67%) and ITZ + DPDS (83.33%).  The combinations AMB + DPDS and AMB + EBS exhibited the highest synergism rate against the fluconazole-susceptible (FS) T asahii strains (90%).  Antagonism was obsd. in the following combinations: FCZ + EBS (80%) and FCZ + DPDS (13.33%) against the FS strains, and ITZ + EBS (20%) against the FR strains.  Our findings suggest that the antimicrobial activity of DPDS and EBS against T. asahii and its use as an adjuvant therapy with antifungal agents warrant in vivo exptl. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxpHhPijDiybVg90H21EOLACvtfcHk0ljrnP6fS7gd2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsV2ktL8%253D&md5=75c857326f4754f1d9121b2249709437</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fmyc.12906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmyc.12906%26sid%3Dliteratum%253Aachs%26aulast%3DFelli%2BKubica%26aufirst%3DT.%26aulast%3DBedin%2BDenardi%26aufirst%3DL.%26aulast%3DSilva%2Bde%2BLoreto%26aufirst%3DE.%26aulast%3DZeni%26aufirst%3DG.%26aulast%3DWeiblen%26aufirst%3DC.%26aulast%3DOliveira%26aufirst%3DV.%26aulast%3DMorais%2BSanturio%26aufirst%3DJ.%26aulast%3DHartz%2BAlves%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520activity%2520of%2520diphenyl%2520diselenide%2520and%2520ebselen%2520alone%2520and%2520in%2520combination%2520with%2520antifungal%2520agents%2520against%2520Trichosporon%2520asahii%26jtitle%3DMycoses%26date%3D2019%26volume%3D62%26spage%3D428%26epage%3D433%26doi%3D10.1111%2Fmyc.12906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-Olivares, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span> <span> </span><span class="NLM_article-title">In vitro efficacy of ebselen and BAY 11-7082 against Naegleria fowleri</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">414</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2018.00414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3389%2Ffmicb.2018.00414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29559968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC1MnjtF2hug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=414&author=A.+Debnathauthor=A.+T.+Nelsonauthor=A.+Silva-Olivaresauthor=M.+Shibayamaauthor=D.+Siegelauthor=J.+H.+McKerrow&title=In+vitro+efficacy+of+ebselen+and+BAY+11-7082+against+Naegleria+fowleri&doi=10.3389%2Ffmicb.2018.00414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri</span></div><div class="casAuthors">Debnath Anjan; McKerrow James H; Nelson Andrew T; Siegel Dionicio; Silva-Olivares Angelica; Shibayama Mineko</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">414</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Primary amebic meningoencephalitis (PAM) is a fatal infection caused by the free-living ameba Naegleria fowleri, popularly known as the "brain-eating ameba." The drugs of choice in treating PAM are the antifungal amphotericin B and an antileishmanial miltefosine, but these are not FDA-approved for this indication and use of amphotericin B is associated with severe adverse effects.  Moreover, very few patients treated with the combination therapy have survived PAM.  Therefore, development of efficient drugs is a critical unmet need to avert future deaths of children.  Since N. fowleri causes extensive inflammation in the brain it is important to select compounds that can enter brain to kill ameba.  In this study, we identified two central nervous system (CNS) active compounds, ebselen and BAY 11-7082 as amebicidal with EC50 of 6.2 and 1.6 μM, respectively.  The closely related BAY 11-7085 was also found active against N. fowleri with EC50 similar to BAY 11-7082.  We synthesized a soluble ebselen analog, which had amebicidal activity similar to ebselen.  Transmission electron microscopy of N. fowleri trophozoites incubated for 48 h with EC50 concentration of ebselen showed alteration in the cytoplasmic membrane, loss of the nuclear membrane, and appearance of electron-dense granules.  Incubation of N. fowleri trophozoites with EC50 concentrations of BAY 11-7082 and BAY 11-7085 for 48 h showed the presence of large lipid droplets in the cytoplasm, disruption of cytoplasmic and nuclear membranes and appearance of several vesicles and chromatin residues.  Blood-brain barrier permeable amebicidal compounds have potential as new drug leads for Naegleria infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtHTTMeEPedkHdcurJClFcfW6udTcc2eY1wgj2wy0sprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnjtF2hug%253D%253D&md5=7f086c05ecaaaec5c123ae6a865f04cb</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.00414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.00414%26sid%3Dliteratum%253Aachs%26aulast%3DDebnath%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DA.%2BT.%26aulast%3DSilva-Olivares%26aufirst%3DA.%26aulast%3DShibayama%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26atitle%3DIn%2520vitro%2520efficacy%2520of%2520ebselen%2520and%2520BAY%252011-7082%2520against%2520Naegleria%2520fowleri%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D414%26doi%3D10.3389%2Ffmicb.2018.00414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ła̧czkowski, K. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motylewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranowska-Ła̧czkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernasiuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández, B.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antimicrobial evaluation and theoretical prediction of NMR chemical shifts of thiazole and selenazole derivatives with high antifungal activity against Candida spp</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1108</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2015.12.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.molstruc.2015.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyqtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1108&publication_year=2016&pages=427-437&author=K.+Z.+%C5%81a%CC%A7czkowskiauthor=K.+Motylewskaauthor=A.+Baranowska-%C5%81a%CC%A7czkowskaauthor=A.+Biernasiukauthor=K.+Misiuraauthor=A.+Malmauthor=B.+Fern%C3%A1ndez&title=Synthesis%2C+antimicrobial+evaluation+and+theoretical+prediction+of+NMR+chemical+shifts+of+thiazole+and+selenazole+derivatives+with+high+antifungal+activity+against+Candida+spp&doi=10.1016%2Fj.molstruc.2015.12.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antimicrobial evaluation and theoretical prediction of NMR chemical shifts of thiazole and selenazole derivatives with high antifungal activity against Candida spp.</span></div><div class="casAuthors">Laczkowski, Krzysztof Z.; Motylewska, Katarzyna; Baranowska-Laczkowska, Angelika; Biernasiuk, Anna; Misiura, Konrad; Malm, Anna; Fernandez, Berta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">427-437</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis and investigation of antimicrobial activities of novel (E)-thiazoles and (E)-selenazoles I (R = CH3, 4-O2NC6H4, CH2CO2CH2CH3, etc.; R1 = CO2CH2CH3, H; X = S, Se) is presented.  To support the expt., theor. calcns. of the 1H NMR shifts were carried out for representative systems within the DFT B3LYP/6-311++G** approxn. which addnl. confirmed the structure of investigated compds. I.  Among the derivs., compds. I (R = 4-FC6H4, 4-CH3C6H4, CH2CO2CH2CH3, 2,4-F2C6H3, CH3; R1 = H; X = S) Candida albicans ATCC and Candida parapsilosis ATCC 22019 with MIC = 0.49-7.81μg/mL.  In the case of compds. I (R = 4-FC6H4, 4-OCH3C6H4, 4-CH3C6H4, CH2CO2CH2CH3, CH3; R1 = H; X = S), the activity was very strong against of Candida spp. isolated from clin. materials, i.e. C. albicans, Candida krusei, Candida inconspicua, Candida famata, Candida lusitaniae, Candida sake, C. parapsilosis and Candida dubliniensis with MIC = 0.24-15.62 μg/mL.  The activity of several of these was similar to the activity of commonly used antifungal agent fluconazole.  Addnl., compds. I (R = 4-O2NC6H4, 4-FC6H4, 4-NCC6H4, 4-BrC6H4, 4-ClC6H4, 4-CH3C6H4; R1 = H; X = Se) were found to be active against Gram-pos. bacteria, both pathogenic staphylococci Staphylococcus aureus ATCC with MIC = 31.25-125 μg/mL and opportunistic bacteria, such as Staphylococcus epidermidis ATCC 12228 and Micrococcus luteus ATCC 10240 with MIC = 7.81-31.25 μg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8Dgg9VMbt0rVg90H21EOLACvtfcHk0lhGzf1ySFtmWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyqtbbJ&md5=2db5e1ca99225232159ed9fc092c5d30</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2015.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2015.12.033%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%2581a%25CC%25A7czkowski%26aufirst%3DK.%2BZ.%26aulast%3DMotylewska%26aufirst%3DK.%26aulast%3DBaranowska-%25C5%2581a%25CC%25A7czkowska%26aufirst%3DA.%26aulast%3DBiernasiuk%26aufirst%3DA.%26aulast%3DMisiura%26aufirst%3DK.%26aulast%3DMalm%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520antimicrobial%2520evaluation%2520and%2520theoretical%2520prediction%2520of%2520NMR%2520chemical%2520shifts%2520of%2520thiazole%2520and%2520selenazole%2520derivatives%2520with%2520high%2520antifungal%2520activity%2520against%2520Candida%2520spp%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2016%26volume%3D1108%26spage%3D427%26epage%3D437%26doi%3D10.1016%2Fj.molstruc.2015.12.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laczkowski, K. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biernasiuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranowska-Laczkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furgala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malm, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antimicrobial and anticonvulsant screening of small library of tetrahydro-2<i>H</i>-thiopyran-4-yl based thiazoles and selenazoles</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1080/14756366.2016.1186020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1080%2F14756366.2016.1186020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27193505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1yqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=24-39&author=K.+Z.+Laczkowskiauthor=A.+Biernasiukauthor=A.+Baranowska-Laczkowskaauthor=S.+Zielinskaauthor=K.+Salatauthor=A.+Furgalaauthor=K.+Misiuraauthor=A.+Malm&title=Synthesis%2C+antimicrobial+and+anticonvulsant+screening+of+small+library+of+tetrahydro-2H-thiopyran-4-yl+based+thiazoles+and+selenazoles&doi=10.1080%2F14756366.2016.1186020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antimicrobial and anticonvulsant screening of small library of tetrahydro-2H-thiopyran-4-yl based thiazoles and selenazoles</span></div><div class="casAuthors">Laczkowski, Krzysztof Z.; Biernasiuk, Anna; Baranowska-Laczkowska, Angelika; Zielinska, Sylwia; Salat, Kinga; Furgala, Anna; Misiura, Konrad; Malm, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup2</span>),
    <span class="NLM_cas:pages">24-39</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Synthesis and investigation of antimicrobial activity of 22 novel thiazoles and selenazoles derived from dihydro-2H-thiopyran-4(3H)-one are presented.  Addnl., anticonvulsant activity of six derivs. is examinated.  Among the derivs., some compds. have very strong activity against Candida spp. with MIC = 1.95-15.62 μg/mL.  In the case of compds. the activity is very strong against some strains of Candida spp. isolated from clin. materials, with MIC = 0.98 to 15.62 μg/mL.  Addnl., compds. are found to be active against Gram-pos. bacteria with MIC = 7.81-62.5 μg/mL.  The results of anticonvulsant screening reveal that compds. I (X = S, Se; R = F, Cl) demonstrate a statistically significant anticonvulsant activity in the pentylenetetrazole model, whereas compds. and showed protection in 6-Hz psychomotor seizure model.  Noteworthy, none of these compds. I (X = S, Se; R = F) impaired animals' motor skills in the rotarod test.  We also performed quantum chem. calcn. of interaction and binding energies in complex of I (X = S; R = F) with cyclodextrin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL5wUp_jYCmLVg90H21EOLACvtfcHk0lhGzf1ySFtmWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1yqur8%253D&md5=93fd104e2f6e0f467466cfe921d57faf</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1186020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1186020%26sid%3Dliteratum%253Aachs%26aulast%3DLaczkowski%26aufirst%3DK.%2BZ.%26aulast%3DBiernasiuk%26aufirst%3DA.%26aulast%3DBaranowska-Laczkowska%26aufirst%3DA.%26aulast%3DZielinska%26aufirst%3DS.%26aulast%3DSalat%26aufirst%3DK.%26aulast%3DFurgala%26aufirst%3DA.%26aulast%3DMisiura%26aufirst%3DK.%26aulast%3DMalm%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520antimicrobial%2520and%2520anticonvulsant%2520screening%2520of%2520small%2520library%2520of%2520tetrahydro-2H-thiopyran-4-yl%2520based%2520thiazoles%2520and%2520selenazoles%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D24%26epage%3D39%26doi%3D10.1080%2F14756366.2016.1186020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angeli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trallori, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cesare Mannelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supuran, C. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">1214</span>– <span class="NLM_lpage">1222</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.08.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2018.08.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30193219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1GksLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=1214-1222&author=A.+Angeliauthor=E.+Tralloriauthor=M.+Ferraroniauthor=L.+Di+Cesare+Mannelliauthor=C.+Ghelardiniauthor=C.+T.+Supuran&title=Discovery+of+new+2%2C+5-disubstituted+1%2C3-selenazoles+as+selective+human+carbonic+anhydrase+IX+inhibitors+with+potent+anti-tumor+activity&doi=10.1016%2Fj.ejmech.2018.08.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new 2,5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity</span></div><div class="casAuthors">Angeli, Andrea; Trallori, Elena; Ferraroni, Marta; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1214-1222</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of disubstituted selenazole derivs. was synthesized and evaluated as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors against the human (h) isoforms hCA I, II, IV, VA, VB and IX, involved in a variety of diseases including glaucoma, retinitis pigmentosa, epilepsy, arthritis and tumors.  The investigated compds. showed potent inhibition against the tumor-assocd. transmembrane hCA IX, with KIs in the subnanomolar low nanomolar range, and were evaluated for their effects on cell viability against the human prostate (PC3) and breast (MDA-MB-231) cancer cell lines, showing effective anti-tumor activity.  These selenazoles are interesting leads for the development of new, isoform-selective CA IX inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj6ye62zw6FLVg90H21EOLACvtfcHk0lhGzf1ySFtmWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1GksLbL&md5=1eff1a110f429c3792c6e01fb5aa196d</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.08.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.08.096%26sid%3Dliteratum%253Aachs%26aulast%3DAngeli%26aufirst%3DA.%26aulast%3DTrallori%26aufirst%3DE.%26aulast%3DFerraroni%26aufirst%3DM.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DDiscovery%2520of%2520new%25202%252C%25205-disubstituted%25201%252C3-selenazoles%2520as%2520selective%2520human%2520carbonic%2520anhydrase%2520IX%2520inhibitors%2520with%2520potent%2520anti-tumor%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D1214%26epage%3D1222%26doi%3D10.1016%2Fj.ejmech.2018.08.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mbaveng, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignat, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngameni, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaharia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngadjui, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuete, V.</span></span> <span> </span><span class="NLM_article-title">In vitro antibacterial activities of <i>p</i>-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypes</span>. <i>BMC Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/s40360-016-0046-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1186%2Fs40360-016-0046-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26782344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1ejtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=3&author=A.+T.+Mbavengauthor=A.+G.+Ignatauthor=B.+Ngameniauthor=V.+Zahariaauthor=B.+T.+Ngadjuiauthor=V.+Kuete&title=In+vitro+antibacterial+activities+of+p-toluenesulfonyl-hydrazinothiazoles+and+hydrazinoselenazoles+against+multi-drug+resistant+Gram-negative+phenotypes&doi=10.1186%2Fs40360-016-0046-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antibacterial activities of p-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypes</span></div><div class="casAuthors">Mbaveng, Armelle T.; Ignat, Adriana Grozav; Ngameni, Bathelemy; Zaharia, Valentin; Ngadjui, Bonaventure T.; Kuete, Victor</div><div class="citationInfo"><span class="NLM_cas:title">BMC Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3/1-3/7</span>CODEN:
                <span class="NLM_cas:coden">BPTMAB</span>;
        ISSN:<span class="NLM_cas:issn">2050-6511</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Bacterial multidrug resistance (MDR) constitutes a major hurdle in the treatment of infectious diseases worldwide.  The present study was designed to evaluate the antibacterial activities of synthetic p-toluenesulfonyl-hydrazinothiazoles against multidrug resistant Gram-neg. bacteria.  Methods: The broth microdilution method was used to det. the minimal inhibitory concns. (MIC).  Results: The results demonstrated that the best activities were obtained with hydrazinoselenazoles. p-Chlorobenzyliden- selenosemicarbazide, 4-methyl-2-[(4-chloro-benzyliden)-hydrazinyl]-1,3-selenazole, p-chloro-benzoylselenosemicarbazide and 4-chloromethyl-2-[(4-chlorobenziliden)-N-acetyl-hydrazinyl]-1,3-selenazole were more active than the choramphenicol on Klebsiella pneumoniae KP63.  Tested alone, the lowest MIC value of 16 mg/L was obtained with p-methoxy-benzyliden-selenosemicarbazide against Enterobacter aerogenes ATCC13048, K. pneumoniae ATCC112296 and KP55.  Tested in the presence of an efflux pump inhibitor, phenylalanine arginine β-naphthylamide (PÂI2N), the activity of p-chloro-benzyliden-selenosemicarbazide, 4-methyl-2-[(4-chloro-benzyliden)-hydrazinyl]-1,3-selenazole, p-chlorobenzoyl-selenosemicarbazide and p-methoxy-benzyliden-selenosemicarbazide significantly increased with MIC values below 10 mg/L obtained resp. on 43.8 %, 31.3 %, 62.5 % and 100 % of the 16 tested bacterial strains.  The lowest MIC value of 0.5 mg/L in the presence of PAβN was recorded with p-chloro-benzoyl-selenosemicarbazide against Escherichia coli ATCC8739 and KP55 as well as p-methoxybenzyliden- selenosemicarbazide against E. aerogenes KP55. p-Chloro-benzyliden-selenosemicarbazide and p-chloro-benzoyl-selenosemicarbazide contained the same pharmacophore as p-methoxy-benzylidenselenosemicarbazide.  Conclusion: This study indicates that p-chloro-benzyliden-selenosemicarbazide, p-chloro-benzoyl-selenosemicarbazide and p-methoxy-benzyliden-selenosemicarbazide could be explored more to develop novel antimicrobial drugs to fight MDR bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsv2rBBGd6GLVg90H21EOLACvtfcHk0lhNKCJmJI2tog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1ejtL8%253D&md5=5d2c32df7b38f113ba3fcbbdc25494b3</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1186%2Fs40360-016-0046-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40360-016-0046-0%26sid%3Dliteratum%253Aachs%26aulast%3DMbaveng%26aufirst%3DA.%2BT.%26aulast%3DIgnat%26aufirst%3DA.%2BG.%26aulast%3DNgameni%26aufirst%3DB.%26aulast%3DZaharia%26aufirst%3DV.%26aulast%3DNgadjui%26aufirst%3DB.%2BT.%26aulast%3DKuete%26aufirst%3DV.%26atitle%3DIn%2520vitro%2520antibacterial%2520activities%2520of%2520p-toluenesulfonyl-hydrazinothiazoles%2520and%2520hydrazinoselenazoles%2520against%2520multi-drug%2520resistant%2520Gram-negative%2520phenotypes%26jtitle%3DBMC%2520Pharmacol.%2520Toxicol.%26date%3D2016%26volume%3D17%26spage%3D3%26doi%3D10.1186%2Fs40360-016-0046-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Rubaie, A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Jadaan, S. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muslim, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Hasani, A. K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Salman, H. N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Fadal, S. A. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and antibacterial activity of some new ferrocenyl selenazoles and 3,5-diferrocenyl-1,2,4-selenadiazole</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>774</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2014.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.jorganchem.2014.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOru7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=774&publication_year=2014&pages=43-47&author=A.+Z.+Al-Rubaieauthor=S.+A.+S.+Al-Jadaanauthor=S.+K.+Muslimauthor=E.+A.+Saeedauthor=E.+T.+Aliauthor=A.+K.+J.+Al-Hasaniauthor=H.+N.+K.+Al-Salmanauthor=S.+A.+M.+Al-Fadal&title=Synthesis%2C+characterization+and+antibacterial+activity+of+some+new+ferrocenyl+selenazoles+and+3%2C5-diferrocenyl-1%2C2%2C4-selenadiazole&doi=10.1016%2Fj.jorganchem.2014.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and antibacterial activity of some new ferrocenyl selenazoles and 3,5-diferrocenyl-1,2,4-selenadiazole</span></div><div class="casAuthors">Al-Rubaie, Ali Z.; Al-Jadaan, Shaker A. S.; Muslim, Salah K.; Saeed, Eman A.; Ali, Eman T.; Al-Hasani, Amer K. J.; Al-Salman, Hussien N. K.; Al-Fadal, Sabaa A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">774</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-47</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New ferrocenyl contg. selenazole derivs. were synthesized from reactions of aryl selenocarboxamide (i.e. Ar-C:Se(NH2); Ar = C6H5 (1), 4-Br-C6H4 (2), 4-PhC6H4 (3), 4-CH3OC6H4 (4), 4-CH3SC6H4 (5), 6-MeO-naphthyl (6), 4-MeO-naphthyl (7), 4-C2H5OC6H4 (8), 3,4-(CH3O)2C6H3 (9), and 3,5-(CH3O)2C6H3 (10)) with (2-bromoacetyl)ferrocene.  The structures of the new compds. were detd. by elemental analyses, IR, 1H and 13C NMR and mass spectroscopic data.  Reaction of 1-cyanoferrocene with sodium hydrogen selenide (NaHSe) in methanol gave the new ferrocenyl selenocarboxamide (11) in 27% yield.  Treatment of compd. 11 with a catalytic amt. of Na2[PdCl4] gave 3,5-diferrocenyl-1,2,4-selenadiazole (12) in 35% yield.  Both compds. were characterized elemental analyses and spectroscopic techniques.  Compds. 1-10 and 12 were screened as antibacterial agents against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa and showed promising properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxUNr9z5IwurVg90H21EOLACvtfcHk0lhNKCJmJI2tog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOru7%252FF&md5=3c8e3ea3aeb8926cc928720b0c30a267</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2014.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Rubaie%26aufirst%3DA.%2BZ.%26aulast%3DAl-Jadaan%26aufirst%3DS.%2BA.%2BS.%26aulast%3DMuslim%26aufirst%3DS.%2BK.%26aulast%3DSaeed%26aufirst%3DE.%2BA.%26aulast%3DAli%26aufirst%3DE.%2BT.%26aulast%3DAl-Hasani%26aufirst%3DA.%2BK.%2BJ.%26aulast%3DAl-Salman%26aufirst%3DH.%2BN.%2BK.%26aulast%3DAl-Fadal%26aufirst%3DS.%2BA.%2BM.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520antibacterial%2520activity%2520of%2520some%2520new%2520ferrocenyl%2520selenazoles%2520and%25203%252C5-diferrocenyl-1%252C2%252C4-selenadiazole%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2014%26volume%3D774%26spage%3D43%26epage%3D47%26doi%3D10.1016%2Fj.jorganchem.2014.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Q.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.-L.</span></span> <span> </span><span class="NLM_article-title">Synthesis, crystal structure, and biological activity of a nickel(II) complex constructed by 2-phenyl-4-selenazole carboxylic acid and 1,10-phenanthroline</span>. <i>J. Coord. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">2605</span>– <span class="NLM_lpage">2614</span>, <span class="refDoi"> DOI: 10.1080/00958972.2013.811497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1080%2F00958972.2013.811497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlGmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=2605-2614&author=B.-B.+Xuauthor=P.+Shiauthor=Q.-Y.+Guanauthor=X.+Shiauthor=G.-L.+Zhao&title=Synthesis%2C+crystal+structure%2C+and+biological+activity+of+a+nickel%28II%29+complex+constructed+by+2-phenyl-4-selenazole+carboxylic+acid+and+1%2C10-phenanthroline&doi=10.1080%2F00958972.2013.811497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, crystal structure, and biological activity of a nickel(II) complex constructed by 2-phenyl-4-selenazole carboxylic acid and 1,10-phenanthroline</span></div><div class="casAuthors">Xu, Bao-Bao; Shi, Pei; Guan, Quan-Yin; Shi, Xia; Zhao, Guo-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Coordination Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2605-2614</span>CODEN:
                <span class="NLM_cas:coden">JCCMBQ</span>;
        ISSN:<span class="NLM_cas:issn">0095-8972</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A nickel(II) complex, [NiL(phen)2]L·5H2O (HL = 2-phenyl-4-selenazolecarboxylic acid, C10H7O2NSe, phen = 1,10-phenanthroline), was synthesized and characterized by elemental anal. and IR.  The single crystal structure was detd. by single-crystal x-ray diffraction.  C88H78N12Ni2O19Se4 crystd. in the triclinic system, space group Pi.  The interaction between the complex and the calf thymus DNA was studied by an ethidium bromide fluorescent probe.  The antibacterial activities of the complex and ligand against five species of bacteria, Escherichia coli, Staphylococcus epidermidis, Streptococcus viridans, Staphylococcus aureus and Acinetobacter baumanii, were tested.  The anticancer activities of the complex against human pancreatic cancer line PANC-28 and human hepatocarcinoma line HuH7 were also studied by employing an MTT assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6LTyswCrbl7Vg90H21EOLACvtfcHk0lhNKCJmJI2tog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlGmsrg%253D&md5=be311c28bcfa1d329f11095186249dc0</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1080%2F00958972.2013.811497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00958972.2013.811497%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DB.-B.%26aulast%3DShi%26aufirst%3DP.%26aulast%3DGuan%26aufirst%3DQ.-Y.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.-L.%26atitle%3DSynthesis%252C%2520crystal%2520structure%252C%2520and%2520biological%2520activity%2520of%2520a%2520nickel%2528II%2529%2520complex%2520constructed%2520by%25202-phenyl-4-selenazole%2520carboxylic%2520acid%2520and%25201%252C10-phenanthroline%26jtitle%3DJ.%2520Coord.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D2605%26epage%3D2614%26doi%3D10.1080%2F00958972.2013.811497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B. Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6577</span>– <span class="NLM_lpage">6579</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2013.10.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24239016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWgtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6577-6579&author=H.+C.+Zhaoauthor=Y.+P.+Shiauthor=Y.+M.+Liuauthor=C.+W.+Liauthor=L.+N.+Xuanauthor=P.+Wangauthor=K.+Zhangauthor=B.+Q.+Chen&title=Synthesis+and+antitumor-evaluation+of+1%2C3-selenazole-containing+1%2C3%2C4-thiadiazole+derivatives&doi=10.1016%2Fj.bmcl.2013.10.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives</span></div><div class="casAuthors">Zhao, Hai-Chuan; Shi, Yan-Ping; Liu, Yu-Ming; Li, Cai-Wen; Xuan, Li-Na; Wang, Peng; Zhang, Kai; Chen, Bao-Quan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6577-6579</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel 1,3-selenazole-contg. 1,3,4-thiadiazole derivs. bearing Schiff base moieties were synthesized and evaluated for their in vitro antiproliferative activities against human breast cancer cells MCF-7 and mouse lymphocytic leukemia cells L1210 by CCK-8 assay.  The majority of the compds. showed better activity against MCF-7 cells, compared with lead compd. PCS.  In particular, compd. I was the most potent compd. with IC50 value of 4.02 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZu2K02knNdbVg90H21EOLACvtfcHk0ligkzlQPjdwIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWgtLnE&md5=a770b10aca61186139aa14195e72ff03</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.062%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%2BC.%26aulast%3DShi%26aufirst%3DY.%2BP.%26aulast%3DLiu%26aufirst%3DY.%2BM.%26aulast%3DLi%26aufirst%3DC.%2BW.%26aulast%3DXuan%26aufirst%3DL.%2BN.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DB.%2BQ.%26atitle%3DSynthesis%2520and%2520antitumor-evaluation%2520of%25201%252C3-selenazole-containing%25201%252C3%252C4-thiadiazole%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6577%26epage%3D6579%26doi%3D10.1016%2Fj.bmcl.2013.10.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2015.03.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25874334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslyqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=92-97&author=M.+Zhouauthor=S.+Jiauthor=Z.+Wuauthor=Y.+Liauthor=W.+Zhengauthor=H.+Zhouauthor=T.+Chen&title=Synthesis+of+selenazolopyridine+derivatives+with+capability+to+induce+apoptosis+in+human+breast+carcinoma+MCF-7+cells+through+scavenge+of+intracellular+ROS&doi=10.1016%2Fj.ejmech.2015.03.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS</span></div><div class="casAuthors">Zhou, Meiyun; Ji, Shengbin; Wu, Zhaojun; Li, Yiqun; Zheng, Wenjie; Zhou, Hua; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-97</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of selenazolopyridine derivs. have been synthesized and characterized by X-ray diffraction, high resoln. NMR and mass spectroscopy.  The in vitro anticancer activities of the synthetic compds. were screened against a panel of human cancer cell lines, human breast carcinoma MCF-7 cells, human liver carcinoma HepG2 cells and L02 normal cell line by MTT assay.  By analyzing the structure-activity relationship among the synthetic compds., it was found that 2-(phenylamino)selenazolo[5,4-b]pyridine, (PSeD, 7) had higher growth inhibitory effect on MCF-7 cells.  The intracellular mechanism of cell death was evaluated by flow cytometric anal. and ROS assay, which revealed that PSeD could induce MCF-7 cells apoptosis by scavenging intracellular ROS (reactive oxygen species).  Taken together, the authors regard PSeD as an antioxidant which could inhibit cancer cell growth through induction of apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwHGwIiYygCrVg90H21EOLACvtfcHk0ligkzlQPjdwIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslyqurg%253D&md5=0adf84483128fa441d0c2707c52da1a2</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.069%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520selenazolopyridine%2520derivatives%2520with%2520capability%2520to%2520induce%2520apoptosis%2520in%2520human%2520breast%2520carcinoma%2520MCF-7%2520cells%2520through%2520scavenge%2520of%2520intracellular%2520ROS%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D96%26spage%3D92%26epage%3D97%26doi%3D10.1016%2Fj.ejmech.2015.03.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.-z.</span></span> <span> </span><span class="NLM_article-title">Study of the effect of molecular structure and alkyl groups bound with tin(IV) on their cytotoxicity of organotin(IV) 2-phenyl-4-selenazole carboxylates</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">102885</span>– <span class="NLM_lpage">102894</span>, <span class="refDoi"> DOI: 10.1039/C5RA18445B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC5RA18445B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWlu7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=102885-102894&author=M.+Hongauthor=Y.+Yangauthor=C.+Liauthor=L.+Xuauthor=D.+Liauthor=C.-z.+Li&title=Study+of+the+effect+of+molecular+structure+and+alkyl+groups+bound+with+tin%28IV%29+on+their+cytotoxicity+of+organotin%28IV%29+2-phenyl-4-selenazole+carboxylates&doi=10.1039%2FC5RA18445B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Study of the effect of molecular structure and alkyl groups bound with tin(IV) on their cytotoxicity of organotin(IV) 2-phenyl-4-selenazole carboxylates</span></div><div class="casAuthors">Hong, Min; Yang, Yuanguang; Li, Chuan; Xu, Lidan; Li, Dacheng; Li, Chen-zhong</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">124</span>),
    <span class="NLM_cas:pages">102885-102894</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Five organotin(IV) compds. Ph3SnL (1), (R2Sn)4O2L4 [R = n-Bu (2), n-Oct (3)], (R2Sn)4O2L2Cl2 [R = n-Bu (4), Me (5)], have been synthesized from the reactions of 2-phenyl-4-selenazole carboxylic acid (HL) with the corresponding organotin(IV) oxide or chlorides.  These compds. have been characterized by elemental anal., IR, 1H, 13C and 119Sn NMR spectroscopy, and single crystal x-ray diffraction anal.  Structural studies reveal that compd. 1 exhibits a mononuclear four-coordinated tetrahedral geometry.  Differently, the crystal structures of compds. 2-5 reveal the formation of the tetranuclear species contg. a planar Sn4O4 core.  All compds. were screened for their in vitro cytotoxic activities toward three cancer cell lines (Caco-2, A549, and HCT-116) and one normal rat hepatocyte cell line (BRL).  The results indicate that both di-n-butyltin(IV) and triphenyltin(IV) derivs. not only show excellent cytotoxic activities on cisplatin-sensitive lung cancer cell line A549 and but also exhibit good cytotoxicity against cisplatin-insensitive colon cancer cell lines HCT-116 and Caco-2.  Whereas, dimethyltin(IV) and di-n-octyltin(IV) complexes exhibit lower or no cytotoxic activity.  The structure-activity relationship of the cytotoxicity of the title complexes has also been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbBEsnQjf2g7Vg90H21EOLACvtfcHk0ligkzlQPjdwIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWlu7zI&md5=8aaa8f77727d6daaaf1f27f6b694f1e5</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1039%2FC5RA18445B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA18445B%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.-z.%26atitle%3DStudy%2520of%2520the%2520effect%2520of%2520molecular%2520structure%2520and%2520alkyl%2520groups%2520bound%2520with%2520tin%2528IV%2529%2520on%2520their%2520cytotoxicity%2520of%2520organotin%2528IV%2529%25202-phenyl-4-selenazole%2520carboxylates%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D102885%26epage%3D102894%26doi%3D10.1039%2FC5RA18445B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elshaflu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todorovic, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visnjevac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padron, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Sosa, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djordjevic, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubisic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipovic, N. R.</span></span> <span> </span><span class="NLM_article-title">Selenazolyl-hydrazones as novel selective MAO inhibitors with antiproliferative and antioxidant activities: experimental and in-silico studies</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">247</span>, <span class="refDoi"> DOI: 10.3389/fchem.2018.00247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3389%2Ffchem.2018.00247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30018949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFaisbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=247&author=H.+Elshafluauthor=T.+R.+Todorovicauthor=M.+Nikolicauthor=A.+Lolicauthor=A.+Visnjevacauthor=S.+Hagenowauthor=J.+M.+Padronauthor=A.+T.+Garcia-Sosaauthor=I.+S.+Djordjevicauthor=S.+Grubisicauthor=H.+Starkauthor=N.+R.+Filipovic&title=Selenazolyl-hydrazones+as+novel+selective+MAO+inhibitors+with+antiproliferative+and+antioxidant+activities%3A+experimental+and+in-silico+studies&doi=10.3389%2Ffchem.2018.00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Selenazolyl-hydrazones as novel selective MAO inhibitors with antiproliferative and antioxidant activities: experimental and in-silico studies</span></div><div class="casAuthors">Elshaflu, Hana; Todorovic, Tamara R.; Nikolic, Milan; Lolic, Aleksandar; Visnjevac, Aleksandar; Hagenow, Stefanie; Padron, Jose M.; Garcia-Sosa, Alfonso T.; Djordjevic, Ivana S.; Grubisic, Sonja; Stark, Holger; Filipovic, Nenad R.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247/1-247/18</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The novel approach in the treatment of complex multifactorial diseases, such as neurodegenerative disorders and cancer, requires a development of efficient multitargeting oriented drugs.  Since oxidative stress significantly contributes to the pathogenesis of cancer and neurodegenerative disorders, potential drug candidates should possess good antioxidant properties.  Due to promising biol. activities shown for structurally related (1,3-thiazol-2-yl)hydrazones, a focused library of 12 structurally related benzylidene-based (1,3-selenazol-2-yl)hydrazones was designed as potential multi-targeting compds.  Monoamine oxidases (MAO) A/B inhibition properties of this class of compds. have been investigated.  Surprisingly, the p-nitrophenyl-substituted (1,3-selenazol-2-yl)hydrazone 4 showed MAO B inhibition in a nanomolar concn. range (IC50 = 73 nM).  Excellent antioxidant properties were confirmed in a no. of different in vitro assays.  Antiproliferative activity screening on a panel of six human solid tumor cell lines showed that potencies of some of the investigated compds. was comparable or even better than that of the pos. control 5-fluorouracil.  In-silico calcns. of ADME properties pointed to promising good pharmacokinetic profiles of investigated compds.  Docking studies suggest that some compds., compared to pos. controls, have the ability to strongly interact with targets relevant to cancer such as 5'-nucleotidase, and to neurodegenerative diseases such as the small conductance calcium-activated potassium channel protein 1, in addn. to confirmation of inhibitory binding at MAO B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJcZ3XYHMw8rVg90H21EOLACvtfcHk0ligkzlQPjdwIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFaisbzF&md5=f9512cd703f6b1c05239935efdb3849f</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2018.00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2018.00247%26sid%3Dliteratum%253Aachs%26aulast%3DElshaflu%26aufirst%3DH.%26aulast%3DTodorovic%26aufirst%3DT.%2BR.%26aulast%3DNikolic%26aufirst%3DM.%26aulast%3DLolic%26aufirst%3DA.%26aulast%3DVisnjevac%26aufirst%3DA.%26aulast%3DHagenow%26aufirst%3DS.%26aulast%3DPadron%26aufirst%3DJ.%2BM.%26aulast%3DGarcia-Sosa%26aufirst%3DA.%2BT.%26aulast%3DDjordjevic%26aufirst%3DI.%2BS.%26aulast%3DGrubisic%26aufirst%3DS.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DFilipovic%26aufirst%3DN.%2BR.%26atitle%3DSelenazolyl-hydrazones%2520as%2520novel%2520selective%2520MAO%2520inhibitors%2520with%2520antiproliferative%2520and%2520antioxidant%2520activities%253A%2520experimental%2520and%2520in-silico%2520studies%26jtitle%3DFront.%2520Chem.%26date%3D2018%26volume%3D6%26spage%3D247%26doi%3D10.3389%2Ffchem.2018.00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grozav Ignat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuete, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silaghi-Dumitrescu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaharia, V.</span></span> <span> </span><span class="NLM_article-title">Microwave-assisted synthesis of new selenazole derivatives with antiproliferative activity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4679</span>– <span class="NLM_lpage">4688</span>, <span class="refDoi"> DOI: 10.3390/molecules18044679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fmolecules18044679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=23603950" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=4679-4688&author=A.+Grozav+Ignatauthor=L.+Gainaauthor=V.+Kueteauthor=L.+Silaghi-Dumitrescuauthor=T.+Efferthauthor=V.+Zaharia&title=Microwave-assisted+synthesis+of+new+selenazole+derivatives+with+antiproliferative+activity&doi=10.3390%2Fmolecules18044679"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18044679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18044679%26sid%3Dliteratum%253Aachs%26aulast%3DGrozav%2BIgnat%26aufirst%3DA.%26aulast%3DGaina%26aufirst%3DL.%26aulast%3DKuete%26aufirst%3DV.%26aulast%3DSilaghi-Dumitrescu%26aufirst%3DL.%26aulast%3DEfferth%26aufirst%3DT.%26aulast%3DZaharia%26aufirst%3DV.%26atitle%3DMicrowave-assisted%2520synthesis%2520of%2520new%2520selenazole%2520derivatives%2520with%2520antiproliferative%2520activity%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D4679%26epage%3D4688%26doi%3D10.3390%2Fmolecules18044679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and bioevaluation of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids as potent xanthine oxidase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2014.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25113879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWisrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=508-516&author=Q.+Guanauthor=Z.+Chengauthor=X.+Maauthor=L.+Wangauthor=D.+Fengauthor=Y.+Cuiauthor=K.+Baoauthor=L.+Wuauthor=W.+Zhang&title=Synthesis+and+bioevaluation+of+2-phenyl-4-methyl-1%2C3-selenazole-5-carboxylic+acids+as+potent+xanthine+oxidase+inhibitors&doi=10.1016%2Fj.ejmech.2014.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and bioevaluation of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids as potent xanthine oxidase inhibitors</span></div><div class="casAuthors">Guan, Qi; Cheng, Zengjin; Ma, Xiaoxue; Wang, Lijie; Feng, Dongjie; Cui, Yuanhang; Bao, Kai; Wu, Lan; Zhang, Weige</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">508-516</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acid derivs. were synthesized and evaluated for inhibitory activity against xanthine oxidase in vitro.  Structure-activity relationship analyses have also been presented.  Most of the target compds. exhibited potency levels in the nanomolar range.  Compd. I emerged as the most potent xanthine oxidase inhibitor (IC50 = 5.5 nM) in comparison to febuxostat (IC50 = 18.6 nM).  Steady-state kinetics measurements with the bovine milk enzyme indicated a mixed type inhibition with Ki and Ki' values of 0.9 and 2.3 nM, resp.  A mol. modeling study on compd. I was performed to gain an insight into its binding mode with xanthine oxidase, and to provide the basis for further structure-guided design of new non-purine xanthine oxidase inhibitors related with the 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acid scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrG7CUw3s7mLVg90H21EOLACvtfcHk0lgAetN93M6Lng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWisrbM&md5=92e866e1002a9d9c95e364ccd3d97e77</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520bioevaluation%2520of%25202-phenyl-4-methyl-1%252C3-selenazole-5-carboxylic%2520acids%2520as%2520potent%2520xanthine%2520oxidase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D508%26epage%3D516%26doi%3D10.1016%2Fj.ejmech.2014.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of selenazole-substituted ritonavir analogs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2379</span>– <span class="NLM_lpage">2381</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bmcl.2018.06.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29934245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2jsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2379-2381&author=J.+Qiaoauthor=C.+Zhaoauthor=J.+Liuauthor=Y.+Du&title=Design+and+synthesis+of+selenazole-substituted+ritonavir+analogs&doi=10.1016%2Fj.bmcl.2018.06.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of selenazole-substituted ritonavir analogs</span></div><div class="casAuthors">Qiao, Junfei; Zhao, Chuanfang; Liu, Jun; Du, Yuguo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2379-2381</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the help of Surflex-Dock calcn., two ritonavir analogs, e.g., I, in which one thiazole unit was replaced by selenazole have been designed and synthesized.  The key selenazole structure was constructed from β-azido diselenide through a cascade diselenide cleavage/selenocarbonylation/Staudinger redn./aza-Wittig reaction and a following MnO2 oxidn.  The accordingly prepd. compds. exhibited good anti-HIV-1 (IIIB) activities comparable to that of the original ritonavir, as well as the pos. SI values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsmxZHbCK-7Vg90H21EOLACvtfcHk0lgAetN93M6Lng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2jsrvJ&md5=b8c3fae632acadbd15e74d6f50291a1a</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520selenazole-substituted%2520ritonavir%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2379%26epage%3D2381%26doi%3D10.1016%2Fj.bmcl.2018.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Desoky, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badria, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abozeid, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandeel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, A. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antitumor studies of novel benzopyrano-1,2,3-selenadiazole and spiro[benzopyrano]-1,3,4-thiadiazoline derivatives</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2105</span>– <span class="NLM_lpage">2114</span>, <span class="refDoi"> DOI: 10.1007/s00044-012-0201-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs00044-012-0201-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Omu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=2105-2114&author=S.+I.+El-Desokyauthor=F.+A.+Badriaauthor=M.+A.+Abozeidauthor=E.+A.+Kandeelauthor=A.+H.+Abdel-Rahman&title=Synthesis+and+antitumor+studies+of+novel+benzopyrano-1%2C2%2C3-selenadiazole+and+spiro%5Bbenzopyrano%5D-1%2C3%2C4-thiadiazoline+derivatives&doi=10.1007%2Fs00044-012-0201-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antitumor studies of novel benzopyrano-1,2,3-selenadiazole and spiro[benzopyrano]-1,3,4-thiadiazoline derivatives</span></div><div class="casAuthors">El-Desoky, S. I.; Badria, F. A.; Abozeid, M. A.; Kandeel, E. A.; Abdel-Rahman, A. H.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2105-2114</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">A convenient and efficient synthetic protocol toward new selenadiazole and thiadiazoline derivs. incorporating a benzopyranone moiety from readily available starting materials was described.  The reaction of different 2,2-dialkyl and 2,2-spirocycloalkyl dihydrobenzopyranones I [R1 = R2 = Me; R1 = Me, R2 = Et; R1, R2 = (CH2)4, (CH2)5, (CH2)6] with semicarbazide hydrochloride and thiosemicarbazide afforded the corresponding semicarbazones and thiosemicarbazones, resp.  Furthermore, cyclization of the semicarbazones via oxidn. using selenium dioxide gave a novel series of chromenoselenadiazoles II.  A series of spirobenzopyrano-1,3,4-thiadiazolines III was synthesized by refluxing the thiosemicarbazones in acetic anhydride.  The synthesized compds. were tested in vitro against four cancer cell lines namely: MCF-7, VERO, WI-38, and HEPG-2.  In vivo studies were also performed using Ehrlich ascites carcinoma for antitumor activity.  Interestingly, compds. II (R1 = Me, R2 = Et) and III (R1 = R2 = Me) showed significant antitumor activities and were capable of improving the hematol. parameters as well as increasing the mean survival time of the mice bearing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8rTy3CTTnrbVg90H21EOLACvtfcHk0lhspuvHIeo1gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Omu73F&md5=7332f8e3b483eedc73c7c3c6d9cb9b54</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1007%2Fs00044-012-0201-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-012-0201-0%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Desoky%26aufirst%3DS.%2BI.%26aulast%3DBadria%26aufirst%3DF.%2BA.%26aulast%3DAbozeid%26aufirst%3DM.%2BA.%26aulast%3DKandeel%26aufirst%3DE.%2BA.%26aulast%3DAbdel-Rahman%26aufirst%3DA.%2BH.%26atitle%3DSynthesis%2520and%2520antitumor%2520studies%2520of%2520novel%2520benzopyrano-1%252C2%252C3-selenadiazole%2520and%2520spiro%255Bbenzopyrano%255D-1%252C3%252C4-thiadiazoline%2520derivatives%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D2105%26epage%3D2114%26doi%3D10.1007%2Fs00044-012-0201-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasinszki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzsotján, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajgut, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zupkó, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csámpai, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, spectral- and theoretical study, x-ray analysis, and antiproliferative activity of 4,5-dihydrobenzoferroceno[1,2-<i>d</i>][1,2,3]selenadiazole and its benzo-fused analogue</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>863</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2018.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.jorganchem.2018.03.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslKlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=863&publication_year=2018&pages=70-76&author=T.+Pasinszkiauthor=D.+Dzsotj%C3%A1nauthor=G.+G.+Lajgutauthor=V.+Harmatauthor=A.+Borauthor=I.+Zupk%C3%B3author=A.+Cs%C3%A1mpai&title=Synthesis%2C+spectral-+and+theoretical+study%2C+x-ray+analysis%2C+and+antiproliferative+activity+of+4%2C5-dihydrobenzoferroceno%5B1%2C2-d%5D%5B1%2C2%2C3%5Dselenadiazole+and+its+benzo-fused+analogue&doi=10.1016%2Fj.jorganchem.2018.03.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, spectral- and theoretical study, x-ray analysis, and antiproliferative activity of 4,5-dihydrobenzoferroceno[1,2-d][1,2,3]selenadiazole and its benzo-fused analogue</span></div><div class="casAuthors">Pasinszki, Tibor; Dzsotjan, Daniel; Lajgut, Gyozo Gyorgy; Harmat, Veronika; Bor, Andrea; Zupko, Istvan; Csampai, Antal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">863</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-76</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Synthesis, structure detn., and in vitro antiproliferative effect of 4,5-dihydronaphto[1,2-d][1,2,3]selenadiazole (1) and 4,5-dihydrobenzoferroceno[1,2-d][1,2,3]selenadiazole (2) are presented.  The synthesized mols. were characterized by NMR, IR, Raman, mass, and UV spectroscopies.  The equil. structures of 1 and 2 were calcd. using the B3LYP/6-31+G* quantum-chem. method, and the solid phase structure of 2 was detd. by single crystal X-ray diffraction.  The antiproliferative effect of 1 and 2 was investigated against three tumorous human cell lines.  Both compds. were active against cervical HeLa and ovarian A2780 cell lines, and 2 was also active against breast MDA-MB-231 cell growth.  The ferrocene deriv. 2 was found to be more effective than its org. analog 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvw9kSRyp6L7Vg90H21EOLACvtfcHk0lhspuvHIeo1gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslKlsLo%253D&md5=18d17dd70ce428ee27a0b98b9e6095ff</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2018.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2018.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DPasinszki%26aufirst%3DT.%26aulast%3DDzsotj%25C3%25A1n%26aufirst%3DD.%26aulast%3DLajgut%26aufirst%3DG.%2BG.%26aulast%3DHarmat%26aufirst%3DV.%26aulast%3DBor%26aufirst%3DA.%26aulast%3DZupk%25C3%25B3%26aufirst%3DI.%26aulast%3DCs%25C3%25A1mpai%26aufirst%3DA.%26atitle%3DSynthesis%252C%2520spectral-%2520and%2520theoretical%2520study%252C%2520x-ray%2520analysis%252C%2520and%2520antiproliferative%2520activity%2520of%25204%252C5-dihydrobenzoferroceno%255B1%252C2-d%255D%255B1%252C2%252C3%255Dselenadiazole%2520and%2520its%2520benzo-fused%2520analogue%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2018%26volume%3D863%26spage%3D70%26epage%3D76%26doi%3D10.1016%2Fj.jorganchem.2018.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiproliferative activity of 17-[1′,2′,3′]-selenadiazolylpregnenolone compounds</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.steroids.2018.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.steroids.2018.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30296550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFyrsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=151-158&author=J.+Cuiauthor=L.+Pangauthor=M.+Weiauthor=C.+Ganauthor=D.+Liuauthor=H.+Yuanauthor=Y.+Huang&title=Synthesis+and+antiproliferative+activity+of+17-%5B1%E2%80%B2%2C2%E2%80%B2%2C3%E2%80%B2%5D-selenadiazolylpregnenolone+compounds&doi=10.1016%2Fj.steroids.2018.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiproliferative activity of 17-[1',2',3']-selenadiazolylpregnenolone compounds</span></div><div class="casAuthors">Cui, Jianguo; Pang, Liping; Wei, Meizhen; Gan, Chunfang; Liu, Dandan; Yuan, Haiyan; Huang, Yanmin</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-158</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Using pregnenolone as a starting material, some 3-substituted 17-[1',2',3']-selenadiazolylpregnenolone derivs. I (R = COEt, 2-MeC6H4CO, 2-furylcarbonyl, etc.) were synthesized, and their structures were characterized by IR, NMR and HRMS.  The in vitro antitumor activity of the compds. was assayed against PC-3,SKOV3,T47D,MCF-7 and HEK293T cell lines.  The results show that some compds. display selective antiproliferative activity against PC-3 and SKOV3 cells lines and are almost inactive to normal kidney epithelial cells (HEK293T).  The IC50 value are much better than that of abiraterone (pos. control).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3opwhNL9Cm7Vg90H21EOLACvtfcHk0lhspuvHIeo1gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFyrsLzM&md5=779af7d3db9f4b83d1fcc82e52e68d55</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.steroids.2018.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.steroids.2018.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DGan%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520antiproliferative%2520activity%2520of%252017-%255B1%25E2%2580%25B2%252C2%25E2%2580%25B2%252C3%25E2%2580%25B2%255D-selenadiazolylpregnenolone%2520compounds%26jtitle%3DSteroids%26date%3D2018%26volume%3D140%26spage%3D151%26epage%3D158%26doi%3D10.1016%2Fj.steroids.2018.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mhaidat, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Smadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Momani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzoubi, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Balas, Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antimicrobial and in vitro antitumor activities of a series of 1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3645</span>– <span class="NLM_lpage">3652</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S86054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2147%2FDDDT.S86054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26316694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=3645-3652&author=N.+M.+Mhaidatauthor=M.+Al-Smadiauthor=F.+Al-Momaniauthor=K.+H.+Alzoubiauthor=I.+Mansiauthor=Q.+Al-Balas&title=Synthesis%2C+antimicrobial+and+in+vitro+antitumor+activities+of+a+series+of+1%2C2%2C3-thiadiazole+and+1%2C2%2C3-selenadiazole+derivatives&doi=10.2147%2FDDDT.S86054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antimicrobial and in vitro antitumor activities of a series of 1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives</span></div><div class="casAuthors">Mhaidat, Nizar M.; Al-Smadi, Mousa; Al-Momani, Fouad; Alzoubi, Karem H.; Mansi, Iman; Al-Balas, Qosay</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3645-3652</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Three derivs. of substituted 1,2,3-thia- or 1,2,3-selenadiazole (4a-c) were prepd. and characterized by different chem. techniques.  These compds. were evaluated for their antimicrobial and antitumor activities.  Compds. 4a (propenoxide deriv.), 4b (carbaldehyde deriv.), and 4c (benzene deriv.) were active against the yeast-like fungi Candida albicans.  Compd. 4a was active against gram-neg. Escherichia coli, and compd. 4c was active against the gram-pos. Staphylococcus aureus.  For the antitumor activity, both compds. 4b and 4c were active against all tested tumor cell lines, namely, SW480, HCT116, C32, MV3, HMT3522, and MCF-7.  The activity of compd. 4c was greater than that of compd. 4b and more than that of the ref. antitumor 5-flourouracil against the SW480, HCT116, and MCF-7 tumor cell lines.  In conclusion, a no. of the prepd. 1,2,3-thia- or 1,2,3-selenadiazole compds. showed promising antifungal, antibacterial, and in vitro antitumor activities.  Further investigations are required to explore the mechanism by which active compd. are inducing their cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJIbr8k_CXJ7Vg90H21EOLACvtfcHk0lhspuvHIeo1gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVOhtL8%253D&md5=0a49f60bfdd91e42dd7c02c95e38881c</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S86054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S86054%26sid%3Dliteratum%253Aachs%26aulast%3DMhaidat%26aufirst%3DN.%2BM.%26aulast%3DAl-Smadi%26aufirst%3DM.%26aulast%3DAl-Momani%26aufirst%3DF.%26aulast%3DAlzoubi%26aufirst%3DK.%2BH.%26aulast%3DMansi%26aufirst%3DI.%26aulast%3DAl-Balas%26aufirst%3DQ.%26atitle%3DSynthesis%252C%2520antimicrobial%2520and%2520in%2520vitro%2520antitumor%2520activities%2520of%2520a%2520series%2520of%25201%252C2%252C3-thiadiazole%2520and%25201%252C2%252C3-selenadiazole%2520derivatives%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2015%26volume%3D9%26spage%3D3645%26epage%3D3652%26doi%3D10.2147%2FDDDT.S86054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthusubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manisankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yogeeswari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, D.</span></span> <span> </span><span class="NLM_article-title">A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5465</span>– <span class="NLM_lpage">5472</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2011.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=21937152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=5465-5472&author=S.+Chitraauthor=N.+Paulauthor=S.+Muthusubramanianauthor=P.+Manisankarauthor=P.+Yogeeswariauthor=D.+Sriram&title=A+facile+synthesis+of+carbocycle-fused+mono+and+bis-1%2C2%2C3-selenadiazoles+and+their+antimicrobial+and+antimycobacterial+studies&doi=10.1016%2Fj.ejmech.2011.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies</span></div><div class="casAuthors">Chitra, Selvam; Paul, Nidhin; Muthusubramanian, Shanmugam; Manisankar, Paramasivam; Yogeeswari, Perumal; Sriram, Dharmarajan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5465-5472</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of mono and bis-1,2,3-selenadiazole derivs. have been synthesized by the oxidative cyclization of mono and bis semicarbazones of 2-(3-oxo-1,3-diarylpropyl)-1-cyclohexanones using selenium(IV) oxide.  The newly synthesized compds. were evaluated for their in vitro antimicrobial activity against Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 11632) and Candida albicans (ATCC 90028) and in vitro antituberculosis activity against Mycobacterium tuberculosis H37Rv (MTB).  Among these compds., 1,3-di(4-chlorophenyl)-3-(4,5,6,7-tetrahydro-1,2,3-benzoselenadiazol-4-yl)-1-propanone (I) and 3-(4-chlorophenyl)-1-(4-methylphenyl)-3-(4,5,6,7-tetrahydro-1,2,3-benzoselenadiazol-4-yl)-1-propanone (II) were found to be the most active compds. with MIC of 3.3 and 3.5 μM resp. against MTB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiW3wG8fhBBbVg90H21EOLACvtfcHk0ljYKt9ty_GTXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKktbfL&md5=e8be5da7844cf7e6605a07326bdbe1d8</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DChitra%26aufirst%3DS.%26aulast%3DPaul%26aufirst%3DN.%26aulast%3DMuthusubramanian%26aufirst%3DS.%26aulast%3DManisankar%26aufirst%3DP.%26aulast%3DYogeeswari%26aufirst%3DP.%26aulast%3DSriram%26aufirst%3DD.%26atitle%3DA%2520facile%2520synthesis%2520of%2520carbocycle-fused%2520mono%2520and%2520bis-1%252C2%252C3-selenadiazoles%2520and%2520their%2520antimicrobial%2520and%2520antimycobacterial%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D5465%26epage%3D5472%26doi%3D10.1016%2Fj.ejmech.2011.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S. J.</span></span> <span> </span><span class="NLM_article-title">Aerobic radical-cascade cycloaddition of isocyanides, selenium and imidamides: facile access to 1,2,4-selenadiazoles under metal-free conditions</span>. <i>Green Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1618</span>, <span class="refDoi"> DOI: 10.1039/C6GC03521C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC6GC03521C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFSh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=1613-1618&author=Y.+Fangauthor=Z.+L.+Zhuauthor=P.+Xuauthor=S.+Y.+Wangauthor=S.+J.+Ji&title=Aerobic+radical-cascade+cycloaddition+of+isocyanides%2C+selenium+and+imidamides%3A+facile+access+to+1%2C2%2C4-selenadiazoles+under+metal-free+conditions&doi=10.1039%2FC6GC03521C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Aerobic radical-cascade cycloaddition of isocyanides, selenium and imidamides: facile access to 1,2,4-selenadiazoles under metal-free conditions</span></div><div class="casAuthors">Fang, Yi; Zhu, Zheng-Lin; Xu, Pei; Wang, Shun-Yi; Ji, Shun-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Green Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1613-1618</span>CODEN:
                <span class="NLM_cas:coden">GRCHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9262</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel and facile metal-free method for the green synthesis of 1,2,4-selenadiazol-5-amine derivs. through the aerobic radical-cascade multi-component reactions of isocyanides, Se powder and imidamides is reported herein.  O2 in the air was employed as the green oxidant to achieve the cycloaddn. with the generation of H2O as the sole byproduct.  It also features good functional group compatibility and broad substrate scope.  This method was successfully applied to the functionalization of biol. active mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpixL1HwwEg5rVg90H21EOLACvtfcHk0ljYKt9ty_GTXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFSh&md5=ce31f224bc99c8058a8459590758cf1b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1039%2FC6GC03521C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6GC03521C%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%2BL.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%2BY.%26aulast%3DJi%26aufirst%3DS.%2BJ.%26atitle%3DAerobic%2520radical-cascade%2520cycloaddition%2520of%2520isocyanides%252C%2520selenium%2520and%2520imidamides%253A%2520facile%2520access%2520to%25201%252C2%252C4-selenadiazoles%2520under%2520metal-free%2520conditions%26jtitle%3DGreen%2520Chem.%26date%3D2017%26volume%3D19%26spage%3D1613%26epage%3D1618%26doi%3D10.1039%2FC6GC03521C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Putta, V. P. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujjarappa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vodnala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malakar, C. C.</span></span> <span> </span><span class="NLM_article-title">The facile and efficient organocatalytic platform for accessing 1,2,4-selenadiazoles and thiadiazoles under aerobic conditions</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">908</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2018.01.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.tetlet.2018.01.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFaqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=904-908&author=V.+P.+R.+K.+Puttaauthor=R.+Gujjarappaauthor=N.+Vodnalaauthor=R.+Guptaauthor=P.+P.+Pujarauthor=C.+C.+Malakar&title=The+facile+and+efficient+organocatalytic+platform+for+accessing+1%2C2%2C4-selenadiazoles+and+thiadiazoles+under+aerobic+conditions&doi=10.1016%2Fj.tetlet.2018.01.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The facile and efficient organocatalytic platform for accessing 1,2,4-selenadiazoles and thiadiazoles under aerobic conditions</span></div><div class="casAuthors">Putta, V. P. Rama Kishore; Gujjarappa, Raghuram; Vodnala, Nagaraju; Gupta, Richa; Pujar, Prasad P.; Malakar, Chandi C.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">904-908</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The organocatalytic approach towards synthesis of rarely explored 1,2,4-selenadiazole and thiadiazole scaffolds have been devised using corresponding carboxamides as substrates.  The transformations were realized using two distinct conditions in the presence of catalytic vitamin B3 or thiourea under aerobic conditions.  Developed methods overcome the assocd. limitations of previous reported approaches and the desired products were obtained in high yields and selectivity without the formation of toxic side-products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIUtmH00zBYrVg90H21EOLACvtfcHk0ljYKt9ty_GTXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFaqsrs%253D&md5=4cac323979eab5a6bcb3adc11cc7d3c4</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2018.01.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2018.01.063%26sid%3Dliteratum%253Aachs%26aulast%3DPutta%26aufirst%3DV.%2BP.%2BR.%2BK.%26aulast%3DGujjarappa%26aufirst%3DR.%26aulast%3DVodnala%26aufirst%3DN.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DPujar%26aufirst%3DP.%2BP.%26aulast%3DMalakar%26aufirst%3DC.%2BC.%26atitle%3DThe%2520facile%2520and%2520efficient%2520organocatalytic%2520platform%2520for%2520accessing%25201%252C2%252C4-selenadiazoles%2520and%2520thiadiazoles%2520under%2520aerobic%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2018%26volume%3D59%26spage%3D904%26epage%3D908%26doi%3D10.1016%2Fj.tetlet.2018.01.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. F.</span></span> <span> </span><span class="NLM_article-title">Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">8383</span>– <span class="NLM_lpage">8393</span>, <span class="refDoi"> DOI: 10.1039/C5TB01501D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC5TB01501D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2jt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=8383-8393&author=L.+Z.+Heauthor=S.+B.+Jiauthor=H.+Q.+Laiauthor=T.+F.+Chen&title=Selenadiazole+derivatives+as+theranostic+agents+for+simultaneous+cancer+chemo-%2Fradiotherapy+by+targeting+thioredoxin+reductase&doi=10.1039%2FC5TB01501D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase</span></div><div class="casAuthors">He, Lizhen; Ji, Shengbin; Lai, Haoqiang; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">8383-8393</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The lack of early and timely diagnosis of tumors and the monitoring of their response to therapeutics have limited the successful cancer treatments.  Theranostic agents are expected to realize the dual-purpose of simultaneous diagnosis and therapy for treatments of cancers.  In the present study, the authors have examd. the effects of the chem. structure of selenadiazole derivs. (SeDs) on their anticancer efficacy and radio-sensitization against clin. used X-rays.  The results showed that the introduction of a nitro group (-NO2) into SeD-3 significantly enhanced the anticancer activity of SeDs.  The higher lipophilicity endowed SeD-3 with higher cellular internalization ability, resulting in higher cellular uptake and anticancer efficacy.  Specifically, the capacity of autofluorescence allowed the use of SeD-3 as a promising theranostic agent to directly monitor the cellular uptake, localization and biodistribution in vitro and in vivo.  Interestingly, SeD-3 also significantly enhanced the sensitivity of HeLa cervical cells to x-ray-induced apoptosis by targeting the inhibition of TrxR and promoting intracellular ROS overprodn., which activated the downstream ROS-mediated signaling pathways to regulate cell apoptosis.  Furthermore, SeD-3 exhibited satisfactory in vivo antitumor efficacy through the inhibition of tumor proliferation and induction of tumor cell apoptosis, and showed no toxicity to the main organs.  Moreover, from the results of hematol. anal., the authors found that not only inhibiting the tumor growth, treatment of SeD-3 also alleviated the damage of liver, kidney and heart function of nude mice induced by HeLa xenografts.  Taken together, this study demonstrates that SeDs could be further developed as an effective and safe theranostic agent for simultaneous cancer chemo-/radiotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR7PLmYlgGo7Vg90H21EOLACvtfcHk0lgAmdPJzJd1tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2jt7fN&md5=b95cb48e9e6f658410f2d847e5d22df6</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1039%2FC5TB01501D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5TB01501D%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%2BZ.%26aulast%3DJi%26aufirst%3DS.%2BB.%26aulast%3DLai%26aufirst%3DH.%2BQ.%26aulast%3DChen%26aufirst%3DT.%2BF.%26atitle%3DSelenadiazole%2520derivatives%2520as%2520theranostic%2520agents%2520for%2520simultaneous%2520cancer%2520chemo-%252Fradiotherapy%2520by%2520targeting%2520thioredoxin%2520reductase%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2015%26volume%3D3%26spage%3D8383%26epage%3D8393%26doi%3D10.1039%2FC5TB01501D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of cancer-targeted benzoselenadiazole by RGD peptide functionalization for cancer theranostics</span>. <i>Macromol. Rapid Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1565</span>, <span class="refDoi"> DOI: 10.1002/marc.201500243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fmarc.201500243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26205253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=1559-1565&author=L.+Yangauthor=W.+Liauthor=Y.+Huangauthor=Y.+Zhouauthor=T.+Chen&title=Rational+design+of+cancer-targeted+benzoselenadiazole+by+RGD+peptide+functionalization+for+cancer+theranostics&doi=10.1002%2Fmarc.201500243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Cancer-Targeted Benzoselenadiazole by RGD Peptide Functionalization for Cancer Theranostics</span></div><div class="casAuthors">Yang, Liye; Li, Wenying; Huang, Yanyu; Zhou, Yangliang; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Macromolecular Rapid Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1559-1565</span>CODEN:
                <span class="NLM_cas:coden">MRCOE3</span>;
        ISSN:<span class="NLM_cas:issn">1022-1336</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A cancer-targeted conjugate of the selenadiazole deriv. BSeC (benzo[1,2,5] selenadiazole-5-carboxylic acid) with RGD peptide as targeting mol. and PEI (polyethylenimine) as a linker is rationally designed and synthesized in the present study.  The results show that RGD-PEI-BSeC forms nanoparticles in aq. soln. with a core-shell nanostructure and high stability under physiol. conditions.  This rational design effectively enhances the selective cellular uptake and cellular retention of BSeC in human glioma cells, and increases its selectivity between cancer and normal cells.  The nanoparticles enter the cells through receptor-mediated endocytosis via clathrin-mediated and nystatin-dependent lipid raft-mediated pathways.  Internalized nanoparticles trigger glioma cell apoptosis by activation of ROS-mediated p53 phosphorylation.  Therefore, this study provides a strategy for the rational design of selenium-contg. cancer-targeted theranostics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-AIge-_cZcrVg90H21EOLACvtfcHk0lgAmdPJzJd1tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7fI&md5=a78aeec5a1dce6406ef0063567ef2218</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fmarc.201500243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmarc.201500243%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520cancer-targeted%2520benzoselenadiazole%2520by%2520RGD%2520peptide%2520functionalization%2520for%2520cancer%2520theranostics%26jtitle%3DMacromol.%2520Rapid%2520Commun.%26date%3D2015%26volume%3D36%26spage%3D1559%26epage%3D1565%26doi%3D10.1002%2Fmarc.201500243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">You, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. F.</span></span> <span> </span><span class="NLM_article-title">Tailored mesoporous silica nanosystem with enhanced permeability of the blood-brain barrier to antagonize glioblastoma</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">5980</span>– <span class="NLM_lpage">5990</span>, <span class="refDoi"> DOI: 10.1039/C6TB01329E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC6TB01329E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlagt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=5980-5990&author=Y.+Y.+Youauthor=L.+Y.+Yangauthor=L.+Z.+Heauthor=T.+F.+Chen&title=Tailored+mesoporous+silica+nanosystem+with+enhanced+permeability+of+the+blood-brain+barrier+to+antagonize+glioblastoma&doi=10.1039%2FC6TB01329E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Tailored mesoporous silica nanosystem with enhanced permeability of the blood-brain barrier to antagonize glioblastoma</span></div><div class="casAuthors">You, Yuanyuan; Yang, Liye; He, Lizhen; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">5980-5990</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cancer-targeted drug delivery systems with permeability of the blood-brain barrier (BBB) have become of great interest for the rational design of high-efficiency anticancer agents.  Herein, a tailored mesoporous silica nanoparticles (MSNs) nanosystem modified by RGD (arginine-glycine-aspartate) peptide was designed and tested for use as a carrier of anticancer agents, by using a novel org. selenium compd. BSeC as a model mol.  As expected, the nanosystem (<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="5b19083e181b1608152876091c1f">[email protected]</a>) could effectively enhance the BBB permeability and the cellular uptake of BSeC in tumor cells.  The internalized <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="2f6d7c4a6c6f627c615c027d686b">[email protected]</a> triggered mitochondrial dysfunction and intracellular ROS overprodn., which subsequently activated the p53 and MAPKs pathways.  Moreover, the nanosystem could inhibit the U87 tumor spheroids growth, significantly prolong the blood circulation time of the loaded drug in vivo and effectively reduce its in vivo toxicity.  Taken together, this study provides a strategy for the rational design of a tailored nanomedicine with enhanced BBB permeability to treat human brain glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYh8vbM-J0rVg90H21EOLACvtfcHk0lgAmdPJzJd1tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlagt7zJ&md5=99981b0ea66fe23be780a80675ca9cb6</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1039%2FC6TB01329E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6TB01329E%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DY.%2BY.%26aulast%3DYang%26aufirst%3DL.%2BY.%26aulast%3DHe%26aufirst%3DL.%2BZ.%26aulast%3DChen%26aufirst%3DT.%2BF.%26atitle%3DTailored%2520mesoporous%2520silica%2520nanosystem%2520with%2520enhanced%2520permeability%2520of%2520the%2520blood-brain%2520barrier%2520to%2520antagonize%2520glioblastoma%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2016%26volume%3D4%26spage%3D5980%26epage%3D5990%26doi%3D10.1039%2FC6TB01329E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. F.</span></span> <span> </span><span class="NLM_article-title">Enhancement of cell uptake and antitumor activity of selenadiazole derivatives through interaction and delivery by serum albumin</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">16721</span>– <span class="NLM_lpage">16729</span>, <span class="refDoi"> DOI: 10.1039/C6RA28801D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC6RA28801D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlKmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=16721-16729&author=S.+L.+Dengauthor=D.+L.+Zengauthor=Y.+Luoauthor=J.+F.+Zhaoauthor=X.+L.+Liauthor=Z.+N.+Zhaoauthor=T.+F.+Chen&title=Enhancement+of+cell+uptake+and+antitumor+activity+of+selenadiazole+derivatives+through+interaction+and+delivery+by+serum+albumin&doi=10.1039%2FC6RA28801D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of cell uptake and antitumor activity of selenadiazole derivatives through interaction and delivery by serum albumin</span></div><div class="casAuthors">Deng, Shulin; Zeng, Delong; Luo, Yi; Zhao, Jianfu; Li, Xiaoling; Zhao, Zhennan; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">16721-16729</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Serum albumin is an important carrier in the transport of endogenous and exogenous substances across cell membranes.  Small mol. drugs could bind to serum albumin to various extents after i.v. injection, which may affect the bioavailability, metab., pharmacol. and toxicol. potency.  Org. selenium (Se) compds. exhibit favorable biocompatibility and low toxicity that attracts increased attention from researchers.  Herein, a series of selenadiazole derivs. (4a-e) have been synthesized and their cytotoxicity towards various kinds of cells were evaluated.  The results suggested that iso-Pr benzo[c][1,2,5]selenadiazole-5-carboxylate (4d) exhibited a broad inhibition spectrum on the proliferation of tested cancer cells, with a relatively higher anticancer activity than other derivs.  We found that the differences in their anticancer activities were attributed to the various binding abilities of the Se compds. toward BSA.  The bimol. quenching const. (Kq), apparent quenching const. (KSV), effective binding const. (KA) and binding site no. (n) were obtained through fluorescence quenching calcns., which indicated that all compds. could efficiently bind to BSA mols. and the fluorescence quenching mechanism was mainly a static quenching procedure.  Moreover, serum albumin was found to interact with selenadiazole derivs. (4a-e), thus promoting the cellular uptake and anticancer activity of the Se compds.  Taken together, this study demonstrated that the synthetic selenadiazole derivs. exhibited high anticancer activity and cellular uptake through delivery by human serum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhLL-UzNjjbbVg90H21EOLACvtfcHk0lgAmdPJzJd1tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlKmsbo%253D&md5=1fa5f893acc43c375fcfacec0be292e4</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1039%2FC6RA28801D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA28801D%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DS.%2BL.%26aulast%3DZeng%26aufirst%3DD.%2BL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%2BF.%26aulast%3DLi%26aufirst%3DX.%2BL.%26aulast%3DZhao%26aufirst%3DZ.%2BN.%26aulast%3DChen%26aufirst%3DT.%2BF.%26atitle%3DEnhancement%2520of%2520cell%2520uptake%2520and%2520antitumor%2520activity%2520of%2520selenadiazole%2520derivatives%2520through%2520interaction%2520and%2520delivery%2520by%2520serum%2520albumin%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D16721%26epage%3D16729%26doi%3D10.1039%2FC6RA28801D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruberte, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Encio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aydillo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartin, C.</span></span> <span> </span><span class="NLM_article-title">Novel selenadiazole derivatives as selective antitumor and radical scavenging agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.07.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2018.07.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30071406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWqsLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=14-27&author=A.+C.+Ruberteauthor=D.+Planoauthor=I.+Encioauthor=C.+Aydilloauthor=A.+K.+Sharmaauthor=C.+Sanmartin&title=Novel+selenadiazole+derivatives+as+selective+antitumor+and+radical+scavenging+agents&doi=10.1016%2Fj.ejmech.2018.07.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selenadiazole derivatives as selective antitumor and radical scavenging agents</span></div><div class="casAuthors">Ruberte, Ana Carolina; Plano, Daniel; Encio, Ignacio; Aydillo, Carlos; Sharma, Arun K.; Sanmartin, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14-27</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Twenty-seven novel benzo[c][1,2,5]selenadiazole-5-carboxylic acid (BSCA) derivs. I [R = Ph, 2-thiazolyl, 4-MeC6H4, etc.; n = 0, 1, 2, 3, 4] were designed and synthesized.  Anti-proliferative activity of these structures was tested in vitro against a panel of five human cancer cell lines, including prostate (PC-3), colon (HT-29), leukemia (CCRF-CEM), lung (HTB-54) and breast (MCF-7).  Four compds. I [R = 4-MeOC6H4, 4-MeSC6H4, 4-MeSeC6H4, 2-benzothiazolyl; n = 0] showed potent inhibitory activity with GI50 values below 10μM in at least one of the cancer cell lines.  The selectivity of these compds. was further examd. in two non-malignant cell lines derived from breast (184B5) and lung (BEAS-2B).  Compd. I [R = 4-MeSeC6H4; n = 0] exhibited promising anti-proliferative activity (GI50=3.7μM) in MCF-7cells, together with high selectivity index (SI>27.1).  The induction of cell death by compd. I [R = 4-MeSeC6H4; n = 0] was independent of the apoptotic process and it did not affect cell cycle progression either.  Likewise, radical scavenging properties of the new selenadiazole derivs. I were confirmed by testing their ability to scavenge DPPH radicals.  Four compds. I [R = Ph, 4-MeC6H4, 4-HSC6H4, 4-HSeC6H4; n = 0] showed potent radical scavenging activity, compd. I [R = 4-HSC6H4; n = 0] being the most effective.  Overall, while compd. I [R = 4-MeSeC6H4; n = 0] was identified as the most cell growth inhibitory agent and selectively toxic to cancer cells, compd. I [R = 4-HSC6H4; n = 0] proved to be the most potent antioxidant among the selenadiazole derivs. synthesized.  This series of compds. I could served as an excellent scaffold to achieve new and potent antioxidant compds. useful for several diseases, i.e. cancer, neurodegenerative, heart diseases and leishmaniasis, considering the high radical scavenging activity and low toxicity showed by most of the compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwC2K7grhW67Vg90H21EOLACvtfcHk0lhHgo20oJeH2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWqsLzK&md5=11772165f38a8dc0be2a499a7842ab72</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.07.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.07.063%26sid%3Dliteratum%253Aachs%26aulast%3DRuberte%26aufirst%3DA.%2BC.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DEncio%26aufirst%3DI.%26aulast%3DAydillo%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DSanmartin%26aufirst%3DC.%26atitle%3DNovel%2520selenadiazole%2520derivatives%2520as%2520selective%2520antitumor%2520and%2520radical%2520scavenging%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D14%26epage%3D27%26doi%3D10.1016%2Fj.ejmech.2018.07.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uriz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo
Barbosa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreiss, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Gaitano, G.</span></span> <span> </span><span class="NLM_article-title">Activity enhancement of selective antitumoral selenodiazoles formulated with poloxamine micelles</span>. <i>Colloids Surf., B</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/j.colsurfb.2018.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.colsurfb.2018.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29960214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1agt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2018&pages=463-469&author=A.+Urizauthor=C.+Sanmartinauthor=D.+Planoauthor=R.+de+Melo%0ABarbosaauthor=C.+A.+Dreissauthor=G.+Gonzalez-Gaitano&title=Activity+enhancement+of+selective+antitumoral+selenodiazoles+formulated+with+poloxamine+micelles&doi=10.1016%2Fj.colsurfb.2018.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Activity enhancement of selective antitumoral selenodiazoles formulated with poloxamine micelles</span></div><div class="casAuthors">Uriz, Amaia; Sanmartin, Carmen; Plano, Daniel; de Melo Barbosa, Raquel; Dreiss, Cecile A.; Gonzalez-Gaitano, Gustavo</div><div class="citationInfo"><span class="NLM_cas:title">Colloids and Surfaces, B: Biointerfaces</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">CSBBEQ</span>;
        ISSN:<span class="NLM_cas:issn">0927-7765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selenium (Se) incorporated into org. frameworks has demonstrated anticancer activity against several cancer types.  One of the drawbacks of most of these constructs is their poor soly. and bioavailability, which can be overcome with the use of suitable nanocarriers.  We have synthesized a series of 5-substituted amide selenodiazoles, based on the parent structure of ebselen, an organoselenium drug with proven cytoprotective activity, and solubilized them in polymeric micelles of poloxamines, poly(ethylene oxide)-poly(propylene oxide) X-shaped tetrablock-copolymers.  Scattering methods (SANS and DLS) were employed to characterize the micellar nanocarriers.  MTT biol. evaluation highlights the selectivity of the Se-compds. towards cancer cells, with MCF-7 standing as the most responsive line.  The alkylation of the heterocycle with a 12-carbon hydrophobic tail displays the highest activity, showing a 100-fold increase with respect to ebselen.  This compd. also exhibits the greatest increase in soly. in poloxamine micelles, overall resulting in a one-fold increase in activity with respect to the non-formulated form, making it a hit compd. for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplFX2N2-1we7Vg90H21EOLACvtfcHk0lhHgo20oJeH2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1agt7vM&md5=6683d2c6e92475f7cd49edbde62c3c7e</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.colsurfb.2018.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.colsurfb.2018.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DUriz%26aufirst%3DA.%26aulast%3DSanmartin%26aufirst%3DC.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3Dde%2BMelo%2BBarbosa%26aufirst%3DR.%26aulast%3DDreiss%26aufirst%3DC.%2BA.%26aulast%3DGonzalez-Gaitano%26aufirst%3DG.%26atitle%3DActivity%2520enhancement%2520of%2520selective%2520antitumoral%2520selenodiazoles%2520formulated%2520with%2520poloxamine%2520micelles%26jtitle%3DColloids%2520Surf.%252C%2520B%26date%3D2018%26volume%3D170%26spage%3D463%26epage%3D469%26doi%3D10.1016%2Fj.colsurfb.2018.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Microwave-assisted syntheses of benzimidazole-containing selenadiazole derivatives that induce cell-cycle arrest and apoptosis in human breast cancer cells by activation of the ROS/AKT pathway</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2339</span>– <span class="NLM_lpage">2346</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fcmdc.201600261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27677422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKru7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2339-2346&author=Y.+Liangauthor=Y.+Zhouauthor=S.+Dengauthor=T.+Chen&title=Microwave-assisted+syntheses+of+benzimidazole-containing+selenadiazole+derivatives+that+induce+cell-cycle+arrest+and+apoptosis+in+human+breast+cancer+cells+by+activation+of+the+ROS%2FAKT+pathway&doi=10.1002%2Fcmdc.201600261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway</span></div><div class="casAuthors">Liang, Yuanwei; Zhou, Yangliang; Deng, Shulin; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2339-2346</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The use of selenium-contg. heterocyclic compds. as potent cancer chemopreventive and chemotherapeutic agents has been well documented by a large no. of clin. studies.  In this study we developed a new approach to synthesize four benzimidazole-contg. selenadiazole derivs. (BSeDs).  The method uses a combination of peptide coupling reagents and microwave irradn.  This strategy features milder reaction conditions, higher yields, and shorter reaction times.  The synthetic BSeDs were identified as potent antiproliferative agents against the human MCF-7 and MDA-MB-231 breast cancer cell lines.  Compds. 1 b (5-(6-methyl-1H-benzo[d]imidazol-2-yl)benzo[c][1,2,5]selenadiazole), 1 c (5-(6-chloro-1H-benzo[d]imidazol-2-yl)benzo[c][1,2,5]selenadiazole), and 1 d (5-(6-bromo-1H-benzo[d]imidazol-2-yl)benzo[c][1,2,5]selenadiazole) were found to show greater cytotoxicity against the triple-neg. breast cancer cell line MDA-MB-231 than MCF-7, and to exhibit dose-dependent inhibition of cell migration, in which a significant decrease in the zone of cell monolayer wound closure was obsd. relative to untreated controls.  Our results demonstrate that BSeDs can cause cell-cycle arrest and apoptosis in MDA-MB-231 cells by inducing DNA damage, inhibiting protein kinase B (AKT), and activating mitogen-activated protein kinase (MAPK) family members through the overprodn. of reactive oxygen species (ROS).  Taken together, the results of this study provide a facile microwave-assisted strategy for the synthesis of selenium-contg. org. compds. that exhibit a high level of anticancer efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEZt24WnURMbVg90H21EOLACvtfcHk0lhHgo20oJeH2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKru7nF&md5=719c3f5094bdf61791b83f3c399b8942</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600261%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DMicrowave-assisted%2520syntheses%2520of%2520benzimidazole-containing%2520selenadiazole%2520derivatives%2520that%2520induce%2520cell-cycle%2520arrest%2520and%2520apoptosis%2520in%2520human%2520breast%2520cancer%2520cells%2520by%2520activation%2520of%2520the%2520ROS%252FAKT%2520pathway%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2339%26epage%3D2346%26doi%3D10.1002%2Fcmdc.201600261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngai, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, X.</span></span> <span> </span><span class="NLM_article-title">A novel selenadiazole derivative induces apoptosis in human glioma cells by dephosphorylation of AKT</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">994</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1248/cpb.c14-00354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1248%2Fcpb.c14-00354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25273058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFaqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=994-999&author=Y.+Zhangauthor=S.+Zhengauthor=S.+M.+Ngaiauthor=W.+Zhengauthor=J.+Liauthor=T.+Chenauthor=X.+Zhong&title=A+novel+selenadiazole+derivative+induces+apoptosis+in+human+glioma+cells+by+dephosphorylation+of+AKT&doi=10.1248%2Fcpb.c14-00354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">A novel selenadiazole derivative induces apoptosis in human glioma cells by dephosphorylation of AKT</span></div><div class="casAuthors">Zhang, Yikai; Zheng, Shanyuan; Ngai, Sai-Ming; Zheng, Wenjie; Li, Jinying; Chen, Tianfeng; Zhong, Xueyun</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">994-999</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Selenadiazole derivs. are synthetic organoselenium compds. with improved anticancer activity and greater selectivity than inorg. selenium.  In this study, 4-(benzo[c][1,2,5]selenadiazol-6-yl)-benzene-1,2-diamine (BSBD) was shown to induce time- and dose-dependent apoptosis in SWO-38 human glioma cells by accumulation of a sub-G1 cell population, DNA fragmentation, nuclear condensation, caspase activation and poly(ADP-ribose) polymerase (PARP) cleavage.  Further mechanistic investigation showed that BSBD treatment induced dephosphorylation of AKT and DNA damage-mediated activation of p53, leading to extensive apoptosis through the mitochondrial pathway.  Our findings suggest that BSBD represents a potential human glioma therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqsIgbtZKLmrVg90H21EOLACvtfcHk0lg5d2wX1nEkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFaqtQ%253D%253D&md5=559ba4373a7ce6e14f6cd3d8497b2874</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1248%2Fcpb.c14-00354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.c14-00354%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DNgai%26aufirst%3DS.%2BM.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DX.%26atitle%3DA%2520novel%2520selenadiazole%2520derivative%2520induces%2520apoptosis%2520in%2520human%2520glioma%2520cells%2520by%2520dephosphorylation%2520of%2520AKT%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2014%26volume%3D62%26spage%3D994%26epage%3D999%26doi%3D10.1248%2Fcpb.c14-00354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2014.04.151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.bbrc.2014.04.151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=24813998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlOqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2014&pages=88-93&author=Q.+Xieauthor=Y.+Zhouauthor=G.+Lanauthor=L.+Yangauthor=W.+Zhengauthor=Y.+Liangauthor=T.+Chen&title=Sensitization+of+cancer+cells+to+radiation+by+selenadiazole+derivatives+by+regulation+of+ROS-mediated+DNA+damage+and+ERK+and+AKT+pathways&doi=10.1016%2Fj.bbrc.2014.04.151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways</span></div><div class="casAuthors">Xie, Qiang; Zhou, Yangliang; Lan, Guoqiang; Yang, Liye; Zheng, Wenjie; Liang, Yuanwei; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-93</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">X-ray-based radiotherapy represents one of the most effective ways in treating human cancers.  However, radioresistance and side effect remain as the most challenging issue.  This study describes the design and application of novel selenadiazole derivs. as radiotherapy sensitizers to enhance X-ray-induced inhibitory effects on A375 human melanoma and Hela human cervical carcinoma cells.  The results showed that, pretreatment of the cells with selenadiazole derivs. dramatically enhance X-ray-induced growth inhibition and colony formation.  Flow cytometry anal. indicates that the sensitization by selenadiazole derivs. was mainly caused by induction of G2/M cell cycle arrest.  Results of Western blotting demonstrated that the combined treatment-induced A375 cells growth inhibition was achieved by triggering reactive oxygen species-mediated DNA damage involving inactivation of AKT and MAPKs.  Further investigation revealed that selenadiazole deriv. in combination with X-ray could synergistically inhibit the activity of thioredoxin reductase-1 in A375 cells.  Taken together, these results suggest that selenadiazole derivs. can act as novel radiosensitizer with potential application in combating human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkBbOmNXurm7Vg90H21EOLACvtfcHk0lg5d2wX1nEkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlOqsbs%253D&md5=7c23c2becc1d6d13a053d67193324b38</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.04.151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.04.151%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLan%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSensitization%2520of%2520cancer%2520cells%2520to%2520radiation%2520by%2520selenadiazole%2520derivatives%2520by%2520regulation%2520of%2520ROS-mediated%2520DNA%2520damage%2520and%2520ERK%2520and%2520AKT%2520pathways%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D449%26spage%3D88%26epage%3D93%26doi%3D10.1016%2Fj.bbrc.2014.04.151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2014.07.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25036792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GrsL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=335-342&author=Y.+W.+Liangauthor=J.+Zhengauthor=X.+Liauthor=W.+Zhengauthor=T.+Chen&title=Selenadiazole+derivatives+as+potent+thioredoxin+reductase+inhibitors+that+enhance+the+radiosensitivity+of+cancer+cells&doi=10.1016%2Fj.ejmech.2014.07.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells</span></div><div class="casAuthors">Liang, Yuan-Wei; Zheng, Junsheng; Li, Xiaoling; Zheng, Wenjie; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-342</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Thioredoxin system is an attractive target to overcome radioresistance in cancer therapy.  The redox enzyme thioredoxin reductase (TrxR) plays a vital role in restoring cellular thiol redox balance disrupted by radiation-induced reactive oxygens species (ROS) generation and oxidative damage.  In this study, a series of 1,2,5-selenadiazoles have been synthesized and identified as highly effective inhibitors of TrxR to disrupt the intracellular redox balance, and thus significantly enhanced the sensitivity of cancer cells to X-ray.  Upon irradn., 1,2,5-selenadiazoles displayed a marked synergistic inhibitory effect on radioresistant A375 melanoma cell through enhancement of ROS overprodn., and subsequent induction of ROS-promoted apoptotic pathways, which triggered then mitochondrial dysfunction and caspase activation, finally resulting in augment of radiotherapeutic efficacy.  Interestingly, we also found the interaction sites between 1,2,5-selenadiazole and the model peptide of TrxR, which can be confirmed by MALDI-ToF-MS.  These results clearly demonstrate TrxR as a potential target for therapy of radioresistant cancers, and selenadiazole derivs. may be attractive radiosensitizing agent by targeting TrxR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvmxu7zPB8mLVg90H21EOLACvtfcHk0lg5d2wX1nEkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GrsL7K&md5=b91c308e0ad2cf3b3330e4cc47896bc5</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%2BW.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSelenadiazole%2520derivatives%2520as%2520potent%2520thioredoxin%2520reductase%2520inhibitors%2520that%2520enhance%2520the%2520radiosensitivity%2520of%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D335%26epage%3D342%26doi%3D10.1016%2Fj.ejmech.2014.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">642</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1002/asia.201403409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fasia.201403409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25641920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFamsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=642-652&author=Y.+Liuauthor=Y.+Luoauthor=X.+Liauthor=W.+Zhengauthor=T.+Chen&title=Rational+design+of+selenadiazole+derivatives+to+antagonize+hyperglycemia-induced+drug+resistance+in+cancer+cells&doi=10.1002%2Fasia.201403409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells</span></div><div class="casAuthors">Liu, Yuedan; Luo, Yi; Li, Xiaoling; Zheng, Wenjie; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">642-652</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Hyperglycemia is an important factor for chemoresistance of hepatocellular carcinoma patients with diabetes to therapeutics.  In the present study, a series of selenadiazole derivs. have been rationally designed, synthesized, and found be able to antagonize drug resistance in HepG2 cells to doxorubicin (DOX) under simulated diabetes conditions.  Hyperglycemia could promote the cell proliferation through upregulation of ERK and AKT phosphorylation.  However, the synthetic selenadiazole derivs. effectively potentiated the cellular uptake of DOX and enhanced the antiproliferative activity of DOX on HepG2 cells by induction of apoptosis, via regulation of ROS-mediated AMPK activation, inhibition of mTORC1, and an increase in DNA damage.  The selenadiazole derivs. that possess an increased lipophilicity could enhance the cellular uptake and anticancer efficacy of DOX.  Taken together, this study provides a rational design strategy of selenadiazole derivs. to overcome hyperglycemia-induced drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNWSI9eXyrl7Vg90H21EOLACvtfcHk0ljxeK1un6U1rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFamsL0%253D&md5=9d449d10947fb85f30ee56dc456d8ff9</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1002%2Fasia.201403409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201403409%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520selenadiazole%2520derivatives%2520to%2520antagonize%2520hyperglycemia-induced%2520drug%2520resistance%2520in%2520cancer%2520cells%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2015%26volume%3D10%26spage%3D642%26epage%3D652%26doi%3D10.1002%2Fasia.201403409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1039/C7MT00001D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1039%2FC7MT00001D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28374040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslSis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=535-545&author=J.+Zhaoauthor=D.+Zengauthor=Y.+Liuauthor=Y.+Luoauthor=S.+Jiauthor=X.+Liauthor=T.+Chen&title=Selenadiazole+derivatives+antagonize+hyperglycemia-induced+drug+resistance+in+breast+cancer+cells+by+activation+of+AMPK+pathways&doi=10.1039%2FC7MT00001D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways</span></div><div class="casAuthors">Zhao, Jianfu; Zeng, Delong; Liu, Yuedan; Luo, Yi; Ji, Shengbin; Li, Xiaoling; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">535-545</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Hyperglycemia is an important factor for chemoresistance of breast cancer patients with diabetes.  In the present study, a novel selenadiazole deriv. has been evaluated and found to be able to antagonize the doxorubicin (DOX) resistance of MCF-7 cells under simulated diabetes conditions.  Hyperglycemia promotes the proliferation, invasion and migration of MCF-7 cells through activation of ERK and AKT pathways, which could be inhibited by the synthetic selenadiazole deriv.  The antitumor effects of the selenadiazole deriv. were attributed to its ability to activate AMPK pathways.  Furthermore, the high lipophilicity (log P = 1.9) of the synthetic selenadiazole deriv. facilitated its uptake by cancer cells and subsequently potentiated the cellular uptake of DOX, leading to a strong enhancment of the antiproliferative activity of DOX on MCF-7 cells by induction of apoptosis.  The apoptosis was initiated by the ROS overprodn. induced by the cooperation of the selenadiazole deriv. and DOX.  The excessive ROS then caused damage to DNA, which upregulated the expression of proapoptosis Bcl-2 family proteins and led to fragmentation of mitochondria, which finally caused apoptosis of the cancer cells.  Taken together, this study provides a rational strategy for using selenadiazole derivs. to overcome hyperglycemia-induced drug resistance in breast cancer by activation of AMPK-mediated pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNO5YB1OVX-bVg90H21EOLACvtfcHk0ljxeK1un6U1rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslSis7g%253D&md5=9ea8279067984f0b0787d4af28b1c35b</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1039%2FC7MT00001D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MT00001D%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSelenadiazole%2520derivatives%2520antagonize%2520hyperglycemia-induced%2520drug%2520resistance%2520in%2520breast%2520cancer%2520cells%2520by%2520activation%2520of%2520AMPK%2520pathways%26jtitle%3DMetallomics%26date%3D2017%26volume%3D9%26spage%3D535%26epage%3D545%26doi%3D10.1039%2FC7MT00001D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Selenadiazole derivatives inhibit angiogenesis-mediated human breast tumor growth by suppressing the VEGFR2-mediated ERK and AKT signaling pathways</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1447</span>– <span class="NLM_lpage">1457</span>, <span class="refDoi"> DOI: 10.1002/asia.201800110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fasia.201800110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29575811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1agsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1447-1457&author=H.+Laiauthor=X.+Fuauthor=C.+Sangauthor=L.+Houauthor=P.+Fengauthor=X.+Liauthor=T.+Chen&title=Selenadiazole+derivatives+inhibit+angiogenesis-mediated+human+breast+tumor+growth+by+suppressing+the+VEGFR2-mediated+ERK+and+AKT+signaling+pathways&doi=10.1002%2Fasia.201800110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways</span></div><div class="casAuthors">Lai, Haoqiang; Fu, Xiaoyan; Sang, Chengcheng; Hou, Liyuan; Feng, Pengju; Li, Xiaoling; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1447-1457</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selenadiazole derivs. (SeDs) have been found to show promise in chemo-/radiotherapy applications by activating various downstream signaling pathways.  However, the functional role of SeDs on angiogenesis, which is pivotal for tumor progression and metastasis, has not yet been elucidated.  In the present study, the authors have examd. the antiangiogenic activities of SeDs and elucidated their underlying mechanisms.  The results showed that the as-synthesized SeDs not only enhanced their anticancer activities against several human cancer cells but also showed more potent inhibition on human umbilical vein endothelial cells (HUVECs).  The in vitro results suggested that SeDs, esp. 1a (I), dose-dependently inhibited the vascular endothelial growth factor (VEGF)-induced cell migration, invasion, and capillary-like structure formation of HUVECs.  Compd. 1a also significantly suppressed VEGF-induced angiogenesis in a Matrigel plug assay as part of a C57/BL6 mice assay by down regulation of VEGF.  Furthermore, the authors found that 1a significantly inhibited MCF-7 human breast tumor growth in nude mice without severe systematic cytotoxicity.  Compd. 1a was more effective in inhibiting cell proliferation and induced a much more pronounced apoptosis effect in endothelial cells than MCF-7 cells, which implies that endothelial cells might be the primary target of 1a.  Further mechanistic studies on tumor growth inhibition effects and neovessel formation suppression demonstrated that 1a inhibited cell viability of MCF-7 and HUVECs by induction of cell apoptosis, accompanied by poly(ADP ribose)polymerase (PARP) cleavage and caspase activation.  Addnl., the 1a-induced antiangiogenesis effect was achieved by abolishing the VEGF-VEGFR2-ERK/AKT (ERK=extracellular signal-regulated kinases; AKT= protein kinase B) signal axis and enhanced the apoptosis effect by triggering reactive oxygen species (ROS)-mediated DNA damage.  Taken together, these results clearly demonstrate the antiangiogenic potency of SeDs and the underlying mol. mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0YPYFmB0IW7Vg90H21EOLACvtfcHk0ljxeK1un6U1rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1agsr0%253D&md5=3537308039998ce78a0c84b275dfeb4f</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1002%2Fasia.201800110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201800110%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DH.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DSang%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DFeng%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DSelenadiazole%2520derivatives%2520inhibit%2520angiogenesis-mediated%2520human%2520breast%2520tumor%2520growth%2520by%2520suppressing%2520the%2520VEGFR2-mediated%2520ERK%2520and%2520AKT%2520signaling%2520pathways%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2018%26volume%3D13%26spage%3D1447%26epage%3D1457%26doi%3D10.1002%2Fasia.201800110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of cancer-targeted selenadiazole derivative as efficient radiosensitizer for precise cancer therapy</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2039</span>– <span class="NLM_lpage">2049</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00247</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00247" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1KntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=2039-2049&author=D.+Zengauthor=S.+Dengauthor=C.+Sangauthor=J.+Zhaoauthor=T.+Chen&title=Rational+design+of+cancer-targeted+selenadiazole+derivative+as+efficient+radiosensitizer+for+precise+cancer+therapy&doi=10.1021%2Facs.bioconjchem.8b00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Cancer-Targeted Selenadiazole Derivative as Efficient Radiosensitizer for Precise Cancer Therapy</span></div><div class="casAuthors">Zeng, Delong; Deng, Shulin; Sang, Chengcheng; Zhao, Jianfu; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2039-2049</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chem. drug design based on the biochem. characteristics of cancer cells has become an important strategy for discovery of targeted therapies for personalized cancer medicine.  Herein, cancer targeting RGD peptide has been covalently conjugated to selenadiazole deriv. (RGD-SeD) to improve its cancer selectivity.  The RGD decoration significantly enhances the anticancer efficacy of RGD-SeD in αVβ3 integrin-overexpressing HepG2 liver cancer cells but not in normal liver cells.  Cellular uptake assay and fluorescent imaging confirmed the selectivity of RGD-SeD to integrin-overexpressing cancer cells.  RGD-SeD strongly sensitizes HepG2 cells to clin. used X-ray radiotherapy through ROS overprodn., which triggers DNA damage-mediated apoptosis and G2/M cell cycle arrest.  This X-ray-responsive DNA damage activates p53 signaling pathways by phosphorylation of ATM/ATR and γ-H2A.X.  Furthermore, in a HepG2 nude mice xenograft model, the combined treatment of RGD-SeD and X-ray demonstrates potent in vivo antitumor efficacy via induction of apoptotic cell death but shows no toxicity on the functions of major organs.  In summary, this study provides a strategy to design a selenium-based cancer targeting radiosensitizer for precise cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEuh6dC_Rr1LVg90H21EOLACvtfcHk0lg4nj6cpSnL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1KntbY%253D&md5=095da8d983d7543c9519088f833fb9c5</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00247%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DSang%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520cancer-targeted%2520selenadiazole%2520derivative%2520as%2520efficient%2520radiosensitizer%2520for%2520precise%2520cancer%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D2039%26epage%3D2049%26doi%3D10.1021%2Facs.bioconjchem.8b00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span> <span> </span><span class="NLM_article-title">Enhancement of antiangiogenic efficacy of iron(II) complex by selenium substitution</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">987</span>, <span class="refDoi"> DOI: 10.1002/asia.201700272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fasia.201700272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28233940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVCqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=982-987&author=H.+Laiauthor=X.+Zhangauthor=P.+Fengauthor=L.+Xieauthor=J.+Chenauthor=T.+Chen&title=Enhancement+of+antiangiogenic+efficacy+of+iron%28II%29+complex+by+selenium+substitution&doi=10.1002%2Fasia.201700272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of Antiangiogenic Efficacy of Iron(II) complex by Selenium Substitution</span></div><div class="casAuthors">Lai, Haoqiang; Zhang, Xiang; Feng, Pengju; Xie, Lina; Chen, Jinjin; Chen, Tianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">982-987</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Antiangiogenesis therapy is a proven strategy for the treatment of cancers.  Herein, we demonstrate that iron(II) complexes contg. 1,10-phenanthroline(phen) derivs. were capable of suppressing angiogenesis in vitro in a dose-dependent manner.  Interestingly, the introduction of selenium into an iron(II) complex (Fe(phenSe)3(ClO4)2 (phenSe=2-selenoimidazole[4,5-f]1,10-phenanthroline)) could enhance its antiangiogenic efficacy.  Mechanistic studies demonstrated that the complex potently induced endothelial cell apoptosis as evidenced by activation of caspases and PARP cleavage.  The iron(II) complex activated p53-mediated mitochondrial dysfunction as can be seen by the upregulation in the expression of p53 and proapoptotic Bcl-2 family proteins, and downregulation in the expression of Bcl-2 family proteins.  Addnl., the complex inhibited VEGF expression and gave rise to dephosphorylated AKT, which suppressed the transmission of the mitogenic signaling pathway.  Taken together, this study could provide a strategy for the rational design of high-efficacy antivascular agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoppaWtXIixrVg90H21EOLACvtfcHk0lg4nj6cpSnL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVCqt70%253D&md5=da81522311ad974a6ce37e25fade46af</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2Fasia.201700272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201700272%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DEnhancement%2520of%2520antiangiogenic%2520efficacy%2520of%2520iron%2528II%2529%2520complex%2520by%2520selenium%2520substitution%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2017%26volume%3D12%26spage%3D982%26epage%3D987%26doi%3D10.1002%2Fasia.201700272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2014.09.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25233100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOls73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=1-9&author=Q.+Guanauthor=F.+Yangauthor=D.+Guoauthor=J.+Xuauthor=M.+Jiangauthor=C.+Liuauthor=K.+Baoauthor=Y.+Wuauthor=W.+Zhang&title=Synthesis+and+biological+evaluation+of+novel+3%2C4-diaryl-1%2C2%2C5-selenadiazol+analogues+of+combretastatin+A-4&doi=10.1016%2Fj.ejmech.2014.09.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazole analogs of combretastatin A-4</span></div><div class="casAuthors">Guan, Qi; Yang, Fushan; Guo, Dandan; Xu, Jingwen; Jiang, Mingyang; Liu, Chunjiang; Bao, Kai; Wu, Yingliang; Zhang, Weige</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A set of novel selenium-contg. heterocyclic analogs of 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]penol (combretastatin A-4,CA-4) have been designed and synthesized using a rigid 1,2,5-selenadiazole as a linker to fix the cis-orientation of ring-A and ring-B.  All of the target compds. were evaluated for their in vitro antiproliferative activity.  Several compds. exhibited superior potency against different tumor cell lines with IC50 values at the nanomolar level.  Moreover, one compd. significantly induced cell cycle arrest in the G2/M phase, [interphase (cell cycle) G2-phase, mitosis] inhibited tubulin polymn. into microtubules (microtubule-disrupting agents) and caused microtubule destabilization.  A mol. modeling study of one compd. was performed to elucidate its binding mode at the colchicine site in the tubulin dimer and to provide a basis for the further structure-guided design of novel CA-4 analogs.  The synthesis of target compds. was achieved by a reaction of selenium oxide (SeO2) with 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-1,2-ethanedione 1,2-dioxime, 1-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-1,2-ethanedione 1,2-dioxime and similar compds.  The tilte compds. thus formed included 3-(4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole, 3-[4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazol-3-yl]phenol, 2-methoxy-5-[4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazol-3-yl]benzenamine and related substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojVNKvNS-L3LVg90H21EOLACvtfcHk0lg4nj6cpSnL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOls73O&md5=06b3bfbea020ce4c1e1c1796e9a0cb6d</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.046%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%25203%252C4-diaryl-1%252C2%252C5-selenadiazol%2520analogues%2520of%2520combretastatin%2520A-4%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.ejmech.2014.09.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span> <span> </span><span class="NLM_article-title">3-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a novel combretastatin A-4 analog, induces G2/M arrest and apoptosis by disrupting tubulin polymerization in human cervical HeLa cells and fibrosarcoma HT-1080 cells</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2014.12.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.cbi.2014.12.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=25529822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkslWrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2015&pages=7-17&author=D.+Zuoauthor=D.+Guoauthor=X.+Jiangauthor=Q.+Guanauthor=H.+Qiauthor=J.+Xuauthor=Z.+Liauthor=F.+Yangauthor=W.+Zhangauthor=Y.+Wu&title=3-%283-Hydroxy-4-methoxyphenyl%29-4-%283%2C4%2C5-trimethoxyphenyl%29-1%2C2%2C5-selenadiazole+%28G-1103%29%2C+a+novel+combretastatin+A-4+analog%2C+induces+G2%2FM+arrest+and+apoptosis+by+disrupting+tubulin+polymerization+in+human+cervical+HeLa+cells+and+fibrosarcoma+HT-1080+cells&doi=10.1016%2Fj.cbi.2014.12.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">3-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a novel combretastatin A-4 analog, induces G2/M arrest and apoptosis by disrupting tubulin polymerization in human cervical HeLa cells and fibrosarcoma HT-1080 cells</span></div><div class="casAuthors">Zuo, Daiying; Guo, Dandan; Jiang, Xuewei; Guan, Qi; Qi, Huan; Xu, Jingwen; Li, Zengqiang; Yang, Fushan; Zhang, Weige; Wu, Yingliang</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-17</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Microtubule is a popular target for anticancer drugs.  In this study, we describe the effect 3-(3-hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a newly synthesized analog of combretastatin A-4 (CA-4), showing a strong time- and dose-dependent anti-proliferative effect on human cervical cancer HeLa cells and human fibrosarcoma HT-1080 cells.  We demonstrated that the growth inhibitory effects of G-1103 in HeLa and HT-1080 cells were assocd. with microtubule depolymn. and proved that G-1103 acted as microtubule destabilizing agent.  Furthermore, cell cycle anal. revealed that G-1103 treatment resulted in cell cycle arrest at the G2/M phase in a time-dependent manner with subsequent apoptosis induction.  Western blot anal. revealed that down-regulation of cdc25c and up-regulation of cyclin B1 was related with G2/M arrest in HeLa and HT-1080 cells treatment with G-1103.  In addn., G-1103 induced HeLa cell apoptosis by up-regulating cleaved caspase-3, Fas, cleaved caspase-8 expression, which indicated that G-1103 induced HeLa cell apoptosis was mainly assocd. with death receptor pathway.  However, G-1103 induced HT-1080 cell apoptosis by up-regulating cleaved caspase-3, Fas, cleaved caspase-8, Bax and cleaved caspase-9 expression and down-regulating anti-apoptotic protein Bcl-2 expression, which indicated that G-1103 induced HT-1080 cell apoptosis was assocd. with both mitochondrial and death receptor pathway.  Taken together, all the data demonstrated that G-1103 exhibited its antitumor activity through disrupting the microtubule assembly, causing cell cycle arrest and consequently inducing apoptosis in HeLa and HT-1080 cells.  Therefore, the novel compd. G-1103 is a promising microtubule inhibitor that has great potentials for therapeutic treatment of various malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMHS9FN5oZ27Vg90H21EOLACvtfcHk0lg4nj6cpSnL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkslWrtQ%253D%253D&md5=c21eb939d24b4fed952cd52fa1e12d83</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2014.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2014.12.016%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26atitle%3D3-%25283-Hydroxy-4-methoxyphenyl%2529-4-%25283%252C4%252C5-trimethoxyphenyl%2529-1%252C2%252C5-selenadiazole%2520%2528G-1103%2529%252C%2520a%2520novel%2520combretastatin%2520A-4%2520analog%252C%2520induces%2520G2%252FM%2520arrest%2520and%2520apoptosis%2520by%2520disrupting%2520tubulin%2520polymerization%2520in%2520human%2520cervical%2520HeLa%2520cells%2520and%2520fibrosarcoma%2520HT-1080%2520cells%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2015%26volume%3D227%26spage%3D7%26epage%3D17%26doi%3D10.1016%2Fj.cbi.2014.12.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jantova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrvova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milata, V.</span></span> <span> </span><span class="NLM_article-title">Pro-apoptotic effect of new quinolone 7- ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo [3,4-<i>h</i>]quinoline-7-carboxylate on cervical cancer cell line HeLa alone/with UVA irradiation</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2016.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.tiv.2016.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=26916084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslSitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=35-44&author=S.+Jantovaauthor=N.+Mrvovaauthor=R.+Hudecauthor=J.+Sedlakauthor=M.+Panikauthor=V.+Milata&title=Pro-apoptotic+effect+of+new+quinolone+7-+ethyl+9-ethyl-6-oxo-6%2C9-dihydro%5B1%2C2%2C5%5Dselenadiazolo+%5B3%2C4-h%5Dquinoline-7-carboxylate+on+cervical+cancer+cell+line+HeLa+alone%2Fwith+UVA+irradiation&doi=10.1016%2Fj.tiv.2016.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Pro-apoptotic effect of new quinolone 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo [3,4-h]quinoline-7-carboxylate on cervical cancer cell line HeLa alone/with UVA irradiation</span></div><div class="casAuthors">Jantova, Sona; Mrvova, Natasa; Hudec, Roman; Sedlak, Jan; Panik, Miroslav; Milata, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-44</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">7-Et 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo [3,4-h]quinoline-7-carboxylate (E2h) is a new synthetically prepd. quinolone deriv., which in our primary study showed cytotoxic effects towards tumor cells.  The aim of the present study was to examine the antiproliferative and apoptosis inducing activities of E2h towards human cervical cancer cell line HeLa with/without the presence of UVA irradn.  Further, the mol. mechanism involved in E2h-induced apoptosis in HeLa cells was investigated.  Our results showed that both non-photoactivated and photoactivated E2h caused morphol. changes and inhibited the cell growth of HeLa cells in a time- and dose-dependent manner.  Irradn. increased the sensitivity of HeLa cells to E2h.  Quinolone induced S and G2/M arrest and apoptosis in HeLa cells, as characterized by DNA fragmentation and flow cytometry.  In addn., E2h elevated the level of reactive oxygen species and activated caspases 3.  In conclusions, E2h alone/in combination with UVA irradn. induced apoptosis in HeLa cells through the ROS-mitochondrial/caspase 3-dependent pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOHF8LqYqcx7Vg90H21EOLACvtfcHk0ljhBdDG9-QC7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslSitL8%253D&md5=8d6d2eb50bddc2e4b26662f8d16350c5</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2016.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2016.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DJantova%26aufirst%3DS.%26aulast%3DMrvova%26aufirst%3DN.%26aulast%3DHudec%26aufirst%3DR.%26aulast%3DSedlak%26aufirst%3DJ.%26aulast%3DPanik%26aufirst%3DM.%26aulast%3DMilata%26aufirst%3DV.%26atitle%3DPro-apoptotic%2520effect%2520of%2520new%2520quinolone%25207-%2520ethyl%25209-ethyl-6-oxo-6%252C9-dihydro%255B1%252C2%252C5%255Dselenadiazolo%2520%255B3%252C4-h%255Dquinoline-7-carboxylate%2520on%2520cervical%2520cancer%2520cell%2520line%2520HeLa%2520alone%252Fwith%2520UVA%2520irradiation%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2016%26volume%3D33%26spage%3D35%26epage%3D44%26doi%3D10.1016%2Fj.tiv.2016.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jantova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulovicova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulovicova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topolska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milata, V.</span></span> <span> </span><span class="NLM_article-title">Assessment of immunomodulatory activities and in vitro toxicity of new quinolone 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo[3,4-<i>h</i>]quinoline-7-carboxylate</span>. <i>Immunol. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1080/08820139.2017.1280050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1080%2F08820139.2017.1280050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28287857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1WntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=341-360&author=S.+Jantovaauthor=E.+Paulovicovaauthor=L.+Paulovicovaauthor=D.+Topolskaauthor=M.+Panikauthor=V.+Milata&title=Assessment+of+immunomodulatory+activities+and+in+vitro+toxicity+of+new+quinolone+7-ethyl+9-ethyl-6-oxo-6%2C9-dihydro%5B1%2C2%2C5%5Dselenadiazolo%5B3%2C4-h%5Dquinoline-7-carboxylate&doi=10.1080%2F08820139.2017.1280050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of Immunomodulatory Activities and in vitro Toxicity of New Quinolone 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo[3,4-h]quinoline-7-carboxylate</span></div><div class="casAuthors">Jantova, Sona; Paulovicova, Ema; Paulovicova, Lucia; Topolska, Dominika; Panik, Miroslav; Milata, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Investigations</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-360</span>CODEN:
                <span class="NLM_cas:coden">IMINEJ</span>;
        ISSN:<span class="NLM_cas:issn">0882-0139</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Our previous studies on leukemia cells L1210 and cervical cancer HeLa cells revealed cytotoxic effects of the 7-Et 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo[3,4-h]quinoline-7-carboxylate (E2h), a new synthetically prepd. quinolone deriv., toward selected cancer cell lines.  The aim of the present study was to examine the cytotoxicity of E2h toward next cell lines and tissues; i.e., human cancer HL-60 and A549 cells, human non-cancer fibroblast BHNF-1 cells, and reconstructed human epidermis tissues.  Further we investigated the immunomodulatory activity of E2h on murine macrophage RAW 264.7 cells.  Selenadiazoloquinolone E2h induced specific antiproliferative/cytotoxic activity against leukemia HL-60 cells and is the potent inducer of apoptotic cell death.  Quinolone deriv. demonstrated the immunomodulatory activities on RAW 264.7 cell line murine macrophages.  The immunobiol. studies revealed time- and concn.-dependent effective immunomodulation of pro- and anti-inflammatory cytokines' release and antiproliferative/cytotoxic effect following exposure of RAW 264.7 cells to E2h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ1GPV09y7ibVg90H21EOLACvtfcHk0lgswgkEFxE5DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1WntLg%253D&md5=a35a251203c8810a2635d284a4def87d</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1080%2F08820139.2017.1280050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08820139.2017.1280050%26sid%3Dliteratum%253Aachs%26aulast%3DJantova%26aufirst%3DS.%26aulast%3DPaulovicova%26aufirst%3DE.%26aulast%3DPaulovicova%26aufirst%3DL.%26aulast%3DTopolska%26aufirst%3DD.%26aulast%3DPanik%26aufirst%3DM.%26aulast%3DMilata%26aufirst%3DV.%26atitle%3DAssessment%2520of%2520immunomodulatory%2520activities%2520and%2520in%2520vitro%2520toxicity%2520of%2520new%2520quinolone%25207-ethyl%25209-ethyl-6-oxo-6%252C9-dihydro%255B1%252C2%252C5%255Dselenadiazolo%255B3%252C4-h%255Dquinoline-7-carboxylate%26jtitle%3DImmunol.%2520Invest.%26date%3D2017%26volume%3D46%26spage%3D341%26epage%3D360%26doi%3D10.1080%2F08820139.2017.1280050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuFort, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hingorani, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, D. T.</span></span> <span> </span><span class="NLM_article-title">Photostable ratiometric Pdot probe for in vitro and in vivo imaging of hypochlorous acid</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">6911</span>– <span class="NLM_lpage">6918</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b01545</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b01545" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=6911-6918&author=L.+Wuauthor=I.+C.+Wuauthor=C.+C.+DuFortauthor=M.+A.+Carlsonauthor=X.+Wuauthor=L.+Chenauthor=C.+T.+Kuoauthor=Y.+Qinauthor=J.+Yuauthor=S.+R.+Hingoraniauthor=D.+T.+Chiu&title=Photostable+ratiometric+Pdot+probe+for+in+vitro+and+in+vivo+imaging+of+hypochlorous+acid&doi=10.1021%2Fjacs.7b01545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Photostable Ratiometric Pdot Probe for in Vitro and in Vivo Imaging of Hypochlorous Acid</span></div><div class="casAuthors">Wu, Li; Wu, I-Che; DuFort, Christopher C.; Carlson, Markus A.; Wu, Xu; Chen, Lei; Kuo, Chun-Ting; Qin, Yuling; Yu, Jiangbo; Hingorani, Sunil R.; Chiu, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6911-6918</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Developing probes for the detection of reactive oxygen species (ROS), a hallmark of many pathophysiol. process, is imperative to both understanding the precise roles of ROS in many life-threatening diseases and optimizing therapeutic interventions.  The authors herein report an all-in-one fluorescent semiconducting polymer based far-red to near-IR (NIR) Pdot nanoprobe for the ratiometric detection of hypochlorous acid (HOCl).  The fabrication takes the advantage of flexible polymer design by incorporating target-sensitive and target-inert fluorophores into a single conjugated polymer to avoid leakage or differential photobleaching problems existed in other nanoprobes.  The obtained nanoprobe has improved performance in HOCl sensing, such as high brightness, ideal far-red to NIR optical window, excellent photostability, self-referenced ratiometric response, fast response, and high selectivity.  The dual-emission property allows the sensitive imaging of HOCl fluctuations produced in living macrophage cells and peritonitis of living mice with high contrast.  This study not only provides a powerful and promising nanoprobe to be potentially used in the investigations of in situ HOCl status of diseases in living systems but also puts forward the design strategy of a new category of ratiometric fluorescent probes facilitating precise and reliable measurement in biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMlJ1RN6fYsbVg90H21EOLACvtfcHk0lgswgkEFxE5DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSjtr8%253D&md5=ac4e8d0f0f7d462f182879703521c498</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b01545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b01545%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DI.%2BC.%26aulast%3DDuFort%26aufirst%3DC.%2BC.%26aulast%3DCarlson%26aufirst%3DM.%2BA.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DC.%2BT.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DHingorani%26aufirst%3DS.%2BR.%26aulast%3DChiu%26aufirst%3DD.%2BT.%26atitle%3DPhotostable%2520ratiometric%2520Pdot%2520probe%2520for%2520in%2520vitro%2520and%2520in%2520vivo%2520imaging%2520of%2520hypochlorous%2520acid%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D6911%26epage%3D6918%26doi%3D10.1021%2Fjacs.7b01545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuan, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span> <span> </span><span class="NLM_article-title">Molecular engineering of photoacoustic performance by chalcogenide variation in conjugated polymer nanoparticles for brain vascular imaging</span>. <i>Small</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1703732</span>, <span class="refDoi"> DOI: 10.1002/smll.201703732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fsmll.201703732" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=1703732&author=J.+Liuauthor=X.+Caiauthor=H.+C.+Panauthor=A.+Bandlaauthor=C.+K.+Chuanauthor=S.+Wangauthor=N.+Thakorauthor=L.+D.+Liaoauthor=B.+Liu&title=Molecular+engineering+of+photoacoustic+performance+by+chalcogenide+variation+in+conjugated+polymer+nanoparticles+for+brain+vascular+imaging&doi=10.1002%2Fsmll.201703732"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1002%2Fsmll.201703732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsmll.201703732%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%2BC.%26aulast%3DBandla%26aufirst%3DA.%26aulast%3DChuan%26aufirst%3DC.%2BK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DThakor%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DL.%2BD.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520engineering%2520of%2520photoacoustic%2520performance%2520by%2520chalcogenide%2520variation%2520in%2520conjugated%2520polymer%2520nanoparticles%2520for%2520brain%2520vascular%2520imaging%26jtitle%3DSmall%26date%3D2018%26volume%3D14%26spage%3D1703732%26doi%3D10.1002%2Fsmll.201703732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palop, J. A.</span></span> <span> </span><span class="NLM_article-title">Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">9649</span>– <span class="NLM_lpage">9672</span>, <span class="refDoi"> DOI: 10.3390/ijms13089649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fijms13089649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22949823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKlu7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=9649-9672&author=C.+Sanmartinauthor=D.+Planoauthor=A.+K.+Sharmaauthor=J.+A.+Palop&title=Selenium+compounds%2C+apoptosis+and+other+types+of+cell+death%3A+an+overview+for+cancer+therapy&doi=10.3390%2Fijms13089649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy</span></div><div class="casAuthors">Sanmartin, Carmen; Plano, Daniel; Sharma, Arun K.; Palop, Juan Antonio</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9649-9672</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Selenium (Se) is an essential trace element involved in different physiol. functions of the human body and plays a role in cancer prevention and treatment.  Induction of apoptosis is considered an important cellular event that can account for the cancer preventive effects of Se.  The mechanisms of Se-induced apoptosis are assocd. with the chem. forms of Se and their metab. as well as the type of cancer studied.  So, some selenocompounds, such as SeO2 involve the activation of caspase-3 while sodium selenite induces apoptosis in the absence of the activation of caspases.  Modulation of mitochondrial functions has been reported to play a key role in the regulation of apoptosis and also to be one of the targets of Se compds.  Other mechanisms for apoptosis induction are the modulation of glutathione and reactive oxygen species levels, which may function as intracellular messengers to regulate signaling pathways, or the regulation of kinase, among others.  Emerging evidence indicates the overlaps between the apoptosis and other types of cell death such as autophagy.  In this review we report different processes of cell death induced by Se compds. in cancer treatment and prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZGfUVLSWqdbVg90H21EOLACvtfcHk0lgswgkEFxE5DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKlu7zF&md5=277e788dc4a0b22c590c767c80f26150</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.3390%2Fijms13089649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms13089649%26sid%3Dliteratum%253Aachs%26aulast%3DSanmartin%26aufirst%3DC.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DPalop%26aufirst%3DJ.%2BA.%26atitle%3DSelenium%2520compounds%252C%2520apoptosis%2520and%2520other%2520types%2520of%2520cell%2520death%253A%2520an%2520overview%2520for%2520cancer%2520therapy%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2012%26volume%3D13%26spage%3D9649%26epage%3D9672%26doi%3D10.3390%2Fijms13089649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frieben, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span> <span> </span><span class="NLM_article-title">Development of isoselenocyanate compounds’ syntheses and biological applications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5261</span>– <span class="NLM_lpage">5275</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01698</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01698" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFCgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5261-5275&author=E.+E.+Friebenauthor=S.+Aminauthor=A.+K.+Sharma&title=Development+of+isoselenocyanate+compounds%E2%80%99+syntheses+and+biological+applications&doi=10.1021%2Facs.jmedchem.8b01698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Isoselenocyanate Compounds' Syntheses and Biological Applications</span></div><div class="casAuthors">Frieben, Emily E.; Amin, Shantu; Sharma, Arun K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5261-5275</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the no. of cases and cancer-related deaths are projected to rise in upcoming years, it is urgent to find ways to prevent or treat cancer.  As such, food-derived products have gained attention as potential chemopreventive agents due to their availability, safety, and low cost.  Isothiocyanates, the breakdown products of sulfur-contg. glucosinolates in cruciferous vegetables, have shown substantial anticarcinogenic and chemopreventive activities for different human cancers.  Furthermore, organoselenium compds. are known to exhibit chemopreventive and chemotherapeutic activity; moreover, these compds. are more effective anticancer agents than their sulfur isosteres.  Hence, isothiocyanates have been modified to yield isoselenocyanates, which are more cytotoxic toward cancer cells when compared to their corresponding sulfur analogs.  Herein, the synthesis and development of isoselenocyanates as novel treatments for cancer and other diseases are reviewed, highlighting the diverse chem. and computational studies of this class of compds. as well as their pertinent biol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE6UAaxt1BvbVg90H21EOLACvtfcHk0ljegzIVkJgyew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFCgsA%253D%253D&md5=be36d9edbbf4980c4eb01eba5a5ffbfe</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01698%26sid%3Dliteratum%253Aachs%26aulast%3DFrieben%26aufirst%3DE.%2BE.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DDevelopment%2520of%2520isoselenocyanate%2520compounds%25E2%2580%2599%2520syntheses%2520and%2520biological%2520applications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5261%26epage%3D5275%26doi%3D10.1021%2Facs.jmedchem.8b01698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cierpial, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luczak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kielbasinski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielczarek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiktorska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilmonczyk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milczarek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karwowska, K.</span></span> <span> </span><span class="NLM_article-title">Organofluorine isoselenocyanate analogues of sulforaphane: synthesis and anticancer activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2398</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fcmdc.201600442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=27714934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1akt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2398-2409&author=T.+Cierpialauthor=J.+Luczakauthor=M.+Kwiatkowskaauthor=P.+Kielbasinskiauthor=L.+Mielczarekauthor=K.+Wiktorskaauthor=Z.+Chilmonczykauthor=M.+Milczarekauthor=K.+Karwowska&title=Organofluorine+isoselenocyanate+analogues+of+sulforaphane%3A+synthesis+and+anticancer+activity&doi=10.1002%2Fcmdc.201600442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Organofluorine Isoselenocyanate Analogues of Sulforaphane: Synthesis and Anticancer Activity</span></div><div class="casAuthors">Cierpial, Tomasz; Luczak, Jerzy; Kwiatkowska, Malgorzata; Kielbasinski, Piotr; Mielczarek, Lidia; Wiktorska, Katarzyna; Chilmonczyk, Zdzislaw; Milczarek, Malgorzata; Karwowska, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2398-2409</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of previously unknown sulforaphane analogs with organofluorine substituents bonded to the sulfinyl sulfur atom, an isoselenocyanate moiety in place of the isothiocyanate group, the central sulfur atom in various oxidn. states, and different nos. of methylene groups in the central alkyl chain were synthesized and fully characterized.  All new compds. were tested for their biol. properties in vitro and demonstrated much higher anticancer activity against two breast cancer cell lines than that shown by native sulforaphane; at the same time, the compds. were less toxic for normal cells.  The influence of the particular structural changes in the mols. on the cytotoxicity is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdPkG-lRLOgrVg90H21EOLACvtfcHk0ljegzIVkJgyew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1akt7vJ&md5=9fd1f917d7e370d1679115aac1defb0a</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600442%26sid%3Dliteratum%253Aachs%26aulast%3DCierpial%26aufirst%3DT.%26aulast%3DLuczak%26aufirst%3DJ.%26aulast%3DKwiatkowska%26aufirst%3DM.%26aulast%3DKielbasinski%26aufirst%3DP.%26aulast%3DMielczarek%26aufirst%3DL.%26aulast%3DWiktorska%26aufirst%3DK.%26aulast%3DChilmonczyk%26aufirst%3DZ.%26aulast%3DMilczarek%26aufirst%3DM.%26aulast%3DKarwowska%26aufirst%3DK.%26atitle%3DOrganofluorine%2520isoselenocyanate%2520analogues%2520of%2520sulforaphane%253A%2520synthesis%2520and%2520anticancer%2520activity%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2398%26epage%3D2409%26doi%3D10.1002%2Fcmdc.201600442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emmert, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bayoumy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aliaga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richie, J. P.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Induction of lung glutathione and glutamylcysteine ligase by 1,4-phenylenebis(methylene)selenocyanate and its glutathione conjugate: role of nuclear factor-erythroid 2-related factor 2</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2064</span>– <span class="NLM_lpage">2071</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2012.03.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.freeradbiomed.2012.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22542796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVaqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=2064-2071&author=S.+W.+Emmertauthor=K.+El-Bayoumyauthor=A.+Dasauthor=Y.+W.+Sunauthor=S.+Aminauthor=D.+Desaiauthor=C.+Aliagaauthor=J.+P.+Richie&title=Induction+of+lung+glutathione+and+glutamylcysteine+ligase+by+1%2C4-phenylenebis%28methylene%29selenocyanate+and+its+glutathione+conjugate%3A+role+of+nuclear+factor-erythroid+2-related+factor+2&doi=10.1016%2Fj.freeradbiomed.2012.03.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of lung glutathione and glutamylcysteine ligase by 1,4-phenylenebis(methylene)selenocyanate and its glutathione conjugate: Role of nuclear factor-erythroid 2-related factor 2</span></div><div class="casAuthors">Emmert, Sans W.; El-Bayoumy, Karam; Das, Arunangshu; Sun, Yuan-Wan; Amin, Shantu; Desai, Dhimant; Aliaga, Cesar; Richie, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2064-2071</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthetic organoselenium agent 1,4-phenylenebis(methylene)selenocyanate (p-XSC) and its glutathione (GSH) conjugate (p-XSeSG) are potent chemopreventive agents in several preclin. models.  P-XSC is also an effective inducer of GSH in mouse lung.  Our objectives were to test the hypothesis that GSH induction by p-XSC occurs through upregulation of the rate-limiting GSH biosynthetic enzyme glutamylcysteine ligase (GCL), through activation of antioxidant response elements (AREs) in GCL genes via activation of nuclear factor-erythroid 2-related factor 2 (Nrf2).  P-XSC feeding (10 ppm Se) increased GSH (230%) and upregulated the catalytic subunit of GCL (GCLc) (55%), extracellular-related kinase (220%), and nuclear Nrf2 (610%) in lung but not liver after 14 days in the rat (P<0.05).  Similarly, p-XSeSG feeding (10 ppm) induced lung GCLc (88%) and GSH (200%) (P<0.05), whereas the naturally occurring selenomethionine had no effect.  Both p-XSC and p-XSeSG activated a luciferase reporter in HepG2 ARE-reporter cells up to threefold for p-XSC and greater than or equal to fivefold for p-XSeSG.  Luciferase activation by p-XSeSG was assocd. with enhanced levels of GSH, GCLc, and nuclear Nrf2, which were significantly reduced by co-incubation with short interfering RNA targeting Nrf2.  The dependence of GCL induction on Nrf2 was confirmed in Nrf2-deficient mouse embryonic fibroblasts, in which p-XSeSG induced GCL subunits in wild-type but not in Nrf2-deficient cells (P<0.05).  These results indicate that p-XSC may act through the Nrf2 pathway in vivo and that p-XSeSG is the putative metabolite responsible for such activation, thus offering p-XSeSG as a less toxic, yet highly efficacious, inducer of GSH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnWrg31BJnLrVg90H21EOLACvtfcHk0ljegzIVkJgyew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVaqsL4%253D&md5=aadeafa393240603c16384e876b3afb4</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2012.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2012.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DEmmert%26aufirst%3DS.%2BW.%26aulast%3DEl-Bayoumy%26aufirst%3DK.%26aulast%3DDas%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DY.%2BW.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DAliaga%26aufirst%3DC.%26aulast%3DRichie%26aufirst%3DJ.%2BP.%26atitle%3DInduction%2520of%2520lung%2520glutathione%2520and%2520glutamylcysteine%2520ligase%2520by%25201%252C4-phenylenebis%2528methylene%2529selenocyanate%2520and%2520its%2520glutathione%2520conjugate%253A%2520role%2520of%2520nuclear%2520factor-erythroid%25202-related%2520factor%25202%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D2064%26epage%3D2071%26doi%3D10.1016%2Fj.freeradbiomed.2012.03.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prigol, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchese, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jesse, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, C. W.</span></span> <span> </span><span class="NLM_article-title">Protective effect of diphenyl diselenide on ischemia and reperfusion-induced cerebral injury: involvement of oxidative stress and pro-inflammatory cytokines</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2249</span>– <span class="NLM_lpage">2258</span>, <span class="refDoi"> DOI: 10.1007/s11064-012-0853-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1007%2Fs11064-012-0853-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22846969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A280%3ADC%252BC38fkt1Sltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=2249-2258&author=C.+A.+Bruningauthor=M.+Prigolauthor=C.+Lucheseauthor=C.+R.+Jesseauthor=M.+M.+Duarteauthor=S.+S.+Romanauthor=C.+W.+Nogueira&title=Protective+effect+of+diphenyl+diselenide+on+ischemia+and+reperfusion-induced+cerebral+injury%3A+involvement+of+oxidative+stress+and+pro-inflammatory+cytokines&doi=10.1007%2Fs11064-012-0853-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effect of diphenyl diselenide on ischemia and reperfusion-induced cerebral injury: involvement of oxidative stress and pro-inflammatory cytokines</span></div><div class="casAuthors">Bruning Cesar A; Prigol Marina; Luchese Cristiane; Jesse Cristiano R; Duarte Marta M M F; Roman Silvane S; Nogueira Cristina W</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2249-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cerebrovascular diseases, including ischemic stroke, are associated with high mortality worldwide.  Oxidative stress and inflammation are important pathophysiological mechanisms involved in post-ischemic cerebral injury.  The present study was designed to investigate the potential protective effect of diphenyl diselenide (PhSe)(2), an organoselenium compound with antioxidant and anti-inflammatory properties, against ischemia/reperfusion (I/R) insult in rat brain.  The experimental model adopted was that of surgically-induced brain ischemia, performed by means of bilateral common carotid artery occlusion in rats.  The effect of a single oral dose of (PhSe)(2) (50 mg/kg), administered 30 min before the onset of ischemia, was investigated by assessing cerebral oxidative stress-related biochemical parameters and pro-inflammatory cytokines in plasma of rats.  The results demonstrated an increase in the levels of malondialdehyde (MDA), reactive oxygen species (ROS) and nitrate/nitrite as well as the alteration in the non-enzymatic and enzymatic (catalase and superoxide dismutase) antioxidant defense system induced by I/R insult in rat brain.  I/R insult increased the levels of IL-1β, IL-6, TNF-α and INF-γ in plasma of rats.  The administration of (PhSe)(2) restored cerebral levels of MDA, ROS, nitrate/nitrite and antioxidant defenses of rats exposed to I/R insult. (PhSe)(2) markedly reduced pro-inflammatory cytokines in plasma of I/R rats.  I/R insult increased the plasma levels of tissue damage markers, such as creatine kinase and α-1-acid glycoprotein.  Pretreatment with (PhSe)(2) was effective in reducing the levels of these proteins.  In addition, (PhSe)(2) attenuated cerebral histological alterations induced by I/R.  This study showed for the first time the in vivo protective effect of (PhSe)(2) against oxidative stress and pro-inflammatory cytokines-induced by I/R insult in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRo6b5OB-IAVuvW160gIxP_fW6udTcc2eatCm9r3LF79Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fkt1Sltw%253D%253D&md5=f72dc300a9ccd14b7ec70804f0a78509</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs11064-012-0853-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-012-0853-7%26sid%3Dliteratum%253Aachs%26aulast%3DBruning%26aufirst%3DC.%2BA.%26aulast%3DPrigol%26aufirst%3DM.%26aulast%3DLuchese%26aufirst%3DC.%26aulast%3DJesse%26aufirst%3DC.%2BR.%26aulast%3DDuarte%26aufirst%3DM.%2BM.%26aulast%3DRoman%26aufirst%3DS.%2BS.%26aulast%3DNogueira%26aufirst%3DC.%2BW.%26atitle%3DProtective%2520effect%2520of%2520diphenyl%2520diselenide%2520on%2520ischemia%2520and%2520reperfusion-induced%2520cerebral%2520injury%253A%2520involvement%2520of%2520oxidative%2520stress%2520and%2520pro-inflammatory%2520cytokines%26jtitle%3DNeurochem.%2520Res.%26date%3D2012%26volume%3D37%26spage%3D2249%26epage%3D2258%26doi%3D10.1007%2Fs11064-012-0853-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karelia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pramanik, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span> <span> </span><span class="NLM_article-title">Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1055</span>– <span class="NLM_lpage">1066</span>, <span class="refDoi"> DOI: 10.1002/mc.22825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1002%2Fmc.22825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=29668110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosl2gu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1055-1066&author=W.+Wuauthor=D.+Kareliaauthor=K.+Pramanikauthor=S.+G.+Aminauthor=A.+K.+Sharmaauthor=C.+Jiangauthor=J.+Lu&title=Phenylbutyl+isoselenocyanate+induces+reactive+oxygen+species+to+inhibit+androgen+receptor+and+to+initiate+p53-mediated+apoptosis+in+LNCaP+prostate+cancer+cells&doi=10.1002%2Fmc.22825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells</span></div><div class="casAuthors">Wu, Wei; Karelia, Deepkamal; Pramanik, Kartick; Amin, Shantu G.; Sharma, Arun K.; Jiang, Cheng; Lu, Junxuan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1055-1066</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Previous studies have established the in vivo bioavailability and efficacious dosages of phenylbutyl isoselenocyanate (ISC-4), a selenium-substituted isothiocyanate, against mouse xenograft models of human melanoma and colorectal cancer.  To explore its potential attributes against prostate cancer, we treated human LNCaP prostate cancer cells with ISC-4 and examd. their apoptosis responses, and interrogated the signaling mechanisms through pharmacol. and siRNA knockdown approaches.  Our results show that ISC-4 was more potent at inducing apoptosis than its sulfur analog phenylbutyl isothiocyanate (PBITC) without suppressing protein kinase AKT Ser473 phosphorylation.  ISC-4 induced apoptosis in concn.- and time-dependent manners, and the apoptosis execution was attenuated by pre-incubation with a pan caspase inhibitor.  ISC-4 decreased the abundance of androgen receptor (AR) and its best known target prostate specific antigen (PSA) without decreasing their steady state mRNA.  ISC-4 upregulated the abundance of p53 protein and its Ser15-phosphorylative activation, and that of DNA double strand break marker Ser139-p-H2A.  X coincident with apoptotic exposure.  Similar to the rapid induction of reactive oxygen species (ROS) by isothiocyanates, ISC-4 increased dihydroethidium-detectable signals in LNCaP cells.  Pre-incubation with ROS scavenger N-acetyl-L-cysteine preserved AR and PSA abundance, markedly reduced ISC-4-induced apoptosis and attenuated p53 Ser phosphorylation, p21Cip1, and p-H2A.  X. Furthermore, siRNA knockdown of p53 did not suppress ROS prodn., but decreased ISC-4-induced apoptosis.  Knocking down p53-targets PUMA and Bax exerted greater protective effect on ISC-4-induced apoptosis than depleting p21Cip1.  In summary, ISC-4 inhibited LNCaP cell growth and survival with ROS-mediated suppression of AR axis signaling and induction of p53-PUMA-Bax mitochondrial apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVaedDX25U4LVg90H21EOLACvtfcHk0liIGPXNSHx5hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosl2gu70%253D&md5=7b3546cc90969d2daad1164e70f983ac</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1002%2Fmc.22825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.22825%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DKarelia%26aufirst%3DD.%26aulast%3DPramanik%26aufirst%3DK.%26aulast%3DAmin%26aufirst%3DS.%2BG.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DJ.%26atitle%3DPhenylbutyl%2520isoselenocyanate%2520induces%2520reactive%2520oxygen%2520species%2520to%2520inhibit%2520androgen%2520receptor%2520and%2520to%2520initiate%2520p53-mediated%2520apoptosis%2520in%2520LNCaP%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Carcinog.%26date%3D2018%26volume%3D57%26spage%3D1055%26epage%3D1066%26doi%3D10.1002%2Fmc.22825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhunapantula, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosca, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. P.</span></span> <span> </span><span class="NLM_article-title">Targeting Akt3 signaling in malignant melanoma using isoselenocyanates</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1674</span>– <span class="NLM_lpage">1685</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-2214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1158%2F1078-0432.CCR-08-2214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=19208796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVWrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1674-1685&author=A.+Sharmaauthor=A.+K.+Sharmaauthor=S.+V.+Madhunapantulaauthor=D.+Desaiauthor=S.+J.+Huhauthor=P.+Moscaauthor=S.+Aminauthor=G.+P.+Robertson&title=Targeting+Akt3+signaling+in+malignant+melanoma+using+isoselenocyanates&doi=10.1158%2F1078-0432.CCR-08-2214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates</span></div><div class="casAuthors">Sharma, Arati; Sharma, Arun K.; Madhunapantula, SubbaRao V.; Desai, Dhimant; Huh, Sung Jin; Mosca, Paul; Amin, Shantu; Robertson, Gavin P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1674-1685</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Melanoma is the most invasive and deadly form of skin cancer.  Few agents are available for treating advanced disease to enable long-term patient survival, which is driving the search for new compds. inhibiting deregulated pathways causing melanoma.  Akt3 is an important target in melanomas because its activity is increased in ∼70% of tumors, decreasing apoptosis in order to promote tumorigenesis.  Exptl. Design: Because naturally occurring products can be effective anticancer agents, a library was screened to identify Akt3 pathway inhibitors.  Isothiocyanates were identified as candidates, but low potency requiring high concns. for therapeutic efficacy made them unsuitable.  Therefore, more potent analogs called isoselenocyanates were created using the isothiocyanate backbone but increasing the alkyl chain length and replacing sulfur with selenium.  Efficacy was measured on cultured cells and tumors by quantifying proliferation, apoptosis, toxicity, and Akt3 pathway inhibition.  RESULTS: Isoselenocyanates significantly decreased Akt3 signaling in cultured melanoma cells and tumors.  Compds. having 4 to 6 carbon alkyl side chains with selenium substituted for sulfur, called ISC-4 and ISC-6, resp., decreased tumor development by ∼60% compared with the corresponding isothiocyanates, which had no effect.  No changes in animal body wt. or in blood parameters indicative of liver-, kidney-, or cardiac-related toxicity were obsd. with isoselenocyanates.  Mechanistically, isoselenocyanates ISC-4 and ISC-6 decreased melanoma tumorigenesis by causing an ∼3-fold increase in apoptosis.  CONCLUSIONS: Synthetic isoselenocyanates are therapeutically effective for inhibiting melanoma tumor development by targeting Akt3 signaling to increase apoptosis in melanoma cells with negligible assocd. systemic toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwC9CIxZd0srVg90H21EOLACvtfcHk0liIGPXNSHx5hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVWrsrc%253D&md5=51dc90931aaab784c9fdb93fcd3df05d</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-2214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-2214%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DMadhunapantula%26aufirst%3DS.%2BV.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DHuh%26aufirst%3DS.%2BJ.%26aulast%3DMosca%26aufirst%3DP.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DRobertson%26aufirst%3DG.%2BP.%26atitle%3DTargeting%2520Akt3%2520signaling%2520in%2520malignant%2520melanoma%2520using%2520isoselenocyanates%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D1674%26epage%3D1685%26doi%3D10.1158%2F1078-0432.CCR-08-2214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Rubio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrea, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena Guerrero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sesma Herrero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamboa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguewa, P. A.</span></span> <span> </span><span class="NLM_article-title">Leishmanicidal activity of isoselenocyanate derivatives</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">e00904-18</span>, <span class="refDoi"> DOI: 10.1128/AAC.00904-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1128%2FAAC.00904-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=30478164" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2019&pages=e00904-18&author=C.+Fernandez-Rubioauthor=E.+Larreaauthor=J.+Pena+Guerreroauthor=E.+Sesma+Herreroauthor=I.+Gamboaauthor=C.+Berrioauthor=D.+Planoauthor=S.+Aminauthor=A.+K.+Sharmaauthor=P.+A.+Nguewa&title=Leishmanicidal+activity+of+isoselenocyanate+derivatives&doi=10.1128%2FAAC.00904-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1128%2FAAC.00904-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00904-18%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Rubio%26aufirst%3DC.%26aulast%3DLarrea%26aufirst%3DE.%26aulast%3DPena%2BGuerrero%26aufirst%3DJ.%26aulast%3DSesma%2BHerrero%26aufirst%3DE.%26aulast%3DGamboa%26aufirst%3DI.%26aulast%3DBerrio%26aufirst%3DC.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26aulast%3DNguewa%26aufirst%3DP.%2BA.%26atitle%3DLeishmanicidal%2520activity%2520of%2520isoselenocyanate%2520derivatives%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2019%26volume%3D63%26spage%3De00904-18%26doi%3D10.1128%2FAAC.00904-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karelia, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sk, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowda, A. S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramisetti, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and identification of a novel napthalamide-isoselenocyanate compound NISC-6 as a dual topoisomerase-IIalpha and AKT pathway inhibitor, and evaluation of its anti-melanoma activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">282</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.1016%2Fj.ejmech.2017.04.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=28458134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFWks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=282-295&author=D.+N.+Kareliaauthor=U.+H.+Skauthor=P.+Singhauthor=A.+S.+P.+Gowdaauthor=M.+K.+Pandeyauthor=S.+R.+Ramisettiauthor=S.+Aminauthor=A.+K.+Sharma&title=Design%2C+synthesis%2C+and+identification+of+a+novel+napthalamide-isoselenocyanate+compound+NISC-6+as+a+dual+topoisomerase-IIalpha+and+AKT+pathway+inhibitor%2C+and+evaluation+of+its+anti-melanoma+activity&doi=10.1016%2Fj.ejmech.2017.04.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and identification of a novel naphthalamide-isoselenocyanate compound NISC-6 as a dual Topoisomerase-IIα and Akt pathway inhibitor, and evaluation of its anti-melanoma activity</span></div><div class="casAuthors">Karelia, Deepkamal N.; Sk, Ugir Hossain; Singh, Parvesh; Gowda, A. S. Prakasha; Pandey, Manoj K.; Ramisetti, Srinivasa R.; Amin, Shantu; Sharma, Arun K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">282-295</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Naphthalimidylalkyl isoselenocyanates such as I and naphthalimidylethyl isoselenoureas were prepd. as dual Akt and topoisomerase IIα inhibitors for use as antitumor agents in the treatment of melanoma with either wild-type or mutant BRAF.  The naphthalimidylalkyl isoselenocyanates were more effective in inhibiting cancer cell viability than the naphthalimidylethyl isoselenoureas.  I was identified as the most cytotoxic compd. in both BRAFV600E mutated and BRAFWT cells, and its selectivity for cancer cells over noncancerous human cells was detd.  I docked strongly into the binding sites of Akt1 and human topoisomerase IIα (Topo-IIα); I inhibited both Akt and topoisomerase IIα activities dose-dependently in vitro.  I induced apoptosis in human melanoma cells and inhibited tumor growth by ∼69% in a melanoma mouse xenograft model; its mol. wt., nos. of hydrogen bond acceptors and donors, total polar surface area, and lipophilicity were calcd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoytXX5btAY0bVg90H21EOLACvtfcHk0lg8p7biF6jGZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFWks7o%253D&md5=d0e56970248ba501e6caac8e003c829c</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.052%26sid%3Dliteratum%253Aachs%26aulast%3DKarelia%26aufirst%3DD.%2BN.%26aulast%3DSk%26aufirst%3DU.%2BH.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DGowda%26aufirst%3DA.%2BS.%2BP.%26aulast%3DPandey%26aufirst%3DM.%2BK.%26aulast%3DRamisetti%26aufirst%3DS.%2BR.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520identification%2520of%2520a%2520novel%2520napthalamide-isoselenocyanate%2520compound%2520NISC-6%2520as%2520a%2520dual%2520topoisomerase-IIalpha%2520and%2520AKT%2520pathway%2520inhibitor%252C%2520and%2520evaluation%2520of%2520its%2520anti-melanoma%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D282%26epage%3D295%26doi%3D10.1016%2Fj.ejmech.2017.04.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karelia, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spallholz, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A. K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel selenium (Se-NSAID) molecules as anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1946</span>– <span class="NLM_lpage">1959</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01503</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01503" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFCiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1946-1959&author=D.+Planoauthor=D.+N.+Kareliaauthor=M.+K.+Pandeyauthor=J.+E.+Spallholzauthor=S.+Aminauthor=A.+K.+Sharma&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+selenium+%28Se-NSAID%29+molecules+as+anticancer+agents&doi=10.1021%2Facs.jmedchem.5b01503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents</span></div><div class="casAuthors">Plano, Daniel; Karelia, Deepkamal N.; Pandey, Manoj K.; Spallholz, Julian E.; Amin, Shantu; Sharma, Arun K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1946-1959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and anticancer evaluation of novel selenium-nonsteroidal anti-inflammatory drug (Se-NSAID) hybrid mols. are reported.  The Se-aspirin analog I was identified as the most effective agent in reducing the viability of different cancer cell lines, particularly colorectal cancer (CRC) cells, was more selective toward cancer cells than normal cells, and was >10 times more potent than 5-FU, the current therapy for CRC.  Compd. I inhibits CRC growth via the inhibition of the cell cycle in G1 and G2/M phases and reduces the cell cycle markers like cyclin E1 and B1 in a dose dependent manner; the inhibition of the cell cycle may be dependent on the ability of I to induce p21 expression.  Furthermore, I induces apoptosis by activating caspase 3/7 and PARP cleavage, and its longer exposure causes increase in intracellular ROS levels in CRC cells.  Taken together, I has the potential to be developed further as a chemotherapeutic agent for CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpR85CRRLLIlrVg90H21EOLACvtfcHk0lg8p7biF6jGZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFCiuw%253D%253D&md5=220f9f5ca563e6e84b0e34fc64306744</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01503%26sid%3Dliteratum%253Aachs%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DKarelia%26aufirst%3DD.%2BN.%26aulast%3DPandey%26aufirst%3DM.%2BK.%26aulast%3DSpallholz%26aufirst%3DJ.%2BE.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%2BK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520selenium%2520%2528Se-NSAID%2529%2520molecules%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1946%26epage%3D1959%26doi%3D10.1021%2Facs.jmedchem.5b01503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tagaram, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rountree, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staveley-O’Carroll, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimchi, E. T.</span></span> <span> </span><span class="NLM_article-title">A selenium containing inhibitor for the treatment of hepatocellular cancer</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.3390/ph9020018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.3390%2Fph9020018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvFyrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=18&author=H.+R.+Tagaramauthor=D.+Desaiauthor=G.+Liauthor=D.+Liuauthor=C.+B.+Rountreeauthor=K.+Gowdaauthor=A.+Bergauthor=S.+Aminauthor=K.+F.+Staveley-O%E2%80%99Carrollauthor=E.+T.+Kimchi&title=A+selenium+containing+inhibitor+for+the+treatment+of+hepatocellular+cancer&doi=10.3390%2Fph9020018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">A selenium containing inhibitor for the treatment of hepatocellular cancer</span></div><div class="casAuthors">Tagaram, Hephzibah Rani S.; Desai, Dhimant; Li, Guangfu; Liu, Dai; Bart, Rountree C.; Gowda, Kavitha; Berg, Arthur; Amin, Shantu; Staveley-O'Carroll, Kevin F.; Kimchi, Eric T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">18/1-18/14</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world.  New treatment strategies are desperately needed due to limited std. therapies.  Activation of the Erk, Akt, and STAT3pathways is implicated in the prognosis of HCC.  The Se,Se'-1,4-phenylenebis(1,2- ethanediyl) bisisoselenourea (PBISe), is a selenium-contg. MAPK and PI3 kinase inhibitor, effectively inhibit tumorigenesis in a variety of exptl. models.  The aim of our study is to demonstrate the potential role of PBISe in the treatment of HCC.  The anti-proliferative and pro-apoptotic ability of PBISe is studied in vitro in four human HCC cell lines and in vivo in a spontaneous murine HCC model.  Inhibition of cancer growth was performed by cell viability assay and apoptosis by caspase 3/7, PARP cleavage, annexin-V, and TUNEL assays.  Role of PBISe on PI3 kinase, MAPK and STAT3 signaling is detd. by Western blotting.  In vivo effects of PBISe on tumor sizes were monitored using MRI in a spontaneous murine HCC.  Liver tissues from the PBISe-treated mice are analyzed for angiogenesis, proliferation, and signaling pathway markers.  Overall, PBISe activated caspase-3/7 and increased DNA fragmentation, which is pos. correlated with the increased PARP cleavage.  PBISe promoted apoptosis by inhibiting PI3K, MAPK, and STAT3 signaling with significant redn. in the tumor sizes (p < 0.007).  PBISe-treated tumors reduced survival marker PCNA, and angiogenesis markers Vegf-A, Vegf-R3 and CD34.  These results demonstrate the chemotherapeutic effects of PBISe, by inhibiting tumor growth and facilitating tumor apoptosis for HCC treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTIQdOtgKAHbVg90H21EOLACvtfcHk0lg8p7biF6jGZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvFyrtg%253D%253D&md5=53271f9971d467dfe8e5e1ca023c1d40</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.3390%2Fph9020018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph9020018%26sid%3Dliteratum%253Aachs%26aulast%3DTagaram%26aufirst%3DH.%2BR.%26aulast%3DDesai%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DRountree%26aufirst%3DC.%2BB.%26aulast%3DGowda%26aufirst%3DK.%26aulast%3DBerg%26aufirst%3DA.%26aulast%3DAmin%26aufirst%3DS.%26aulast%3DStaveley-O%25E2%2580%2599Carroll%26aufirst%3DK.%2BF.%26aulast%3DKimchi%26aufirst%3DE.%2BT.%26atitle%3DA%2520selenium%2520containing%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatocellular%2520cancer%26jtitle%3DPharmaceuticals%26date%3D2016%26volume%3D9%26spage%3D18%26doi%3D10.3390%2Fph9020018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agliano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguewa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redrado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Zubeldia, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palop, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo, A.</span></span> <span> </span><span class="NLM_article-title">The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3031</span>– <span class="NLM_lpage">3043</span>, <span class="refDoi"> DOI: 10.2174/092986712800672076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=10.2174%2F092986712800672076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=22455594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFertr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3031-3043&author=E.+Ibanezauthor=A.+Aglianoauthor=C.+Priorauthor=P.+Nguewaauthor=M.+Redradoauthor=I.+Gonzalez-Zubeldiaauthor=D.+Planoauthor=J.+A.+Palopauthor=C.+Sanmartinauthor=A.+Calvo&title=The+quinoline+imidoselenocarbamate+EI201+blocks+the+AKT%2FmTOR+pathway+and+targets+cancer+stem+cells+leading+to+a+strong+antitumor+activity&doi=10.2174%2F092986712800672076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity</span></div><div class="casAuthors">Ibanez, E.; Agliano, A.; Prior, C.; Nguewa, P.; Redrado, M.; Gonzalez-Zubeldia, I.; Plano, D.; Palop, J. A.; Sanmartin, C.; Calvo, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3031-3043</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Methylimidoselenocarbamates have previously proven to display potent antitumor activities.  In the present study we show that these compds. act as multikinase inhibitors.  We found that the most effective compd., quinoline imidoselenocarbamate EI201, inhibits the PI3K/AKT/mTOR pathway, which is persistently activated and contributes to malignant progression in various cancers.  EI201 blocked the phosphorylation of AKT, mTOR and several of its downstream regulators (p70S6K and 4E-BP1) and ERK1/2 in PC-3, HT-29 and MCF-7 cells in vitro, inducing both autophagy and apoptosis.  EI201 also contributes to the loss of maintenance of the selfrenewal and tumorigenic capacity of cancer stem cells (CSCs).  0.1 μMol/L EI201 triggered a redn. in size and no. of tumorspheres in PC-3, HT-29 and MCF-7 cells and 4 μmol/L induced the elimination of almost all the tumorspheres in the three studied cell lines.  In addn., EI201 suppressed almost 80% prostate tumor growth in vivo (p < 0.01) compared to controls at a relatively low dose (10 mg/kg) in a mouse xenograft model.  There was a significant decrease in the s.c. primary tumor [18F]-FDG uptake (76.5% redn., p < 0.05) and in the total tumor burden (76.8% redn., p < 0.05) after EI201 treatment compared to vehicle control, without causing toxicity in mice.  Taken together, our results support further development of EI201 as a novel multi-kinase inhibitor that may be useful against cancers with aberrant upregulation of PI3K/AKT and MAPK signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5jsfLcw3MmbVg90H21EOLACvtfcHk0lhkfMSmJzAaBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFertr8%253D&md5=b3c6a3983ea9e8508d4a6459dba3ba35</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.2174%2F092986712800672076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712800672076%26sid%3Dliteratum%253Aachs%26aulast%3DIbanez%26aufirst%3DE.%26aulast%3DAgliano%26aufirst%3DA.%26aulast%3DPrior%26aufirst%3DC.%26aulast%3DNguewa%26aufirst%3DP.%26aulast%3DRedrado%26aufirst%3DM.%26aulast%3DGonzalez-Zubeldia%26aufirst%3DI.%26aulast%3DPlano%26aufirst%3DD.%26aulast%3DPalop%26aufirst%3DJ.%2BA.%26aulast%3DSanmartin%26aufirst%3DC.%26aulast%3DCalvo%26aufirst%3DA.%26atitle%3DThe%2520quinoline%2520imidoselenocarbamate%2520EI201%2520blocks%2520the%2520AKT%252FmTOR%2520pathway%2520and%2520targets%2520cancer%2520stem%2520cells%2520leading%2520to%2520a%2520strong%2520antitumor%2520activity%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3031%26epage%3D3043%26doi%3D10.2174%2F092986712800672076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Targeting the thioredoxin system as a strategy for cancer therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7309</span>– <span class="NLM_lpage">7321</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvFSjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7309-7321&author=M.+Bianauthor=R.+Fanauthor=S.+Zhaoauthor=W.+Liu&title=Targeting+the+thioredoxin+system+as+a+strategy+for+cancer+therapy&doi=10.1021%2Facs.jmedchem.8b01595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the thioredoxin system as a strategy for cancer therapy</span></div><div class="casAuthors">Bian, Mianli; Fan, Rong; Zhao, Sai; Liu, Wukun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7309-7321</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Thioredoxin reductase (TrxR) participates in the regulation of redox reactions in organisms.  It works mainly via its substrate mol., thioredoxin, to maintain the redox balance and regulate signal transduction, which controls cell proliferation, differentiation, death, and other important physiol. processes.  In recent years, increasing evidence has shown that the overactivation of TrxR is related to the development of tumors.  The exploration of TrxR-targeted antitumor drugs has attracted wide attention and is expected to provide new therapies for cancer treatment.  In this perspective, we highlight the specific relationship between TrxR and apoptotic signaling pathways.  The cytoplasm and mitochondria both contain TrxR, resulting in the activation of apoptosis.  TrxR activity influences reactive oxygen species (ROS) and further regulates the inflammatory signaling pathway.  In addn., we discuss representative TrxR inhibitors with anticancer activity and analyze the challenges in developing TrxR inhibitors as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOsl-4Fp0n4rVg90H21EOLACvtfcHk0lhkfMSmJzAaBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvFSjt7s%253D&md5=95309462c2e2d52137f8f637fe5a1948</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01595%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DTargeting%2520the%2520thioredoxin%2520system%2520as%2520a%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7309%26epage%3D7321%26doi%3D10.1021%2Facs.jmedchem.8b01595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01152&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01152%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01152" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b30023aabd1b7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
